Citrus Sinensis ID: 022853

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-
Protein Sequence
MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVRS
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEcccccEEEEEEEEccccEEEEEEEcHHHHHHHHHHHHHHHHHHHHHHccccEEEEEEEEEEccccEEEEEEEcccHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccEEccccccccccccccEcccccccccccccccccccccccccccccccccEEEEcccccEEcccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccHHHEEEEEEEEEEccEEEEEEEEccccEEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEc
Coil and Loop (DISEMBL)
mvssqlsslngdcagkpflnqlllprgppdalssdyvefdfsdvfgpapvqasieVGGEISyanelvydqpavihsrshslvgpssyvsqslklSKLTLHEAEdslglvegineetqegpnnlSVVDAalgkptghidnlpsenqcvgledfEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSErniltkvdhpfIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLhangimhrdlkpenilldadghvrs
Flexible Loop (DISEMBL)
mvssqlsslngdcAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGafakvyqvrrigtseiyamkvmRKDKIMEKNHAEYMKSerniltkvdhpfIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANgimhrdlkpenilldadghvrs
Low Complexity Region (SEG)
MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVRS
Disordered region (IsUnstruct)
****************PFLNQLLLPR****ALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSR****************************************************L****GHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL********
Disordered Region (DISOPRED)
***********************************YVEFDFSDVFGPAPV**********SYANELVYDQPAVIHSRSHSLVGPSSYVSQ************************************************************DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV**
Disordered Region (DISEMBL)
*********NGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHS***************LKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVRS
Disordered Region (DISPRO)
**************GKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG**********************************CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD**V**
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVRS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	291	2.2.26 [Sep-21-2011]
Q39030	471	Serine/threonine-protein	yes	no	0.948	0.585	0.655	1e-101
P42818	465	Serine/threonine-protein	no	no	0.931	0.582	0.626	1e-87
P28178	479	Protein kinase 2 OS=Dicty	yes	no	0.498	0.302	0.565	5e-45
P54644	444	RAC family serine/threoni	no	no	0.512	0.335	0.543	2e-43
P12688	680	Serine/threonine-protein	yes	no	0.742	0.317	0.393	2e-42
P18961	677	Serine/threonine-protein	no	no	0.742	0.319	0.385	4e-39
Q8MYF1	456	Probable serine/threonine	no	no	0.491	0.313	0.489	1e-38
P11792	824	Serine/threonine-protein	no	no	0.487	0.172	0.524	4e-38
Q8R4U9	367	Serine/threonine-protein	yes	no	0.542	0.430	0.496	6e-38
Q9QZS5	367	Serine/threonine-protein	yes	no	0.542	0.430	0.496	7e-38

>sp|Q39030|KPK2_ARATH Serine/threonine-protein kinase AtPK2/AtPK19 OS=Arabidopsis thaliana GN=ATPK2 PE=1 SV=2

 Score =  367 bits (943), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 190/290 (65%), Positives = 218/290 (75%), Gaps = 14/290 (4%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MVSSQ S  N +  GKPF   L L   PP ++  D +E  FSDVFGP P   S E     
Sbjct: 1   MVSSQCSVANKNQTGKPFQKHLSLSISPPKSVLGDNLELQFSDVFGPMPEANSEE----- 55

Query: 61  SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
             A ++ YD+PAV++SRSHSLVGPS  VS SLK++KLTL E EDS+ LVE +  E+ +  
Sbjct: 56  --ACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETEDSVDLVECVEGESIKEN 113

Query: 121 NNLSVVDAALGKPTGHIDNLPSE-NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYA 179
           +  S      G      +  P E +  VG+EDFEVLKVVGQGAF KVYQVR+  TSEIYA
Sbjct: 114 DEFS------GNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKKDTSEIYA 167

Query: 180 MKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF 239
           MKVMRKDKI+EKNHAEYMK+ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFF
Sbjct: 168 MKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFF 227

Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           QLY QGLFREDLAR+YTAEIVSAVSHLH  GIMHRDLKPENIL+D DGHV
Sbjct: 228 QLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDVDGHV 277

Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P42818|KPK1_ARATH Serine/threonine-protein kinase AtPK1/AtPK6 OS=Arabidopsis thaliana GN=ATPK1 PE=1 SV=1

 Score =  323 bits (827), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 181/289 (62%), Positives = 213/289 (73%), Gaps = 18/289 (6%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MVSSQ    N          Q  L   P +++  D VE +FSDVFGP P +A        
Sbjct: 1   MVSSQRPVPN------KIQKQQYLSISPSNSVLKDDVELEFSDVFGPLPEEA-------- 46

Query: 61  SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
              N++ YD+PAV++SRSHSLVGP S  S SLKL+KLTL E EDS+ LVE +  E+ +  
Sbjct: 47  ---NDIAYDEPAVVYSRSHSLVGPCSLDSHSLKLTKLTLLETEDSIDLVECLEGESLKEN 103

Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           ++ S  D +  +     D L   +  VG++DFEV+KVVG+GAF KVYQVR+  TSEIYAM
Sbjct: 104 DDFSGNDDSDNEKALEGD-LVKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSEIYAM 162

Query: 181 KVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ 240
           KVMRKD IMEKNHAEYMK+ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFFQ
Sbjct: 163 KVMRKDHIMEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQ 222

Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           LY QGLFREDLAR+YTAEIVSAVSHLH  GIMHRDLKPENIL+D DGHV
Sbjct: 223 LYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDTDGHV 271

Downstream effector of TOR signaling pathway involved in osmotic stress response. Could be involved in the control of plant growth and development. Phosphorylates the ribosomal proteins P14, P16 and S6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28178|PK2_DICDI Protein kinase 2 OS=Dictyostelium discoideum GN=pkgB PE=1 SV=2

 Score =  181 bits (459), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 82/145 (56%), Positives = 108/145 (74%)

Query: 145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           Q    +DFE+L V+G+G+F KV QV++ G  +I+AMKV+RKD I+ +    + KSE+ IL
Sbjct: 146 QSATKDDFELLNVIGKGSFGKVMQVKKKGEDKIFAMKVLRKDAIIARKQVNHTKSEKTIL 205

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
             + HPFIV L Y+FQTK +LY+VLDFVNGG LFF L R+G F E   +IY AEIVSA+ 
Sbjct: 206 QCISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIVSALD 265

Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           HLH   I++RDLKPENILLD++GH+
Sbjct: 266 HLHKQDIVYRDLKPENILLDSEGHI 290

Required for morphogenesis during multicellular development. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P54644|KRAC_DICDI RAC family serine/threonine-protein kinase homolog OS=Dictyostelium discoideum GN=pkbA PE=1 SV=1

 Score =  176 bits (445), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 81/149 (54%), Positives = 111/149 (74%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P +++ VG+ DFE+L +VG+G+F KV QVR+  T E+YAMKV+ K  I+E N  E+  SE
Sbjct: 109 PKKSEKVGVADFELLNLVGKGSFGKVIQVRKKDTGEVYAMKVLSKKHIVEHNEVEHTLSE 168

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           RNIL K++HPF+V L YSFQT+ +LY +LD+VNGG LF+ L +   F ED  R Y AEIV
Sbjct: 169 RNILQKINHPFLVNLNYSFQTEDKLYFILDYVNGGELFYHLQKDKKFTEDRVRYYGAEIV 228

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHV 289
            A+ HLH +G+++RDLKPEN+LL  +GH+
Sbjct: 229 LALEHLHLSGVIYRDLKPENLLLTNEGHI 257

Predominantly involved during the aggregation to control cell polarity and chemotaxis. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P12688|YPK1_YEAST Serine/threonine-protein kinase YPK1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=YPK1 PE=1 SV=2

 Score =  172 bits (436), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/231 (39%), Positives = 138/231 (59%), Gaps = 15/231 (6%)

Query: 74  IHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLS--------- 124
           + +R  S++ PS    Q + L    L    D +   + I+ ++   P NLS         
Sbjct: 254 VFARIPSILLPSKTWQQEMGLQDEKLQTIFDKINSNQDIHLDSFHLPINLSFDSAASIRL 313

Query: 125 ------VVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY 178
                  +D  LGK    ID  PS N+ + ++DF++LKV+G+G+F KV QVR+  T ++Y
Sbjct: 314 YNHHWITLDNGLGKINISIDYKPSRNKPLSIDDFDLLKVIGKGSFGKVMQVRKKDTQKVY 373

Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF 238
           A+K +RK  I+ K+   +  +ER +L +VD PFIV L++SFQ+  +LY VL F+NGG LF
Sbjct: 374 ALKAIRKSYIVSKSEVTHTLAERTVLARVDCPFIVPLKFSFQSPEKLYFVLAFINGGELF 433

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           + L ++G F    AR YTAE++ A+ +LH   +++RDLKPENILLD  GH+
Sbjct: 434 YHLQKEGRFDLSRARFYTAELLCALDNLHKLDVVYRDLKPENILLDYQGHI 484

Plays an essential role in the proliferation of yeast cells. Involved in a signaling pathway, required for optimal cell wall integrity, that acts in parallel with the PKC1-SLT2-dependent pathway. Downstream kinase in the sphingolipid-mediated signaling pathway. Its phosphorylation is regulated by the intracellular sphingolipid concentration. Cooperates with SLI1 in mediating resistance to the sphingolipid biosynthesis inhibitor drug myriocin (ISP-1). Its kinase activity is essential for the resistance. Required for both receptor-mediated and fluid-phase endocytosis, but is not necessary for receptor phosphorylation or ubiquitination. Necessary for the internalization of plasma membrane proteins carrying different types of internalization signals. Acts downstream of the PKH kinases to control endocytosis by phosphorylating components of the endocytic machinery. Phosphorylation of residue Thr-504 in the activation loop is essential for activity. phosphorylates and down-regulates flippase activator FPK1.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P18961|YPK2_YEAST Serine/threonine-protein kinase YPK2/YKR2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=YPK2 PE=1 SV=1

 Score =  161 bits (408), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 89/231 (38%), Positives = 134/231 (58%), Gaps = 15/231 (6%)

Query: 74  IHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAA---- 129
           + +R  SL+ PS    Q +      L E    +   + I+ ++   P NL +  AA    
Sbjct: 251 VFARIPSLLLPSKNWQQEIGEQDEVLKEILKKINTNQDIHLDSFHLPLNLKIDSAAQIRL 310

Query: 130 -----------LGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY 178
                       GK    +D  PS+N+ + ++DF++LKV+G+G+F KV QVR+  T +IY
Sbjct: 311 YNHHWISLERGYGKLNITVDYKPSKNKPLSIDDFDLLKVIGKGSFGKVMQVRKKDTQKIY 370

Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF 238
           A+K +RK  I+ K    +  +ER +L +VD PFIV L++SFQ+  +LYLVL F+NGG LF
Sbjct: 371 ALKALRKAYIVSKCEVTHTLAERTVLARVDCPFIVPLKFSFQSPEKLYLVLAFINGGELF 430

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           + L  +G F    +R Y AE++ A+  LH   +++RDLKPENILLD  GH+
Sbjct: 431 YHLQHEGRFSLARSRFYIAELLCALDSLHKLDVIYRDLKPENILLDYQGHI 481

May act as a downstream kinase in the sphingolipid-mediated signaling pathway. Plays an essential role in the proliferation of yeast cells. Involved in a signaling pathway, required for optimal cell wall integrity, that acts in parallel with the PKC1-SLT2-dependent pathway. A substrate of TOR complex 2 (TORC2) and required for TORC2 to regulate spatial aspects of cell growth. Phosphorylation of residue Thr-501 is indispensable for function.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8MYF1|Y2070_DICDI Probable serine/threonine-protein kinase DDB_G0277449 OS=Dictyostelium discoideum GN=DDB_G0277449 PE=3 SV=1

 Score =  160 bits (404), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 70/143 (48%), Positives = 102/143 (71%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + L +F +  +VG+G F KV+QV  + T ++YA+KV++K+ I+ K       +E++IL K
Sbjct: 123 INLSNFIIKHLVGKGGFGKVFQVVHVDTQKVYALKVIKKNHIIAKKSVVNTLAEKDILKK 182

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           + HPFIV L Y+FQ + +LYLV+DFVNGG LF+ L ++ +F ED  R Y AE++ A+ HL
Sbjct: 183 ISHPFIVNLHYAFQNEKKLYLVMDFVNGGQLFYHLQKEAIFSEDQVRFYMAELILALEHL 242

Query: 267 HANGIMHRDLKPENILLDADGHV 289
           H + I+HRDLKPENILLD+ GH 
Sbjct: 243 HDSNIVHRDLKPENILLDSQGHC 265

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P11792|SCH9_YEAST Serine/threonine-protein kinase SCH9 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=SCH9 PE=1 SV=3

 Score =  158 bits (400), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 76/145 (52%), Positives = 104/145 (71%), Gaps = 3/145 (2%)

Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           G +DFEVL+++G+G F +VYQV++  T  IYAMKV+ K  I++KN   +   ERNIL   
Sbjct: 408 GPQDFEVLRLLGKGTFGQVYQVKKKDTQRIYAMKVLSKKVIVKKNEIAHTIGERNILVTT 467

Query: 208 ---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
                PFIV L++SFQT   LYLV D+++GG LF+ L ++G F ED A+ Y AE+V A+ 
Sbjct: 468 ASKSSPFIVGLKFSFQTPTDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALE 527

Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           HLH N I++RDLKPENILLDA+G++
Sbjct: 528 HLHDNDIVYRDLKPENILLDANGNI 552

Protein kinase that is part of growth control pathway which is at least partially redundant with the cAMP pathway. Regulates both BCY1 phosphorylation and MPK1 activity.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8R4U9|SGK2_RAT Serine/threonine-protein kinase Sgk2 OS=Rattus norvegicus GN=Sgk2 PE=1 SV=2

 Score =  157 bits (398), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 79/159 (49%), Positives = 106/159 (66%), Gaps = 1/159 (0%)

Query: 132 KPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK 191
           +  G+I+  PS N      DF+ LKV+G+G + KV   +R      YA+KV++K  I++ 
Sbjct: 15  RANGNINLGPSANPNARPTDFDFLKVIGKGNYGKVLLAKRKSDGAFYAVKVLQKKSILKN 74

Query: 192 NHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
               ++ +ERN+L K V HPF+V LRYSFQT  +LY VLD+VNGG LFF L R+  F E 
Sbjct: 75  KEQSHIMAERNVLLKNVRHPFLVGLRYSFQTPEKLYFVLDYVNGGELFFHLQREHRFLEP 134

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
            AR YTAE+ SA+ +LH+  I++RDLKPENILLD  GHV
Sbjct: 135 RARFYTAEVASAIGYLHSLNIIYRDLKPENILLDCQGHV 173

Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, survival and proliferation. Up-regulates Na(+) channels: SCNN1A/ENAC, K(+) channels: KCNA3/Kv1.3, KCNE1 and KCNQ1, amino acid transporter: SLC6A19, glutamate transporter: SLC1A6/EAAT4, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9QZS5|SGK2_MOUSE Serine/threonine-protein kinase Sgk2 OS=Mus musculus GN=Sgk2 PE=1 SV=1

 Score =  157 bits (398), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 79/159 (49%), Positives = 106/159 (66%), Gaps = 1/159 (0%)

Query: 132 KPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK 191
           +  G+I+  PS N      DF+ LKV+G+G + KV   +R      YA+KV++K  I++ 
Sbjct: 15  RANGNINLGPSANPNARPTDFDFLKVIGKGNYGKVLLAKRKSDGAFYAVKVLQKKSILKN 74

Query: 192 NHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
               ++ +ERN+L K V HPF+V LRYSFQT  +LY VLD+VNGG LFF L R+  F E 
Sbjct: 75  KEQNHIMAERNVLLKNVRHPFLVGLRYSFQTPEKLYFVLDYVNGGELFFHLQRERRFLEP 134

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
            AR YTAE+ SA+ +LH+  I++RDLKPENILLD  GHV
Sbjct: 135 RARFYTAEVASAIGYLHSLNIIYRDLKPENILLDCQGHV 173

Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, survival and proliferation. Up-regulates Na(+) channels: SCNN1A/ENAC, K(+) channels: KCNA3/Kv1.3, KCNE1 and KCNQ1, amino acid transporter: SLC6A19, glutamate transporter: SLC1A6/EAAT4, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	291
356532147	479	PREDICTED: serine/threonine-protein kina	0.972	0.590	0.689	1e-107
255575604	481	ribosomal protein S6 kinase, putative [R	0.958	0.580	0.691	1e-106
225439717	489	PREDICTED: serine/threonine-protein kina	0.993	0.591	0.675	1e-104
115452853	480	Os03g0334000 [Oryza sativa Japonica Grou	0.955	0.579	0.659	1e-103
326524133	481	predicted protein [Hordeum vulgare subsp	0.962	0.582	0.644	1e-102
224139384	475	predicted protein [Populus trichocarpa]	0.958	0.587	0.665	1e-102
363806700	479	uncharacterized protein LOC100805922 [Gl	0.972	0.590	0.668	1e-102
356551817	472	PREDICTED: serine/threonine-protein kina	0.951	0.586	0.642	1e-101
357112350	481	PREDICTED: serine/threonine-protein kina	0.958	0.580	0.643	1e-100
242046942	486	hypothetical protein SORBIDRAFT_02g04307	0.962	0.576	0.651	1e-100

>gi|356532147|ref|XP_003534635.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Glycine max]

 Score =  393 bits (1009), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 202/293 (68%), Positives = 231/293 (78%), Gaps = 10/293 (3%)

Query: 1   MVSSQLSSLNGDCAG-KPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQAS---IEV 56
           MVSSQ S L    AG KP   QLL P   PD ++++++E DFSDVFGP  V  +      
Sbjct: 1   MVSSQFSGLT--MAGYKPAQTQLLFPANLPDTVNTEHIELDFSDVFGPVTVDLNNIDSTT 58

Query: 57  GGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEET 116
           G  +   NELVYD P VI++RSHSLVGPS+ VSQSLKL KLT+HE EDSL LV+ +N ET
Sbjct: 59  GEPLEEVNELVYDDPPVIYTRSHSLVGPSTCVSQSLKLGKLTIHETEDSLELVDHVNGET 118

Query: 117 QEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE 176
            +   + S VD +L    G++  +    Q V +EDFE+LKVVGQGAFAKVYQVR+ GTSE
Sbjct: 119 IKDIKDSSFVDKSLKDEDGNLKKI----QRVSIEDFEILKVVGQGAFAKVYQVRKKGTSE 174

Query: 177 IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH 236
           IYAMKVMRKDKIMEKNHAEYMK+ER+I TK++HPF+VQLRYSFQTKYRLYLVLDFVNGGH
Sbjct: 175 IYAMKVMRKDKIMEKNHAEYMKAERDIWTKIEHPFVVQLRYSFQTKYRLYLVLDFVNGGH 234

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           LFFQLY QGLFREDLARIYTAEIV AVSHLH+NGIMHRDLKPENILLDADGHV
Sbjct: 235 LFFQLYHQGLFREDLARIYTAEIVCAVSHLHSNGIMHRDLKPENILLDADGHV 287

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255575604|ref|XP_002528702.1| ribosomal protein S6 kinase, putative [Ricinus communis] gi|223531874|gb|EEF33691.1| ribosomal protein S6 kinase, putative [Ricinus communis]

 Score =  389 bits (999), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 206/298 (69%), Positives = 233/298 (78%), Gaps = 19/298 (6%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPP--DALSSDYVEFDFSDVFGPAPVQASIEVG- 57
           MVSSQ S L+     KPF +QLL    PP  DAL SD VE DF+DVFGP PVQ S EV  
Sbjct: 1   MVSSQFSELSKAHMCKPFRSQLLFTENPPPPDALVSD-VELDFADVFGPLPVQTSTEVNS 59

Query: 58  GEISY------ANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG 111
           G+++         EL+YD P VIH+RSHSLVGPSS+VS SLKL+KLTLHE EDS+ L+E 
Sbjct: 60  GDLANPLSGADVTELIYDDPVVIHNRSHSLVGPSSFVSHSLKLNKLTLHETEDSMELLE- 118

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
           ++E + +  N+    D   G      D L  E + VG+EDFEVLKVVGQGAF KVYQV++
Sbjct: 119 LDESSLDDDNSEKATDDVSG------DAL--EVRSVGIEDFEVLKVVGQGAFGKVYQVKK 170

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
            GTSEIYAMKVMRKDKI+EKNH EYMK+ER+ILTKVDHPFIVQL+YSFQTKYRLYL+LDF
Sbjct: 171 KGTSEIYAMKVMRKDKIVEKNHVEYMKAERDILTKVDHPFIVQLKYSFQTKYRLYLILDF 230

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           +NGGHLFFQLY QGLFREDLARIY AEIVSAV HLHANGIMHRDLKPENILLDADGHV
Sbjct: 231 INGGHLFFQLYHQGLFREDLARIYAAEIVSAVCHLHANGIMHRDLKPENILLDADGHV 288

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225439717|ref|XP_002273012.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Vitis vinifera]

 Score =  383 bits (984), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 200/296 (67%), Positives = 224/296 (75%), Gaps = 7/296 (2%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEV---- 56
           MV S +  L      KP  NQLL P  P D +  D+VE DF+DVFGP PVQ   E+    
Sbjct: 1   MVFSDVPGLTKTRMCKPIQNQLLFPMNPTDIVPLDHVELDFADVFGPLPVQTPSEMNPGD 60

Query: 57  -GGEISYA--NELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGIN 113
            G  +S A  N+L+Y  P VI+SRSHSLVGPS+ +SQSLKLSKL LHE EDS  LVE ++
Sbjct: 61  SGDSVSAADTNDLIYGDPVVIYSRSHSLVGPSTCLSQSLKLSKLALHEIEDSEELVECLH 120

Query: 114 EETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG 173
           EE  +     S  D    K    ID+  +  + VGLEDFEV+K+VGQGAF KV+QVR+  
Sbjct: 121 EEAVKELQRTSSSDDISEKSFEDIDSDSTTVETVGLEDFEVMKLVGQGAFGKVFQVRKRN 180

Query: 174 TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN 233
           TSEIYAMKVMRKDKIMEK+HAEYMK+ER+ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN
Sbjct: 181 TSEIYAMKVMRKDKIMEKDHAEYMKAERDILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN 240

Query: 234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           GGHLFFQLY  GLFREDLARIY AEIVSAVSHLHANGIMHRDLKPENILLDADGH 
Sbjct: 241 GGHLFFQLYNHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLDADGHA 296

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115452853|ref|NP_001050027.1| Os03g0334000 [Oryza sativa Japonica Group] gi|108707998|gb|ABF95793.1| Serine/threonine-protein kinase AtPK19, putative, expressed [Oryza sativa Japonica Group] gi|113548498|dbj|BAF11941.1| Os03g0334000 [Oryza sativa Japonica Group] gi|125586157|gb|EAZ26821.1| hypothetical protein OsJ_10738 [Oryza sativa Japonica Group] gi|215704239|dbj|BAG93079.1| unnamed protein product [Oryza sativa Japonica Group] gi|215769106|dbj|BAH01335.1| unnamed protein product [Oryza sativa Japonica Group]

 Score =  382 bits (981), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 196/297 (65%), Positives = 232/297 (78%), Gaps = 19/297 (6%)

Query: 1   MVSSQLSSLNGDCAGKP--FLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVG- 57
           MVSS++SS+    A  P  F  ++LLP GPPD + S+ VEFDFSDVFGP  VQ   ++  
Sbjct: 1   MVSSEISSVTTTHAQGPKLFRGKILLPMGPPDVVPSENVEFDFSDVFGPTAVQTPTDLSI 60

Query: 58  ------GEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG 111
                   ++ ++E +Y+ P VI  RSHSLVGPSS VSQSL LSKLTLHE++ +L L+E 
Sbjct: 61  LTPDSPAPLTESSEGIYNDPLVIVKRSHSLVGPSSLVSQSLPLSKLTLHESDSALDLLEC 120

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
             E+     N  ++ D  L       D+  +EN  VGL+DFEVLK+VGQGAF KV+QVR+
Sbjct: 121 TKEKKS---NQEALSDEEL-------DDTKNENGVVGLDDFEVLKLVGQGAFGKVFQVRK 170

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
            GTSEIYAMKVMRKDKI+EKNHAEYMK+ER+ILTKVDHPF+VQLRYSFQTKYRLYLVLDF
Sbjct: 171 KGTSEIYAMKVMRKDKILEKNHAEYMKAERDILTKVDHPFVVQLRYSFQTKYRLYLVLDF 230

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
           +NGGHLFFQLY+QGLFRE+LARIYTAEIVSAV+HLHANGIMHRDLKPENILLDADGH
Sbjct: 231 INGGHLFFQLYQQGLFREELARIYTAEIVSAVAHLHANGIMHRDLKPENILLDADGH 287

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326524133|dbj|BAJ97077.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  377 bits (969), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 192/298 (64%), Positives = 227/298 (76%), Gaps = 18/298 (6%)

Query: 1   MVSSQLSSLNGDCAGKP--FLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVG- 57
           MVSS++ S+      +P  F   +LLP+GPPD +  + VEFDF+DVFG   V    EV  
Sbjct: 1   MVSSEMPSVTTAHTQRPKLFTGMILLPKGPPDVVLPENVEFDFNDVFGATAVHTPTEVSI 60

Query: 58  ------GEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG 111
                   ++ +NE VY+ P VI  RSHSLVGP+S VSQSL LSKLTLHE+E SL L+E 
Sbjct: 61  LTPGSPAPLAESNEEVYNDPVVITKRSHSLVGPTSLVSQSLPLSKLTLHESESSLDLLEC 120

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
           +++E +     L+            ++N   EN+ VGL+DFE+LK+VGQGAF KVYQVRR
Sbjct: 121 LSKEKKSEQGGLN---------DEELNNTTKENEAVGLDDFELLKLVGQGAFGKVYQVRR 171

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
             TSEIYAMKVMRKDKI+EKNHAEYMK+ER+ILTKVDHPF+VQLRYSFQTKYRLYLVLDF
Sbjct: 172 KCTSEIYAMKVMRKDKILEKNHAEYMKAERDILTKVDHPFVVQLRYSFQTKYRLYLVLDF 231

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           VNGGHLFFQLY+QGLFRE+LAR+YTAEIVSAV+HLHANGIMHRDLKPENILLDA GH 
Sbjct: 232 VNGGHLFFQLYQQGLFREELARLYTAEIVSAVAHLHANGIMHRDLKPENILLDAHGHA 289

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139384|ref|XP_002323086.1| predicted protein [Populus trichocarpa] gi|222867716|gb|EEF04847.1| predicted protein [Populus trichocarpa]

 Score =  376 bits (966), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 193/290 (66%), Positives = 220/290 (75%), Gaps = 11/290 (3%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MVSSQL  L          N+LL P  P D + SD+VE DF+DVFGP P    +  G  +
Sbjct: 1   MVSSQLPGLTK--------NRLLFPVNPSDTVVSDHVELDFTDVFGPLP-SIDVNCGDPL 51

Query: 61  SYAN--ELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQE 118
           S  +  EL+YD P V+H+RSHSLVGPSSYVSQSLKLSKL L E EDSL LVE + +ET +
Sbjct: 52  SVGDGSELIYDDPVVVHNRSHSLVGPSSYVSQSLKLSKLNLQETEDSLELVECVLDETIK 111

Query: 119 GPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY 178
                 + D A+ K    +    S+ Q VG+EDFEVLKVVGQGAF KVYQVR+ GT EIY
Sbjct: 112 ELEESFIDDDAVEKDMEDVSGDTSKVQTVGIEDFEVLKVVGQGAFGKVYQVRKKGTPEIY 171

Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF 238
           AMKVMRKD+I+EKNH EYM+ ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLF
Sbjct: 172 AMKVMRKDRIVEKNHVEYMRGERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLF 231

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
           FQLY  GLFREDLA IY AEI SAVSHLHANGIMHRDLKPENILLD+DGH
Sbjct: 232 FQLYNHGLFREDLACIYAAEIASAVSHLHANGIMHRDLKPENILLDSDGH 281

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363806700|ref|NP_001242011.1| uncharacterized protein LOC100805922 [Glycine max] gi|255636025|gb|ACU18357.1| unknown [Glycine max]

 Score =  376 bits (965), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 196/293 (66%), Positives = 225/293 (76%), Gaps = 10/293 (3%)

Query: 1   MVSSQLSSLNGDCAG-KPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQAS---IEV 56
           MVSSQ S+     AG KP   QLL P    D ++++++E DFSDVFGP  +  +      
Sbjct: 1   MVSSQFSAFT--LAGYKPSQTQLLFPAKLVDTVNTEHIELDFSDVFGPVTLDLNNIDSTT 58

Query: 57  GGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEET 116
              +   NELVYD P VI++RSHSLVGPS+ VSQSLK  KLT+HE EDSL LVE +N E 
Sbjct: 59  SEPMEEVNELVYDDPPVIYTRSHSLVGPSTCVSQSLKFGKLTIHETEDSLELVEHVNGEA 118

Query: 117 QEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE 176
            +     S V+ +L    G++  +      V ++DFE+LKVVGQGAFAKVYQVR+ GTSE
Sbjct: 119 IKDIKESSFVEESLKDEDGNLMKI----HRVSIDDFEILKVVGQGAFAKVYQVRKKGTSE 174

Query: 177 IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH 236
           IYAMKVMRKDKIMEKNHAEYMK+ER+I TK++HPF VQLRYSFQTKYRLYLVLDFVNGGH
Sbjct: 175 IYAMKVMRKDKIMEKNHAEYMKAERDIWTKIEHPFGVQLRYSFQTKYRLYLVLDFVNGGH 234

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           LFFQLY QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV
Sbjct: 235 LFFQLYHQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 287

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356551817|ref|XP_003544270.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Glycine max]

 Score =  375 bits (962), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 192/299 (64%), Positives = 227/299 (75%), Gaps = 22/299 (7%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDAL-SSDYVEFDFSDVFGPAPVQAS--IEVG 57
           MVS+Q S LN + + KPFLNQLLLP GPPD L SS+ V+F+FSDVFGP+PV+AS  I V 
Sbjct: 1   MVSAQFSILNENGSQKPFLNQLLLPNGPPDRLPSSNCVDFEFSDVFGPSPVEASNSISVS 60

Query: 58  GE-------ISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVE 110
            E          ++E +Y  P  IH RS SL+ P++ + QSL+LSKLT HE +D+L LVE
Sbjct: 61  SEKHGNSVATRGSSENIYKDPDCIHIRSQSLLAPTTCIGQSLQLSKLTFHETDDALDLVE 120

Query: 111 GINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
            +  ET E     SV +  L             NQ +G++DFEVLKVVGQGAF KVYQVR
Sbjct: 121 EVFIETHEELKEYSVNNYCLN------------NQTIGVQDFEVLKVVGQGAFGKVYQVR 168

Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD 230
           R GTSEIYAMKVMRKDKIM++NHAEY+KSER+ILTK+D+PF+V++RY+FQTKYRLYLVLD
Sbjct: 169 RTGTSEIYAMKVMRKDKIMQRNHAEYVKSERDILTKLDNPFVVRIRYAFQTKYRLYLVLD 228

Query: 231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           FVNGGHLFF LY QGLFREDLAR Y AEI+ AVS+LHAN IMHRDLKPENILLDADGH 
Sbjct: 229 FVNGGHLFFHLYHQGLFREDLARFYAAEIICAVSYLHANDIMHRDLKPENILLDADGHA 287

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357112350|ref|XP_003557972.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Brachypodium distachyon]

 Score =  371 bits (953), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 191/297 (64%), Positives = 226/297 (76%), Gaps = 18/297 (6%)

Query: 1   MVSSQLSSLNGDCAGKP--FLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVG- 57
           MVSS+++S+    A  P  F   ++LP+GPPD +  + +EFDF+DVFG   VQ   EV  
Sbjct: 1   MVSSEINSVTTTHAQGPKLFTGTIILPKGPPDVVVPENIEFDFNDVFGATAVQTPTEVSI 60

Query: 58  ------GEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG 111
                    + +++ VY+ P VI  RSHSLVGP+S VSQSL LSKLTLHE + +  L+E 
Sbjct: 61  LTPESPAPFAESSDEVYNDPVVITKRSHSLVGPTSLVSQSLPLSKLTLHETDSTPDLLEC 120

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
           +++E +   + LS  D  L  P         EN+ VGL+DFEVLK+VGQGAF KVYQVR+
Sbjct: 121 LSKEKESNQDQLS--DEELTNPK-------KENEVVGLDDFEVLKLVGQGAFGKVYQVRK 171

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
            GTSEIYAMKVMRKDKI+EKNHAEYMK+ER+ILTKVDHPF+VQLR SFQTKYRLYLVLDF
Sbjct: 172 KGTSEIYAMKVMRKDKILEKNHAEYMKAERDILTKVDHPFVVQLRCSFQTKYRLYLVLDF 231

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
           VNGGHLFFQLY+QGLFRE+LARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  GH
Sbjct: 232 VNGGHLFFQLYQQGLFREELARIYTAEIVSAVSHLHANGIMHRDLKPENILLDDHGH 288

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242046942|ref|XP_002461217.1| hypothetical protein SORBIDRAFT_02g043070 [Sorghum bicolor] gi|241924594|gb|EER97738.1| hypothetical protein SORBIDRAFT_02g043070 [Sorghum bicolor]

 Score =  371 bits (953), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 194/298 (65%), Positives = 228/298 (76%), Gaps = 18/298 (6%)

Query: 1   MVSSQLSSLNGDCAGKPFLN--QLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGG 58
           MVSSQ SSL       P L   ++LLP GPPD +SSD +E+DFSDVFG  PVQ    +GG
Sbjct: 1   MVSSQPSSLTAILTQGPNLCPVKILLPMGPPDVVSSDNIEYDFSDVFGSTPVQTPTNLGG 60

Query: 59  -------EISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG 111
                      +NE  Y  P +I +RSHSLVGP+S VS+SL+LSKL+L + E S  LV+ 
Sbjct: 61  LGPDSPSPTVESNEEFYSDPIIIINRSHSLVGPTSLVSRSLRLSKLSLGKTEGSSELVKC 120

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
           ++EE +     LS  D  LG       N  +E++ VGL+DFE+LK+VGQGAF KV+QVR+
Sbjct: 121 LSEEKEGDQGQLS--DEELG-------NAMTEDEGVGLDDFEILKLVGQGAFGKVFQVRK 171

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
             TSEIYAMKVMRKDKI+EKNH+EYMK+ER ILTKVDHPFIVQLRYSFQTKYRLYLVLDF
Sbjct: 172 KNTSEIYAMKVMRKDKILEKNHSEYMKAEREILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           +NGGHLFFQLY+QGLFRE+LARIYTAEIVSAV+HLHANGIMHRDLKPENILLDA+GH 
Sbjct: 232 INGGHLFFQLYKQGLFREELARIYTAEIVSAVAHLHANGIMHRDLKPENILLDAEGHA 289

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	291
TAIR|locus:2077843	471	S6K2 "serine/threonine protein	0.948	0.585	0.655	1.7e-91
TAIR|locus:2077873	465	PK1 "protein-serine kinase 1"	0.883	0.552	0.650	8e-85
DICTYBASE|DDB_G0268620	444	pkbA "AKT/PKB protein kinase P	0.512	0.335	0.543	1.1e-41
DICTYBASE|DDB_G0290157	479	pkgB "SGK family protein kinas	0.508	0.308	0.563	1.4e-41
SGD|S000001609	680	YPK1 "Serine/threonine protein	0.563	0.241	0.475	3.5e-38
UNIPROTKB|E1BZK5	364	SGK2 "Uncharacterized protein"	0.539	0.431	0.512	4.3e-38
DICTYBASE|DDB_G0277449	456	DDB_G0277449 "SGK family prote	0.759	0.484	0.379	3.9e-37
UNIPROTKB|E2R7K9	482	RPS6KB2 "Uncharacterized prote	0.621	0.375	0.451	3.9e-37
UNIPROTKB|Q9UBS0	482	RPS6KB2 "Ribosomal protein S6	0.659	0.398	0.448	4.9e-37
ZFIN|ZDB-GENE-030131-2860	433	sgk1 "serum/glucocorticoid reg	0.539	0.362	0.493	6.3e-37

TAIR|locus:2077843 S6K2 "serine/threonine protein kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 912 (326.1 bits), Expect = 1.7e-91, P = 1.7e-91
 Identities = 190/290 (65%), Positives = 218/290 (75%)

Query:     1 MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
             MVSSQ S  N +  GKPF   L L   PP ++  D +E  FSDVFGP P   S E     
Sbjct:     1 MVSSQCSVANKNQTGKPFQKHLSLSISPPKSVLGDNLELQFSDVFGPMPEANSEE----- 55

Query:    61 SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
               A ++ YD+PAV++SRSHSLVGPS  VS SLK++KLTL E EDS+ LVE +  E+ +  
Sbjct:    56 --ACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETEDSVDLVECVEGESIKEN 113

Query:   121 NNLSVVDAALGKPTGHIDNLPSE-NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYA 179
             +  S      G      +  P E +  VG+EDFEVLKVVGQGAF KVYQVR+  TSEIYA
Sbjct:   114 DEFS------GNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKKDTSEIYA 167

Query:   180 MKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF 239
             MKVMRKDKI+EKNHAEYMK+ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFF
Sbjct:   168 MKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFF 227

Query:   240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
             QLY QGLFREDLAR+YTAEIVSAVSHLH  GIMHRDLKPENIL+D DGHV
Sbjct:   228 QLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDVDGHV 277

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0009408 "response to heat" evidence=IEP

TAIR|locus:2077873 PK1 "protein-serine kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 849 (303.9 bits), Expect = 8.0e-85, P = 8.0e-85
 Identities = 175/269 (65%), Positives = 207/269 (76%)

Query:    21 QLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHS 80
             Q  L   P +++  D VE +FSDVFGP P +A           N++ YD+PAV++SRSHS
Sbjct:    15 QQYLSISPSNSVLKDDVELEFSDVFGPLPEEA-----------NDIAYDEPAVVYSRSHS 63

Query:    81 LVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNL 140
             LVGP S  S SLKL+KLTL E EDS+ LVE +  E+ +  ++ S  D +  +     D L
Sbjct:    64 LVGPCSLDSHSLKLTKLTLLETEDSIDLVECLEGESLKENDDFSGNDDSDNEKALEGD-L 122

Query:   141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
                +  VG++DFEV+KVVG+GAF KVYQVR+  TSEIYAMKVMRKD IMEKNHAEYMK+E
Sbjct:   123 VKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSEIYAMKVMRKDHIMEKNHAEYMKAE 182

Query:   201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             R+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFFQLY QGLFREDLAR+YTAEIV
Sbjct:   183 RDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIV 242

Query:   261 SAVSHLHANGIMHRDLKPENILLDADGHV 289
             SAVSHLH  GIMHRDLKPENIL+D DGHV
Sbjct:   243 SAVSHLHEKGIMHRDLKPENILMDTDGHV 271

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IMP;IDA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

DICTYBASE|DDB_G0268620 pkbA "AKT/PKB protein kinase PkbA" [Dictyostelium discoideum (taxid:44689)]

 Score = 442 (160.7 bits), Expect = 1.1e-41, P = 1.1e-41
 Identities = 81/149 (54%), Positives = 111/149 (74%)

Query:   141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             P +++ VG+ DFE+L +VG+G+F KV QVR+  T E+YAMKV+ K  I+E N  E+  SE
Sbjct:   109 PKKSEKVGVADFELLNLVGKGSFGKVIQVRKKDTGEVYAMKVLSKKHIVEHNEVEHTLSE 168

Query:   201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             RNIL K++HPF+V L YSFQT+ +LY +LD+VNGG LF+ L +   F ED  R Y AEIV
Sbjct:   169 RNILQKINHPFLVNLNYSFQTEDKLYFILDYVNGGELFYHLQKDKKFTEDRVRYYGAEIV 228

Query:   261 SAVSHLHANGIMHRDLKPENILLDADGHV 289
              A+ HLH +G+++RDLKPEN+LL  +GH+
Sbjct:   229 LALEHLHLSGVIYRDLKPENLLLTNEGHI 257

GO:0043327 "chemotaxis to cAMP" evidence=IGI;IMP

GO:0030010 "establishment of cell polarity" evidence=IGI

GO:0006468 "protein phosphorylation" evidence=IEA;IGI;IDA

GO:0000281 "cytokinesis after mitosis" evidence=IGI

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005938 "cell cortex" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0045859 "regulation of protein kinase activity" evidence=TAS

GO:0031154 "culmination involved in sorocarp development" evidence=TAS

GO:0031036 "myosin II filament assembly" evidence=TAS

GO:0019887 "protein kinase regulator activity" evidence=TAS

GO:0007163 "establishment or maintenance of cell polarity" evidence=TAS

GO:0006935 "chemotaxis" evidence=IEA;TAS

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

GO:0004691 "cAMP-dependent protein kinase activity" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA;IC

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

DICTYBASE|DDB_G0290157 pkgB "SGK family protein kinase PkgB" [Dictyostelium discoideum (taxid:44689)]

 Score = 441 (160.3 bits), Expect = 1.4e-41, P = 1.4e-41
 Identities = 84/149 (56%), Positives = 111/149 (74%)

Query:   142 SEN-QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             S+N Q    +DFE+L V+G+G+F KV QV++ G  +I+AMKV+RKD I+ +    + KSE
Sbjct:   142 SKNKQSATKDDFELLNVIGKGSFGKVMQVKKKGEDKIFAMKVLRKDAIIARKQVNHTKSE 201

Query:   201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             + IL  + HPFIV L Y+FQTK +LY+VLDFVNGG LFF L R+G F E   +IY AEIV
Sbjct:   202 KTILQCISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIV 261

Query:   261 SAVSHLHANGIMHRDLKPENILLDADGHV 289
             SA+ HLH   I++RDLKPENILLD++GH+
Sbjct:   262 SALDHLHKQDIVYRDLKPENILLDSEGHI 290

GO:0006468 "protein phosphorylation" evidence=IEA;IGI;IDA

GO:0043327 "chemotaxis to cAMP" evidence=IGI

GO:0031288 "sorocarp morphogenesis" evidence=IMP

GO:0005886 "plasma membrane" evidence=IEA;IDA

GO:0004691 "cAMP-dependent protein kinase activity" evidence=IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0006935 "chemotaxis" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

SGD|S000001609 YPK1 "Serine/threonine protein kinase" [Saccharomyces cerevisiae (taxid:4932)]

 Score = 414 (150.8 bits), Expect = 3.5e-38, P = 3.5e-38
 Identities = 78/164 (47%), Positives = 115/164 (70%)

Query:   126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
             +D  LGK    ID  PS N+ + ++DF++LKV+G+G+F KV QVR+  T ++YA+K +RK
Sbjct:   321 LDNGLGKINISIDYKPSRNKPLSIDDFDLLKVIGKGSFGKVMQVRKKDTQKVYALKAIRK 380

Query:   186 DKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG 245
               I+ K+   +  +ER +L +VD PFIV L++SFQ+  +LY VL F+NGG LF+ L ++G
Sbjct:   381 SYIVSKSEVTHTLAERTVLARVDCPFIVPLKFSFQSPEKLYFVLAFINGGELFYHLQKEG 440

Query:   246 LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
              F    AR YTAE++ A+ +LH   +++RDLKPENILLD  GH+
Sbjct:   441 RFDLSRARFYTAELLCALDNLHKLDVVYRDLKPENILLDYQGHI 484

GO:0061093 "negative regulation of phospholipid translocation" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;IMP;IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0070941 "eisosome assembly" evidence=IGI

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IMP;IDA

GO:0005886 "plasma membrane" evidence=IEA;IDA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0006897 "endocytosis" evidence=IEA

GO:0005935 "cellular bud neck" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|E1BZK5 SGK2 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 408 (148.7 bits), Expect = 4.3e-38, P = 4.3e-38
 Identities = 81/158 (51%), Positives = 106/158 (67%)

Query:   133 PTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN 192
             PT +I+  PS N      DF+ LKV+G+G+F KV   +R      YA+KV+ K  I++K 
Sbjct:    16 PTDNINLGPSANPNAKPTDFDFLKVIGKGSFGKVLLAKRKSDGTFYAVKVLHKKTILKKK 75

Query:   193 HAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL 251
                ++ +ERN+L K V HPF+V L YSFQT  +LY VLD+VNGG LFF L R+  FRE  
Sbjct:    76 EQNHIMAERNVLLKNVKHPFLVGLHYSFQTSEKLYFVLDYVNGGELFFHLQRERCFREPR 135

Query:   252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
             AR Y AE+ SA+ +LH+  I++RDLKPENILLD  GHV
Sbjct:   136 ARFYAAEVASAIGYLHSLNIIYRDLKPENILLDCQGHV 173

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0015459 "potassium channel regulator activity" evidence=IEA

DICTYBASE|DDB_G0277449 DDB_G0277449 "SGK family protein kinase DDB_G0277449" [Dictyostelium discoideum (taxid:44689)]

 Score = 399 (145.5 bits), Expect = 3.9e-37, P = 3.9e-37
 Identities = 87/229 (37%), Positives = 132/229 (57%)

Query:    61 SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
             ++ N ++   P      S S +   S  S S      ++ ++E  +     I   T   P
Sbjct:    43 TFKNTIISTSPTECEESSSSTITTPSEESLSSGEESSSISDSESKI-----ITIATLLKP 97

Query:   121 NNLSVVD-AALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYA 179
             +N SV D   L       + +   N  + L +F +  +VG+G F KV+QV  + T ++YA
Sbjct:    98 SN-SVQDFTPLCNGAQETEIVKISNS-INLSNFIIKHLVGKGGFGKVFQVVHVDTQKVYA 155

Query:   180 MKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF 239
             +KV++K+ I+ K       +E++IL K+ HPFIV L Y+FQ + +LYLV+DFVNGG LF+
Sbjct:   156 LKVIKKNHIIAKKSVVNTLAEKDILKKISHPFIVNLHYAFQNEKKLYLVMDFVNGGQLFY 215

Query:   240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
              L ++ +F ED  R Y AE++ A+ HLH + I+HRDLKPENILLD+ GH
Sbjct:   216 HLQKEAIFSEDQVRFYMAELILALEHLHDSNIVHRDLKPENILLDSQGH 264

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|E2R7K9 RPS6KB2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 399 (145.5 bits), Expect = 3.9e-37, P = 3.9e-37
 Identities = 88/195 (45%), Positives = 130/195 (66%)

Query:   110 EGINEETQEGPNN---LSVVDAALGKPTGHIDNLP----SEN---QCVGLEDFEVLKVVG 159
             EG   E +  P++   L+   AA  +P GH + +     S N   + +G   FE+L+V+G
Sbjct:    13 EGSEGEPEFSPSDVCPLAESRAAGPEPVGHCEEVELTETSVNLGPERIGPHCFELLRVLG 72

Query:   160 QGAFAKVYQVRRI-GTS--EIYAMKVMRKDKIMEK-NHAEYMKSERNILTKVDHPFIVQL 215
             +G + KV+QVR++ GT+  +IYAMKV+RK KI+       + ++ERNIL  V HPFIV+L
Sbjct:    73 KGGYGKVFQVRKVQGTNLGKIYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVEL 132

Query:   216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
              Y+FQT  +LYL+L+ ++GG LF  L R+G+F ED A  Y AEI  A+ HLH+ GI++RD
Sbjct:   133 AYAFQTGGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRD 192

Query:   276 LKPENILLDADGHVR 290
             LKPENI+L++ GH++
Sbjct:   193 LKPENIMLNSQGHIK 207

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q9UBS0 RPS6KB2 "Ribosomal protein S6 kinase beta-2" [Homo sapiens (taxid:9606)]

 Score = 398 (145.2 bits), Expect = 4.9e-37, P = 4.9e-37
 Identities = 92/205 (44%), Positives = 132/205 (64%)

Query:    97 LTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLP----SEN---QCVGL 149
             L L   E S G  EG  E +      L+ + AA  +P GH + +     S N   + +G 
Sbjct:     7 LDLETEEGSEG--EGEPELSPADACPLAELRAAGLEPVGHYEEVELTETSVNVGPERIGP 64

Query:   150 EDFEVLKVVGQGAFAKVYQVRRI-GTS--EIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
               FE+L+V+G+G + KV+QVR++ GT+  +IYAMKV+RK KI+       + ++ERNIL 
Sbjct:    65 HCFELLRVLGKGGYGKVFQVRKVQGTNLGKIYAMKVLRKAKIVRNAKDTAHTRAERNILE 124

Query:   206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
              V HPFIV+L Y+FQT  +LYL+L+ ++GG LF  L R+G+F ED A  Y AEI  A+ H
Sbjct:   125 SVKHPFIVELAYAFQTGGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGH 184

Query:   266 LHANGIMHRDLKPENILLDADGHVR 290
             LH+ GI++RDLKPENI+L + GH++
Sbjct:   185 LHSQGIIYRDLKPENIMLSSQGHIK 209

GO:0004711 "ribosomal protein S6 kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0042277 "peptide binding" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IMP

GO:0004672 "protein kinase activity" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0006412 "translation" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

ZFIN|ZDB-GENE-030131-2860 sgk1 "serum/glucocorticoid regulated kinase 1" [Danio rerio (taxid:7955)]

 Score = 397 (144.8 bits), Expect = 6.3e-37, P = 6.3e-37
 Identities = 78/158 (49%), Positives = 107/158 (67%)

Query:   133 PTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN 192
             P+  I+  PS N      DF+ LKV+G+G+F KV   R     + YA+KV++K  I++K 
Sbjct:    81 PSQQINLGPSSNPTAKPSDFDFLKVIGKGSFGKVLLARHRSDEKFYAVKVLQKKAILKKK 140

Query:   193 HAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL 251
               +++ SERN+L K V HPF+V L YSFQT  +LY VLD++NGG LF+ L R+  F E  
Sbjct:   141 EEKHIMSERNVLLKNVKHPFLVGLHYSFQTTDKLYFVLDYINGGELFYHLQRERCFLEPR 200

Query:   252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
             AR Y AEI SA+ +LH+  I++RDLKPENILLD+ GH+
Sbjct:   201 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI 238

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0006950 "response to stress" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0005783 "endoplasmic reticulum" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	291
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-74
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-60
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-58
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-55
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-52
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-52
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-51
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-51
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-49
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-49
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-49
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-47
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-46
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-46
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-46
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-45
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-45
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-45
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-44
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-43
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-43
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-43
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-42
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-42
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-42
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-42
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-41
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-41
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-41
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-40
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-40
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-40
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-40
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-39
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-39
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-38
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-38
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-38
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-38
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-37
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-37
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-37
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-37
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-37
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-36
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-36
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-36
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-35
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-34
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-34
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-34
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-34
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-33
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-33
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-33
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-33
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-33
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-32
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-32
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-32
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-31
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-31
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-30
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-30
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-30
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-29
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-29
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-28
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-27
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-22
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-20
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-19
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-17
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-16
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-15
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-15
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-15
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-14
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-14
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-08
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-08
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-07
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-06
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-06
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-06
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-05
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-05
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-05
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-05
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-04
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-04
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-04
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-04
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-04
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-04
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-04
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	7e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.002
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.002
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.002
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.003
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	0.004

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  228 bits (584), Expect = 1e-74
 Identities = 72/133 (54%), Positives = 105/133 (78%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F KV  VR+  T ++YAMKV++K KI+++   E+  +ERNIL++++HPFIV+L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           +FQT+ +LYLVL++  GG LF  L ++G F E+ AR Y AEIV A+ +LH+ GI++RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 278 PENILLDADGHVR 290
           PENILLDADGH++
Sbjct: 121 PENILLDADGHIK 133

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  192 bits (491), Expect = 4e-60
 Identities = 63/141 (44%), Positives = 98/141 (69%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +K +G G+F +V  VR  G+ + YA+K++ K KI++    E++ +E+ IL  + H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF+V L  SFQ    LYLV+++V GG LF  L + G F E +AR Y A++V A+ +LH+ 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
            I++RDLKPEN+LLD+DG+++
Sbjct: 121 DIVYRDLKPENLLLDSDGYIK 141

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  187 bits (478), Expect = 1e-58
 Identities = 66/139 (47%), Positives = 95/139 (68%), Gaps = 2/139 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+L+ +G+G+F KVY  R   T ++ A+KV++K KI  K   E +  E  IL K+ HP 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L   F+ + +LYLV+++  GG LF  L ++G   ED AR Y  +I+SA+ +LH+ GI
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 272 MHRDLKPENILLDADGHVR 290
           +HRDLKPENILLD DGHV+
Sbjct: 119 VHRDLKPENILLDEDGHVK 137

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  182 bits (464), Expect = 2e-55
 Identities = 68/141 (48%), Positives = 105/141 (74%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFEV+KV+G+GAF +V+ VR   T ++YAMKV+RK  ++++N   ++++ER+IL   D 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P+IV+L YSFQ +  LYLV++++ GG L   L R+ +F E+ AR Y AE+V A+  +H  
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
           G +HRD+KP+NIL+DADGH++
Sbjct: 121 GFIHRDIKPDNILIDADGHIK 141

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  173 bits (441), Expect = 2e-52
 Identities = 71/136 (52%), Positives = 96/136 (70%), Gaps = 1/136 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   +     + YA+KV++K  I++K   +++ +ERN+L K V HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLD+VNGG LFF L R+  F E  AR Y AEI SA+ +LH+  I++R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 275 DLKPENILLDADGHVR 290
           DLKPENILLD+ GHV 
Sbjct: 121 DLKPENILLDSQGHVV 136

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  171 bits (435), Expect = 3e-52
 Identities = 64/139 (46%), Positives = 96/139 (69%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE+L+V+G+GAF KV  V++  T +++AMK M K K +EK     + +ER IL +++HPF
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V L YSFQ +  +YLV+D + GG L + L ++  F E+  + +  EIV A+ +LH+ GI
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 272 MHRDLKPENILLDADGHVR 290
           +HRD+KP+NILLD  GHV 
Sbjct: 122 IHRDIKPDNILLDEQGHVH 140

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  170 bits (433), Expect = 1e-51
 Identities = 56/141 (39%), Positives = 95/141 (67%), Gaps = 1/141 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD- 208
           +DF+  K++G+G+F+ V   +   T++ YA+K++ K +++++   +Y+K E+ +LT+++ 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L Y+FQ +  LY VL++   G L   + + G   E   R Y AEI+ A+ +LH+
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 269 NGIMHRDLKPENILLDADGHV 289
            GI+HRDLKPENILLD D H+
Sbjct: 121 KGIIHRDLKPENILLDKDMHI 141

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  170 bits (432), Expect = 1e-51
 Identities = 61/132 (46%), Positives = 97/132 (73%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           + +GA+ +V+  ++  T +IYA+KV++K  ++ KN  + + +ER+IL++   P++V+L Y
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           SFQ K  LYLV++++ GG L   L   G   ED+ARIY AEIV A+ +LH+NGI+HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 278 PENILLDADGHV 289
           P+NIL+D++GH+
Sbjct: 121 PDNILIDSNGHL 132

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  169 bits (429), Expect = 1e-50
 Identities = 76/141 (53%), Positives = 105/141 (74%), Gaps = 6/141 (4%)

Query: 155 LKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDH 209
           LKV+G+G + KV+QVR++    T +I+AMKV++K  I+  +K+ A + K+ERNIL  V H
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTA-HTKAERNILEAVKH 59

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PFIV L Y+FQT  +LYL+L++++GG LF  L R+G+F ED A  Y +EI  A+ HLH  
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119

Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI++RDLKPENILLDA GHV+
Sbjct: 120 GIIYRDLKPENILLDAQGHVK 140

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  164 bits (417), Expect = 1e-49
 Identities = 58/139 (41%), Positives = 87/139 (62%), Gaps = 1/139 (0%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+L+ +G G+F  VY+ +  GT +I A+K+++K     K        E  IL ++ HP 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L  +F+ K  LYLV+++  GG LF  L R G   ED A+    +I+  + +LH+NGI
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 272 MHRDLKPENILLDADGHVR 290
           +HRDLKPENILLD +G V+
Sbjct: 120 IHRDLKPENILLDENGVVK 138

Length = 260

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  167 bits (424), Expect = 2e-49
 Identities = 60/141 (42%), Positives = 100/141 (70%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +KV+G+GAF +V  V++  T  IYAMK +RK +++EK    ++++ER+IL + D+
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++V+L YSFQ +  LYL+++++ GG +   L ++  F E+  R Y AE + A+  +H  
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
           G +HRD+KP+N+LLDA GH++
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIK 141

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  163 bits (414), Expect = 7e-49
 Identities = 72/144 (50%), Positives = 105/144 (72%), Gaps = 5/144 (3%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNH-AEYMKSERNILTK 206
           +FE+L+V+G GA+ KV+ VR++G     ++YAMKV++K  I++K   AE+ ++ER +L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 207 VDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           V   PF+V L Y+FQT  +L+L+LD+VNGG LF  LY++  F E   R+Y AEIV A+ H
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 266 LHANGIMHRDLKPENILLDADGHV 289
           LH  GI++RD+K ENILLD++GHV
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHV 144

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  161 bits (408), Expect = 5e-47
 Identities = 64/139 (46%), Positives = 98/139 (70%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  +K +G GAF +V  VR++ T+ +YAMK +RK  ++ +N A ++K+ER+IL + D+ +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V+L YSFQ K  LY V+D++ GG +   L R G+F EDLAR Y AE+  A+  +H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 272 MHRDLKPENILLDADGHVR 290
           +HRD+KP+NIL+D DGH++
Sbjct: 123 IHRDIKPDNILIDRDGHIK 141

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  158 bits (402), Expect = 1e-46
 Identities = 60/141 (42%), Positives = 95/141 (67%), Gaps = 2/141 (1%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            F+ +K++G+G   +V+ VR  GT +++A+KV+ K +++++N  + + +E+ IL  +DHP
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHA 268
           F+  L  SFQT+  L LV+D+  GG LF  L RQ      E++AR Y AE++ A+ +LH 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 269 NGIMHRDLKPENILLDADGHV 289
            GI++RDLKPENILL   GH+
Sbjct: 122 LGIVYRDLKPENILLHESGHI 142

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  157 bits (398), Expect = 4e-46
 Identities = 69/139 (49%), Positives = 103/139 (74%), Gaps = 4/139 (2%)

Query: 155 LKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           LKV+GQG+F KV+ VR+I      ++YAMKV++K  +  ++     K ER+IL +V+HPF
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+ GI
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 272 MHRDLKPENILLDADGHVR 290
           ++RDLKPENILLD +GH++
Sbjct: 120 IYRDLKPENILLDEEGHIK 138

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  157 bits (398), Expect = 5e-46
 Identities = 70/135 (51%), Positives = 94/135 (69%), Gaps = 3/135 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQ 214
           +G+G F +VYQVR+  T  IYAMKV+ K +I+ K    +   ERNIL +    + PFIV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L++SFQT   LYLV D+++GG LF+ L ++G F ED A+ Y AE+V A+ HLH   I++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 275 DLKPENILLDADGHV 289
           DLKPENILLDA GH+
Sbjct: 121 DLKPENILLDATGHI 135

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  156 bits (395), Expect = 1e-45
 Identities = 70/135 (51%), Positives = 95/135 (70%), Gaps = 1/135 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   +R      YA+KV++K  I++K    ++ +ERN+L K + HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLD+VNGG LFF L R+  F E  AR Y AE+ SA+ +LH+  I++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 275 DLKPENILLDADGHV 289
           DLKPENILLD+ GHV
Sbjct: 121 DLKPENILLDSQGHV 135

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  155 bits (394), Expect = 1e-45
 Identities = 65/132 (49%), Positives = 93/132 (70%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F KV QVR+  T  IYA+K +RK  I+ ++   +  +ER +L +V+ PFIV L++
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           SFQ+  +LYLVL F+NGG LF  L R+G F    AR YTAE++ A+ +LH   +++RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 278 PENILLDADGHV 289
           PENILLD  GH+
Sbjct: 121 PENILLDYQGHI 132

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  155 bits (394), Expect = 2e-45
 Identities = 63/135 (46%), Positives = 93/135 (68%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  VR   T + YAMK+++K+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +LH+  +++RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 276 LKPENILLDADGHVR 290
           LK EN++LD DGH++
Sbjct: 121 LKLENLMLDKDGHIK 135

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  153 bits (388), Expect = 2e-44
 Identities = 69/144 (47%), Positives = 106/144 (73%), Gaps = 5/144 (3%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNH-AEYMKSERNILTK 206
           +FE+LKV+G GA+ KV+ VR++    T ++YAMKV++K  +++K    E+ ++ERN+L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           V   PF+V L Y+FQT+ +L+L+LD+V+GG +F  LY++  F ED  R Y+ EI+ A+ H
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 266 LHANGIMHRDLKPENILLDADGHV 289
           LH  GI++RD+K ENILLD++GHV
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHV 144

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  149 bits (378), Expect = 1e-43
 Identities = 54/133 (40%), Positives = 88/133 (66%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F +V  V+    +  +A+K ++K  I+E    E++ SE+ IL + +HPFIV+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           +F+ K  +Y+++++  GG L+  L  +GLF E  AR Y A +V A  +LH  GI++RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 278 PENILLDADGHVR 290
           PEN+LLD++G+V+
Sbjct: 121 PENLLLDSNGYVK 133

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  149 bits (379), Expect = 3e-43
 Identities = 63/136 (46%), Positives = 91/136 (66%), Gaps = 1/136 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           KV+G+G+F KV      GT E+YA+KV++KD I++ +  E   +E+ +L     HPF+ Q
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQTK RL+ V+++VNGG L F + R G F E  AR Y AEIV  +  LH  GI++R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 275 DLKPENILLDADGHVR 290
           DLK +N+LLD++GH++
Sbjct: 121 DLKLDNVLLDSEGHIK 136

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 6e-43
 Identities = 61/141 (43%), Positives = 95/141 (67%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF  +KV+G+GAF +V  V++  T +IYAMK + K ++ +K+   ++K+ER++L + D 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++V L YSFQ    LYL+++F+ GG L   L +   F ED+ R Y AE V A+  +H  
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
           G +HRD+KP+NIL+D  GH++
Sbjct: 121 GFIHRDIKPDNILIDRGGHIK 141

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  148 bits (374), Expect = 1e-42
 Identities = 69/135 (51%), Positives = 96/135 (71%), Gaps = 1/135 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   R     + YA+KV++K  I++K   +++ SERN+L K V HPF+V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L +SFQT  +LY VLD++NGG LF+ L R+  F E  AR Y AEI SA+ +LH+  I++R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 275 DLKPENILLDADGHV 289
           DLKPENILLD+ GH+
Sbjct: 121 DLKPENILLDSQGHI 135

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  147 bits (373), Expect = 2e-42
 Identities = 71/135 (52%), Positives = 96/135 (71%), Gaps = 1/135 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   +R    + YA+KV++K  ++ +   +++ +ERN+L K V HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLDFVNGG LFF L R+  F E  AR Y AEI SA+ +LH+  I++R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 275 DLKPENILLDADGHV 289
           DLKPENILLD+ GHV
Sbjct: 121 DLKPENILLDSQGHV 135

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  147 bits (372), Expect = 3e-42
 Identities = 61/136 (44%), Positives = 90/136 (66%), Gaps = 1/136 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQ 214
           KV+G+G+F KV      GT E+YA+KV++KD I++ +  +   +E+ IL     HPF+  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQTK RL+ V+++VNGG L FQ+ R   F E  +R Y AE+  A+  LH +G+++R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 275 DLKPENILLDADGHVR 290
           DLK +NILLDA+GH +
Sbjct: 121 DLKLDNILLDAEGHCK 136

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  146 bits (369), Expect = 5e-42
 Identities = 54/141 (38%), Positives = 89/141 (63%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D E +K VG G F +V+ VR   +   YA+KVM   +++     +++ +E+ +L +V H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PFI++L ++   +  LY+++++V GG LF  L   G F       Y +EIV A+ +LH+ 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
            I++RDLKPENILLD +GH++
Sbjct: 121 EIVYRDLKPENILLDKEGHIK 141

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  146 bits (369), Expect = 1e-41
 Identities = 62/142 (43%), Positives = 96/142 (67%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L DFE+ + +G G+F +V   +  GT E YA+K ++K +I++    +++  E++IL ++ 
Sbjct: 17  LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV +  SFQ + R+Y +L+FV GG LF  L + G F  D+A+ Y AE+V A  +LH+
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             I++RDLKPEN+LLD  GHV+
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVK 158

Length = 329

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  146 bits (369), Expect = 3e-41
 Identities = 63/139 (45%), Positives = 95/139 (68%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  +K +G GAF +V   R++ T  +YAMK +RK  ++ +N   ++K+ER+IL + D+ +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V+L YSFQ K  LY V+D++ GG +   L R G+F EDLAR Y AE+  AV  +H  G 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 272 MHRDLKPENILLDADGHVR 290
           +HRD+KP+NIL+D DGH++
Sbjct: 123 IHRDIKPDNILIDRDGHIK 141

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  144 bits (364), Expect = 6e-41
 Identities = 62/142 (43%), Positives = 95/142 (66%), Gaps = 1/142 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DF+V  +VG+G F +V  VR   T +IYAMKVM+K  ++ +    + + ER+IL+  + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
           P+I QL+Y+FQ K  LYLV+++  GG L   L R +  F ED+A+ Y AE+V A+  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVR 290
            G +HRD+KPEN+L+D  GH++
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIK 142

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  142 bits (359), Expect = 1e-40
 Identities = 67/144 (46%), Positives = 104/144 (72%), Gaps = 5/144 (3%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEK-NHAEYMKSERNILTK 206
           +FE+LKV+G GA+ KV+ VR++    + ++YAMKV++K  I++K    E+ ++ER +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 207 VDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +   PF+V L Y+FQT  +L+L+LD++NGG LF  L ++  F+E   +IY+ EIV A+ H
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 266 LHANGIMHRDLKPENILLDADGHV 289
           LH  GI++RD+K ENILLD++GHV
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHV 144

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  143 bits (361), Expect = 1e-40
 Identities = 61/135 (45%), Positives = 92/135 (68%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +LH+  +++RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 276 LKPENILLDADGHVR 290
           +K EN++LD DGH++
Sbjct: 121 IKLENLMLDKDGHIK 135

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  142 bits (360), Expect = 2e-40
 Identities = 59/140 (42%), Positives = 87/140 (62%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF++L  VGQG + +V+  ++  T EI A+K M+K  + + N   ++ +ER+ILT     
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           ++V+L Y+FQ    LYL +++V GG     L   G+  ED AR Y AE+  AV  LH  G
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 271 IMHRDLKPENILLDADGHVR 290
            +HRDLKPEN L+DA GH++
Sbjct: 122 YIHRDLKPENFLIDASGHIK 141

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  141 bits (357), Expect = 5e-40
 Identities = 64/135 (47%), Positives = 94/135 (69%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  VR   + + YAMK+++K+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +YSFQTK RL  V+++VNGG LFF L R+ +F ED  R Y AEIVSA+ +LH+  I++RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 276 LKPENILLDADGHVR 290
           LK EN++LD DGH++
Sbjct: 121 LKLENLMLDKDGHIK 135

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  137 bits (347), Expect = 5e-39
 Identities = 47/144 (32%), Positives = 87/144 (60%), Gaps = 5/144 (3%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            +E++K +G+G+F KVY VRR    ++Y +K +    + EK   + +  E  IL K++HP
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHP 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHL 266
            I++   SF+ K +L +V+++ +GG L  ++ +Q      F E+    +  ++  A+ +L
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  I+HRD+KP+NI L ++G V+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVK 143

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  138 bits (349), Expect = 8e-39
 Identities = 60/141 (42%), Positives = 91/141 (64%), Gaps = 1/141 (0%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF  L V+G+G+F KV    R GT E+YA+K+++KD I++ +  E    E+ +L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  LH+ 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI++RDLK +N++LDA+GH++
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIK 141

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  138 bits (350), Expect = 2e-38
 Identities = 59/139 (42%), Positives = 92/139 (66%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  +K +G GAF +V    ++ T  +YAMK +RK  ++ +N   ++K+ER+IL + D+ +
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V+L YSFQ K  LY V+D++ GG +   L R  +F E LAR Y AE+  A+  +H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122

Query: 272 MHRDLKPENILLDADGHVR 290
           +HRD+KP+NIL+D DGH++
Sbjct: 123 IHRDIKPDNILIDLDGHIK 141

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  137 bits (346), Expect = 4e-38
 Identities = 61/141 (43%), Positives = 97/141 (68%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE LKV+G+GAF +V  V++  T  IYAMK++RK  ++EK    ++++ER+IL + D 
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            ++V++ YSFQ K  LYL+++F+ GG +   L ++    E+  + Y AE V A+  +H  
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
           G +HRD+KP+N+LLDA GHV+
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVK 141

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  136 bits (344), Expect = 5e-38
 Identities = 59/136 (43%), Positives = 96/136 (70%), Gaps = 1/136 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIVQ 214
           +V+G+G++AKV  V    T  IYAMKV++K+ + +    +++++E+++  T  +HPF+V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT+ RL+ V++FV+GG L F + RQ    E+ AR Y+AEI  A++ LH  GI++R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 275 DLKPENILLDADGHVR 290
           DLK +N+LLDA+GH++
Sbjct: 121 DLKLDNVLLDAEGHIK 136

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  137 bits (345), Expect = 6e-38
 Identities = 60/141 (42%), Positives = 97/141 (68%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE LKV+G+GAF +V  V++  T  +YAMK++RK  ++EK    ++++ER+IL + D 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            ++V++ YSFQ K  LYL+++F+ GG +   L ++    E+  + Y AE V A+  +H  
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
           G +HRD+KP+N+LLD+ GHV+
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVK 141

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 2e-37
 Identities = 59/142 (41%), Positives = 94/142 (66%), Gaps = 1/142 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE+LKV+G+GAF +V  V+   T ++YAMK++ K +++++      + ER++L   D 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y AE+V A+  +H 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVR 290
            G +HRD+KP+N+LLD +GH+R
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIR 142

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  134 bits (338), Expect = 3e-37
 Identities = 62/136 (45%), Positives = 92/136 (67%), Gaps = 1/136 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHR 274
           +YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +LH+   +++R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 275 DLKPENILLDADGHVR 290
           DLK EN++LD DGH++
Sbjct: 121 DLKLENLMLDKDGHIK 136

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  134 bits (338), Expect = 3e-37
 Identities = 60/136 (44%), Positives = 89/136 (65%), Gaps = 1/136 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           +V+G+G+F KV   R   +  +YA+KV++KD I++ +  E   +E+ IL+   +HPF+ Q
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT  RL+ V++FVNGG L F + +   F E  AR Y AEI SA+  LH  GI++R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 275 DLKPENILLDADGHVR 290
           DLK +N+LLD +GH +
Sbjct: 121 DLKLDNVLLDHEGHCK 136

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  132 bits (333), Expect = 6e-37
 Identities = 54/135 (40%), Positives = 81/135 (60%), Gaps = 2/135 (1%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V   +   T ++YA K + K ++ ++   +   +E+ IL KV   FIV L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +F+TK  L LV+  +NGG L + +Y  G   F E  A  Y A+I+  + HLH   I++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 276 LKPENILLDADGHVR 290
           LKPEN+LLD  G+VR
Sbjct: 121 LKPENVLLDDHGNVR 135

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 7e-37
 Identities = 56/137 (40%), Positives = 89/137 (64%), Gaps = 1/137 (0%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIV 213
           LK + +GAF  VY  ++  T + +A+KV++K  ++ KN    +K+ER I+  + + P++ 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           +L YSFQ+K  LYLV++++NGG     +   G   ED A+ Y AE+V  V  LH  GI+H
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 274 RDLKPENILLDADGHVR 290
           RD+KPEN+L+D  GH++
Sbjct: 121 RDIKPENLLIDQTGHLK 137

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  133 bits (336), Expect = 2e-36
 Identities = 57/144 (39%), Positives = 96/144 (66%), Gaps = 1/144 (0%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  EDF+V+KV+G+GAF +V  VR   + ++YAMK++ K ++++++ + +   ER+I+  
Sbjct: 40  MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            +  +IVQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTAEVVLALDAI 158

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+ G +HRD+KP+N+LLD  GH++
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLK 182

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  129 bits (327), Expect = 5e-36
 Identities = 47/142 (33%), Positives = 82/142 (57%), Gaps = 3/142 (2%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++   +++G+G+F  VY      T E+ A+K +      E+      + E  IL+ + HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALER-EIRILSSLQHP 59

Query: 211 FIVQLRYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+   S + + +  L + L++V+GG L   L + G   E + R YT +I+  +++LH+
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 269 NGIMHRDLKPENILLDADGHVR 290
           NGI+HRD+K  NIL+D+DG V+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVK 141

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  130 bits (329), Expect = 6e-36
 Identities = 58/136 (42%), Positives = 87/136 (63%), Gaps = 1/136 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQ 214
           KV+G+G+F KV      GT+E +A+K ++KD ++E +  E    ER +L    +HPF+  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L  +FQTK  L+ V++++NGG L F +   G F E  AR Y AEI+  +  LH  GI++R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 275 DLKPENILLDADGHVR 290
           DLK +N+LLD DGH++
Sbjct: 121 DLKLDNVLLDKDGHIK 136

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  135 bits (342), Expect = 6e-36
 Identities = 56/142 (39%), Positives = 96/142 (67%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F ++K + +GAF KVY  R+   S++YA+KV++K  ++ KN    +++ER+ L    
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            PFIV L YS Q+   +YLV++++ GG +   L+  G F E++A  Y +E+  A+ +LH 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 269 NGIMHRDLKPENILLDADGHVR 290
           +GI+HRDLKP+N+L+  +GH++
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIK 144

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  125 bits (317), Expect = 4e-35
 Identities = 51/130 (39%), Positives = 75/130 (57%), Gaps = 3/130 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY  R   T +  A+K+++K+        E +  E  IL K++HP IV+L  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
            F+ +  LYLV+++  GG L   L    G   ED       +I+  + +LH+NGI+HRDL
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 277 KPENILLDAD 286
           KPENILLD+D
Sbjct: 119 KPENILLDSD 128

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  127 bits (319), Expect = 2e-34
 Identities = 58/136 (42%), Positives = 98/136 (72%), Gaps = 1/136 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           +V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +  +HPF+V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++LH  GI++R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 275 DLKPENILLDADGHVR 290
           DLK +N+LLD++GH++
Sbjct: 121 DLKLDNVLLDSEGHIK 136

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  126 bits (318), Expect = 2e-34
 Identities = 59/141 (41%), Positives = 92/141 (65%), Gaps = 1/141 (0%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V+++VNGG L +Q+ + G F+E  A  Y AEI   +  LH+ 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI++RDLK +N++LD++GH++
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIK 141

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  126 bits (317), Expect = 3e-34
 Identities = 58/141 (41%), Positives = 91/141 (64%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE +K++  GA+  VY VR   T + +AMK + K  ++ +N  + +  ER+ILT  ++
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF+V +  SF+TK  L +V+++V GG     L   G    D+AR+Y AE V A+ +LH  
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKP+N+L+ + GH++
Sbjct: 121 GIVHRDLKPDNLLITSMGHIK 141

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  126 bits (317), Expect = 4e-34
 Identities = 59/136 (43%), Positives = 95/136 (69%), Gaps = 1/136 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQ 214
           +V+G+G++AKV  VR     +IYAMKV++K+ + +    +++++E+++  +   +PF+V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT  RL+LV+++VNGG L F + RQ    E+ AR Y AEI  A++ LH  GI++R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 275 DLKPENILLDADGHVR 290
           DLK +N+LLDADGH++
Sbjct: 121 DLKLDNVLLDADGHIK 136

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  124 bits (313), Expect = 2e-33
 Identities = 50/142 (35%), Positives = 79/142 (55%), Gaps = 4/142 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL---TKVD 208
           F  L V+G+G F KV       T E+YA+K ++K  I+ ++  E +  E+ I        
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPF+V L   FQT+  +  V+++  GG L   ++   +F E  A  Y A +V  + +LH 
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119

Query: 269 NGIMHRDLKPENILLDADGHVR 290
           N I++RDLK +N+LLD +G V+
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVK 141

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  124 bits (312), Expect = 2e-33
 Identities = 59/142 (41%), Positives = 92/142 (64%), Gaps = 1/142 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE++KV+G+GAF +V  V+   T  IYAMK++ K +++++      + ERN+L   D 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y AE+V A+  +H 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HRD+KP+N+LLD +GH+R
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIR 142

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  122 bits (308), Expect = 2e-33
 Identities = 58/137 (42%), Positives = 84/137 (61%), Gaps = 3/137 (2%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIV 213
           ++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V   D PFIV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
            + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  + H+H   +++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 274 RDLKPENILLDADGHVR 290
           RDLKP NILLD  GHVR
Sbjct: 121 RDLKPANILLDEHGHVR 137

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  122 bits (308), Expect = 7e-33
 Identities = 59/141 (41%), Positives = 91/141 (64%), Gaps = 1/141 (0%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L   D P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  LH  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI++RDLK +N++LD++GH++
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIK 141

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 7e-33
 Identities = 60/142 (42%), Positives = 84/142 (59%), Gaps = 4/142 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK-SERNILTKVDHP 210
           F   +V+G+G F +V   +   T ++YA K + K +I +K   E M  +E+ IL KV+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSR 60

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHA 268
           F+V L Y+++TK  L LVL  +NGG L F +Y      F E+ A  Y AEI   +  LH 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             I++RDLKPENILLD  GH+R
Sbjct: 121 ERIVYRDLKPENILLDDYGHIR 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  122 bits (307), Expect = 2e-32
 Identities = 58/141 (41%), Positives = 96/141 (68%), Gaps = 1/141 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 270 GIMHRDLKPENILLDADGHVR 290
           G +HRD+KP+N+LLD  GH++
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLK 182

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  118 bits (297), Expect = 7e-32
 Identities = 51/144 (35%), Positives = 80/144 (55%), Gaps = 10/144 (6%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEYMKSERNILTKVD 208
            FE+L+ +G+G F +VY+ R   T +  A+KV+     +  EK   E       IL K  
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEI-----QILKKCK 55

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           HP IV+   S+  K  L++V++F +GG L    +   Q L    +A +   E++  + +L
Sbjct: 56  HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV-CKELLKGLEYL 114

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+NGI+HRD+K  NILL +DG V+
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVK 138

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  120 bits (301), Expect = 8e-32
 Identities = 57/142 (40%), Positives = 93/142 (65%), Gaps = 1/142 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE+LKV+G+GAF +V  V+     +++AMK++ K +++++      + ER++L   D+
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y AE+V A+  +H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HRD+KP+NIL+D +GH+R
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIR 142

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  116 bits (292), Expect = 7e-31
 Identities = 57/141 (40%), Positives = 83/141 (58%), Gaps = 2/141 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ IL KV+  F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHAN 269
           +V L Y+++TK  L LVL  +NGG L F +Y  G   F E+ A  Y AEI+  +  LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 270 GIMHRDLKPENILLDADGHVR 290
             ++RDLKPENILLD  GH+R
Sbjct: 122 NTVYRDLKPENILLDDYGHIR 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  116 bits (291), Expect = 7e-31
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 3/137 (2%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIV 213
           ++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V   D PFIV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
            + Y+F T  +L  +LD +NGG L + L + G+F E   R Y  EI+  + H+H   +++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 274 RDLKPENILLDADGHVR 290
           RDLKP NILLD  GHVR
Sbjct: 121 RDLKPANILLDEHGHVR 137

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  115 bits (290), Expect = 1e-30
 Identities = 58/137 (42%), Positives = 82/137 (59%), Gaps = 4/137 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V   +   T ++YA K + K ++ ++   E    E+ IL KV   FIV L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           +FQTK  L LV+  +NGG L + +Y        F E  A  YTA+I+S + HLH   I++
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 274 RDLKPENILLDADGHVR 290
           RDLKPEN+LLD DG+VR
Sbjct: 121 RDLKPENVLLDNDGNVR 137

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  117 bits (293), Expect = 2e-30
 Identities = 54/141 (38%), Positives = 96/141 (68%), Gaps = 1/141 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED++V+KV+G+GAF +V  VR   + ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL  +FQ    LY+V++++ GG L   L       E  A+ YTAE+V A+  +H+ 
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 270 GIMHRDLKPENILLDADGHVR 290
           G++HRD+KP+N+LLD  GH++
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLK 182

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  115 bits (288), Expect = 4e-30
 Identities = 54/138 (39%), Positives = 89/138 (64%), Gaps = 5/138 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           K++G+G+F KV+     GT++ +A+K ++KD ++  +  E    E+ +L+   +HPF+  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR--IYTAEIVSAVSHLHANGIM 272
           L  +FQTK  L+ V++++NGG L F +  Q   + DL R   Y AEI+  +  LH+ GI+
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118

Query: 273 HRDLKPENILLDADGHVR 290
           +RDLK +NILLD DGH++
Sbjct: 119 YRDLKLDNILLDTDGHIK 136

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  112 bits (282), Expect = 2e-29
 Identities = 58/141 (41%), Positives = 82/141 (58%), Gaps = 2/141 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ IL KV+  F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHAN 269
           +V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AEI   +  LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 270 GIMHRDLKPENILLDADGHVR 290
            I++RDLKPENILLD  GH+R
Sbjct: 122 RIVYRDLKPENILLDDHGHIR 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  112 bits (282), Expect = 3e-29
 Identities = 53/136 (38%), Positives = 84/136 (61%), Gaps = 1/136 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           KV+G+G+F KV      G  E +A+K ++KD ++  +  E    E+ +L    ++PF+  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L  +FQTK  L+ V++F+NGG L F +  +G F    A  Y AEIV  +  LH+ GI++R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 275 DLKPENILLDADGHVR 290
           DLK +N++LD DGH++
Sbjct: 121 DLKLDNVMLDRDGHIK 136

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  109 bits (273), Expect = 3e-28
 Identities = 52/135 (38%), Positives = 85/135 (62%), Gaps = 2/135 (1%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V  V+   T ++YA K + K ++ +K+  +    E+ IL KV+ PFIV L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLHANGIMHRD 275
           +F++K  L LV+  +NGG L + +Y  G    ++ R+  Y+A+I   + HLH+  I++RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 276 LKPENILLDADGHVR 290
           +KPEN+LLD  G+ R
Sbjct: 121 MKPENVLLDDQGNCR 135

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (276), Expect = 5e-28
 Identities = 56/143 (39%), Positives = 86/143 (60%), Gaps = 7/143 (4%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            + +L+ +G+G+F +VY  R     ++ A+KV+ K    +    E    E  IL  ++HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             IV+L   FQ +  LYLV+++V+GG    L  ++ R+G   E  A    A+I+SA+ +L
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 267 HANGIMHRDLKPENILLDADGHV 289
           H+ GI+HRD+KPENILLD DG V
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRV 140

Length = 384

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  108 bits (271), Expect = 2e-27
 Identities = 57/151 (37%), Positives = 85/151 (56%), Gaps = 1/151 (0%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P     +  EDF  ++ +G G+F +V     +       A+K   K KI+++   +++ S
Sbjct: 21  PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80

Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           ER IL  ++HPF V L  SF+ +  LYLVL+FV GG  F  L R   F  D+   Y A+I
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           V    +L +  I++RDLKPEN+LLD DG ++
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIK 171

Length = 340

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 2e-27
 Identities = 44/134 (32%), Positives = 76/134 (56%), Gaps = 1/134 (0%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           ++G+GAF  VY+   + T +  A+K +  +KI E+     M  E ++L  + HP IV+  
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIM-QEIDLLKNLKHPNIVKYI 65

Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
            S +T   LY++L++   G L   + + G F E L  +Y  +++  +++LH  G++HRD+
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125

Query: 277 KPENILLDADGHVR 290
           K  NIL   DG V+
Sbjct: 126 KAANILTTKDGVVK 139

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  106 bits (266), Expect = 3e-27
 Identities = 56/141 (39%), Positives = 81/141 (57%), Gaps = 2/141 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ IL KV+  F
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHAN 269
           +V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AE+   +  L   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 270 GIMHRDLKPENILLDADGHVR 290
            I++RDLKPENILLD  GH+R
Sbjct: 122 RIVYRDLKPENILLDDRGHIR 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  101 bits (253), Expect = 2e-25
 Identities = 46/142 (32%), Positives = 80/142 (56%), Gaps = 5/142 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D E +KV+GQG+   VY+VR   T +IYA+K +  D   ++   + +  E   L   + 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD--GDEEFRKQLLRELKTLRSCES 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED-LARIYTAEIVSAVSHLHA 268
           P++V+   +F  +  + +VL++++GG L   L + G   E  LA I   +I+  + +LH 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYI-ARQILKGLDYLHT 117

Query: 269 N-GIMHRDLKPENILLDADGHV 289
              I+HRD+KP N+L+++ G V
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEV 139

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 8e-24
 Identities = 48/138 (34%), Positives = 74/138 (53%), Gaps = 12/138 (8%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM-RKDKIMEKNHAEYMK-SERNILTKV-D 208
           ++V+K +G G F  VY  R   T E+ A+K M +K    E    E M   E   L K+ +
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE----ECMNLREVKSLRKLNE 56

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSH 265
           HP IV+L+  F+    LY V +++ G    +QL +      F E + R    +I+  ++H
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYMEGN--LYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 266 LHANGIMHRDLKPENILL 283
           +H +G  HRDLKPEN+L+
Sbjct: 115 IHKHGFFHRDLKPENLLV 132

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 1e-23
 Identities = 44/141 (31%), Positives = 79/141 (56%), Gaps = 11/141 (7%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E L+ +G+G +  VY+ R   T EI A+K +R D   E   +  ++ E ++L ++ HP 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPN 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSAVSHL 266
           IV+L     T+ +LYLV ++ +       L      R G    +L +    +++  +++ 
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 267 HANGIMHRDLKPENILLDADG 287
           H++ I+HRDLKP+NIL++ DG
Sbjct: 115 HSHRILHRDLKPQNILINRDG 135

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.7 bits (241), Expect = 1e-23
 Identities = 43/137 (31%), Positives = 77/137 (56%), Gaps = 2/137 (1%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMR--KDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           +++G G+F  VY+   +   + +A+K +    D    +   + ++ E  +L+K+ HP IV
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           Q   + + +  LY+ L+ V GG L   L + G F E + R+YT +I+  + +LH    +H
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125

Query: 274 RDLKPENILLDADGHVR 290
           RD+K  NIL+D +G V+
Sbjct: 126 RDIKGANILVDTNGVVK 142

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 1e-23
 Identities = 51/143 (35%), Positives = 78/143 (54%), Gaps = 11/143 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKV 207
             +EVL VVG+GA+  V + R   T EI A+K   K K  E +      + R +  L ++
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK---KFKESEDDEDVKKTALREVKVLRQL 57

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVS 264
            H  IV L+ +F+ K RLYLV ++V       +L      GL   D  R Y  +++ A++
Sbjct: 58  RHENIVNLKEAFRRKGRLYLVFEYV--ERTLLELLEASPGGL-PPDAVRSYIWQLLQAIA 114

Query: 265 HLHANGIMHRDLKPENILLDADG 287
           + H++ I+HRD+KPENIL+   G
Sbjct: 115 YCHSHNIIHRDIKPENILVSESG 137

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 95.6 bits (238), Expect = 3e-23
 Identities = 43/144 (29%), Positives = 79/144 (54%), Gaps = 5/144 (3%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF+VLK +G+G++  VY+V+R+  ++ YA+K +    + +K   + + +E  IL  V+HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHP 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHL 266
            I+  + +F    +L +V+++   G L   + ++     L  E        +++  +  L
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H   I+HRDLK  NILL A+  V+
Sbjct: 120 HEQKILHRDLKSANILLVANDLVK 143

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 93.6 bits (233), Expect = 2e-22
 Identities = 42/134 (31%), Positives = 75/134 (55%), Gaps = 3/134 (2%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
              +G G F KVY    + T E+ A+K +R      K   E +  E  +L  + HP +V+
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLVK 63

Query: 215 LRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
             Y  +  + ++Y+ +++ +GG L   L    +  E + R+YT +++  +++LH++GI+H
Sbjct: 64  Y-YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122

Query: 274 RDLKPENILLDADG 287
           RD+KP NI LD +G
Sbjct: 123 RDIKPANIFLDHNG 136

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 92.3 bits (229), Expect = 5e-22
 Identities = 48/142 (33%), Positives = 80/142 (56%), Gaps = 4/142 (2%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            + VL+VVG+G+F +   V+ + + + YAMK +R  K    +  E  + E  +L K+ HP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV  + SF+    LY+V+++ +GG L    +L R  LF ED    +  ++   V H+H 
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRD+K +NI L  +G V+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVK 140

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 3e-21
 Identities = 42/144 (29%), Positives = 80/144 (55%), Gaps = 9/144 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-HAEYMKSERNILTKVDHP 210
           +E +  +G+G + +VY+ R   T E+ A+K +R +   EK         E  +L K+ HP
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHP 58

Query: 211 FIVQLRYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHL 266
            IV+L+    +K +  +Y+V ++++  H    L      +   ++I  Y  +++  + +L
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMD--HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+NGI+HRD+K  NIL++ DG ++
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLK 140

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 90.0 bits (224), Expect = 3e-21
 Identities = 48/151 (31%), Positives = 80/151 (52%), Gaps = 12/151 (7%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D+EVL+ +G+G+F  V +VRR    +I   K +    + EK   + + SE NIL ++ HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHP 59

Query: 211 FIVQL--RYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ--GLFREDLARIYTAEIVSAVS 264
            IV+   R   ++   LY+V+++  GG L    Q  ++      E+       +++ A+ 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 265 HLH-----ANGIMHRDLKPENILLDADGHVR 290
             H      N ++HRDLKP NI LDA+ +V+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVK 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 89.9 bits (223), Expect = 3e-21
 Identities = 45/142 (31%), Positives = 79/142 (55%), Gaps = 3/142 (2%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE+L  +G+G+F  V++V R     +YAMK +   K+  +   E +   R +L K+D  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSS 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           +I++   SF  K +L +V+++   G  H   ++ R     ED    +  +I+  ++HLH+
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             I+HRD+K  N+ LDA  +V+
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVK 141

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 45/140 (32%), Positives = 78/140 (55%), Gaps = 9/140 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTKV 207
           ++ L  +G+G +  VY+ R   T EI A+K     KI  +  +E +      E  +L ++
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIK-----KIKLRFESEGIPKTALREIKLLKEL 55

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           +HP I++L   F+ K  LYLV +F++         RQ    E L + Y  +++  ++  H
Sbjct: 56  NHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 268 ANGIMHRDLKPENILLDADG 287
           ++GI+HRDLKPEN+L++ +G
Sbjct: 116 SHGILHRDLKPENLLINTEG 135

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.6 bits (220), Expect = 1e-20
 Identities = 45/144 (31%), Positives = 80/144 (55%), Gaps = 5/144 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D+E+++V+G GA A VY    +  +E  A+K +  +K  + +  E  K E   +++ +H
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRK-EVQAMSQCNH 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +V+   SF     L+LV+ +++GG    +    Y +G   E +      E++  + +L
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+NG +HRD+K  NILL  DG V+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVK 142

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.1 bits (218), Expect = 1e-20
 Identities = 49/140 (35%), Positives = 77/140 (55%), Gaps = 3/140 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G+G+F K+Y  +    SE   +K +   K M     E  K E  +L K+ HP 
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           IV    SFQ   RL++V+++ +GG L  ++ RQ   LF ED    +  +I   + H+H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 270 GIMHRDLKPENILLDADGHV 289
            I+HRD+K +NI L  +G V
Sbjct: 121 KILHRDIKSQNIFLSKNGMV 140

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 87.8 bits (218), Expect = 3e-20
 Identities = 38/144 (26%), Positives = 72/144 (50%), Gaps = 6/144 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D E L  +G G    V +V    T +I A+K +R +             E +IL K + 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR--ELDILHKCNS 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P+IV    +F     + + +++++GG L    +  +  +    L +I  A ++  +++LH
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTYLH 117

Query: 268 AN-GIMHRDLKPENILLDADGHVR 290
               I+HRD+KP NIL+++ G ++
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIK 141

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 4e-20
 Identities = 47/144 (32%), Positives = 83/144 (57%), Gaps = 6/144 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            ED+E+++ +G G +  VY+ R I T E+ A+KV+   K+   +  E ++ E ++L +  
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR 58

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           HP IV    S+  + +L++V+++  GG L   +Q+ R  L    +A +   E +  +++L
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYV-CRETLKGLAYL 117

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H  G +HRD+K  NILL  DG V+
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVK 141

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 87.3 bits (217), Expect = 4e-20
 Identities = 39/145 (26%), Positives = 72/145 (49%), Gaps = 11/145 (7%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            +++L  +G+GA   V++ +   T E  A+K +   ++      + ++ E   L    HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHP 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSAVSH 265
           ++V+L   F       LV++++        L       +    E   + Y   ++  V++
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           +HANGIMHRDLKP N+L+ ADG ++
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLK 139

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 86.4 bits (214), Expect = 5e-20
 Identities = 47/141 (33%), Positives = 77/141 (54%), Gaps = 3/141 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +  +K +G+G+F K   V+     + Y +K +   K+  K   E  K E  +L+ + HP 
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK-EVAVLSNMKHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           IVQ + SF+    LY+V+D+  GG L+ ++  Q   LF ED    +  +I  A+ H+H  
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
            I+HRD+K +NI L  DG ++
Sbjct: 121 KILHRDIKSQNIFLTKDGTIK 141

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 86.2 bits (214), Expect = 7e-20
 Identities = 38/143 (26%), Positives = 79/143 (55%), Gaps = 8/143 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F++L+ +G+G++  VY+     T ++ A+KV+  +        + +  E +IL + D 
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDS 57

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P+IV+   S+     L++V+++   G +    ++  + L  E++A I   + +  + +LH
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI-LYQTLKGLEYLH 116

Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +N  +HRD+K  NILL+ +G  +
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAK 139

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 1e-19
 Identities = 45/139 (32%), Positives = 79/139 (56%), Gaps = 7/139 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMK-------VMRKDKIMEKNHAEYMKSERNILTKVD 208
           +++G+G + +VY    + T E+ A+K       +  +    +K+  + ++SE   L  +D
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IVQ      T+  L + L++V GG +   L   G F E L R +T +++  +++LH+
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126

Query: 269 NGIMHRDLKPENILLDADG 287
            GI+HRDLK +N+L+DADG
Sbjct: 127 KGILHRDLKADNLLVDADG 145

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 1e-19
 Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 2/137 (1%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKVDHPFIV 213
           K++GQGAF +VY    + T    A+K +  D      K     ++ E  +L  + H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           Q     +    L + ++++ GG +  QL   G   E + R YT +I+  V +LH+N I+H
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127

Query: 274 RDLKPENILLDADGHVR 290
           RD+K  NIL D+ G+V+
Sbjct: 128 RDIKGANILRDSAGNVK 144

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 40/141 (28%), Positives = 77/141 (54%), Gaps = 7/141 (4%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           ++ L+ +G+GA  +VY+     T +  A+K MR    + K + E + +E  I+    HP 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIYTAEIVSAVSHLHAN 269
           IV    S+     L++V+++++GG L   + +  +      +A +   E++  + +LH+ 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135

Query: 270 GIMHRDLKPENILLDADGHVR 290
            ++HRD+K +NILL  DG V+
Sbjct: 136 NVIHRDIKSDNILLSKDGSVK 156

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 15/152 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
             FE+++V+G+G + KVY+ R   T ++ A+K+M   +  E    E +K E NIL K  +
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSN 61

Query: 209 HPFIVQLRYSFQTK------YRLYLVLDFVNGG---HLFFQLYRQG-LFREDLARIYTAE 258
           HP I     +F  K       +L+LV++   GG    L   L ++G   +E+       E
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +  +++LH N ++HRD+K +NILL  +  V+
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVK 153

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 41/145 (28%), Positives = 77/145 (53%), Gaps = 11/145 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM----RKDKIMEKNHAEYMKSERNILT 205
           E F +L+ +G+G+F +VY+     T+++ A+KV+     +D+I      E ++ E   L+
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI------EDIQQEIQFLS 54

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +   P+I +   SF    +L++++++  GG     L + G   E        E++  + +
Sbjct: 55  QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVLLGLEY 113

Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH  G +HRD+K  NILL  +G V+
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVK 138

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.4 bits (206), Expect = 8e-19
 Identities = 43/135 (31%), Positives = 74/135 (54%), Gaps = 3/135 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E ++VVG+GAF  V+  RR    ++  +K +  ++ M K+     ++E  +L  + HP 
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ-MTKDERLAAQNECQVLKLLSHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           I++   +F     L +V+++  GG L  + Q     L  ED    +  +I+ A+ H+H  
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 270 GIMHRDLKPENILLD 284
            I+HRDLK +NILLD
Sbjct: 121 LILHRDLKTQNILLD 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.0 bits (206), Expect = 2e-18
 Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 32/156 (20%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDH 209
           +E  K +G+G +A VY+ R   T  I A+K ++  +  E        + R I  L ++ H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--------------- 254
           P I+ L   F  K  + LV +F+                 DL ++               
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMET---------------DLEKVIKDKSIVLTPADIKS 106

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           Y    +  + +LH+N I+HRDLKP N+L+ +DG ++
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLK 142

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.8 bits (202), Expect = 3e-18
 Identities = 38/136 (27%), Positives = 76/136 (55%), Gaps = 3/136 (2%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVM---RKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           + +G GAF+  YQ R + T  + A+K +   R     ++   E ++ E  ++ +++HP I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           +++  +        L ++++ GG +   L + G F+E +   YT +++  +S+LH N I+
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125

Query: 273 HRDLKPENILLDADGH 288
           HRD+K  N+L+D+ G 
Sbjct: 126 HRDVKGANLLIDSTGQ 141

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.0 bits (200), Expect = 8e-18
 Identities = 39/140 (27%), Positives = 80/140 (57%), Gaps = 2/140 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++HP 
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H++ 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 271 IMHRDLKPENILLDADGHVR 290
           ++HRDLKP+N+L++ +G ++
Sbjct: 121 VLHRDLKPQNLLINTEGAIK 140

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 79.8 bits (197), Expect = 1e-17
 Identities = 45/141 (31%), Positives = 77/141 (54%), Gaps = 3/141 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +  ++V+G+GAF +    RR     +   K +   ++ EK   + + +E  IL+ + HP 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILSLLQHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           I+     F     L + +++ NGG L+ ++ RQ   LF E++   Y  +IVSAVS++H  
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRD+K  NI L   G ++
Sbjct: 121 GILHRDIKTLNIFLTKAGLIK 141

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.4 bits (196), Expect = 3e-17
 Identities = 41/146 (28%), Positives = 78/146 (53%), Gaps = 4/146 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F++ K +G+G F+ VY+   +    + A+K ++  ++M+    +    E ++L ++D
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQG-LFREDLARIYTAEIVSAVS 264
           HP +++   SF     L +VL+  + G    +     +Q  L  E     Y  ++ SA+ 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 265 HLHANGIMHRDLKPENILLDADGHVR 290
           H+H+  IMHRD+KP N+ + A G V+
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVK 146

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 79.3 bits (195), Expect = 4e-17
 Identities = 51/145 (35%), Positives = 81/145 (55%), Gaps = 9/145 (6%)

Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           E+F E++  +G GAF KVY+ +   T  + A KV+  D   E+   +YM  E +IL   D
Sbjct: 4   EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   R+   + + A+++
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNY 118

Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH N I+HRDLK  NIL   DG ++
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIK 143

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 76.6 bits (188), Expect = 2e-16
 Identities = 43/141 (30%), Positives = 74/141 (52%), Gaps = 3/141 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE+++ +G G +  VY+ R + T E+ A+KV+   K+        ++ E  ++    H
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKH 65

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV    S+  + +L++ ++F  GG L    +  G   E      + E +  + +LH+ 
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 270 GIMHRDLKPENILLDADGHVR 290
           G MHRD+K  NILL  +GHV+
Sbjct: 126 GKMHRDIKGANILLTDNGHVK 146

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 4e-16
 Identities = 41/142 (28%), Positives = 79/142 (55%), Gaps = 12/142 (8%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTKV 207
           ++ ++ +G+G +  VY+ R   T EI A+K     KI  +   E + S    E ++L ++
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKEL 55

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +HP IV+L     ++ +LYLV +F++             GL    L + Y  +++  +++
Sbjct: 56  NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAY 114

Query: 266 LHANGIMHRDLKPENILLDADG 287
            H++ ++HRDLKP+N+L+D +G
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREG 136

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 76.2 bits (187), Expect = 4e-16
 Identities = 45/148 (30%), Positives = 81/148 (54%), Gaps = 13/148 (8%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE+++VVG G + +VY+ R + T ++ A+KVM     + ++  E +K E N+L K  H  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73

Query: 212 IVQLRY-SFQTKY------RLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            +   Y +F  K       +L+LV++F   G +    +  +    +ED       EI+  
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           ++HLHA+ ++HRD+K +N+LL  +  V+
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVK 161

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.8 bits (186), Expect = 6e-16
 Identities = 48/144 (33%), Positives = 83/144 (57%), Gaps = 8/144 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+  +   E+   +YM  E  IL   +H
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYM-VEIEILATCNH 68

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P+IV+L  +F    +L+++++F  GG    +  +L R GL  E   ++   +++ A+ +L
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR-GL-TEPQIQVICRQMLEALQYL 126

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  I+HRDLK  N+LL  DG ++
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIK 150

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 75.2 bits (186), Expect = 6e-16
 Identities = 42/144 (29%), Positives = 73/144 (50%), Gaps = 7/144 (4%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNILTKVD 208
            E+ K +G+GAF +VY+    G  E    KV     K+   E+   E+++ E +I+ K+ 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLE-EASIMKKLS 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           HP IV+L         LY+V +++ GG L  F + + + L  +DL +    +I   + +L
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQ-MALQIAKGMEYL 118

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
            +   +HRDL   N L+  +  V+
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVK 142

Length = 258

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.5 bits (186), Expect = 8e-16
 Identities = 51/144 (35%), Positives = 79/144 (54%), Gaps = 7/144 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEYMKSERNILTKV 207
           E +E L +VG+G++  V + +   T +I A+K     +D  M K  A  M+ E  +L ++
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA--MR-EIRMLKQL 57

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            H  +V L   F+ K RLYLV +FV+   L   + Y  GL  E   R Y  +I+  +   
Sbjct: 58  RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGL-DESRVRKYLFQILRGIEFC 116

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H++ I+HRD+KPENIL+   G V+
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVK 140

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 43/146 (29%), Positives = 77/146 (52%), Gaps = 21/146 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--DKIMEKNHAEYMKSERNILTKV-D 208
           +++L  +G+G F++V + +   T + YA+K M+K    + + N+      E   L ++  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL----REIQALRRLSP 56

Query: 209 HPFIVQLR---YSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIV 260
           HP I++L    +  +T  RL LV + ++       LY     R+    E   + Y  +++
Sbjct: 57  HPNILRLIEVLFDRKTG-RLALVFELMDM-----NLYELIKGRKRPLPEKRVKSYMYQLL 110

Query: 261 SAVSHLHANGIMHRDLKPENILLDAD 286
            ++ H+H NGI HRD+KPENIL+  D
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD 136

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 1e-15
 Identities = 45/144 (31%), Positives = 80/144 (55%), Gaps = 8/144 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E++  +G GAF KVY+ +   T    A K++   +I  +   E    E +IL++  H
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECKH 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P IV L  ++  + +L+++++F +GG L     +L R     E   R    +++ A++ L
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H++ ++HRDLK  NILL  DG V+
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVK 143

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 14/150 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E L  +G+GA+  VY+ R + T    A+K +R   +        + + R I     L  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57

Query: 207 VDHPFIVQLRYSFQTKYR-----LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIV 260
            +HP IV+L              L LV + V+     +     +     +  +    +++
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
             V  LH++ I+HRDLKP+NIL+ +DG V+
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVK 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 73.3 bits (180), Expect = 3e-15
 Identities = 40/130 (30%), Positives = 63/130 (48%), Gaps = 8/130 (6%)

Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           G   KV  V    T + + +K +RK        +EY +    I+     P +V L     
Sbjct: 4   GVIDKVLLVMDTRTQQTFILKGLRKS-------SEYSRERLTIIPHC-VPNMVCLHKYIV 55

Query: 221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN 280
           ++  ++LVL    GG L+  + +     E+  + + AE+V A+  LH  GI+ RDL P N
Sbjct: 56  SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115

Query: 281 ILLDADGHVR 290
           ILLD  GH++
Sbjct: 116 ILLDDRGHIQ 125

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 73.3 bits (181), Expect = 3e-15
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 18/149 (12%)

Query: 156 KVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K +G+GAF +VY+     + G +   A+K +++D   E+   +++K E  ++ K+ HP +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA-SEEERKDFLK-EARVMKKLGHPNV 58

Query: 213 VQLR-YSFQTKYRLYLVLDFVNGGHL----------FFQLYRQGLFREDLARIYTAEIVS 261
           V+L       +  LYLVL+++ GG L          F    +  L  +DL      +I  
Sbjct: 59  VRLLGVCT-EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQIAK 116

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVR 290
            + +L +   +HRDL   N L+  D  V+
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVK 145

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.5 bits (183), Expect = 4e-15
 Identities = 45/146 (30%), Positives = 78/146 (53%), Gaps = 14/146 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           L + E +  +G GA   VY+V    T  +YA+KV+        NH + ++     E  IL
Sbjct: 73  LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG------NHEDTVRRQICREIEIL 126

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
             V+HP +V+    F     + ++L+F++GG L         F  D+AR    +I+S ++
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIA 182

Query: 265 HLHANGIMHRDLKPENILLDADGHVR 290
           +LH   I+HRD+KP N+L+++  +V+
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVK 208

Length = 353

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 73.0 bits (180), Expect = 4e-15
 Identities = 37/142 (26%), Positives = 70/142 (49%), Gaps = 8/142 (5%)

Query: 155 LKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            K +G+GAF +VY+     +  G     A+K +++D   E+   E+++ E  I+ K+DHP
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLR-EARIMRKLDHP 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+L      +  L +V++++ GG L  + +  R           +  +I   + +L +
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HRDL   N L+  +  V+
Sbjct: 122 KNFIHRDLAARNCLVGENLVVK 143

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 73.5 bits (180), Expect = 4e-15
 Identities = 45/135 (33%), Positives = 70/135 (51%), Gaps = 1/135 (0%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FEVL VVG+GA+  V + R   T EI A+K   KD    +   E    E  +L  +    
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L+ +F+ + +LYLV ++V    L            +  R Y  +++ A+   H N I
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121

Query: 272 MHRDLKPENILLDAD 286
           +HRD+KPEN+L+  +
Sbjct: 122 VHRDIKPENLLISHN 136

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.8 bits (178), Expect = 6e-15
 Identities = 41/147 (27%), Positives = 82/147 (55%), Gaps = 6/147 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F++ K +G+G F++VY+   +   +  A+K ++  ++M+    +    E ++L +++
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL-----FFQLYRQGLFREDLARIYTAEIVSAV 263
           HP +++   SF     L +VL+  + G L     +F+  ++ L  E     Y  ++ SAV
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKR-LIPERTVWKYFVQLCSAV 119

Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            H+H+  +MHRD+KP N+ + A G V+
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVK 146

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.4 bits (177), Expect = 9e-15
 Identities = 45/145 (31%), Positives = 80/145 (55%), Gaps = 4/145 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKV 207
            ++ + K++G+GAF +VY      T    A+K +  D   ++   E   ++ E  +L  +
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 208 DHPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
            H  IVQ     +   + +L + ++++ GG +  QL   G   E++ R YT +I+  VS+
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121

Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH+N I+HRD+K  NIL D+ G+V+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVK 146

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 1e-14
 Identities = 35/141 (24%), Positives = 77/141 (54%), Gaps = 6/141 (4%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-- 209
           ++ L+++G+GA+  VY+ + + T  + A+K++  D     +    ++ E  +L+++    
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQ 60

Query: 210 -PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            P I +   S+    RL++++++  GG +   L + G   E    +   E++ A+ ++H 
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVALKYIHK 119

Query: 269 NGIMHRDLKPENILLDADGHV 289
            G++HRD+K  NIL+   G+V
Sbjct: 120 VGVIHRDIKAANILVTNTGNV 140

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.8 bits (176), Expect = 1e-14
 Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 18/154 (11%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIY-AMK-------VMRKDKIMEKNHAEYMKSERNI 203
           + VL+ +G GAF  VY+VR+    +   A+K          KDK         + SE  I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 204 LTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNG---GHLFFQLY-RQGLFREDLARIYT-- 256
           + + + HP IV+   +F    RLY+V+D + G   G  F  L  ++  F E+  RI+   
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE--RIWNIF 119

Query: 257 AEIVSAVSHLHANG-IMHRDLKPENILLDADGHV 289
            ++V A+ +LH    I+HRDL P NI+L  D  V
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKV 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 71.8 bits (176), Expect = 1e-14
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 6/140 (4%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA------EYMKSERNILTKVDHP 210
           ++G G+F  VY      + E+ A+K +    +   +        + +  E  +L ++ H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IVQ   S      L + L++V GG +   L   G F E L R +  +I+  +++LH  G
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRD+K  NIL+D  G ++
Sbjct: 127 IIHRDIKGANILVDNKGGIK 146

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 71.4 bits (176), Expect = 1e-14
 Identities = 40/142 (28%), Positives = 76/142 (53%), Gaps = 9/142 (6%)

Query: 155 LKVVGQGAFAKVYQ---VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            K +G+GAF +VY+     + G  ++  A+K +++D   E+   E+++ E  I+ K+DHP
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLR-EARIMRKLDHP 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            +V+L      +  LY+V++++ GG L  + +  R  L   DL   +  +I   + +L +
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLS-FALQIARGMEYLES 120

Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HRDL   N L+  +  V+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVK 142

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 71.3 bits (175), Expect = 2e-14
 Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 6/155 (3%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
            +  +     L D E L  +G G   +VY++R   T  + A+K MR+    E+N    M 
Sbjct: 4   TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD 63

Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYT 256
            +  +L   D P+IV+    F T   +++ ++ +       +L +  QG   ED+    T
Sbjct: 64  LDV-VLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMT 120

Query: 257 AEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR 290
             IV A+ +L    G++HRD+KP NILLDA G+V+
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVK 155

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 71.0 bits (174), Expect = 3e-14
 Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 11/150 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E L+ +G+G + KVY+ R   T ++ A+K  R +   E      ++ E ++L  +  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSE 59

Query: 210 -PFIVQLRYSFQT-----KYRLYLVLDFVNGG-HLFFQLYRQGLFR---EDLARIYTAEI 259
             +IV+L           K  LYLV ++++     F     +G  R       + +  ++
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHV 289
           +  V+H H +G+MHRDLKP+N+L+D    +
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGL 149

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 40/147 (27%), Positives = 77/147 (52%), Gaps = 6/147 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F + K +G+G F++VY+   +      A+K ++   +M+         E ++L +++
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL-----FFQLYRQGLFREDLARIYTAEIVSAV 263
           HP +++   SF     L +VL+  + G L      F+  ++ L  E     Y  ++ SA+
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR-LIPEKTVWKYFVQLCSAL 119

Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            H+H+  +MHRD+KP N+ + A G V+
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVK 146

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.1 bits (171), Expect = 5e-14
 Identities = 45/139 (32%), Positives = 75/139 (53%), Gaps = 4/139 (2%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDHPFIV 213
           K++GQGAF +VY    + T    A K ++ D    +   E   ++ E  +L  + H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 214 QLRYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           Q     + +    L + ++++ GG +  QL   G   E + R YT +I+  +S+LH+N I
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 272 MHRDLKPENILLDADGHVR 290
           +HRD+K  NIL D+ G+V+
Sbjct: 128 VHRDIKGANILRDSAGNVK 146

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 69.3 bits (169), Expect = 9e-14
 Identities = 47/140 (33%), Positives = 75/140 (53%), Gaps = 6/140 (4%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDHPFIV 213
           K++GQGAF +VY      T    A+K ++ D    +   E   ++ E  +L  + H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 214 QLRYSF---QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           Q  Y       +  L + ++ + GG +  QL   G   E++ R YT +I+  VS+LH+N 
Sbjct: 68  QY-YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126

Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRD+K  NIL D+ G+V+
Sbjct: 127 IVHRDIKGANILRDSVGNVK 146

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.4 bits (169), Expect = 1e-13
 Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 13/148 (8%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE++++VG G + +VY+ R + T ++ A+KVM     +  +  E +K E N+L K  H  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63

Query: 212 IVQLRYSFQTKY-------RLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            +   Y    K        +L+LV++F   G +    +  +    +E+       EI+  
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           +SHLH + ++HRD+K +N+LL  +  V+
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVK 151

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.9 bits (168), Expect = 1e-13
 Identities = 39/141 (27%), Positives = 75/141 (53%), Gaps = 3/141 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D+E+++ VG G +  VY+ R + T E+ A+K++   K+   +    ++ E  ++ +  H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKH 65

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV    S+ ++ +L++ +++  GG L    +  G   E        E +  +++LH+ 
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 270 GIMHRDLKPENILLDADGHVR 290
           G MHRD+K  NILL  +G V+
Sbjct: 126 GKMHRDIKGANILLTDNGDVK 146

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 68.3 bits (167), Expect = 3e-13
 Identities = 38/148 (25%), Positives = 76/148 (51%), Gaps = 18/148 (12%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F+ L+ +G+G +A VY+ R   T EI A+K +  D   E+        E +++ ++ H  
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHEN 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNG---------GHLFFQLYRQGLFREDLARIYTAEIVSA 262
           IV+L     T+ +L LV ++++          G        +G    +  + +T +++  
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGV-------RGALDPNTVKSFTYQLLKG 112

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           ++  H N ++HRDLKP+N+L++  G ++
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELK 140

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.0 bits (166), Expect = 3e-13
 Identities = 44/141 (31%), Positives = 79/141 (56%), Gaps = 6/141 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D +  +++G G    VY+   + T  I A+KV+  D  +E    + + SE  IL K D 
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDS 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P+I+    +F  + R+ +  +F++GG L   +YR+ +    L RI  A +V  +++L + 
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL--DVYRK-IPEHVLGRIAVA-VVKGLTYLWSL 114

Query: 270 GIMHRDLKPENILLDADGHVR 290
            I+HRD+KP N+L++  G V+
Sbjct: 115 KILHRDVKPSNMLVNTRGQVK 135

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 43/147 (29%), Positives = 79/147 (53%), Gaps = 13/147 (8%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTK 206
           D+  ++ +G+G +  VY+ R   T +I AMK     KI  ++  E + S    E ++L +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKE 55

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           + HP IV L+     + RLYL+ +F++     +L   L +      +L + Y  +I+  +
Sbjct: 56  LQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLD-SLPKGQYMDAELVKSYLYQILQGI 114

Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
              H+  ++HRDLKP+N+L+D  G ++
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIK 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 67.3 bits (164), Expect = 5e-13
 Identities = 44/134 (32%), Positives = 73/134 (54%), Gaps = 8/134 (5%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           ++VVG+G++ +V  VR     + Y +K +  R     E+  AE    E  +L+++ HP I
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE---QEAQLLSQLKHPNI 61

Query: 213 VQLRYSFQTK-YRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           V  R S++ +   LY+V+ F  GG L+ +L  Q   L  E+    +  +I  A+ +LH  
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 270 GIMHRDLKPENILL 283
            I+HRDLK +N+ L
Sbjct: 122 HILHRDLKTQNVFL 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 67.2 bits (165), Expect = 5e-13
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 25/151 (16%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
           C  ++++E L  + +G +  VY+ R   T EI A+K ++ +K  E      ++ E NIL 
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILL 59

Query: 206 KVDHPFIVQLRY----SFQTKYRLYLVLDFV---------NGGHLFFQLYRQGLFREDLA 252
           K+ HP IV ++     S   K  +Y+V+++V              F Q   + L  + L 
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDK--IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL- 116

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILL 283
                   S V+HLH N I+HRDLK  N+LL
Sbjct: 117 --------SGVAHLHDNWILHRDLKTSNLLL 139

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 38/139 (27%), Positives = 75/139 (53%), Gaps = 3/139 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G+G+F +VY+     T E+ A+K++  D    ++  E ++ E  +L++ D P+
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I +   S+    +L+++++++ GG     L + G   E        EI+  + +LH+   
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERK 122

Query: 272 MHRDLKPENILLDADGHVR 290
           +HRD+K  N+LL   G V+
Sbjct: 123 IHRDIKAANVLLSEQGDVK 141

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 21/156 (13%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +I A+K     K++ +N  E        E 
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREI 62

Query: 202 NILTKVDHPFIVQL------RYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L      + +   +Y+   YLV +F    H    L      +  L+ 
Sbjct: 63  KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE--HDLAGLLSNKNVKFTLSE 120

Query: 254 IYTA--EIVSAVSHLHANGIMHRDLKPENILLDADG 287
           I      +++ + ++H N I+HRD+K  NIL+  DG
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG 156

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 23/160 (14%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  L D+E+L  +G+G F +VY+ R+I T  + A+K     KI+  N  +        E 
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREI 58

Query: 202 NILTKVDHPFIVQL-----RYSFQTKYRL---YLVLDFVN---GGHLFFQLYRQGLFRED 250
            IL K+ HP +V L         ++K +    Y+V  +++    G L     +     E 
Sbjct: 59  KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTES 115

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             + Y  +++  +++LH N I+HRD+K  NIL+D  G ++
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILK 155

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.5 bits (159), Expect = 2e-12
 Identities = 38/141 (26%), Positives = 77/141 (54%), Gaps = 3/141 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L R G F E        EI+  + +LH+ 
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
             +HRD+K  N+LL   G V+
Sbjct: 121 KKIHRDIKAANVLLSEQGDVK 141

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 64.3 bits (157), Expect = 6e-12
 Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 14/150 (9%)

Query: 152 FEVLKVV---GQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
              LK +   G+G F KV   R       T E  A+K +      E+ H    + E  IL
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS--GEEQHRSDFEREIEIL 60

Query: 205 TKVDHPFIVQLRYSFQTKYR--LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
             +DH  IV+ +   +      L L+++++  G L  + Q +R  +  + L   ++++I 
Sbjct: 61  RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FSSQIC 119

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
             + +L +   +HRDL   NIL++++  V+
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVK 149

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 37/138 (26%), Positives = 72/138 (52%), Gaps = 4/138 (2%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMR---KDKIMEKNHAEYMKSERNILTKVDHPFI 212
           +V+G+GA+  VY        ++ A+K +     + +  +   E ++ E ++L  + H  I
Sbjct: 6   EVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           VQ   +      + + ++FV GG +   L R G   E +   YT +I+  V++LH N ++
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124

Query: 273 HRDLKPENILLDADGHVR 290
           HRD+K  N++L  +G ++
Sbjct: 125 HRDIKGNNVMLMPNGIIK 142

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 20/153 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTK 206
           E    L  +G+GA   V + R   T  I+A+K      I    + +  K    E  I   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKT-----ITTDPNPDLQKQILRELEINKS 55

Query: 207 VDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFFQLYRQGLFREDLARI------YTAE 258
              P+IV+   +F  +    + + +++  GG L   +Y++   ++   RI        AE
Sbjct: 56  CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKK--VKKRGGRIGEKVLGKIAE 112

Query: 259 -IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            ++  +S+LH+  I+HRD+KP NILL   G V+
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVK 145

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 3/116 (2%)

Query: 174 TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-YRLYLVLDFV 232
           T    A+K++R D   E++     + E  +  ++ HP IV L  S +     L+ V ++V
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 233 NGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG 287
            G  L   L   G L   +  R+   +++ A++  H  GI+HRDLKP+NI++   G
Sbjct: 62  PGRTLREVLAADGALPAGETGRLML-QVLDALACAHNQGIVHRDLKPQNIMVSQTG 116

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 20/154 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
           + +E+++ +G+G + KVY+V       + A+K++  D I + +  E +++E NIL  + +
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVD--EEIEAEYNILQSLPN 77

Query: 209 HPFIVQLRYSF--QTKY---RLYLVLDFVNGG---HLFFQLYRQGLFREDLARI----YT 256
           HP +V+    F    K    +L+LVL+  NGG    L   L   G  R D A I    Y 
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYG 136

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           A +   + HLH N I+HRD+K  NILL  +G V+
Sbjct: 137 ALL--GLQHLHNNRIIHRDVKGNNILLTTEGGVK 168

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 62.8 bits (152), Expect = 2e-11
 Identities = 35/141 (24%), Positives = 76/141 (53%), Gaps = 3/141 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  ++   ++  E ++ E  +L++ D 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDS 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 270 GIMHRDLKPENILLDADGHVR 290
             +HRD+K  N+LL   G V+
Sbjct: 121 KKIHRDIKAANVLLSEHGEVK 141

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 42/146 (28%), Positives = 76/146 (52%), Gaps = 11/146 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILT 205
           E +E L  +G+G++  V++ R   T +I A+K     K +E      +K     E  +L 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLK 55

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVS 264
           ++ HP +V L   F+ K +L+LV ++ +   L   +   +G+  E L +    + + AV+
Sbjct: 56  QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVN 114

Query: 265 HLHANGIMHRDLKPENILLDADGHVR 290
             H +  +HRD+KPENIL+   G ++
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIK 140

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 42/154 (27%), Positives = 79/154 (51%), Gaps = 15/154 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ F+++  +G+G + +VY+ R   T E+ A+K +R D   E      ++ E  IL +++
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLN 64

Query: 209 HPFIVQLR---------YSF-QTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYT 256
           H  IV L+           F + K   YLV ++++  H    L   GL  F ED  + + 
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--HDLMGLLESGLVHFSEDHIKSFM 122

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +++  +++ H    +HRD+K  NILL+  G ++
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIK 156

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.8 bits (152), Expect = 3e-11
 Identities = 37/142 (26%), Positives = 76/142 (53%), Gaps = 4/142 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK-SERNILTKVD 208
           + +E L+ +G+G++A VY+ +     ++ A+KV+R   + E+    +    E ++L  + 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLK 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     TK  L LV ++V+     +     G    +  +++  +++  +S++H 
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             I+HRDLKP+N+L+   G ++
Sbjct: 122 RYILHRDLKPQNLLISDTGELK 143

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 19/163 (11%)

Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           D+ P  +     + +E+++ +G+G + KV++V         A+K++  D I + +  E +
Sbjct: 11  DSFPDPS-----DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDID--EEI 61

Query: 198 KSERNILTKV-DHPFIVQL-----RYSFQTKYRLYLVLDFVNGGHLF----FQLYRQGLF 247
           ++E NIL  + DHP +V+      +   +   +L+LVL+  NGG +       L R    
Sbjct: 62  EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            E +      E +  + HLH N  +HRD+K  NILL  +G V+
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVK 164

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 32/159 (20%)

Query: 152 FEVLKVVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEY----MKSERNI-- 203
           +E+   +G+G + +VY+ +R      + YA+K  + DK       +Y      + R I  
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDK------EQYTGISQSACREIAL 55

Query: 204 LTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTA- 257
           L ++ H  +V L   F       +YL+ D+    H  +Q+   +RQ         I  + 
Sbjct: 56  LRELKHENVVSLVEVFLEHADKSVYLLFDYAE--HDLWQIIKFHRQ----AKRVSIPPSM 109

Query: 258 ------EIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
                 +I++ V +LH+N ++HRDLKP NIL+  +G  R
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 38/138 (27%), Positives = 83/138 (60%), Gaps = 4/138 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E ++ +G+G +  VY+ R   T+E  A+K +R ++  E   +  ++ E ++L ++ 
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQ 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED--LARIYTAEIVSAVSHL 266
           H  IV+L+    ++ RLYLV ++++   L   +     F ++  L + Y  +I+  +++ 
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 267 HANGIMHRDLKPENILLD 284
           H++ ++HRDLKP+N+L+D
Sbjct: 119 HSHRVLHRDLKPQNLLID 136

Length = 294

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 62.2 bits (152), Expect = 3e-11
 Identities = 39/141 (27%), Positives = 72/141 (51%), Gaps = 15/141 (10%)

Query: 149 LEDFEV---LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK--IMEKNHAEYMKSERNI 203
           L++ E+   LK++  G F KV  ++   T +++  K+++      +E    + MK     
Sbjct: 13  LKNCEIVKKLKLI-DGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMK----- 66

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
               D+P  ++L YS  T     L++D++  G LF  L ++G   E   +    ++V A+
Sbjct: 67  ----DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122

Query: 264 SHLHANGIMHRDLKPENILLD 284
           + LH + I+H D+K EN+L D
Sbjct: 123 NDLHKHNIIHNDIKLENVLYD 143

Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 40/141 (28%), Positives = 73/141 (51%), Gaps = 4/141 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +    +G+G+   V       T    A+K M    + ++   E + +E  I+    H
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQH 75

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV++  S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA 
Sbjct: 76  PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA-VLKALSFLHAQ 134

Query: 270 GIMHRDLKPENILLDADGHVR 290
           G++HRD+K ++ILL +DG V+
Sbjct: 135 GVIHRDIKSDSILLTSDGRVK 155

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 40/133 (30%), Positives = 70/133 (52%), Gaps = 4/133 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A+K M   +  +K   E + +E  ++ +  HP IV    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 142

Query: 278 PENILLDADGHVR 290
            +NILL  DG V+
Sbjct: 143 SDNILLGMDGSVK 155

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 43/146 (29%), Positives = 80/146 (54%), Gaps = 8/146 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ EVL  +G+G +  VY+V    T    AMK +R +  ++++    +  E +IL K   
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR----EDLARIYTAEIVSAVSH 265
           P+IV    +F  +  +Y+ +++++ G L  +LY  G+      ED+ R  T  +V  +  
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 266 L-HANGIMHRDLKPENILLDADGHVR 290
           L   + I+HRD+KP N+L++ +G V+
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVK 143

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 36/140 (25%), Positives = 74/140 (52%), Gaps = 2/140 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R + T+E+ A+K M           + +  E   L ++ HP 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 212 IVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            ++ +  +  ++  +LV+++  G      +++++ L   ++A I T   +  +++LH++ 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI-THGALQGLAYLHSHN 145

Query: 271 IMHRDLKPENILLDADGHVR 290
           ++HRD+K  NILL   G V+
Sbjct: 146 MIHRDIKAGNILLTEPGQVK 165

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 35/140 (25%), Positives = 72/140 (51%), Gaps = 2/140 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R + T+E+ A+K M           + +  E   L ++ HP 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            ++ +  +  ++  +LV+++  G      +++++ L   ++A I     +  +++LH++ 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI-CHGALQGLAYLHSHE 135

Query: 271 IMHRDLKPENILLDADGHVR 290
            +HRD+K  NILL   G V+
Sbjct: 136 RIHRDIKAGNILLTEPGTVK 155

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 38/140 (27%), Positives = 73/140 (52%), Gaps = 2/140 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ HP 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 212 IVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            +Q R  +  ++  +LV+++  G      +++++ L   ++A + T   +  +++LH++ 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV-THGALQGLAYLHSHN 135

Query: 271 IMHRDLKPENILLDADGHVR 290
           ++HRD+K  NILL   G V+
Sbjct: 136 MIHRDVKAGNILLSEPGLVK 155

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 59.0 bits (142), Expect = 4e-10
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 4/133 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    I T +  A+K M    + ++   E + +E  ++ +  +P IV    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALDFLHSNQVIHRDIK 142

Query: 278 PENILLDADGHVR 290
            +NILL  DG V+
Sbjct: 143 SDNILLGMDGSVK 155

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 8e-10
 Identities = 43/142 (30%), Positives = 73/142 (51%), Gaps = 9/142 (6%)

Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++V+G+G F KV    Y     GT E+ A+K ++++    + +    K E NIL  + H 
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHE 66

Query: 211 FIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+ +   S Q    L L++++V  G L   L +  L    L  ++  +I   +++LH+
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL-LFAQQICEGMAYLHS 125

Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HRDL   N+LLD D  V+
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVK 147

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 58.3 bits (141), Expect = 8e-10
 Identities = 36/144 (25%), Positives = 70/144 (48%), Gaps = 7/144 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR--KDKIMEKNHAEYMKSERNILTKV 207
           ED E +  +G G    V +V+ I T  + A KV+       + K     +  E  I+ + 
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ----ILRELQIMHEC 60

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
             P+IV    +F  +  + + ++F++ G L     + G    ++       +V  +++L+
Sbjct: 61  RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120

Query: 268 -ANGIMHRDLKPENILLDADGHVR 290
             + IMHRD+KP NIL+++ G ++
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIK 144

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 41/146 (28%), Positives = 78/146 (53%), Gaps = 24/146 (16%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           ++G G+F  VY+   I TSE  A+K + +D        +Y   E  I+  ++H  I+ L+
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLNHINIIFLK 125

Query: 217 -YSFQTKYR-------LYLVLDFV-NGGHLFFQLYRQG-----LFREDLARIYTAEIVSA 262
            Y +   ++       L +V++F+    H + + Y +      LF   L ++Y+ ++  A
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF---LVKLYSYQLCRA 182

Query: 263 VSHLHANGIMHRDLKPENILLDADGH 288
           ++++H+  I HRDLKP+N+L+D + H
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTH 208

Length = 440

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 11/151 (7%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C  + +FE L  +G+G +  VY+ R   + EI A+K +R D   E++    + S R I  
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN--ERDGIP-ISSLREITL 59

Query: 204 LTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNG--GHLFFQLYRQGLFREDLARIYTAEI 259
           L  + HP IV+L+     K+   ++LV+++       L   +     F E   +    ++
Sbjct: 60  LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQL 117

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           +  + +LH N I+HRDLK  N+LL   G ++
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLLTDKGCLK 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 37/133 (27%), Positives = 70/133 (52%), Gaps = 4/133 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143

Query: 278 PENILLDADGHVR 290
            +NILL  DG V+
Sbjct: 144 SDNILLGMDGSVK 156

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 34/143 (23%), Positives = 76/143 (53%), Gaps = 9/143 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTKV 207
           +E L+ +G+G +  V++ +   T EI A+K +R D     +  E + S    E  +L ++
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD-----DDDEGVPSSALREICLLKEL 56

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            H  IV+L     +  +L LV ++ +     +     G    ++ + +  +++  ++  H
Sbjct: 57  KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELK 139

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 32/147 (21%), Positives = 65/147 (44%), Gaps = 14/147 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----EKNHAEYMKSERNILTKV 207
           ++ ++ +G GA+  V       + +  A+K     KI         A+    E  IL   
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRHF 61

Query: 208 DHPFIVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            H  I+ +R   +         Y+V+D +    L   ++      E+  R +  +++  +
Sbjct: 62  KHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120

Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            ++H+  ++HRDLKP N+L++ D  +R
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELR 147

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.5 bits (136), Expect = 2e-09
 Identities = 36/132 (27%), Positives = 68/132 (51%), Gaps = 6/132 (4%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS--ERNILTKVDHPFIVQL 215
           +G+G+F  VY V+         +KV+++  + E N  E +++  E  +L+K+DHP IV+ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQL--YRQG--LFREDLARIYTAEIVSAVSHLHANGI 271
             SF  +    ++ ++  G  L  +L   +       E+    +  +++  V ++H   I
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127

Query: 272 MHRDLKPENILL 283
           +HRDLK +NI L
Sbjct: 128 LHRDLKAKNIFL 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 35/133 (26%), Positives = 73/133 (54%), Gaps = 4/133 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V   R   +    A+K+M    + ++   E + +E  I+    H  +V++  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L+++++F+ GG L   + +  L  E +A +  + ++ A+ +LH+ G++HRD+K
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCES-VLQALCYLHSQGVIHRDIK 144

Query: 278 PENILLDADGHVR 290
            ++ILL  DG V+
Sbjct: 145 SDSILLTLDGRVK 157

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 56.8 bits (138), Expect = 3e-09
 Identities = 43/150 (28%), Positives = 81/150 (54%), Gaps = 16/150 (10%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNI--L 204
           L  +E+L+ +G+GA+  V++     T E+ A+K     KI +  +N  +  ++ R I  L
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK-----KIFDAFRNATDAQRTFREIMFL 60

Query: 205 TKV-DHPFIVQLR--YSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIV 260
            ++ DHP IV+L      +    +YLV +++    H    + R  +  +   R    +++
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLH---AVIRANILEDVHKRYIMYQLL 117

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
            A+ ++H+  ++HRDLKP NILL++D  V+
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVK 147

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 41/148 (27%), Positives = 79/148 (53%), Gaps = 14/148 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L ++EV+K +G G F +V+ V+   T E +  K +    + E+  ++ +  E N++ ++ 
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQ-LVIEVNVMRELK 70

Query: 209 HPFIVQL--RYSFQTKYRLYLVLDFVNGGHL---FFQLYRQ-GLFREDLARIYTAEIVSA 262
           H  IV+   R+  +   +LY++++F + G L     + Y+  G   E      T +++ A
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 263 VSHLH-----ANG--IMHRDLKPENILL 283
           +++ H      NG  ++HRDLKP+NI L
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFL 158

Length = 1021

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 55.5 bits (134), Expect = 6e-09
 Identities = 39/148 (26%), Positives = 80/148 (54%), Gaps = 11/148 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNI-LTK 206
           +D EV++ +G+GA+  V ++R + T  I A+K +R       N  E   +  + +I +  
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIR----ATVNSQEQKRLLMDLDISMRS 56

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQGLF-REDLARIYTAEIVSAV 263
           VD P+ V    +   +  +++ ++ ++      + ++Y +GL   ED+       IV A+
Sbjct: 57  VDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116

Query: 264 SHLHAN-GIMHRDLKPENILLDADGHVR 290
            +LH+   ++HRD+KP N+L++ +G V+
Sbjct: 117 EYLHSKLSVIHRDVKPSNVLINRNGQVK 144

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 55.5 bits (133), Expect = 6e-09
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 4/133 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   V+    + T +  A+K +   K  +K   E + +E  ++ ++ +P IV    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKELKNPNIVNFLD 83

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           SF     L++V++++ GG L   +    +    +A +   E + A+  LHAN ++HRD+K
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV-CRECLQALEFLHANQVIHRDIK 142

Query: 278 PENILLDADGHVR 290
            +N+LL  DG V+
Sbjct: 143 SDNVLLGMDGSVK 155

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.2 bits (133), Expect = 6e-09
 Identities = 39/138 (28%), Positives = 71/138 (51%), Gaps = 8/138 (5%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           +K +G G F  V+  +     ++ A+K + +  + E++  E    E  ++ K+ HP +VQ
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQ 63

Query: 215 LRYSFQTKYR-LYLVLDFV-NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           L Y   T+ + LY+V +F+ NG  L +   RQG   +D+      ++   + +L  N  +
Sbjct: 64  L-YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122

Query: 273 HRDLKPENILLDADGHVR 290
           HRDL   N L+ + G V+
Sbjct: 123 HRDLAARNCLVSSTGVVK 140

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 55.2 bits (134), Expect = 9e-09
 Identities = 36/160 (22%), Positives = 64/160 (40%), Gaps = 47/160 (29%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK---DKIMEKNHAEYMKSERNILTKVD 208
           +E+LK +G GA+  V       T    A+K +     D I     A+ +  E  +L  + 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI----DAKRILREIKLLRHLR 57

Query: 209 HPFIVQL--------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------ 254
           H  I+ L           F     +Y+V +               L   DL ++      
Sbjct: 58  HENIIGLLDILRPPSPEDFND---VYIVTE---------------LMETDLHKVIKSPQP 99

Query: 255 --------YTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
                   +  +I+  + +LH+  ++HRDLKP NIL++++
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN 139

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 37/133 (27%), Positives = 72/133 (54%), Gaps = 4/133 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLKALSVLHAQGVIHRDIK 143

Query: 278 PENILLDADGHVR 290
            ++ILL  DG V+
Sbjct: 144 SDSILLTHDGRVK 156

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 27/154 (17%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKVDHPFIV 213
           +V+G GA   V   +R+   E +A+KV+  + + E  KN A+   +E   L   D   IV
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ---AEVCCLLNCDFFSIV 94

Query: 214 QLRYSFQTK--------YRLYLVLDFVNGGHLFFQLYRQGL---------FREDLARIYT 256
           +    F  K          + LVLD+ N G L     RQ +         FRE  A +  
Sbjct: 95  KCHEDFAKKDPRNPENVLMIALVLDYANAGDL-----RQEIKSRAKTNRTFREHEAGLLF 149

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +++ AV H+H+  ++HRD+K  NILL ++G V+
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183

Length = 496

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 41/138 (29%), Positives = 73/138 (52%), Gaps = 8/138 (5%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           LK +G G F  V+  +  G  ++ A+K++R+  + E +  E    E  ++ K+ HP +VQ
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQ 63

Query: 215 LRYSFQTKYR-LYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           L Y   TK R +++V ++  NG  L +   R+G    +      +++  A+ +L +NG +
Sbjct: 64  L-YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122

Query: 273 HRDLKPENILLDADGHVR 290
           HRDL   N L+  D  V+
Sbjct: 123 HRDLAARNCLVGEDNVVK 140

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 37/142 (26%), Positives = 71/142 (50%), Gaps = 2/142 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LE +  L  +G+G +A V++ R   T  + A+K +R +   E+        E ++L  + 
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLK 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T+  L LV ++++     +      L      +I+  +++  +S+ H 
Sbjct: 62  HANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             I+HRDLKP+N+L++  G ++
Sbjct: 122 RKILHRDLKPQNLLINEKGELK 143

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 29/108 (26%), Positives = 61/108 (56%), Gaps = 1/108 (0%)

Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           ++K  + ++   E + +E  I+    H  +V +  S+     L++V++F+ GG L   + 
Sbjct: 52  VKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT 111

Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
              +  E +A +    ++ A+S+LH  G++HRD+K ++ILL +DG ++
Sbjct: 112 HTRMNEEQIATV-CLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIK 158

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 36/142 (25%), Positives = 72/142 (50%), Gaps = 2/142 (1%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L  +G G+F  VY      T+E+ A+K M           + +  E   L ++ H
Sbjct: 21  EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P  ++ +  +  ++  +LV+++  G      +++++ L   ++A I T   +  +++LH+
Sbjct: 81  PNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI-THGALQGLAYLHS 139

Query: 269 NGIMHRDLKPENILLDADGHVR 290
           + ++HRD+K  NILL   G V+
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVK 161

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 52.8 bits (127), Expect = 5e-08
 Identities = 41/150 (27%), Positives = 74/150 (49%), Gaps = 19/150 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE L  +G G    V +V    +  I A K++         H E   + RN       
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI---------HLEIKPAIRNQIIRELK 51

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED-LARIYTAEIVS 261
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E+ L +I  A ++ 
Sbjct: 52  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLR 110

Query: 262 AVSHLHAN-GIMHRDLKPENILLDADGHVR 290
            +++L     IMHRD+KP NIL+++ G ++
Sbjct: 111 GLTYLREKHKIMHRDVKPSNILVNSRGEIK 140

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 7e-08
 Identities = 31/146 (21%), Positives = 62/146 (42%), Gaps = 14/146 (9%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +  ++ ++   +G+G F  V      G    +  A+K ++ D       A+   +E +++
Sbjct: 3   INSKELKLGATIGKGEFGDVML----GDYRGQKVAVKCLKDDS----TAAQAFLAEASVM 54

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVS 261
           T + HP +VQL         LY+V +++  G L   L    R  +        +  ++  
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQ-LGFALDVCE 113

Query: 262 AVSHLHANGIMHRDLKPENILLDADG 287
            + +L     +HRDL   N+L+  D 
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDL 139

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 36/154 (23%), Positives = 75/154 (48%), Gaps = 15/154 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-MEKNHAEYMKSERNILTKV 207
           ++ +++++++G+G   +VY       S   A+K +R+D          +++ E  I   +
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR-EAKIAADL 59

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNG---GHLFFQLYRQGLFREDLA---------RIY 255
            HP IV +         +Y  + ++ G     L   ++++    ++LA          I+
Sbjct: 60  IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
             +I + + ++H+ G++HRDLKP+NILL   G V
Sbjct: 120 H-KICATIEYVHSKGVLHRDLKPDNILLGLFGEV 152

Length = 932

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 36/140 (25%), Positives = 67/140 (47%), Gaps = 8/140 (5%)

Query: 156 KVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K +G G+F  V +       G     A+K ++ DK +     +++K E  I+  +DH  +
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK-LSDIMDDFLK-EAAIMHSLDHENL 58

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLHANG 270
           ++L Y     + L +V +    G L  +L +  L    ++ +  Y  +I + + +L +  
Sbjct: 59  IRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 271 IMHRDLKPENILLDADGHVR 290
            +HRDL   NILL +D  V+
Sbjct: 118 FIHRDLAARNILLASDDKVK 137

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 35/137 (25%), Positives = 71/137 (51%), Gaps = 4/137 (2%)

Query: 155 LKVVGQGAFAKVYQ-VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           L+ +G+G++A VY+ + RI   ++ A+KV+      E+        E ++L  + H  IV
Sbjct: 10  LEKLGEGSYATVYKGISRI-NGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIV 66

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
            L     TK  L  V ++++     + +   G       R++  +++  ++++H   I+H
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 274 RDLKPENILLDADGHVR 290
           RDLKP+N+L+   G ++
Sbjct: 127 RDLKPQNLLISYLGELK 143

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 37/149 (24%), Positives = 73/149 (48%), Gaps = 17/149 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  I A K++         H E   + RN       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLI---------HLEIKPAIRNQIIRELQ 55

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 115

Query: 263 VSHL-HANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 116 LTYLREKHKIMHRDVKPSNILVNSRGEIK 144

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 16/146 (10%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SERNIL 204
           LE ++ L  +G+G++A VY+ R   T ++ A+K +R        H E        E ++L
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL------EHEEGAPFTAIREASLL 57

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVS 261
             + H  IV L     TK  L LV +++       + Y     G       R++  +++ 
Sbjct: 58  KDLKHANIVTLHDIIHTKKTLTLVFEYL---DTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114

Query: 262 AVSHLHANGIMHRDLKPENILLDADG 287
            +++ H   ++HRDLKP+N+L+   G
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERG 140

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 31/138 (22%), Positives = 63/138 (45%), Gaps = 9/138 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           + V+K +  G+  +V+   + G  +   +K+ +K   +          E  +L  V+HP 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +++++ +  +     +VL   +     +   R      D A I   +I+  + +LHA  I
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRI 178

Query: 272 MHRDLKPENILLDADGHV 289
           +HRD+K ENI ++    V
Sbjct: 179 IHRDVKTENIFINDVDQV 196

Length = 357

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 6/106 (5%)

Query: 190 EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--- 246
           ++  A Y +SE + L   DH  IV+    F++  +L L++++ +GG L  Q+ +Q L   
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEH 163

Query: 247 --FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             F+E    +   +IV A+  +H+  +MHRDLK  NI L   G ++
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIK 209

Length = 478

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 34/142 (23%), Positives = 71/142 (50%), Gaps = 2/142 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +A V++ R   T  + A+K +R +   E+        E ++L  + 
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T   L LV ++++     +      +      +I+  +I+  +++ H 
Sbjct: 63  HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRDLKP+N+L++  G ++
Sbjct: 123 RKVLHRDLKPQNLLINERGELK 144

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 20/153 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEA 58

Query: 207 VDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIYTA 257
            DHP IV+L       R   +TK  + LV + V+     +  ++   GL  E + +    
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETK--VTLVFEHVDQDLRTYLDKVPPPGLPAETI-KDLMR 115

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           + +  +  LHAN I+HRDLKPENIL+ + G V+
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVK 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 34/138 (24%), Positives = 65/138 (47%), Gaps = 9/138 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ED  + + +G+G F  VYQ   +         A+K  +          E    E  I+ +
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV--REKFLQEAYIMRQ 63

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
            DHP IV+L     T+  +++V++    G L  + Q+ +  L    L  +Y+ ++ +A++
Sbjct: 64  FDHPHIVKL-IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLI-LYSYQLSTALA 121

Query: 265 HLHANGIMHRDLKPENIL 282
           +L +   +HRD+   N+L
Sbjct: 122 YLESKRFVHRDIAARNVL 139

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 18/155 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQV----RRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +   +L+ +G GAF +VY+     R     E+  A+K + +    E++ ++++  E  I+
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLM-EALIM 63

Query: 205 TKVDHPFIVQL-RYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFR------EDLARIY 255
           +K +H  IV+L   SF+   R +++L+ + GG L  F +  R    R      +DL    
Sbjct: 64  SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC- 121

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             ++     +L  N  +HRD+   N LL   G  R
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR 156

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 34/142 (23%), Positives = 70/142 (49%), Gaps = 2/142 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LE +  L  +G+G +A VY+ R   T  + A+K +R +   E+        E ++L  + 
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T+  L LV ++++     +             +++  +++  +++ H 
Sbjct: 63  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRDLKP+N+L++  G ++
Sbjct: 123 RKVLHRDLKPQNLLINERGELK 144

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 30/140 (21%), Positives = 61/140 (43%), Gaps = 8/140 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+F + + +G G F +V++        + A+K+++ D        ++ K E   L ++ H
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSD--DLLKQQDFQK-EVQALKRLRH 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR---QGLFREDLARIYTAEIVSAVSHL 266
             ++ L         +Y++ + +  G L   L     Q L    L  +   ++   +++L
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDM-ACQVAEGMAYL 120

Query: 267 HANGIMHRDLKPENILLDAD 286
                +HRDL   NIL+  D
Sbjct: 121 EEQNSIHRDLAARNILVGED 140

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 47.6 bits (113), Expect = 2e-06
 Identities = 35/143 (24%), Positives = 70/143 (48%), Gaps = 8/143 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++ K+ H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSH 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +VQL      +  +Y+V ++++ G L   L R+   R   +++     ++   +++L 
Sbjct: 59  EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLE 117

Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +   +HRDL   N L+D  G V+
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVK 140

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.2 bits (114), Expect = 2e-06
 Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 10/144 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74

Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLY-QMLCG 131

Query: 263 VSHLHANGIMHRDLKPENILLDAD 286
           + HLH+ GI+HRDLKP NI++ +D
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSD 155

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 47.8 bits (113), Expect = 2e-06
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 23/148 (15%)

Query: 158 VGQGAFAKVYQVRRI-GTSEI-YAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDHPFIV 213
           VG+G +  VY+ +R  G  E  YA+K +    I        M + R I  L ++ HP ++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-------MSACREIALLRELKHPNVI 61

Query: 214 QLRYSF--QTKYRLYLVLDFVNGG--HLFFQLYRQG-------LFREDLARIYTAEIVSA 262
            L+  F   +  +++L+ D+      H+  + +R              + +    +I+  
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHII-KFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + +LHAN ++HRDLKP NIL+  +G  R
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPER 148

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 33/134 (24%), Positives = 67/134 (50%), Gaps = 10/134 (7%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +++G+G F  V Q    G  +  A+K ++ D       A+    E  ++TK+ H  +V+L
Sbjct: 12  EIIGEGEFGAVLQGEYTG--QKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRL 64

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLHANGIMH 273
                    LY+V++ ++ G+L   L  +G     + ++  ++ ++   + +L +  ++H
Sbjct: 65  -LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH 123

Query: 274 RDLKPENILLDADG 287
           RDL   NIL+  DG
Sbjct: 124 RDLAARNILVSEDG 137

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 36/141 (25%), Positives = 71/141 (50%), Gaps = 10/141 (7%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T++ 
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQLR 57

Query: 209 HPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSH 265
           H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+ +
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 266 LHANGIMHRDLKPENILLDAD 286
           L AN  +HRDL   N+L+  D
Sbjct: 118 LEANNFVHRDLAARNVLVSED 138

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 39/144 (27%), Positives = 69/144 (47%), Gaps = 10/144 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  +L  V+
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 78

Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLY-QMLCG 135

Query: 263 VSHLHANGIMHRDLKPENILLDAD 286
           + HLH+ GI+HRDLKP NI++ +D
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSD 159

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 37/151 (24%), Positives = 66/151 (43%), Gaps = 21/151 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK---DKIMEKNHAEYMKSERNILTKVD 208
           ++ L  VG GA+ +V       T    A+K + +     I    HA+    E  +L  +D
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRTYRELRLLKHMD 72

Query: 209 HPFIVQL---------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           H  ++ L            FQ    +YLV   +  G     + +     +D  +    +I
Sbjct: 73  HENVIGLLDVFTPASSLEDFQD---VYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQI 127

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           +  + ++H+ GI+HRDLKP NI ++ D  ++
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 158

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 47/162 (29%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSE-----------IYAMKVMRKDKIMEKNHAEYMKSE 200
           +E++K +GQGA+  V   R   TSE           +++ K++ K  + E     + +  
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARI----- 254
           +NI    D                    +D V  G+ F +LY  + L   DL +I     
Sbjct: 62  KNITCLYD--------------------MDIVFPGN-FNELYLYEELMEADLHQIIRSGQ 100

Query: 255 ---------YTAEIVSAVSHLHANGIMHRDLKPENILLDADG 287
                    +  +I+  + ++H+  ++HRDLKP N+L++AD 
Sbjct: 101 PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC 142

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 33/162 (20%), Positives = 58/162 (35%), Gaps = 44/162 (27%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS-------------ERN 202
             +G+G + KV +     T +I A+K ++  +I   N     +              E  
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEI--SNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           I+ ++ H  I+ L   +     + LV+D +                 DL ++   +I   
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS---------------DLKKVVDRKIRLT 117

Query: 263 VSH--------------LHANGIMHRDLKPENILLDADGHVR 290
            S               LH    MHRDL P NI +++ G  +
Sbjct: 118 ESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK 159

Length = 335

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 47.0 bits (111), Expect = 5e-06
 Identities = 36/149 (24%), Positives = 72/149 (48%), Gaps = 17/149 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V +V+   +  I A K++         H E   + RN       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLI---------HLEIKPAIRNQIIRELQ 55

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L       E++    +  ++  
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 115

Query: 263 VSHL-HANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 116 LAYLREKHQIMHRDVKPSNILVNSRGEIK 144

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 6e-06
 Identities = 35/144 (24%), Positives = 66/144 (45%), Gaps = 15/144 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTK 206
             ++ L  +G+GA+  V       T    A+K     KI    H  + +    E  IL +
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISPFEHQTFCQRTLREIKILRR 59

Query: 207 VDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
             H  I+ +       SF++   +Y+V + +    L+  +  Q L   D  + +  +I+ 
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHL-SNDHIQYFLYQILR 117

Query: 262 AVSHLHANGIMHRDLKPENILLDA 285
            + ++H+  ++HRDLKP N+LL+ 
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNT 141

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 46.1 bits (109), Expect = 7e-06
 Identities = 35/141 (24%), Positives = 74/141 (52%), Gaps = 18/141 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+     G +++ A+K ++   +  ++  E    E  I+ K+ H
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMKKLRH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSA 262
             +VQL Y+  ++  +Y+V ++++ G L   L + G  R        D+A    A++ + 
Sbjct: 61  DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMA----AQVAAG 114

Query: 263 VSHLHANGIMHRDLKPENILL 283
           ++++     +HRDL+  NIL+
Sbjct: 115 MAYIERMNYIHRDLRSANILV 135

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 45.9 bits (109), Expect = 8e-06
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 14/145 (9%)

Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F  V    Y   +  T E+ A+K ++        H    + E  IL  + H 
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHD 65

Query: 211 FIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSH 265
            IV+ +   YS   +  L LV++++  G L  + Q +R+ L    L  +Y ++I   + +
Sbjct: 66  NIVKYKGVCYS-AGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQICKGMEY 123

Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           L +   +HRDL   NIL++++  V+
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVK 148

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 46.2 bits (110), Expect = 8e-06
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 12/145 (8%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V       T +  A+K + +       HA+    E  ++  V+
Sbjct: 15  LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVN 73

Query: 209 HPFIVQLRYSF--QTKYR----LYLVLDFVNGGHLFFQLYRQGLFREDLAR-IYTAEIVS 261
           H  I+ L   F  Q        +YLV++ ++      Q+ +  L  E ++  +Y  +++ 
Sbjct: 74  HKNIIGLLNVFTPQKSLEEFQDVYLVMELMD--ANLCQVIQMDLDHERMSYLLY--QMLC 129

Query: 262 AVSHLHANGIMHRDLKPENILLDAD 286
            + HLH+ GI+HRDLKP NI++ +D
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSD 154

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 46.0 bits (109), Expect = 8e-06
 Identities = 34/130 (26%), Positives = 66/130 (50%), Gaps = 10/130 (7%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +  +   E++K E  ++ ++ HP +VQL  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLK-EAAVMKEIKHPNLVQLLG 69

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L   L      R+++     +Y A +I SA+ +L     +H
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 274 RDLKPENILL 283
           RDL   N L+
Sbjct: 128 RDLAARNCLV 137

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 45.8 bits (108), Expect = 8e-06
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67

Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 68  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127

Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 128 LRAANILV 135

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 45.5 bits (108), Expect = 9e-06
 Identities = 35/135 (25%), Positives = 68/135 (50%), Gaps = 6/135 (4%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY+    G +E+ A+K  R     +    ++++    IL + DHP IV+L  
Sbjct: 3   IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPD-LKRKFLQEAE-ILKQYDHPNIVKLIG 59

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRD 275
               K  +Y+V++ V GG L   L ++   L  + L ++ + +  + + +L +   +HRD
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM-SLDAAAGMEYLESKNCIHRD 118

Query: 276 LKPENILLDADGHVR 290
           L   N L+  +  ++
Sbjct: 119 LAARNCLVGENNVLK 133

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 45.9 bits (109), Expect = 9e-06
 Identities = 35/160 (21%), Positives = 62/160 (38%), Gaps = 23/160 (14%)

Query: 147 VGLEDFEVLKVVGQGAFAKVY-----QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           V  +   + + +G+GAF KV+      +      E+ A+K + K+        ++ + E 
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER-EA 59

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---------------L 246
            +LT   H  IV+            +V +++  G L   L   G               L
Sbjct: 60  ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
               L +I   +I S + +L +   +HRDL   N L+  D
Sbjct: 120 TLSQLLQI-AVQIASGMVYLASQHFVHRDLATRNCLVGYD 158

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 36/144 (25%), Positives = 71/144 (49%), Gaps = 10/144 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81

Query: 209 HPFIVQL------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L      + S +    +Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLY-QMLCG 138

Query: 263 VSHLHANGIMHRDLKPENILLDAD 286
           + HLH+ GI+HRDLKP NI++ +D
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSD 162

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 23/148 (15%)

Query: 158 VGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDHPFIV 213
           VG+G +  VY+ +R    +   YA+K +    I        M + R I  L ++ HP ++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-------MSACREIALLRELKHPNVI 61

Query: 214 QLRYSF--QTKYRLYLVLDFVNGG--HLFFQLYRQGLFRED-------LARIYTAEIVSA 262
            L+  F      +++L+ D+      H+  + +R     +        + +    +I+  
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHII-KFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + +LHAN ++HRDLKP NIL+  +G  R
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPER 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 1/91 (1%)

Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E +IL  ++HP I+QL+ +F       L+L         +   ++ +   D+  I  + 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERS- 190

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           ++ A+ +LH N I+HRD+K ENI ++  G V
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDV 221

Length = 391

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 19/151 (12%)

Query: 156 KVVGQGAFAKVYQ-----VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
             +G GAF +VY+     +   G+  I  A+K +RK    ++   E++K E ++++  +H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNH 58

Query: 210 PFIV-QLRYSFQTKYRLYLVLDFVNGGHLFFQL--------YRQGLFREDLARIYTAEIV 260
           P IV  L      +   Y++++ + GG L   L            L  ++L  I   ++ 
Sbjct: 59  PNIVKLLGVCLLNE-PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI-CLDVA 116

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVRS 291
               +L     +HRDL   N L+   G+   
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDAD 147

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 32/127 (25%), Positives = 61/127 (48%), Gaps = 6/127 (4%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E    E    E  ++ K+ HP +VQL  
Sbjct: 12  IGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q G F ++       ++   +++L ++ ++HRDL
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 277 KPENILL 283
              N L+
Sbjct: 127 AARNCLV 133

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 12/135 (8%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTKVDHP 210
           L+ VG GAF  V   R   T +  A+K     KIM+       A+    E  +L  + H 
Sbjct: 15  LQPVGMGAFGLVCSARDQLTGQNVAIK-----KIMKPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 211 FIVQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            I+ L   F +    +Y V + +  G    +L       +   + +  +I+  + ++H+ 
Sbjct: 70  NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 270 GIMHRDLKPENILLD 284
           G++HRDLKP NIL++
Sbjct: 128 GVVHRDLKPSNILIN 142

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 20/150 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            E +KV+G GAF  VY+   I   E      A+KV+R++    K + E +  E  ++  V
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILD-EAYVMASV 66

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-------YTAEIV 260
           DHP +V+L        ++ L+   +  G L   +      R     I       +  +I 
Sbjct: 67  DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYV------RNHKDNIGSQYLLNWCVQIA 119

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +S+L    ++HRDL   N+L+    HV+
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVK 149

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 27/100 (27%), Positives = 48/100 (48%), Gaps = 19/100 (19%)

Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-------DL 251
            E +IL  + H  I+ L ++++ K  + +V+            Y+  LF          L
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVM----------PKYKCDLFTYVDRSGPLPL 184

Query: 252 ARIYTAE--IVSAVSHLHANGIMHRDLKPENILLDADGHV 289
            +  T +  ++ A+++LH  GI+HRD+K ENI LD   + 
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENA 224

Length = 392

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 13/27 (48%), Positives = 21/27 (77%)

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLD 284
           +I+ A+  LH+ GI+HRD+KP+NI+  
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFS 289

Length = 566

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 25/151 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQV--RRIGT------------SEIYAMKVMRKDKIMEKNHAE 195
           + +  LK VG GA+  V     RR G             SE++A +  R+ ++++     
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK----- 69

Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
           +MK E N++  +D   +     S    +  YLV+ F+  G    +L +     ED  +  
Sbjct: 70  HMKHE-NVIGLLD---VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFL 123

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
             +++  + ++HA GI+HRDLKP N+ ++ D
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVNED 154

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 43.8 bits (103), Expect = 4e-05
 Identities = 34/128 (26%), Positives = 63/128 (49%), Gaps = 5/128 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V+  R    +   A+K  R + +     A++++  R IL +  HP IV+L  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEAR-ILKQYSHPNIVRLIG 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRD 275
               K  +Y+V++ V GG     L  +G  L  ++L ++      + + +L +   +HRD
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VENAAAGMEYLESKHCIHRD 119

Query: 276 LKPENILL 283
           L   N L+
Sbjct: 120 LAARNCLV 127

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 34/156 (21%), Positives = 67/156 (42%), Gaps = 17/156 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNIL 204
           E   +++ +GQG+F  VY+   + +   E     A+K + ++  M +        E +++
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN--EASVM 63

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--------GLFREDLARIY- 255
            + +   +V+L     T     +V++ +  G L   L  +        GL    L +   
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 256 -TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             AEI   +++L A   +HRDL   N ++  D  V+
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 43.3 bits (102), Expect = 5e-05
 Identities = 36/133 (27%), Positives = 60/133 (45%), Gaps = 10/133 (7%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL--TKVDHPFIVQ 214
           V+G+G +  VY  R + T    A+K     +I E++          I   + + H  IVQ
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGI 271
              S        + ++ V GG L   L  +       E     YT +I+  + +LH N I
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 272 MHRDLKPENILLD 284
           +HRD+K +N+L++
Sbjct: 130 VHRDIKGDNVLVN 142

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 43.0 bits (101), Expect = 6e-05
 Identities = 36/132 (27%), Positives = 69/132 (52%), Gaps = 12/132 (9%)

Query: 158 VGQGAFAKVYQ-VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +G G F  V + V ++   +I  A+KV++ +   EK+  + M  E  I+ ++D+P+IV++
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS----HLHANGI 271
               + +  L LV++  +GG L   L  +   ++++      E++  VS    +L     
Sbjct: 61  IGVCEAE-ALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 272 MHRDLKPENILL 283
           +HRDL   N+LL
Sbjct: 117 VHRDLAARNVLL 128

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 42.9 bits (101), Expect = 7e-05
 Identities = 33/136 (24%), Positives = 70/136 (51%), Gaps = 8/136 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+     G +++ A+K + K   M     E   +E N++ ++ H
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSL-KQGSMS---PEAFLAEANLMKQLQH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
           P +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++ + 
Sbjct: 61  PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119

Query: 268 ANGIMHRDLKPENILL 283
               +HRDL+  NIL+
Sbjct: 120 RKNYIHRDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 43.1 bits (101), Expect = 7e-05
 Identities = 32/130 (24%), Positives = 66/130 (50%), Gaps = 6/130 (4%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +++G+G F +V++      + + A+K  ++D  + +       SE  IL + DHP IV+L
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKL 57

Query: 216 RYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
                 +  +Y+V++ V GG    F +  +  L  + L + +  +  + +++L +   +H
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK-FALDAAAGMAYLESKNCIH 116

Query: 274 RDLKPENILL 283
           RDL   N L+
Sbjct: 117 RDLAARNCLV 126

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 33/138 (23%), Positives = 70/138 (50%), Gaps = 8/138 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 61  DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 268 ANGIMHRDLKPENILLDA 285
               +HRDL+  NIL+ A
Sbjct: 120 QRNYIHRDLRAANILVSA 137

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 31/155 (20%)

Query: 152 FEV------LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNI 203
           FEV      +K +G+GA+  V   +   T+E  A+K     KI     N  +  ++ R I
Sbjct: 1   FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIK-----KIANAFDNRIDAKRTLREI 55

Query: 204 --LTKVDHPFIVQL--------RYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDL 251
             L  +DH  ++ +        R +F   Y +Y ++D         Q+ R  Q L  +D 
Sbjct: 56  KLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTL-SDDH 109

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
            + +  +++  + ++H+  ++HRDLKP N+LL+A+
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN 144

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 37/149 (24%), Positives = 71/149 (47%), Gaps = 25/149 (16%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +++ +V+G+G++  V       T E  A+K +  D     + A  +  E  +L  + HP 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 60

Query: 212 IVQLRY-----SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR-----EDLAR----IYTA 257
           IV++++     S +    +Y+V          F+L    L +     +DL       +  
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVV----------FELMESDLHQVIKANDDLTPEHHQFFLY 110

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDAD 286
           +++ A+ ++H   + HRDLKP+NIL +AD
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANAD 139

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 36/152 (23%), Positives = 69/152 (45%), Gaps = 21/152 (13%)

Query: 151 DFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           D +   V+G+G F +V +  +++ G     A+K M K+   + +H ++   E  +L K+ 
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDF-AGELEVLCKLG 65

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------- 254
            HP I+ L  + + +  LYL +++   G+L   L +  +   D A               
Sbjct: 66  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 255 ---YTAEIVSAVSHLHANGIMHRDLKPENILL 283
              + A++   + +L     +HRDL   NIL+
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILV 157

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 22/101 (21%), Positives = 50/101 (49%), Gaps = 16/101 (15%)

Query: 200 ERNILTKVDHPFIVQL-------------RYSFQTKYR-LYLVLDFVNGGHLFFQLYRQG 245
           E  I+ ++DH  IV++                  T+   +Y+V +++        +  QG
Sbjct: 52  EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQG 109

Query: 246 LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
              E+ AR++  +++  + ++H+  ++HRDLKP N+ ++ +
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE 150

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 29/136 (21%), Positives = 63/136 (46%), Gaps = 6/136 (4%)

Query: 158 VGQGAFAKVYQ--VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           +G G F  V +         E+  A+K ++++  +     E+++ E +++ ++DHP IV+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLR-EASVMAQLDHPCIVR 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L    + +  L LV++    G L   L ++        +    ++   +++L +   +HR
Sbjct: 61  LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 275 DLKPENILLDADGHVR 290
           DL   N+LL      +
Sbjct: 120 DLAARNVLLVNRHQAK 135

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 34/138 (24%), Positives = 59/138 (42%), Gaps = 10/138 (7%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           LK VG GA+  V       T E  A+K + +     +  A+    E  +L  + H  ++ 
Sbjct: 20  LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 215 LR------YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           L        S       YLV+ ++       Q        ED  +    +++  + ++H+
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYM---QTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135

Query: 269 NGIMHRDLKPENILLDAD 286
            GI+HRDLKP N+ ++ D
Sbjct: 136 AGIIHRDLKPGNLAVNED 153

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 35/135 (25%), Positives = 69/135 (51%), Gaps = 11/135 (8%)

Query: 153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           ++L+ +G G F +V++     T+ + A+K ++   +  K   +++  E  I+ K+ HP +
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDPK---DFLA-EAQIMKKLRHPKL 63

Query: 213 VQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHA 268
           +QL Y+  T    +Y+V + +  G L   L       L    L  +  A++ S +++L A
Sbjct: 64  IQL-YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM-AAQVASGMAYLEA 121

Query: 269 NGIMHRDLKPENILL 283
              +HRDL   N+L+
Sbjct: 122 QNYIHRDLAARNVLV 136

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.8 bits (100), Expect = 1e-04
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 33/165 (20%)

Query: 149 LEDFEVLKVVGQGAFAKVY-----------QVRRIGTSEIYAMKVMRKDKIMEK------ 191
           L  F V+  +  GAF K++           + RR   S        + ++++ K      
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNST--NQGKPKCERLIAKRVKAGS 204

Query: 192 NHAEYMKSERNILTKVDHPFIVQ----LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF 247
             A  +++E   L +++H  I++    LR    T Y +    DF     L+  +Y +   
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANT-YMITQKYDF----DLYSFMYDEAFD 259

Query: 248 RED-----LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG 287
            +D       R    +++ AV ++H   ++HRD+K ENI L+ DG
Sbjct: 260 WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304

Length = 501

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 50/168 (29%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR--------KDKIMEKNHAEYMKSER 201
           ED + L  +G+GAF  V ++    +  I A+K +R        K  +M+      M+S  
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMD--LDVVMRSS- 60

Query: 202 NILTKVDHPFIVQ-----------------LRYSFQTKYRL-YLVLDFVNGGHLFFQLYR 243
                 D P+IV+                 +  S    Y+  Y VL              
Sbjct: 61  ------DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-------------- 100

Query: 244 QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR 290
           + +  E++        V A+++L     I+HRD+KP NILLD +G+++
Sbjct: 101 KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIK 148

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 34/155 (21%), Positives = 77/155 (49%), Gaps = 19/155 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----L 204
           + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +     L
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 205 TKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIY 255
              +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +  + 
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM- 115

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +++  +  LH++ ++HRDLKP+NIL+ + G ++
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 42.2 bits (99), Expect = 1e-04
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 13/146 (8%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERN 202
           CV +E+     V+G G F +V   +++  G  EI+ A+K + K    EK   +++ SE +
Sbjct: 5   CVKIEE-----VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFL-SEAS 57

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
           I+ + DHP I+ L         + ++ +F+  G L  F +    G F           I 
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIA 116

Query: 261 SAVSHLHANGIMHRDLKPENILLDAD 286
           + + +L     +HRDL   NIL++++
Sbjct: 117 AGMKYLSEMNYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 28/155 (18%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +F+ +KV+G GAF  VY+   I   E      A+K +R +    K + E +  E  ++  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEIL-DEAYVMAS 65

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF----REDLARI-------Y 255
           VD+P + +L           L +   +   L  QL   G      RE    I       +
Sbjct: 66  VDNPHVCRL-----------LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 114

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +I   +++L    ++HRDL   N+L+    HV+
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVK 149

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 38/154 (24%), Positives = 75/154 (48%), Gaps = 18/154 (11%)

Query: 152 FEVLKVVGQGAFAKVYQVR---RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           F + +++G+G F  V + +     G+ +  A+K+++ D     +  E+++ E   + + D
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFD 59

Query: 209 HPFIVQL---RYSFQTKYRL---YLVLDFVNGG--HLFFQLYRQG-----LFREDLARIY 255
           HP +++L       + K RL    ++L F+  G  H F  + R G     L  + L R +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR-F 118

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
             +I S + +L +   +HRDL   N +L+ +  V
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTV 152

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 37/146 (25%), Positives = 68/146 (46%), Gaps = 13/146 (8%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
            V +E     KV+G G F +V +  ++  G  EI       K    +K   +++ +E +I
Sbjct: 5   YVTIE-----KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASI 58

Query: 204 LTKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
           + + DHP I++L     TK R + ++ +++  G L  F +          L  +    I 
Sbjct: 59  MGQFDHPNIIRL-EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRG-IA 116

Query: 261 SAVSHLHANGIMHRDLKPENILLDAD 286
           S + +L     +HRDL   NIL++++
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.0 bits (98), Expect = 2e-04
 Identities = 15/33 (45%), Positives = 25/33 (75%)

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           ++++ +  LH  GI+HRD+KPEN+L+  DG V+
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVK 349

Length = 507

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 37/164 (22%), Positives = 74/164 (45%), Gaps = 38/164 (23%)

Query: 156 KVVGQGAFAKVYQVR------RIGTSEIYAMKVMRKDKIMEKNHAEYMK--SERNILTKV 207
           K +G+G F KV +        R G + + A+K+++++     + +E     SE N+L +V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTV-AVKMLKENA----SSSELRDLLSEFNLLKQV 60

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ---------------GLFRED 250
           +HP +++L  +      L L++++   G L  F +  R+                L   D
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 251 LARIYTAEIVS-------AVSHLHANGIMHRDLKPENILLDADG 287
              +   +++S        + +L    ++HRDL   N+L+ A+G
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEG 163

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 26/113 (23%), Positives = 51/113 (45%), Gaps = 6/113 (5%)

Query: 182 VMRKDKIMEKNHAEY--MKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH--- 236
            ++K  +   +  +   ++ E     ++ HP I+    SF     LY+V   +  G    
Sbjct: 29  AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           L    + +G   E        ++++A+ ++H+ G +HR +K  +ILL  DG V
Sbjct: 89  LLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKV 140

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 37/145 (25%), Positives = 73/145 (50%), Gaps = 14/145 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ + +G G F +V+     GT+++ A+K + K   M      +++ E  I+ K+ H
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTL-KPGTMSP--EAFLQ-EAQIMKKLRH 60

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVS 264
             +VQL Y+  ++   +Y+V ++++ G L     + G    L    L  +  A+I   ++
Sbjct: 61  DKLVQL-YAVCSEEEPIYIVTEYMSKGSLL-DFLKSGEGKKLRLPQLVDM-AAQIAEGMA 117

Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           +L +   +HRDL   NIL+  +  V
Sbjct: 118 YLESRNYIHRDLAARNILVG-ENLV 141

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 32/150 (21%), Positives = 63/150 (42%), Gaps = 28/150 (18%)

Query: 156 KVVGQGAFAKVYQVRRIG---------------TSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           K++G G F  VY+ +                   +E   M+ +  + I + +     K+ 
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77

Query: 201 RNILTKVDHPFIVQL----RYSFQTKYRLYLVLD--FVNGGHLFFQLYRQGLFREDLARI 254
            NI    DH  I +      +     Y  +++L+    N   +F    R     + L + 
Sbjct: 78  HNI----DHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIF---KRIKCKNKKLIKN 130

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLD 284
              ++++ + ++H +GI H D+KPENI++D
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVD 160

Length = 294

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 40.7 bits (95), Expect = 4e-04
 Identities = 39/148 (26%), Positives = 61/148 (41%), Gaps = 25/148 (16%)

Query: 158 VGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           +G+G F KV    Y      T E  A+K ++ +     NH   +K E  IL  + H  IV
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR-----------IYTAEIVSA 262
                   KY+     D  NG  L  +    G  +E L R            Y  +I   
Sbjct: 70  --------KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKG 121

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + +L +   +HRDL   N+L++++  V+
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVK 149

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 35/133 (26%), Positives = 67/133 (50%), Gaps = 18/133 (13%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+++ A+K ++   +M     E    E  I+ K+ H  +V L Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPL-Y 67

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSAVSHLHANG 270
           +  ++  +Y+V +F+  G L     ++G  +        D+A    A+I   ++++    
Sbjct: 68  AVVSEEPIYIVTEFMGKGSLL-DFLKEGDGKYLKLPQLVDMA----AQIADGMAYIERMN 122

Query: 271 IMHRDLKPENILL 283
            +HRDL+  NIL+
Sbjct: 123 YIHRDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 40.3 bits (94), Expect = 7e-04
 Identities = 37/141 (26%), Positives = 67/141 (47%), Gaps = 18/141 (12%)

Query: 156 KVVGQGAFAKVY--QVRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           KV+G G F +V   +++  G  EI  A+K + K    EK   +++ SE +I+ + DHP I
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFL-SEASIMGQFDHPNI 67

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------SAVSH 265
           + L         + +V +++  G L          R+   +    ++V       S + +
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 266 LHANGIMHRDLKPENILLDAD 286
           L   G +HRDL   NIL++++
Sbjct: 122 LSDMGYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.9 bits (91), Expect = 7e-04
 Identities = 29/132 (21%), Positives = 56/132 (42%), Gaps = 13/132 (9%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFI 212
           +K++  G   +VY +      E Y +K+               + E  IL  +      +
Sbjct: 3   IKLLKGGLTNRVYLLG--TKDEDYVLKINPSR-----EKGADREREVAILQLLARKGLPV 55

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
            ++  S ++    YL+++++ G  L          +ED+A    AE+++ +  L    + 
Sbjct: 56  PKVLASGESDGWSYLLMEWIEGETLDE---VSEEEKEDIAEQL-AELLAKLHQLPLLVLC 111

Query: 273 HRDLKPENILLD 284
           H DL P NIL+D
Sbjct: 112 HGDLHPGNILVD 123

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 40.0 bits (93), Expect = 7e-04
 Identities = 35/153 (22%), Positives = 71/153 (46%), Gaps = 21/153 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ED +   V+G+G F +V +  +++ G     A+K M K+   E +H ++   E  +L K+
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIK-MLKEFASENDHRDF-AGELEVLCKL 59

Query: 208 -DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------ 254
             HP I+ L  + + +  LY+ +++   G+L   L +  +   D A              
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 255 ----YTAEIVSAVSHLHANGIMHRDLKPENILL 283
               + +++ + + +L     +HRDL   N+L+
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 40.0 bits (93), Expect = 7e-04
 Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 10/146 (6%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----KNHAEYMKSERNILT 205
           + + +KV+G GAF  VY  + I   E   +K+    KI+      K + E+M  E  I+ 
Sbjct: 8   ELKRVKVLGSGAFGTVY--KGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIMA 64

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVS 264
            +DHP +V+L         + LV   +  G L   ++  +      L   +  +I   + 
Sbjct: 65  SMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123

Query: 265 HLHANGIMHRDLKPENILLDADGHVR 290
           +L    ++HRDL   N+L+ +  HV+
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVK 149

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 13/37 (35%), Positives = 28/37 (75%)

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
           D  +++  +I+  + +LH+ GI+HRD+KP N+L++++
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN 139

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 31/127 (24%), Positives = 59/127 (46%), Gaps = 5/127 (3%)

Query: 166 VYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL 225
           VY  R   T  +  +++   +   E+ H + +++E  +     HP I+     F T   L
Sbjct: 16  VYLARHTPTGTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74

Query: 226 YLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
           +++  F+  G    L    + +G+  E L        +  +++LH NG +HR++K  +IL
Sbjct: 75  WVISPFMAYGSANSLLKTYFPEGM-SEALIGNILFGALRGLNYLHQNGYIHRNIKASHIL 133

Query: 283 LDADGHV 289
           +  DG V
Sbjct: 134 ISGDGLV 140

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 35/147 (23%), Positives = 66/147 (44%), Gaps = 9/147 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V         +  A+K + +       HA     E  +L  + H
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKH 73

Query: 210 PFIVQL------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L        S +    +YLV + + G  L   +  Q L  ++  +    +++  +
Sbjct: 74  ENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKL-SDEHVQFLIYQLLRGL 131

Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            ++H+ GI+HRDLKP N+ ++ D  +R
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELR 158

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 43/173 (24%)

Query: 135 GHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR------KD-- 186
           GH   +  E+  V  + F++L ++G+G F KV +       E  A+K++R      +D  
Sbjct: 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK 173

Query: 187 ---KIMEK-------NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH 236
              + MEK       +    MK +R    +  H  IV  +Y                G  
Sbjct: 174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY----------------GPC 217

Query: 237 LFFQLYRQGLFREDLARIYTAEIV----SAVSHLHAN-GIMHRDLKPENILLD 284
           L   + + G F       + A+I+     A+ + H    +MH DLKPENIL++
Sbjct: 218 LLDWIMKHGPFSHR----HLAQIIFQTGVALDYFHTELHLMHTDLKPENILME 266

Length = 467

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 26/97 (26%), Positives = 48/97 (49%), Gaps = 4/97 (4%)

Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLA 252
           +++ E ++    +HP IV  R +F     L++V  F+  G    L    +  G+    +A
Sbjct: 45  FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIA 104

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
            I    ++ A+ ++H  G +HR +K  +IL+  DG V
Sbjct: 105 YILQG-VLKALDYIHHMGYVHRSVKASHILISVDGKV 140

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 37.6 bits (88), Expect = 0.003
 Identities = 34/144 (23%), Positives = 54/144 (37%), Gaps = 26/144 (18%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNILTK----- 206
           + ++ QGA A +Y    +G   +      K  R  ++ EK   E  + E  IL K     
Sbjct: 1   MDLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAG 60

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA---EIVSAV 263
           V  P +    Y         +V++++ G           L ++ L         E+   V
Sbjct: 61  VPVPIV----YDVDP-DNGLIVMEYIEGE----------LLKDALEEARPDLLREVGRLV 105

Query: 264 SHLHANGIMHRDLKPENILLDADG 287
             LH  GI+H DL   NI+L    
Sbjct: 106 GKLHKAGIVHGDLTTSNIILSGGR 129

Length = 204

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 37.9 bits (88), Expect = 0.004
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 15/144 (10%)

Query: 156 KVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHA-----EYMKSERNILTKV-D 208
           K +G GAF KV +    G S     MKV  K   M K  A     E + SE  I++ + +
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVK---MLKPTAHSSEREALMSELKIMSHLGN 97

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSH 265
           H  IV L  +      + ++ ++   G L   L R+    L  EDL   ++ ++   ++ 
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS-FSYQVAKGMAF 156

Query: 266 LHANGIMHRDLKPENILLDADGHV 289
           L +   +HRDL   N+LL   G +
Sbjct: 157 LASKNCIHRDLAARNVLL-THGKI 179

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	291
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.98
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.97
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.97
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.97
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.96
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.96
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.96
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.96
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.96
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.96
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.96
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.95
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.95
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.95
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.95
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.95
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.95
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.95
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.95
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.95
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.95
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.95
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.95
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.94
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.94
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.94
KOG0198	313	consensus MEKK and related serine/threonine protei	99.94
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.94
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.94
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.94
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.94
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.94
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.94
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.94
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.94
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.94
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.94
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.94
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.93
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.93
KOG0586	596	consensus Serine/threonine protein kinase [General	99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.93
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.93
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.93
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.93
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.93
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.93
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.93
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.93
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.93
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.93
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.93
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.93
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.93
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.93
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.93
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.93
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.93
PHA03212	391	serine/threonine kinase US3; Provisional	99.93
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.93
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.93
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.92
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.92
KOG0589	426	consensus Serine/threonine protein kinase [General	99.92
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.92
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.92
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.92
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.92
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.92
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.92
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.92
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.92
PTZ00267	478	NIMA-related protein kinase; Provisional	99.92
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.92
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.92
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.92
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.92
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.92
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.92
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.92
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.92
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.91
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.91
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.91
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.91
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.91
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.91
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.91
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.91
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.91
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.91
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.91
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.91
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.91
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.91
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.91
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.91
PHA03209	357	serine/threonine kinase US3; Provisional	99.91
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.91
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.91
PTZ00283	496	serine/threonine protein kinase; Provisional	99.91
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.91
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.91
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.91
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.91
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.91
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.91
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.91
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.91
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.91
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.91
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.91
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.91
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.91
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.91
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.91
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.91
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.91
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.91
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.91
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.91
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.91
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.91
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.91
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.91
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.91
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.91
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.91
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.91
PHA03207	392	serine/threonine kinase US3; Provisional	99.91
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.91
KOG0578	550	consensus p21-activated serine/threonine protein k	99.91
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.91
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.91
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.9
PHA02988	283	hypothetical protein; Provisional	99.9
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.9
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.9
PTZ00036	440	glycogen synthase kinase; Provisional	99.9
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.9
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.9
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.9
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.9
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.9
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.9
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.9
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.9
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.9
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.9
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.9
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.9
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.9
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.9
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.9
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.9
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.9
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.9
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.9
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.9
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.9
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.9
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.9
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.9
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.9
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.9
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.9
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.9
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.9
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.9
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.9
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.9
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.9
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.9
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.9
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.9
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.9
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.9
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.9
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.9
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.9
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.9
PHA03211	461	serine/threonine kinase US3; Provisional	99.9
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.9
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.9
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.9
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.9
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.9
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.9
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.9
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.9
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.9
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.9
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.9
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.9
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.9
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.9
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.9
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.9
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.9
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.9
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.9
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.9
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.89
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.89
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.89
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.89
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.89
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.89
KOG1152	772	consensus Signal transduction serine/threonine kin	99.89
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.89
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.89
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.89
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.89
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.89
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.89
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.89
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.89
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.89
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.89
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.89
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.89
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.89
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.89
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.89
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.89
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.89
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.89
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.89
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.89
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.89
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.89
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.89
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.89
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.89
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.89
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.89
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.89
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.89
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.89
PTZ00284	467	protein kinase; Provisional	99.89
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.89
PLN00009	294	cyclin-dependent kinase A; Provisional	99.89
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.89
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.89
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.89
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.89
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.89
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.89
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.89
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.89
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.89
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.89
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.88
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.88
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.88
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.88
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.88
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.88
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.88
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.88
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.88
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.88
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.88
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.88
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.88
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.88
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.88
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.88
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.88
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.88
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.88
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.88
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.88
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.88
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.88
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.88
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.88
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.88
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.88
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.88
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.88
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.88
KOG0584	632	consensus Serine/threonine protein kinase [General	99.88
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.88
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.88
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.88
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.87
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.87
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.87
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.87
PHA03210	501	serine/threonine kinase US3; Provisional	99.87
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.87
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.87
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.87
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.87
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.87
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.87
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.87
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.87
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.87
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.87
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.87
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.87
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.87
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.87
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.87
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.87
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.86
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.86
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.86
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.86
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.86
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.86
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.86
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.86
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.86
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.86
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.85
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.85
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.85
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.85
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.85
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.85
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.85
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.84
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.84
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.84
PRK10345	210	hypothetical protein; Provisional	99.84
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.84
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.84
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.84
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.83
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.83
PHA02882	294	putative serine/threonine kinase; Provisional	99.83
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.82
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.82
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.82
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.81
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.81
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.81
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.8
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.8
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.8
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
KOG3653	534	consensus Transforming growth factor beta/activin	99.78
smart00090	237	RIO RIO-like kinase.	99.78
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.78
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.78
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.77
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.77
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.77
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.76
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.74
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.72
PRK12274	218	serine/threonine protein kinase; Provisional	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.7
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.7
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.69
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.69
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.68
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.67
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.65
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.59
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.43
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.36
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.36
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.32
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.31
PLN00181	793	protein SPA1-RELATED; Provisional	99.27
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.26
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.26
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.2
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.17
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.13
KOG3087	229	consensus Serine/threonine protein kinase [General	99.05
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.98
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.89
KOG1243	690	consensus Protein kinase [General function predict	98.86
PF06760	217	DUF1221: Protein of unknown function (DUF1221); In	98.85
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.83
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.78
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	98.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.74
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.64
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.57
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.44
PRK09902	216	hypothetical protein; Provisional	98.41
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.36
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.26
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.25
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.23
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.11
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.02
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.01
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.92
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.91
PLN02876	822	acyl-CoA dehydrogenase	97.9
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.85
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	97.42
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.4
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.35
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.2
PF01636	239	APH: Phosphotransferase enzyme family This family	97.01
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.99
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.95
PRK10593	297	hypothetical protein; Provisional	96.87
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.63
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.53
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.12
PRK05231	319	homoserine kinase; Provisional	96.1
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.06
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.81
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.71
PRK09550	401	mtnK methylthioribose kinase; Reviewed	95.68
PRK12396	409	5-methylribose kinase; Reviewed	95.36
KOG0576	829	consensus Mitogen-activated protein kinase kinase	95.25
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.09
KOG2270	520	consensus Serine/threonine protein kinase involved	95.0
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.88
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.87
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.66
PLN02236	344	choline kinase	94.37
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	93.5
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	93.17
COG4248	637	Uncharacterized protein with protein kinase and he	92.97
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.9
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	92.41
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	91.63
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	91.1
PLN02756	418	S-methyl-5-thioribose kinase	91.06
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	90.97
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	90.38
PTZ00384	383	choline kinase; Provisional	90.37
PHA03111	444	Ser/Thr kinase; Provisional	90.03
PRK11768	325	serine/threonine protein kinase; Provisional	86.2
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	83.23
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	82.11
KOG2137	700	consensus Protein kinase [Signal transduction mech	81.81
PRK06148	1013	hypothetical protein; Provisional	81.63

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=264.06  Aligned_cols=145  Identities=61%  Similarity=1.016  Sum_probs=140.1

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      ....++|+++++||+|+||+||+++.+++++.||+|+++|..+......+....|..+|..++||+||+++..|++...+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            45678999999999999999999999999999999999999988888888899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|+||+.||.|+..|.+++.|+++.++.|+++|+.||.|||++|||||||||+|||||.+|+|+
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~  165 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIK  165 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEE
Confidence            99999999999999999999999999999999999999999999999999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-33  Score=251.27  Aligned_cols=137  Identities=38%  Similarity=0.618  Sum_probs=129.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|.+.+.||+|+||.||+|+++.++..||||.+.+... .....+.+..|+.+|+.++|||||+++++..+++.+|+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            4689999999999999999999999999999999988764 445678889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      ||||.||+|..++.+.+.+++..++.++.||+.||++||+++||||||||+||||+..
T Consensus        88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~  145 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTT  145 (429)
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccC
Confidence            9999999999999999999999999999999999999999999999999999999875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-34  Score=263.99  Aligned_cols=144  Identities=42%  Similarity=0.743  Sum_probs=139.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  225 (291)
                      ....||.+++.||.|+|++|++|+.+.+++.||||++.+..+......+++..|..+|.+| .||.|++||..|+++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            4457999999999999999999999999999999999999888888899999999999999 999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|+||+++|+|..++.+.+.|++.+++.|++||+.||+|||++|||||||||+|||||.||++|
T Consensus       150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEE
Confidence            99999999999999999999999999999999999999999999999999999999999999986

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.1e-33  Score=258.18  Aligned_cols=145  Identities=46%  Similarity=0.863  Sum_probs=141.4

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .+..++|+++++||+|+||.||+|+.+.||..||+|++++......+.++.++.|..+|...++|+||+||..|++..++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            46788999999999999999999999999999999999999988889999999999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||||++||++..+|.+.+.++++++++|+++++.|++-||..|+|||||||+|+|||..|+||
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiK  281 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIK  281 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEe
Confidence            99999999999999999999999999999999999999999999999999999999999999997

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=6.2e-32  Score=244.65  Aligned_cols=139  Identities=35%  Similarity=0.567  Sum_probs=127.8

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch----HHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      ..+.|.+.+.||+|+||.|-+|..+.+++.||||++.+.....    ......+.+|+++|++|+|||||+++++|+...
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4457889999999999999999999999999999998876544    223344679999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      ..||||||++||+|++.+...+.+.++..+.+++|++.|+.|||++||+||||||+|||+..+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~  312 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND  312 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC
Confidence            999999999999999999999999999999999999999999999999999999999999876

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-32  Score=235.13  Aligned_cols=144  Identities=44%  Similarity=0.762  Sum_probs=139.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ..+++|++++.||.|+||+|.+++.+.++..||+|++.+..+..-...+...+|..+|+.+.||+++++++.|.+...+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            66789999999999999999999999999999999999988887778888999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||||++||.|+.++.+.++|++..|++|++||+.||+|||+++|++|||||+|||+|.+|++|
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iK  184 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIK  184 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEE
Confidence            9999999999999999999999999999999999999999999999999999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.2e-31  Score=247.60  Aligned_cols=141  Identities=32%  Similarity=0.532  Sum_probs=136.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      .+|+..+.||+|+|++||.+++..+|+.||+|++.+..+......+.+.+|++|.+.|+|||||+++.+|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            46999999999999999999999999999999999988877888899999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|..++|..++.+++.++|.+|+.|+.||+.||.|||+++|||||||..||+++++.+||
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VK  158 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVK  158 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEE
Confidence            9999999999999999999999999999999999999999999999999999999998887

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=4e-31  Score=239.57  Aligned_cols=146  Identities=41%  Similarity=0.667  Sum_probs=138.1

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      ...+++++|++++.||+|.-|+||+|+..+++..+|+|++.+.....++...+.+.|.+||..++||+++.||..|+.+.
T Consensus        71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            34567789999999999999999999999999999999999998887888888999999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      ..|+|||||+||+|..+++++  +.|++..+++|+++++.||+|||-.|||.|||||+||||.++|+|
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHI  218 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHI  218 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcE
Confidence            999999999999999988876  579999999999999999999999999999999999999999997

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8e-31  Score=244.29  Aligned_cols=234  Identities=21%  Similarity=0.275  Sum_probs=185.5

Q ss_pred             cccCCCCCCCCccccCCccccccccccCCC--eeeecCCccCccCCCcccccccccccc--ccccccccccccccccccc
Q 022853           42 SDVFGPAPVQASIEVGGEISYANELVYDQP--AVIHSRSHSLVGPSSYVSQSLKLSKLT--LHEAEDSLGLVEGINEETQ  117 (291)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~v~~~~~sl~~p~~~~~~~~~~~~~~--~~~~e~~~~~~~~~~~~~~  117 (291)
                      -|..|+|.|++|++.+|.++.+..+.....  ..|.          +|..+......+.  ..+.+.+..+.+.++.++.
T Consensus       101 ~~~~G~flvR~se~~~g~yslsv~~~~~~~~~~~v~----------hyri~~~~~~~~~~~~~~~~~F~~l~~lv~~~~~  170 (468)
T KOG0197|consen  101 ENKEGAFLVRESESDKGDYSLSVREGDSGGLGAKVK----------HYRIRQLDGGGLYPYIDERELFSSLQQLVNYYSK  170 (468)
T ss_pred             CCCccceeeecccCCcCCeeEEEEeccccCCcccee----------eeeeeEcCCCCeecCCCHHHhhhhHHHHHhhhhc
Confidence            356799999999999999998887766432  1222          4555555566555  7777777777777777776


Q ss_pred             CCCCCCcccccccCC---CCCCCCCCCCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHH
Q 022853          118 EGPNNLSVVDAALGK---PTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA  194 (291)
Q Consensus       118 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~  194 (291)
                      +.+.-..........   ......+...+.|.+....+++++.||+|.||.||.|.+... ..||+|.++.....    .
T Consensus       171 ~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~----~  245 (468)
T KOG0197|consen  171 NADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS----P  245 (468)
T ss_pred             cCcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC----h
Confidence            666554444333322   222233344567777888889999999999999999999754 36999999876443    3


Q ss_pred             HHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCE
Q 022853          195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIM  272 (291)
Q Consensus       195 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~gIi  272 (291)
                      +.|.+|+.+|++|+|+|||++++++..+..+|||||||+.|+|.++|..  ...+.......++.|||.||+||+++++|
T Consensus       246 ~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~I  325 (468)
T KOG0197|consen  246 EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYI  325 (468)
T ss_pred             hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCcc
Confidence            4567999999999999999999999998899999999999999999987  45678888899999999999999999999


Q ss_pred             ecccCCCcEEecCCCCcC
Q 022853          273 HRDLKPENILLDADGHVR  290 (291)
Q Consensus       273 HrDLKp~NILl~~~g~vK  290 (291)
                      ||||.++||||+.++.||
T Consensus       326 HRDLAARNiLV~~~~~vK  343 (468)
T KOG0197|consen  326 HRDLAARNILVDEDLVVK  343 (468)
T ss_pred             chhhhhhheeeccCceEE
Confidence            999999999999998887

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-30  Score=230.73  Aligned_cols=143  Identities=31%  Similarity=0.524  Sum_probs=132.2

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE-
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR-  224 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-  224 (291)
                      .+...+++.++.||+|+.|+||+|+|+.+++.+|+|++...  .+....+.+.+|+++++.++||+||.+|+.|..++. 
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            46667899999999999999999999999999999999543  244556778899999999999999999999999994 


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|+||||++|+|...+...+.+++.....++.+|++||.|||. ++||||||||+|||++..|.||
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVK  219 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVK  219 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEE
Confidence            99999999999999999988999999999999999999999996 8999999999999999999997

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.8e-31  Score=240.08  Aligned_cols=141  Identities=33%  Similarity=0.578  Sum_probs=137.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      .+|++.+.||+|.||+|-+|.....|+.||||.++++.+.+....-.+++|++||..|+||||+++|.+|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            57999999999999999999999999999999999999999888889999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||..+|.|++++.+.+.+++..++.+++||..|+.|||.++++|||||.+|||+|.++++|
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiK  193 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIK  193 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCee
Confidence            9999999999999999999999999999999999999999999999999999999999987

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-29  Score=234.26  Aligned_cols=144  Identities=37%  Similarity=0.668  Sum_probs=131.1

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch--HHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKY  223 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~  223 (291)
                      ...+.|.+.+.||+|+||+|+.|++..+++.||+|++++.....  ....+.+.+|+.+++.+. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            44568999999999999999999999999999999887753221  134556778999999998 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC-CCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~-g~vK  290 (291)
                      .+|+||||+.||+|++++...+++.+..++.+++|++.|++|||++||+||||||+|||++.+ +++|
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~K  161 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLK  161 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEE
Confidence            999999999999999999999999999999999999999999999999999999999999999 8876

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=241.66  Aligned_cols=149  Identities=42%  Similarity=0.752  Sum_probs=138.2

Q ss_pred             CCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEE
Q 022853          141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (291)
Q Consensus       141 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~  219 (291)
                      |.....+++++|.++++||+|+||+|+++..+.+++.||||+++|+.+...+.++....|.+|+... +||+++.++.+|
T Consensus       359 ~~~~~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f  438 (694)
T KOG0694|consen  359 PPRRGPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF  438 (694)
T ss_pred             CCCCCcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc
Confidence            3333567889999999999999999999999999999999999999999999999999999999988 599999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          220 QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++..++|+||||+.||++ ..+.+.+.|++..+++|++.|+.||+|||++|||+||||.+|||||.+|+||
T Consensus       439 QT~~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~k  508 (694)
T KOG0694|consen  439 QTKEHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVK  508 (694)
T ss_pred             ccCCeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEE
Confidence            999999999999999994 4444557899999999999999999999999999999999999999999987

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=1.5e-28  Score=228.38  Aligned_cols=141  Identities=43%  Similarity=0.812  Sum_probs=131.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||+||+|++..+++.||+|++.+...........+..|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765444555677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||++||+|..++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++|
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vk  141 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVK  141 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEE
Confidence            9999999999999888999999999999999999999999999999999999999998875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.8e-30  Score=218.85  Aligned_cols=145  Identities=32%  Similarity=0.569  Sum_probs=136.7

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      ...+++|++.+.||+|-||.||+|+.+.++..+|+|++.+..+........+++|++|...|+||||.++|++|.+...+
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            45677999999999999999999999999999999999998877777778899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLY--RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~--~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++||...|+++..+.  +...+.+..+..|+.|++.|+.|+|.++||||||||+|+|++.+|.+|
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lk  164 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELK  164 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCee
Confidence            99999999999999998  567799999999999999999999999999999999999999999876

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.3e-28  Score=228.20  Aligned_cols=141  Identities=43%  Similarity=0.802  Sum_probs=130.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            37999999999999999999999999999999997765444555677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||++||+|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~k  141 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIK  141 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEE
Confidence            9999999999998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.2e-28  Score=226.87  Aligned_cols=141  Identities=43%  Similarity=0.834  Sum_probs=130.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|+.++..++||||+++++.+.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            37999999999999999999999999999999998765444455667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.+|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~k  141 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIK  141 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence            9999999999998888899999999999999999999999999999999999999998765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.96  E-value=3.3e-28  Score=227.60  Aligned_cols=140  Identities=42%  Similarity=0.782  Sum_probs=130.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|++++.||+|+||+||+|++..+++.||+|++.+.........+.+..|+.+++.++||||+++++.+.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            58999999999999999999999999999999987655555566778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~k  141 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIK  141 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEE
Confidence            999999999998888899999999999999999999999999999999999999988775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.2e-29  Score=231.10  Aligned_cols=142  Identities=29%  Similarity=0.518  Sum_probs=126.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC--CE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YR  224 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~  224 (291)
                      ...+.|+.++.||+|+||.||+|++..+|+.||+|.++.+.. +......+.+|+.||++|+||||++|.+.....  ..
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            445679999999999999999999999999999999987753 234456678999999999999999999988766  78


Q ss_pred             EEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|||+|||+. +|.-++.. .-.|++.+++.|+.||+.||+|||.+||+|||||.+|||||.+|.+|
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LK  258 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLK  258 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEE
Confidence            9999999998 67666665 34799999999999999999999999999999999999999999886

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.96  E-value=3.9e-28  Score=226.47  Aligned_cols=141  Identities=45%  Similarity=0.849  Sum_probs=129.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      .+|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            37999999999999999999999999999999997654444445667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ik  141 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIK  141 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEE
Confidence            9999999999999888899999999999999999999999999999999999999988775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.96  E-value=4.8e-28  Score=222.13  Aligned_cols=144  Identities=43%  Similarity=0.773  Sum_probs=132.6

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ..+++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++..++||||+++++.+..++.+|
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence            44678999999999999999999999999999999998765444445667889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+.+|+|...+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~k  158 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVK  158 (329)
T ss_pred             EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEE
Confidence            9999999999999999888899999999999999999999999999999999999999998775

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.96  E-value=4.4e-28  Score=226.67  Aligned_cols=140  Identities=45%  Similarity=0.836  Sum_probs=130.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++..+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            59999999999999999999999999999999987654445556778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~k  141 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIK  141 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence            999999999998888899999999999999999999999999999999999999998875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.96  E-value=2.8e-29  Score=219.94  Aligned_cols=140  Identities=28%  Similarity=0.430  Sum_probs=123.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      +.|+.+..+|+|+||.||+|+++.||+.||||.+.... .+....+-..+|+++|+++.|||+|.+.++|.....+++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            56899999999999999999999999999999986543 33444566679999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+..-|..+-.-...++...++.|++|++.|+.|+|++++|||||||+||||+.+|.+|
T Consensus        81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvK  141 (396)
T KOG0593|consen   81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVK  141 (396)
T ss_pred             eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEE
Confidence            9999854544333345688999999999999999999999999999999999999999887

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=9.6e-29  Score=227.32  Aligned_cols=147  Identities=32%  Similarity=0.548  Sum_probs=126.0

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch-----------HHHHHHHHHHHHHHHhCCCCCe
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----------KNHAEYMKSERNILTKVDHPFI  212 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-----------~~~~~~~~~E~~il~~l~HpnI  212 (291)
                      ..+..++.|++++.||+|.||+|-+|++..+++.||||++.+.....           ....+.+++|+.+|++|.||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            34556779999999999999999999999999999999997654321           1124678899999999999999


Q ss_pred             eEEeEEEEe--CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          213 VQLRYSFQT--KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       213 v~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|+++..+  ...+|||+|||..|.+.+.-....-+.+..|++|+++++.||+|||.+|||||||||+|+||+.+|+||
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence            999999865  457999999999997754332222288999999999999999999999999999999999999999997

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-27  Score=218.28  Aligned_cols=148  Identities=32%  Similarity=0.523  Sum_probs=136.2

Q ss_pred             CCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE
Q 022853          141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (291)
Q Consensus       141 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  220 (291)
                      +...+....++|++...||.|..+.||+|+...+++.||||+++.+.....  .+.+++|+..|+.++||||++++..|.
T Consensus        17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            344566778899999999999999999999999999999999988775443  788999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+..+|+||.||.+|++.+++...  ..+.|..+..+.+++++||.|||.+|.||||||+.||||+.+|.||
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~Vk  166 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVK  166 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEE
Confidence            999999999999999999998864  4588999999999999999999999999999999999999999986

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7e-29  Score=220.23  Aligned_cols=149  Identities=43%  Similarity=0.818  Sum_probs=142.3

Q ss_pred             CCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEE
Q 022853          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ  220 (291)
Q Consensus       142 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  220 (291)
                      ...|.+++++|.++++||+|+|++|.+++++.|.+.||+|++++....+.+..+.++.|..+..+. +||++|-+..+|+
T Consensus       242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq  321 (593)
T KOG0695|consen  242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ  321 (593)
T ss_pred             ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence            356788999999999999999999999999999999999999999888888888899999998877 8999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++.++|+|.||.+||+|...+.++.+++++.|++|..+|+.||.|||++|||.||||.+|+|+|..|+||
T Consensus       322 tesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghik  391 (593)
T KOG0695|consen  322 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIK  391 (593)
T ss_pred             ccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCcee
Confidence            9999999999999999999999999999999999999999999999999999999999999999999987

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.95  E-value=1.5e-27  Score=221.47  Aligned_cols=141  Identities=43%  Similarity=0.818  Sum_probs=130.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++++.........+.+..|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998655444555677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||++||+|..++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++|
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vk  141 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVK  141 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEE
Confidence            9999999999998888899999999999999999999999999999999999999998875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.95  E-value=1.9e-27  Score=219.59  Aligned_cols=147  Identities=38%  Similarity=0.620  Sum_probs=132.3

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCC-cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ......++|++.+.||+|+||.||+|.+..++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.
T Consensus        24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            34456779999999999999999999876654 68999999776544445566788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|+||||+.+|+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ik  171 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIK  171 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEE
Confidence            99999999999999999999888899999999999999999999999999999999999999998875

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.3e-28  Score=216.60  Aligned_cols=141  Identities=38%  Similarity=0.695  Sum_probs=129.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            37999999999999999999999999999999997654433344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.+|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~k  141 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIK  141 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEE
Confidence            9999999999998888899999999999999999999999999999999999999988775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-27  Score=217.87  Aligned_cols=141  Identities=42%  Similarity=0.732  Sum_probs=130.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|+.++..++||||+++++.+.....+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            37999999999999999999999999999999998765444445667888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k  141 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIK  141 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEE
Confidence            9999999999998888899999999999999999999999999999999999999998775

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=220.65  Aligned_cols=145  Identities=26%  Similarity=0.490  Sum_probs=127.8

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .+.+...++.+.+.||.|+||+||++.+.++.. +|+|++......... .+.|.+|+.+|.+++|||||++++++....
T Consensus        35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~  112 (362)
T KOG0192|consen   35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP  112 (362)
T ss_pred             ceecChHHhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            344556677778889999999999999964422 999999876655544 778999999999999999999999998877


Q ss_pred             -EEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CEecccCCCcEEecCCC-CcC
Q 022853          224 -RLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANG-IMHRDLKPENILLDADG-HVR  290 (291)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~g-IiHrDLKp~NILl~~~g-~vK  290 (291)
                       .++||||||++|+|..++.+  ...++...+..++.||++||+|||+++ ||||||||+|||++.++ ++|
T Consensus       113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~K  184 (362)
T KOG0192|consen  113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLK  184 (362)
T ss_pred             CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEE
Confidence             79999999999999999988  678999999999999999999999999 99999999999999997 665

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.9e-27  Score=217.86  Aligned_cols=141  Identities=48%  Similarity=0.902  Sum_probs=130.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|+.++..++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            37999999999999999999999999999999998765444455667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.+++|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~k  141 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIK  141 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEE
Confidence            9999999999998888899999999999999999999999999999999999999998775

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.9e-29  Score=219.16  Aligned_cols=143  Identities=30%  Similarity=0.529  Sum_probs=126.9

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeE-EEEeCCE-
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY-SFQTKYR-  224 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~-~~~~~~~-  224 (291)
                      ..+.+|++++.||+|+||.||++.+..+|..+|.|.+.-+.. +....+.+..|+.+|++|+|||||++++ .|..++. 
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev   94 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV   94 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence            345689999999999999999999999999999999985544 4455677889999999999999999998 5666665 


Q ss_pred             EEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--CEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHA--NG--IMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~--~g--IiHrDLKp~NILl~~~g~vK  290 (291)
                      ++||||||.+|+|...+..    ...+++..+++++.|++.||.++|.  .+  |+||||||.||+++.+|.||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK  168 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK  168 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence            9999999999999888764    3579999999999999999999999  45  99999999999999999987

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=4.1e-27  Score=215.36  Aligned_cols=135  Identities=47%  Similarity=0.818  Sum_probs=123.9

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (291)
                      +.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+||||+.+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765444445566778999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~k  135 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIK  135 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEE
Confidence            9999998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=6.1e-27  Score=215.02  Aligned_cols=141  Identities=42%  Similarity=0.793  Sum_probs=128.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+.........+.+.+|+.++..++||||+++++++.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998654444445667888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.||+|..++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~k  142 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR  142 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEE
Confidence            99999999998876 45789999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.95  E-value=9.3e-27  Score=213.79  Aligned_cols=141  Identities=42%  Similarity=0.762  Sum_probs=128.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+.........+.+..|+.++..++|+||+++++.+.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997654444444566788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.||+|..++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~k  142 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIR  142 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEE
Confidence            99999999999987 46789999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=5.8e-27  Score=218.74  Aligned_cols=143  Identities=37%  Similarity=0.718  Sum_probs=128.5

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++.+.||+|+||.||+|++..+++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+.++..+|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34468999999999999999999999999999999997654444444566788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+++|+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~k  182 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLK  182 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEE
Confidence            999999999999888654 578999999999999999999999999999999999999988875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1e-27  Score=226.57  Aligned_cols=141  Identities=45%  Similarity=0.844  Sum_probs=136.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      .-|..++.||-|+||+|.+++..+|...||+|.+++.....++.+..++.|..||+..+.+.||+||..|++++++|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            35889999999999999999999999999999999888878888889999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||++||++..+|.+.+.|.|+.|++|++++..|+++.|..|+|||||||+|||||.+|+||
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIK  769 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIK  769 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCcee
Confidence            9999999999999999999999999999999999999999999999999999999999997

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-29  Score=247.23  Aligned_cols=144  Identities=44%  Similarity=0.777  Sum_probs=137.3

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...+||.++++||+|+||.|.+++++.+++.||+|++.+...........|+.|..+|...+.+.|++++..|+++.++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            44579999999999999999999999999999999999877766677788999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|||||+||+|..++.+.+.+++++|++|++.|+.||.-||+.|+|||||||+|||||..|+||
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEe
Confidence            9999999999999999988999999999999999999999999999999999999999999987

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.95  E-value=4.6e-28  Score=226.68  Aligned_cols=139  Identities=37%  Similarity=0.632  Sum_probs=130.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.|....+++ .+.+++|++|++.++||||+.++++|++..++|+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~-l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE-LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH-HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            5789999999999999999999999999999999887654433 566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.| +|..++...+.++++.++.++.|++.||.|||+++|+|||+||.|||++..|++|
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~K  140 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLK  140 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCcee
Confidence            99998 9999999999999999999999999999999999999999999999999999887

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.95  E-value=1e-26  Score=213.05  Aligned_cols=141  Identities=44%  Similarity=0.804  Sum_probs=129.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++++.........+.+..|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            37999999999999999999999999999999998765544455677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++|+|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~k  142 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIK  142 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEE
Confidence            999999999998876 6789999999999999999999999999999999999999998875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.95  E-value=1.2e-27  Score=206.46  Aligned_cols=139  Identities=26%  Similarity=0.453  Sum_probs=124.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      .+|..++.||+|.||.||+|++..+++.||||.++.....+.-... ..+|+.+|+.++|+||+.+.++|.....+.||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~t-alREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRT-ALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHH-HHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            4688899999999999999999999999999999877554433333 457999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+. +|...+... ..++...++.|+.++++||+|||++.|+||||||.|+|++++|.+|
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lK  141 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLK  141 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEE
Confidence            99986 787777654 5678999999999999999999999999999999999999999887

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.1e-27  Score=227.66  Aligned_cols=142  Identities=32%  Similarity=0.533  Sum_probs=133.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .+-|++.+.||.|+-|.|-+|++..||+.+|||++.+...........+.+|+.+|+.+.|||++++|++|++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            45699999999999999999999999999999999887444444456688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .||++||.|++++.+.+++++..|.++++||+.|+.|||..+|+||||||+|+|||..++||
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIK  152 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIK  152 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEe
Confidence            99999999999999999999999999999999999999999999999999999999999887

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=8.8e-27  Score=213.26  Aligned_cols=135  Identities=45%  Similarity=0.816  Sum_probs=123.5

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (291)
                      +.||+|+||.||++++..++..||+|++.+...........+..|+.+++.++||||+++++.|.....+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765444445566778999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k  135 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK  135 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEE
Confidence            9999888888899999999999999999999999999999999999999988775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.95  E-value=9.8e-27  Score=217.09  Aligned_cols=143  Identities=39%  Similarity=0.744  Sum_probs=128.5

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+..|+.+++.++||||+++++++.+...+|
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            45678999999999999999999999999999999997654444444566778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||++||+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus       120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~k  182 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK  182 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEE
Confidence            99999999999887765 4578999999999999999999999999999999999999998875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.94  E-value=1.7e-26  Score=211.20  Aligned_cols=140  Identities=43%  Similarity=0.792  Sum_probs=126.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCC-CeeEEeEEEEeCCEEEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP-FIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~l~~~~~~~~~~~lV~  229 (291)
                      +|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..+.|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999876544444566677899999999765 6888999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  141 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIK  141 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEE
Confidence            9999999999998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.94  E-value=1.5e-26  Score=216.05  Aligned_cols=143  Identities=40%  Similarity=0.743  Sum_probs=128.6

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++.+.||+|+||.||+|++..+++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+.++..+|
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            44578999999999999999999999999999999997654444444566788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||++||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus       120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ik  182 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK  182 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEE
Confidence            999999999998887654 578999999999999999999999999999999999999998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.94  E-value=1.2e-26  Score=212.88  Aligned_cols=135  Identities=47%  Similarity=0.832  Sum_probs=123.9

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (291)
                      +.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.....+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999998765444455667788999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~k  135 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIK  135 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEE
Confidence            9999888888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=8.4e-27  Score=210.66  Aligned_cols=138  Identities=33%  Similarity=0.561  Sum_probs=123.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC--EEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYL  227 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~l  227 (291)
                      .+|...+.||+|+||.||++.+..+|+.+|+|.+.....   ...+.+.+|+.+|.+++|||||++++......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            458889999999999999999999999999999876521   11667889999999999999999999744444  6999


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC-CCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~-~g~vK  290 (291)
                      .|||+++|+|..++.+.+ .+++..++.+.+||++||+|||++|||||||||+|||++. +|.+|
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~K  158 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVK  158 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEE
Confidence            999999999999999877 7999999999999999999999999999999999999999 57765

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.5e-26  Score=210.45  Aligned_cols=133  Identities=49%  Similarity=0.846  Sum_probs=122.3

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCH
Q 022853          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (291)
                      ||+|+||.||+|++..+++.||+|++.+...........+..|+.++.+++||||+++++.+.....+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999999865544444566778899999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       238 ~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~k  133 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIA  133 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEE
Confidence            99998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-28  Score=225.03  Aligned_cols=141  Identities=30%  Similarity=0.544  Sum_probs=123.2

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCC-E
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKY-R  224 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~-~  224 (291)
                      +..++|.+++.||.|+||.||+|+.+.+++.||||.+++....-.+ .- -.+|+..|++++ |||||++.+++.+.+ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~-nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HH-HHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            4567899999999999999999999999999999999876543222 22 237999999998 999999999998887 9


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+|||||+. +|++++..+ ..|++..++.|+.||++||+|+|.+|+.|||+||||||+.....||
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iK  150 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIK  150 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeE
Confidence            9999999987 898888764 6799999999999999999999999999999999999998655554

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.94  E-value=3.4e-26  Score=210.04  Aligned_cols=141  Identities=40%  Similarity=0.764  Sum_probs=127.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||++++..+++.+|+|++.+.........+.+..|+.++..++|+||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999997654444444566788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.+|+|..++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~k  142 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR  142 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEE
Confidence            99999999999877 46789999999999999999999999999999999999999888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.94  E-value=3.8e-26  Score=205.02  Aligned_cols=140  Identities=39%  Similarity=0.666  Sum_probs=124.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.++..++|+||+++++.+.+.+.+|+|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            38899999999999999999999999999999986654443444557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++|+|...+...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~k  142 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIR  142 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEE
Confidence            99999998777643  3588999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.94  E-value=2.9e-26  Score=209.76  Aligned_cols=135  Identities=46%  Similarity=0.815  Sum_probs=123.0

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (291)
                      +.||+|+||.||+|++..+++.||+|++.+...........+..|+.++..++||||+++++.+.....+|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765444445566778999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~k  136 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK  136 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEE
Confidence            999988888889999999999999999999997 7999999999999999998775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.6e-28  Score=215.79  Aligned_cols=147  Identities=46%  Similarity=0.820  Sum_probs=140.4

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      ...+.+++|..+++||+|.||+|.+|+.+.+++.||||+++++.+..++.+..-..|-++|...+||++..+-..|++.+
T Consensus       162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d  241 (516)
T KOG0690|consen  162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD  241 (516)
T ss_pred             cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence            34467889999999999999999999999999999999999998888888888889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|+||||+.||.|+..+.+...|+++.+++|..+|+.||.|||+++||.||||.+|+|+|.||+||
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIK  308 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIK  308 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceE
Confidence            9999999999999999999999999999999999999999999999999999999999999999997

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.94  E-value=2.7e-26  Score=210.57  Aligned_cols=135  Identities=43%  Similarity=0.811  Sum_probs=124.1

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.||+|++++.........+.+..|..++..+ +||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999999999999999999876555555566788899999988 799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~k  136 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIK  136 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence            99999888888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.94  E-value=5.5e-26  Score=207.77  Aligned_cols=140  Identities=42%  Similarity=0.789  Sum_probs=125.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      +|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+..|..++..+ +||+|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            589999999999999999999999999999999876544444455566788888777 6899999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++|+|...+...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~k  141 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIK  141 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEE
Confidence            9999999999998888899999999999999999999999999999999999999998775

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.94  E-value=4.7e-26  Score=208.42  Aligned_cols=140  Identities=42%  Similarity=0.788  Sum_probs=125.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      +|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788999999999999999999999999999998765444444566778888888885 577888999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ik  141 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIK  141 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEE
Confidence            9999999999998888899999999999999999999999999999999999999998765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.94  E-value=6e-27  Score=207.64  Aligned_cols=146  Identities=29%  Similarity=0.462  Sum_probs=126.5

Q ss_pred             CCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-
Q 022853          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-  221 (291)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-  221 (291)
                      -..|..+++|+.+..|++|+||.||+|+++.+++.||+|.++.+.-.+.--.- -.+|+.+|.+++|||||.+..+... 
T Consensus        69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIt-sLREIniLl~~~H~NIV~vkEVVvG~  147 (419)
T KOG0663|consen   69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPIT-SLREINILLKARHPNIVEVKEVVVGS  147 (419)
T ss_pred             ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcch-hHHHHHHHHhcCCCCeeeeEEEEecc
Confidence            45567788999999999999999999999999999999999876522211122 3579999999999999999887754 


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 -KYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       -+.+|||||||+. +|..++..-+ +|....++.++.|+++|++|||.+.|+||||||+|+|++..|.+|
T Consensus       148 ~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lK  217 (419)
T KOG0663|consen  148 NMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILK  217 (419)
T ss_pred             ccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEE
Confidence             3579999999988 7888887654 899999999999999999999999999999999999999999876

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=6.3e-26  Score=208.22  Aligned_cols=135  Identities=43%  Similarity=0.818  Sum_probs=123.2

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.||+|++.+.........+.+..|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876554555566778898888876 899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~k  136 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK  136 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEE
Confidence            99998888888899999999999999999999999999999999999999998775

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=5.3e-26  Score=207.73  Aligned_cols=135  Identities=45%  Similarity=0.806  Sum_probs=122.0

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.||+|++.+.........+.+..|..++..+ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            3689999999999999999999999999876544444556677788888866 899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~k  136 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCK  136 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEE
Confidence            99999998888899999999999999999999999999999999999999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.94  E-value=6.5e-26  Score=207.40  Aligned_cols=138  Identities=36%  Similarity=0.646  Sum_probs=121.9

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHH---HhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL---TKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il---~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      |++.+.||+|+||.||+|.+..+++.||+|++++.........+.+..|+.++   +.++||||+++++++.+...+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78899999999999999999999999999999876544444456677777665   456899999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~k  141 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVK  141 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEE
Confidence            999999999877654 5789999999999999999999999999999999999999998775

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=7e-26  Score=206.78  Aligned_cols=135  Identities=50%  Similarity=0.851  Sum_probs=118.7

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHH-HHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER-NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~-~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.||+|++.+...........+..|. .+++.++||||+++++.+.+.+.+|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999865443333334444454 467889999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|...+.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~k  136 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVV  136 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence            99998888888899999999999999999999999999999999999999998775

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.94  E-value=1e-25  Score=202.61  Aligned_cols=139  Identities=27%  Similarity=0.437  Sum_probs=122.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++.+.||.|+||.||+|++..+++.||+|+++.....  .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            56899999999999999999999999999999999754321  1233466899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+ +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~k  143 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELK  143 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEE
Confidence            999986 888877654 3578889999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=7.1e-26  Score=206.65  Aligned_cols=135  Identities=43%  Similarity=0.804  Sum_probs=119.7

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.||+|++++.........+.+..|..++..+ +||||+++++.+.....+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999876543334445556677777654 899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~k  136 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIK  136 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEE
Confidence            99999998888899999999999999999999999999999999999999988775

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=1.4e-25  Score=205.61  Aligned_cols=140  Identities=49%  Similarity=0.881  Sum_probs=124.6

Q ss_pred             CeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccccch-HHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  225 (291)
                      +|++.+.||+|+||.||++++.   .+++.||+|++.+..... ....+.+..|+.++..+ +||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999998864   478999999997654322 23345677899999999 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+.+|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~k  145 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVV  145 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEE
Confidence            99999999999999998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=1.1e-25  Score=206.32  Aligned_cols=135  Identities=44%  Similarity=0.820  Sum_probs=124.0

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.||+|++.+.........+.+..|+.++.++ +||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876655555567788899999888 799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~k  136 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIK  136 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEE
Confidence            99998888888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=8.3e-26  Score=206.61  Aligned_cols=135  Identities=52%  Similarity=0.862  Sum_probs=118.6

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHH-HHHhCCCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.++||||+++++.+.+...+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999998654433333344444544 56789999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~k  136 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVV  136 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEE
Confidence            99999998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.94  E-value=9.7e-26  Score=204.00  Aligned_cols=139  Identities=27%  Similarity=0.464  Sum_probs=121.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|++..+++.||+|++......  .....+.+|+.+++.++||||+++++++.++...|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            35799999999999999999999999999999999754321  1123456799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+ +|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  143 (303)
T cd07869          82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELK  143 (303)
T ss_pred             EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence            999975 66666655 35688899999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.94  E-value=9.2e-26  Score=210.43  Aligned_cols=137  Identities=37%  Similarity=0.594  Sum_probs=127.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l  227 (291)
                      ...|++.+.||+|.||.||+|..+.+|+.+|+|++.+.........+.+.+|+.+|+++. ||||+.+++.|++...+|+
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            356999999999999999999999999999999999887665555678999999999998 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      |||++.||.|++.+.+. .+++..+..++.|++.|+.|||+.||+||||||+|+|+...
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~  171 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASK  171 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccc
Confidence            99999999999999887 49999999999999999999999999999999999999765

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=9.8e-26  Score=206.29  Aligned_cols=135  Identities=52%  Similarity=0.851  Sum_probs=118.6

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHH-HHHhCCCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.+|+|++.+...........+..|.. +++.++||||+++++.+...+.+|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999999999999999997654333333344445544 56778999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|...+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~k  136 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVV  136 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEE
Confidence            99999988888899999999999999999999999999999999999999998775

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=7.3e-26  Score=206.91  Aligned_cols=135  Identities=44%  Similarity=0.789  Sum_probs=121.5

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.||+|++.+.........+.+..|..++..+ +||||+++++++.+...+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999876544444456667788888776 799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|..++.+...+++..+..++.|++.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~k  136 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCK  136 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEE
Confidence            99999998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.8e-25  Score=200.58  Aligned_cols=140  Identities=41%  Similarity=0.683  Sum_probs=124.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.++..+|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48899999999999999999998999999999976554433344556789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++|+|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~  142 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIR  142 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEE
Confidence            99999998877654  4588999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.93  E-value=2.8e-26  Score=205.21  Aligned_cols=140  Identities=27%  Similarity=0.496  Sum_probs=122.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCC-eeEEeEEEEeCC----
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKY----  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~----  223 (291)
                      +..|+.++.||+|+||+||+|+.+.+|+.||+|.++..... +..-....+|+.+++.++|+| |+.+++++.+..    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            45688888999999999999999999999999999866432 112334568999999999999 999999998877    


Q ss_pred             --EEEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 --RLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                        .+++|+||+.. +|..++....    .++...++.+++||+.||+|||+++|+||||||+||||+.+|.+|
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lK  160 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLK  160 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEe
Confidence              89999999987 7888887654    467788999999999999999999999999999999999999886

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.93  E-value=1.2e-25  Score=205.26  Aligned_cols=135  Identities=39%  Similarity=0.737  Sum_probs=119.8

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.||+|++++.........+.+..|..++..+ +||||+++++.+.+.+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999999999999999999875433333345566777777754 999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~k  136 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIK  136 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence            99999998888899999999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=8.8e-26  Score=213.44  Aligned_cols=143  Identities=36%  Similarity=0.571  Sum_probs=132.7

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      .....|.+.+.||+|.|++|.+|++..++..||||++++....... .+.+.+|+++|+.++|||||+++.+.+....+|
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            3456799999999999999999999999999999999987765444 344889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+.+|.+++++.+.+...+..++.++.|++.|++|||+++|+|||||++||||+.+.++|
T Consensus       132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnik  195 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIK  195 (596)
T ss_pred             EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccccee
Confidence            9999999999999999999999999999999999999999999999999999999999998776

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=2.3e-25  Score=222.59  Aligned_cols=142  Identities=39%  Similarity=0.740  Sum_probs=131.4

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|.+.+.||+|+||.||+|++..+++.||||++++.........+.+..|+.++..++||||+++++.+.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            46899999999999999999999999999999999876555555567788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.|++|..++...+.+.+..++.|+.||+.||+|||.+||+||||||+|||++.+|.+|
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vk  144 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIK  144 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEE
Confidence            99999999999998888889999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.93  E-value=1.3e-25  Score=206.25  Aligned_cols=144  Identities=23%  Similarity=0.337  Sum_probs=119.7

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~  218 (291)
                      |.+..++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+..|+.++..+ +||||++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            4556678999999999999999999753     345689999987542  223345678899999999 89999999998


Q ss_pred             EEeC-CEEEEEEeccCCCCHHHHHHHc-----------------------------------------------------
Q 022853          219 FQTK-YRLYLVLDFVNGGHLFFQLYRQ-----------------------------------------------------  244 (291)
Q Consensus       219 ~~~~-~~~~lV~E~~~gg~L~~~l~~~-----------------------------------------------------  244 (291)
                      +... ..+|++|||+++|+|..++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            7654 4689999999999999888653                                                     


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          245 ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       245 ---------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                               ..++...+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~k  214 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVK  214 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEE
Confidence                     2356677788999999999999999999999999999999888765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.93  E-value=2.7e-25  Score=197.34  Aligned_cols=141  Identities=17%  Similarity=0.239  Sum_probs=123.5

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      ...+|++.+.||+|+||.||+|.+.   ..+..+|+|.++....  ....+.+.+|+.++++++||||+++++++..+..
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            4467999999999999999999865   3467899999876432  2334567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .|+||||+++|+|..++.+. ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~  147 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCK  147 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEE
Confidence            99999999999999888764 5688999999999999999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.93  E-value=1.9e-25  Score=204.38  Aligned_cols=135  Identities=49%  Similarity=0.827  Sum_probs=117.2

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHH-HHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE-RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E-~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.||+|++.+...........+..| ..+++.++||||+++++.+...+.+|+||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999999999999999976543322222333334 4456788999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|..++...+.+.+..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~k  136 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV  136 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence            99999998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.93  E-value=6.1e-25  Score=201.63  Aligned_cols=141  Identities=23%  Similarity=0.391  Sum_probs=128.1

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..++|++.+.||+|+||.||++++..++..+|+|++....  .....+.+.+|+.++++++||||+++++++..++.+|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            3468999999999999999999999999999999997642  22345668899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+++++|..++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~k  144 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIK  144 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEE
Confidence            999999999999998888899999999999999999999986 699999999999999988765

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.93  E-value=1.9e-25  Score=203.86  Aligned_cols=135  Identities=47%  Similarity=0.839  Sum_probs=122.7

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.||+|++++.........+.+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999876544444566677888999888 799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|...+.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~k  136 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIK  136 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEE
Confidence            99999988888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.93  E-value=1.8e-25  Score=200.11  Aligned_cols=140  Identities=31%  Similarity=0.490  Sum_probs=124.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++..+..+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            3699999999999999999999999999999999765322 233456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+|
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~k  140 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLK  140 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEE
Confidence            9999987766555556789999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.93  E-value=4.1e-25  Score=198.56  Aligned_cols=141  Identities=45%  Similarity=0.793  Sum_probs=130.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++.+.........+.+.+|+.++++++||||+++++.+.....+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36999999999999999999999999999999998765544455677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|..++.+.+.+++..+..++.|++.||.|||++||+||||+|+|||++.+|.+|
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~k  141 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIK  141 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEE
Confidence            9999999999998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=2e-25  Score=204.17  Aligned_cols=135  Identities=54%  Similarity=0.943  Sum_probs=120.0

Q ss_pred             EEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          156 KVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIM-EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      +.||+|+||.||+|++.   .+++.||+|++.+.... .......+..|+.+++.++||||+++++.+..++.+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999864   46889999999765432 222345567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+++|...+.+.+.+.+..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k  140 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVK  140 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEE
Confidence            99999999998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.93  E-value=2.7e-25  Score=202.97  Aligned_cols=135  Identities=39%  Similarity=0.739  Sum_probs=119.1

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHh-CCCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||+|+||.||+|++..+++.||+|++++.........+....|..++.. ++||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999987543223334455667777776 4999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|..++.+...+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~k  136 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIK  136 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEE
Confidence            99999998878889999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-25  Score=210.51  Aligned_cols=153  Identities=22%  Similarity=0.334  Sum_probs=135.1

Q ss_pred             CCCCCCCcccccCCeEEEEEecccCceEEEEEEEcCCCc---E-EEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCee
Q 022853          138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---I-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV  213 (291)
Q Consensus       138 ~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~---~-vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv  213 (291)
                      .+.+...|.+.-++..+.+.||+|+||.||+|+.+..+.   . ||+|..+............+..|+++|++++|||||
T Consensus       145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV  224 (474)
T KOG0194|consen  145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV  224 (474)
T ss_pred             ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence            345666788888888999999999999999998765422   3 899998865445566788899999999999999999


Q ss_pred             EEeEEEEeCCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       214 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++||+...+.++|+|||+|.||+|.++|.+.+ .++......++.+.+.||+|||++++|||||-.+|+|+..++.+|
T Consensus       225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEE
Confidence            99999999999999999999999999999876 488888899999999999999999999999999999999987765

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.3e-25  Score=203.10  Aligned_cols=133  Identities=53%  Similarity=0.893  Sum_probs=116.9

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC---CCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      ||+|+||.||+|++..+++.||+|++.+..............|..++..+   +||||++++..+.+...+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999999999999999999765443333334445566666655   799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|...+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~k  136 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIA  136 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence            99999998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=3.4e-25  Score=201.99  Aligned_cols=134  Identities=51%  Similarity=0.902  Sum_probs=119.3

Q ss_pred             EEecccCceEEEEEEEc---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEecc
Q 022853          156 KVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  232 (291)
                      +.||+|+||.||++++.   .+++.||+|++.+..... .....+..|+.++++++||||+++++.+.+.+.+|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            67999999999998763   578999999998654322 22345667999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          233 NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       233 ~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  138 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIK  138 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEE
Confidence            9999999998888899999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.93  E-value=7.9e-25  Score=201.25  Aligned_cols=141  Identities=24%  Similarity=0.428  Sum_probs=127.7

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..++|++.+.||+|+||.||++.+..++..+|+|++....  .....+.+.+|+.+++.++||||+++++++.+++.+|+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            3468999999999999999999999999999999987643  22335568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+.+++|..++.+.+.+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~k  144 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK  144 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEE
Confidence            999999999999998888889999999999999999999985 799999999999999988765

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.93  E-value=3.7e-25  Score=198.15  Aligned_cols=133  Identities=44%  Similarity=0.702  Sum_probs=118.2

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCH
Q 022853          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (291)
                      ||+|+||+||++.+..+++.||+|.+.+.........+.+..|+.+++.++||||+++.+.+.....+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999999766544444456677899999999999999999999999999999999999999


Q ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          238 FFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       238 ~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...+..    ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~  137 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVR  137 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence            877643    34688999999999999999999999999999999999999887764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=5.8e-25  Score=201.23  Aligned_cols=138  Identities=22%  Similarity=0.406  Sum_probs=120.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----CEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YRL  225 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~  225 (291)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            58999999999999999999999999999999864322 122234577899999999999999999887543     358


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+. ++|...+.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~k  143 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLK  143 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEE
Confidence            99999996 58888888888899999999999999999999999999999999999999998765

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.93  E-value=8.4e-25  Score=197.80  Aligned_cols=140  Identities=21%  Similarity=0.296  Sum_probs=119.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcC----------------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCe
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIG----------------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI  212 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI  212 (291)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++.+++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence            4589999999999999999997532                34579999987643  23345668889999999999999


Q ss_pred             eEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEe
Q 022853          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-------------------LFREDLARIYTAEIVSAVSHLHANGIMH  273 (291)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-------------------~~~~~~~~~i~~qil~aL~yLH~~gIiH  273 (291)
                      +++++++.+....|+||||+.+|+|..++....                   .++...+..++.||+.||.|||++||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999998886532                   2456677889999999999999999999


Q ss_pred             cccCCCcEEecCCCCcC
Q 022853          274 RDLKPENILLDADGHVR  290 (291)
Q Consensus       274 rDLKp~NILl~~~g~vK  290 (291)
                      |||||+|||++.++.+|
T Consensus       162 ~dlkp~Nill~~~~~~k  178 (304)
T cd05096         162 RDLATRNCLVGENLTIK  178 (304)
T ss_pred             cCcchhheEEcCCccEE
Confidence            99999999999988765

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.93  E-value=6.9e-25  Score=192.60  Aligned_cols=138  Identities=36%  Similarity=0.591  Sum_probs=125.1

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      |++.+.||+|+||+||++.+..+++.||+|++......... ......|+.+++.++||||+++++++.....+++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            88999999999999999999999999999999877543333 23344599999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+++|..++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~  138 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVK  138 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999998888899999999999999999999999999999999999999887653

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=6.2e-25  Score=206.55  Aligned_cols=134  Identities=25%  Similarity=0.330  Sum_probs=121.3

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +...+|++++.||+|+||.||+|.+..+++.||+|....         +.+.+|+.+++.++||||++++++|......|
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            445689999999999999999999999999999996532         23568999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vk  222 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC  222 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEE
Confidence            9999996 57888887777889999999999999999999999999999999999999988765

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.93  E-value=1.8e-24  Score=191.32  Aligned_cols=141  Identities=28%  Similarity=0.503  Sum_probs=125.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++||||+++++.+.+.+..|++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999999999999999987644444555667788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|..++..    ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~  146 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEE
Confidence            99999999877753    34578888999999999999999999999999999999999888664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.93  E-value=1.9e-24  Score=195.76  Aligned_cols=141  Identities=41%  Similarity=0.704  Sum_probs=128.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.+.........+.+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36999999999999999999999999999999998765444445567788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||++|++|..++...+.+++..+..++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~  141 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIK  141 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEE
Confidence            9999999999998888899999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.92  E-value=1.9e-24  Score=194.04  Aligned_cols=140  Identities=40%  Similarity=0.682  Sum_probs=124.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|+..+.||+|+||+||+|.+..+++.+|+|++.+...........+.+|+.+++.++|+||+.+++.+..++..|++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            37888999999999999999999999999999977654444445567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+++|...+...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~k  142 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIR  142 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEE
Confidence            99999998877653  3589999999999999999999999999999999999999887664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.92  E-value=8.5e-25  Score=202.39  Aligned_cols=138  Identities=30%  Similarity=0.492  Sum_probs=121.1

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ....+|++++.||+|+||.||+|++..+++.||+|++....  .....+.+.+|+.+++.++|+||+++++++...+.+|
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            44568999999999999999999999999999999996543  2334566889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+.+++|...    ....+..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k  208 (353)
T PLN00034        149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVK  208 (353)
T ss_pred             EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEE
Confidence            99999999988532    3456777888999999999999999999999999999999988775

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=1.1e-25  Score=209.11  Aligned_cols=141  Identities=34%  Similarity=0.578  Sum_probs=129.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE-EEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR-LYL  227 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~~l  227 (291)
                      +++|..++++|+|+||.+++++++..+..|++|.+......+... +....|+.+++++.|||||.+.+.|..++. +||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            468999999999999999999999999999999998877655543 367789999999999999999999999888 999


Q ss_pred             EEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+||+||+|.+.+.+++  .|+++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.||
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~Vk  146 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVK  146 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCcee
Confidence            999999999999988754  689999999999999999999999999999999999999998875

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.92  E-value=2.2e-24  Score=193.78  Aligned_cols=140  Identities=41%  Similarity=0.694  Sum_probs=124.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.+.........+.+..|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            37889999999999999999999999999999976654444444556789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~  142 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIR  142 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEE
Confidence            99999998887653  3588889999999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.5e-26  Score=208.20  Aligned_cols=147  Identities=46%  Similarity=0.738  Sum_probs=136.8

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .+.+..+.|..-++||+|+||.||-|+.+.||+.||+|.+.+..+..+.......+|..+|.+++.++||.+-..|++++
T Consensus       179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD  258 (591)
T ss_pred             hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence            46677788999999999999999999999999999999998877766666666778999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||..|+||+|...++..+  .|++..+++|+++|+.||++||+.+||.|||||+|||+|+.|+|+
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvR  327 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVR  327 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeE
Confidence            9999999999999999998876  799999999999999999999999999999999999999999986

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.92  E-value=2.4e-24  Score=190.63  Aligned_cols=139  Identities=27%  Similarity=0.477  Sum_probs=126.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++.....   .....+.+|+.++.+++||||+++++.+..+..+|+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            4579999999999999999999999999999999965432   2234577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|..++.+.+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~  146 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVK  146 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEE
Confidence            99999999999888888889999999999999999999999999999999999999888764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=3.4e-24  Score=194.55  Aligned_cols=139  Identities=25%  Similarity=0.426  Sum_probs=125.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....  .....+.+.+|++++..++||||+++++.+.+++.+|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            36999999999999999999999999999999987542  2234556778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|..++.+.+.+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+|
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~  140 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIK  140 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEE
Confidence            999999999999888889999999999999999999998 5999999999999999887654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.92  E-value=1.3e-25  Score=201.22  Aligned_cols=132  Identities=35%  Similarity=0.608  Sum_probs=113.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC--C---EE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--Y---RL  225 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~---~~  225 (291)
                      .|.-.+++|.|+||.||+|....+++.+|||.+..+..       +-.+|+.+|+.++|||||++..+|...  .   ++
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            48889999999999999999999999999999876642       335799999999999999998887532  2   45


Q ss_pred             EEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC-CCcC
Q 022853          226 YLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~-g~vK  290 (291)
                      .+|||||+. +|...+..    +..++.-.++.|++||++||.|||+.||+||||||.|||+|.+ |.+|
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LK  166 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLK  166 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEE
Confidence            689999987 78777764    4667888899999999999999999999999999999999987 6554

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=1.6e-24  Score=198.29  Aligned_cols=136  Identities=23%  Similarity=0.363  Sum_probs=120.5

Q ss_pred             EEEEeccc--CceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          154 VLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       154 i~~~LG~G--~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      ++++||+|  +|++||++.+..+++.||+|.++..... ....+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            46789999  7899999999999999999999765432 33456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +++|+|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~  141 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY  141 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEE
Confidence            9999999888653  4588999999999999999999999999999999999999887654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.92  E-value=1.7e-24  Score=196.46  Aligned_cols=139  Identities=24%  Similarity=0.417  Sum_probs=121.5

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|.+.+.||+|+||.||+|++..+++.+|+|.++.....  .....+.+|+.+++.++||||+++++++..++..|+|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            46799999999999999999999999999999998754322  1233466799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+ +|..++... ..++...++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~k  144 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELK  144 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence            999986 777776654 4578888999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.92  E-value=2.8e-24  Score=216.86  Aligned_cols=142  Identities=24%  Similarity=0.347  Sum_probs=123.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            36899999999999999999999999999999999765443444456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-----------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-----------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||++|++|..++...           ...+...+..++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEE
Confidence            9999999998887642           1234456678899999999999999999999999999999988764

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.92  E-value=9.6e-25  Score=192.26  Aligned_cols=140  Identities=46%  Similarity=0.810  Sum_probs=128.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+......|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            48999999999999999999998999999999987655444556778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+++|...+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+|
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~  140 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVH  140 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEE
Confidence            999999999988877889999999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=7.8e-25  Score=203.32  Aligned_cols=140  Identities=24%  Similarity=0.314  Sum_probs=122.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC-EE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-RL  225 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~  225 (291)
                      ...++|.-...||+|+||.||+|...+. ..||||.+.......   ...|.+|+.++.+++|||+|+|+++|.+.+ ..
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~  147 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR  147 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence            3446788889999999999999988654 889999876654321   233899999999999999999999999988 59


Q ss_pred             EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANG---IMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKp~NILl~~~g~vK  290 (291)
                      +||+|||++|+|.+.+....  .+++....+|+.+++.||+|||...   |||||||++|||||.+.+.|
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            99999999999999998764  7888888999999999999999964   99999999999999988765

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.92  E-value=9.5e-25  Score=204.05  Aligned_cols=145  Identities=21%  Similarity=0.299  Sum_probs=123.5

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~  217 (291)
                      .|....++|++.+.||+|+||.||+|.+..++     ..||+|++.....  ....+.+.+|+.+++.+ +||||+++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~  109 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLG  109 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEee
Confidence            45566778999999999999999999865443     5799999976532  23356688899999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHc-----------------------------------------------------
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-----------------------------------------------------  244 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------------------------------------------  244 (291)
                      .+...+.+|+||||+.+|+|..++...                                                     
T Consensus       110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (374)
T cd05106         110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS  189 (374)
T ss_pred             EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence            999999999999999999999887542                                                     


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          245 -----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       245 -----------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                                       ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~k  252 (374)
T cd05106         190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAK  252 (374)
T ss_pred             cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEE
Confidence                             1356777889999999999999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.92  E-value=5.2e-24  Score=205.23  Aligned_cols=138  Identities=27%  Similarity=0.399  Sum_probs=122.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCC-CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGT-SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      ..|.+.+.||+|+||.||+|.+..+ ++.+|+|.+...   .......+++|+.+++.++||||+++++.+...+.+|+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            3599999999999999999998877 788999977443   233455678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||++||+|..++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~k  209 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIK  209 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEE
Confidence            999999999887653    34688999999999999999999999999999999999999998775

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=3.9e-24  Score=188.57  Aligned_cols=141  Identities=32%  Similarity=0.478  Sum_probs=127.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch--HHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+.......  ....+.+.+|+.++++++||||+++++++.....+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46899999999999999999999999999999987543221  2234568889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||+++++|.+.+...+.+++..++.++.|++.||.|||++||+||||+|+||+++.++.+|
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~  144 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVK  144 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence            999999999999998888899999999999999999999999999999999999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.92  E-value=9.4e-25  Score=204.10  Aligned_cols=144  Identities=22%  Similarity=0.269  Sum_probs=121.7

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEE-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~  218 (291)
                      +.+..++|++.+.||+|+||.||+|++     ..++..||+|+++....  ....+.+.+|+.++..+ +||||++++++
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            345566899999999999999999974     34567899999865432  22345678899999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcC-----------------------------------------------------
Q 022853          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG-----------------------------------------------------  245 (291)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------------------------------------  245 (291)
                      +......|+||||+++|+|..++....                                                     
T Consensus       108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            999999999999999999988886432                                                     


Q ss_pred             ----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          246 ----------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       246 ----------------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                                            .+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~k  254 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITK  254 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEE
Confidence                                  356677888999999999999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.92  E-value=2.9e-24  Score=192.05  Aligned_cols=133  Identities=38%  Similarity=0.689  Sum_probs=115.9

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCH
Q 022853          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (291)
                      ||+|+||.||+++...+++.||+|.+.............+..|++++++++||||+++++.+.++..+|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999999999999999765433333334456799999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          238 FFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       238 ~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++....  .+++..+..++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~  135 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCR  135 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEE
Confidence            88776543  477888888999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.92  E-value=2.9e-24  Score=194.59  Aligned_cols=142  Identities=23%  Similarity=0.380  Sum_probs=121.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcE--EEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~  223 (291)
                      +.+++|++.+.||+|+||.||+|.+..++..  +|+|.+...  ........+.+|+.++.++ +||||+++++++...+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            4567899999999999999999998877754  466665432  2233456678899999999 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      .+|+||||+++++|..++.+.+                .+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            9999999999999999887543                467888999999999999999999999999999999999888


Q ss_pred             CcC
Q 022853          288 HVR  290 (291)
Q Consensus       288 ~vK  290 (291)
                      .+|
T Consensus       162 ~~k  164 (303)
T cd05088         162 VAK  164 (303)
T ss_pred             cEE
Confidence            764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=4.9e-24  Score=193.65  Aligned_cols=141  Identities=43%  Similarity=0.741  Sum_probs=128.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.+.........+.+..|+.++..++||||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            37999999999999999999999999999999998776554455677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.+++|..++.+.  ..+++..++.++.|++.||+|||++|++||||||+||+++.+|.+|
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~  143 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIM  143 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEE
Confidence            999999999988764  5688999999999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.92  E-value=6.7e-24  Score=187.23  Aligned_cols=141  Identities=28%  Similarity=0.509  Sum_probs=126.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.++..........+.+.+|+.++++++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999999899999999987654444455667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|..++..    ...+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+|
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~  146 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEE
Confidence            99999999888764    24578889999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.92  E-value=2.1e-24  Score=201.11  Aligned_cols=138  Identities=22%  Similarity=0.355  Sum_probs=121.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC-----EE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----RL  225 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~  225 (291)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++....     .+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            4889999999999999999999999999999986532 22233456778999999999999999999998776     89


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+.+ +|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~k  143 (372)
T cd07853          80 YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLK  143 (372)
T ss_pred             EEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEE
Confidence            999999975 7878887778899999999999999999999999999999999999999988775

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.92  E-value=1.2e-23  Score=186.06  Aligned_cols=141  Identities=32%  Similarity=0.461  Sum_probs=124.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC--CEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRL  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~  225 (291)
                      .+|++.+.||+|+||.||.+.+..++..||+|.+.....  ......+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            479999999999999999999999999999999864321  1223456788999999999999999999988763  578


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++|||+++++|..++.+.+.+++..+..++.|++.||+|||+++|+||||||+||+++.++.+|
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~  146 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVK  146 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEE
Confidence            89999999999999988877889999999999999999999999999999999999999888664

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.91  E-value=4e-24  Score=189.09  Aligned_cols=141  Identities=27%  Similarity=0.493  Sum_probs=126.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+......+....+.+.+|+.+++.++||||+++++.+..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57999999999999999999999899999999887654444445567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|..++..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+|
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~  146 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEE
Confidence            99999999888763    34578899999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.91  E-value=1.2e-23  Score=187.65  Aligned_cols=140  Identities=27%  Similarity=0.408  Sum_probs=124.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.++++++||||+++++.+.....+|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            3699999999999999999999999999999998654321 122345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||++++.|..++.....+++..++.++.|++.||+|||++|++||||||+||+++.+|.+|
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~  140 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIK  140 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEE
Confidence            9999998887776667789999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1e-24  Score=195.23  Aligned_cols=138  Identities=25%  Similarity=0.423  Sum_probs=121.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-----CCEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-----KYRL  225 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~  225 (291)
                      .|..++.||+|+||.|+.|.++.+|+.||||.+... +...-..++..+|+.+|+.++|+||+.+++.+..     -+.+
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            466689999999999999999999999999998633 3344456777899999999999999999998865     3569


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|+|+|+ .+|...+..+..++++.+..++.||++||.|+|+.+|+||||||.|+|++.+..+|
T Consensus       102 YiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lK  165 (359)
T KOG0660|consen  102 YLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLK  165 (359)
T ss_pred             EEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEE
Confidence            99999994 47888887777799999999999999999999999999999999999999998765

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.91  E-value=2.5e-23  Score=182.87  Aligned_cols=138  Identities=34%  Similarity=0.645  Sum_probs=123.0

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||.|+||.||++.+..+++.+|+|.++....  ....+.+..|+.+++.++||||+++++.+.+++.+|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            58999999999999999999999999999999865432  2235567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|..++...  ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~  140 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVK  140 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEE
Confidence            99999998887653  4578899999999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-26  Score=198.50  Aligned_cols=137  Identities=34%  Similarity=0.557  Sum_probs=126.5

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .+.|++.+.||+|.|+.|+++.+..+|+.+|+|+++...+... ..+.+.+|++|.+.|+||||+++.+.+......|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            3579999999999999999999999999999999987766554 456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      +|+|.|++|..-+..+..+++..+..+++||+.||.|+|.+||||||+||+|+|+.+.
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK  146 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASK  146 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeec
Confidence            9999999999888888888999999999999999999999999999999999999754

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.91  E-value=6e-24  Score=200.48  Aligned_cols=145  Identities=21%  Similarity=0.285  Sum_probs=121.6

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~  217 (291)
                      .+....++|++.+.||+|+||.||+|.+...     +..||+|++....  .....+.+.+|+.+++++. ||||+++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            3445567899999999999999999987543     3469999996543  2233567889999999996 999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHc-----------------------------------------------------
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-----------------------------------------------------  244 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------------------------------------------  244 (291)
                      ++.....+|+|||||++|+|..++.+.                                                     
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            999999999999999999998887642                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcE
Q 022853          245 -------------------------------------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (291)
Q Consensus       245 -------------------------------------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NI  281 (291)
                                                                 ..+++..+..++.||+.||.|||+++|+||||||+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni  268 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV  268 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence                                                       1356667788999999999999999999999999999


Q ss_pred             EecCCCCcC
Q 022853          282 LLDADGHVR  290 (291)
Q Consensus       282 Ll~~~g~vK  290 (291)
                      |++.++.+|
T Consensus       269 ll~~~~~~k  277 (400)
T cd05105         269 LLAQGKIVK  277 (400)
T ss_pred             EEeCCCEEE
Confidence            999887654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.6e-23  Score=182.93  Aligned_cols=138  Identities=32%  Similarity=0.552  Sum_probs=126.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++.....   ...+.+..|+.++++++||||+++++.+.....+|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            579999999999999999999998999999999976532   24567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.+++|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+|
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~  141 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVK  141 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEE
Confidence            999999999988776 7889999999999999999999999999999999999999988764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.91  E-value=8.2e-24  Score=188.02  Aligned_cols=140  Identities=21%  Similarity=0.370  Sum_probs=123.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .++|++.+.||+|+||.||+|+.+.     ..+.+++|.+....  .....+.+.+|+.++++++||||+++++++.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            3579999999999999999999754     34679999886532  2234566889999999999999999999999989


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG---------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..|+||||+++++|..++....         .+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEE
Confidence            9999999999999999988665         688999999999999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.91  E-value=8.3e-24  Score=191.02  Aligned_cols=140  Identities=25%  Similarity=0.408  Sum_probs=122.3

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      .+++|++.+.||+|+||.||+|.+..+++.||+|.+......  .....+.+|+.+++.++||||+++++++..+..+|+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            356899999999999999999999999999999998754321  123346679999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+.+ +|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~k  144 (301)
T cd07873          82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELK  144 (301)
T ss_pred             EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEE
Confidence            9999985 787777653 5678899999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.91  E-value=8.2e-24  Score=185.70  Aligned_cols=133  Identities=23%  Similarity=0.366  Sum_probs=118.2

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (291)
                      +.||+|+||.||+|.+..+++.+|+|.+....  ..+....+.+|+.+++.++||||+++++++.....+|+||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            36899999999999999899999999886432  2334556888999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          236 HLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       236 ~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|..++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~k  134 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLK  134 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEE
Confidence            9999887643 578889999999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.91  E-value=4e-24  Score=189.22  Aligned_cols=139  Identities=30%  Similarity=0.520  Sum_probs=126.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++....   .....+.+|+.+++.++||||+++++.+.....+|+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            3579999999999999999999999999999999875532   2234577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|..++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~  146 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVK  146 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence            99999999999998888899999999999999999999999999999999999999887664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.91  E-value=2.4e-23  Score=182.60  Aligned_cols=139  Identities=33%  Similarity=0.561  Sum_probs=124.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|.+.+.||+|+||.||+|.+..+++.|++|.+...... ....+.+..|+.+++.++||||+++++.+...+..|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            588999999999999999999999999999998765433 3335667889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|..++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~  141 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVK  141 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEE
Confidence            99999999988764  5678888889999999999999999999999999999999887664

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.91  E-value=1.2e-23  Score=186.56  Aligned_cols=140  Identities=24%  Similarity=0.315  Sum_probs=121.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .++|++.+.||+|+||.||+|.+..++   ..+|+|.++....  ....+.+..|+.+++.++||||+++++++..++..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            457999999999999999999886444   3799998865432  23356788899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+++++|..++.+. +.++...+..++.|++.||.|||++|++||||||+|||++.++.+|
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~  146 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCK  146 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEE
Confidence            9999999999999988764 4678888899999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.91  E-value=9.6e-24  Score=195.69  Aligned_cols=139  Identities=26%  Similarity=0.389  Sum_probs=118.0

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC----
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----  223 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----  223 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++....    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            35789999999999999999999999999999999975432 2233456778999999999999999999886543    


Q ss_pred             --EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 --RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                        .+|+||||+.++ |...+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        98 ~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876          98 FQDVYLVMELMDAN-LCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             cceeEEEEeCCCcC-HHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEE
Confidence              579999999874 555443  3478888899999999999999999999999999999999998775

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.91  E-value=8.8e-24  Score=192.40  Aligned_cols=140  Identities=24%  Similarity=0.365  Sum_probs=119.4

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcE----EEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEI----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      ...+|++.+.||+|+||.||+|.+..+++.    ||+|++....  .....+.+..|+.+++.++||||+++++++... 
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            346899999999999999999998766554    8999986432  223355678899999999999999999988764 


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++++||+.+|+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~k  149 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVK  149 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEE
Confidence            578999999999999988764 4578888889999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.91  E-value=1.3e-23  Score=184.98  Aligned_cols=137  Identities=26%  Similarity=0.412  Sum_probs=119.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||++.+.. +..+|+|.+......    .+.+..|+.+++.++||||+++++++......|+|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            4579999999999999999998764 457999988654322    23467799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++|+|..++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~k  140 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVK  140 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEE
Confidence            999999999988875 35678889999999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=1.2e-23  Score=195.36  Aligned_cols=133  Identities=24%  Similarity=0.386  Sum_probs=117.5

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|+..+..         ...|+.++++++||||+++++++......|+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3457999999999999999999999999999999864432         2458999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||++.+ +|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       135 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~k  197 (357)
T PHA03209        135 VLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVC  197 (357)
T ss_pred             EEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence            9999965 67666654 46789999999999999999999999999999999999999888764

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.91  E-value=1.5e-23  Score=185.98  Aligned_cols=140  Identities=22%  Similarity=0.321  Sum_probs=123.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      ..+|++.+.||+|+||.||+|.+..+++   .||+|++....  .....+.+..|+.+++.++||||+++++++.++...
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            4579999999999999999999877664   69999986542  233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+++++|..++.. .+.++...++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~k  146 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCK  146 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEE
Confidence            999999999999988875 35678888999999999999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.91  E-value=1.8e-23  Score=185.12  Aligned_cols=140  Identities=22%  Similarity=0.288  Sum_probs=122.6

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .++|++.+.||+|+||.||+|.+..+   ...+|+|.++...  .......+.+|+.+++.++||||+++++.+......
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            35799999999999999999988644   4579999886543  233345677899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++|||+++++|..++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~  146 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCK  146 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEE
Confidence            9999999999999988764 4688999999999999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.8e-23  Score=202.31  Aligned_cols=143  Identities=30%  Similarity=0.453  Sum_probs=123.7

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC---
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY---  223 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---  223 (291)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....... .....+.+|+.++..++|+||++++..+....   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34468999999999999999999999999999999997765433 34556788999999999999999987765432   


Q ss_pred             -----EEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 -----RLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 -----~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                           .+++||||+.+|+|..++...    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence                 378999999999999888643    4688999999999999999999999999999999999999988765

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.91  E-value=1e-23  Score=186.41  Aligned_cols=138  Identities=27%  Similarity=0.508  Sum_probs=124.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      +|+..+.||+|+||.||++.+..+++.+|+|++......   .....+.+..|+.++++++||||+++++.+.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999999999999999999754321   12235678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      ||||+.+++|..++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~  141 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ  141 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence            9999999999999988888999999999999999999999999999999999999987653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.91  E-value=1.3e-23  Score=185.83  Aligned_cols=140  Identities=23%  Similarity=0.342  Sum_probs=124.3

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +...+|.+.+.||+|+||.||+|.+..+++.+|+|++.....    ..+.+.+|+.+++.++||||+++++.+..+..++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            455679999999999999999999999999999999875432    2445778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|||+++++|..++...  ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+|
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~k  144 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK  144 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEE
Confidence            999999999999888753  3578888889999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.91  E-value=1.2e-23  Score=189.19  Aligned_cols=139  Identities=28%  Similarity=0.429  Sum_probs=123.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+......  .......+..|+.+++.++|+||+++++++.+...+|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            488999999999999999999989999999999765433  122234566799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+ +++|..++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.+|
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~  142 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLK  142 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEE
Confidence            9999 889999887765 789999999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-24  Score=204.73  Aligned_cols=145  Identities=26%  Similarity=0.363  Sum_probs=130.6

Q ss_pred             CCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE
Q 022853          141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (291)
Q Consensus       141 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  220 (291)
                      ..+.|.+..+++.+...||+|.||+||+|+|.++   ||||+++.+..... ..+.|+.|+..+++-+|.||+-+.+++.
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            3467888889999999999999999999999764   99999988776554 7899999999999999999999999988


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+.. .||+.+|+|.+|+.+++-. ..|.....+.|++||++||.|||.++|||||||..||++..++.||
T Consensus       459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVk  528 (678)
T KOG0193|consen  459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVK  528 (678)
T ss_pred             CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEE
Confidence            7766 9999999999999888753 4677888899999999999999999999999999999999998876

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=1.6e-23  Score=185.20  Aligned_cols=140  Identities=29%  Similarity=0.467  Sum_probs=125.0

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch------HHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME------KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      +|.+.+.||+|+||.||+|.+..+++.+|+|.+.......      ....+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677899999999999999998889999999886543321      2234668889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+++|||+++++|..++.+.+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+|
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEE
Confidence            999999999999999998888889999999999999999999999999999999999999888664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.91  E-value=1.6e-23  Score=187.17  Aligned_cols=141  Identities=20%  Similarity=0.331  Sum_probs=121.0

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEc----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRI----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .+.+|++.+.||+|+||.||+|...    ..+..+|+|.+....  .......+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            4568999999999999999999853    356789999987533  2333466788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG-----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~-----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      ..|+||||+++++|..++....                 .+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            9999999999999998886432                 36677888899999999999999999999999999999988


Q ss_pred             CCcC
Q 022853          287 GHVR  290 (291)
Q Consensus       287 g~vK  290 (291)
                      +.+|
T Consensus       161 ~~~k  164 (283)
T cd05090         161 LHVK  164 (283)
T ss_pred             CcEE
Confidence            7764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.91  E-value=2.1e-23  Score=186.36  Aligned_cols=135  Identities=28%  Similarity=0.468  Sum_probs=119.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.++++++||||+++++.+......++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            36889999999999999999999999999999987653  2233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|..+    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~  135 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVK  135 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEE
Confidence            99999988543    3467888899999999999999999999999999999999988764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=7.3e-25  Score=193.52  Aligned_cols=135  Identities=33%  Similarity=0.530  Sum_probs=123.0

Q ss_pred             eEEE-EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEE
Q 022853          152 FEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       152 y~i~-~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      |++. +.||+|+|+.|--|....++..||||++.+..   ...+.++.+|++++.++ .|+||++++++|+++.++|+||
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            5543 67999999999999999999999999998763   33466778899999988 7999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      |-|.||.|...+.++..|++..|..+..+|+.||.|||.+||.||||||+|||-...+.|
T Consensus       156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~v  215 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKV  215 (463)
T ss_pred             ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCc
Confidence            999999999999999999999999999999999999999999999999999998766553

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1e-23  Score=188.12  Aligned_cols=139  Identities=30%  Similarity=0.511  Sum_probs=125.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||.|+||.||++.+..++..+|+|++...   .....+.+..|+.++++++||||+++++.+..+...|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            35799999999999999999999889999999998654   233456677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|..++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~  143 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVK  143 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEE
Confidence            9999999998888763 5689999999999999999999999999999999999999887654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.91  E-value=2.3e-23  Score=187.02  Aligned_cols=144  Identities=21%  Similarity=0.227  Sum_probs=120.4

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF  219 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  219 (291)
                      |.+..++|++.+.||+|+||.||+|..+.     .+..||+|.+.....  ......+.+|+.+++.++||||+++++.+
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVV   78 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            34567789999999999999999997653     245799998864432  22234567899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          220 QTKYRLYLVLDFVNGGHLFFQLYRQG----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      .+....|+||||+.+|+|..++.+.+          .+....+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence            99999999999999999999987532          23456778899999999999999999999999999999988765


Q ss_pred             C
Q 022853          290 R  290 (291)
Q Consensus       290 K  290 (291)
                      |
T Consensus       159 ~  159 (288)
T cd05061         159 K  159 (288)
T ss_pred             E
Confidence            4

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.91  E-value=4.4e-23  Score=181.29  Aligned_cols=139  Identities=32%  Similarity=0.537  Sum_probs=125.0

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++++.||.|+||.||.++...+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+...++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            5899999999999999999999999999999987654333 334557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|..++.+.  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+|
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~k  141 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIK  141 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEE
Confidence            99999999988765  4578899999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=1.8e-23  Score=185.57  Aligned_cols=140  Identities=32%  Similarity=0.529  Sum_probs=124.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-------EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      +|.+.+.||.|+||.||+|....+++.+|+|.+......       .....+.+..|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            488899999999999999999889999999988643211       1123456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+++||||+.+++|..++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.+|
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~  148 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICK  148 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEE
Confidence            9999999999999999998888899999999999999999999999999999999999999887664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.2e-25  Score=202.37  Aligned_cols=145  Identities=41%  Similarity=0.772  Sum_probs=137.1

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~  224 (291)
                      .+...+|.++.+||+|+||+|.+|..+++.+.||||+++++.+...+.++.-..|.++|+.. +-|++++++.+|++-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            46667999999999999999999999999999999999999888878788888899998877 67899999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+||||+.||+|...+.+-+.|.+..|.+|+++|+.||-|||++|||.||||.+|||++.+|+||
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiK  490 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIK  490 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceE
Confidence            999999999999999999999999999999999999999999999999999999999999999997

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=2.2e-23  Score=183.34  Aligned_cols=138  Identities=22%  Similarity=0.366  Sum_probs=123.6

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +..++|++.+.||.|+||.||+|...  ++.+|+|.+.....    ..+.+.+|+.+++.++|+||+++++.+.+....|
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            45678999999999999999999874  78899999976532    3556788999999999999999999999899999


Q ss_pred             EEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+++++|..++....  .+++..+..++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~  142 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAK  142 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEE
Confidence            9999999999999987765  689999999999999999999999999999999999999888754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.91  E-value=1.9e-23  Score=184.26  Aligned_cols=141  Identities=19%  Similarity=0.322  Sum_probs=122.9

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      |.+..++|++.+.||+|+||.||+|... .+..||+|.+.....    ..+.+.+|+.+++.++||||+++++.+.....
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP   75 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3456779999999999999999999875 456799998865432    24567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .|++|||+++++|..++.+.  ..++......++.|++.||+|||+++++||||||+||+++.++.+|
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~  143 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCK  143 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEE
Confidence            99999999999999988753  4577888888999999999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.91  E-value=1.4e-23  Score=187.33  Aligned_cols=141  Identities=23%  Similarity=0.354  Sum_probs=122.9

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ..++|++.+.||+|+||.||+|.+...+     ..+|+|.+....  .....+.+.+|+.++..++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            3568999999999999999999876655     679999886543  233456688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      ...|++|||+++++|..++.+.                ..+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            9999999999999999988764                346778888999999999999999999999999999999988


Q ss_pred             CCcC
Q 022853          287 GHVR  290 (291)
Q Consensus       287 g~vK  290 (291)
                      +.+|
T Consensus       161 ~~~~  164 (283)
T cd05048         161 LTVK  164 (283)
T ss_pred             CcEE
Confidence            8764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.91  E-value=2.8e-23  Score=186.68  Aligned_cols=139  Identities=30%  Similarity=0.515  Sum_probs=124.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .+.|++++.||.|+||.||+|++..+++.+++|++....   ....+.+..|+.+++.++||||+++++.+..++.+|+|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            357999999999999999999999999999999986542   33456677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|..++.+ ...+++..+..++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~k  150 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIK  150 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEE
Confidence            999999999877654 45688999999999999999999999999999999999999887664

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.91  E-value=2.4e-23  Score=185.75  Aligned_cols=138  Identities=29%  Similarity=0.511  Sum_probs=120.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++.+.++..+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            589999999999999999999999999999998654322 2223557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~---~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+ +|..++...   ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~  141 (285)
T cd07861          80 FLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIK  141 (285)
T ss_pred             cCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEE
Confidence            9984 787776542   4688999999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.91  E-value=2.3e-23  Score=183.86  Aligned_cols=137  Identities=23%  Similarity=0.384  Sum_probs=120.5

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||++.+.. +..+|+|.+......    .+.+.+|+.++.+++||||+++++++.....+|++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            4579999999999999999998764 445999988754432    24577899999999999999999999988999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+++|..++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~k  140 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVK  140 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEE
Confidence            9999999999988764 4688999999999999999999999999999999999999888765

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.91  E-value=3e-23  Score=183.47  Aligned_cols=139  Identities=27%  Similarity=0.441  Sum_probs=123.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI---MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      +|++.+.||+|+||.||+|.. .+++.+|+|.+.....   ......+.+.+|+.+++.++|+||+++++++.+...+|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            478899999999999999986 4788899999875432   122334568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|||+++++|..++.+.+.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+|
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~  142 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIK  142 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEE
Confidence            999999999999998878889999999999999999999999999999999999999887664

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=2.7e-23  Score=184.74  Aligned_cols=143  Identities=21%  Similarity=0.258  Sum_probs=122.5

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  220 (291)
                      .+..++|++.+.||+|+||.||+|.+....     ..+|+|.+.....  ......+.+|+.++..++||||+++++++.
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            355678999999999999999999886543     7899999865432  222445778999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQG----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .....|+||||+++++|..++....          .+.+..+..++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence            9999999999999999998886532          356678888999999999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.91  E-value=2.7e-23  Score=186.38  Aligned_cols=139  Identities=27%  Similarity=0.439  Sum_probs=121.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++.+.||+|+||.||+|.+..+++.||+|.+.......  ....+.+|+.+++.++||||+++++++.++...|+|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            468999999999999999999999899999999987543211  123356799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+ +|..++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+|
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~k  143 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELK  143 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEE
Confidence            999986 888877664 4678899999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=3.3e-23  Score=182.94  Aligned_cols=139  Identities=21%  Similarity=0.349  Sum_probs=122.3

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +..++|++.+.||+|+||.||+|.+.. ++.||+|.++.....    .+.+.+|+.++++++||||+++++++...+..|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            445689999999999999999998754 567999998765422    345778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|||+++++|..++....  .++...+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~  143 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICK  143 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEE
Confidence            9999999999999887654  678899999999999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.91  E-value=2.4e-23  Score=186.92  Aligned_cols=141  Identities=22%  Similarity=0.322  Sum_probs=123.6

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCC----------------cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTS----------------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF  211 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn  211 (291)
                      ..++|++.+.||+|+||.||+|.+..++                ..+|+|.+.....  ....+.+.+|+.++.+++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence            3468999999999999999999876543                5689999876532  244567889999999999999


Q ss_pred             eeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCc
Q 022853          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (291)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~N  280 (291)
                      |+++++++..+...+++|||+.+++|..++.+..           .+++..+..++.|++.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999987765           68889999999999999999999999999999999


Q ss_pred             EEecCCCCcC
Q 022853          281 ILLDADGHVR  290 (291)
Q Consensus       281 ILl~~~g~vK  290 (291)
                      |+++.++.+|
T Consensus       161 ili~~~~~~~  170 (296)
T cd05051         161 CLVGKNYTIK  170 (296)
T ss_pred             eeecCCCceE
Confidence            9999887654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.91  E-value=3.6e-23  Score=184.87  Aligned_cols=138  Identities=24%  Similarity=0.395  Sum_probs=119.2

Q ss_pred             CCeEEEEEecccCceEEEEEEE----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--CC
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KY  223 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~  223 (291)
                      ++|++.+.||+|+||.||+|..    ..+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            4799999999999999999974    4568899999986543   2335668899999999999999999887643  45


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+++++|..++.+. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~  148 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVK  148 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEE
Confidence            689999999999999988764 4578899999999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.91  E-value=2.5e-23  Score=185.60  Aligned_cols=133  Identities=41%  Similarity=0.706  Sum_probs=119.1

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCH
Q 022853          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (291)
                      ||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999999765443333455567899999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          238 FFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       238 ~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++.+.+  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~  135 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVR  135 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEE
Confidence            99888765  689999999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.91  E-value=1e-23  Score=188.22  Aligned_cols=140  Identities=31%  Similarity=0.449  Sum_probs=124.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+..... ...+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            36999999999999999999999899999999986543222 33456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||++++.|..+......+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+|
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~  140 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVK  140 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEE
Confidence            9999998887776666789999999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.91  E-value=3.3e-23  Score=184.62  Aligned_cols=143  Identities=20%  Similarity=0.248  Sum_probs=120.1

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  220 (291)
                      .+..++|++.+.||+|+||.||+|.+..     ++..+|+|.+.....  ......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            3455789999999999999999998653     356799998864321  223445778999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQG----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .....++||||+++++|..++.+..          .++...+..++.|++.||.|||++|++||||||+|||++.++.+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            9999999999999999998887532          245667788899999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=5.7e-23  Score=193.10  Aligned_cols=134  Identities=25%  Similarity=0.364  Sum_probs=118.2

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      ...+|++++.||+|+||.||+|...+  +++.+|+|.+....        ...+|+.++++++||||+++++.+.....+
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            34579999999999999999997643  46789999886532        245799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++||++.+ +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       162 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~  225 (392)
T PHA03207        162 CMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV  225 (392)
T ss_pred             EEEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEE
Confidence            999999974 7878887778899999999999999999999999999999999999999988764

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=4.6e-23  Score=181.67  Aligned_cols=140  Identities=22%  Similarity=0.314  Sum_probs=123.5

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .+..++|++.+.||+|+||.||+|.+. .+..+|+|.+......    .+.+.+|+.+++.++||||+++++.+......
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence            356678999999999999999999876 4577999998765432    34577899999999999999999999998999


Q ss_pred             EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+++++|..++...  ..++...+..++.|++.|+.|||++|++||||||+||+++.++.+|
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~  143 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCK  143 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEE
Confidence            9999999999999988764  3678889999999999999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.2e-24  Score=202.32  Aligned_cols=138  Identities=33%  Similarity=0.511  Sum_probs=125.7

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      ...|.....||+|+-|.||.|+...+++.||||.+.....   ...+.+.+|+.+|+..+|+|||.+++.|...+.+|+|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            4568889999999999999999999999999999976643   3356788999999999999999999999988999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+||+|.+.+.. ..++|.++..++++++.||+|||.+||+|||||.+|||++.+|.||
T Consensus       349 MEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vK  409 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVK  409 (550)
T ss_pred             EeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEE
Confidence            999999998776654 4589999999999999999999999999999999999999999987

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.9e-23  Score=184.14  Aligned_cols=137  Identities=24%  Similarity=0.394  Sum_probs=120.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      ..+|++.+.||+|+||.||++.+. ++..+|+|++.+....    .+.+.+|+.+++.++||||+++++++......|+|
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            357899999999999999999886 4567999998654332    23466799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~k  140 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVK  140 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEE
Confidence            9999999999988763 4678899999999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.91  E-value=3.6e-23  Score=187.50  Aligned_cols=145  Identities=20%  Similarity=0.297  Sum_probs=122.9

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCC-------CcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGT-------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQL  215 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l  215 (291)
                      .+.+..++|.+.+.||+|+||.||+|++...       ...+|+|.+.....  ......+..|+.++..+ +||||+++
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            3455567899999999999999999987532       34699999876431  22345577899999999 89999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCC
Q 022853          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (291)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~  279 (291)
                      ++.+......|+||||+.+|+|..++....                .++...+..++.|++.||+|||++|++||||||+
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  169 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR  169 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence            999999999999999999999999987642                3677888899999999999999999999999999


Q ss_pred             cEEecCCCCcC
Q 022853          280 NILLDADGHVR  290 (291)
Q Consensus       280 NILl~~~g~vK  290 (291)
                      |||++.++.+|
T Consensus       170 Nill~~~~~~k  180 (307)
T cd05098         170 NVLVTEDNVMK  180 (307)
T ss_pred             heEEcCCCcEE
Confidence            99999888764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=6.2e-23  Score=181.64  Aligned_cols=141  Identities=31%  Similarity=0.475  Sum_probs=123.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC--CEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK--IMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRL  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~  225 (291)
                      .+|++.+.||+|+||.||+|.+..+++.+|+|.+....  .........+.+|+.++++++||||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            36999999999999999999999999999999885432  11233456788999999999999999999988664  568


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +++|||+++++|..++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~  146 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVK  146 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEE
Confidence            99999999999999988877889999999999999999999999999999999999999887654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA02988 hypothetical protein; Provisional

Probab=99.90  E-value=3.2e-23  Score=186.31  Aligned_cols=133  Identities=13%  Similarity=0.112  Sum_probs=118.8

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe----CCEEEEEEec
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRLYLVLDF  231 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~  231 (291)
                      ..||+|++|.||+|.+  +++.||+|.+.+.........+.+.+|+.+|.+++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999988  688999999987654444446778899999999999999999999876    4578999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +++|+|..++...+.+++.....++.|++.||.|||+. +++||||||+|||++.+|.+|
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~k  163 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLK  163 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEE
Confidence            99999999998888888899999999999999999985 999999999999999998775

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.90  E-value=4.7e-23  Score=181.53  Aligned_cols=139  Identities=28%  Similarity=0.528  Sum_probs=127.0

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.++..... ....+.+..|+.+++.++|+||+++++.+.....+++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            588999999999999999999889999999999766433 3456778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|.+++.....+++..+..++.|++.||.|||++||+||||+|+||+++.++.+|
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~k  139 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIK  139 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence            999999999998877788999999999999999999999999999999999999887664

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.90  E-value=3.7e-23  Score=185.63  Aligned_cols=140  Identities=21%  Similarity=0.322  Sum_probs=121.9

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ..++|.+.+.||+|+||.||++...     .++..+|+|.+....   ....+.+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            3468999999999999999999853     345678999886542   23355688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQG-------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~-------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      ..+|+||||+++++|..++...+             .+++..+..++.|++.||+|||++|++||||||+|||++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999887543             37889999999999999999999999999999999999998876


Q ss_pred             C
Q 022853          290 R  290 (291)
Q Consensus       290 K  290 (291)
                      |
T Consensus       160 k  160 (288)
T cd05093         160 K  160 (288)
T ss_pred             E
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.90  E-value=2.5e-23  Score=198.49  Aligned_cols=135  Identities=27%  Similarity=0.459  Sum_probs=112.8

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----  222 (291)
                      ...+|++.+.||+|+||.||+|.+..+++.||||.+....       ....+|+.+++.++||||+++++++...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3457999999999999999999999999999999886542       2235799999999999999998876432     


Q ss_pred             ---CEEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC-CcC
Q 022853          223 ---YRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVR  290 (291)
Q Consensus       223 ---~~~~lV~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g-~vK  290 (291)
                         ..+++||||+++ +|..++.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCcee
Confidence               257899999986 5655543    345688999999999999999999999999999999999998665 354

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.90  E-value=1.4e-23  Score=186.23  Aligned_cols=141  Identities=40%  Similarity=0.761  Sum_probs=128.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV  228 (291)
                      ++|.+.+.||+|+||.||+|....+++.+|+|++.+.........+.+..|+.++.+++ ||||+++++.+..+...|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            37999999999999999999999999999999998755444444567788999999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+++|..++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.+|.+|
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~  142 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIK  142 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEE
Confidence            99999999999999888899999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.90  E-value=3.4e-23  Score=185.84  Aligned_cols=138  Identities=24%  Similarity=0.389  Sum_probs=118.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++......  .....+.+|+.+++.++|+||+++++++..+...|+||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            5799999999999999999999999999999998654321  11234567999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+. +++...+.. ...+.+..++.++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~  143 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELK  143 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEE
Confidence            9996 566666554 35577888889999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.90  E-value=8.2e-23  Score=180.10  Aligned_cols=139  Identities=31%  Similarity=0.536  Sum_probs=125.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||.|+||.||+|....++..+|+|++.......  ..+.+.+|+.+++.++|+||+++++.+..+...|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999998899999999987654332  4567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++++++|..++...   ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~  142 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVK  142 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEE
Confidence            999999999998764   4588999999999999999999999999999999999999887654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.90  E-value=4.3e-23  Score=181.01  Aligned_cols=140  Identities=30%  Similarity=0.514  Sum_probs=125.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +|+..+.||+|+||.||+|....+++.|++|.+.....  ......+.+.+|+.+++.++||||+++++.+.....+|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            47788999999999999999988899999999865432  1233456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||+++++|..++.+...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+|
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~k  142 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVK  142 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence            99999999999998877789999999999999999999999999999999999999888765

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-23  Score=203.60  Aligned_cols=145  Identities=30%  Similarity=0.440  Sum_probs=126.3

Q ss_pred             CCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEE-E
Q 022853          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSF-Q  220 (291)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~-~  220 (291)
                      ....++..++++.+.|.+|+|+.||+|++...+..||+|.+...   ++...+.+++|+.+|++|. |+|||.+++.. .
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            34456667889999999999999999999988899999988543   5666888999999999995 99999999932 1


Q ss_pred             e------CCEEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecccCCCcEEecCCCCcC
Q 022853          221 T------KYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~------~~~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~g~vK  290 (291)
                      .      ...++|+||||.||.|.+++..  +..|++.++.+|+.|+++|+.+||...  |||||||-|||||+.+|+.|
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence            1      2468899999999999999884  456999999999999999999999998  99999999999999999876

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.90  E-value=1.7e-23  Score=193.06  Aligned_cols=144  Identities=22%  Similarity=0.325  Sum_probs=118.9

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~  218 (291)
                      |....++|++.+.||+|+||.||+|.+.     .+++.||||+++....  ......+.+|+.++.++ +||||++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            4455678999999999999999999853     4568899999975432  23345677899999999 78999999987


Q ss_pred             EEe-CCEEEEEEeccCCCCHHHHHHHcC----------------------------------------------------
Q 022853          219 FQT-KYRLYLVLDFVNGGHLFFQLYRQG----------------------------------------------------  245 (291)
Q Consensus       219 ~~~-~~~~~lV~E~~~gg~L~~~l~~~~----------------------------------------------------  245 (291)
                      +.. +..+|++|||+++|+|..++....                                                    
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            754 456899999999999998876421                                                    


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          246 ---------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       246 ---------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                                     .++...+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~k  219 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVK  219 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEE
Confidence                           245667788999999999999999999999999999999887764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.90  E-value=4.2e-23  Score=184.86  Aligned_cols=134  Identities=41%  Similarity=0.763  Sum_probs=113.8

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHH---HHhCCCCCeeEEeEEEEeCCEEEEEEeccC
Q 022853          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI---LTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (291)
Q Consensus       157 ~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~i---l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (291)
                      .||+|+||.||++.+..+++.+|+|.+.+.............+|..+   +...+||||+.+++.+...+..|+||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999999999999999976544322222233344433   334589999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       234 gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +++|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~  137 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR  137 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEE
Confidence            999999988888899999999999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.90  E-value=3.8e-23  Score=182.49  Aligned_cols=133  Identities=41%  Similarity=0.703  Sum_probs=122.4

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCH
Q 022853          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (291)
                      ||.|+||.||+|.+..+++.+|+|++.+.........+.+..|+.+++.++||||+++++.+.++..+|++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999988999999999876655445567788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       238 ~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~  133 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVK  133 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEE
Confidence            99998887889999999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.4e-23  Score=187.45  Aligned_cols=140  Identities=20%  Similarity=0.303  Sum_probs=119.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCC--------------CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGT--------------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ  214 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~--------------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~  214 (291)
                      ..+|++.+.||+|+||.||+|++..+              ...||+|.+....  .....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            35899999999999999999987543              2358999987643  2334566889999999999999999


Q ss_pred             EeEEEEeCCEEEEEEeccCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEE
Q 022853          215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (291)
Q Consensus       215 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NIL  282 (291)
                      +++++......|+||||+.+++|..++....            .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999998886532            2567778889999999999999999999999999999


Q ss_pred             ecCCCCcC
Q 022853          283 LDADGHVR  290 (291)
Q Consensus       283 l~~~g~vK  290 (291)
                      ++.++.+|
T Consensus       162 l~~~~~~k  169 (295)
T cd05097         162 VGNHYTIK  169 (295)
T ss_pred             EcCCCcEE
Confidence            99887665

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.90  E-value=7.4e-23  Score=181.36  Aligned_cols=140  Identities=31%  Similarity=0.481  Sum_probs=123.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--CCEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLY  226 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~  226 (291)
                      +|++.+.||+|+||.||+|.+..++..||+|.+......  .....+.+.+|+.+++.++||||+++++++.+  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            689999999999999999999999999999998754322  22345668889999999999999999998875  46789


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +++||+++++|..++...+.+++.....++.|++.||+|||+++|+||||||+||+++.++.+|
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~  146 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVK  146 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEE
Confidence            9999999999999998877889999999999999999999999999999999999999887654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.90  E-value=5.2e-23  Score=184.66  Aligned_cols=144  Identities=20%  Similarity=0.335  Sum_probs=123.6

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~  218 (291)
                      +.+..++|++.+.||+|+||.||++.+....     ..+|+|.+.....  ......+.+|+.++.++ +||||++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            4456678999999999999999999886543     7899999875432  22345577899999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEE
Q 022853          219 FQTKYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (291)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NIL  282 (291)
                      +..++.+|++|||+++|+|..++.+.                ..+++..+..++.|++.||.|||++||+||||||+|||
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            99999999999999999999888642                35778888999999999999999999999999999999


Q ss_pred             ecCCCCcC
Q 022853          283 LDADGHVR  290 (291)
Q Consensus       283 l~~~g~vK  290 (291)
                      ++.++.+|
T Consensus       165 ~~~~~~~k  172 (293)
T cd05053         165 VTEDHVMK  172 (293)
T ss_pred             EcCCCeEE
Confidence            99888764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.90  E-value=8.4e-23  Score=184.41  Aligned_cols=137  Identities=27%  Similarity=0.442  Sum_probs=123.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      .+|++.+.||+|+||.||+|.+..+++.+|+|.+......   ..+.+.+|+.+++.++||||+++++.+......|+||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            5799999999999999999999999999999998765432   2456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~k  156 (296)
T cd06654          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK  156 (296)
T ss_pred             cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEE
Confidence            99999999988754 4578888899999999999999999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.90  E-value=4.7e-23  Score=184.67  Aligned_cols=139  Identities=25%  Similarity=0.431  Sum_probs=112.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC---CCCCeeEEeEEEE-----
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQ-----  220 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~-----  220 (291)
                      ++|++.+.||+|+||.||+|++.. +++.+|+|.++....... ....+.+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            369999999999999999999854 468899999875433221 123344577766655   7999999999875     


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ....+++||||+.+ +|..++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~k  150 (290)
T cd07862          80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK  150 (290)
T ss_pred             CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEE
Confidence            34569999999975 788877653  3578899999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.90  E-value=4.6e-23  Score=182.59  Aligned_cols=138  Identities=24%  Similarity=0.352  Sum_probs=118.6

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +..++|++.+.||+|+||.||+|.+..+. .+|+|++.+....    .+.+.+|+.++++++||||+++++.+. ....|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY   76 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence            45578999999999999999999887654 5999998764322    245788999999999999999998774 45689


Q ss_pred             EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+.+|+|..++.+.  ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+|
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~  142 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK  142 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEE
Confidence            999999999999988763  3578888999999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.90  E-value=3.1e-23  Score=191.86  Aligned_cols=139  Identities=25%  Similarity=0.405  Sum_probs=117.8

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----  222 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .....+.+.+|+.+++.++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45789999999999999999999999999999999875432 223345677899999999999999999988643     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 -YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 -~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ..+|+||||+++ +|...+..  .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~k  159 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEE
Confidence             357999999987 45555543  478888899999999999999999999999999999999988775

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.90  E-value=4.5e-23  Score=184.57  Aligned_cols=138  Identities=25%  Similarity=0.367  Sum_probs=119.5

Q ss_pred             CeEEEEEecccCceEEEEEEE----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC--CE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YR  224 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~  224 (291)
                      -|++++.||+|+||.||+|..    ..++..||+|.++...  .....+.+.+|+.+++.++||||+++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            478999999999999999974    4568899999986543  233356788999999999999999999988765  57


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+||||++|++|..++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~  149 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK  149 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEE
Confidence            89999999999999988765 3578888999999999999999999999999999999999888754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-23  Score=195.06  Aligned_cols=130  Identities=33%  Similarity=0.530  Sum_probs=117.3

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (291)
                      ++||.|.||+||-|.++.+|+.||||++.+.++..+. ...+++|+.||..++||.||.+...|++...+|+|||-+.|.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            7899999999999999999999999999988776554 367899999999999999999999999999999999999875


Q ss_pred             CHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          236 HLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       236 ~L~~~l~-~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      -|.-.+. ..+++++...++++.||+.||.|||.++|+|+||||+|||+.+.
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~  700 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA  700 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC
Confidence            5544443 35789999999999999999999999999999999999999764

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.90  E-value=1.8e-23  Score=187.10  Aligned_cols=139  Identities=29%  Similarity=0.491  Sum_probs=123.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++++.||+|+||.||+|.+..++..||+|.+....  .....+.+.+|+.++.+++||||+++++.+...+.+|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            36899999999999999999999999999999986542  2233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|..++...   ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+|
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~  143 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVK  143 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEE
Confidence            999999998887663   368999999999999999999997 5999999999999999887664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.90  E-value=2.7e-23  Score=196.02  Aligned_cols=145  Identities=19%  Similarity=0.289  Sum_probs=121.9

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~  217 (291)
                      .+.+..++|.+.+.||+|+||.||+|++..     .++.||+|+++....  ....+.+..|+.++.++. ||||+++++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~  108 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLG  108 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            356677789999999999999999998643     456899999976432  222446788999999997 999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcC----------------------------------------------------
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------------------------------------------  245 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------------------------------------  245 (291)
                      .+.....+|+||||+.+|+|.+++.+.+                                                    
T Consensus       109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence            9999999999999999999999886532                                                    


Q ss_pred             ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCC
Q 022853          246 ----------------------------------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (291)
Q Consensus       246 ----------------------------------------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~  279 (291)
                                                                    .++...+..++.||+.||+|||+++|+||||||+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~  268 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR  268 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence                                                          2445567788999999999999999999999999


Q ss_pred             cEEecCCCCcC
Q 022853          280 NILLDADGHVR  290 (291)
Q Consensus       280 NILl~~~g~vK  290 (291)
                      |||++.++.+|
T Consensus       269 NiLl~~~~~~k  279 (401)
T cd05107         269 NVLICEGKLVK  279 (401)
T ss_pred             eEEEeCCCEEE
Confidence            99999877654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.90  E-value=6.9e-23  Score=182.79  Aligned_cols=140  Identities=24%  Similarity=0.355  Sum_probs=120.1

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      ...+|++.+.||+|+||.||+|.+..++.    .||+|++....  .....+.+.+|+.++..++||||+++++.+.. .
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S   81 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence            45689999999999999999999877765    48999986543  22334567889999999999999999998865 4


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++++||+++|+|..++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~k  149 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVK  149 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEE
Confidence            578999999999999888764 5689999999999999999999999999999999999998887664

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.90  E-value=8.3e-23  Score=184.54  Aligned_cols=137  Identities=28%  Similarity=0.445  Sum_probs=123.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+......   ..+.+.+|+.+++.++||||+++++.+......|+||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            5799999999999999999999999999999998754322   2455788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|..++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.+|.+|
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~  155 (297)
T cd06656          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVK  155 (297)
T ss_pred             cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence            99999999888765 4578888999999999999999999999999999999999888764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.90  E-value=1.2e-22  Score=178.37  Aligned_cols=139  Identities=28%  Similarity=0.508  Sum_probs=121.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-CCEEEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KYRLYLVL  229 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lV~  229 (291)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....... ...+.+..|+.++++++|||++++++.+.. ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            5899999999999999999999999999999997654322 234567889999999999999999988764 45689999


Q ss_pred             eccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|...+..  ...+++..+..++.|++.|+.|||++|++||||||+||+++.++.+|
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~  142 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIK  142 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEE
Confidence            99999999888875  34588999999999999999999999999999999999999888664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.90  E-value=5.3e-23  Score=186.34  Aligned_cols=145  Identities=21%  Similarity=0.302  Sum_probs=124.2

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~  217 (291)
                      .+....++|.+.+.||+|+||.||++.+.     .++..+|+|.++...  .....+.+.+|+.+++++ +||||+++++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  106 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLG  106 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence            34556678999999999999999999753     345689999886543  223356788999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+...+.+|++|||+.+|+|..++.+..  .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus       107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~  181 (302)
T cd05055         107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK  181 (302)
T ss_pred             EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEE
Confidence            9999999999999999999999887643  378899999999999999999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.90  E-value=5.6e-23  Score=185.41  Aligned_cols=139  Identities=21%  Similarity=0.366  Sum_probs=119.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCc--EEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~  226 (291)
                      ++|++.+.||+|+||.||+|....++.  .+++|.++...  .....+.+.+|+.++.++ +||||+++++++...+.+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            579999999999999999999877664  46888775321  223345678899999999 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|||+++++|..++....                .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999887542                467888899999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.90  E-value=2.9e-23  Score=190.08  Aligned_cols=134  Identities=24%  Similarity=0.349  Sum_probs=117.8

Q ss_pred             EEeccc--CceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccC
Q 022853          156 KVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (291)
Q Consensus       156 ~~LG~G--~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (291)
                      ..||+|  +||.||+|++..+++.||+|++....... ...+.+.+|+.+++.++||||++++++|..+...|+||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            346666  99999999999999999999987654333 345778899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          234 GGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       234 gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +++|..++.+.  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~  141 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVS  141 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEE
Confidence            99999888764  3478888899999999999999999999999999999999887654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.90  E-value=1.6e-23  Score=187.00  Aligned_cols=138  Identities=24%  Similarity=0.471  Sum_probs=120.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.++..... ......+.+|+.+++.++||||+++++++.+...+|+++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            489999999999999999999999999999999754322 1223446679999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+ +|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~  139 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELK  139 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEE
Confidence            9986 67666654 56789999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=7.4e-23  Score=182.57  Aligned_cols=140  Identities=26%  Similarity=0.396  Sum_probs=121.8

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      ...+|++.+.||+|+||.||+|.+..+++    .+|+|.+.....  ......+.+|+.++++++||||+++++++.. .
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            34689999999999999999999876654    589998876543  3345567889999999999999999998877 7


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++||||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~k  149 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVK  149 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEE
Confidence            899999999999999988764 4688999999999999999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.90  E-value=5.8e-23  Score=184.27  Aligned_cols=140  Identities=47%  Similarity=0.862  Sum_probs=123.6

Q ss_pred             CeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccccch-HHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  225 (291)
                      +|++.+.||.|+||.||+|++.   .+++.||+|++....... ....+.+..|+.++.++ +|+||+++++.++.+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999875   478899999997643322 22345677899999999 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+++++|..++.....+++..+..++.|++.||.|||++|++||||||+|||++.++.+|
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~k  145 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV  145 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEE
Confidence            99999999999999998888889999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.90  E-value=2.1e-24  Score=187.16  Aligned_cols=142  Identities=30%  Similarity=0.480  Sum_probs=127.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeC
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK-----IMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~  222 (291)
                      ...|.-.+.||.|..+.|-+|.++.++..+|+|++....     .......+.-..|+.||+++ .||+|+++.++|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            345777789999999999999999999999999996322     11334466677899999998 899999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|+|+|.|+.|.|++++...-.+++..++.+++|++.|++|||.++||||||||+|||++++.+||
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceE
Confidence            99999999999999999999998999999999999999999999999999999999999999998876

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.90  E-value=7.6e-23  Score=182.78  Aligned_cols=136  Identities=32%  Similarity=0.542  Sum_probs=121.7

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      |++.+.||+|+||.||+|.+..++..+++|.+....   ....+.+.+|+.+++.++||||+++++.+..+...|+||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            678899999999999999999999999999986542   23355677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +++++|..++.+ ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.+|
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~k  143 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIK  143 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEE
Confidence            999999887765 45688999999999999999999999999999999999999888764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.90  E-value=6.1e-23  Score=183.63  Aligned_cols=138  Identities=30%  Similarity=0.446  Sum_probs=113.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC---CCCCeeEEeEEEEe-----C
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQT-----K  222 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~-----~  222 (291)
                      +|++.+.||+|+||.||+|++..+++.||+|.++....... ....+.+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            48999999999999999999999999999999875432211 122344566666554   79999999998764     3


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++++|||+.+ +|..++.+.  ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~k  148 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVK  148 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence            468999999986 787777653  3488999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.90  E-value=8e-23  Score=179.97  Aligned_cols=139  Identities=25%  Similarity=0.443  Sum_probs=120.2

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEE-EeCC
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF-QTKY  223 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~  223 (291)
                      |.+...+|++.+.||+|+||.||++...  +..+|+|.+....     ..+.+.+|+.++++++|+|++++++++ ..+.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   73 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence            4566779999999999999999999774  6779999886542     245678899999999999999999875 4566


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..|++|||+++++|..++....  .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~k  142 (256)
T cd05082          74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAK  142 (256)
T ss_pred             ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEE
Confidence            7999999999999999887643  378888899999999999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.90  E-value=2.8e-23  Score=184.93  Aligned_cols=140  Identities=22%  Similarity=0.297  Sum_probs=122.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .++|.+.+.||+|+||.||+|.+..     +++.+|+|++.....  .+..+.+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            4579999999999999999998753     357899999875432  223567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG--------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      ..|+||||+++++|..++...+              .+++..+..++.|++.|+.|||++|++||||||+||+++.++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            9999999999999999987543              36778888999999999999999999999999999999988876


Q ss_pred             C
Q 022853          290 R  290 (291)
Q Consensus       290 K  290 (291)
                      |
T Consensus       162 k  162 (280)
T cd05049         162 K  162 (280)
T ss_pred             E
Confidence            5

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.90  E-value=7e-23  Score=185.24  Aligned_cols=144  Identities=19%  Similarity=0.306  Sum_probs=121.8

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEe
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLR  216 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~  216 (291)
                      +.+..++|.+.+.||+|+||.||+|++..       .+..+|+|.+....  .....+.+.+|+.+++.+ +||||++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            45667789999999999999999997532       34579999886542  223345678899999999 899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCc
Q 022853          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (291)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~N  280 (291)
                      +.+......|++|||+.+|+|..++.+..                .++...+..++.||+.||.|||++||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            99999999999999999999999987642                35666778889999999999999999999999999


Q ss_pred             EEecCCCCcC
Q 022853          281 ILLDADGHVR  290 (291)
Q Consensus       281 ILl~~~g~vK  290 (291)
                      ||++.++.+|
T Consensus       168 ili~~~~~~k  177 (304)
T cd05101         168 VLVTENNVMK  177 (304)
T ss_pred             EEEcCCCcEE
Confidence            9999888664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.90  E-value=7e-23  Score=181.50  Aligned_cols=136  Identities=32%  Similarity=0.512  Sum_probs=117.3

Q ss_pred             EEEEEecccCceEEEEEEEc----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          153 EVLKVVGQGAFAKVYQVRRI----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       153 ~i~~~LG~G~fg~Vy~~~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      ++.+.||.|+||.||+|.+.    ..+..|+||.++..  ......+.+.+|+..+++++||||+++++++.....+++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            57899999999999999998    34678999999543  2333467788899999999999999999999988889999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++|+|.+++...  ..++......++.||+.||.|||+++++||||+++|||++.++.+|
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~K  143 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVK  143 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999886  6788999999999999999999999999999999999999988775

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.90  E-value=9.9e-23  Score=180.39  Aligned_cols=141  Identities=20%  Similarity=0.260  Sum_probs=122.6

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      ..++|+..+.||+|+||.||+|....++.   .+|+|.+....  .....+.+..|+.++++++||||+++++++...+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            34579999999999999999999876554   79999886543  22335567889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .|+||||+++++|..++... +.+++..+..++.|++.|++|||++|++||||||+||+++.++.+|
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~k  147 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECK  147 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEE
Confidence            99999999999999888764 5688889999999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.90  E-value=5.7e-24  Score=203.88  Aligned_cols=133  Identities=36%  Similarity=0.471  Sum_probs=116.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC------E
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY------R  224 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~  224 (291)
                      -+...+.||+|+||.||+++++.+|+.||||.+++...  ...++.+.+|+++|++++|||||+++++-++..      .
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            46677899999999999999999999999999987542  233677889999999999999999988765543      4


Q ss_pred             EEEEEeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      ..+|||||.||+|...+.+.   ..+++...+.+..++..||.|||++||+||||||.||++-.
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~  155 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQI  155 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee
Confidence            67999999999999998763   45899999999999999999999999999999999999864

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.90  E-value=1.7e-23  Score=184.44  Aligned_cols=138  Identities=19%  Similarity=0.322  Sum_probs=122.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      ..+|++.+.||.|+||.||+|.+.. +..+|+|++.....   ...+.+..|+.+++.++||||+++++++.....+|+|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            4579999999999999999999987 88899999876532   2245577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|..++.+.  ..++...+..++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~k  144 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCK  144 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEE
Confidence            9999999999998753  4578888999999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.90  E-value=1.2e-22  Score=178.73  Aligned_cols=138  Identities=31%  Similarity=0.534  Sum_probs=126.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||+|+||.||+|.+..+++.+++|++......  ...+.+..|+..+..++||||+++++.+.....+|+|||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            689999999999999999999999999999998765422  335668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|..++.....+++.....++.|++.|+.|||+ +|++||||+|+||+++.++.+|
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~  140 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVK  140 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEE
Confidence            99999999999888889999999999999999999999 9999999999999999888764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.90  E-value=2.4e-23  Score=191.63  Aligned_cols=138  Identities=24%  Similarity=0.391  Sum_probs=117.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC------C
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------Y  223 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~  223 (291)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            579999999999999999999999999999999875432 222345567899999999999999999887543      4


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..|++++++ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        94 ~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~k  158 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELR  158 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEE
Confidence            579999988 668866554 45689999999999999999999999999999999999999988775

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.90  E-value=2.9e-23  Score=182.37  Aligned_cols=133  Identities=46%  Similarity=0.856  Sum_probs=122.2

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCH
Q 022853          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (291)
                      ||.|+||.||++.+..+++.+++|++...........+.+.+|+.++++++||||+++++.+..+...|++|||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999989999999999776554445567788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       238 ~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.+|
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~  133 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLK  133 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEE
Confidence            99998878899999999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.90  E-value=3.1e-23  Score=185.65  Aligned_cols=141  Identities=25%  Similarity=0.423  Sum_probs=126.4

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..++|++.+.||+|+||.||++.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++.+.....+|+
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            3467999999999999999999999999999999986543  22335668899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+++++|..++.+.+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+|
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~  144 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIK  144 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEE
Confidence            99999999999988887889999999999999999999997 5899999999999999887653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=6.5e-23  Score=196.48  Aligned_cols=132  Identities=20%  Similarity=0.249  Sum_probs=117.2

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|....         ..+.+|+.++++++||||+++++++...+..|+|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            3479999999999999999999999999999996422         2245799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||++. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vk  300 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC  300 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEE
Confidence            99996 5777777653 5689999999999999999999999999999999999999888764

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.90  E-value=9.3e-23  Score=181.88  Aligned_cols=137  Identities=27%  Similarity=0.507  Sum_probs=120.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||.|++|.||+|++..+++.||+|++......  ...+.+.+|+.+++.++||||+++++.+...+..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            589999999999999999999999999999999765321  223456679999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~---~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+ +|..++...   ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~  140 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELK  140 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEE
Confidence            9986 777776653   3578999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=9e-24  Score=196.26  Aligned_cols=139  Identities=37%  Similarity=0.543  Sum_probs=125.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      -|.+.+.||+|.|+.|-+|++.-+|+.||||++.+.+..+..... +..|+++|+..+|||||++|++..+...+|+|+|
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~h-lfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGH-LFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhH-HHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            488889999999999999999999999999999998776554444 5579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC-CCcC
Q 022853          231 FVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~-g~vK  290 (291)
                      +-.+|+|++++.+. ..+.++.+++|++||+.|+.|+|...+|||||||+|+.+.+. |-||
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVK  159 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVK  159 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceE
Confidence            99999999998875 568999999999999999999999999999999999987643 5444

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.90  E-value=3.2e-23  Score=191.03  Aligned_cols=144  Identities=22%  Similarity=0.322  Sum_probs=119.8

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~  218 (291)
                      |.+..++|++.+.||+|+||.||+|.+.+     +++.||+|+++....  ....+.+..|+.++.++ +||||++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            45566789999999999999999997543     357899999865432  22345567899999999 89999999988


Q ss_pred             EEe-CCEEEEEEeccCCCCHHHHHHHc-----------------------------------------------------
Q 022853          219 FQT-KYRLYLVLDFVNGGHLFFQLYRQ-----------------------------------------------------  244 (291)
Q Consensus       219 ~~~-~~~~~lV~E~~~gg~L~~~l~~~-----------------------------------------------------  244 (291)
                      +.. +..++++|||+++++|..++...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            754 46789999999999998887642                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          245 --------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       245 --------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                              ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vk  213 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVK  213 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEE
Confidence                    2567788899999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.90  E-value=1.1e-22  Score=184.36  Aligned_cols=140  Identities=24%  Similarity=0.375  Sum_probs=122.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ..|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++++.++...|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            46999999999999999999999899999999987554444444566888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.| ++...+. ....+++..+..++.|++.||.|||++||+||||+|+||+++.+|.+|
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~k  155 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVK  155 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEE
Confidence            99986 5555554 345689999999999999999999999999999999999999988764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.90  E-value=4.8e-23  Score=196.34  Aligned_cols=133  Identities=32%  Similarity=0.495  Sum_probs=118.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-C-----CCeeEEeEEEEeCCE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-H-----PFIVQLRYSFQTKYR  224 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-H-----pnIv~l~~~~~~~~~  224 (291)
                      +|++++.||+|+||.|.+|++..|++.||||+++...    ........|+.+|..|+ |     -|+|+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            7999999999999999999999999999999998754    33445567999999886 3     489999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      +|||+|.+.. +|.+++...  ..++...++.++.||+.||.+||..||||+|||||||||..-++
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r  327 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR  327 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc
Confidence            9999999876 899999875  35789999999999999999999999999999999999986553

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.90  E-value=1.7e-22  Score=177.51  Aligned_cols=139  Identities=33%  Similarity=0.590  Sum_probs=123.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||+|+||.||++....+++.||+|.+........ ..+.+.+|+.++++++||||+++++.+...+..|+|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH-HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            58999999999999999999999999999999875433322 34567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+++|...+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+|
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~  141 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIK  141 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEE
Confidence            999999988887542  578888999999999999999999999999999999999887664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.90  E-value=6.1e-23  Score=183.33  Aligned_cols=128  Identities=21%  Similarity=0.255  Sum_probs=109.2

Q ss_pred             EecccCceEEEEEEEcCC------------------------CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCe
Q 022853          157 VVGQGAFAKVYQVRRIGT------------------------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI  212 (291)
Q Consensus       157 ~LG~G~fg~Vy~~~~~~~------------------------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI  212 (291)
                      .||+|+||.||+|....+                        ...+|+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            589999999999875321                        2358888886432   2334557788999999999999


Q ss_pred             eEEeEEEEeCCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      +++++++......|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..|
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence            9999999999999999999999999888865 46688999999999999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.90  E-value=1.2e-22  Score=184.69  Aligned_cols=144  Identities=18%  Similarity=0.281  Sum_probs=121.7

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEe
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLR  216 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~  216 (291)
                      +....++|.+.+.||+|+||.||+|++..       ....+|+|.+.....  ......+..|+.+++.+ +||||++++
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLL   84 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence            34455789999999999999999998643       345799998875432  23355677899999999 699999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCc
Q 022853          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (291)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~N  280 (291)
                      +++.....+|++|||+.+|+|..++...                ..++...+..++.|++.||.|||++||+||||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  164 (314)
T cd05099          85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN  164 (314)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence            9999999999999999999999988753                236777888899999999999999999999999999


Q ss_pred             EEecCCCCcC
Q 022853          281 ILLDADGHVR  290 (291)
Q Consensus       281 ILl~~~g~vK  290 (291)
                      ||++.++.+|
T Consensus       165 ill~~~~~~k  174 (314)
T cd05099         165 VLVTEDNVMK  174 (314)
T ss_pred             EEEcCCCcEE
Confidence            9999888765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.90  E-value=7.5e-23  Score=190.06  Aligned_cols=139  Identities=24%  Similarity=0.396  Sum_probs=117.6

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----  222 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            35689999999999999999999999999999999975432 223345567899999999999999999887543     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 -YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 -~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ..+|+||||+.+ +|...+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEE
Confidence             458999999986 56555543  477888889999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.90  E-value=9.8e-23  Score=187.04  Aligned_cols=145  Identities=19%  Similarity=0.299  Sum_probs=121.3

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCC-------CcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGT-------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQL  215 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l  215 (291)
                      .|.+...+|++.+.||+|+||.||+|++...       ...+|+|++....  .....+.+.+|+.+++++ +||||+++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            3445556899999999999999999986532       2368999886532  223356678899999999 89999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCC
Q 022853          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (291)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~  279 (291)
                      ++.+.....+|++|||+++|+|..++.+..                .++...+..++.|++.||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            999999999999999999999999887532                3566777889999999999999999999999999


Q ss_pred             cEEecCCCCcC
Q 022853          280 NILLDADGHVR  290 (291)
Q Consensus       280 NILl~~~g~vK  290 (291)
                      |||++.++.+|
T Consensus       164 Nill~~~~~~k  174 (334)
T cd05100         164 NVLVTEDNVMK  174 (334)
T ss_pred             eEEEcCCCcEE
Confidence            99999887664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.90  E-value=1.3e-22  Score=181.35  Aligned_cols=139  Identities=29%  Similarity=0.474  Sum_probs=119.3

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEE-----e
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ-----T  221 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~-----~  221 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++.....    ..+.+.+|+.+++.+ +||||+++++++.     .
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            45689999999999999999999999999999998865321    124567899999998 7999999999873     4


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +..+|+||||+++++|..++..    ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+|
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEE
Confidence            5679999999999999887653    34678888999999999999999999999999999999999888664

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.90  E-value=8.6e-23  Score=183.96  Aligned_cols=139  Identities=22%  Similarity=0.351  Sum_probs=118.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcC----------------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCee
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIG----------------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV  213 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv  213 (291)
                      ++|++.+.||+|+||.||++.+..                ++..+|+|++....  .....+.+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            579999999999999999986543                34578999987542  233356788899999999999999


Q ss_pred             EEeEEEEeCCEEEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEE
Q 022853          214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (291)
Q Consensus       214 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NIL  282 (291)
                      ++++++......|++|||+.+++|..++....           .+++..+..++.|++.||+|||++|++||||||+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999998887643           2556678899999999999999999999999999999


Q ss_pred             ecCCCCcC
Q 022853          283 LDADGHVR  290 (291)
Q Consensus       283 l~~~g~vK  290 (291)
                      ++.++.+|
T Consensus       163 i~~~~~~~  170 (296)
T cd05095         163 VGKNYTIK  170 (296)
T ss_pred             EcCCCCEE
Confidence            99887764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.4e-22  Score=175.64  Aligned_cols=139  Identities=30%  Similarity=0.566  Sum_probs=126.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||+|++|.||++.+..+++.|++|.+...... ....+.+.+|++++.+++|||++++++++.....+|++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            488999999999999999999989999999999776543 2345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~  139 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVK  139 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEE
Confidence            999999999998888899999999999999999999999999999999999999887654

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.90  E-value=7e-23  Score=182.89  Aligned_cols=140  Identities=34%  Similarity=0.549  Sum_probs=124.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|+.++++++|+||+++++.+..++..|++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            369999999999999999999999999999999865432 2233566888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||++++.+..+..+...+++..+..++.||+.||.|||.+|++||||+|+||+++.++.+|
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~k  140 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLK  140 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEE
Confidence            9999987776666666789999999999999999999999999999999999999988775

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.90  E-value=1.1e-22  Score=179.48  Aligned_cols=139  Identities=22%  Similarity=0.344  Sum_probs=119.4

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .+..++|++.+.||+|+||.||+|... +++.+|+|.+......    .+.+.+|+.++++++||||+++++.+ ....+
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~   75 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVV-TQEPI   75 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCc
Confidence            455678999999999999999999865 5678999998765432    34577899999999999999999876 45678


Q ss_pred             EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++|||+.+++|..++...  ..++...+..++.|++.||+|||+.|++||||||+||+++.++.++
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~  142 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCK  142 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEE
Confidence            9999999999999888653  3578888899999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.90  E-value=6.9e-23  Score=181.67  Aligned_cols=133  Identities=23%  Similarity=0.282  Sum_probs=111.2

Q ss_pred             EEecccCceEEEEEEEcC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccC
Q 022853          156 KVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (291)
                      +.||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.++||||+++++.+.....+|+||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            368999999999996543  34568888775432  22334557789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          234 GGHLFFQLYRQG-----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       234 gg~L~~~l~~~~-----~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+|..++....     ...+..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~k  140 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVK  140 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEE
Confidence            999999887643     235677888999999999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.90  E-value=1e-22  Score=182.06  Aligned_cols=134  Identities=42%  Similarity=0.772  Sum_probs=113.9

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHH---HHHHhCCCCCeeEEeEEEEeCCEEEEEEeccC
Q 022853          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (291)
Q Consensus       157 ~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~---~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (291)
                      .||+|+||.||+|.+..+++.||+|++.+..............|.   .++....||+|+++++.+.....+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999999765433222222233333   34455689999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       234 gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++|..++...+.+++..++.++.|++.||.|||+++|+||||||+||+++.++.+|
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~k  137 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR  137 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEE
Confidence            999999888888899999999999999999999999999999999999999888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.90  E-value=1.4e-22  Score=180.79  Aligned_cols=138  Identities=29%  Similarity=0.484  Sum_probs=123.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||.|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.....+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            589999999999999999999989999999999765432 2334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+ +++|..++.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+|
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~  139 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLK  139 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEE
Confidence            99 9999988765 45689999999999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.1e-22  Score=179.24  Aligned_cols=135  Identities=41%  Similarity=0.755  Sum_probs=116.0

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHH-HhCCCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      +.||.|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+||||+++++.+.....+|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5789999999999999999999999999765433333333344454444 455999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|..++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+|
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~  137 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK  137 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEE
Confidence            99999998888899999999999999999999999999999999999999887664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.90  E-value=1.4e-22  Score=181.11  Aligned_cols=137  Identities=28%  Similarity=0.406  Sum_probs=116.6

Q ss_pred             Ce-EEEEEecccCceEEEEEEE----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--CC
Q 022853          151 DF-EVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KY  223 (291)
Q Consensus       151 ~y-~i~~~LG~G~fg~Vy~~~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~  223 (291)
                      +| ++.+.||+|+||+||++..    ..++..+|+|+++....  ....+.+.+|+.++++++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence            45 8999999999999988653    35678899999875431  2234567789999999999999999998765  34


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|++|||+.+++|..++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~  147 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVK  147 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEE
Confidence            689999999999998888764 589999999999999999999999999999999999999887764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.1e-22  Score=180.03  Aligned_cols=138  Identities=22%  Similarity=0.274  Sum_probs=116.5

Q ss_pred             eEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE----
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR----  224 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----  224 (291)
                      |++.+.||+|+||.||+|....+   +..+|+|.+...... ....+.+.+|+.+++.++||||+++++.+.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            56789999999999999987643   478999998765432 3335668889999999999999999988765443    


Q ss_pred             --EEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 --LYLVLDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 --~~lV~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                        .+++|||+++++|..++...      ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEE
Confidence              79999999999998887542      3578888999999999999999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.89  E-value=1e-22  Score=178.34  Aligned_cols=133  Identities=28%  Similarity=0.440  Sum_probs=120.0

Q ss_pred             EEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEecc
Q 022853          156 KVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  232 (291)
                      +.||+|+||.||+|.+...   +..+|+|++.......  ..+.+.+|+.++..++|+||+++++++.+...++++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4689999999999999866   8899999997654322  4567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          233 NGGHLFFQLYRQ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       233 ~gg~L~~~l~~~---------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++++|..++...         ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~  145 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVK  145 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEE
Confidence            999999998875         6789999999999999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.89  E-value=1.2e-22  Score=180.90  Aligned_cols=139  Identities=25%  Similarity=0.382  Sum_probs=121.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEc----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--CC
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRI----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KY  223 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~  223 (291)
                      .+|++.+.||+|+||.||+|.+.    .++..+|+|++......  ...+.+..|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            46889999999999999999864    34789999999765432  345678899999999999999999998877  56


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..|++|||+++++|..++.... .++...+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~  149 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVK  149 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEE
Confidence            7999999999999999887654 578888999999999999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.89  E-value=6.6e-23  Score=184.16  Aligned_cols=140  Identities=30%  Similarity=0.491  Sum_probs=121.6

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC--CEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLY  226 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~  226 (291)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.++..... ......+.+|+.++++++||||+++++++...  ..+|
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            45799999999999999999999999999999999755432 22233456799999999999999999998877  8999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+.+ +|..++... ..+++..++.++.||+.||+|||++|++||||||+||+++.+|.+|
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~  146 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILK  146 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEE
Confidence            99999985 888877664 4589999999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.89  E-value=1.9e-22  Score=179.75  Aligned_cols=138  Identities=25%  Similarity=0.449  Sum_probs=115.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHH-HHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++...... ...+ +..|.. .++.++||||+++++.+..+..+|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~-~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKR-LLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHH-HHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            37999999999999999999999999999999997653222 2233 334544 46677999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++ +|..++..    ...+++..+..++.||+.||+|||++ +++||||||+|||++.++.+|
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~k  144 (283)
T cd06617          79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVK  144 (283)
T ss_pred             hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEE
Confidence            999974 67666543    34688999999999999999999997 999999999999999988765

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.89  E-value=1.7e-22  Score=180.27  Aligned_cols=137  Identities=23%  Similarity=0.332  Sum_probs=119.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .++|++.+.||+|+||.||+|.+..     ++..+|+|.+.....  ......+..|+.+++.++|+||+++++++.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            4579999999999999999999987     778899998864432  222345778999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG-------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ..|+||||+.+++|..++.+.+       .+++..+..++.||+.||+|||+++++||||||+|||++.++
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~  153 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG  153 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC
Confidence            9999999999999999887653       478888899999999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-23  Score=197.07  Aligned_cols=146  Identities=27%  Similarity=0.447  Sum_probs=129.7

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHH-----HHHHHHHHHHhCC---CCCeeEEe
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAE-----YMKSERNILTKVD---HPFIVQLR  216 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~-----~~~~E~~il~~l~---HpnIv~l~  216 (291)
                      ......+|..++.+|.|+||+|++|.++.....|+||.+.|+++.....++     .+-.|+.||..++   |+||++++
T Consensus       556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL  635 (772)
T KOG1152|consen  556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL  635 (772)
T ss_pred             eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence            344566899999999999999999999999999999999988765433322     2346999999997   99999999


Q ss_pred             EEEEeCCEEEEEEecc-CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          217 YSFQTKYRLYLVLDFV-NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       217 ~~~~~~~~~~lV~E~~-~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|++++++||+||-- +|-+|++++.....+.|..++.|++|++.|+++||++||||||||-+|++++.+|-+|
T Consensus       636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             heeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEE
Confidence            9999999999999975 4559999999999999999999999999999999999999999999999999999876

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.89  E-value=2.4e-22  Score=176.20  Aligned_cols=136  Identities=29%  Similarity=0.506  Sum_probs=122.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....... ...+.+..|+.+++.++||||+++++.+..+..+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            4899999999999999999999999999999997654333 335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       231 ~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~  138 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK  138 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence            99999999988764  3478889999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.89  E-value=1.3e-22  Score=182.37  Aligned_cols=140  Identities=23%  Similarity=0.319  Sum_probs=120.6

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ...+|.+.+.||+|+||.||+|.+..     ++..+++|.+....   ....+.+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            34579999999999999999998643     45568899886543   22345678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      ...++||||+++++|.+++...+                .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999987543                36788899999999999999999999999999999999988


Q ss_pred             CCcC
Q 022853          287 GHVR  290 (291)
Q Consensus       287 g~vK  290 (291)
                      +.+|
T Consensus       160 ~~~~  163 (291)
T cd05094         160 LLVK  163 (291)
T ss_pred             CcEE
Confidence            8764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.89  E-value=1.1e-22  Score=181.84  Aligned_cols=140  Identities=21%  Similarity=0.301  Sum_probs=117.2

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcE----EEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEI----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.    +++|.+....  .......+..|+.+++.++||||+++++++. ..
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~   81 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA   81 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence            446899999999999999999999777764    6667664321  2233455677888899999999999999875 45


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++++||+.+|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+|
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~k  149 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQ  149 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEE
Confidence            678999999999999998764 5688999999999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.5e-24  Score=198.22  Aligned_cols=138  Identities=25%  Similarity=0.493  Sum_probs=128.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|..++.||+|+||.||+|.+..+++.||+|+++.+..  .+..+.+++|+.+|..++++||.++|+.|..+..+|++||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            58888999999999999999999999999999987753  3446778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||.||++..++.....+.+.....++++++.|+.|||.++.+|||||+.|||+..+|.||
T Consensus        92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vk  151 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVK  151 (467)
T ss_pred             HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEE
Confidence            999999999998888778888889999999999999999999999999999999999876

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.89  E-value=2.8e-22  Score=181.11  Aligned_cols=137  Identities=28%  Similarity=0.456  Sum_probs=123.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++.+.....+|+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            469999999999999999999999999999999865432   22456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.+++|..++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.+|.+|
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~k  155 (296)
T cd06655          96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVK  155 (296)
T ss_pred             EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence            99999999887764 4678999999999999999999999999999999999999888764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.89  E-value=5.5e-24  Score=174.82  Aligned_cols=139  Identities=25%  Similarity=0.491  Sum_probs=121.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ..|.-.+.||+|.||+||+|+...+++.||+|.++.+.-.+. .-....+|+-+++.+.|.|||++++....+..+-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            356777899999999999999999999999999987653322 2334567999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||.. +|..+... ++.+....++.++.|+++||.|+|++++.||||||.|+||+.+|.+|
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelk  141 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELK  141 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEE
Confidence            99986 55555443 57789999999999999999999999999999999999999999876

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.89  E-value=1.1e-22  Score=182.31  Aligned_cols=141  Identities=22%  Similarity=0.363  Sum_probs=121.5

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ..++|++.+.||+|+||.||+|.+..     ++..+|+|++....  .......+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            34689999999999999999998753     57889999987543  223345688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCc
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQG----------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~----------------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~N  280 (291)
                      ...|++|||+++++|..++....                      .+++..+..++.|++.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999998887532                      35677788999999999999999999999999999


Q ss_pred             EEecCCCCcC
Q 022853          281 ILLDADGHVR  290 (291)
Q Consensus       281 ILl~~~g~vK  290 (291)
                      |+++.++.+|
T Consensus       161 il~~~~~~~~  170 (288)
T cd05050         161 CLVGENMVVK  170 (288)
T ss_pred             eEecCCCceE
Confidence            9999888764

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.89  E-value=1.4e-22  Score=178.92  Aligned_cols=139  Identities=21%  Similarity=0.318  Sum_probs=119.4

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .+..++|++.+.||+|+||.||+|.+. .+..+|+|.+......    .+.+.+|+.++++++||||+++++.+. ....
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI   75 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence            455678999999999999999999876 4566999998765432    245788999999999999999998775 4568


Q ss_pred             EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++|||+.+++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~  142 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCK  142 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEE
Confidence            9999999999999988753  3578888999999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.89  E-value=2.6e-22  Score=203.61  Aligned_cols=139  Identities=27%  Similarity=0.489  Sum_probs=121.2

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--CC
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KY  223 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~  223 (291)
                      ...+++|++++.||+|+||.||+|++..++..+|+|++....... .....+..|+.++..++||||++++++|..  ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            345678999999999999999999999999999999997654333 335667889999999999999999998854  45


Q ss_pred             EEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CCEecccCCCcEEecC
Q 022853          224 RLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHAN-------GIMHRDLKPENILLDA  285 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~-------gIiHrDLKp~NILl~~  285 (291)
                      .+||||||+.+|+|..++..    .+.+++..++.|+.||+.||.|||+.       +||||||||+||||+.
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            79999999999999988865    25689999999999999999999994       4999999999999975

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.4e-22  Score=187.71  Aligned_cols=140  Identities=22%  Similarity=0.204  Sum_probs=109.1

Q ss_pred             CCCCCcccccCCeEEEEEecccCceEEEEEEEcC-CCcEEEEEEeecccc--chHHHHHHHHHHHHHHHhCCCCCeeE-E
Q 022853          140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQ-L  215 (291)
Q Consensus       140 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~-l  215 (291)
                      +|........++|.+.+.||+|+||+||+|.+.. +++.+|||++.....  ......+.+.+|+.+|+.++|+||+. +
T Consensus         8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l   87 (365)
T PRK09188          8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL   87 (365)
T ss_pred             CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence            3444445566789999999999999999998876 677789998753311  12334567899999999999999985 4


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeccc-CCCcEEecCCCCcC
Q 022853          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL-KPENILLDADGHVR  290 (291)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDL-Kp~NILl~~~g~vK  290 (291)
                      +.    .+..|+||||++|++|.. +.   ...   ...++.|++.||.|||++||+|||| ||+|||++.+|.+|
T Consensus        88 ~~----~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         88 LA----TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             EE----cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEE
Confidence            43    246899999999999962 21   111   1457889999999999999999999 99999998887764

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.89  E-value=2.2e-22  Score=179.52  Aligned_cols=137  Identities=26%  Similarity=0.506  Sum_probs=122.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|+..+.||.|+||.||+|.+..++..+|+|++.....  ....+.+.+|+.+++.++||||+++++.+.+....|+|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            58888999999999999999998999999999875432  2335678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+++|.+++.. +.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.+|
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~  141 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVK  141 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEE
Confidence            9999999888764 5678888899999999999999999999999999999999887654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.89  E-value=1.5e-22  Score=177.99  Aligned_cols=137  Identities=26%  Similarity=0.425  Sum_probs=118.4

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .+..++|++.+.||+|+||.||++..  +++.+|+|.+....     ..+.+.+|+.+++.++||||+++++.+... ..
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   73 (254)
T cd05083           2 LLNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GL   73 (254)
T ss_pred             cccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-Cc
Confidence            44567899999999999999999864  67789999986542     234577899999999999999999988654 47


Q ss_pred             EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++|||+.+++|..++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~k  140 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAK  140 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEE
Confidence            99999999999999887643  478888889999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.89  E-value=1.9e-22  Score=181.09  Aligned_cols=138  Identities=21%  Similarity=0.330  Sum_probs=117.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      +|++.+.||+|+||.||+|....     ....+|+|.+.....  ....+.+..|+.+++.++||||+++++.+......
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            47889999999999999998753     235688988865432  22345678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcE
Q 022853          226 YLVLDFVNGGHLFFQLYRQ------------------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NI  281 (291)
                      |++|||+.+++|..++...                        ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999887642                        2366778889999999999999999999999999999


Q ss_pred             EecCCCCcC
Q 022853          282 LLDADGHVR  290 (291)
Q Consensus       282 Ll~~~g~vK  290 (291)
                      |++.++.+|
T Consensus       159 ll~~~~~~k  167 (290)
T cd05045         159 LVAEGRKMK  167 (290)
T ss_pred             EEcCCCcEE
Confidence            999888765

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.8e-22  Score=179.45  Aligned_cols=138  Identities=28%  Similarity=0.527  Sum_probs=123.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++.....  ......+.+|+.+++.++||||+++++.+.++..+|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            368899999999999999999999999999999875531  233455778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|..++... .+++..+..++.|++.|+.|||+++++||||+|+||+++.+|.++
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~  138 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVK  138 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEE
Confidence            999999999888765 788999999999999999999999999999999999999988654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.89  E-value=5.7e-22  Score=172.99  Aligned_cols=139  Identities=34%  Similarity=0.532  Sum_probs=126.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC--CEEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLYLV  228 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV  228 (291)
                      +|++.+.||+|++|.||+|.+..+++.+++|++...... ....+.+.+|+.++++++||||+++++.+...  ..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            488899999999999999999989999999999765432 34467788999999999999999999999888  899999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||+.+++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+|
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~  141 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVK  141 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEE
Confidence            99999999999998877889999999999999999999999999999999999999887664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.89  E-value=3.3e-22  Score=175.60  Aligned_cols=139  Identities=32%  Similarity=0.567  Sum_probs=121.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--CCEEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLYLV  228 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV  228 (291)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+...... ....+.+..|+.+++.++||||+++++.+..  ...+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            589999999999999999999999999999998765433 3345667889999999999999999987753  4578999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLH-----ANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH-----~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|..++.+    ...+++..++.++.||+.||.|||     +.+++||||||+||+++.++.+|
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~k  150 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVK  150 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEE
Confidence            999999999888865    357888999999999999999999     89999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.89  E-value=3.2e-22  Score=176.70  Aligned_cols=138  Identities=23%  Similarity=0.340  Sum_probs=117.3

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +..++|++.+.||+|+||.||+|.+..+. .+|+|.+.....    ..+.+.+|+.+++.++||||+++++++. ....|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY   76 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence            44567999999999999999999886654 589998865432    2345778999999999999999988775 45689


Q ss_pred             EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|||+.+++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~  142 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCK  142 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEE
Confidence            999999999999988764  2467888899999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.89  E-value=5.8e-23  Score=183.47  Aligned_cols=141  Identities=21%  Similarity=0.328  Sum_probs=120.7

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ...+|++.+.||+|+||.||+|.+..+     +..+|+|++....  .....+.+..|+.++..++||||+++++.+...
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            445788999999999999999987643     5789999987543  223356688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      ...++++||+.+++|..++...                ..++...+..++.|++.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999998887532                246777888899999999999999999999999999999988


Q ss_pred             CCcC
Q 022853          287 GHVR  290 (291)
Q Consensus       287 g~vK  290 (291)
                      +.+|
T Consensus       161 ~~~k  164 (283)
T cd05091         161 LNVK  164 (283)
T ss_pred             CceE
Confidence            7665

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.89  E-value=2e-22  Score=180.23  Aligned_cols=140  Identities=22%  Similarity=0.299  Sum_probs=120.9

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ...+|.+.+.||+|+||.||++...     .++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            3467999999999999999999743     346688999876432   23356788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQG---------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~---------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ...|++|||+++++|..++...+               .+++..+..++.|++.|++|||++|++||||||+|||++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999887643               367888899999999999999999999999999999999887


Q ss_pred             CcC
Q 022853          288 HVR  290 (291)
Q Consensus       288 ~vK  290 (291)
                      .+|
T Consensus       160 ~~k  162 (280)
T cd05092         160 VVK  162 (280)
T ss_pred             CEE
Confidence            664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.89  E-value=1.2e-22  Score=178.44  Aligned_cols=127  Identities=20%  Similarity=0.242  Sum_probs=110.7

Q ss_pred             EEecccCceEEEEEEEcCCC----------cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          156 KVVGQGAFAKVYQVRRIGTS----------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~----------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      +.||+|+||.||+|.+..++          ..+++|++.....   . ...+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---D-SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---h-HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46899999999999998766          3577787654421   1 4567789999999999999999998887 778


Q ss_pred             EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          226 YLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      |+||||+++|+|..++.+.. .++...+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~  138 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYG  138 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCc
Confidence            99999999999999988765 688899999999999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=2.9e-22  Score=176.49  Aligned_cols=132  Identities=23%  Similarity=0.324  Sum_probs=115.7

Q ss_pred             EEecccCceEEEEEEEcCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEecc
Q 022853          156 KVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  232 (291)
                      +.||+|+||.||+|.+...+   ..+|+|.+......  ...+.+.+|+.+++.++||||+++++++. ....++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            46999999999999876554   78999998766533  33456788999999999999999998775 45689999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          233 NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       233 ~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+++|..++.+...+++..+..++.|++.||+|||.++++||||||+|||++.++.+|
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~k  135 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAK  135 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEE
Confidence            9999999998887889999999999999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.89  E-value=3.4e-22  Score=176.53  Aligned_cols=139  Identities=22%  Similarity=0.329  Sum_probs=119.3

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .+..++|++.+.||+|+||.||++.+. .+..+|+|.+....    ...+.+.+|+.++++++|+||+++++.+.. ...
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   75 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI   75 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence            455678999999999999999999865 45569999886542    224567889999999999999999988877 778


Q ss_pred             EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++|||+++++|.+++.+.  ..++...+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~  142 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCK  142 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEE
Confidence            9999999999999988764  3467778888999999999999999999999999999999887764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.89  E-value=2.1e-22  Score=178.53  Aligned_cols=138  Identities=22%  Similarity=0.309  Sum_probs=114.2

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCc--EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC------C
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------Y  223 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~  223 (291)
                      |.+.+.||+|+||.||+|.+..++.  .+|+|.++.... .....+.+..|+.+++.++||||+++++.+...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3467899999999999999877665  689998876432 334466788899999999999999999876432      3


Q ss_pred             EEEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+++|||+.+|+|..++...      ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  152 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVC  152 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEE
Confidence            578999999999998876421      3478888999999999999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=3.6e-22  Score=176.51  Aligned_cols=138  Identities=32%  Similarity=0.517  Sum_probs=121.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCC----
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY----  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~----  223 (291)
                      .++|++.+.||+|+||.||+|.+..+++.+++|++.....    ..+.+.+|+.+++++ +||||+++++++....    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            4689999999999999999999998999999999876532    235678899999998 7999999999997644    


Q ss_pred             --EEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 --RLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 --~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                        .+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++||||+|+||+++.++.+|
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~  153 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVK  153 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEE
Confidence              48999999999999888764    35788999999999999999999999999999999999999888764

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.89  E-value=9.5e-23  Score=179.88  Aligned_cols=139  Identities=27%  Similarity=0.448  Sum_probs=125.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+......  ...+.+.+|+.+++.++||||+++++.+.....+|+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            3688899999999999999999999999999998765422  34556778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.+++|..++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.+|.+|
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~  141 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIK  141 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEE
Confidence            999999999998876 778999999999999999999999 9999999999999999988764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.89  E-value=2e-22  Score=176.48  Aligned_cols=137  Identities=27%  Similarity=0.401  Sum_probs=121.4

Q ss_pred             eEEEEEecccCceEEEEEEEcCCC----cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      +++.+.||.|+||.||+|.+...+    ..+|+|.+.....  ....+.+..|+.++..++||||+++++.+.+.+..|+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            356789999999999999998766    8999999966532  2245678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|||+++++|..++.....  +++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~  143 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVK  143 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEE
Confidence            9999999999998876544  89999999999999999999999999999999999999988654

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.89  E-value=4.8e-22  Score=174.69  Aligned_cols=137  Identities=23%  Similarity=0.386  Sum_probs=120.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      ..+|++.+.||+|+||.||++.+.. +..+|+|.+......    ...+..|+.++++++||||+++++.+......|+|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            3579999999999999999998863 667999998755432    23467899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+++|..++... +.+++..++.++.|++.|++|||++|++||||||+||+++.++.+|
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~  140 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVK  140 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEE
Confidence            9999999999888754 4678888999999999999999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.89  E-value=2.1e-22  Score=177.51  Aligned_cols=132  Identities=20%  Similarity=0.311  Sum_probs=114.9

Q ss_pred             EecccCceEEEEEEE--cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          157 VVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       157 ~LG~G~fg~Vy~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      .||+|+||.||+|.+  ..++..+|+|+++.... .....+.+..|+.+++.++||||+++++++. ....++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            589999999999965  45678999999865432 3344567888999999999999999998875 4567899999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|..++.....+++..+..++.|++.||+|||++||+||||||.||+++.++.+|
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~k  135 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAK  135 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEE
Confidence            99999998888899999999999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.89  E-value=2.9e-22  Score=175.74  Aligned_cols=136  Identities=26%  Similarity=0.465  Sum_probs=123.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||.|+||.||+|.+..+++.+++|.+.....     .+.+.+|+.+++.++||||+++++.+.....+|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            579999999999999999999998899999999865421     567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.+++|..++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+|
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~  139 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAK  139 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEE
Confidence            99999999998875 45678999999999999999999999999999999999999988764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.89  E-value=2e-22  Score=182.47  Aligned_cols=139  Identities=27%  Similarity=0.456  Sum_probs=117.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC--CEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLY  226 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~  226 (291)
                      .|++.+.||+|+||.||+|.+..  +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+.  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48899999999999999999988  8899999999874322233345567899999999999999999999888  8899


Q ss_pred             EEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC----CCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA----DGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~----~g~vK  290 (291)
                      +||||+++ +|...+...     ..+++..++.++.||+.||.|||+++|+||||||+|||++.    +|.+|
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEE
Confidence            99999986 565555422     25788999999999999999999999999999999999998    66554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.89  E-value=3.7e-22  Score=178.00  Aligned_cols=137  Identities=25%  Similarity=0.502  Sum_probs=121.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      -|++.+.||.|+||.||+|.+..+++.+|+|++.....  ....+.+.+|+.++..++||||+++++.+..+...|+|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            37788999999999999999988999999999865432  2334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+++|..++.. ..+++..+..++.|++.|+.|||++|++|+||||+||+++.+|.+|
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~  141 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVK  141 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEE
Confidence            9999999887754 4678899999999999999999999999999999999999888654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.89  E-value=4.3e-22  Score=181.46  Aligned_cols=139  Identities=25%  Similarity=0.401  Sum_probs=121.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|...+.||+|+||.||++.+..++..+|+|.+.............+..|+.+++.++|||++++++++..+...|+|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            48889999999999999999999999999999976544444455668889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.+|
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~k  165 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVK  165 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEE
Confidence            9986 66665543 56688899999999999999999999999999999999999888764

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PTZ00284 protein kinase; Provisional

Probab=99.89  E-value=1.2e-21  Score=188.22  Aligned_cols=136  Identities=26%  Similarity=0.377  Sum_probs=112.8

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC------CCCeeEEeEEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD------HPFIVQLRYSFQ  220 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~  220 (291)
                      ...++|++.+.||+|+||+||+|.+..+++.||||+++....    .......|+.++..+.      |+++++++++|.
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            345789999999999999999999999999999999964321    1233455666666654      456888888887


Q ss_pred             eC-CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCC
Q 022853          221 TK-YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADG  287 (291)
Q Consensus       221 ~~-~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g  287 (291)
                      .. ..+|+|||++ |++|..++.+.+.+++..++.++.||+.||+|||+ .|||||||||+|||++.++
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSD  269 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCC
Confidence            54 5789999988 66888888888889999999999999999999998 5999999999999998765

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.89  E-value=6.1e-23  Score=181.25  Aligned_cols=131  Identities=20%  Similarity=0.276  Sum_probs=112.4

Q ss_pred             EEecccCceEEEEEEEcCCCc-------EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          156 KVVGQGAFAKVYQVRRIGTSE-------IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~-------~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +.||+|+||.||+|.+...+.       .+|+|.+....   ....+.+..|+.+++.++||||+++++.+..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            368999999999998865543       38888775432   23345677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      |||+.+|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~  139 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDR  139 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEeccccc
Confidence            99999999999887644 57888899999999999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.89  E-value=5.6e-22  Score=178.19  Aligned_cols=136  Identities=26%  Similarity=0.456  Sum_probs=116.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            5799999999999999999999999999999998654322 122355778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          230 DFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ||+++ +|...+.....  +++..++.++.||+.||+|||++|++||||+|+||+++.++
T Consensus        81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~  139 (294)
T PLN00009         81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT  139 (294)
T ss_pred             ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC
Confidence            99975 67676655433  57788889999999999999999999999999999998543

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.89  E-value=3.6e-22  Score=177.44  Aligned_cols=133  Identities=24%  Similarity=0.387  Sum_probs=113.7

Q ss_pred             EEecccCceEEEEEEEcCCCc--EEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEEecc
Q 022853          156 KVVGQGAFAKVYQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFV  232 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~  232 (291)
                      +.||+|+||.||+|.+..++.  .+|+|.+....  .....+.+..|+.++.++ +||||+++++.+...+.+|+||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            368999999999999987775  45788776432  233355678899999999 8999999999999999999999999


Q ss_pred             CCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          233 NGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       233 ~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|+|..++....                .+++..++.++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEE
Confidence            9999999887543                367888899999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.3e-23  Score=197.01  Aligned_cols=228  Identities=22%  Similarity=0.271  Sum_probs=164.2

Q ss_pred             cCCCCCCCCccccCCccccccccccCCCeeeecCCccCccCCCcccccccccccccccccccccccccccccccCCCCCC
Q 022853           44 VFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNL  123 (291)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~sl~~p~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~  123 (291)
                      .-|.|.|+||++.+|-+|-+.+-   +.++.|-|.+-----..|+++..           .+..|.+.+-+...-..+..
T Consensus       172 InGSFLVRESEsSpgQ~sISlRy---eGRVyHYRINt~~dgK~yvt~Es-----------rF~TLaELVHHHStvADGLi  237 (1157)
T KOG4278|consen  172 INGSFLVRESESSPGQYSISLRY---EGRVYHYRINTDNDGKMYVTQES-----------RFRTLAELVHHHSTVADGLI  237 (1157)
T ss_pred             cccceEEeeccCCCcceeEEEEe---cceEEEEEeeccCCccEEEeehh-----------hhhHHHHHHhhcccccccee
Confidence            47999999999999988765433   56777744433322223333332           23333333322221111111


Q ss_pred             cccc-cc--cCCCCCCCCCCC-CCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHH
Q 022853          124 SVVD-AA--LGKPTGHIDNLP-SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS  199 (291)
Q Consensus       124 ~~~~-~~--~~~~~~~~~~~~-~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~  199 (291)
                      ..+- .+  ..+++- ..-.| .+.|.....+......||-|.||.||.|.|+.-...||||.++.+...    ++.|..
T Consensus       238 ttLhYPApK~nKptv-ygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLk  312 (1157)
T KOG4278|consen  238 TTLHYPAPKKNKPTV-YGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLK  312 (1157)
T ss_pred             EeeeccCccCCCCce-eeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHH
Confidence            1110 01  111110 11111 246777777888899999999999999999999999999999876543    667889


Q ss_pred             HHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccC
Q 022853          200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLK  277 (291)
Q Consensus       200 E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLK  277 (291)
                      |+.+|+.+.|||+|+|+++|..+..+|||+|||..|+|.++|.+..  .++.-....++.||..||+||..+++|||||.
T Consensus       313 EAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLA  392 (1157)
T KOG4278|consen  313 EAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLA  392 (1157)
T ss_pred             HHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhh
Confidence            9999999999999999999999999999999999999999998743  35555666778899999999999999999999


Q ss_pred             CCcEEecCCCCcC
Q 022853          278 PENILLDADGHVR  290 (291)
Q Consensus       278 p~NILl~~~g~vK  290 (291)
                      .+|+|+.++..||
T Consensus       393 ARNCLVgEnhiVK  405 (1157)
T KOG4278|consen  393 ARNCLVGENHIVK  405 (1157)
T ss_pred             hhhccccccceEE
Confidence            9999999887665

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.89  E-value=8.1e-22  Score=176.90  Aligned_cols=138  Identities=30%  Similarity=0.498  Sum_probs=120.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeC-----
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK-----  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~-----  222 (291)
                      .++|++.+.||+|+||.||+|....+++.+|+|++.....    ..+.+..|+.++.++ +||||+++++++...     
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            5689999999999999999999999999999999865421    234567788999988 899999999988653     


Q ss_pred             CEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|+||||+++++|..++..    ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEE
Confidence            468999999999999887753    35688999999999999999999999999999999999999888764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=8.4e-22  Score=176.75  Aligned_cols=139  Identities=27%  Similarity=0.425  Sum_probs=120.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--CCEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLYL  227 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~l  227 (291)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+.....  ......+.+|+++++.++||||+++++++..  .+.+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            369999999999999999999999999999999875432  2335567889999999999999999998854  447999


Q ss_pred             EEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+|
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~  145 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVK  145 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEE
Confidence            9999999999877653    34578888999999999999999999999999999999999887654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.89  E-value=2.8e-22  Score=177.69  Aligned_cols=137  Identities=31%  Similarity=0.522  Sum_probs=119.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeC------
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK------  222 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~------  222 (291)
                      +.|++.+.||+|+||.||+|.+..+++.+|+|++.....    ....+..|+.++.++ +||||+++++.+...      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            468889999999999999999999999999999875431    134567889999988 799999999998653      


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|++|||+.+++|..++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+|
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~  151 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK  151 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEE
Confidence            4689999999999999988763  4678999999999999999999999999999999999999888664

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.89  E-value=2.8e-22  Score=181.73  Aligned_cols=143  Identities=29%  Similarity=0.479  Sum_probs=121.3

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC--C
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--Y  223 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~  223 (291)
                      +...++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.++++++|+||+++++++...  .
T Consensus         3 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            345678999999999999999999999999999999987543222 1122345799999999999999999998755  5


Q ss_pred             EEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+.+ +|..++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~k  148 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLK  148 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence            78999999976 67777665 36688999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.89  E-value=4.3e-22  Score=175.98  Aligned_cols=131  Identities=24%  Similarity=0.320  Sum_probs=112.3

Q ss_pred             EecccCceEEEEEEEc--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          157 VVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       157 ~LG~G~fg~Vy~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      .||+|+||.||+|.+.  ..+..+|+|++....  .....+.+.+|+.++++++||||+++++.+. ....|+||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            3899999999999765  445679999986543  2334566889999999999999999999875 4578999999999


Q ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|..++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+|
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~k  135 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAK  135 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEE
Confidence            999988875 45689999999999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.89  E-value=7.3e-22  Score=175.01  Aligned_cols=135  Identities=27%  Similarity=0.379  Sum_probs=116.9

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      +.....||+|+||.||+|.+..++..+|+|.+....   ....+.+.+|+.+++.++|+||+++++++..+...|+++||
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   86 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ   86 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence            334468999999999999999899999999886543   23355688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC-CCCc
Q 022853          232 VNGGHLFFQLYRQ-GLF--REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHV  289 (291)
Q Consensus       232 ~~gg~L~~~l~~~-~~~--~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~-~g~v  289 (291)
                      +++++|..++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.+
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~  148 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVV  148 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeE
Confidence            9999999888764 445  77888889999999999999999999999999999976 4443

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=3.4e-22  Score=177.80  Aligned_cols=137  Identities=25%  Similarity=0.524  Sum_probs=121.4

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC---CCCeeEEeEEEEeCCEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~l  227 (291)
                      .|++.+.||+|+||.||+|.+..+++.+|+|.+....  .....+.+.+|+.+++.+.   |||++++++.+..+...|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4788899999999999999999999999999987543  2233456778999999886   9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+++++|..++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+|
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~  141 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVK  141 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEE
Confidence            9999999999888755 4788999999999999999999999999999999999999888764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.89  E-value=3.4e-22  Score=177.36  Aligned_cols=133  Identities=25%  Similarity=0.224  Sum_probs=111.4

Q ss_pred             EEecccCceEEEEEEEcC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccC
Q 022853          156 KVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (291)
                      +.||+|+||.||+|....  ++..+|+|.++....  ......+.+|+.+++.++||||+++++.+.+...+|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            368999999999997643  456799998865532  1223457789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          234 GGHLFFQLYRQG-----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       234 gg~L~~~l~~~~-----~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+|..++....     ..+...+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~k  140 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVK  140 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEE
Confidence            999998887532     345667778899999999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.88  E-value=5e-22  Score=176.24  Aligned_cols=140  Identities=23%  Similarity=0.350  Sum_probs=119.3

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      ...+|.+.+.||+|+||.||+|.+...   ...+|+|......  .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            345799999999999999999987644   4568999886543  23345678889999999999999999998875 55


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .|+||||+++++|..++.+.. .+++..+..++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~  147 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVK  147 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeE
Confidence            789999999999999987643 578899999999999999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.88  E-value=2.2e-22  Score=179.69  Aligned_cols=138  Identities=28%  Similarity=0.510  Sum_probs=120.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+...... ....+.+..|++++++++||||+++++++.+....|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            489999999999999999999999999999998654322 2223467789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+. ++|..++..  ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.+|
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~  140 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK  140 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence            996 478777765  35678899999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.88  E-value=1e-21  Score=171.66  Aligned_cols=139  Identities=33%  Similarity=0.616  Sum_probs=124.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||.|+||.||++.+..++..+|+|++...... ....+.+..|+++++.++|||++++.+.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            589999999999999999999989999999999765432 2345567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~----~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|...+.+.    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+|
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~  143 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVK  143 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEE
Confidence            99999999888764    6788999999999999999999999999999999999999877654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.88  E-value=5e-22  Score=183.78  Aligned_cols=138  Identities=26%  Similarity=0.429  Sum_probs=118.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC------
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------  222 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.+++.++||||++++++|...      
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4689999999999999999999999999999999865432 223345567899999999999999999988643      


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...|+||||+.+ +|...+...  +++..+..++.|++.||+|||++||+||||||+||+++.+|.+|
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~k  158 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  158 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEE
Confidence            357999999976 777766544  78888999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.88  E-value=4.4e-22  Score=176.51  Aligned_cols=130  Identities=20%  Similarity=0.248  Sum_probs=110.3

Q ss_pred             EEecccCceEEEEEEEcCC------------CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          156 KVVGQGAFAKVYQVRRIGT------------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~------------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      +.||+|+||.||+|.....            ...+++|++....   ......+.+|+.+++.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3689999999999985422            2358888875532   233456778899999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      ..++||||+++++|..++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~  143 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGI  143 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCc
Confidence            999999999999998887753 56899999999999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.88  E-value=5.3e-22  Score=173.88  Aligned_cols=132  Identities=25%  Similarity=0.376  Sum_probs=116.9

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (291)
                      +.||+|+||.||+|.+.. ++.||+|.+......  ...+.+..|+.++++++||||+++++++......|+||||+.++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            468999999999999887 899999998765432  34566888999999999999999999999999999999999999


Q ss_pred             CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          236 HLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       236 ~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|..++.+ ...++......++.|++.||.|||+++++||||||+|||++.++.+|
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~  133 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLK  133 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEE
Confidence            99988865 34578888889999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.88  E-value=4.9e-22  Score=174.36  Aligned_cols=137  Identities=34%  Similarity=0.598  Sum_probs=121.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||+|+||.||++.+..++..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+.....+|+++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            4899999999999999999999999999999987653322 234567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          231 FVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      |+.+++|..++.+..  .+++..+..++.|++.||.|||+++++||||||+||+++.++.
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~  139 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM  139 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC
Confidence            999999999887643  4688899999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.88  E-value=4.1e-22  Score=175.21  Aligned_cols=132  Identities=26%  Similarity=0.360  Sum_probs=115.8

Q ss_pred             EEecccCceEEEEEEEcC-CC--cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEecc
Q 022853          156 KVVGQGAFAKVYQVRRIG-TS--EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~-~~--~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~  232 (291)
                      +.||+|+||.||+|.+.. .+  ..+|+|.+......  ...+.+..|+.++++++||||+++++.+.. ..+++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999998865 23  36999999776543  446678899999999999999999999888 8999999999


Q ss_pred             CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          233 NGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       233 ~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++++|...+....  .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~k  137 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVK  137 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEE
Confidence            9999999987754  578889999999999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.88  E-value=2.5e-22  Score=180.88  Aligned_cols=141  Identities=28%  Similarity=0.497  Sum_probs=119.9

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC----
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----  223 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----  223 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.++...... .....+.+|+.+++.++||||+++++++.+..    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            4568999999999999999999999999999999997543211 22345678999999999999999999886654    


Q ss_pred             ------EEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 ------RLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ------~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                            .+|+|+||+++ ++...+.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEE
Confidence                  79999999987 56555554 34689999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.88  E-value=6.3e-22  Score=176.24  Aligned_cols=137  Identities=30%  Similarity=0.545  Sum_probs=120.8

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC--CEEEEEE
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLYLVL  229 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV~  229 (291)
                      |++.+.||.|+||.||+|.+..+++.+|+|.+.... ......+.+.+|+.+++.++|||++++++.+...  ...|+||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            678999999999999999999999999999998654 2223345577899999999999999999999888  8999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++ +|..++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.+|.+|
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~  140 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLK  140 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEE
Confidence            99986 787777654 5789999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.88  E-value=3.8e-23  Score=193.93  Aligned_cols=140  Identities=26%  Similarity=0.367  Sum_probs=126.4

Q ss_pred             CCCCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEE
Q 022853          139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS  218 (291)
Q Consensus       139 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~  218 (291)
                      ....+.|.+.++...-++.||.|+.|.||+|+..  ++.||||.++.          .-..++..|++|+||||+.|.++
T Consensus       113 ~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGV  180 (904)
T KOG4721|consen  113 QQQEELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGV  180 (904)
T ss_pred             hhhhhhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeee
Confidence            3445678888888888999999999999999984  67899997742          22357888999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          219 FQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |.....+|||||||..|.|...|.....+.......|..+|+.||.|||.+.|||||||.-||||..+..||
T Consensus       181 CtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VK  252 (904)
T KOG4721|consen  181 CTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVK  252 (904)
T ss_pred             ecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEE
Confidence            999999999999999999999999999999999999999999999999999999999999999999988876

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.88  E-value=1.1e-22  Score=181.30  Aligned_cols=137  Identities=27%  Similarity=0.520  Sum_probs=121.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|+..+.||+|+||.||+|.+..+++.+|+|.+.....  ....+.+.+|+.+++.++||||+++++.+......|+|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            46777889999999999999988899999999875432  2345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|..++.. +.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.+|
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~  141 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVK  141 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEE
Confidence            9999999887754 5678899999999999999999999999999999999999888764

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.88  E-value=6.5e-22  Score=177.58  Aligned_cols=139  Identities=27%  Similarity=0.488  Sum_probs=116.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCE----
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR----  224 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~----  224 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.+ +||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            3699999999999999999999999999999998654321 12234567799999999 56999999999877665    


Q ss_pred             -EEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC-CCCcC
Q 022853          225 -LYLVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVR  290 (291)
Q Consensus       225 -~~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~-~g~vK  290 (291)
                       +|+||||+.+ +|..++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+|
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEE
Confidence             8999999997 677776542     34789999999999999999999999999999999999998 66543

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.88  E-value=4.3e-22  Score=174.04  Aligned_cols=133  Identities=54%  Similarity=0.939  Sum_probs=122.4

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCH
Q 022853          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (291)
                      ||.|+||.||++.+..+++.+|+|++.+.........+.+..|+.++++++||||+++++.+..+..+|++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999888999999999877655555667788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       238 ~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~  133 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIK  133 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEE
Confidence            99998887889999999999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.88  E-value=1.1e-21  Score=178.50  Aligned_cols=138  Identities=25%  Similarity=0.375  Sum_probs=120.8

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      |...+.||+|+||.||+|.+..+++.+|+|++...........+.+..|+.+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            67778899999999999999999999999999765544444556678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+ ++...+.. ...+++..+..++.||+.||.|||++|++||||+|+||+++.++.+|
T Consensus       103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~k  161 (313)
T cd06633         103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVK  161 (313)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEE
Confidence            975 56565554 45688889999999999999999999999999999999999888764

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.88  E-value=1.4e-21  Score=169.79  Aligned_cols=137  Identities=36%  Similarity=0.576  Sum_probs=124.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|.+.+.||+|++|.||++.+..+++.+++|++.....   ...+.+.+|+.+++.++||||+++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            58899999999999999999998899999999976543   335668889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|..++... ..+++..+..++.|++.||.|||.+|++||||+|+||+++.++.+|
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~  138 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVK  138 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEE
Confidence            99999999988776 5789999999999999999999999999999999999999887654

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.88  E-value=4.8e-22  Score=179.96  Aligned_cols=140  Identities=24%  Similarity=0.357  Sum_probs=118.3

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      ..++|+..+.||+|+||.||+|.+..++.    .+|+|.+.....  ......+.+|+.+++.++||||+++++.+... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            34679999999999999999999877765    468888765432  22234577899999999999999999988654 


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++++||+++|+|..++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~k  149 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVK  149 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceE
Confidence            5679999999999998887643 578888999999999999999999999999999999999887764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.88  E-value=6.9e-22  Score=182.32  Aligned_cols=139  Identities=26%  Similarity=0.401  Sum_probs=119.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC-----
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----  223 (291)
                      .++|++.+.||+|+||.||+|.+..++..||+|++.+... .....+.+.+|+.+++.++||||+++++++....     
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            3579999999999999999999999999999999865422 2233455778999999999999999999887654     


Q ss_pred             -EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       .+|+||||+ +++|..++. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+|
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence             468999999 668876665 45789999999999999999999999999999999999999888765

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.88  E-value=7.8e-22  Score=172.75  Aligned_cols=132  Identities=23%  Similarity=0.401  Sum_probs=114.8

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (291)
                      +.||+|+||.||+|... .+..+|+|.+....  .......+.+|+.+++.++||||+++++.+......|+||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            36899999999999865 57889999987543  2233445778999999999999999999999999999999999999


Q ss_pred             CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          236 HLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       236 ~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|..++... ..+.+..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~  133 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLK  133 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEE
Confidence            999888653 4578888899999999999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.88  E-value=5.3e-22  Score=179.01  Aligned_cols=141  Identities=28%  Similarity=0.404  Sum_probs=118.4

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC----
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----  223 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----  223 (291)
                      .+++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.++++++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            4568999999999999999999999999999999986543221 12233557999999999999999999876543    


Q ss_pred             ----EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 ----RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ----~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                          ..|+||||+.+ +|...+... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~k  159 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILK  159 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEE
Confidence                46999999976 676666554 3689999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.88  E-value=2e-22  Score=185.00  Aligned_cols=139  Identities=22%  Similarity=0.385  Sum_probs=121.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE----eCCEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ----TKYRL  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----~~~~~  225 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            579999999999999999999999999999999875432 2223456678999999999999999988775    34578


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+|
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~k  147 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELR  147 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEE
Confidence            99999996 58888887777899999999999999999999999999999999999999998765

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.88  E-value=3.8e-22  Score=181.29  Aligned_cols=124  Identities=27%  Similarity=0.470  Sum_probs=103.7

Q ss_pred             EEEecccCceEEEEEEEc--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--CCEEEEEEe
Q 022853          155 LKVVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLYLVLD  230 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV~E  230 (291)
                      .+.||+|+||.||+|++.  .+++.+|+|.+.....     ...+.+|+.+++.++||||+++++.+..  +..+|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            368999999999999976  3678999999865432     2335679999999999999999998854  567899999


Q ss_pred             ccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec
Q 022853          231 FVNGGHLFFQLYRQ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (291)
Q Consensus       231 ~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~  284 (291)
                      |+.+ +|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~  142 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM  142 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEe
Confidence            9876 676666432         2478899999999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.88  E-value=1e-21  Score=175.80  Aligned_cols=137  Identities=30%  Similarity=0.475  Sum_probs=124.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      +.|++.+.||+|+||.||+|.+..++..+++|++.....    ..+.+..|+.+++.++|+||+++++.+......|+++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            468899999999999999999988899999999976532    3456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.+|.+|
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~  156 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVK  156 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEE
Confidence            9999999999998876 789999999999999999999999999999999999999888764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.88  E-value=6.4e-22  Score=177.32  Aligned_cols=140  Identities=50%  Similarity=0.880  Sum_probs=122.3

Q ss_pred             CeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccccch-HHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  225 (291)
                      +|++.+.||+|+||.||++++.   .+++.+|+|++++..... ....+.+..|+.++.++ +||||+++++.+.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   357889999997643322 22345677899999999 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+.+++|...+.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.+|
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~  145 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVV  145 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEE
Confidence            99999999999999988877889999999999999999999999999999999999999887653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.88  E-value=1.1e-21  Score=175.00  Aligned_cols=142  Identities=16%  Similarity=0.286  Sum_probs=121.2

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcC----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-  221 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-  221 (291)
                      +..++|++.+.||+|+||.||+|.+..    ++..+++|.+....  .....+.+.+|+.++++++||||+++++++.. 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            345689999999999999999999876    35789999886432  33445678889999999999999999997655 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQ--------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ....+++++|+.+++|..++...        ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEE
Confidence            57789999999999999888753        3478888999999999999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.88  E-value=8.2e-22  Score=172.63  Aligned_cols=139  Identities=31%  Similarity=0.532  Sum_probs=123.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+..|+.+++.++||||+++++.+.+....|+|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999997654333 334556789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|..++.+    ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+|
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~k  143 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVK  143 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEE
Confidence            9999999888766    35678888999999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.88  E-value=9.3e-22  Score=177.35  Aligned_cols=137  Identities=28%  Similarity=0.468  Sum_probs=121.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....   ....+.+.+|+.+++.++||||+++++.+......|+|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            58999999999999999999998889999999986432   222456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+++++|..++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~k  155 (293)
T cd06647          96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK  155 (293)
T ss_pred             ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEE
Confidence            999999998887653 577888899999999999999999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.88  E-value=7.7e-22  Score=175.28  Aligned_cols=132  Identities=21%  Similarity=0.266  Sum_probs=109.2

Q ss_pred             EecccCceEEEEEEEcCC--CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          157 VVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       157 ~LG~G~fg~Vy~~~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      .||+|+||.||++.....  ...+++|.+.....  ....+.+.+|+.+++.++||||+++++.+.+....|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            589999999999975433  23456666654321  23356788899999999999999999999999999999999999


Q ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          235 GHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       235 g~L~~~l~~~----~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|..++.+.    ..++...+..++.||+.||+|||+++++||||||+|||++.++.+|
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~  139 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVK  139 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEE
Confidence            9999888754    2345667788899999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.88  E-value=4e-23  Score=207.20  Aligned_cols=140  Identities=29%  Similarity=0.484  Sum_probs=118.4

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC------
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------  222 (291)
                      ..+|+.++.||+|+||.||+++.+-+|+.||||.|....  .......+.+|+.+|++|+|||||++|..|.+.      
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            467899999999999999999999999999999997654  333455677899999999999999998765210      


Q ss_pred             --------------------------------------------------------------------------------
Q 022853          223 --------------------------------------------------------------------------------  222 (291)
Q Consensus       223 --------------------------------------------------------------------------------  222 (291)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CEEEEEEeccCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHH
Q 022853          223 ---------------------------------YRLYLVLDFVNGGHLFFQLYRQGLF-REDLARIYTAEIVSAVSHLHA  268 (291)
Q Consensus       223 ---------------------------------~~~~lV~E~~~gg~L~~~l~~~~~~-~~~~~~~i~~qil~aL~yLH~  268 (291)
                                                       ..+||-||||+..++.+++.++... ..+.++++++||+.||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                             1358999999997776666655443 478899999999999999999


Q ss_pred             CCCEecccCCCcEEecCCCCcC
Q 022853          269 NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       269 ~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|||||||||.||++++++.||
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VK  737 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVK  737 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCee
Confidence            9999999999999999999987

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.4e-23  Score=195.98  Aligned_cols=139  Identities=25%  Similarity=0.383  Sum_probs=125.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      -|.-++.||.|+||.||-|++..+.+.||||.+.-......+..+.+..|+..|.++.|||+|.+.++|..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            37778999999999999999999999999999987666666778889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~-~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||-|. -.+++. ..+++.+..+..|+.+.+.||.|||+.+.||||||..|||+++.|.||
T Consensus       107 YClGS-AsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VK  166 (948)
T KOG0577|consen  107 YCLGS-ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVK  166 (948)
T ss_pred             HHhcc-HHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeee
Confidence            99874 444443 356788888899999999999999999999999999999999999887

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.88  E-value=9.5e-23  Score=193.31  Aligned_cols=138  Identities=22%  Similarity=0.371  Sum_probs=121.2

Q ss_pred             EEEEEecccCceEEEEEEEcCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE--EEEEE
Q 022853          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR--LYLVL  229 (291)
Q Consensus       153 ~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~--~~lV~  229 (291)
                      +....||+|+|-+||+|.+..+|..||--.++-..+ ......++|..|+.+|+.|+||||+++|.+|.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            556889999999999999999998888665543322 234557899999999999999999999999987665  88999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecccCCCcEEecCC-CCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDAD-GHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~-g~vK  290 (291)
                      |.+..|+|..++.+.+.+.....+.|++||++||.|||++.  |||||||.+||+|+.+ |.||
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VK  186 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVK  186 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCcee
Confidence            99999999999999999999999999999999999999994  9999999999999864 6665

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.88  E-value=7.6e-22  Score=181.28  Aligned_cols=137  Identities=20%  Similarity=0.385  Sum_probs=117.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----CE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YR  224 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~  224 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....  .......+..|+.+++.++||||+++++++...     ..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            57999999999999999999999999999999986422  222345567899999999999999999876543     35


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+++||+.+ +|...+. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        83 ~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~k  146 (336)
T cd07849          83 VYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLK  146 (336)
T ss_pred             EEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEE
Confidence            8999999976 6766554 45789999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.88  E-value=1.3e-21  Score=174.62  Aligned_cols=138  Identities=32%  Similarity=0.534  Sum_probs=119.2

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEe------
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT------  221 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~------  221 (291)
                      .+.|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+..|+.++.++ +||||+++++++..      
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            357999999999999999999999999999999986542    2234567888888888 79999999998853      


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...+|++|||+.+|+|..++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence            46789999999999999888753  4578888899999999999999999999999999999999888664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.88  E-value=3.4e-22  Score=180.22  Aligned_cols=136  Identities=26%  Similarity=0.419  Sum_probs=119.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|.....||+|+||.||++.+..++..||+|.+....   ....+.+.+|+.+++.++||||+++++.+...+..|+|||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            4555678999999999999999899999999986532   2335567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|..++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+|
T Consensus       100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~k  158 (292)
T cd06658         100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIK  158 (292)
T ss_pred             CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEE
Confidence            9999999887654 4688899999999999999999999999999999999999888764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.87  E-value=2.2e-22  Score=196.56  Aligned_cols=145  Identities=22%  Similarity=0.354  Sum_probs=126.6

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS  218 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~  218 (291)
                      ...+...+.+..+.||+|+||+||+|+..+     ....||||.++...  +....+.|++|+++++.++|||||+|+++
T Consensus       480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGV  557 (774)
T KOG1026|consen  480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGV  557 (774)
T ss_pred             eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            445666788899999999999999998653     34679999997653  34457789999999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec
Q 022853          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG--------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (291)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~  284 (291)
                      +..++.+|+|+|||..|+|.++|....              .++..+...++.||+.||+||-++.+|||||..+|+||.
T Consensus       558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG  637 (774)
T ss_pred             EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence            999999999999999999999987432              266778889999999999999999999999999999999


Q ss_pred             CCCCcC
Q 022853          285 ADGHVR  290 (291)
Q Consensus       285 ~~g~vK  290 (291)
                      ++-.||
T Consensus       638 e~l~VK  643 (774)
T KOG1026|consen  638 ENLVVK  643 (774)
T ss_pred             cceEEE
Confidence            988876

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.87  E-value=2.5e-21  Score=173.72  Aligned_cols=136  Identities=29%  Similarity=0.454  Sum_probs=120.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|...+.||+|++|.||++.+..+++.+++|.+....   ....+.+.+|+.+++.++||||+++++.+...+..|+++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            3555689999999999999998899999999886432   2234557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+++|..++.. ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.+|
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~  155 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVK  155 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEE
Confidence            9999999988876 6688889999999999999999999999999999999999988764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.87  E-value=8.7e-22  Score=181.05  Aligned_cols=139  Identities=21%  Similarity=0.406  Sum_probs=120.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----CE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YR  224 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~  224 (291)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...     ..
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            4699999999999999999999999999999998754322 22244566899999999999999999877544     35


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+|+||+. ++|..++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+|
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~k  148 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK  148 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEE
Confidence            899999997 57888888778899999999999999999999999999999999999999888765

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.87  E-value=1.7e-21  Score=173.42  Aligned_cols=132  Identities=27%  Similarity=0.466  Sum_probs=112.5

Q ss_pred             CCeEEEEEe--cccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHh-CCCCCeeEEeEEEEeCCEEE
Q 022853          150 EDFEVLKVV--GQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       150 ~~y~i~~~L--G~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ++|++.+.+  |+|+||.||++.+..++..+|+|++.......        .|+..... .+||||+++++.+...+.+|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            356666665  99999999999999999999999987643221        12222222 27999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC-Cc
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HV  289 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g-~v  289 (291)
                      +||||+++++|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~  149 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRI  149 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeE
Confidence            9999999999999998877899999999999999999999999999999999999999887 44

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=4.9e-22  Score=192.58  Aligned_cols=142  Identities=23%  Similarity=0.339  Sum_probs=109.1

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCC-cEEEEEE--------------eeccccchHHHHHHHHHHHHHHHhCCCCCe
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKV--------------MRKDKIMEKNHAEYMKSERNILTKVDHPFI  212 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-~~vAiK~--------------i~~~~~~~~~~~~~~~~E~~il~~l~HpnI  212 (291)
                      ..++|++++.||+|+||+||+|..+... ...+.|.              +.+...........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3568999999999999999998765432 2222221              111111122234567899999999999999


Q ss_pred             eEEeEEEEeCCEEEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      +++++++...+..|+|++++.+ +|..++...     .......++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            9999999999999999999865 566665432     1233566788999999999999999999999999999999988


Q ss_pred             CcC
Q 022853          288 HVR  290 (291)
Q Consensus       288 ~vK  290 (291)
                      .+|
T Consensus       305 ~vk  307 (501)
T PHA03210        305 KIV  307 (501)
T ss_pred             CEE
Confidence            775

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.87  E-value=8.3e-22  Score=177.81  Aligned_cols=141  Identities=29%  Similarity=0.468  Sum_probs=117.8

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----  222 (291)
                      ..++|++.+.||.|+||.||+|.+..+++.+|+|.+......+. ....+.+|+.+++.++||||+++++.+...     
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            36789999999999999999999999999999999865432221 123456799999999999999998877443     


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 ---YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ---~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                         ..+|+||||+.+ ++...+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~  155 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILK  155 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence               357999999986 56555544 45789999999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.7e-24  Score=197.80  Aligned_cols=148  Identities=34%  Similarity=0.583  Sum_probs=138.8

Q ss_pred             CCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      +...+.+.+++++..||-|+||.|=++........+|+|++++..+.+....+.+..|.++|..++.|+||++|..|.+.
T Consensus       413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~  492 (732)
T KOG0614|consen  413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS  492 (732)
T ss_pred             hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence            44556778899999999999999999988766667999999999988888888999999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .++|++||-|-||.|+..+..++.|.+..+++|+..+++|++|||++|||.|||||+|+|++.+|.+|
T Consensus       493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~K  560 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLK  560 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceE
Confidence            99999999999999999999999999999999999999999999999999999999999999999876

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.87  E-value=7.2e-22  Score=178.51  Aligned_cols=136  Identities=26%  Similarity=0.416  Sum_probs=119.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|.....||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.++..++||||+++++.+..+...|++||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence            35555689999999999999988999999999865432   224557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~k  157 (297)
T cd06659          99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVK  157 (297)
T ss_pred             cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEE
Confidence            9999999876644 5678999999999999999999999999999999999999888764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.87  E-value=1e-21  Score=175.22  Aligned_cols=137  Identities=28%  Similarity=0.500  Sum_probs=120.4

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      |++.+.||.|++|.||+|.+..++..||+|++....... ...+.+.+|+.+++.++||||+++++++.+....|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            678899999999999999999999999999987653222 2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++ ++|..++....  .+++..+..++.|++.||+|||+++++||||+|+||+++.++.+|
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~  139 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALK  139 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEE
Confidence            96 58888887665  688999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.87  E-value=1.2e-21  Score=179.69  Aligned_cols=140  Identities=24%  Similarity=0.291  Sum_probs=120.5

Q ss_pred             CCeE-EEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHH-----------HHHHHHHHHHHHHhCCCCCeeEEeE
Q 022853          150 EDFE-VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-----------HAEYMKSERNILTKVDHPFIVQLRY  217 (291)
Q Consensus       150 ~~y~-i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~~E~~il~~l~HpnIv~l~~  217 (291)
                      ++|. +.+.||.|+||.||+|.+..+++.||+|++.........           ....+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 457799999999999999999999999998654322100           0123668999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++......|+||||+.+ +|...+.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence            99999999999999974 8888888877899999999999999999999999999999999999999988764

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.87  E-value=1.4e-23  Score=184.20  Aligned_cols=135  Identities=21%  Similarity=0.384  Sum_probs=124.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      -|.++..||+|+||.||+|.++.+|..+|||.+..+.     ..+.+..|+.++.+++.|++|++|+.|.....+|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            4788899999999999999999999999999987654     25667889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~-~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||..|+..+.+. +++.+.++.+..+++..+.||+|||...-||||||..|||++.+|+.|
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AK  169 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAK  169 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhh
Confidence            999999988876 457899999999999999999999999999999999999999999865

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.87  E-value=2.8e-21  Score=178.40  Aligned_cols=139  Identities=24%  Similarity=0.360  Sum_probs=117.7

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC------
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------  222 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.++++++||||+++++++...      
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            3689999999999999999999999999999999875432 222345577899999999999999999887543      


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...|++++++ +++|...+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.+|.+|
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEE
Confidence            3478888887 6688766654 4688999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.87  E-value=2e-21  Score=172.99  Aligned_cols=135  Identities=28%  Similarity=0.513  Sum_probs=114.2

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeC--CEEEEE
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK--YRLYLV  228 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~~lV  228 (291)
                      |++.+.||+|+||.||+|.+..+++.+|+|.+++... ...... ...|+.++.++ +||||+++++++.+.  +.+|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~-~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQVN-NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhhh-HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6789999999999999999999999999999875432 112222 34688888888 599999999999887  899999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+ +|...+.. ...+++..++.++.|++.||+|||++|++||||||+||+++. |.+|
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~k  139 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILK  139 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeE
Confidence            999985 67666665 356899999999999999999999999999999999999998 6654

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.87  E-value=1.8e-21  Score=172.64  Aligned_cols=138  Identities=22%  Similarity=0.321  Sum_probs=114.4

Q ss_pred             eEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC-----
Q 022853          152 FEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----  223 (291)
                      |++.+.||+|+||.||+|.+.   .+++.+|+|++....... ...+.+.+|+.+++.++||||+++++.+....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            677889999999999999864   357899999997654332 33556788999999999999999999875432     


Q ss_pred             -EEEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 -RLYLVLDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ..+++++|+.+|+|..++...      ..++...+..++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~k  153 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC  153 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEE
Confidence             357899999999998776532      2467888899999999999999999999999999999999887765

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=4.2e-22  Score=169.44  Aligned_cols=131  Identities=19%  Similarity=0.243  Sum_probs=100.3

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHH-----------------------HHHHHHHHHHHHHhCCCCC
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-----------------------HAEYMKSERNILTKVDHPF  211 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~-----------------------~~~~~~~E~~il~~l~Hpn  211 (291)
                      ...||+|+||.||+|.+. +|+.||+|+++........                       .......|+.++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            367999999999999987 8999999999865321111                       0123345899999998777


Q ss_pred             eeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCCEecccCCCcEEecCCCCc
Q 022853          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL-HANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yL-H~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      +........ . ..+|||||++|+++.......+.++...+..++.|++.+|.|+ |+.||+||||||+|||++. +.+
T Consensus        81 v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~v  156 (190)
T cd05147          81 IPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GKL  156 (190)
T ss_pred             CCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-CcE
Confidence            644332222 2 2389999999987765545566788899999999999999999 7999999999999999984 554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.87  E-value=3.8e-21  Score=176.43  Aligned_cols=139  Identities=25%  Similarity=0.374  Sum_probs=118.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-CCEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KYRLYL  227 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~l  227 (291)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.+.+.... ....+.+..|+.+++.++||||++++++|.. ....|+
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            35799999999999999999999999999999988654322 2234557789999999999999999998865 567899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|||+. ++|..++. ...+++..+..++.|++.||.|||++||+||||+|+|||++.++.+|
T Consensus        88 v~e~~~-~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~  148 (328)
T cd07856          88 VTELLG-TDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLK  148 (328)
T ss_pred             Eeehhc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEE
Confidence            999984 57876665 45678888889999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.87  E-value=7.3e-23  Score=180.35  Aligned_cols=140  Identities=28%  Similarity=0.488  Sum_probs=116.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCC----cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-CC
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KY  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~  223 (291)
                      +..|++...||+|.||.||+|...++.    +.+|||.++..+... .......+|+.+++.++|||++.+..+|.. +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            457999999999999999999665543    378999987653221 223345689999999999999999988876 88


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC----CCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD----GHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~----g~vK  290 (291)
                      .+|+++||++. +|...+.-.     ..++...++.++.||+.|+.|||++-|+||||||+||||..+    |.||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence            99999999988 677766532     457888999999999999999999999999999999999998    6665

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.87  E-value=1.7e-21  Score=183.41  Aligned_cols=141  Identities=24%  Similarity=0.333  Sum_probs=123.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...+...+.+.||+|.||.|.+|+-.. +..||+|.++.+..  .+....|..|+++|.+|+||||++++++|..++.++
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            344567889999999999999998754 68899999987653  344677999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++||||++|+|.+++.+...  ........++.||+.||+||.+.++|||||.+.|+|++.++++|
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iK  677 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIK  677 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEE
Confidence            99999999999999988733  23344456899999999999999999999999999999999987

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.5e-23  Score=197.15  Aligned_cols=138  Identities=32%  Similarity=0.567  Sum_probs=124.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      +.|.|+..||.|+||+||+|..+.++-..|.|++...   ..+..+.+.-|+.||..++||+|++|++.|..++.+||+.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            3477889999999999999999999998999998543   3445667778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||.||-....+.. ...+.++.+..+++|++.||.|||+++|||||||..|||++-+|.||
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdir  170 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIR  170 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEe
Confidence            99999998777665 45689999999999999999999999999999999999999999886

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.87  E-value=2.1e-21  Score=176.19  Aligned_cols=139  Identities=27%  Similarity=0.396  Sum_probs=120.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|...+.||+|+||.||+|.+..+++.+|+|.+...........+.+..|+.+++.++|+|++++++++......|+|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            48888999999999999999999999999999875433333445567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+.+ ++...+.. ...+++..+..++.|++.||.|||+++++||||||+|||++.+|.+|
T Consensus        96 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~k  155 (308)
T cd06634          96 YCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK  155 (308)
T ss_pred             ccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEE
Confidence            9975 66665543 45688899999999999999999999999999999999999888764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.87  E-value=3.1e-21  Score=175.04  Aligned_cols=124  Identities=27%  Similarity=0.477  Sum_probs=102.8

Q ss_pred             EEEecccCceEEEEEEEcC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE--eCCEEEEEEe
Q 022853          155 LKVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKYRLYLVLD  230 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lV~E  230 (291)
                      ...||+|+||.||+|++..  ++..||+|.+.....     ...+.+|+.+++.++||||+++++++.  .+..+|+|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            3679999999999999754  568899999865432     234668999999999999999999884  4567899999


Q ss_pred             ccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec
Q 022853          231 FVNGGHLFFQLYRQ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (291)
Q Consensus       231 ~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~  284 (291)
                      |+.+ +|...+...         ..+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~  142 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM  142 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEc
Confidence            9886 565655421         2477888999999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.87  E-value=2.1e-21  Score=176.04  Aligned_cols=128  Identities=23%  Similarity=0.312  Sum_probs=110.8

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHHH
Q 022853          162 AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL  241 (291)
Q Consensus       162 ~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l  241 (291)
                      ++|.||.++...+++.||+|++..... .....+.+..|+.+++.++||||+++++++......|++|||+++++|..++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            445566666667899999999976532 2334667889999999999999999999999999999999999999999888


Q ss_pred             HHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          242 YRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       242 ~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...  ..+++..++.++.|++.||+|||+++|+||||||+||+++.+|.+|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~k  141 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVV  141 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceE
Confidence            763  4578899999999999999999999999999999999999888764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.87  E-value=1.8e-21  Score=170.15  Aligned_cols=122  Identities=32%  Similarity=0.486  Sum_probs=108.6

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHH
Q 022853          161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ  240 (291)
Q Consensus       161 G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~  240 (291)
                      |.||+||++++..+++.||+|.+.+...        ...|...+....||||+++++.+......|++|||++||+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            8899999999999999999999976431        22344555566899999999999999999999999999999999


Q ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       241 l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+...+++..+..++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  125 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQ  125 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEE
Confidence            88877899999999999999999999999999999999999999988754

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.86  E-value=1.2e-21  Score=179.96  Aligned_cols=139  Identities=28%  Similarity=0.491  Sum_probs=118.6

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeC--CEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK--YRL  225 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~  225 (291)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+.+... .......+..|+.+++++ +||||+++++++...  ..+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3579999999999999999999998899999998865322 222244566899999999 999999999988643  468


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+.+ +|..++... .+.+..++.++.||+.||.|||++||+||||||+||+++.+|.+|
T Consensus        85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~k  147 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVK  147 (337)
T ss_pred             EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEE
Confidence            999999985 887777655 778888888999999999999999999999999999999998765

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.86  E-value=4.5e-22  Score=170.48  Aligned_cols=144  Identities=24%  Similarity=0.364  Sum_probs=124.9

Q ss_pred             CCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE--
Q 022853          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--  220 (291)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--  220 (291)
                      ....++.++|++.+.||+|+|+.||+++...++..||+|.+....   .+..+...+|++..++++|||++++++...  
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            345677789999999999999999999999999999999997654   344667789999999999999999876653  


Q ss_pred             ---eCCEEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecccCCCcEEecCCCCc
Q 022853          221 ---TKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHV  289 (291)
Q Consensus       221 ---~~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~g~v  289 (291)
                         .....|++++|...|+|.+.+.+.    ..+++.....|+.+|++||++||+..  ++||||||.|||+.+++.+
T Consensus        91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~  168 (302)
T KOG2345|consen   91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP  168 (302)
T ss_pred             hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence               234599999999999998887643    36899999999999999999999998  9999999999999987654

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.86  E-value=1.2e-21  Score=178.96  Aligned_cols=138  Identities=23%  Similarity=0.380  Sum_probs=122.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC-----EE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----RL  225 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~  225 (291)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+.... ......+.+.+|+.+++.++||||+++++++....     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            5899999999999999999999889999999987543 12334566888999999999999999999887765     79


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++|||+.+ +|...+.+...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~  143 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLK  143 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence            999999985 7888887777899999999999999999999999999999999999999988764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.86  E-value=4.3e-21  Score=175.98  Aligned_cols=138  Identities=25%  Similarity=0.353  Sum_probs=116.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCC--CcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEe----CC
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT----KY  223 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~----~~  223 (291)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+..... .....+.+.+|+.+++++ +||||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            489999999999999999999888  88999999864321 222345567899999999 69999999886532    24


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|++++|+. ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~k  145 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELK  145 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEE
Confidence            5889999987 58888888778899999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.86  E-value=4.7e-21  Score=168.92  Aligned_cols=133  Identities=21%  Similarity=0.265  Sum_probs=109.9

Q ss_pred             EEecccCceEEEEEEEcC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE-eCCEEEEEEec
Q 022853          156 KVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ-TKYRLYLVLDF  231 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lV~E~  231 (291)
                      +.||+|+||.||+|.+..   ....+|+|.+....  .....+.+..|+.+++.++||||+++++.+. .++..|++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            368999999999998754   34579999875422  2333566778999999999999999999765 45668999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+++|..++.+. ..........++.|++.||.|||+++++||||||+|||++.++.+|
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~k  138 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVK  138 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEE
Confidence            9999999988764 3456677788899999999999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.86  E-value=4.9e-21  Score=169.62  Aligned_cols=140  Identities=31%  Similarity=0.503  Sum_probs=117.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcC-CCcEEEEEEeecccc-------chHHHHHHHHHHHHHHHh-CCCCCeeEEeEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKI-------MEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQT  221 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~-------~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~  221 (291)
                      +|++.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+..|+.++.+ ++||||+++++.+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999987 688999998864321       122234456678887765 799999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++..|++|||+++++|..++..    ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEE
Confidence            9999999999999999877643    3468888999999999999999996 6899999999999999888664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=2.7e-21  Score=172.31  Aligned_cols=136  Identities=33%  Similarity=0.580  Sum_probs=118.1

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEEEEe
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      |++.+.||+|+||.||+|....+++.+|+|.+...... .. .....+|+..+++++ ||||+++++.+..++..|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            67889999999999999999989999999998654321 11 223346888999998 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+ +|+|...+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+|
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~  139 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVK  139 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEE
Confidence            99 778988887754  788999999999999999999999999999999999999887664

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.86  E-value=3.3e-21  Score=173.92  Aligned_cols=135  Identities=27%  Similarity=0.441  Sum_probs=118.2

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      |.....||+|+||.||++....+++.+|+|.+....   ....+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            333467999999999999999999999999885432   22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +++++|..++. ...+++..++.++.|++.||+|||++|++||||+|+||+++.++.+|
T Consensus        99 ~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~  156 (292)
T cd06657          99 LEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVK  156 (292)
T ss_pred             CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence            99999987664 45678899999999999999999999999999999999999888654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=4.4e-21  Score=163.03  Aligned_cols=132  Identities=21%  Similarity=0.227  Sum_probs=102.2

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccch-----------------------HHHHHHHHHHHHHHHhCCCCC
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----------------------KNHAEYMKSERNILTKVDHPF  211 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~~~~E~~il~~l~Hpn  211 (291)
                      .+.||+|+||.||+|.+. +|+.||||+++......                       ......+..|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 89999999998653210                       001233467899999999998


Q ss_pred             eeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.....+....  .|+||||++|+++.........++...+..++.|++.++.++|+ +||+||||||+|||++ ++.++
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            75443333222  48999999998654443345567788889999999999999999 9999999999999998 66653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=2.2e-21  Score=172.48  Aligned_cols=137  Identities=32%  Similarity=0.547  Sum_probs=121.2

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      |++.+.||+|.||.||+|....+++.+|+|++..... .....+.+..|+.+++.++||||+++++++.....+|+||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            6778899999999999999999999999999976542 222345567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+ +|..++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+|
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~  138 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLK  138 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEE
Confidence            985 898888876 5789999999999999999999999999999999999999887664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.86  E-value=3.4e-21  Score=170.44  Aligned_cols=130  Identities=23%  Similarity=0.357  Sum_probs=110.9

Q ss_pred             EEecccCceEEEEEEEcCCC------cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          156 KVVGQGAFAKVYQVRRIGTS------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      +.||+|+||.||+|++....      +.+|+|.+.+...  ......+.+|+.+++.++||||+++++++......|+||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36899999999999886543      6799998865421  223456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          230 DFVNGGHLFFQLYRQ-------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       230 E~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ||+++++|..++.+.       ..+++..+..++.|++.||.|||+++++||||||+||+++.++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~  143 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKG  143 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCC
Confidence            999999999888743       2367788888999999999999999999999999999998866

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.86  E-value=1.4e-20  Score=167.70  Aligned_cols=137  Identities=31%  Similarity=0.463  Sum_probs=115.6

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC---CCCCeeEEeEEEEeCCE----
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYR----  224 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~----  224 (291)
                      |++.+.||+|+||.||+|++..+++.||+|.+....... .....+.+|+.+++++   +||||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            688999999999999999998889999999997543322 2233455677776655   69999999999988776    


Q ss_pred             -EEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 -LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 -~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       +|++|||+.+ +|..++.+..  .+++..++.++.|++.||.|||+++++|+||+|+||+++.++.+|
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~  147 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVK  147 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEE
Confidence             9999999986 7877776643  488999999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.85  E-value=4.5e-21  Score=170.56  Aligned_cols=137  Identities=31%  Similarity=0.557  Sum_probs=119.8

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      |++.+.||.|++|.||+|.+..+++.+++|.+....... .....+..|+.+++.++||||+++++.+..+..+|+++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            567899999999999999999899999999987654322 2345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+ +|...+.. ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.+|
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~  138 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLK  138 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEE
Confidence            986 77776665 45788999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.85  E-value=6.2e-21  Score=175.84  Aligned_cols=133  Identities=22%  Similarity=0.395  Sum_probs=114.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-------
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-------  222 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-------  222 (291)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.++++++||||+++++.+...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            579999999999999999999999999999999865532   2345677899999999999999998766543       


Q ss_pred             -------CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          223 -------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       223 -------~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                             ..+|+||||+.+ +|...+. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~  151 (342)
T cd07854          82 VGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC
Confidence                   468999999985 7876665 45688999999999999999999999999999999999998543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.85  E-value=5.8e-21  Score=170.94  Aligned_cols=139  Identities=24%  Similarity=0.412  Sum_probs=116.5

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l  227 (291)
                      .++|+..+.||+|+||.||++.+..+++.+|+|.+......  .....+..|+.++.++. ||||+++++.+..+...|+
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            34677889999999999999999999999999998754322  33456778999999985 9999999999999999999


Q ss_pred             EEeccCCCCHHHH---HH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQ---LY--RQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~---l~--~~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|||+.+ ++..+   +.  ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~k  148 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIK  148 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEE
Confidence            9999875 44332   22  235689999999999999999999985 999999999999999887654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.85  E-value=1.1e-20  Score=170.27  Aligned_cols=144  Identities=33%  Similarity=0.502  Sum_probs=119.2

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~  222 (291)
                      .+.+..++|++.+.||+|+||.||+|.+..+++.||+|.+.+....  .....+..|+.++.+. +||||+++++++.+.
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            3456678999999999999999999999988999999999764322  2233445566666655 599999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...|++|||+.+ ++..++.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+|
T Consensus        87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~k  155 (296)
T cd06618          87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVK  155 (296)
T ss_pred             CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEE
Confidence            999999999865 66665554 4578888889999999999999997 5999999999999999887664

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-22  Score=203.50  Aligned_cols=139  Identities=28%  Similarity=0.530  Sum_probs=125.9

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +++-...||.|.||.||.|....+|+..|+|-++-.... ......+.+|..++..++|||+|++|++-.....++|.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            466678899999999999999999999999988654333 3345667889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||.+|+|.+.+...+..++...+.|..|++.|+.|||+.|||||||||+||+++.+|-+|
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEE
Confidence            999999999999888888899999999999999999999999999999999999999876

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.85  E-value=5.4e-21  Score=176.29  Aligned_cols=139  Identities=26%  Similarity=0.404  Sum_probs=119.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE----
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR----  224 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----  224 (291)
                      .++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.....    
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3579999999999999999999999999999999865422 22334556789999999999999999887765554    


Q ss_pred             --EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 --LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 --~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                        +|+|+||+ +++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+|
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK  158 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEE
Confidence              89999998 5588777764 5689999999999999999999999999999999999999888764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.85  E-value=7.6e-21  Score=191.60  Aligned_cols=142  Identities=24%  Similarity=0.369  Sum_probs=124.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCc-----EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE-----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      +.....++.+.||+|+||.||.|...+...     .||+|.+++..  +......|.+|+.+|++++||||+++++++.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            445678899999999999999998765433     48888886553  45567778999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQ-------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ....+|++|||+||+|..++...       ..+.......++.||++|+.||+++++|||||..+|+||+....||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEE
Confidence            99999999999999999999865       3467778888999999999999999999999999999999987776

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.84  E-value=1.8e-20  Score=172.68  Aligned_cols=137  Identities=26%  Similarity=0.405  Sum_probs=115.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC------C
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------Y  223 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~  223 (291)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+.+.... ......+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            5799999999999999999999999999999998754322 22234567899999999999999999988654      3


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+|+||+.. +|...+  ...+++..+..++.|++.||+|||++||+||||||+|||++.+|.+|
T Consensus        94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~k  157 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELK  157 (342)
T ss_pred             eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence            56999999975 565443  34688899999999999999999999999999999999999988765

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.84  E-value=3.1e-20  Score=181.58  Aligned_cols=138  Identities=30%  Similarity=0.557  Sum_probs=122.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEe-----C
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT-----K  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~-----~  222 (291)
                      .+-|++.+.||.|.+|+||+++.+.+++..|+|++..+.-    ..+.+..|.++|+.+ +|||++.+|++|..     +
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            3468999999999999999999999999999999976642    234567788899887 89999999999853     5


Q ss_pred             CEEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+|||||||.||+..++...  ...+.|.++..|++.++.|+.+||.+.+||||||-.|||++.+|.||
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEE
Confidence            689999999999999888764  45688899999999999999999999999999999999999999987

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=3.7e-21  Score=184.07  Aligned_cols=132  Identities=27%  Similarity=0.447  Sum_probs=117.2

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg  235 (291)
                      -+||+|.||+||.|+++.+...+|||-+...   +....+.+..|+.+.+.|+|.|||++++++..++.+-|.||-.+||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            4699999999999999999999999998643   2344677889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC-CCCcC
Q 022853          236 HLFFQLYRQ-GLF--REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVR  290 (291)
Q Consensus       236 ~L~~~l~~~-~~~--~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~-~g~vK  290 (291)
                      +|..++... +++  .+....+|..||++||.|||.+.|||||||-+|+||+. .|.+|
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlK  716 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLK  716 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEE
Confidence            999988764 666  67888899999999999999999999999999999974 35444

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=3e-20  Score=160.25  Aligned_cols=123  Identities=20%  Similarity=0.220  Sum_probs=98.7

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-----CCCCeeEEeEEEEeCC---EEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-----DHPFIVQLRYSFQTKY---RLY  226 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~---~~~  226 (291)
                      .+.||+|+||.||.  +..++.. +||++......   ..+.+.+|+.+++.+     +||||++++++++++.   .+|
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            47899999999995  6666665 69988764321   245688999999999     6799999999998874   434


Q ss_pred             -EEEec--cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHCCCEecccCCCcEEecCC
Q 022853          227 -LVLDF--VNGGHLFFQLYRQGLFREDLARIYTAEIVSAV-SHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       227 -lV~E~--~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL-~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                       +||||  +.+++|.+++.+. .+.+.  ..++.|++.++ +|||+++|+||||||+|||++..
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~  141 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRI  141 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEecc
Confidence             78999  5589999999664 46655  35577888887 99999999999999999999753

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.84  E-value=1.2e-20  Score=166.26  Aligned_cols=135  Identities=25%  Similarity=0.433  Sum_probs=114.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +|.+.+.||+|+||.||++.+...+..+++|+++.....  .......+..|+.+++.++||||+++++.+.+....|+|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            488999999999999999999887777777777543221  112233456789999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      |||+++++|..++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~  141 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN  141 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec
Confidence            999999999887753    356889999999999999999999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.84  E-value=2.7e-21  Score=169.73  Aligned_cols=132  Identities=33%  Similarity=0.469  Sum_probs=113.4

Q ss_pred             ccCCeEEE-EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEe----
Q 022853          148 GLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT----  221 (291)
Q Consensus       148 ~~~~y~i~-~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~----  221 (291)
                      -.++|.+- ++||-|--|+|..|.++.|++.+|+|++.-.        ...++|+++.-.. .|||||+++++|++    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            34677765 6799999999999999999999999988532        2356788775554 89999999988754    


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ..++.+|||.|+||.|+..+..++.  |++..|..|+.||+.|+.|||+.+|.||||||+|+|....+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~  198 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS  198 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC
Confidence            4678999999999999999998765  99999999999999999999999999999999999987643

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.84  E-value=1.1e-20  Score=196.25  Aligned_cols=129  Identities=22%  Similarity=0.324  Sum_probs=112.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|...+.||+|+||.||+|.+..++..||+|.+.....       ....|+.++++++||||+++++++.+....|+|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            46667889999999999999988999999998864321       11246788999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecccCCCcEEecCCCCc
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH---ANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      |+++|+|.+++..   +++.....++.|++.||+|||   +.+|+||||||+||+++.++..
T Consensus       764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~  822 (968)
T PLN00113        764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP  822 (968)
T ss_pred             CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCce
Confidence            9999999988853   678888999999999999999   6699999999999999987654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.83  E-value=1.2e-20  Score=182.42  Aligned_cols=142  Identities=23%  Similarity=0.305  Sum_probs=124.5

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      +......|.++||.|.||.||+|+.+..+   ..||||.++... .+ ..+..|..|+.||.+++||||++|.++.....
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-te-kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TE-KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cH-HHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            44556789999999999999999987655   579999997653 33 34556889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+.||+|||++|.|..+|..+ +.|...+..-+++.|+.||.||-+.|+|||||..+||||+.+-.+|
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCK  771 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCK  771 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEE
Confidence            999999999999999998864 6788888888899999999999999999999999999999987765

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=7e-20  Score=169.51  Aligned_cols=132  Identities=23%  Similarity=0.378  Sum_probs=112.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-----C---CCeeEEeEEEEe
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----H---PFIVQLRYSFQT  221 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----H---pnIv~l~~~~~~  221 (291)
                      .+|.+.++||.|.|++||+|++....+.||+|+.+...    ...+....|+.+|++++     |   .+||+|++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            68999999999999999999999999999999997543    33555677999998872     3   469999999964


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCC
Q 022853          222 ----KYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDAD  286 (291)
Q Consensus       222 ----~~~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~  286 (291)
                          +.++|||+|++.. +|..++.+  .+.++...++.|++||+.||.|||.+ ||||-||||+|||+...
T Consensus       154 sGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             cCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence                5689999999854 67677665  35688999999999999999999986 99999999999999754

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.83  E-value=1.5e-19  Score=163.13  Aligned_cols=141  Identities=18%  Similarity=0.216  Sum_probs=104.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHH--------HHHHHHHHHHHhCCCCCeeEEeE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHA--------EYMKSERNILTKVDHPFIVQLRY  217 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~--------~~~~~E~~il~~l~HpnIv~l~~  217 (291)
                      .++|++.+.||+|+||.||+|.+..+   +..+|+|+............        .....+...+..++|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            35899999999999999999998877   66778886543221100000        01112333455679999999998


Q ss_pred             EEEeCC----EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          218 SFQTKY----RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       218 ~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++....    ..|++++++.. ++...+.....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence            765443    45788887754 5656665555567888899999999999999999999999999999999877654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.82  E-value=3.1e-21  Score=163.89  Aligned_cols=131  Identities=27%  Similarity=0.468  Sum_probs=113.3

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeC--CE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTK--YR  224 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~--~~  224 (291)
                      ..++|++.+.+|+|-|+.||.|....+.+.++||++++-+      .+.+.+|+.||..|. ||||+++++...+.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            4578999999999999999999999999999999997654      456889999999995 99999999998664  45


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      .-+++||+++.+...+.   ..++.-.++.++.|++.||.|||+.||+|||+||.|++||...
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~  169 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL  169 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh
Confidence            78999999987654433   3466778899999999999999999999999999999998653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.82  E-value=1.2e-21  Score=186.64  Aligned_cols=139  Identities=29%  Similarity=0.478  Sum_probs=128.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|+++.++|.|+||.||+++++.+++..|+|+++.....+   ..-++.|+-+++.++||||+.+++.+.....+|++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            458999999999999999999999999999999998765333   55577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||.||+|.+.-.--+++++.++...++..+.|++|||++|-+|||||-.|||+++.|.||
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvk  152 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVK  152 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCcee
Confidence            99999999988777778999999999999999999999999999999999999999999887

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.82  E-value=4.7e-19  Score=151.62  Aligned_cols=137  Identities=46%  Similarity=0.721  Sum_probs=122.9

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      |.+.+.||.|++|.||++....+++.+|+|.+......  ...+.+..|+..+..++|+|++++++.+......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            56789999999999999999988999999999765432  2356788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~~~~-~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+++|..++..... +++.....++.+++.++.|||.++++|+||+|.||+++.++.++
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~  138 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVK  138 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence            999999999887766 78899999999999999999999999999999999999877653

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=9.7e-20  Score=167.03  Aligned_cols=142  Identities=27%  Similarity=0.382  Sum_probs=117.4

Q ss_pred             CCCCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHh--CCCCCeeEEe
Q 022853          139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLR  216 (291)
Q Consensus       139 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~  216 (291)
                      .+|.-.+..-..+..+.+.||+|.||.||+|.+  .|+.||||++....      .+.+.+|.+|...  |+|+||..++
T Consensus       200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFI  271 (513)
T KOG2052|consen  200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFI  271 (513)
T ss_pred             CchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhh
Confidence            455555666667899999999999999999999  46789999996542      3346677777764  6999999988


Q ss_pred             EEEEeC----CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEecccCCCcEEec
Q 022853          217 YSFQTK----YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--------GIMHRDLKPENILLD  284 (291)
Q Consensus       217 ~~~~~~----~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~--------gIiHrDLKp~NILl~  284 (291)
                      +.-..+    ..+|||++|-+.|+|+++|.+ ..++.+...+++..++.||+|||..        .|.|||||..||||.
T Consensus       272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK  350 (513)
T KOG2052|consen  272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  350 (513)
T ss_pred             hccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence            764333    258999999999999999998 5678888889999999999999964        499999999999999


Q ss_pred             CCCCc
Q 022853          285 ADGHV  289 (291)
Q Consensus       285 ~~g~v  289 (291)
                      .+|.+
T Consensus       351 kn~~C  355 (513)
T KOG2052|consen  351 KNGTC  355 (513)
T ss_pred             cCCcE
Confidence            98864

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.81  E-value=2.4e-20  Score=162.10  Aligned_cols=144  Identities=30%  Similarity=0.471  Sum_probs=120.5

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~  222 (291)
                      .....+++.+.+..||.|+.|.||+++.+.++..+|||.+.+..  ..+..+++...+.++.+. +.|+||+.+++|..+
T Consensus        86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n  163 (391)
T KOG0983|consen   86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN  163 (391)
T ss_pred             ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence            34455677888999999999999999999999999999998764  334455666677776665 699999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+++.||.|.. .+..++.+ +++++|..+-++...++.||.||-.+ ||||||+||+|||+|..|+||
T Consensus       164 ~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniK  232 (391)
T KOG0983|consen  164 TDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIK  232 (391)
T ss_pred             chHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEE
Confidence            999999999864 23333333 57799999999999999999999876 899999999999999999987

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=2.2e-20  Score=171.27  Aligned_cols=137  Identities=31%  Similarity=0.446  Sum_probs=120.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH----HHHHHHHHHHHHHHhCCCCCeeEEeEEEE-eCC
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK----NHAEYMKSERNILTKVDHPFIVQLRYSFQ-TKY  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~  223 (291)
                      .++|-++.+||+|+|+.||+|.+....+.||+|+-...+.+..    +..+...+|.+|.+.|+||-||++|++|. +..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            4578899999999999999999999999999998754443322    22344568999999999999999999995 556


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--CCEecccCCCcEEecC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--GIMHRDLKPENILLDA  285 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~--gIiHrDLKp~NILl~~  285 (291)
                      .+|-|+|||+|.+|..++...+.+++..|+.|+.||+.||.||...  .|||-||||.|||+..
T Consensus       542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~  605 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVN  605 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEec
Confidence            7899999999999999999999999999999999999999999987  5999999999999964

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.80  E-value=1.8e-18  Score=145.02  Aligned_cols=130  Identities=40%  Similarity=0.632  Sum_probs=116.0

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCH
Q 022853          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L  237 (291)
                      ||+|++|.||++....+++.+++|++.......  ..+.+.+|+..++.+.|++|+++++.+......++++|++.+++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999997664321  346688999999999999999999999999999999999999999


Q ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC-CCCc
Q 022853          238 FFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHV  289 (291)
Q Consensus       238 ~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~-~g~v  289 (291)
                      ..++... ..++...+..++.+++.++.+||++|++|+||+|.||+++. ++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~  132 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKV  132 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcE
Confidence            9988765 46788899999999999999999999999999999999998 5654

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.80  E-value=1.1e-19  Score=152.33  Aligned_cols=142  Identities=27%  Similarity=0.472  Sum_probs=117.9

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHh-CCCCCeeEEeEEEEeCCE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~  224 (291)
                      .+..++..-+..||+|+||.|-+-++..+|...|+|.+.... ..+ ..+.+..|+.+..+ .++|++|.+|+.+.....
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            344556777889999999999999999999999999997543 222 34456667776555 489999999999999999


Q ss_pred             EEEEEeccCCCCHHHH----HHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQ----LYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~----l~~~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+.||.|.- +|..+    +.+.+.++|...-+++..+..||.|||++ .+||||+||.|||++.+|+||
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVK  189 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVK  189 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEE
Confidence            9999999975 44322    33457789999999999999999999998 899999999999999999997

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.80  E-value=3.4e-19  Score=169.09  Aligned_cols=139  Identities=23%  Similarity=0.365  Sum_probs=117.2

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCC----CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGT----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      .+...+.+.||.|.||.||+|.+...    .--||||..+.+.  ..+..+.|..|+.+|+.++||||+++++++.+ ..
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            34455568899999999999987543    3458888887654  33447788999999999999999999999865 57


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .|||||.++-|.|..++..+ ..++......|+.||+.||.|||++++|||||..+|||+.+...||
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVK  531 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVK  531 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceee
Confidence            99999999999999999875 4567777888999999999999999999999999999998876665

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.80  E-value=7.1e-19  Score=169.57  Aligned_cols=144  Identities=25%  Similarity=0.334  Sum_probs=107.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEc----------------CCCcEEEEEEeeccccchH-----------HHHHHHHH
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRI----------------GTSEIYAMKVMRKDKIMEK-----------NHAEYMKS  199 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~----------------~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~  199 (291)
                      ...++|++.++||+|+||.||+|.+.                ..++.||||.+........           ...+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            45779999999999999999999752                2346799999864321110           01122334


Q ss_pred             HHHHHHhCCCCCe-----eEEeEEEE--------eCCEEEEEEeccCCCCHHHHHHHcC---------------------
Q 022853          200 ERNILTKVDHPFI-----VQLRYSFQ--------TKYRLYLVLDFVNGGHLFFQLYRQG---------------------  245 (291)
Q Consensus       200 E~~il~~l~HpnI-----v~l~~~~~--------~~~~~~lV~E~~~gg~L~~~l~~~~---------------------  245 (291)
                      |+.++.++.|.++     ++++++|.        .++..|+||||+.+++|.+++....                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777766654     55555553        2456899999999999988876321                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          246 ---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       246 ---~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                         .++...++.++.|++.||.|||+++|+||||||+|||++.++.+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~k  349 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVK  349 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEE
Confidence               124566788999999999999999999999999999999888765

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=9e-19  Score=152.27  Aligned_cols=129  Identities=16%  Similarity=0.178  Sum_probs=104.7

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHH------HHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY------MKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      .++|++.+.+|.|+||.||++..  ++..+|+|++...........+.      +.+|+..+.++.||+|..+..++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            35899999999999999999765  46679999997665444443333      67899999999999999998876543


Q ss_pred             --------CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          223 --------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       223 --------~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                              +..+++|||++|.+|.+..    .+++    ....+++.+|..+|..|++|||+||.||+++.+|
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC
Confidence                    3589999999999997653    2233    2356999999999999999999999999999877

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.79  E-value=7.3e-20  Score=175.37  Aligned_cols=144  Identities=21%  Similarity=0.325  Sum_probs=124.7

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  220 (291)
                      ...|..++.++.+.||+|.||.|++|.|...   .-.||||+++.+....  ....|.+|+.+|.+|+|||+++||++..
T Consensus       104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl  181 (1039)
T KOG0199|consen  104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVL  181 (1039)
T ss_pred             ceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence            3446667788889999999999999998753   3468999998776543  5778999999999999999999999987


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      + ..+.+|||+++.|+|.+.|.+  +..|.......|+.||+.||.||.++++|||||..+|+||.....||
T Consensus       182 ~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVK  252 (1039)
T KOG0199|consen  182 D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVK  252 (1039)
T ss_pred             c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceee
Confidence            7 789999999999999999987  34577788889999999999999999999999999999998776665

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.4e-19  Score=172.39  Aligned_cols=135  Identities=35%  Similarity=0.520  Sum_probs=117.1

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHh-CCCCCeeEEeEEEEeCCEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ..++|++...+|.|+|+.|-.+.+..+++.+++|++.+....       ..+|+.++.. -+||||+++.+.+.+..+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceee
Confidence            467899999999999999999999999999999999776221       2346655544 48999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEe-cCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL-DADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl-~~~g~vK  290 (291)
                      +|||.+.|+.+...+.....+. ..+..|++||+.|+.|||++|||||||||+|||+ +..|++|
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lr  456 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLR  456 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEE
Confidence            9999999998888887766555 7778899999999999999999999999999999 5888765

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.78  E-value=3e-19  Score=164.84  Aligned_cols=135  Identities=24%  Similarity=0.393  Sum_probs=115.1

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHh--CCCCCeeEEeEEEEeCC
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~~  223 (291)
                      ...+...++++++|+|.||.||+|..  .++.||||++...      ..+.+.+|.+|...  +.|+||+++++.-....
T Consensus       206 l~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t  277 (534)
T KOG3653|consen  206 LLELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT  277 (534)
T ss_pred             cccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence            34566788999999999999999988  4589999998643      36678889888875  58999999987765444


Q ss_pred             ----EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCEecccCCCcEEecCCCCc
Q 022853          224 ----RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN---------GIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       224 ----~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~---------gIiHrDLKp~NILl~~~g~v  289 (291)
                          .++||++|.+.|+|.++|..+ .+++....+++.-+++||+|||+-         .|+|||||.+||||..|+.+
T Consensus       278 ~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  278 ADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             ccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence                799999999999999999865 568888899999999999999974         59999999999999998763

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=6.5e-19  Score=154.87  Aligned_cols=134  Identities=22%  Similarity=0.220  Sum_probs=102.9

Q ss_pred             CeEEEEEecccCceEEEEEE-EcCCCcEEEEEEeeccccch---------------------HHHHHHHHHHHHHHHhCC
Q 022853          151 DFEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIME---------------------KNHAEYMKSERNILTKVD  208 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~-~~~~~~~vAiK~i~~~~~~~---------------------~~~~~~~~~E~~il~~l~  208 (291)
                      .|++.+.||+|+||.||+|. +..+|+.||+|+++......                     ......+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48889999999999999998 66789999999997543110                     001234568999999997


Q ss_pred             CCC--eeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC-CEecccCCCcEEecC
Q 022853          209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG-IMHRDLKPENILLDA  285 (291)
Q Consensus       209 Hpn--Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~g-IiHrDLKp~NILl~~  285 (291)
                      +.+  +++++..    ...|+||||++|++|.........+....+..++.|++.++.+||.+| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            533  3444432    235899999999888665544445566667789999999999999999 99999999999998 


Q ss_pred             CCCc
Q 022853          286 DGHV  289 (291)
Q Consensus       286 ~g~v  289 (291)
                      ++.+
T Consensus       184 ~~~i  187 (237)
T smart00090      184 DGKV  187 (237)
T ss_pred             CCCE
Confidence            5554

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.78  E-value=1.2e-18  Score=170.86  Aligned_cols=137  Identities=23%  Similarity=0.375  Sum_probs=98.1

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCC----CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEE----
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS----  218 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~----  218 (291)
                      ...++|++.+.||+|+||.||+|++..+    +..||+|.+.....     .+....+  .+....+.++..+...    
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            4567899999999999999999999988    89999998754321     1111111  1122222222222111    


Q ss_pred             --EEeCCEEEEEEeccCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCCEeccc
Q 022853          219 --FQTKYRLYLVLDFVNGGHLFFQLYRQGL--------------------FREDLARIYTAEIVSAVSHLHANGIMHRDL  276 (291)
Q Consensus       219 --~~~~~~~~lV~E~~~gg~L~~~l~~~~~--------------------~~~~~~~~i~~qil~aL~yLH~~gIiHrDL  276 (291)
                        ......+++||||+.+++|.+++.....                    .....+..++.||+.||+|||++||+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              2456789999999999999888865421                    112345678999999999999999999999


Q ss_pred             CCCcEEecC-CCCcC
Q 022853          277 KPENILLDA-DGHVR  290 (291)
Q Consensus       277 Kp~NILl~~-~g~vK  290 (291)
                      ||+|||++. ++.+|
T Consensus       282 KP~NILl~~~~~~~K  296 (566)
T PLN03225        282 KPQNIIFSEGSGSFK  296 (566)
T ss_pred             CHHHEEEeCCCCcEE
Confidence            999999986 45554

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=1.8e-21  Score=167.36  Aligned_cols=144  Identities=27%  Similarity=0.400  Sum_probs=117.8

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe---
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT---  221 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~---  221 (291)
                      .+.....|+-+..+|+|.||.||+|+.+.+++.||+|++-.+...+ ..-....+|+.+|..+.|+|++.+++.|..   
T Consensus        12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            3445567888899999999999999999999999998764322111 112234579999999999999988776632   


Q ss_pred             -----CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 -----KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 -----~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                           ...+|+|+++|+. +|..++... .+++...+.+++.+++.||.|+|+..|+|||+||+|+||+.+|.+|
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilk  164 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILK  164 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEE
Confidence                 3459999999987 677777654 5788999999999999999999999999999999999999999875

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.5e-18  Score=162.81  Aligned_cols=143  Identities=29%  Similarity=0.400  Sum_probs=116.8

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~  222 (291)
                      ...+.-..|+++++||+|+-++||++...+. +.||+|.+.... .+.....-+.+|+.+|.+| .|.+||+|+++-..+
T Consensus       355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             eEEECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            3445556899999999999999999987644 456766654332 3445677889999999999 799999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCH-HHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~~~~-~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+||||||=+ .+|...|.+.....+ ...+.|..|++.|+.++|..||||.||||+|+|+- +|.+|
T Consensus       433 ~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LK  499 (677)
T KOG0596|consen  433 GYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLK  499 (677)
T ss_pred             ceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEE
Confidence            99999999654 489888887765444 57888999999999999999999999999999985 34443

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.77  E-value=6.5e-20  Score=158.79  Aligned_cols=142  Identities=24%  Similarity=0.389  Sum_probs=115.0

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHH-hCCCCCeeEEeEEEEeCCE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~  224 (291)
                      ....++.+-+..||.|+||+|++-.++.+|+.+|||.++.... + ...+++..|.+... .-+.||||++|+....++.
T Consensus        60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd  137 (361)
T KOG1006|consen   60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-E-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD  137 (361)
T ss_pred             ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-h-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence            3444567778899999999999999999999999999986653 2 23445666666544 4589999999999999999


Q ss_pred             EEEEEeccCCCCHHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQL-----YRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l-----~~~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||.||.|.- +|..+.     .++..++|...-.+....+.||.||-.. .|||||+||+|||++..|.||
T Consensus       138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEe
Confidence            9999999975 342221     1345688888888888889999999875 899999999999999999987

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.77  E-value=4.9e-18  Score=146.26  Aligned_cols=127  Identities=50%  Similarity=0.808  Sum_probs=113.7

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHHH
Q 022853          162 AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL  241 (291)
Q Consensus       162 ~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l  241 (291)
                      +||.||+|.+..+++.+|+|++........  .+.+.+|+..+++++|+||+++++.+......++++||+.+++|..++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999998899999999976543221  567889999999999999999999999999999999999999999988


Q ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .....++...+..++.+++.++.|||+.+++|+||+|+||+++.++.++
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~  127 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVK  127 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEE
Confidence            8766688899999999999999999999999999999999999887653

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.76  E-value=1e-18  Score=157.66  Aligned_cols=136  Identities=27%  Similarity=0.392  Sum_probs=115.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCC--C----CeeEEeEEEEeC
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--P----FIVQLRYSFQTK  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H--p----nIv~l~~~~~~~  222 (291)
                      ..+|++.+.+|+|.||+|.++++..++..||+|+++.-.    ...+..+-|+++|.++.+  |    -++++.++|.-.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            568999999999999999999999999999999996432    234556679999999832  2    377888899999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      +++|||+|.+. -++++++..+  .+++.+.++.+++|++.+++|||+.+++|-||||+|||+.+...+
T Consensus       164 ghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  164 GHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             CceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence            99999999884 4788888775  458889999999999999999999999999999999999776543

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.76  E-value=5.5e-19  Score=171.83  Aligned_cols=136  Identities=24%  Similarity=0.292  Sum_probs=116.8

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      .+..++||+|+||+||+|.+...++    +||||++......  .....+..|+.+|.+++|||+++|++++.... +.|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            4556899999999999998876554    6888888665432  33456788999999999999999999987765 889


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |++||++|.|.++++.. ..+.......|..||++||.|||.++++||||-.+|+||..-.+||
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvk  838 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVK  838 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEE
Confidence            99999999999998764 5677788889999999999999999999999999999999888776

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=9e-18  Score=144.14  Aligned_cols=127  Identities=21%  Similarity=0.306  Sum_probs=102.6

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccch-----HHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      +.||+|++|.||+|.+  .+..+++|+........     ......+.+|+.++..+.|++|.....++.+....+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5789999999999987  56779999865433211     1123457789999999999998776666777788999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      |++|++|...+.....    ....++.+++.+|.++|..|++|||++|.|||++ ++.+
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~  133 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKI  133 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCE
Confidence            9999999888765432    6677889999999999999999999999999998 4543

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.74  E-value=7e-19  Score=152.84  Aligned_cols=131  Identities=23%  Similarity=0.322  Sum_probs=111.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeE-EEEeCCEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY-SFQTKYRLYL  227 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~-~~~~~~~~~l  227 (291)
                      +.|.+.+.||+|-||++.+|+++.+...+++|.+.+....    ...|.+|..---.| .|.||+.-|+ .|++.+.+++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            5799999999999999999999999999999999776433    44566676554445 6899998765 4788889999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      ++||++.|+|..-+... .+.+...+.++.|++.|++|||++++||||||.+||||-.
T Consensus       100 ~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~  156 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD  156 (378)
T ss_pred             eeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec
Confidence            99999999998766553 4678888999999999999999999999999999999954

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1.2e-19  Score=157.70  Aligned_cols=138  Identities=22%  Similarity=0.372  Sum_probs=114.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC-----EE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----RL  225 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~  225 (291)
                      +.+-.+.||-|+||.||.+.+..+|+.+|+|.+..-. ..-...+.+.+|+.+|..++|.|+...++..+...     .+
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            3444588999999999999999999999999885422 22223456778999999999999999888776543     36


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++|.|.. +|...+.....++.+.++.+.+||++||.|||+.||.||||||.|+|++++..+|
T Consensus       133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLK  196 (449)
T KOG0664|consen  133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILK  196 (449)
T ss_pred             HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEE
Confidence            888888865 6777777777889999999999999999999999999999999999999987665

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=3.2e-17  Score=139.51  Aligned_cols=123  Identities=20%  Similarity=0.201  Sum_probs=95.7

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeeccccch-----HHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       157 ~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      .||+|+||.||++.+  .+..+++|+........     ......+.+|+.++..+.|+++.....++......+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            379999999999985  56779999865432211     11235677899999999888765544455566678999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       232 ~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      ++|++|...+.....       .++.|++.+|.+||+.|++|||++|+||+++ ++.+
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~  128 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKL  128 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcE
Confidence            999999887654321       6788999999999999999999999999998 5554

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.72  E-value=6.4e-17  Score=138.68  Aligned_cols=136  Identities=21%  Similarity=0.295  Sum_probs=112.3

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  225 (291)
                      +..+.|++++.||.|+||.+|+|.....|+.||||+-.....     .-.+..|..+.+.|+ -..|..+..++.+...-
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            445689999999999999999999999999999998754431     123567888888885 46788888888888888


Q ss_pred             EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          226 YLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      .+|||.+ |.+|.+++.- ...|+...+..++-|++.-++|+|.+++|||||||+|+|+.-+-+
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh  149 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRH  149 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccc
Confidence            9999987 4578766653 456888888999999999999999999999999999999865433

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=1.1e-16  Score=136.99  Aligned_cols=125  Identities=19%  Similarity=0.227  Sum_probs=95.5

Q ss_pred             EEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHH-HHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEEEEe
Q 022853          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-HAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       153 ~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .+...|++|+||+||++..  .+..++.+.+......... ....+.+|+++|+++. |++|++++++    +..|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3568899999999997765  5667777766544332111 2235789999999994 5889998875    45799999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeccc-CCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL-KPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDL-Kp~NILl~~~g~vK  290 (291)
                      |+.|.+|...+..      . ...++.|++.+|+++|++||+|||| ||+|||++.+|.++
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~  132 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPA  132 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEE
Confidence            9999988643321      1 1346789999999999999999999 79999999888764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=1.2e-16  Score=156.30  Aligned_cols=128  Identities=19%  Similarity=0.210  Sum_probs=99.5

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeecccc-----chHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-----MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .|...+.||+|+||.||++.+....  +++|+......     ......+.+.+|+.++..++|++++....++.+....
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            3456789999999999999875443  44444322111     1112245678999999999999998877777777778


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      ++||||++|++|..++.        ....++.|++.+|.|||+.|++||||||+|||++ ++.+
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~~  466 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDRL  466 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCcE
Confidence            99999999999988775        2456788999999999999999999999999994 4444

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=5e-17  Score=138.76  Aligned_cols=128  Identities=20%  Similarity=0.185  Sum_probs=97.1

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH-------------------HHHHHHHHHHHHHHhCCCCC-
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK-------------------NHAEYMKSERNILTKVDHPF-  211 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~-------------------~~~~~~~~E~~il~~l~Hpn-  211 (291)
                      |.+.+.||+|+||.||++... +++.+|||+++.......                   ........|..++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            777899999999999999875 789999999875431000                   01123567888888887774 


Q ss_pred             -eeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          212 -IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       212 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ++..++    ....++||||++|++|......      ..+..++.+++.++.++|..||+||||||+||+++.++.+|
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             444433    2456899999999988654321      33556788999999999999999999999999999888764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.70  E-value=1.6e-16  Score=157.33  Aligned_cols=145  Identities=22%  Similarity=0.360  Sum_probs=124.3

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQL  215 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l  215 (291)
                      .|.+..++..+.+.||+|+||.|++|....       ....||+|.++.....  ...+.+..|+.+|+.+ .||||+.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence            566666777888899999999999987432       1467999988765433  4467788999999998 69999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCC
Q 022853          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (291)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~  279 (291)
                      .+++..++.+++|+||+..|+|..++...+                .+.......++.||+.|++||+++++|||||-.+
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            999999999999999999999999998765                3677788889999999999999999999999999


Q ss_pred             cEEecCCCCcC
Q 022853          280 NILLDADGHVR  290 (291)
Q Consensus       280 NILl~~~g~vK  290 (291)
                      |||+..+..+|
T Consensus       448 NVLi~~~~~~k  458 (609)
T KOG0200|consen  448 NVLITKNKVIK  458 (609)
T ss_pred             hEEecCCCEEE
Confidence            99999886665

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.70  E-value=2e-17  Score=150.94  Aligned_cols=128  Identities=25%  Similarity=0.471  Sum_probs=113.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  225 (291)
                      ..|.+.+.||.|+|+.||++.+..   .++.||+|.+....     ...++..|+++|..+ .+.||+.+.+++...+..
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            468999999999999999998877   78899999886543     245688999999998 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      .+||||++.....++...   ++...++.|++.++.||.++|.+|||||||||.|+|.+.
T Consensus       111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~  167 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR  167 (418)
T ss_pred             EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc
Confidence            999999999877666554   457788999999999999999999999999999999875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.69  E-value=1e-15  Score=135.27  Aligned_cols=133  Identities=41%  Similarity=0.657  Sum_probs=117.6

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCC-CeeEEeEEEEeCCEEEEEEe
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP-FIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~l~~~~~~~~~~~lV~E  230 (291)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.............+.+|+.++..+.|+ +|+++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999987   77899999876544433567788999999999988 79999999988888999999


Q ss_pred             ccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          231 FVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~---~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ++.++++...+....   .+....+..++.|++.++.|+|+.+++|||+||+||+++..+
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~  138 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG  138 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC
Confidence            999999996666554   688999999999999999999999999999999999999876

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.69  E-value=3.4e-16  Score=143.61  Aligned_cols=133  Identities=26%  Similarity=0.394  Sum_probs=110.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCC-cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCC----CCeeEEeEEE-EeCCE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH----PFIVQLRYSF-QTKYR  224 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H----pnIv~l~~~~-~~~~~  224 (291)
                      +|++.+.||+|+||.||.|.+..++ ..+|+|+.........   ..+..|..++..+..    +++..+++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            7999999999999999999988764 6799998866432211   146678888888863    6888998888 57788


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      -|+||+.+ |.+|.++....  +.|+...+..++.|++.+|++||+.|++||||||+|+++...+
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~  159 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSS  159 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCC
Confidence            99999977 55888877543  5789999999999999999999999999999999999998653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.68  E-value=2.7e-17  Score=145.71  Aligned_cols=137  Identities=25%  Similarity=0.413  Sum_probs=114.7

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC------
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------  222 (291)
                      ..+|.-++.+|.|+- .|..|.+.-+++.||+|.+... ........+..+|..++..+.|+||++++.+|.-.      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            357888999999998 7888888888999999988665 33345566778999999999999999999988543      


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|+|||+|.. +|...+.  -.+.-...+.+..|++.|++|||+.||+||||||+||+++.++.+|
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lK  158 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLK  158 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhhee
Confidence            358999999986 6766655  2346677889999999999999999999999999999999988765

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.68  E-value=5.3e-17  Score=158.46  Aligned_cols=123  Identities=26%  Similarity=0.405  Sum_probs=101.2

Q ss_pred             EEEEecccCceE-EEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEEec
Q 022853          154 VLKVVGQGAFAK-VYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       154 i~~~LG~G~fg~-Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      -.+.+|.|+-|+ ||+|..  .++.||||.+-.+      ......+|+.+|+.- +|||||++|+.-.+....||..|.
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             cHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            346788999886 689988  5779999987543      355677899999987 799999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCC---C-CHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          232 VNGGHLFFQLYRQGL---F-REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       232 ~~gg~L~~~l~~~~~---~-~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      |.. +|.+++...+.   . .....+....|++.||++||+.+||||||||.||||+.
T Consensus       585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~  641 (903)
T KOG1027|consen  585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISV  641 (903)
T ss_pred             hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEc
Confidence            987 89888876311   1 11334677889999999999999999999999999987

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=1.1e-16  Score=134.80  Aligned_cols=129  Identities=24%  Similarity=0.276  Sum_probs=88.1

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHH---------------------HHHHHHHHHhCCCCC--
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY---------------------MKSERNILTKVDHPF--  211 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~---------------------~~~E~~il~~l~Hpn--  211 (291)
                      .+.||+|+||.||+|.+. +++.||||+++............                     ...|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999886 78899999987643221111111                     134555666654432  


Q ss_pred             eeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+.++.    ...++||||++++.+........... ..++.++.+++.++.++|. +||+||||||+||+++ ++.++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~  154 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY  154 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence            4444432    23689999999964422111111111 5677889999999999999 9999999999999998 66543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.67  E-value=1.1e-16  Score=149.39  Aligned_cols=135  Identities=27%  Similarity=0.436  Sum_probs=116.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC------CCCeeEEeEEEEeCC
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD------HPFIVQLRYSFQTKY  223 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~  223 (291)
                      .+|.+....|+|-|++|.+|.+...+..||||+|.....+.+    .=..|+++|++|+      --++++|+..|...+
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh----hhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            579999999999999999999999999999999988765433    3346999999984      347899999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      ++|||+|.+.- +|...+.+.+   .+....++.|+.|+..||..|-.+||+|.||||+||||+...++
T Consensus       508 HLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  508 HLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             eeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcce
Confidence            99999998755 7888888765   36678889999999999999999999999999999999986543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.65  E-value=9.1e-16  Score=136.86  Aligned_cols=133  Identities=21%  Similarity=0.313  Sum_probs=114.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      -.|++.+.||+|+||.++.|...-+++.||||.-....     ..-.++.|.+..+.| ..++|...|.+..++.+-.||
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            36999999999999999999999999999999765432     134467788888877 679999999888888888999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      ||++ |.+|.+++.- ...|+...+..++.|++.-++|+|++.+|.|||||+|+||...|.
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~  162 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGT  162 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCC
Confidence            9987 5578777654 467999999999999999999999999999999999999987654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=1.4e-15  Score=153.80  Aligned_cols=135  Identities=26%  Similarity=0.429  Sum_probs=108.5

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC---CCCeeEEeEEEEe
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQT  221 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~  221 (291)
                      ..+....|.|.+.||+|+||+||+|...+ |+.||+|+-++...++.-..      .+++.+|+   -+.|..+..++.-
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHHHcc
Confidence            34556789999999999999999999987 99999999877655432211      11222332   2344455555566


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      .+..++|+||.+.|+|.+++...+.+++..+..+..|++.-++.||..+|||+||||+|+||...
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~  830 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRRE  830 (974)
T ss_pred             CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecc
Confidence            67788999999999999999988889999999999999999999999999999999999999753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.59  E-value=1.5e-14  Score=127.34  Aligned_cols=127  Identities=20%  Similarity=0.285  Sum_probs=91.2

Q ss_pred             EEec-ccCceEEEEEEEcCCCcEEEEEEeeccccc----------hHHHHHHHHHHHHHHHhCCCCCe--eEEeEEEEeC
Q 022853          156 KVVG-QGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----------EKNHAEYMKSERNILTKVDHPFI--VQLRYSFQTK  222 (291)
Q Consensus       156 ~~LG-~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~----------~~~~~~~~~~E~~il~~l~HpnI--v~l~~~~~~~  222 (291)
                      ..|| .|+.|+||.+...  +..+++|.+......          .......+.+|+.++..+.|++|  ++.++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4565 6777777777663  677999988643210          11223457789999999988875  5666554332


Q ss_pred             -C---EEEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          223 -Y---RLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       223 -~---~~~lV~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                       .   ..++|||+++| .+|..++.. ..+++..    +.||+.+|.+||++||+||||||+|||++.++.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCE
Confidence             2   23599999998 688777654 3455433    5689999999999999999999999999987765

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.59  E-value=6.7e-15  Score=117.78  Aligned_cols=122  Identities=21%  Similarity=0.281  Sum_probs=99.2

Q ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCC--CCeeEEeEEEEeCCEEEEEEec
Q 022853          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       154 i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      +.+.||.|.++.||++...+  ..+++|.......     ...+..|+.++..+.+  .++++++..+...+..|++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            45789999999999999854  6799999865432     3457789999999966  5899998888888889999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecccCCCcEEecCCCCc
Q 022853          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN---GIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       232 ~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKp~NILl~~~g~v  289 (291)
                      +.|+.+..+       +......++.+++.++.++|..   +++|+|++|+||+++..+.+
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~  128 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKIL  128 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEE
Confidence            999877543       3445566788999999999985   79999999999999886654

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.43  E-value=1.5e-14  Score=138.19  Aligned_cols=134  Identities=44%  Similarity=0.746  Sum_probs=116.8

Q ss_pred             EecccCceEEEEEEE---cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEEEEecc
Q 022853          157 VVGQGAFAKVYQVRR---IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFV  232 (291)
Q Consensus       157 ~LG~G~fg~Vy~~~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~  232 (291)
                      .+|+|+||+|++++.   ...+..||+|+.++......... ....|..++...+ ||+++++...|+.+..+|++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999998653   34577899999987665443333 4556888888886 999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcCC
Q 022853          233 NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVRS  291 (291)
Q Consensus       233 ~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vKs  291 (291)
                      .||.|...+.....+.+...+.+...++.|++++|..+|+|||+|++||+++.+|++|.
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~  138 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKL  138 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCcccc
Confidence            99999999988888999999999999999999999999999999999999999999874

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.36  E-value=4.4e-13  Score=129.97  Aligned_cols=131  Identities=18%  Similarity=0.289  Sum_probs=83.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch-------------------------------HHHHHHH
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-------------------------------KNHAEYM  197 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-------------------------------~~~~~~~  197 (291)
                      +.+|+. +.||.|++|.||+|+.+.+|+.||||+.++.....                               .+..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 78999999999999998889999999998652110                               0112222


Q ss_pred             HH------HHHHHHhC----CCCCeeEEeEEEEe-CCEEEEEEeccCCCCHHHH--HHHcCC----CCHHHHHHHHHHHH
Q 022853          198 KS------ERNILTKV----DHPFIVQLRYSFQT-KYRLYLVLDFVNGGHLFFQ--LYRQGL----FREDLARIYTAEIV  260 (291)
Q Consensus       198 ~~------E~~il~~l----~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--l~~~~~----~~~~~~~~i~~qil  260 (291)
                      .+      |+..+.++    .+.+.+.+-..+.+ ...-+|||||+.|+.+.+.  +...+.    +.+..+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence            23      33333332    23333333233321 3456799999999998653  333332    3333444455554 


Q ss_pred             HHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          261 SAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       261 ~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                            ...|++|+|+||.||+++.+|
T Consensus       277 ------f~~GffHaDpHPGNIlv~~~g  297 (537)
T PRK04750        277 ------FRDGFFHADMHPGNIFVSYDP  297 (537)
T ss_pred             ------HhCCeeeCCCChHHeEEecCC
Confidence                  358999999999999999887

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=3.2e-13  Score=133.05  Aligned_cols=137  Identities=24%  Similarity=0.336  Sum_probs=107.6

Q ss_pred             EEEEEecccCceEEEEEEEcCCCcEEEEEEeecc---ccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKD---KIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       153 ~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      .....+|.|++|.|+.+......+.++.|.....   ..........+..|.-+-..+.|||++.....+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4568899999998888877766666666655421   1112222222556777778899999988766666655555569


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||++ +|+.++.+.+.+....+..++.|++.|+.|||+.||.||||||+|+++..+|.+|
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lk  460 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILK  460 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceE
Confidence            99999 9999998887889999999999999999999999999999999999999998775

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.32  E-value=1.1e-11  Score=118.27  Aligned_cols=130  Identities=17%  Similarity=0.270  Sum_probs=83.8

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchH-------------------------------HHHH------HHH
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK-------------------------------NHAE------YMK  198 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~-------------------------------~~~~------~~~  198 (291)
                      +.||.|++|.||+|+.. +|+.||||+.++.....-                               +...      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            67999999999999875 688999999876421100                               0000      123


Q ss_pred             HHHHHHHhC-----CCCCeeEEeEEE-EeCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 022853          199 SERNILTKV-----DHPFIVQLRYSF-QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVS-AVSHLHANG  270 (291)
Q Consensus       199 ~E~~il~~l-----~HpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~-aL~yLH~~g  270 (291)
                      .|+..+.++     +++++. +-..+ ......++||||++|++|.+..... ....   ...++.+++. .+..+|..|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       202 REAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            345444443     234432 22222 2234568999999999987665432 1122   1234444544 467889999


Q ss_pred             CEecccCCCcEEecCCCCcC
Q 022853          271 IMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       271 IiHrDLKp~NILl~~~g~vK  290 (291)
                      ++|+|+||.||+++.+|.++
T Consensus       278 ~~H~D~hPgNilv~~~g~i~  297 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKII  297 (437)
T ss_pred             ceeCCCCcccEEECCCCcEE
Confidence            99999999999999888753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.31  E-value=2.1e-12  Score=117.70  Aligned_cols=140  Identities=15%  Similarity=0.226  Sum_probs=109.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE-eC
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ-TK  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~  222 (291)
                      ..++++...+-+|.||.||.|.++...     +.+-+|.++...  ..-....+..|..++..+.|||+..+.++.. +.
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY  360 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence            356888888999999999999776432     334455543322  2234566778999999999999999988764 45


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ--------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...++++.++.-|+|..++..-        ..++..+...++.|++.|++|||+.||||.||..+|++|++.-+||
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence            5688899999999998888721        2345566677889999999999999999999999999999876665

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.27  E-value=1.5e-12  Score=133.01  Aligned_cols=80  Identities=18%  Similarity=0.146  Sum_probs=64.0

Q ss_pred             CCeeEEeEEE-------EeCCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcE
Q 022853          210 PFIVQLRYSF-------QTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (291)
Q Consensus       210 pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NI  281 (291)
                      +||.++++.|       .....+++++||+ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            4666666665       2334677888887 4589998865 34589999999999999999999999999999999999


Q ss_pred             EecCCCCcC
Q 022853          282 LLDADGHVR  290 (291)
Q Consensus       282 Ll~~~g~vK  290 (291)
                      ||+..|.+|
T Consensus       112 Ll~~~~~~k  120 (793)
T PLN00181        112 VMSSFNHVS  120 (793)
T ss_pred             EEcccCcEE
Confidence            997655443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.26  E-value=1.1e-10  Score=104.73  Aligned_cols=137  Identities=30%  Similarity=0.439  Sum_probs=88.8

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCC-----------CCeeEEeEE-
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-----------PFIVQLRYS-  218 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-----------pnIv~l~~~-  218 (291)
                      .+...+.||.|+++.||.+++..|++.+|+|+............+.+++|.-....+.+           ..++.+ +. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~   91 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLL   91 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEE
Confidence            46778999999999999999999999999999876554444556667766644433322           112211 11 


Q ss_pred             --------EEeC---C-----EEEEEEeccCCCCHHHHHH---HcCCCC---HHHHH-HHHHHHHHHHHHHHHCCCEecc
Q 022853          219 --------FQTK---Y-----RLYLVLDFVNGGHLFFQLY---RQGLFR---EDLAR-IYTAEIVSAVSHLHANGIMHRD  275 (291)
Q Consensus       219 --------~~~~---~-----~~~lV~E~~~gg~L~~~l~---~~~~~~---~~~~~-~i~~qil~aL~yLH~~gIiHrD  275 (291)
                              +...   .     +.+++|+-+.+ +|...+.   ......   ...++ .+..|+++.+++||+.|++|+|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd  170 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD  170 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence                    1111   1     23677777754 6755543   222221   22333 3447999999999999999999


Q ss_pred             cCCCcEEecCCCCc
Q 022853          276 LKPENILLDADGHV  289 (291)
Q Consensus       276 LKp~NILl~~~g~v  289 (291)
                      |||+|++++.+|.+
T Consensus       171 i~~~nfll~~~G~v  184 (288)
T PF14531_consen  171 IKPENFLLDQDGGV  184 (288)
T ss_dssp             -SGGGEEE-TTS-E
T ss_pred             cceeeEEEcCCCCE
Confidence            99999999999976

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.26  E-value=1.6e-11  Score=101.28  Aligned_cols=118  Identities=22%  Similarity=0.291  Sum_probs=84.2

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCe-eEEeEEEEeCCEEEEEEeccC
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVLDFVN  233 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~  233 (291)
                      .+.|+.|.++.||+++..  +..|++|+.......    ...+..|+.++..+.+.++ .+++...  ....++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence            467899999999999864  678999987654311    1234678888888754443 4555443  233579999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----EecccCCCcEEecCCCCc
Q 022853          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI-----MHRDLKPENILLDADGHV  289 (291)
Q Consensus       234 gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gI-----iHrDLKp~NILl~~~g~v  289 (291)
                      |.++...    .    .....++.+++.+|..||..++     +|+|++|.||+++ ++.+
T Consensus        75 G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~  126 (170)
T cd05151          75 GSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRL  126 (170)
T ss_pred             CCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeE
Confidence            9877532    0    1123456789999999999985     9999999999998 4443

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.20  E-value=1.1e-10  Score=99.37  Aligned_cols=126  Identities=14%  Similarity=0.195  Sum_probs=87.9

Q ss_pred             EEecccCceEEEEEEEcC------CCcEEEEEEeecccc--------c-----------hHHHHHHHH----HHHHHHHh
Q 022853          156 KVVGQGAFAKVYQVRRIG------TSEIYAMKVMRKDKI--------M-----------EKNHAEYMK----SERNILTK  206 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~------~~~~vAiK~i~~~~~--------~-----------~~~~~~~~~----~E~~il~~  206 (291)
                      ..||.|-=+.||.|....      .+..+|+|+.+....        .           ..+..+.+.    +|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468889999999997643      247899999853211        0           011122333    78888888


Q ss_pred             CCC--CCeeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCCEecccCCCcEEe
Q 022853          207 VDH--PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL-HANGIMHRDLKPENILL  283 (291)
Q Consensus       207 l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yL-H~~gIiHrDLKp~NILl  283 (291)
                      +..  -++++.+..    ..-+|||||+.++.+.....+...+++..+..+..|++.+|..| |..||||+||++.|||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~  158 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW  158 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            843  455666544    45679999998764433222333455556667788999999998 89999999999999999


Q ss_pred             cC
Q 022853          284 DA  285 (291)
Q Consensus       284 ~~  285 (291)
                      ..
T Consensus       159 ~~  160 (197)
T cd05146         159 HD  160 (197)
T ss_pred             EC
Confidence            74

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=1.7e-11  Score=112.14  Aligned_cols=140  Identities=30%  Similarity=0.427  Sum_probs=97.5

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCC-----------------------------------cEEEEEEeeccccc
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----------------------------------EIYAMKVMRKDKIM  189 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-----------------------------------~~vAiK~i~~~~~~  189 (291)
                      +...+++|++.+.||+|--..||.++....+                                   -+.|||.+..-...
T Consensus       152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~  231 (598)
T KOG4158|consen  152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD  231 (598)
T ss_pred             cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence            4466789999999999999999998755422                                   13456655322211


Q ss_pred             h--HHHHHHHHHHHH------H--------HH-------h-CCCCCeeEEeEEEEe------------------------
Q 022853          190 E--KNHAEYMKSERN------I--------LT-------K-VDHPFIVQLRYSFQT------------------------  221 (291)
Q Consensus       190 ~--~~~~~~~~~E~~------i--------l~-------~-l~HpnIv~l~~~~~~------------------------  221 (291)
                      .  ....+.+.+|.-      .        .+       . ..|||||++...|.+                        
T Consensus       232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g  311 (598)
T KOG4158|consen  232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG  311 (598)
T ss_pred             CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence            1  111222222310      1        11       1 369999999887743                        


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          222 ---KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       222 ---~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                         ...+|+||.-... +|..++..+.. +....+.++.|+++|+.|||.+||.|||+|.+|||+.-+
T Consensus       312 ~g~~~tlylvMkrY~~-tLr~yl~~~~~-s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~Eld  377 (598)
T KOG4158|consen  312 AGEPKTLYLVMKRYRQ-TLREYLWTRHR-SYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELD  377 (598)
T ss_pred             cCCCceEEEehhcchh-hHHHHHhcCCC-chHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEec
Confidence               2357999988766 78888876543 566777889999999999999999999999999999643

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.13  E-value=1.1e-11  Score=124.94  Aligned_cols=131  Identities=21%  Similarity=0.317  Sum_probs=105.0

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK--IMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +|...+.||.+.|=+|.+|++.. | .|++|++-+..  +.-....+++. |+. ...+++||.+.+..+.+++...|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~-~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLE-EIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHH-HHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            58888999999999999998854 3 38999986543  22233334443 444 5667999999988777778888999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      -+|... +|++.+..+..+..-+.+.|+.|++.||.-+|..||+|+|||.+||||+.=
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW  156 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW  156 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee
Confidence            999876 788888877667777778889999999999999999999999999999863

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.05  E-value=2.6e-09  Score=89.11  Aligned_cols=133  Identities=25%  Similarity=0.274  Sum_probs=97.4

Q ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEeecccc-----chHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-----MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       154 i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .+..+-+|+=+.|+++.+  .|+.+.||.-....+     ..+-...+..+|+++|.++.--.|..-.-+|.+...-+|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567888999999999987  567777775433322     2233456677899999988655555544466677778899


Q ss_pred             EeccCC-CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          229 LDFVNG-GHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       229 ~E~~~g-g~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      |||++| .++..++....  .........++.+|-..+.-||.++|||+||..+||++..+|.
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~  151 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGN  151 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCC
Confidence            999988 35666665432  2222223567888999999999999999999999999988875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.98  E-value=1.8e-09  Score=92.63  Aligned_cols=108  Identities=14%  Similarity=0.168  Sum_probs=70.5

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCC--CCeeEEeEEEEeC---CEEEEEEe
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFIVQLRYSFQTK---YRLYLVLD  230 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~---~~~~lV~E  230 (291)
                      +.|+.|..+.||++...+ |+.+++|+.......  .....+..|..++..+.+  .++.+++.+....   +..|+|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            678999999999998753 578999987654321  123456789999998865  3456666665443   36789999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH  267 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH  267 (291)
                      |++|.++...+.. ..+++.....++.+++.+|.+||
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH  116 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALH  116 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHh
Confidence            9999877543321 22344444444555555555555

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=8.7e-09  Score=86.08  Aligned_cols=123  Identities=24%  Similarity=0.227  Sum_probs=89.2

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccch-----HHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      ..+++|+=+.+|.+.+.  +..+++|.=.+..+..     +-..++..+|+.++.++.--.|..-.-++.+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            35788999999998774  3346666543333322     2234566789999998865555554445567788889999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      |++|..|.+.+...   .    ..++..+-.-+.-||..||+|+||.++||++..++
T Consensus        80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~  129 (204)
T COG3642          80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR  129 (204)
T ss_pred             EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc
Confidence            99999888777765   1    33556677777889999999999999999998764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.89  E-value=1.2e-09  Score=110.13  Aligned_cols=101  Identities=41%  Similarity=0.727  Sum_probs=75.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      .+|..++.+..|+||.||.++++.+.+.+|+| +++....       +++   ++.....|++|                
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFAGNPFVV----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---cccccCCccee----------------
Confidence            47999999999999999999999999999995 4443321       111   44445556555                


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                           |+-...+..-+.++.+        ++.|++|+|+.||+|||+||+|.||+.-|++|
T Consensus       136 -----gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiK  183 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIK  183 (1205)
T ss_pred             -----chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeeccccc
Confidence                 3444444444454433        37899999999999999999999999999887

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.86  E-value=9.6e-09  Score=99.70  Aligned_cols=115  Identities=19%  Similarity=0.247  Sum_probs=93.2

Q ss_pred             EEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCC
Q 022853          168 QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF  247 (291)
Q Consensus       168 ~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~  247 (291)
                      .|..+.++.++.+.+.+....   ...+...+-+.-|+.++||||++++..++.++.+|||+|-+.  .|...+.+.+  
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence            355666788888888866543   335556777888999999999999999999999999999876  4666666554  


Q ss_pred             CHHHHHHHHHHHHHHHHHHH-HCCCEecccCCCcEEecCCCCcC
Q 022853          248 REDLARIYTAEIVSAVSHLH-ANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       248 ~~~~~~~i~~qil~aL~yLH-~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ......-+.||+.||.||| .++++|++|.-+.|+|+..|..|
T Consensus       103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWk  145 (690)
T KOG1243|consen  103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWK  145 (690)
T ss_pred             -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEE
Confidence             4455566789999999997 56899999999999999999865

>PF06760 DUF1221: Protein of unknown function (DUF1221); InterPro: IPR010632 This is a group of plant proteins, most of which are hypothetical and of unknown function

Probab=98.85  E-value=3.6e-12  Score=104.43  Aligned_cols=87  Identities=25%  Similarity=0.331  Sum_probs=78.3

Q ss_pred             CCCCccccccccCCCCC-CCCccccCCccccccccccCCCeeeecCC-----------ccCccCCCcccccccccccccc
Q 022853           33 SSDYVEFDFSDVFGPAP-VQASIEVGGEISYANELVYDQPAVIHSRS-----------HSLVGPSSYVSQSLKLSKLTLH  100 (291)
Q Consensus        33 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~v~~~~-----------~sl~~p~~~~~~~~~~~~~~~~  100 (291)
                      .+||||||+||+++||| |+|+|+++|++|+||+++++.+++++++.           ++.+|.++.+++.+ +.++...
T Consensus        82 n~dcVE~hiHnlL~c~~vviEAIE~AgE~sG~D~dE~~rkRl~~a~kYdk~~~dpklFqw~fGKqYLvs~e~-c~R~d~a  160 (217)
T PF06760_consen   82 NTDCVEFHIHNLLWCFPVVIEAIETAGEISGSDQDEMARKRLVLARKYDKEWLDPKLFQWRFGKQYLVSREL-CARMDTA  160 (217)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHHHHHhhccCCCHHHHHHHHHHHHHhhhhhccchHHHHHHhhhhheeHHHH-HHHHHHH
Confidence            45899999999999999 59999999999999999999999999988           88899999999998 8899999


Q ss_pred             cccccccccccccccccCCC
Q 022853          101 EAEDSLGLVEGINEETQEGP  120 (291)
Q Consensus       101 ~~e~~~~~~~~~~~~~~~~~  120 (291)
                      ++||.+-+...+.+....++
T Consensus       161 WkEDRW~L~~~l~Ekk~~~s  180 (217)
T PF06760_consen  161 WKEDRWLLSQLLDEKKGSGS  180 (217)
T ss_pred             HHHHHHHHHHHHHHhccCCC
Confidence            99999998877776665543

All members contain the IPR000719 from INTERPRO domain, suggesting that they may possess kinase activity.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.83  E-value=2.3e-09  Score=102.57  Aligned_cols=140  Identities=26%  Similarity=0.371  Sum_probs=114.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEc-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRI-GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~  224 (291)
                      ....+|..+..||.|.|+.|+.+... .++..|++|-+.+...........+ .|+.+...+ .|.+++.++..|....+
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCcccccc
Confidence            34568999999999999999987755 6788999998877665544443333 455555555 79999998888888888


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      .|+-.|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+|
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~  403 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG  403 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch
Confidence            899999999998876665445677888888999999999999999999999999999998753

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.78  E-value=2e-07  Score=83.42  Aligned_cols=119  Identities=16%  Similarity=0.086  Sum_probs=78.3

Q ss_pred             EEEEEEEcCCCcEEEEEEeeccccch--H------HHHHHHHHHHHHHHhCCCCCee--EEeEEEEe-----CCEEEEEE
Q 022853          165 KVYQVRRIGTSEIYAMKVMRKDKIME--K------NHAEYMKSERNILTKVDHPFIV--QLRYSFQT-----KYRLYLVL  229 (291)
Q Consensus       165 ~Vy~~~~~~~~~~vAiK~i~~~~~~~--~------~~~~~~~~E~~il~~l~HpnIv--~l~~~~~~-----~~~~~lV~  229 (291)
                      .|+++..  .|+.|.+|.........  +      .-...+.+|...+.+|..-+|.  ....+++.     ....++||
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3555544  45678888664322110  0      0011356787777766332322  22333332     24578999


Q ss_pred             eccCCC-CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          230 DFVNGG-HLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       230 E~~~gg-~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      |++++. +|.+++..  ...........++.+++..+.-||..||+|+|+++.|||++.
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~  173 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHL  173 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEec
Confidence            999986 78777653  234556677788999999999999999999999999999985

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=98.75  E-value=1.7e-09  Score=94.87  Aligned_cols=141  Identities=14%  Similarity=0.245  Sum_probs=113.3

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .+...+..++.+|.+...|..|+|++.+  ..++.|++.......+ ....|..|.-.|+-+.||||..+++.+....++
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnl  262 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNL  262 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence            4556677788889999999999999954  4577788765543332 234577888888999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC-CEe-cccCCCcEEecCCCCc
Q 022853          226 YLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANG-IMH-RDLKPENILLDADGHV  289 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qil~aL~yLH~~g-IiH-rDLKp~NILl~~~g~v  289 (291)
                      .++..||+.|+|+..+..+..  ....++.+++.++++|+.|||+.. ++- --|....+++|++-+.
T Consensus       263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlta  330 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTA  330 (448)
T ss_pred             eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhh
Confidence            999999999999999987654  456788899999999999999974 443 3678888999887543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.74  E-value=6.1e-10  Score=109.97  Aligned_cols=139  Identities=25%  Similarity=0.407  Sum_probs=112.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..|.+.+.||+|+|+.|-.+.... ....+|+|.+.... ......+....|..+-..+. |+|++.+++........++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            458888899999999998876643 34556666664433 23344555666887878886 9999999999999999999


Q ss_pred             EEeccCCCCHHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-HCCCEecccCCCcEEecCCC-Cc
Q 022853          228 VLDFVNGGHLFFQL-YRQG-LFREDLARIYTAEIVSAVSHLH-ANGIMHRDLKPENILLDADG-HV  289 (291)
Q Consensus       228 V~E~~~gg~L~~~l-~~~~-~~~~~~~~~i~~qil~aL~yLH-~~gIiHrDLKp~NILl~~~g-~v  289 (291)
                      .++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l  164 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSAL  164 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcc
Confidence            99999999998887 4443 5667788889999999999999 99999999999999999888 44

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.64  E-value=2.1e-07  Score=88.36  Aligned_cols=125  Identities=21%  Similarity=0.308  Sum_probs=97.4

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe----CCEEEEEEeccCCC-CH
Q 022853          163 FAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRLYLVLDFVNGG-HL  237 (291)
Q Consensus       163 fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~gg-~L  237 (291)
                      -.+.|+++...+|..|++|.+..++....+.   ...-++.++++.|+|+|.+.++|.+    +..+++|++|.++. +|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            3578999999999999999995544332211   1234678899999999999988863    45799999999874 55


Q ss_pred             HHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          238 FFQLYR---------------QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       238 ~~~l~~---------------~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .++...               ....++...+.|+.|+..||.++|+.|+.-+-|.|.+||++.+.+||
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIr  433 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIR  433 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEE
Confidence            544331               12356788999999999999999999999999999999999876554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.57  E-value=1.2e-06  Score=75.37  Aligned_cols=92  Identities=26%  Similarity=0.332  Sum_probs=67.6

Q ss_pred             HHHHHHHHHHhCCCCC--eeEEeEEEEeC----CEEEEEEeccCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 022853          196 YMKSERNILTKVDHPF--IVQLRYSFQTK----YRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA  268 (291)
Q Consensus       196 ~~~~E~~il~~l~Hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~  268 (291)
                      ...+|...+..|..-.  +++.+++.+..    ...++|||++++. +|..++......+......++.+++..+.-||.
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence            3556766666553222  22333333332    3468999999985 788887764446667778889999999999999


Q ss_pred             CCCEecccCCCcEEecCCC
Q 022853          269 NGIMHRDLKPENILLDADG  287 (291)
Q Consensus       269 ~gIiHrDLKp~NILl~~~g  287 (291)
                      +||+|+|+++.|||++.++
T Consensus       137 ~gi~H~Dl~~~NILv~~~~  155 (206)
T PF06293_consen  137 AGIYHGDLNPSNILVDPDD  155 (206)
T ss_pred             CcCCCCCCCcccEEEeCCC
Confidence            9999999999999999875

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.50  E-value=6.2e-07  Score=76.03  Aligned_cols=115  Identities=24%  Similarity=0.303  Sum_probs=71.2

Q ss_pred             EEEEEEEcCCCcEEEEEEeecccc-----------------------chHHHHHHHHHHHHHHHhCCCC--CeeEEeEEE
Q 022853          165 KVYQVRRIGTSEIYAMKVMRKDKI-----------------------MEKNHAEYMKSERNILTKVDHP--FIVQLRYSF  219 (291)
Q Consensus       165 ~Vy~~~~~~~~~~vAiK~i~~~~~-----------------------~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~~  219 (291)
                      .||.|... .+..+|+|+.+....                       .........++|.+.|.++..-  ++++.+.+ 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            38888774 567899998854210                       0111234567899999999665  46666544 


Q ss_pred             EeCCEEEEEEeccC--CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHCCCEecccCCCcEEecCC
Q 022853          220 QTKYRLYLVLDFVN--GGHLFFQLYRQGLFREDLARIYTAEIVSAVSH-LHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       220 ~~~~~~~lV~E~~~--gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~y-LH~~gIiHrDLKp~NILl~~~  286 (291)
                       .  .-+|||||++  |..+.. +.... +.......++.+++..+.. +|..||+|+||.+.|||++.+
T Consensus        79 -~--~~~ivME~I~~~G~~~~~-l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~  143 (188)
T PF01163_consen   79 -N--RNVIVMEYIGEDGVPLPR-LKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG  143 (188)
T ss_dssp             -E--TTEEEEE--EETTEEGGC-HHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT
T ss_pred             -e--CCEEEEEecCCCccchhh-HHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc
Confidence             2  2369999999  655533 22211 1123445567778876555 579999999999999999876

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.44  E-value=2e-07  Score=89.44  Aligned_cols=137  Identities=22%  Similarity=0.245  Sum_probs=105.6

Q ss_pred             ccCCeEEEEEecc--cCceEEEEEEE--cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeC
Q 022853          148 GLEDFEVLKVVGQ--GAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~--G~fg~Vy~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~  222 (291)
                      ..+.|.+...+|.  |.+|.||.+..  ..++..+|+|.-+...-.... ...-.+|....+++ .|+|.++.+..+...
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccC
Confidence            3346778889999  99999999888  778889999974322110111 11122455555555 699999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHH----HHHHHHHCCCEecccCCCcEEecCC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVS----AVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~----aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      +..|+-+|++.. +|..+.... ..++...++.+..+...    ||.++|+.+++|-|+||+||++..+
T Consensus       191 ~~lfiqtE~~~~-sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~  258 (524)
T KOG0601|consen  191 GILFIQTELCGE-SLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSD  258 (524)
T ss_pred             Ccceeeeccccc-hhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccc
Confidence            999999999974 666665544 34778888888888888    9999999999999999999999888

>PRK09902 hypothetical protein; Provisional

Probab=98.41  E-value=3.8e-06  Score=72.25  Aligned_cols=128  Identities=13%  Similarity=0.171  Sum_probs=84.0

Q ss_pred             cccCceEEEEEEEcCCCcEEEEEEeeccccch---HHHHHHHHHHHHHHHhCCCCC--eeEEeEEEEe----CCEEEEEE
Q 022853          159 GQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME---KNHAEYMKSERNILTKVDHPF--IVQLRYSFQT----KYRLYLVL  229 (291)
Q Consensus       159 G~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~~~~----~~~~~lV~  229 (291)
                      |+|+.+-|+.....+  ..+-+|.-.......   ..-...+.+|...+..|..-+  +++.......    ...-+||+
T Consensus        27 ~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            557777888766532  346666543111000   112456778888888774322  4444322211    23478999


Q ss_pred             eccCCC-CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          230 DFVNGG-HLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       230 E~~~gg-~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      |-+.|- +|.+++...  ...+......++.+++.++.-||+.|+.|+|+.+.|||++.+|.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~  166 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGK  166 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCC
Confidence            987753 776666543  23456666788899999999999999999999999999986665

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.36  E-value=2e-06  Score=76.11  Aligned_cols=128  Identities=20%  Similarity=0.211  Sum_probs=89.3

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc------------h-------HHHHHHHHHHHHHHHhCCCC--
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM------------E-------KNHAEYMKSERNILTKVDHP--  210 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~------------~-------~~~~~~~~~E~~il~~l~Hp--  210 (291)
                      +.+...||-|-=+.||.|.+. .|.++|||.-+.....            +       .-.....++|.++|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            346689999999999999886 5788999975432110            0       11133456788889888544  


Q ss_pred             CeeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       211 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      .+++.+++    +.-.+||||++|-.|...-     +....+..++..|+.-+.-+-..||||+|+.+=|||++.||.+
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence            56665543    5667999999997664322     1233444556666666666668999999999999999999764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.26  E-value=1.2e-06  Score=83.81  Aligned_cols=87  Identities=18%  Similarity=0.238  Sum_probs=76.0

Q ss_pred             HHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCC-EecccCCCcE
Q 022853          204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGI-MHRDLKPENI  281 (291)
Q Consensus       204 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gI-iHrDLKp~NI  281 (291)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.. ...++.-....++++|+.||+|+|.-.| .|+.|+..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            3568999999999999999999999999999999998886 3445666666778899999999999866 9999999999


Q ss_pred             EecCCCCcC
Q 022853          282 LLDADGHVR  290 (291)
Q Consensus       282 Ll~~~g~vK  290 (291)
                      +++....+|
T Consensus        81 lvd~~w~lk   89 (484)
T KOG1023|consen   81 LVDSRWVLK   89 (484)
T ss_pred             eeeeeEEEE
Confidence            999887765

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.25  E-value=2.6e-05  Score=67.49  Aligned_cols=129  Identities=19%  Similarity=0.259  Sum_probs=80.6

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHH------HHHHHHHHHHhC---CCCCeeEEeEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAE------YMKSERNILTKV---DHPFIVQLRYSF  219 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~------~~~~E~~il~~l---~HpnIv~l~~~~  219 (291)
                      ..+|++.+.+-......|.+..-  .++.+++|..+......+....      ...+++..+..+   .--....++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            35789999998888888877665  5678999987654322111111      112223322222   222233322222


Q ss_pred             -----EeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          220 -----QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       220 -----~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                           .-....+++|||++|..|.+...    +.+.    +...+..++.-||..|+.|+|..|.|++++.++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc
Confidence                 22234678999999987754322    2222    334677789999999999999999999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.23  E-value=7.8e-07  Score=80.26  Aligned_cols=90  Identities=22%  Similarity=0.382  Sum_probs=75.7

Q ss_pred             HHHHHhCCCCCeeEEeEEEEeC-----CEEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC-
Q 022853          201 RNILTKVDHPFIVQLRYSFQTK-----YRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANG-  270 (291)
Q Consensus       201 ~~il~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qil~aL~yLH~~g-  270 (291)
                      ..-+.++.|.||++++.+|.+.     .+..+++|||..|++..+|++-    ..+.....++|+.||+.||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            4456677899999998888543     4588999999999999988763    34566677889999999999999984 


Q ss_pred             -CEecccCCCcEEecCCCCcC
Q 022853          271 -IMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       271 -IiHrDLKp~NILl~~~g~vK  290 (291)
                       |+|+++..+-|++..+|-||
T Consensus       198 piihgnlTc~tifiq~ngLIk  218 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIK  218 (458)
T ss_pred             ccccCCcchhheeecCCceEE
Confidence             99999999999999888776

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.11  E-value=2e-07  Score=94.57  Aligned_cols=145  Identities=29%  Similarity=0.376  Sum_probs=119.4

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      ....+++.+.+-+-+|+++.++.+.-..++-..++|+..+......+..+....+..++-...+|.+++....+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            45677899999999999999999988888877777776554433333344455555555556778888877777778889


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +++++|+.+++|...+..-+..+++.++.+...+..+++|||...++|||++|.|+|...+|+.+
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~  944 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRP  944 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcc
Confidence            99999999999999999888888889999999999999999999999999999999999888754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.02  E-value=0.00012  Score=62.66  Aligned_cols=124  Identities=23%  Similarity=0.272  Sum_probs=85.2

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccch-------------HHHHHHHHHHHHHHHhCC------CCCeeEEe
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-------------KNHAEYMKSERNILTKVD------HPFIVQLR  216 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-------------~~~~~~~~~E~~il~~l~------HpnIv~l~  216 (291)
                      ..||+|+.-.||.  +.. ....+||++.......             ........+|+.-...+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            5789999999995  332 3346899987765100             111233445655544444      88999999


Q ss_pred             EEEEeCCEEEEEEeccCC--C----CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          217 YSFQTKYRLYLVLDFVNG--G----HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       217 ~~~~~~~~~~lV~E~~~g--g----~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ++.+++..+-+|+|.+..  |    +|.+++.. +.+++ .   +...+-.-.+||-..+|+.+||+|.||++...+
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence            999999999999998643  2    67777744 44554 2   223334456688899999999999999997643

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.01  E-value=0.00012  Score=62.56  Aligned_cols=118  Identities=24%  Similarity=0.326  Sum_probs=83.2

Q ss_pred             CCeEEEEEecccCc-eEEEEEEEcCCCcEEEEEEeeccccc----------h--------HHHHHHHHHHHHHHHhC---
Q 022853          150 EDFEVLKVVGQGAF-AKVYQVRRIGTSEIYAMKVMRKDKIM----------E--------KNHAEYMKSERNILTKV---  207 (291)
Q Consensus       150 ~~y~i~~~LG~G~f-g~Vy~~~~~~~~~~vAiK~i~~~~~~----------~--------~~~~~~~~~E~~il~~l---  207 (291)
                      .+++.++.||.|.- |.||+++.  .|+.||+|++..-...          .        ......|..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 99999987  5779999994321110          0        02234577888887776   


Q ss_pred             CCCCe--eEEeEEEEeC------------------CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 022853          208 DHPFI--VQLRYSFQTK------------------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH  267 (291)
Q Consensus       208 ~HpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH  267 (291)
                      .+.++  ++.++++.-.                  ...-||.||++...         .+.    ..-+.+|++-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence            44555  8888776221                  12457888776643         112    223567888899999


Q ss_pred             HCCCEecccCCCcEE
Q 022853          268 ANGIMHRDLKPENIL  282 (291)
Q Consensus       268 ~~gIiHrDLKp~NIL  282 (291)
                      ..||+-+|+++.|..
T Consensus       182 k~gI~~~Dv~~~ny~  196 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR  196 (207)
T ss_pred             HCCeeeccCcccccc
Confidence            999999999999975

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.92  E-value=5.8e-05  Score=73.36  Aligned_cols=129  Identities=20%  Similarity=0.278  Sum_probs=77.9

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccch-------------------------------HHHHHHH------H
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-------------------------------KNHAEYM------K  198 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-------------------------------~~~~~~~------~  198 (291)
                      +.|+.++-|.||+|+... |+.||||+.+++-...                               .+..+.+      .
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            679999999999999875 8999999987642110                               0111112      2


Q ss_pred             HHHHHHHhC-----CCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHH--HHHcCCCCHHHHHHHHHHHHHH-HHHHHHCC
Q 022853          199 SERNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ--LYRQGLFREDLARIYTAEIVSA-VSHLHANG  270 (291)
Q Consensus       199 ~E~~il~~l-----~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~--l~~~~~~~~~~~~~i~~qil~a-L~yLH~~g  270 (291)
                      +|+..+.++     +.|++.--.-+++-.+.-.++|||++|-.+.+.  +... .++....   +..++.+ +.-+-..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~-g~d~k~i---a~~~~~~f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA-GIDRKEL---AELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc-CCCHHHH---HHHHHHHHHHHHHhcC
Confidence            344333333     334433222233334556799999999877665  3343 3332221   1111111 22333479


Q ss_pred             CEecccCCCcEEecCCCCc
Q 022853          271 IMHRDLKPENILLDADGHV  289 (291)
Q Consensus       271 IiHrDLKp~NILl~~~g~v  289 (291)
                      ++|.|..|.||+++.+|.+
T Consensus       286 ffHaDpHpGNi~v~~~g~i  304 (517)
T COG0661         286 FFHADPHPGNILVRSDGRI  304 (517)
T ss_pred             ccccCCCccceEEecCCcE
Confidence            9999999999999999764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.91  E-value=0.00019  Score=62.68  Aligned_cols=72  Identities=18%  Similarity=0.137  Sum_probs=52.1

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCC--eeEEeEEEEeCCEEEEEEeccC
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVN  233 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~  233 (291)
                      ..||+|..+.||+.    .+..+++|.......     ...+.+|.+++..+..-.  +.+.+.+....+..++|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~-----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD-----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCC-----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            67899999999974    244578898765331     233578888888875333  4566677777788899999999


Q ss_pred             CCC
Q 022853          234 GGH  236 (291)
Q Consensus       234 gg~  236 (291)
                      |.+
T Consensus        78 G~~   80 (226)
T TIGR02172        78 GKR   80 (226)
T ss_pred             Ccc
Confidence            963

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.90  E-value=0.00013  Score=75.23  Aligned_cols=80  Identities=11%  Similarity=0.260  Sum_probs=56.2

Q ss_pred             EEEecccCceEEEEEEEcCCC--cEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCe--eEEeEEEEeC---CEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTS--EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFI--VQLRYSFQTK---YRLY  226 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnI--v~l~~~~~~~---~~~~  226 (291)
                      ++.++.|.++.+|+......+  ..+++|+........  ....+.+|..+++.+. |+++  ++++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            577899999999998765432  467788765432211  1235778999999885 6665  6777766554   4689


Q ss_pred             EEEeccCCCC
Q 022853          227 LVLDFVNGGH  236 (291)
Q Consensus       227 lV~E~~~gg~  236 (291)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999999864

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.85  E-value=0.00016  Score=63.52  Aligned_cols=125  Identities=21%  Similarity=0.208  Sum_probs=79.2

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHH---------------------HHHHHHHHHHHHhCC--CCCe
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH---------------------AEYMKSERNILTKVD--HPFI  212 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~---------------------~~~~~~E~~il~~l~--HpnI  212 (291)
                      -.|..|--+.||+|.. ..+..+|+|+.+.....-+..                     ......|..-|.++.  +-.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3677788888999876 457889999997543322111                     112335666666652  3333


Q ss_pred             eEEeEEEEeCCEEEEEEeccCCCCH-HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCC
Q 022853          213 VQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDAD  286 (291)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L-~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~  286 (291)
                      ++-+.+.    .-.|||||+..... .-.|.. -.+....+..+..++++.+.-|-. .++||+||..=|||+..+
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~  203 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDG  203 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECC
Confidence            4444332    24589999875421 111111 122333677778899999988877 899999999999999843

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.66  E-value=0.00041  Score=60.73  Aligned_cols=74  Identities=16%  Similarity=0.083  Sum_probs=50.6

Q ss_pred             EecccCc-eEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEEEeccCC
Q 022853          157 VVGQGAF-AKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       157 ~LG~G~f-g~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g  234 (291)
                      .|-.|.. ..||++...  +..+.+|+.....      ...+.+|+.++..+ .+--+.+++++....+..++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            4445555 788988653  3568888875432      22355688888777 234466777777766778999999999


Q ss_pred             CCHH
Q 022853          235 GHLF  238 (291)
Q Consensus       235 g~L~  238 (291)
                      .++.
T Consensus        77 ~~l~   80 (244)
T cd05150          77 VPAA   80 (244)
T ss_pred             ccHh
Confidence            8765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=97.42  E-value=6.1e-05  Score=71.73  Aligned_cols=65  Identities=29%  Similarity=0.405  Sum_probs=54.8

Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGL---FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~---~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .++||.|++|...+|.+++.+...   .+......++.|++.|++|   +|.+|||+||.||++..++.+|
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence            368999999999999999976533   3455677889999999999   9999999999999998776554

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.40  E-value=0.00089  Score=65.24  Aligned_cols=124  Identities=19%  Similarity=0.304  Sum_probs=74.6

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccch----------------------------HHHHHHHH------HHH
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----------------------------KNHAEYMK------SER  201 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~----------------------------~~~~~~~~------~E~  201 (291)
                      +.||.-+.|.||+|+.+. |+.||||+-+++-...                            .+..+.+.      .|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            679999999999999886 9999999986542110                            01111111      222


Q ss_pred             H----HHHhCCCCC------eeEEeEEEEeCCEEEEEEeccCCCCHH--HHHHHcCCCCHHHHHHHHHHHHHH-HHHHHH
Q 022853          202 N----ILTKVDHPF------IVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGLFREDLARIYTAEIVSA-VSHLHA  268 (291)
Q Consensus       202 ~----il~~l~Hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~--~~l~~~~~~~~~~~~~i~~qil~a-L~yLH~  268 (291)
                      +    +.+.+.|-+      |+++|..+  ...-.|+||||+|..+.  +.+.+.+.-+.+.+.    .+.++ ++-|-.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~----~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILN----KLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHH----HHHHHHHHHHHh
Confidence            2    222334444      55554333  33467999999998664  344444433332222    22222 223345


Q ss_pred             CCCEecccCCCcEEecCC
Q 022853          269 NGIMHRDLKPENILLDAD  286 (291)
Q Consensus       269 ~gIiHrDLKp~NILl~~~  286 (291)
                      .|++|+|-.|-||++..+
T Consensus       320 ~GffHaDPHPGNilv~~~  337 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPN  337 (538)
T ss_pred             cCCccCCCCCCcEEEecC
Confidence            689999999999999954

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.35  E-value=0.0013  Score=55.02  Aligned_cols=116  Identities=21%  Similarity=0.269  Sum_probs=77.8

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCee-EEeEEEEeCCEEEEEEe
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV-QLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~~~~~~~~~~~lV~E  230 (291)
                      .+..+.|++|.+|.||++.+.  +..+|+|+-+.+..     ...+..|+++|..+.--++. ++|.+    +..++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhh
Confidence            345688999999999999984  45799998766542     55688899999988765554 44444    23456699


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccC-CC-cEEecC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK-PE-NILLDA  285 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLK-p~-NILl~~  285 (291)
                      |+.|-.|.......   .    +.-...++.+---|-..||-|..|. |. ||+++.
T Consensus        93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~  142 (201)
T COG2112          93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVND  142 (201)
T ss_pred             hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecC
Confidence            99998886543321   1    2223345555445667789898884 44 455443

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.20  E-value=0.00088  Score=56.81  Aligned_cols=89  Identities=17%  Similarity=0.207  Sum_probs=67.4

Q ss_pred             HHHHHHHHhCCC-CCeeEEeEEEEeCCEEEEEEeccCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 022853          198 KSERNILTKVDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ---LYRQGLFREDLARIYTAEIVSAVSHLHA---NG  270 (291)
Q Consensus       198 ~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~---l~~~~~~~~~~~~~i~~qil~aL~yLH~---~g  270 (291)
                      ..|.-++..+.+ +++++++|++-    -++|+||...+++...   +......++.....++.+++..+++++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357778888865 69999999873    2568899987655321   1111234677778899999999999988   34


Q ss_pred             CEecccCCCcEEecCCCCcC
Q 022853          271 IMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       271 IiHrDLKp~NILl~~~g~vK  290 (291)
                      +.-.|++|+|+-++.+|++|
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk  102 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLK  102 (188)
T ss_pred             EEEeecchHHeEEeCCCcEE
Confidence            77799999999999998876

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.01  E-value=0.017  Score=49.14  Aligned_cols=78  Identities=19%  Similarity=0.272  Sum_probs=54.6

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCC--CeeEEeEEE---EeCCEEEEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIVQLRYSF---QTKYRLYLVL  229 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~~---~~~~~~~lV~  229 (291)
                      ++.|+.|..+.||++...+  ..+++|+....     .....+..|..++..+...  .+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            4789999999999998865  47999987544     2345566788887777322  345665533   3345689999


Q ss_pred             eccCCCCHHH
Q 022853          230 DFVNGGHLFF  239 (291)
Q Consensus       230 E~~~gg~L~~  239 (291)
                      ++++|..+..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.99  E-value=0.0031  Score=55.00  Aligned_cols=72  Identities=10%  Similarity=0.109  Sum_probs=43.1

Q ss_pred             EEecccCce-EEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCC---CeeEEeEEEEeC---CEEEEE
Q 022853          156 KVVGQGAFA-KVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP---FIVQLRYSFQTK---YRLYLV  228 (291)
Q Consensus       156 ~~LG~G~fg-~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~~~~~~~---~~~~lV  228 (291)
                      +.|+.|+.. .||+..     ..+++|+.....     ....+.+|..++..+...   -+.+++......   ...|++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            467766666 588752     247778754321     134577899888877421   233444333221   245889


Q ss_pred             EeccCCCCH
Q 022853          229 LDFVNGGHL  237 (291)
Q Consensus       229 ~E~~~gg~L  237 (291)
                      |++++|.++
T Consensus        73 ~~~i~G~~l   81 (235)
T cd05155          73 YRWLEGETA   81 (235)
T ss_pred             EEeecCCCC
Confidence            999998765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.95  E-value=0.0097  Score=51.58  Aligned_cols=75  Identities=20%  Similarity=0.257  Sum_probs=46.9

Q ss_pred             EEEecccCceEEEEEEEcC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEEEEecc
Q 022853          155 LKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFV  232 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~  232 (291)
                      ++.|..|-...+|++.... .++.|++|+.......    .-...+|..++..+. +...++++..+. .   .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEee
Confidence            4677888888999987543 3567889977543211    111235777777773 333445544432 2   3799999


Q ss_pred             CCCCH
Q 022853          233 NGGHL  237 (291)
Q Consensus       233 ~gg~L  237 (291)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=96.87  E-value=0.01  Score=53.97  Aligned_cols=78  Identities=9%  Similarity=0.029  Sum_probs=54.4

Q ss_pred             EEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCC---CCeeEEeEEEEe---CCEEE
Q 022853          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH---PFIVQLRYSFQT---KYRLY  226 (291)
Q Consensus       153 ~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H---pnIv~l~~~~~~---~~~~~  226 (291)
                      .-.+.||.|..+.||+....+ + .+.+|..+...     ....+..|+..|+.+.-   -.++++++.+..   .+..|
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~   89 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV   89 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence            345789999999999886432 3 46777743311     12457789998888743   356777776644   46689


Q ss_pred             EEEeccCCCCH
Q 022853          227 LVLDFVNGGHL  237 (291)
Q Consensus       227 lV~E~~~gg~L  237 (291)
                      +|||+++|+++
T Consensus        90 LVmE~i~G~~~  100 (297)
T PRK10593         90 LLLERLRGVSV  100 (297)
T ss_pred             EEEeccCCEec
Confidence            99999998765

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.63  E-value=0.03  Score=50.86  Aligned_cols=78  Identities=15%  Similarity=0.087  Sum_probs=45.8

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCC--CeeEEeEE------EEeCC
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIVQLRYS------FQTKY  223 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~------~~~~~  223 (291)
                      ...++.++.|.-..+|++...  +..+++|+......     .+.+..|..++..|...  .+++++..      ....+
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~-----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g   96 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVK-----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG   96 (307)
T ss_pred             ceeccccCCccccceEEEEeC--CCcEEEEEecCCCC-----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence            444677788887899987642  33588898754321     12234556666555221  13343321      12346


Q ss_pred             EEEEEEeccCCCC
Q 022853          224 RLYLVLDFVNGGH  236 (291)
Q Consensus       224 ~~~lV~E~~~gg~  236 (291)
                      ..+++++|++|..
T Consensus        97 ~~~~l~e~i~G~~  109 (307)
T TIGR00938        97 KPACLVEFLQGLS  109 (307)
T ss_pred             eEEEEEEeCCCCC
Confidence            6899999999854

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.53  E-value=0.025  Score=50.89  Aligned_cols=75  Identities=17%  Similarity=0.158  Sum_probs=47.2

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCC--eeEEeE------EEEeCCEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRY------SFQTKYRLY  226 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~------~~~~~~~~~  226 (291)
                      .+.+..|....+|+....  +..+++|+.....      .+.+..|+.++..+.+.+  +++++.      .....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKVS------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCCC------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            567778887899987653  3468899875421      233556777776663222  344432      123345678


Q ss_pred             EEEeccCCCCH
Q 022853          227 LVLDFVNGGHL  237 (291)
Q Consensus       227 lV~E~~~gg~L  237 (291)
                      +|++|++|..+
T Consensus        91 ~l~~~i~G~~~  101 (296)
T cd05153          91 ALVEFLAGEHL  101 (296)
T ss_pred             EEEEeCCCCCC
Confidence            99999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.12  E-value=0.05  Score=50.74  Aligned_cols=77  Identities=13%  Similarity=0.065  Sum_probs=47.8

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeecccc--c-h-HHHHHHHHHHHHHHHhCC--CC-CeeEEeEEEEeCCEEEEEE
Q 022853          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--M-E-KNHAEYMKSERNILTKVD--HP-FIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       157 ~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~-~-~~~~~~~~~E~~il~~l~--Hp-nIv~l~~~~~~~~~~~lV~  229 (291)
                      .||.|....||++.....++.++||.-.+-..  . . .-..++...|...|+...  -| .++++|.  .++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            57999999999999754446799997532110  0 0 112344456777776652  23 5666643  3555667999


Q ss_pred             eccCCC
Q 022853          230 DFVNGG  235 (291)
Q Consensus       230 E~~~gg  235 (291)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK05231 homoserine kinase; Provisional

Probab=96.10  E-value=0.18  Score=45.85  Aligned_cols=74  Identities=14%  Similarity=0.148  Sum_probs=41.7

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-----CCCCeeEEe---EEEEeCCEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-----DHPFIVQLR---YSFQTKYRLY  226 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~---~~~~~~~~~~  226 (291)
                      .+.++.|....+|+....  +..+++|+....   ..   +.+..|..++..|     .-|.++.-.   .+....+..+
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~---~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFERL---TA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEeccC---Ch---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            355777777889988653  336889987521   11   2223344444443     233333210   1123356789


Q ss_pred             EEEeccCCCC
Q 022853          227 LVLDFVNGGH  236 (291)
Q Consensus       227 lV~E~~~gg~  236 (291)
                      ++++|++|..
T Consensus        99 ~l~~~l~G~~  108 (319)
T PRK05231         99 AIVTFLEGKW  108 (319)
T ss_pred             EEEEecCCCC
Confidence            9999999874

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.06  E-value=0.024  Score=50.02  Aligned_cols=71  Identities=8%  Similarity=0.112  Sum_probs=41.7

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCe-eEEeEEEEeCCEEEEEEeccCCCC
Q 022853          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVLDFVNGGH  236 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~gg~  236 (291)
                      +..|-.+.+|+...  .++.+++|+.......-  .. ...+|..+++.+....+ .+++...  .  -++||||++|..
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~--~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKAL--GV-DRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccccc--cC-cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence            45677778888763  45678888754331110  01 13567778877743322 3444332  2  368999999865


Q ss_pred             H
Q 022853          237 L  237 (291)
Q Consensus       237 L  237 (291)
                      +
T Consensus        75 ~   75 (256)
T TIGR02721        75 I   75 (256)
T ss_pred             c
Confidence            4

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.81  E-value=0.056  Score=48.80  Aligned_cols=75  Identities=13%  Similarity=0.148  Sum_probs=45.4

Q ss_pred             EEEecccCceEEEEEEEcC------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCC-CeeEEeEEEEeCCEEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIG------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP-FIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~l~~~~~~~~~~~l  227 (291)
                      ++.|..|-...+|++....      .++.+++|+.......    .....+|..++..+... -..++++.+..    .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFPN----GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence            3556677777888887543      2578999987553211    12245677777776322 23455555432    35


Q ss_pred             EEeccCCCCH
Q 022853          228 VLDFVNGGHL  237 (291)
Q Consensus       228 V~E~~~gg~L  237 (291)
                      |+||++|..+
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            8999988755

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.71  E-value=0.12  Score=46.71  Aligned_cols=76  Identities=16%  Similarity=0.246  Sum_probs=47.4

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC---CCCCeeEEeEEEEeCCEEEEE
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .+-.+.++.|....+|+..  .+++.+.+|+-....      ...+..|+.-|+.|   .--.+++.+.+....+..|+|
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            3456789999999999877  577889999876322      33467788777777   344567888888777778999


Q ss_pred             EeccCCC
Q 022853          229 LDFVNGG  235 (291)
Q Consensus       229 ~E~~~gg  235 (291)
                      |||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=95.68  E-value=0.21  Score=47.29  Aligned_cols=80  Identities=11%  Similarity=0.074  Sum_probs=54.3

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccc--h--HHHHHHHHHHHHHHHhC---CCCCeeEEeEEEEeCCEEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--E--KNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~--~--~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~~~l  227 (291)
                      .+.||.|.+..||++...+.++.++||.-.+....  +  .-..++...|.+.|..+   ....+++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46799999999999998654468999985421100  0  11245566777777765   23467777655  4466789


Q ss_pred             EEeccCCCC
Q 022853          228 VLDFVNGGH  236 (291)
Q Consensus       228 V~E~~~gg~  236 (291)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998754

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.36  E-value=0.11  Score=49.15  Aligned_cols=79  Identities=14%  Similarity=0.142  Sum_probs=50.3

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccc--h-HHHHHHHHHHHHHHHhC---CCCCeeEEeEEEEeCCEEEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--E-KNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~--~-~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .+.||-|.-..||++.+...++.++||.-..-...  + .-..++..-|..+|+.+   .-..++++|.  .+.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            57889999999999998533567899875321110  0 11244556677777765   2235666653  355667789


Q ss_pred             EeccCCC
Q 022853          229 LDFVNGG  235 (291)
Q Consensus       229 ~E~~~gg  235 (291)
                      ||+++..
T Consensus       112 MEdL~~~  118 (409)
T PRK12396        112 MEDLSDH  118 (409)
T ss_pred             HHhCccc
Confidence            9998653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=95.25  E-value=0.0032  Score=61.99  Aligned_cols=121  Identities=17%  Similarity=0.177  Sum_probs=82.0

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCC-eeEEeEEEEeCCEEEEEEe
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~E  230 (291)
                      |.....+++|+++++++.+...+.... .+.+...        ...+-++++|.+++||| .+..++.++.+...+++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            455566899999999998876665544 5655432        22445788999999999 7777777788889999999


Q ss_pred             ccCCC-CHHH-HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          231 FVNGG-HLFF-QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       231 ~~~gg-~L~~-~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      ++.++ +... .....-.+.+-......+.-+++++++|+---+|||    ||+...
T Consensus       315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~  367 (829)
T KOG0576|consen  315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE  367 (829)
T ss_pred             hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc
Confidence            99887 2111 100111122222334455667889999998778998    777654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.09  E-value=0.2  Score=44.96  Aligned_cols=45  Identities=16%  Similarity=0.210  Sum_probs=27.2

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC
Q 022853          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD  208 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~  208 (291)
                      .+.|--..|+.+.. ..|..+++|.-+...     ....+.+|..+|+.+.
T Consensus        19 ~~~g~~~~v~~i~~-~~g~~~VlR~p~~~~-----~~~~l~rE~~vL~~L~   63 (276)
T cd05152          19 NESGLDFQVVFAKD-TDGVPWVLRIPRRPD-----VSERAAAEKRVLALVR   63 (276)
T ss_pred             cCCcceeEEEEEEc-CCCCeEEEEecCCHH-----HHHHHHHHHHHHHHHH
Confidence            34554556665532 246678888764322     2345678998888874

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.00  E-value=0.14  Score=47.93  Aligned_cols=130  Identities=16%  Similarity=0.234  Sum_probs=81.1

Q ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc-------------------h---HHHHH-HHHHHHHHHHhCCCC
Q 022853          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-------------------E---KNHAE-YMKSERNILTKVDHP  210 (291)
Q Consensus       154 i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-------------------~---~~~~~-~~~~E~~il~~l~Hp  210 (291)
                      +-..|..|-=+.||.|... .|..+|||+++.....                   .   ...+. ....|++-|.+++..
T Consensus       148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3356777888899998765 4667999998643211                   0   11111 223567777777554


Q ss_pred             CeeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHCCCEecccCCCcEEecCC
Q 022853          211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL-HANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       211 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yL-H~~gIiHrDLKp~NILl~~~  286 (291)
                      .|..---...  ..-.|||+|+.......-..+.-.++...++.+-.|++.-|.-| +.+++||.||.-=|+|+-..
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG  301 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG  301 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC
Confidence            4433211111  12458999997543333233344566777787777887777766 55699999999999998543

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.88  E-value=0.092  Score=49.71  Aligned_cols=63  Identities=24%  Similarity=0.292  Sum_probs=41.5

Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHCCCEecccCCCcEEecCCC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH-LHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~y-LH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ...++-+|+.|-.+..++...+ .++...++++.-...|+-- +--.+++|.|+.|.||++.-..
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            3457778888888877666433 3444555555444455433 3446899999999999996543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.87  E-value=0.019  Score=52.72  Aligned_cols=127  Identities=18%  Similarity=0.240  Sum_probs=80.9

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch---HH--------------H--HHHHHHHHHHHHhC-CCCC
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME---KN--------------H--AEYMKSERNILTKV-DHPF  211 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~---~~--------------~--~~~~~~E~~il~~l-~Hpn  211 (291)
                      +.+.+.||-|-=+.||.+-+. .|.+.++|+-+.....-   ++              .  +-...+|...|+.| .|.+
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            567789999999999998775 46778888653322110   00              0  11123577777777 3332


Q ss_pred             -eeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          212 -IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       212 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                       +++.+    +-++-++|||++.|-.|...-.-.      .+..+...+..-+--|-..|+||+|..-=||+++.++.+
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence             22322    335678999999988775432111      122233444555666888999999999999999988764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.66  E-value=0.89  Score=40.92  Aligned_cols=64  Identities=16%  Similarity=0.185  Sum_probs=35.4

Q ss_pred             EEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCC--CeeEEeEE------EEeCCEEEEEEeccCCCC
Q 022853          165 KVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIVQLRYS------FQTKYRLYLVLDFVNGGH  236 (291)
Q Consensus       165 ~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~------~~~~~~~~lV~E~~~gg~  236 (291)
                      .||++...  +..+++|+....       .+.+..|..++..|...  .+++++..      ...++..|++++|++|..
T Consensus        11 ~v~~v~t~--~g~~~LK~~~~~-------~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~   81 (313)
T TIGR02906        11 NVYKVETD--SGNKCLKKINYP-------PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRE   81 (313)
T ss_pred             cEEEEEeC--CCCeEEEEcCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcC
Confidence            48887642  335889987532       12233455555444211  33333322      234667899999999854


Q ss_pred             H
Q 022853          237 L  237 (291)
Q Consensus       237 L  237 (291)
                      +
T Consensus        82 ~   82 (313)
T TIGR02906        82 C   82 (313)
T ss_pred             C
Confidence            3

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02236 choline kinase

Probab=94.37  E-value=0.37  Score=44.72  Aligned_cols=75  Identities=11%  Similarity=0.062  Sum_probs=45.0

Q ss_pred             EEEecccCceEEEEEEEcC----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCC-eeEEeEEEEeCCEEEEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~  229 (291)
                      ++.|-.|-...+|++....    .++.|++|+......   ...++ ..|..++..+..-+ -.++++.+...    .|+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~---~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE---LFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC---eeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence            3455558888999987532    246789998754321   11222 45777777774333 33555555332    579


Q ss_pred             eccCCCCH
Q 022853          230 DFVNGGHL  237 (291)
Q Consensus       230 E~~~gg~L  237 (291)
                      +|+++.++
T Consensus       113 efi~g~~l  120 (344)
T PLN02236        113 EFIHARTL  120 (344)
T ss_pred             EeeCCCCC
Confidence            99987665

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=93.50  E-value=0.41  Score=42.08  Aligned_cols=77  Identities=16%  Similarity=0.269  Sum_probs=50.4

Q ss_pred             EEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC---CCCeeEEeEEEEeCCEEEEEE
Q 022853          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       153 ~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      +-.+.+.-|..-..|...+  ....+-+|+-.      ......+..|+.-|..+.   --.+.+.+.......+.|+||
T Consensus        19 ~er~~v~gG~inea~~v~d--g~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVl   90 (286)
T COG3001          19 KEREEVSGGDINEAWRLRD--GTDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVL   90 (286)
T ss_pred             hcccccCCccccceeEeec--CCcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEE
Confidence            3344555555555555443  34567788643      233566778877666653   345677788888899999999


Q ss_pred             eccCCCCH
Q 022853          230 DFVNGGHL  237 (291)
Q Consensus       230 E~~~gg~L  237 (291)
                      ||++-+.+
T Consensus        91 e~L~~~~~   98 (286)
T COG3001          91 EYLPTGPL   98 (286)
T ss_pred             eeccCCCC
Confidence            99987544

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=93.17  E-value=0.018  Score=55.26  Aligned_cols=74  Identities=20%  Similarity=0.322  Sum_probs=59.2

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ....+|+....+|.|+||.|+.+.....+..+|||.|.....  ........+|..-+..+.|++|++++..|...
T Consensus        46 r~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~--e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~  119 (516)
T KOG1033|consen   46 REANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNR--EESRSRVLREVSSLAEFEHPGIKRYFHAWYER  119 (516)
T ss_pred             hhhccccccccccccCccccCCccccccchhhHHHHhcccch--hhhhhhhhccccchhhhcccchhhheeceecC
Confidence            345679999999999999999999988888899998865432  22345566788889999999999998777543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=92.97  E-value=0.41  Score=45.54  Aligned_cols=126  Identities=18%  Similarity=0.262  Sum_probs=79.7

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeE--------EeEEEEeCCEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ--------LRYSFQTKYRLY  226 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~--------l~~~~~~~~~~~  226 (291)
                      .+.||+|+-+.+|-.-...   ..+.|+..+.......     +.-..+...-.||-+..        +++. .....+.
T Consensus        16 gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iG   86 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIG   86 (637)
T ss_pred             CccccCCccceeeecchhh---chhheeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeE
Confidence            4789999999999643322   1356777654422111     11112222336665433        1111 1223377


Q ss_pred             EEEeccCCCCHHHHHH----Hc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCc
Q 022853          227 LVLDFVNGGHLFFQLY----RQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~----~~---~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~v  289 (291)
                      +.|..+.|..=...++    ++   ..+.++.+.+.++.++.+..-||..|.+-+|+.++|+|+.+++.|
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V  156 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKV  156 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceE
Confidence            8888887753222222    12   235677888889999999999999999999999999999998865

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.90  E-value=3.4  Score=37.44  Aligned_cols=67  Identities=19%  Similarity=0.291  Sum_probs=36.6

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeE------EEEeCCEEEEEEeccCCC
Q 022853          163 FAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY------SFQTKYRLYLVLDFVNGG  235 (291)
Q Consensus       163 fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~------~~~~~~~~~lV~E~~~gg  235 (291)
                      -+.||++.-  ++..+++|.+...    .+....+..-...|..-.-+.++.++.      +...++..|++|++++|.
T Consensus        19 ~~~v~~v~T--~~G~~~Lk~~~~~----~~~l~~~~~~~~~L~~~G~~~~~~~~~t~~G~~~~~~~~~~~~L~~wi~G~   91 (309)
T TIGR02904        19 TGKLFKVYT--DQGVFALKKLYAD----RNTIESFVSQIQVLSEKGFSRIVPVYPTKDGSYYLFHGHFLYYLMPWLDIE   91 (309)
T ss_pred             cCcEEEEEe--CCCCEEEEEeccc----hHhHHHHHHHHHHHHHcCCCcCCceeecCCCCeeeEECCEEEEEeCCcccc
Confidence            458888765  2345899988633    111222222233333333344555532      223456679999998874

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=92.41  E-value=1.5  Score=40.39  Aligned_cols=78  Identities=14%  Similarity=0.185  Sum_probs=44.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCe-eEEeEEEEeCCEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLY  226 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~  226 (291)
                      +.++.. |..|-...+|++...+.   +..|++|+.......   ... -.+|..+++.+..-++ +++++.+. .+   
T Consensus        16 ~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~---~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G---   86 (330)
T PLN02421         16 DFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY---VID-RERELQAIKYLSAAGFGAKLLGVFG-NG---   86 (330)
T ss_pred             ceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcCe---Eec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence            444444 44477778898865432   237889987543211   111 2357777777744333 45555553 22   


Q ss_pred             EEEeccCCCCH
Q 022853          227 LVLDFVNGGHL  237 (291)
Q Consensus       227 lV~E~~~gg~L  237 (291)
                      +|.+|++|.++
T Consensus        87 ~i~~fi~g~~l   97 (330)
T PLN02421         87 MIQSFINARTL   97 (330)
T ss_pred             EeehhhcCCCC
Confidence            58899887654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=91.63  E-value=0.85  Score=48.39  Aligned_cols=119  Identities=15%  Similarity=0.098  Sum_probs=79.5

Q ss_pred             ecccCceEEEEEEEcCC----CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE----EEEEE
Q 022853          158 VGQGAFAKVYQVRRIGT----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR----LYLVL  229 (291)
Q Consensus       158 LG~G~fg~Vy~~~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----~~lV~  229 (291)
                      +..-.+|+++..++...    .+++-++.-.-.....+........|...+.+..|+|++.++.+-.....    ..+..
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~  265 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ  265 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence            55566777777665321    11122221111111223345556667888889999999998877544322    23455


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeccc
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL  276 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDL  276 (291)
                      +++..-++...+..-+..+...++.+..+++.|+.|+|+....|.=+
T Consensus       266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L  312 (1351)
T KOG1035|consen  266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVL  312 (1351)
T ss_pred             hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEE
Confidence            78888889888888888999999999999999999999985554443

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=91.10  E-value=2.5  Score=38.84  Aligned_cols=80  Identities=13%  Similarity=0.186  Sum_probs=45.0

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCC--CeeEEeEEEEeCC--EEEE
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIVQLRYSFQTKY--RLYL  227 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~~~~~~--~~~l  227 (291)
                      ..+.+.+..|.--.+|....  +++.++++ ... ............+|..+++.+.--  -+...++.+.++.  ..|.
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            34445553443334454443  36778888 332 222223345567788888877432  2233455555544  6799


Q ss_pred             EEeccCCC
Q 022853          228 VLDFVNGG  235 (291)
Q Consensus       228 V~E~~~gg  235 (291)
                      ||+|++|.
T Consensus       103 v~~~veGe  110 (321)
T COG3173         103 VMEWVEGE  110 (321)
T ss_pred             EEEEecce
Confidence            99999983

>PLN02756 S-methyl-5-thioribose kinase

Probab=91.06  E-value=1.8  Score=41.28  Aligned_cols=78  Identities=15%  Similarity=0.063  Sum_probs=49.7

Q ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH----HHHHHHHHHHHHHHhCC---CCCeeEEeEEEEeCCEEE
Q 022853          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK----NHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       154 i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~  226 (291)
                      ..+.||.|....||+....  +..++||.-........    ...++...|...|+.+.   ...+++++.+..  ...+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            3678999999999998873  44688997652211000    01333344566665542   357778876655  4567


Q ss_pred             EEEeccCCC
Q 022853          227 LVLDFVNGG  235 (291)
Q Consensus       227 lV~E~~~gg  235 (291)
                      ++||+++++
T Consensus       112 lvME~L~~~  120 (418)
T PLN02756        112 IGMRYLEPP  120 (418)
T ss_pred             EEEeecCCc
Confidence            889999873

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=90.97  E-value=0.1  Score=40.80  Aligned_cols=32  Identities=25%  Similarity=0.224  Sum_probs=27.4

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccc
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK  187 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~  187 (291)
                      .+.||.|+.|.||+|+.+. |+.||||+.+++.
T Consensus        16 ~~PlasASiaQVh~a~l~~-g~~VaVKV~rP~i   47 (119)
T PF03109_consen   16 PEPLASASIAQVHRARLKD-GEEVAVKVQRPGI   47 (119)
T ss_pred             cchhhheehhhheeeeecc-cchhhhhhcchHH
Confidence            3679999999999999865 8899999987653

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=90.38  E-value=0.85  Score=40.00  Aligned_cols=78  Identities=15%  Similarity=0.324  Sum_probs=52.3

Q ss_pred             HHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--CCEe
Q 022853          196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--GIMH  273 (291)
Q Consensus       196 ~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~--gIiH  273 (291)
                      .+..+.++++++.  .|+++..-  +...+.+++|+|-.....            . ..++..=+.+|.-.|+.  +.+|
T Consensus       104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~------------~-~N~i~agi~~L~~fH~~~~~~lH  166 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN------------F-SNFITAGIKDLMDFHSENQHCLH  166 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc------------h-hHHHHHhHHHHHHhhccCCCeec
Confidence            4567788888764  56776522  445677899988543210            0 11121224667778843  7999


Q ss_pred             cccCCCcEEecCCCCcC
Q 022853          274 RDLKPENILLDADGHVR  290 (291)
Q Consensus       274 rDLKp~NILl~~~g~vK  290 (291)
                      +|..|+||+-|..|.+|
T Consensus       167 GD~np~NiM~D~~G~lK  183 (308)
T PF07387_consen  167 GDCNPDNIMCDKFGYLK  183 (308)
T ss_pred             CCCChhheeecCCCCEE
Confidence            99999999999999887

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=90.37  E-value=1.5  Score=41.28  Aligned_cols=78  Identities=17%  Similarity=0.239  Sum_probs=44.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCC-cE-----EEEEEeeccccchHHHHHHHHHHHHHHHhCCC-CCeeEEeEEEEeCC
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTS-EI-----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSFQTKY  223 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~-~~-----vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~  223 (291)
                      ++++ +.|..|-...+|++...... ..     |.+++.....   .-..+ -.+|..+++.+.. ..-.++++.+..  
T Consensus        52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~---~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~--  124 (383)
T PTZ00384         52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN---SLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD--  124 (383)
T ss_pred             cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC---ceEec-cHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence            3444 45556888899998754321 22     3444321111   00111 2457888888854 444566666642  


Q ss_pred             EEEEEEeccCCCCH
Q 022853          224 RLYLVLDFVNGGHL  237 (291)
Q Consensus       224 ~~~lV~E~~~gg~L  237 (291)
                        +++.||++|.+|
T Consensus       125 --g~l~efIeGr~l  136 (383)
T PTZ00384        125 --FTIQEWVEGNTM  136 (383)
T ss_pred             --EEEEEEeccccC
Confidence              589999998766

>PHA03111 Ser/Thr kinase; Provisional

Probab=90.03  E-value=1.1  Score=41.49  Aligned_cols=38  Identities=24%  Similarity=0.381  Sum_probs=27.3

Q ss_pred             HHHHHHHHHHHHHHHHHHHH----CCCEecccCCCcEEecCC
Q 022853          249 EDLARIYTAEIVSAVSHLHA----NGIMHRDLKPENILLDAD  286 (291)
Q Consensus       249 ~~~~~~i~~qil~aL~yLH~----~gIiHrDLKp~NILl~~~  286 (291)
                      .+.++.++.||+.-.-.+-.    .+.+|-||||+|||+-+.
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            45667788888655433423    258999999999999654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=86.20  E-value=27  Score=31.96  Aligned_cols=68  Identities=13%  Similarity=0.132  Sum_probs=38.6

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC---CCCeeE---EeE--EEEeCCEEEEEEeccCC
Q 022853          163 FAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQ---LRY--SFQTKYRLYLVLDFVNG  234 (291)
Q Consensus       163 fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~---l~~--~~~~~~~~~lV~E~~~g  234 (291)
                      -..||+.... .+..+++|+.+.....    ...+..|...+..|.   -| ++.   .-+  ....++..+.++++++|
T Consensus        38 eN~vy~v~~~-~~~~~vlKv~r~~~~~----~~~i~~E~~~l~~L~~~gip-v~~p~~~~G~~~~~~~g~~~~l~~~~~G  111 (325)
T PRK11768         38 ENRVYQFGDE-DGRRVVAKFYRPERWS----DAQILEEHAFALELAEAEIP-VVAPLAFNGQTLHEHQGFRFALFPRRGG  111 (325)
T ss_pred             cceEEEEecC-CCCEEEEEEcCcccCC----HHHHHHHHHHHHHHHHCCCC-CCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence            3578887653 4567999988644321    233455666665542   22 121   111  12335678889999987


Q ss_pred             CC
Q 022853          235 GH  236 (291)
Q Consensus       235 g~  236 (291)
                      ..
T Consensus       112 ~~  113 (325)
T PRK11768        112 RA  113 (325)
T ss_pred             CC
Confidence            63

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=83.23  E-value=1.2  Score=41.49  Aligned_cols=38  Identities=24%  Similarity=0.374  Sum_probs=25.0

Q ss_pred             HHHHHHHHHHHHHHHHHHHH----CCCEecccCCCcEEecCC
Q 022853          249 EDLARIYTAEIVSAVSHLHA----NGIMHRDLKPENILLDAD  286 (291)
Q Consensus       249 ~~~~~~i~~qil~aL~yLH~----~gIiHrDLKp~NILl~~~  286 (291)
                      ...++.++.||+.-.--+-+    .+.+|-||||+|||+-+.
T Consensus       274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  315 (434)
T PF05445_consen  274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDS  315 (434)
T ss_pred             HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecC
Confidence            34566777777443211222    368999999999999654

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=82.11  E-value=10  Score=36.14  Aligned_cols=67  Identities=19%  Similarity=0.365  Sum_probs=41.2

Q ss_pred             HHHH---HHHhCCCCCee--EEeEEE--EeC--CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 022853          199 SERN---ILTKVDHPFIV--QLRYSF--QTK--YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN  269 (291)
Q Consensus       199 ~E~~---il~~l~HpnIv--~l~~~~--~~~--~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~  269 (291)
                      +|+.   ++.+.+||++.  ++|..-  .++  ..-+|+|||+++....   .-...++.++    +.||++||+.+|..
T Consensus       115 rEv~~Y~~~~k~~~~~l~~PKvY~~k~f~~en~~kG~IimE~ven~~~~---~~~e~~~~eq----l~~iv~aLA~~~A~  187 (414)
T PF07914_consen  115 REVNFYKIFEKFNHPNLPYPKVYFGKKFDEENKLKGFIIMEYVENVHSM---DMYENLSVEQ----LLQIVRALAKFHAL  187 (414)
T ss_pred             HHHHHHHHHHhcCCCCCCCCceeEEEecCCCCCCCCEEEEeccCCceee---cccCCCCHHH----HHHHHHHHHHHHHh
Confidence            4554   45566788775  444332  222  2479999999986332   2223456555    45788888889987


Q ss_pred             CCE
Q 022853          270 GIM  272 (291)
Q Consensus       270 gIi  272 (291)
                      ++-
T Consensus       188 sl~  190 (414)
T PF07914_consen  188 SLK  190 (414)
T ss_pred             Hcc
Confidence            654

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=81.81  E-value=0.69  Score=46.24  Aligned_cols=33  Identities=24%  Similarity=0.664  Sum_probs=29.2

Q ss_pred             HHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          258 EIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       258 qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +++.|+.|+|.. ++||++|.|++|.++..|.+|
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wk  140 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWK  140 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCccee
Confidence            455899999976 899999999999999998765

>PRK06148 hypothetical protein; Provisional

Probab=81.63  E-value=40  Score=36.14  Aligned_cols=76  Identities=16%  Similarity=0.193  Sum_probs=41.0

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-------CCCCeeEEe-----EEEEe-C
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-------DHPFIVQLR-----YSFQT-K  222 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~l~-----~~~~~-~  222 (291)
                      +.|+ |..-.+|+... .++..+++|+.+...  .   ...+..|..+|..|       .-|.++.-.     ..... +
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~--~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~  103 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE--P---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD  103 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc--c---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence            4564 34577787764 346679999997642  1   11223344444433       233444321     11111 2


Q ss_pred             C--EEEEEEeccCCCCHH
Q 022853          223 Y--RLYLVLDFVNGGHLF  238 (291)
Q Consensus       223 ~--~~~lV~E~~~gg~L~  238 (291)
                      +  +.+.+++|++|..+.
T Consensus       104 G~~~~vrLl~~l~G~~l~  121 (1013)
T PRK06148        104 GEPRLLRLLSWLPGTPLA  121 (1013)
T ss_pred             CceEEEEEEeccCCCcHH
Confidence            2  567789999997664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	291
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-38
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-38
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-37
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-36
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-36
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-36
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-35
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-35
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-35
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-35
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-35
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-35
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-35
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-35
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-35
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-33
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-33
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-33
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-33
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-33
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-33
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-33
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-33
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-33
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-33
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-33
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-33
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-33
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-33
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-33
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-33
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-33
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-33
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-33
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-33
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-33
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-33
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-33
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-33
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-33
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-33
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-33
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-33
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-33
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-32
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-32
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-30
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-29
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-29
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-28
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-28
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-28
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-28
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-28
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-28
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-28
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-28
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-28
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-28
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-28
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-28
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-28
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-28
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-28
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-28
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-28
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-28
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-28
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-28
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-28
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-28
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-28
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-28
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-28
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-28
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-28
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-28
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-27
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-27
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-27
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-27
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-27
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-27
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-27
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-27
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-27
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-27
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-27
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-27
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-27
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-27
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-27
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-27
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-27
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-27
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-27
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-27
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-27
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-27
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-27
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-27
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-27
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-27
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-27
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-27
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-27
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-27
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-27
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-27
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-27
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-27
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-27
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-27
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-26
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-26
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-26
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-25
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-23
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-23
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-23
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-23
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-21
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-21
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-21
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-20
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-20
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-20
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-20
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-20
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-20
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-19
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-19
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-18
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-18
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-18
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-17
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-17
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-17
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-17
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-17
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-17
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-17
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-17
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-17
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-16
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-16
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-16
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-16
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-16
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-16
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-16
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-16
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-16
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-16
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-16
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-16
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-15
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-15
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-15
3soa_A	444	Full-Length Human Camkii Length = 444		2e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-15
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-15
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-14
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-14
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-13
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-13
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-13
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-13
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-09
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-08
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-08
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-08
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-08
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		9e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-07
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-07
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		9e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-06
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-06
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-05
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-05
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-05
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		5e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-05
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-05
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-05
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-05
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-05
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-05
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-05
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-05
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		9e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-05
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-05
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-04
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-04
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-04
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-04
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-04
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-04
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-04
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-04
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-04
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-04
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-04
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-04
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-04
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-04
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-04
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-04
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-04
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-04
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-04
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-04
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-04
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-04
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-04
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-04
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-04
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-04
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-04
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		6e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-04
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-04
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-04
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-04

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 75/145 (51%), Positives = 106/145 (73%), Gaps = 4/145 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH  GI++RDLKPENI+L+  GHV+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVK 161

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 75/145 (51%), Positives = 106/145 (73%), Gaps = 4/145 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH  GI++RDLKPENI+L+  GHV+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVK 161

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 75/150 (50%), Positives = 101/150 (67%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS N      DF  LKV+G+G+F KV   R       YA+KV++K  I++K   +++ SE
Sbjct: 29  PSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE 88
Query: 201 RNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           RN+L K V HPF+V L +SFQT  +LY VLD++NGG LF+ L R+  F E  AR Y AEI
Sbjct: 89  RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHV 289
            SA+ +LH+  I++RDLKPENILLD+ GH+
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHI 178

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  147 bits (372), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 71/142 (50%), Positives = 107/142 (75%), Gaps = 4/142 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ V++I  S   ++YAMKV++K  +  ++     K ER+IL +V+
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 84
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI++RDLKPENILLD +GH++
Sbjct: 145 LGIIYRDLKPENILLDEEGHIK 166

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  147 bits (372), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 71/142 (50%), Positives = 107/142 (75%), Gaps = 4/142 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ V++I  S   ++YAMKV++K  +  ++     K ER+IL +V+
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 85
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 145
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI++RDLKPENILLD +GH++
Sbjct: 146 LGIIYRDLKPENILLDEEGHIK 167

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  147 bits (371), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 71/142 (50%), Positives = 107/142 (75%), Gaps = 4/142 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ V++I  S   ++YAMKV++K  +  ++     K ER+IL +V+
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 84
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI++RDLKPENILLD +GH++
Sbjct: 145 LGIIYRDLKPENILLDEEGHIK 166

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 74/156 (47%), Positives = 110/156 (70%), Gaps = 5/156 (3%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEK-NHA 194
           NL    + VG+E+FE+LKV+G GA+ KV+ VR+I    T ++YAMKV++K  I++K    
Sbjct: 43  NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 102
Query: 195 EYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E+ ++ER +L  +   PF+V L Y+FQT+ +L+L+LD++NGG LF  L ++  F E   +
Sbjct: 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ 162
Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           IY  EIV A+ HLH  GI++RD+K ENILLD++GHV
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV 198

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  144 bits (362), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 68/142 (47%), Positives = 104/142 (73%), Gaps = 4/142 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ VR++    +  +YAMKV++K  +  ++     K ER+IL  V+
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVR-TKMERDILADVN 88
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPF+V+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+   + HLH+
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS 148
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI++RDLKPENILLD +GH++
Sbjct: 149 LGIIYRDLKPENILLDEEGHIK 170

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  144 bits (362), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 65/144 (45%), Positives = 98/144 (68%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  +++RD+K EN++LD DGH++
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIK 145

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  144 bits (362), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 65/144 (45%), Positives = 98/144 (68%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 5   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  +++RD+K EN++LD DGH++
Sbjct: 125 HSRDVVYRDIKLENLMLDKDGHIK 148

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  144 bits (362), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 65/144 (45%), Positives = 98/144 (68%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  +++RD+K EN++LD DGH++
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIK 145

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  144 bits (362), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 65/144 (45%), Positives = 98/144 (68%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 7   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  +++RD+K EN++LD DGH++
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGHIK 150

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  144 bits (362), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 65/144 (45%), Positives = 98/144 (68%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  +++RD+K EN++LD DGH++
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIK 145

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  143 bits (361), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 65/144 (45%), Positives = 98/144 (68%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  +++RD+K EN++LD DGH++
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIK 145

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  143 bits (361), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 65/144 (45%), Positives = 98/144 (68%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  +++RD+K EN++LD DGH++
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIK 145

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 66/145 (45%), Positives = 98/145 (67%), Gaps = 1/145 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 267 HA-NGIMHRDLKPENILLDADGHVR 290
           H+   +++RDLK EN++LD DGH++
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIK 289

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 66/145 (45%), Positives = 98/145 (67%), Gaps = 1/145 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 208 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 267
Query: 267 HA-NGIMHRDLKPENILLDADGHVR 290
           H+   +++RDLK EN++LD DGH++
Sbjct: 268 HSEKNVVYRDLKLENLMLDKDGHIK 292

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 66/145 (45%), Positives = 98/145 (67%), Gaps = 1/145 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 267 HA-NGIMHRDLKPENILLDADGHVR 290
           H+   +++RDLK EN++LD DGH++
Sbjct: 125 HSEKNVVYRDLKLENLMLDKDGHIK 149

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 66/145 (45%), Positives = 98/145 (67%), Gaps = 1/145 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 125
Query: 267 HA-NGIMHRDLKPENILLDADGHVR 290
           H+   +++RDLK EN++LD DGH++
Sbjct: 126 HSEKNVVYRDLKLENLMLDKDGHIK 150

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 66/145 (45%), Positives = 98/145 (67%), Gaps = 1/145 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 267 HA-NGIMHRDLKPENILLDADGHVR 290
           H+   +++RDLK EN++LD DGH++
Sbjct: 127 HSEKNVVYRDLKLENLMLDKDGHIK 151

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 63/145 (43%), Positives = 107/145 (73%), Gaps = 1/145 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH  GI++RDLK +N+LLD++GH++
Sbjct: 137 LHERGIIYRDLKLDNVLLDSEGHIK 161

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 63/145 (43%), Positives = 107/145 (73%), Gaps = 1/145 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH  GI++RDLK +N+LLD++GH++
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIK 146

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 63/145 (43%), Positives = 107/145 (73%), Gaps = 1/145 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH  GI++RDLK +N+LLD++GH++
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIK 150

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 62/145 (42%), Positives = 107/145 (73%), Gaps = 1/145 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAM+V++K+ + +    +++++E+++  +
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH  GI++RDLK +N+LLD++GH++
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIK 193

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 152 GIIHRDLKPENILLNEDMHIQ 172

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 153 GIIHRDLKPENILLNEDMHIQ 173

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 155 GIIHRDLKPENILLNEDMHIQ 175

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 152 GIIHRDLKPENILLNEDMHIQ 172

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 152 GIIHRDLKPENILLNEDMHIQ 172

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 153 GIIHRDLKPENILLNEDMHIQ 173

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 150 GIIHRDLKPENILLNEDMHIQ 170

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 152 GIIHRDLKPENILLNEDMHIQ 172

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 152 GIIHRDLKPENILLNEDMHIQ 172

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 150 GIIHRDLKPENILLNEDMHIQ 170

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 150 GIIHRDLKPENILLNEDMHIQ 170

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 130 GIIHRDLKPENILLNEDMHIQ 150

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  137 bits (345), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 94/141 (66%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L + FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 157 GIIHRDLKPENILLNEDMHIQ 177

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  137 bits (345), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 152 GIIHRDLKPENILLNEDMHIQ 172

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  137 bits (345), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 129 GIIHRDLKPENILLNEDMHIQ 149

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  137 bits (345), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 149 GIIHRDLKPENILLNEDMHIQ 169

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  137 bits (345), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 134 GIIHRDLKPENILLNEDMHIQ 154

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 149 GIIHRDLKPENILLNEDMHIQ 169

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 127 GIIHRDLKPENILLNEDMHIQ 147

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 62/141 (43%), Positives = 95/141 (67%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 128 GIIHRDLKPENILLNEDMHIQ 148

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 61/141 (43%), Positives = 94/141 (66%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+     R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 150 GIIHRDLKPENILLNEDMHIQ 170

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  134 bits (337), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 64/145 (44%), Positives = 99/145 (68%), Gaps = 1/145 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +G+++FE ++V+G+G+F KV   R   T ++YA+KV++KD I++ +  E   +E+ IL+ 
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+ QL   FQT  RL+ V++FVNGG L F + +   F E  AR Y AEI+SA+  
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH  GI++RDLK +N+LLD +GH +
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCK 164

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  127 bits (319), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 59/147 (40%), Positives = 96/147 (65%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           EN+ V  + FE+L+ +G+G+F KV  V++  T ++YAMK M K K +E+N    +  E  
Sbjct: 8   ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           I+  ++HPF+V L YSFQ +  +++V+D + GG L + L +   F+E+  +++  E+V A
Sbjct: 68  IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 263 VSHLHANGIMHRDLKPENILLDADGHV 289
           + +L    I+HRD+KP+NILLD  GHV
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHV 154

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 64/152 (42%), Positives = 97/152 (63%), Gaps = 2/152 (1%)
Query: 141 PSEN-QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           PS N   V L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    
Sbjct: 9   PSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMV 68
Query: 200 ERNILTKVDHP-FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           E+ +L  +D P F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AE
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 128
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           I   +  LH  GI++RDLK +N++LD++GH++
Sbjct: 129 ISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIK 160

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 54/142 (38%), Positives = 95/142 (66%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+DF++L+ +G G+F +V+ +R       YAMKV++K+ ++     E+   ER +L+ V 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFI+++  +FQ   ++++++D++ GG LF  L +   F   +A+ Y AE+  A+ +LH+
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 269 NGIMHRDLKPENILLDADGHVR 290
             I++RDLKPENILLD +GH++
Sbjct: 125 KDIIYRDLKPENILLDKNGHIK 146

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIK 181

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 60/142 (42%), Positives = 93/142 (65%), Gaps = 1/142 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE+LKV+G+GAF++V  V+   T ++YAMK+M K  ++++      + ER++L   D 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHA 268
            +I QL ++FQ +  LYLV+++  GG L   L + G     ++AR Y AEIV A+  +H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            G +HRD+KP+NILLD  GH+R
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIR 202

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 58/141 (41%), Positives = 96/141 (68%), Gaps = 1/141 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 270 GIMHRDLKPENILLDADGHVR 290
           G +HRD+KP+N+LLD  GH++
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLK 208

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 58/141 (41%), Positives = 96/141 (68%), Gaps = 1/141 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 270 GIMHRDLKPENILLDADGHVR 290
           G +HRD+KP+N+LLD  GH++
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLK 213

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 58/141 (41%), Positives = 96/141 (68%), Gaps = 1/141 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 270 GIMHRDLKPENILLDADGHVR 290
           G +HRD+KP+N+LLD  GH++
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLK 213

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 182

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 61/147 (41%), Positives = 90/147 (61%), Gaps = 3/147 (2%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 207 V---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           V   D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            H+H   +++RDLKP NILLD  GHVR
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVR 332

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 61/147 (41%), Positives = 90/147 (61%), Gaps = 3/147 (2%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 207 V---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           V   D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            H+H   +++RDLKP NILLD  GHVR
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVR 332

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 61/147 (41%), Positives = 90/147 (61%), Gaps = 3/147 (2%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ 
Sbjct: 185 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 244
Query: 207 V---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           V   D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  +
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            H+H   +++RDLKP NILLD  GHVR
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGHVR 331

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 182

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 61/147 (41%), Positives = 90/147 (61%), Gaps = 3/147 (2%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 207 V---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           V   D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            H+H   +++RDLKP NILLD  GHVR
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVR 332

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 58/142 (40%), Positives = 91/142 (64%), Gaps = 1/142 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE++KV+G+GAF +V  V+   T  IYAMK++ K +++++      + ER++L   D 
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y  E+V A+  +H 
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HRD+KP+N+LLD +GH+R
Sbjct: 210 LHYVHRDIKPDNVLLDVNGHIR 231

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 182

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 58/142 (40%), Positives = 91/142 (64%), Gaps = 1/142 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE++KV+G+GAF +V  V+   T  IYAMK++ K +++++      + ER++L   D 
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y  E+V A+  +H 
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HRD+KP+N+LLD +GH+R
Sbjct: 194 LHYVHRDIKPDNVLLDVNGHIR 215

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 19  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 77
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 78  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 137
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 138 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 167

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V++++ GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIK 181

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 97/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V++++ GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIK 181

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  120 bits (301), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 54  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 172
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 202

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   +AMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L YSF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 182

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 182

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 26  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 144
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 174

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 26  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 144
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 174

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   +AMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L YSF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   +AMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L YSF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 182

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 57/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+++D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIK 181

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 57/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+++D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIK 181

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 57/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+++D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIK 181

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 58/143 (40%), Positives = 91/143 (63%), Gaps = 1/143 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KV 207
           L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L    
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
             PF+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  L 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           + GI++RDLK +N++LD++GH++
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIK 482

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 57/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+++D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQ 181

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 54  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 172
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 202

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 34  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 182

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 57/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+++D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQ 181

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 54  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 172
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 202

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/143 (40%), Positives = 91/143 (63%), Gaps = 1/143 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L    
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 209 HP-FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            P F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  L 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           + GI++RDLK +N++LD++GH++
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIK 161

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 28  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 86
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 87  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 146
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 147 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 176

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 20  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 78
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 79  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 138
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 139 LTFEYLHSLDLIYRDLKPENLLIDEQGYIQ 168

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 95/150 (63%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+ +L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+++D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIK 182

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 95/150 (63%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+ +L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+++D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIK 182

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 57/150 (38%), Positives = 95/150 (63%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+++D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIK 182

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 56/150 (37%), Positives = 95/150 (63%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+ +L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+++D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIK 182

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 56/142 (39%), Positives = 91/142 (64%), Gaps = 1/142 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE+LKV+G+GAF +V  V+     +++AMK++ K +++++      + ER++L   D 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ    LYLV+D+  GG L   L + +    E++AR Y AE+V A+  +H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HRD+KP+NIL+D +GH+R
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIR 215

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 57/150 (38%), Positives = 96/150 (64%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+++D  G+++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLIIDQQGYIQ 181

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 57/150 (38%), Positives = 94/150 (62%), Gaps = 1/150 (0%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE ++ +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + I   V+ PF+V+L +SF+    LY+VL++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIK 182

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 54/141 (38%), Positives = 96/141 (68%), Gaps = 1/141 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED++V+KV+G+GAF +V  VR   + ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL  +FQ    LY+V++++ GG L   L       E  A+ YTAE+V A+  +H+ 
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 193
Query: 270 GIMHRDLKPENILLDADGHVR 290
           G++HRD+KP+N+LLD  GH++
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLK 214

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 57/153 (37%), Positives = 98/153 (64%), Gaps = 5/153 (3%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS    + +EDFE+ K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 68
Query: 201 RNILT-KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR--IYTA 257
           + +L+   +HPF+  +  +FQTK  L+ V++++NGG L + +  Q   + DL+R   Y A
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 126
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           EI+  +  LH+ GI++RDLK +NILLD DGH++
Sbjct: 127 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIK 159

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 56/153 (36%), Positives = 97/153 (63%), Gaps = 5/153 (3%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS    + +EDF + K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 201 RNILT-KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR--IYTA 257
           + +L+   +HPF+  +  +FQTK  L+ V++++NGG L + +  Q   + DL+R   Y A
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 125
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           EI+  +  LH+ GI++RDLK +NILLD DGH++
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIK 158

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/152 (40%), Positives = 92/152 (60%), Gaps = 4/152 (2%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           IVS + HLH   I++RDLKPEN+LLD DG+VR
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/152 (40%), Positives = 92/152 (60%), Gaps = 4/152 (2%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           IVS + HLH   I++RDLKPEN+LLD DG+VR
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/152 (40%), Positives = 92/152 (60%), Gaps = 4/152 (2%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           IVS + HLH   I++RDLKPEN+LLD DG+VR
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 61/152 (40%), Positives = 92/152 (60%), Gaps = 4/152 (2%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           IVS + HLH   I++RDLKPEN+LLD DG+VR
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/150 (40%), Positives = 85/150 (56%), Gaps = 2/150 (1%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q V    F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ 
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIV 260
           IL KV+  F+V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AEI 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +  LH   I++RDLKPENILLD  GH+R
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIR 326

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/150 (40%), Positives = 85/150 (56%), Gaps = 2/150 (1%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q V    F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ 
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIV 260
           IL KV+  F+V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AEI 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +  LH   I++RDLKPENILLD  GH+R
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIR 326

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 53/133 (39%), Positives = 86/133 (64%), Gaps = 9/133 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--DKIMEKNHAEYMKSERNILTKVDH 209
           FEV   +G+GA + VY+ ++ GT + YA+KV++K  DK       + +++E  +L ++ H
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-------KIVRTEIGVLLRLSH 107
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L+  F+T   + LVL+ V GG LF ++  +G + E  A     +I+ AV++LH N
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 270 GIMHRDLKPENIL 282
           GI+HRDLKPEN+L
Sbjct: 168 GIVHRDLKPENLL 180

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 86/140 (61%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 66
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLK EN+LLDAD +++
Sbjct: 127 IVHRDLKAENLLLDADMNIK 146

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 86/140 (61%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLK EN+LLDAD +++
Sbjct: 134 IVHRDLKAENLLLDADMNIK 153

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 86/140 (61%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLK EN+LLDAD +++
Sbjct: 134 IVHRDLKAENLLLDADMNIK 153

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 86/140 (61%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLK EN+LLDAD +++
Sbjct: 134 IVHRDLKAENLLLDADMNIK 153

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 48/131 (36%), Positives = 83/131 (63%), Gaps = 3/131 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  ++V+G GAF++V+ V++  T +++A+K ++K      +  E   +E  +L K+ H  
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHEN 67
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV L   +++    YLV+  V+GG LF ++  +G++ E  A +   +++SAV +LH NGI
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 272 MHRDLKPENIL 282
           +HRDLKPEN+L
Sbjct: 128 VHRDLKPENLL 138

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 85/140 (60%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T    A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVR-IMKILNHP 71
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYL++++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLK EN+LLDAD +++
Sbjct: 132 IVHRDLKAENLLLDADMNIK 151

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 86/140 (61%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A++++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLK EN+LLDAD +++
Sbjct: 134 IVHRDLKAENLLLDADMNIK 153

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 85/140 (60%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T    A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVR-IMKILNHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYL++++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLK EN+LLDAD +++
Sbjct: 135 IVHRDLKAENLLLDADMNIK 154

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 86/140 (61%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A++++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLK EN+LLDAD +++
Sbjct: 134 IVHRDLKAENLLLDADMNIK 153

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 86/152 (56%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           N  S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++
Sbjct: 23  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
            E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 142
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           + +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELK 174

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 86/151 (56%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELK 153

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 86/152 (56%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           N  S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++
Sbjct: 23  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
            E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 142
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           + +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELK 174

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 86/151 (56%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELK 153

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 84/140 (60%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I   ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IXKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV ++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLK EN+LLDAD +++
Sbjct: 134 IVHRDLKAENLLLDADXNIK 153

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 86/152 (56%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           N  S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++
Sbjct: 14  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 73
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
            E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E
Sbjct: 74  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 133
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           + +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 134 LANALSYCHSKRVIHRDIKPENLLLGSAGELK 165

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 86/151 (56%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELK 153

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 88/156 (56%), Gaps = 3/156 (1%)
Query: 135 GHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA 194
           GH +   S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +    
Sbjct: 1   GHXE---SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 57
Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
             ++ E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 117
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           Y  E+ +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELK 153

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 86/151 (56%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELK 151

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVR 290
           A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLLGSAGELK 150

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVR 290
           A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELK 149

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVR 290
           A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELK 149

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVR 290
           A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELK 153

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVR 290
           A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLLGSAGELK 150

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELK 148

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 86/151 (56%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELK 151

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 86/151 (56%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELK 151

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELK 148

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELK 151

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 86/151 (56%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELK 151

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 85/150 (56%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P  ++   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E
Sbjct: 2   PLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
           +A+S+ H+  ++HRD+KPEN+LL + G ++
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELK 151

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELK 149

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELK 148

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELK 148

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 48/134 (35%), Positives = 80/134 (59%), Gaps = 1/134 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++++ + +G+GAF+ V +  +I T + YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDH-QKLEREARICRLLKH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ +V+H H N
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 270 GIMHRDLKPENILL 283
           GI+HRDLKPEN+LL
Sbjct: 123 GIVHRDLKPENLLL 136

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELK 148

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 129
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 130 SKRVIHRDIKPENLLLGSAGELK 152

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELK 148

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELK 148

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 124
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 125 SKRVIHRDIKPENLLLGSAGELK 147

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 82/143 (57%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELK 148

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 87/151 (57%), Gaps = 1/151 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           L S+ Q   LEDF++ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 3   LGSKRQWT-LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRR 61
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+S+ H+  ++HRD+KPEN+LL ++G ++
Sbjct: 122 ANALSYCHSKRVIHRDIKPENLLLGSNGELK 152

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 48/134 (35%), Positives = 80/134 (59%), Gaps = 1/134 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++++ + +G+GAF+ V +  +I T + YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDH-QKLEREARICRLLKH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ +V+H H N
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 270 GIMHRDLKPENILL 283
           GI+HRDLKPEN+LL
Sbjct: 123 GIVHRDLKPENLLL 136

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 87/151 (57%), Gaps = 1/151 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           L S+ Q   LEDF++ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 3   LGSKRQWT-LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRR 61
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+S+ H+  ++HRD+KPEN+LL ++G ++
Sbjct: 122 ANALSYCHSKRVIHRDIKPENLLLGSNGELK 152

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 82/142 (57%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DF++++ +G+G F  VY  R      I A+KV+ K ++ ++     ++ E  I + + 
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+++   F  + R+YL+L+F   G L+ +L + G F E  +  +  E+  A+ + H 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRD+KPEN+L+   G ++
Sbjct: 133 RKVIHRDIKPENLLMGYKGELK 154

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 50/140 (35%), Positives = 83/140 (59%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ + K +G+G FAKV   R + T    A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVR-IMKILNHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY 134
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLK EN+LLD D +++
Sbjct: 135 IVHRDLKAENLLLDGDMNIK 154

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 96/168 (57%), Gaps = 9/168 (5%)
Query: 131 GKPTGHIDNLP----SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKD 186
           G P  H+   P      +  +  + ++  +V+G+G+F +V   +   T +  A+KV+ K 
Sbjct: 27  GGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 86
Query: 187 KIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
           ++ +K   E +  E  +L ++DHP I++L   F+ K   YLV +   GG LF ++  +  
Sbjct: 87  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 146
Query: 247 FRE-DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVR 290
           F E D ARI   +++S ++++H N I+HRDLKPEN+LL++   D ++R
Sbjct: 147 FSEVDAARI-IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIR 193

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 96/168 (57%), Gaps = 9/168 (5%)
Query: 131 GKPTGHIDNLP----SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKD 186
           G P  H+   P      +  +  + ++  +V+G+G+F +V   +   T +  A+KV+ K 
Sbjct: 26  GGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 85
Query: 187 KIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
           ++ +K   E +  E  +L ++DHP I++L   F+ K   YLV +   GG LF ++  +  
Sbjct: 86  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 145
Query: 247 FRE-DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVR 290
           F E D ARI   +++S ++++H N I+HRDLKPEN+LL++   D ++R
Sbjct: 146 FSEVDAARI-IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIR 192

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 81/143 (56%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R      I A+KV+ K ++ +      ++ E  I + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +  ++HRD+KPEN+LL + G ++
Sbjct: 123 SKRVIHRDIKPENLLLGSAGELK 145

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 86/139 (61%), Gaps = 5/139 (3%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DHP I++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++  +  F E D ARI   +++S ++++H N I+HR
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYMHKNKIVHR 150
Query: 275 DLKPENILLDA---DGHVR 290
           DLKPEN+LL++   D ++R
Sbjct: 151 DLKPENLLLESKSKDANIR 169

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 81/142 (57%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DF++ + +G+G F  VY  R      I A+KV+ K ++ ++     ++ E  I + + 
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+++   F  + R+YL+L+F   G L+ +L + G F E  +  +  E+  A+ + H 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 133
Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRD+KPEN+L+   G ++
Sbjct: 134 RKVIHRDIKPENLLMGYKGELK 155

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 86/139 (61%), Gaps = 5/139 (3%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DHP I++L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++  +  F E D ARI   +++S ++++H N I+HR
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYMHKNKIVHR 156
Query: 275 DLKPENILLDA---DGHVR 290
           DLKPEN+LL++   D ++R
Sbjct: 157 DLKPENLLLESKSKDANIR 175

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/144 (34%), Positives = 78/144 (54%), Gaps = 3/144 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G+F K   V+       Y +K +   ++  K   E  + E  +L  + 
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE-SRREVAVLANMK 81
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHL 266
           HP IVQ R SF+    LY+V+D+  GG LF ++  Q   LF+ED    +  +I  A+ H+
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H   I+HRD+K +NI L  DG V+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQ 165

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 84/139 (60%), Gaps = 5/139 (3%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DHP I +L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++  +  F E D ARI   +++S +++ H N I+HR
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYXHKNKIVHR 150
Query: 275 DLKPENILLDA---DGHVR 290
           DLKPEN+LL++   D ++R
Sbjct: 151 DLKPENLLLESKSKDANIR 169

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 46/131 (35%), Positives = 77/131 (58%), Gaps = 2/131 (1%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE  + +G GAF++V       T +++A+K + K  +  K  +  +++E  +L K+ H  
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS--IENEIAVLRKIKHEN 81
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV L   +++   LYLV+  V+GG LF ++  +G + E  A     +++ AV +LH  GI
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 272 MHRDLKPENIL 282
           +HRDLKPEN+L
Sbjct: 142 VHRDLKPENLL 152

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 86/153 (56%), Gaps = 6/153 (3%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K+ +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHV 289
           + AV +LH  GI+HRDLKPEN+L   LD D  +
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI 158

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 86/153 (56%), Gaps = 6/153 (3%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K+ +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHV 289
           + AV +LH  GI+HRDLKPEN+L   LD D  +
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI 158

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 86/153 (56%), Gaps = 6/153 (3%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K+ +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHV 289
           + AV +LH  GI+HRDLKPEN+L   LD D  +
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI 158

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 85/151 (56%), Gaps = 6/151 (3%)
Query: 139 NLPSEN---QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA- 194
           +L +EN   Q +  + +E+ + +G G FA V + R+ GT + YA K ++K ++       
Sbjct: 12  DLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGV 71
Query: 195 --EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
             E ++ E NIL ++ HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A
Sbjct: 72  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA 131
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILL 283
             +  +I+  V +LH+  I H DLKPENI+L
Sbjct: 132 TQFLKQILDGVHYLHSKRIAHFDLKPENIML 162

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 85/153 (55%), Gaps = 6/153 (3%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K  +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHV 289
           + AV +LH  GI+HRDLKPEN+L   LD D  +
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI 158

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 49/135 (36%), Positives = 77/135 (57%), Gaps = 3/135 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVD 208
           +E+ + +G G FA V + R+ GT + YA K ++K ++         E ++ E NIL ++ 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A  +  +I+  V +LH+
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 269 NGIMHRDLKPENILL 283
             I H DLKPENI+L
Sbjct: 134 KRIAHFDLKPENIML 148

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 49/135 (36%), Positives = 77/135 (57%), Gaps = 3/135 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVD 208
           +E+ + +G G FA V + R+ GT + YA K ++K ++         E ++ E NIL ++ 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A  +  +I+  V +LH+
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 269 NGIMHRDLKPENILL 283
             I H DLKPENI+L
Sbjct: 127 KRIAHFDLKPENIML 141

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 83/139 (59%), Gaps = 1/139 (0%)
Query: 148 GLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           GL D ++ +K +G GA+ +V   +   T    A+K+++K  +   +++  +  E  +L +
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +DHP I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S  ++L
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 267 HANGIMHRDLKPENILLDA 285
           H + I+HRDLKPEN+LL++
Sbjct: 121 HKHNIVHRDLKPENLLLES 139

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 84/137 (61%), Gaps = 3/137 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+ +  ++ E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHA 268
           P I++L    +     Y+V +   GG LF ++ ++  F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLDA 285
           + I+HRDLKPENILL++
Sbjct: 140 HNIVHRDLKPENILLES 156

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 83/139 (59%), Gaps = 1/139 (0%)
Query: 148 GLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           GL D ++ +K +G GA+ +V   +   T    A+K+++K  +   +++  +  E  +L +
Sbjct: 18  GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 77
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +DHP I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S  ++L
Sbjct: 78  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 137
Query: 267 HANGIMHRDLKPENILLDA 285
           H + I+HRDLKPEN+LL++
Sbjct: 138 HKHNIVHRDLKPENLLLES 156

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 79/134 (58%), Gaps = 1/134 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 87
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 270 GIMHRDLKPENILL 283
           GI+HR+LKPEN+LL
Sbjct: 148 GIVHRNLKPENLLL 161

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 84/137 (61%), Gaps = 3/137 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+ +  ++ E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHA 268
           P I++L    +     Y+V +   GG LF ++ ++  F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLDA 285
           + I+HRDLKPENILL++
Sbjct: 140 HNIVHRDLKPENILLES 156

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 84/137 (61%), Gaps = 3/137 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+ +  ++ E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHA 268
           P I++L    +     Y+V +   GG LF ++ ++  F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLDA 285
           + I+HRDLKPENILL++
Sbjct: 140 HNIVHRDLKPENILLES 156

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 79/134 (58%), Gaps = 1/134 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 270 GIMHRDLKPENILL 283
           GI+HR+LKPEN+LL
Sbjct: 125 GIVHRNLKPENLLL 138

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 79/134 (58%), Gaps = 1/134 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQH 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 270 GIMHRDLKPENILL 283
           GI+HR+LKPEN+LL
Sbjct: 125 GIVHRNLKPENLLL 138

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 79/134 (58%), Gaps = 1/134 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 123
Query: 270 GIMHRDLKPENILL 283
           GI+HR+LKPEN+LL
Sbjct: 124 GIVHRNLKPENLLL 137

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 83/136 (61%), Gaps = 1/136 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ +K +G GA+ +V   R   T    A+K++RK  +   ++++ ++ E  +L  +DH
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVLKLLDH 95
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S V++LH +
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 270 GIMHRDLKPENILLDA 285
            I+HRDLKPEN+LL++
Sbjct: 156 NIVHRDLKPENLLLES 171

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 79/134 (58%), Gaps = 1/134 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D+++ + +G+GAF+ V +  +   ++ YA K++   K+  ++H + ++ E  I   + H
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQK-LEREARICRLLKH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ +V+H+H +
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 270 GIMHRDLKPENILL 283
            I+HRDLKPEN+LL
Sbjct: 150 DIVHRDLKPENLLL 163

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/135 (34%), Positives = 78/135 (57%), Gaps = 6/135 (4%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL K++HP
Sbjct: 15  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 75  CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 133
Query: 271 IMHRDLKPENILLDA 285
           I+HRDLKPEN+LL +
Sbjct: 134 IIHRDLKPENVLLSS 148

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/135 (34%), Positives = 78/135 (57%), Gaps = 6/135 (4%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL K++HP
Sbjct: 22  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 81
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 82  CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 140
Query: 271 IMHRDLKPENILLDA 285
           I+HRDLKPEN+LL +
Sbjct: 141 IIHRDLKPENVLLSS 155

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/135 (34%), Positives = 78/135 (57%), Gaps = 6/135 (4%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL K++HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 76  CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 271 IMHRDLKPENILLDA 285
           I+HRDLKPEN+LL +
Sbjct: 135 IIHRDLKPENVLLSS 149

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 88/148 (59%), Gaps = 3/148 (2%)
Query: 146 CVG--LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C+G  +EDF+V  ++G+G+FA VY+   I T    A+K++ K  + +    + +++E  I
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSA 262
             ++ HP I++L   F+    +YLVL+  + G +   L  R   F E+ AR +  +I++ 
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + +LH++GI+HRDL   N+LL  + +++
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIK 152

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 75/132 (56%), Gaps = 1/132 (0%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +++ + +G+GAF+ V +  ++   + YA K++   K+  ++H + ++ E  I   + HP 
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQK-LEREARICRLLKHPN 82
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L  S   +   YL+ D V GG LF  +  +  + E  A     +I+ AV H H  G+
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 272 MHRDLKPENILL 283
           +HRDLKPEN+LL
Sbjct: 143 VHRDLKPENLLL 154

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/135 (34%), Positives = 78/135 (57%), Gaps = 6/135 (4%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL K++HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 76  CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 271 IMHRDLKPENILLDA 285
           I+HRDLKPEN+LL +
Sbjct: 135 IIHRDLKPENVLLSS 149

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/135 (34%), Positives = 78/135 (57%), Gaps = 6/135 (4%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL K++HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 76  CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 271 IMHRDLKPENILLDA 285
           I+HRDLKPEN+LL +
Sbjct: 135 IIHRDLKPENVLLSS 149

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 81/138 (58%), Gaps = 6/138 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDH 209
           +E+ +V+G+GAF+ V +     T + +A+K++   K         E +K E +I   + H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSH 265
           P IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A  Y  +I+ A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 266 LHANGIMHRDLKPENILL 283
            H N I+HRD+KPEN+LL
Sbjct: 146 CHDNNIIHRDVKPENVLL 163

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 72/132 (54%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DFE+ + +G+G F  VY  R   +  I A+KV+ K +I ++     ++ E  I   + 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L   F  + R+YL+L++   G L+ +L +   F E        E+  A+ + H 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 269 NGIMHRDLKPEN 280
             ++HRD+KPEN
Sbjct: 142 KKVIHRDIKPEN 153

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 82/145 (56%), Gaps = 9/145 (6%)
Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           EDF E++  +G GAF KVY+ +   TS + A KV+  D   E+   +YM  E +IL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   ++   + + A+++
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 150
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH N I+HRDLK  NIL   DG ++
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIK 175

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 76/134 (56%), Gaps = 1/134 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++++ + +G+GAF+ V +  ++ T   YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQK-LEREARICRLLKH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ AV H H  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 270 GIMHRDLKPENILL 283
           G++HRDLKPEN+LL
Sbjct: 123 GVVHRDLKPENLLL 136

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 82/145 (56%), Gaps = 9/145 (6%)
Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           EDF E++  +G GAF KVY+ +   TS + A KV+  D   E+   +YM  E +IL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   ++   + + A+++
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 150
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH N I+HRDLK  NIL   DG ++
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIK 175

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 78/135 (57%), Gaps = 6/135 (4%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A++++ K K       E + A  +++E  IL K++HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 201 CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 259
Query: 271 IMHRDLKPENILLDA 285
           I+HRDLKPEN+LL +
Sbjct: 260 IIHRDLKPENVLLSS 274

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 82/145 (56%), Gaps = 9/145 (6%)
Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           EDF E++  +G GAF KVY+ +   TS + A KV+  D   E+   +YM  E +IL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   ++   + + A+++
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 150
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH N I+HRDLK  NIL   DG ++
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIK 175

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 78/135 (57%), Gaps = 6/135 (4%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHP 210
           K +G GA  +V       T +  A++++ K K       E + A  +++E  IL K++HP
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 214
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV +LH NG
Sbjct: 215 CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 273
Query: 271 IMHRDLKPENILLDA 285
           I+HRDLKPEN+LL +
Sbjct: 274 IIHRDLKPENVLLSS 288

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 77/134 (57%), Gaps = 4/134 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +++N    + + R++     HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 272 MHRDLKPENILLDA 285
            HRDLK EN LLD 
Sbjct: 137 CHRDLKLENTLLDG 150

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 76/134 (56%), Gaps = 1/134 (0%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E++++ + +G+GAF+ V +  ++   + YA  ++   K+  ++H + ++ E  I   + H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YL+ D V GG LF  +  +  + E  A     +I+ AV H H  
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 270 GIMHRDLKPENILL 283
           G++HR+LKPEN+LL
Sbjct: 130 GVVHRNLKPENLLL 143

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 77/134 (57%), Gaps = 4/134 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +++N    + + R++     HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 272 MHRDLKPENILLDA 285
            HRDLK EN LLD 
Sbjct: 137 CHRDLKLENTLLDG 150

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 77/134 (57%), Gaps = 4/134 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +++N    + + R++     HP 
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RHPN 75
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 272 MHRDLKPENILLDA 285
            HRDLK EN LLD 
Sbjct: 136 CHRDLKLENTLLDG 149

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/149 (35%), Positives = 83/149 (55%), Gaps = 13/149 (8%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK-----------DKIMEKNHAE 195
           +G   F+V K+ G GA+ +V   +        A+KV++K           +K +EK H E
Sbjct: 34  IGESYFKVRKL-GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
            + +E ++L  +DHP I++L   F+ K   YLV +F  GG LF Q+  +  F E  A   
Sbjct: 93  -IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLD 284
             +I+S + +LH + I+HRD+KPENILL+
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLE 180

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 75/134 (55%), Gaps = 4/134 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +  N    + + R++     HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSL----RHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 272 MHRDLKPENILLDA 285
            HRDLK EN LLD 
Sbjct: 137 CHRDLKLENTLLDG 150

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 45/129 (34%), Positives = 75/129 (58%), Gaps = 7/129 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQ 214
           K +G+G+F+   +     +++ +A+K++ K   ME N     + E   L   + HP IV+
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEAN----TQKEITALKLCEGHPNIVK 70
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F  +   +LV++ +NGG LF ++ ++  F E  A     ++VSAVSH+H  G++HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 275 DLKPENILL 283
           DLKPEN+L 
Sbjct: 131 DLKPENLLF 139

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 76/133 (57%), Gaps = 4/133 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R    +E+ A+K + + + +++N    + + R++     HP 
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSL----RHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQV 136
Query: 272 MHRDLKPENILLD 284
            HRDLK EN LLD
Sbjct: 137 AHRDLKLENTLLD 149

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 82/140 (58%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 132
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLKPEN+LLD   +V+
Sbjct: 133 IVHRDLKPENLLLDEHLNVK 152

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 82/140 (58%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 133
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLKPEN+LLD   +V+
Sbjct: 134 IVHRDLKPENLLLDEHLNVK 153

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 82/140 (58%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLKPEN+LLD   +V+
Sbjct: 128 IVHRDLKPENLLLDEHLNVK 147

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 82/140 (58%), Gaps = 1/140 (0%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLKPEN+LLD   +V+
Sbjct: 124 IVHRDLKPENLLLDEHLNVK 143

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/128 (35%), Positives = 69/128 (53%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F KV       T    A+K++ + KI   +    +K E   L    HP I++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
              T    ++V+++V+GG LF  + + G   E  AR    +I+SAV + H + ++HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 278 PENILLDA 285
           PEN+LLDA
Sbjct: 139 PENVLLDA 146

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/128 (35%), Positives = 69/128 (53%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F KV       T    A+K++ + KI   +    +K E   L    HP I++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
              T    ++V+++V+GG LF  + + G   E  AR    +I+SAV + H + ++HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 278 PENILLDA 285
           PEN+LLDA
Sbjct: 139 PENVLLDA 146

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 79/147 (53%), Gaps = 16/147 (10%)
Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAE---YMKSE 200
           NQ   LE+      +G+G++ +V    + GT      ++ R  K + K   E     K E
Sbjct: 8   NQYYTLEN-----TIGRGSWGEVKIAVQKGT------RIRRAAKKIPKYFVEDVDRFKQE 56
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEI 259
             I+  +DHP I++L  +F+    +YLV++   GG LF ++  + +FRE D ARI   ++
Sbjct: 57  IEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDV 115
Query: 260 VSAVSHLHANGIMHRDLKPENILLDAD 286
           +SAV++ H   + HRDLKPEN L   D
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTD 142

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 79/147 (53%), Gaps = 16/147 (10%)
Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAE---YMKSE 200
           NQ   LE+      +G+G++ +V    + GT      ++ R  K + K   E     K E
Sbjct: 25  NQYYTLEN-----TIGRGSWGEVKIAVQKGT------RIRRAAKKIPKYFVEDVDRFKQE 73
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEI 259
             I+  +DHP I++L  +F+    +YLV++   GG LF ++  + +FRE D ARI   ++
Sbjct: 74  IEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDV 132
Query: 260 VSAVSHLHANGIMHRDLKPENILLDAD 286
           +SAV++ H   + HRDLKPEN L   D
Sbjct: 133 LSAVAYCHKLNVAHRDLKPENFLFLTD 159

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 8/168 (4%)
Query: 131 GKPTGHID--NLPSENQCVGLEDFEVLK------VVGQGAFAKVYQVRRIGTSEIYAMKV 182
            KP+ H+D  + P +     L D   +K       +G+G FAK Y++  + T E++A KV
Sbjct: 15  AKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           + K  +++ +  E M +E  I   +D+P +V     F+    +Y+VL+      L     
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           R+    E  AR +  + +  V +LH N ++HRDLK  N+ L+ D  V+
Sbjct: 135 RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVK 182

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 8/168 (4%)
Query: 131 GKPTGHID--NLPSENQCVGLEDFEVLK------VVGQGAFAKVYQVRRIGTSEIYAMKV 182
            KP+ H+D  + P +     L D   +K       +G+G FAK Y++  + T E++A KV
Sbjct: 15  AKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           + K  +++ +  E M +E  I   +D+P +V     F+    +Y+VL+      L     
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           R+    E  AR +  + +  V +LH N ++HRDLK  N+ L+ D  V+
Sbjct: 135 RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVK 182

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 8/168 (4%)
Query: 131 GKPTGHID--NLPSENQCVGLEDFEVLK------VVGQGAFAKVYQVRRIGTSEIYAMKV 182
            KP+ H+D  + P +     L D   +K       +G+G FAK Y++  + T E++A KV
Sbjct: 15  AKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           + K  +++ +  E M +E  I   +D+P +V     F+    +Y+VL+      L     
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           R+    E  AR +  + +  V +LH N ++HRDLK  N+ L+ D  V+
Sbjct: 135 RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVK 182

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 70/129 (54%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
            +G G F KV   +   T    A+K++ + KI   +    ++ E   L    HP I++L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               T   +++V+++V+GG LF  + + G   E  +R    +I+S V + H + ++HRDL
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 277 KPENILLDA 285
           KPEN+LLDA
Sbjct: 143 KPENVLLDA 151

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 74/134 (55%), Gaps = 4/134 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           ++ +K +G G F     +R   T E+ A+K + +   +++N    + + R++     HP 
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL----RHPN 77
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +++++ +GG L+ ++   G F ED AR +  +++S VS+ H+  I
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 272 MHRDLKPENILLDA 285
            HRDLK EN LLD 
Sbjct: 138 CHRDLKLENTLLDG 151

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 78/138 (56%), Gaps = 6/138 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDH 209
           +E+ +V+G+G F+ V +     T + +A+K++   K         E +K E +I   + H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSH 265
           P IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A  Y  +I+ A+ +
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 266 LHANGIMHRDLKPENILL 283
            H N I+HRD+KP  +LL
Sbjct: 148 CHDNNIIHRDVKPHCVLL 165

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/140 (35%), Positives = 73/140 (52%), Gaps = 6/140 (4%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVM-----RKDKIMEKNHAEYMKSERNILTKV-DHP 210
           V+G+G  + V +     T   +A+K+M     R      +   E  + E +IL +V  HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I+ L  S+++   ++LV D +  G LF  L  +    E   R     ++ AVS LHAN 
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLKPENILLD +  +R
Sbjct: 221 IVHRDLKPENILLDDNMQIR 240

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 72/135 (53%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           + +G+G FAK Y++  + T E++A KV+ K  +++ +  E M +E  I   +D+P +V  
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
              F+    +Y+VL+      L     R+    E  AR +  + +  V +LH N ++HRD
Sbjct: 92  HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRD 151
Query: 276 LKPENILLDADGHVR 290
           LK  N+ L+ D  V+
Sbjct: 152 LKLGNLFLNDDMDVK 166

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 78/138 (56%), Gaps = 6/138 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDH 209
           +E+ +V+G+G F+ V +     T + +A+K++   K         E +K E +I   + H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSH 265
           P IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A  Y  +I+ A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 266 LHANGIMHRDLKPENILL 283
            H N I+HRD+KP  +LL
Sbjct: 146 CHDNNIIHRDVKPHCVLL 163

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 76/128 (59%), Gaps = 4/128 (3%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +++G G F +V++     T    A K+++   + +K   E +K+E +++ ++DH  ++QL
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANLIQL 151
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSAVSHLHANGIMHR 274
             +F++K  + LV+++V+GG LF ++  +     +L  I +  +I   + H+H   I+H 
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 275 DLKPENIL 282
           DLKPENIL
Sbjct: 212 DLKPENIL 219

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 84/144 (58%), Gaps = 2/144 (1%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           G+E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L ++
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H++ ++HRDLKP+N+L++ +G ++
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIK 143

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 116
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 175 YIHSFGICHRDIKPQNLLLDPDTAV 199

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----------- 190
           S   CV L  + +   +G+G++  V        +  YAMKV+ K K++            
Sbjct: 5   SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 191 ------------KNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKYRLYLVLDFVNGGH 236
                       +   E +  E  IL K+DHP +V+L        +  LY+V + VN G 
Sbjct: 65  GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           +  ++       ED AR Y  +++  + +LH   I+HRD+KP N+L+  DGH++
Sbjct: 125 VM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIK 177

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 106
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 165 YIHSFGICHRDIKPQNLLLDPDTAV 189

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 157
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 216 YIHSFGICHRDIKPQNLLLDPDTAV 240

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 81/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 112
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAV 195

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 81/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 112
Query: 216 RYSF----QTKYRLYL--VLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F    + K  +YL  VLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAV 195

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 114
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 173 YIHSFGICHRDIKPQNLLLDPDTAV 197

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 93/182 (51%), Gaps = 27/182 (14%)
Query: 119 GPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY 178
           G  +LS V   +  P G   + P E   V   D    KV+G G+F  VYQ +   + E+ 
Sbjct: 1   GAMSLSKVTTVVATP-GQGPDRPQE---VSYTD---TKVIGNGSFGVVYQAKLCDSGELV 53
Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF------QTKYRLYLVLDFV 232
           A+K + +DK        +   E  I+ K+DH  IV+LRY F      + +  L LVLD+V
Sbjct: 54  AIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 106
Query: 233 NGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG 287
                 +++ R     ++ L     ++Y  ++  +++++H+ GI HRD+KP+N+LLD D 
Sbjct: 107 --PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT 164
Query: 288 HV 289
            V
Sbjct: 165 AV 166

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 82/144 (56%), Gaps = 8/144 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+      E+   +Y+  E  IL   DH
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDH 67
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P+IV+L  ++    +L+++++F  GG    +  +L R GL  E   ++   +++ A++ L
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GL-TEPQIQVVCRQMLEALNFL 125
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  I+HRDLK  N+L+  +G +R
Sbjct: 126 HSKRIIHRDLKAGNVLMTLEGDIR 149

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 90
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAV 173

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 86
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 145 YIHSFGICHRDIKPQNLLLDPDTAV 169

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 97
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 156 YIHSFGICHRDIKPQNLLLDPDTAV 180

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 90
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAV 173

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 77/148 (52%), Gaps = 12/148 (8%)
Query: 148 GLEDFEVLKV---------VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---E 195
           G+E F+  KV         +G G FA V + R   T   YA K ++K +          E
Sbjct: 1   GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
            ++ E +IL +V HP I+ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILL 283
             +I+  V++LH   I H DLKPENI+L
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIML 148

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAV 161

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 91
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 150 YIHSFGICHRDIKPQNLLLDPDTAV 174

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAV 161

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 82/144 (56%), Gaps = 8/144 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+      E+   +Y+  E  IL   DH
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDH 75
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P+IV+L  ++    +L+++++F  GG    +  +L R GL  E   ++   +++ A++ L
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GL-TEPQIQVVCRQMLEALNFL 133
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  I+HRDLK  N+L+  +G +R
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIR 157

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 79
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 138 YIHSFGICHRDIKPQNLLLDPDTAV 162

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 82
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 141 YIHSFGICHRDIKPQNLLLDPDTAV 165

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKPEN+L++ +G ++
Sbjct: 123 SHRVLHRDLKPENLLINTEGAIK 145

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAV 161

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKPEN+L++ +G ++
Sbjct: 124 SHRVLHRDLKPENLLINTEGAIK 146

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKPEN+L++ +G ++
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIK 144

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKPEN+L++ +G ++
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIK 144

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 12/161 (7%)
Query: 140 LPSENQCVGL-EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--------RKDKIME 190
           LP  +   G  E++E  +++G+G  + V +     T + YA+K++          +++ E
Sbjct: 6   LPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQE 65
Query: 191 KNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE 249
              A     E +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E
Sbjct: 66  LREATL--KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
              R     ++  +  LH   I+HRDLKPENILLD D +++
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 164

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 12/161 (7%)
Query: 140 LPSENQCVGL-EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--------RKDKIME 190
           LP  +   G  E++E  +++G+G  + V +     T + YA+K++          +++ E
Sbjct: 6   LPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQE 65
Query: 191 KNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE 249
              A     E +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E
Sbjct: 66  LREATL--KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
              R     ++  +  LH   I+HRDLKPENILLD D +++
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 164

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 84/145 (57%), Gaps = 2/145 (1%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 62
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           ++HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++ 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
            H++ ++HRDLKP+N+L++ +G ++
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIK 147

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  +S  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIK 143

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 79/145 (54%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSFQTK------YRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F +         L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAV 161

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 76/135 (56%), Gaps = 4/135 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +++L+ +G GAF  V++     T  ++  K +     ++K     +K+E +I+ ++ HP 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPK 109
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSAVSHLHANG 270
           ++ L  +F+ KY + L+L+F++GG LF ++  +     +   I Y  +    + H+H + 
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 271 IMHRDLKPENILLDA 285
           I+H D+KPENI+ + 
Sbjct: 170 IVHLDIKPENIMCET 184

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIK 146

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKPEN+L++ +G ++
Sbjct: 121 SHRVLHRDLKPENLLINTEGAIK 143

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--------RKDKIMEKNHAEYMKSER 201
           E++E  +++G+G  + V +     T + YA+K++          +++ E   A     E 
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL--KEV 61
Query: 202 NILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E   R     ++
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 121
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +  LH   I+HRDLKPENILLD D +++
Sbjct: 122 EVICALHKLNIVHRDLKPENILLDDDMNIK 151

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIK 150

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 138 DLKPENIML 146

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 138 DLKPENIML 146

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIK 150

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIK 145

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIK 146

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 64
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIK 147

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIK 146

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIK 145

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIK 143

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIK 144

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIK 143

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIK 144

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIK 143

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIK 142

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIK 143

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIK 144

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIK 143

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIK 142

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIK 142

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIK 143

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIK 146

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIK 145

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 76/139 (54%), Gaps = 5/139 (3%)
Query: 154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDHPF 211
           + + +G+G+F KV       T +  A+K + +  +  K    +M+ ER I  L  + HP 
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLLRHPH 70
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I++L     T   + +V+++  GG LF  +  +    ED  R +  +I+ A+ + H + I
Sbjct: 71  IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 272 MHRDLKPENILLDADGHVR 290
           +HRDLKPEN+LLD + +V+
Sbjct: 130 VHRDLKPENLLLDDNLNVK 148

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 82/142 (57%), Gaps = 2/142 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H+
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NGIMHRDLKPENILLDADGHVR 290
           + ++HRDLKP+N+L++ +G ++
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIK 142

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 13/148 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE++++VG G + +VY+ R + T ++ A+KVM     +  +  E +K E N+L K  H  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 81
Query: 212 IVQLRYSFQTKY-------RLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            +   Y    K        +L+LV++F   G +    +  +    +E+       EI+  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           +SHLH + ++HRD+K +N+LL  +  V+
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVK 169

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 79/145 (54%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + + K        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPAT--VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAV 161

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 82/143 (57%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV + V+     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIK 146

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 85/155 (54%), Gaps = 20/155 (12%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE + V+GQGAF +V + R    S  YA+K +R      +     + SE  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQ 62
Query: 211 FIVQL------RYSF-------QTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIY 255
           ++V+       R +F       + K  L++ +++   G L+  ++ + L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +I+ A+S++H+ GI+HRDLKP NI +D   +V+
Sbjct: 123 R-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 79/145 (54%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + + K        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAV 161

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 82/143 (57%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV + V+     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIK 142

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 79/145 (54%), Gaps = 20/145 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + + K        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           ++H+ GI HRD+KP+N+LLD D  V
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAV 161

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 3/161 (1%)
Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           GK TG++  +  +     + D E L  +G G   +V+++R   T  + A+K MR+    E
Sbjct: 7   GKQTGYL-TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65
Query: 191 KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
           +N    M  +  +L   D P+IVQ   +F T   +++ ++ +       +   QG   E 
Sbjct: 66  ENKRILMDLD-VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER 124
Query: 251 LARIYTAEIVSAVSHL-HANGIMHRDLKPENILLDADGHVR 290
           +    T  IV A+ +L   +G++HRD+KP NILLD  G ++
Sbjct: 125 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIK 165

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 9/153 (5%)
Query: 135 GHIDNLPSENQCVGLEDFEVL--KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN 192
           G  D+LP +      ED   L  +++G+GA+AKV     +   + YA+K++ K     ++
Sbjct: 1   GSTDSLPGK-----FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS 55
Query: 193 HAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
                +    +     +  I++L   F+   R YLV + + GG +   + +Q  F E  A
Sbjct: 56  RV--FREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREA 113
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDA 285
                ++ +A+  LH  GI HRDLKPENIL ++
Sbjct: 114 SRVVRDVAAALDFLHTKGIAHRDLKPENILCES 146

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 82/143 (57%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+  +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIK 143

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 82/143 (57%), Gaps = 2/143 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+  +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIK 142

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 74/139 (53%), Gaps = 9/139 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHP 210
           + V + +G G++++  +     T+  YA+KV+ K K   ++ +E    E  IL +   HP
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK---RDPSE----EIEILLRYGQHP 81
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I+ L+  +     +YLV + + GG L  ++ RQ  F E  A      I   V +LH+ G
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG 141
Query: 271 IMHRDLKPENIL-LDADGH 288
           ++HRDLKP NIL +D  G+
Sbjct: 142 VVHRDLKPSNILYVDESGN 160

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 68/133 (51%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 278 PENILLDADGHVR 290
             N+ L+ D  V+
Sbjct: 169 LGNLFLNEDLEVK 181

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 70/140 (50%), Gaps = 7/140 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + + V + +G G++++  +     T+  YA+KV+ K K       E +      L    H
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL------LRYGQH 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I+ L+  +     +YLV + + GG L  ++ RQ  F E  A      I   V +LH+ 
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ 140
Query: 270 GIMHRDLKPENIL-LDADGH 288
           G++HRDLKP NIL +D  G+
Sbjct: 141 GVVHRDLKPSNILYVDESGN 160

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 68/133 (51%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 278 PENILLDADGHVR 290
             N+ L+ D  V+
Sbjct: 149 LGNLFLNEDLEVK 161

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 81/147 (55%), Gaps = 6/147 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV 207
           L +F + K +G+G F++VY+   +      A+K ++   +M+ K  A+ +K E ++L ++
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQL 89
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAV 263
           +HP +++   SF     L +VL+  + G L   +     ++ L  E     Y  ++ SA+
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            H+H+  +MHRD+KP N+ + A G V+
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVK 176

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 79/147 (53%), Gaps = 6/147 (4%)
Query: 141 PSENQCVGLEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EY 196
           P + Q V  EDF ++ + +G G FA V + R   T   YA K ++K +          E 
Sbjct: 4   PFKQQKV--EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 197 MKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYT 256
           ++ E +IL +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  + 
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILL 283
            +I+  V++LH   I H DLKPENI+L
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIML 148

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 3/129 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+ + V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENILL 283
           DLKPENI+L
Sbjct: 139 DLKPENIML 147

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 72/136 (52%), Gaps = 4/136 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 212
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++  +     ED A  Y  ++   + H+H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 268 ANGIMHRDLKPENILL 283
            N  +H DLKPENI+ 
Sbjct: 273 ENNYVHLDLKPENIMF 288

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 68/133 (51%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 278 PENILLDADGHVR 290
             N+ L+ D  V+
Sbjct: 167 LGNLFLNEDLEVK 179

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 68/133 (51%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 278 PENILLDADGHVR 290
             N+ L+ D  V+
Sbjct: 145 LGNLFLNEDLEVK 157

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 68/133 (51%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 278 PENILLDADGHVR 290
             N+ L+ D  V+
Sbjct: 145 LGNLFLNEDLEVK 157

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 72/136 (52%), Gaps = 4/136 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 106
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++  +     ED A  Y  ++   + H+H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 268 ANGIMHRDLKPENILL 283
            N  +H DLKPENI+ 
Sbjct: 167 ENNYVHLDLKPENIMF 182

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 76/139 (54%), Gaps = 4/139 (2%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENILL 283
           +LH   I H DLKPENI+L
Sbjct: 130 YLHTKKIAHFDLKPENIML 148

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 76/139 (54%), Gaps = 4/139 (2%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENILL 283
           +LH   I H DLKPENI+L
Sbjct: 130 YLHTKKIAHFDLKPENIML 148

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 76/139 (54%), Gaps = 4/139 (2%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENILL 283
           +LH   I H DLKPENI+L
Sbjct: 130 YLHTKKIAHFDLKPENIML 148

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 76/139 (54%), Gaps = 4/139 (2%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENILL 283
           +LH   I H DLKPENI+L
Sbjct: 130 YLHTKKIAHFDLKPENIML 148

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 68/133 (51%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 278 PENILLDADGHVR 290
             N+ L+ D  V+
Sbjct: 143 LGNLFLNEDLEVK 155

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 80/147 (54%), Gaps = 11/147 (7%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +E L +VG+G++  V + R   T  I A+K     K +E +  + +K     E  +L
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLL 78
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAV 263
            ++ H  +V L    + K R YLV +FV+   L   +L+  GL  + + + Y  +I++ +
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQ-VVQKYLFQIINGI 137
Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
              H++ I+HRD+KPENIL+   G V+
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVK 164

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 76/140 (54%), Gaps = 11/140 (7%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +E +  +G+G++  V++ R   T +I A+K     K +E      +K     E  +L
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRML 56
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAV 263
            ++ HP +V L   F+ K RL+LV ++ +   L     Y++G+  E L +  T + + AV
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGV-PEHLVKSITWQTLQAV 115
Query: 264 SHLHANGIMHRDLKPENILL 283
           +  H +  +HRD+KPENIL+
Sbjct: 116 NFCHKHNCIHRDVKPENILI 135

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 69/141 (48%), Gaps = 7/141 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EV + +G G+++   +     T+  +A+K++ K K       E +      L    HP 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEIL------LRYGQHPN 77
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I+ L+  +     +Y+V +   GG L  ++ RQ  F E  A      I   V +LHA G+
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 272 MHRDLKPENIL-LDADGHVRS 291
           +HRDLKP NIL +D  G+  S
Sbjct: 138 VHRDLKPSNILYVDESGNPES 158

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 84/155 (54%), Gaps = 20/155 (12%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE + V+GQGAF +V + R    S  YA+K +R      +     + SE  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQ 62
Query: 211 FIVQL------RYSF-------QTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIY 255
           ++V+       R +F       + K  L++ +++     L+  ++ + L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +I+ A+S++H+ GI+HRDLKP NI +D   +V+
Sbjct: 123 R-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 70/141 (49%), Gaps = 7/141 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EV + +G G+++   +     T+  +A+K++ K K       E +      L    HP 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL------LRYGQHPN 77
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I+ L+  +     +Y+V + + GG L  ++ RQ  F E  A      I   V +LHA G+
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 272 MHRDLKPENIL-LDADGHVRS 291
           +HRDLKP NIL +D  G+  S
Sbjct: 138 VHRDLKPSNILYVDESGNPES 158

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 14/153 (9%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFIVQL--RYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSA 262
           P IV+   R   +T   LY+V+++  GG L   +      RQ L  E + R+ T ++  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTLA 123
Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVR 290
           +   H      + ++HRDLKP N+ LD   +V+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 14/153 (9%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFIVQL--RYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSA 262
           P IV+   R   +T   LY+V+++  GG L   +      RQ L  E + R+ T ++  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTLA 123
Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVR 290
           +   H      + ++HRDLKP N+ LD   +V+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 14/153 (9%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFIVQL--RYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSA 262
           P IV+   R   +T   LY+V+++  GG L   +      RQ L  E + R+ T ++  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTLA 123
Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVR 290
           +   H      + ++HRDLKP N+ LD   +V+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 77/142 (54%), Gaps = 8/142 (5%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKV 207
           ++ +  ++G+G F  V+   R+      A+KV+ +++++     + +     E  +L KV
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 208 D----HPFIVQLRYSFQTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
                HP +++L   F+T+    LVL+  +    LF  +  +G   E  +R +  ++V+A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 263 VSHLHANGIMHRDLKPENILLD 284
           + H H+ G++HRD+K ENIL+D
Sbjct: 152 IQHCHSRGVVHRDIKDENILID 173

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 76/136 (55%), Gaps = 2/136 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLD 284
            GI HRD+KPEN+LLD
Sbjct: 123 IGITHRDIKPENLLLD 138

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 76/136 (55%), Gaps = 2/136 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLD 284
            GI HRD+KPEN+LLD
Sbjct: 124 IGITHRDIKPENLLLD 139

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 42/171 (24%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDHPFIVQL 215
           +GQG++  V       T  I A+K+M K+KI + N    E +K+E  ++ K+ HP I +L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQL---------------------------------- 241
              ++ +  + LV++  +GGHL  +L                                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 242 ---YRQGL---FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
              +R+ L    RE L      +I SA+ +LH  GI HRD+KPEN L   +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  +D+E+ +V+G GA A V         E  A+K +  +K  + +  E +K E   +++
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLK-EIQAMSQ 69
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL--------YRQGLFREDLARIYTAE 258
             HP IV    SF  K  L+LV+  ++GG +   +        ++ G+  E        E
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           ++  + +LH NG +HRD+K  NILL  DG V+
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  +D+E+ +V+G GA A V         E  A+K +  +K  + +  E +K E   +++
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLK-EIQAMSQ 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL--------YRQGLFREDLARIYTAE 258
             HP IV    SF  K  L+LV+  ++GG +   +        ++ G+  E        E
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 124
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           ++  + +LH NG +HRD+K  NILL  DG V+
Sbjct: 125 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 156

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 76/136 (55%), Gaps = 2/136 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLD 284
            GI HRD+KPEN+LLD
Sbjct: 124 IGITHRDIKPENLLLD 139

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 76/136 (55%), Gaps = 2/136 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLD 284
            GI HRD+KPEN+LLD
Sbjct: 124 IGITHRDIKPENLLLD 139

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 76/136 (55%), Gaps = 2/136 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLD 284
            GI HRD+KPEN+LLD
Sbjct: 124 IGITHRDIKPENLLLD 139

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 82/157 (52%), Gaps = 4/157 (2%)
Query: 135 GHIDNLPSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
            H+    +++  V  E+ F  L  +G+G+F +VY+     T E+ A+K++  D    ++ 
Sbjct: 3   AHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKII--DLEEAEDE 60
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            E ++ E  +L++ D P+I +   S+    +L+++++++ GG     L + G   E    
Sbjct: 61  IEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIA 119
Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
               EI+  + +LH+   +HRD+K  N+LL   G V+
Sbjct: 120 TILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVK 156

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 72/130 (55%), Gaps = 6/130 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G GAF  V+ V    +     +K + KD+   +   E +++E  +L  +DHP I+++  
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI----VSAVSHLHANGIMH 273
            F+  + +Y+V++   GG L  ++       + L+  Y AE+    ++A+++ H+  ++H
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 274 RDLKPENILL 283
           +DLKPENIL 
Sbjct: 148 KDLKPENILF 157

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 85/155 (54%), Gaps = 20/155 (12%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE + V+GQGAF +V + R    S  YA+K +R  +  EK     + SE  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EK--LSTILSEVXLLASLNHQ 62
Query: 211 FIVQL------RYSF-------QTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIY 255
           ++V+       R +F       + K  L++  ++     L+  ++ + L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +I+ A+S++H+ GI+HR+LKP NI +D   +V+
Sbjct: 123 R-QILEALSYIHSQGIIHRNLKPXNIFIDESRNVK 156

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINAMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 124 IGITHRDIKPENLLLDERDNLK 145

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 123 IGITHRDIKPENLLLDERDNLK 144

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 122 IGITHRDIKPENLLLDERDNLK 143

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 123 IGITHRDIKPENLLLDERDNLK 144

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 123 IGITHRDIKPENLLLDERDNLK 144

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 123 IGITHRDIKPENLLLDERDNLK 144

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 76/136 (55%), Gaps = 2/136 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLD 284
            GI HRD+KPEN+LLD
Sbjct: 123 IGITHRDIKPENLLLD 138

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 123 IGITHRDIKPENLLLDERDNLK 144

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 124 IGITHRDIKPENLLLDERDNLK 145

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 123 IGITHRDIKPENLLLDERDNLK 144

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 123 IGITHRDIKPENLLLDERDNLK 144

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 123 IGITHRDIKPENLLLDERDNLK 144

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 124 IGITHRDIKPENLLLDERDNLK 145

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 124 IGITHRDIKPENLLLDERDNLK 145

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 123 IGITHRDIKPENLLLDERDNLK 144

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 25  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 73
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 74  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 133
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 134 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 183

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 6   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 54
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 55  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 114
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 115 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 164

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 5   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 53
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 54  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 113
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 114 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 163

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 6   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 54
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 55  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 114
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 115 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 164

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 2/141 (1%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDH 209
           +E L  +G+G FA VY+ R   T++I A+K ++     E        + R I  L ++ H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I+ L  +F  K  + LV DF+             +      + Y    +  + +LH +
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 270 GIMHRDLKPENILLDADGHVR 290
            I+HRDLKP N+LLD +G ++
Sbjct: 132 WILHRDLKPNNLLLDENGVLK 152

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 6   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 54
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 55  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 114
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 115 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 164

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 5   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 53
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 54  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 113
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 114 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 163

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 177

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 177

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 177

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 176

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 33  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 81
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 82  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 141
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 142 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 191

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 38  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 86
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 87  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 146
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 147 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 196

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 176

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 176

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 177

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 33  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 81
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 82  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 141
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 142 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 191

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 176

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 6/135 (4%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH--AEYMKSERNILTKVDHPFIVQ 214
           V+G+GA A+V     + TS+ YA+K++ K    +  H  +   +    +     H  +++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK----QPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++++  F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 275 DLKPENILLDADGHV 289
           DLKPENIL +    V
Sbjct: 136 DLKPENILCEHPNQV 150

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 135 GHIDNLPSENQCVGLED---------------FEVLKVVGQGAFAKVYQVRRIGTSEIYA 179
           G +D +P+  +   L+D               F  L+ +G G+F  VY  R +  SE+ A
Sbjct: 24  GAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVA 83
Query: 180 MKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG-GHLF 238
           +K M           + +  E   L K+ HP  +Q R  +  ++  +LV+++  G     
Sbjct: 84  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 143
Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +++++ L   ++A + T   +  +++LH++ ++HRD+K  NILL   G V+
Sbjct: 144 LEVHKKPLQEVEIAAV-THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK 194

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 74/139 (53%), Gaps = 6/139 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+ +     LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 266 LHANGIMHRDLKPENILLD 284
            H  G++HRD+K ENIL+D
Sbjct: 130 CHNCGVLHRDIKDENILID 148

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 6/135 (4%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH--AEYMKSERNILTKVDHPFIVQ 214
           V+G+GA A+V     + TS+ YA+K++ K    +  H  +   +    +     H  +++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK----QPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++++  F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 275 DLKPENILLDADGHV 289
           DLKPENIL +    V
Sbjct: 136 DLKPENILCEHPNQV 150

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 80/143 (55%), Gaps = 4/143 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E ++ L+ VG+G +  VY+ +      I A+K +R D   E   +  ++ E ++L ++ 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELH 77
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV L     ++  L LV +F+           + GL ++   +IY  +++  V+H H
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGL-QDSQIKIYLYQLLRGVAHCH 136
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
            + I+HRDLKP+N+L+++DG ++
Sbjct: 137 QHRILHRDLKPQNLLINSDGALK 159

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 80/143 (55%), Gaps = 4/143 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E ++ L+ VG+G +  VY+ +      I A+K +R D   E   +  ++ E ++L ++ 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELH 77
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV L     ++  L LV +F+           + GL ++   +IY  +++  V+H H
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGL-QDSQIKIYLYQLLRGVAHCH 136
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
            + I+HRDLKP+N+L+++DG ++
Sbjct: 137 QHRILHRDLKPQNLLINSDGALK 159

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 73/140 (52%), Gaps = 2/140 (1%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ HP 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            +Q R  +  ++  +LV+++  G      +++++ L   ++A + T   +  +++LH++ 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV-THGALQGLAYLHSHN 135
Query: 271 IMHRDLKPENILLDADGHVR 290
           ++HRD+K  NILL   G V+
Sbjct: 136 MIHRDVKAGNILLSEPGLVK 155

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 6/139 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLD 284
            H  G++HRD+K ENIL+D
Sbjct: 131 CHNCGVLHRDIKDENILID 149

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 76/141 (53%), Gaps = 3/141 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            ++ +   S+    +L+++++++ GG     L R G F E        EI+  + +LH+ 
Sbjct: 81  SYVTKYYGSYLKGSKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSE 139
Query: 270 GIMHRDLKPENILLDADGHVR 290
             +HRD+K  N+LL   G V+
Sbjct: 140 KKIHRDIKAANVLLSEQGDVK 160

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 78/142 (54%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA  +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 123 IGITHRDIKPENLLLDERDNLK 144

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 6/139 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLD 284
            H  G++HRD+K ENIL+D
Sbjct: 131 CHNCGVLHRDIKDENILID 149

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 6/139 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 266 LHANGIMHRDLKPENILLD 284
            H  G++HRD+K ENIL+D
Sbjct: 130 CHNCGVLHRDIKDENILID 148

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 6/139 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 266 LHANGIMHRDLKPENILLD 284
            H  G++HRD+K ENIL+D
Sbjct: 153 CHNCGVLHRDIKDENILID 171

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 6/139 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLD 284
            H  G++HRD+K ENIL+D
Sbjct: 131 CHNCGVLHRDIKDENILID 149

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 75/141 (53%), Gaps = 3/141 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 84
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 85  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 143
Query: 270 GIMHRDLKPENILLDADGHVR 290
             +HRD+K  N+LL   G V+
Sbjct: 144 KKIHRDIKAANVLLSEHGEVK 164

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/142 (23%), Positives = 76/142 (53%), Gaps = 1/142 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   E   +  ++ E  +L ++ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELK 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     +  +L LV +F +     +     G    ++ + +  +++  +   H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRDLKP+N+L++ +G ++
Sbjct: 120 RNVLHRDLKPQNLLINRNGELK 141

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 6/139 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLD 284
            H  G++HRD+K ENIL+D
Sbjct: 126 CHNCGVLHRDIKDENILID 144

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 75/141 (53%), Gaps = 3/141 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 270 GIMHRDLKPENILLDADGHVR 290
             +HRD+K  N+LL   G V+
Sbjct: 139 KKIHRDIKAANVLLSEHGEVK 159

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/142 (23%), Positives = 76/142 (53%), Gaps = 1/142 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   E   +  ++ E  +L ++ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELK 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     +  +L LV +F +     +     G    ++ + +  +++  +   H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRDLKP+N+L++ +G ++
Sbjct: 120 RNVLHRDLKPQNLLINRNGELK 141

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 6/139 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 266 LHANGIMHRDLKPENILLD 284
            H  G++HRD+K ENIL+D
Sbjct: 129 CHNCGVLHRDIKDENILID 147

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 6/139 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLD 284
            H  G++HRD+K ENIL+D
Sbjct: 126 CHNCGVLHRDIKDENILID 144

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 75/141 (53%), Gaps = 3/141 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 270 GIMHRDLKPENILLDADGHVR 290
             +HRD+K  N+LL   G V+
Sbjct: 124 KKIHRDIKAANVLLSEHGEVK 144

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 6/139 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLD 284
            H  G++HRD+K ENIL+D
Sbjct: 126 CHNXGVLHRDIKDENILID 144

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 75/141 (53%), Gaps = 3/141 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 270 GIMHRDLKPENILLDADGHVR 290
             +HRD+K  N+LL   G V+
Sbjct: 124 KKIHRDIKAANVLLSEHGEVK 144

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 79/143 (55%), Gaps = 8/143 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F+VL+ +G+G++  VY+     T +I A+K +     +E +  E +K E +I+ + D 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIK-EISIMQQCDS 83
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P +V+   S+     L++V+++   G +    +L  + L  +++A I  + +   + +LH
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL-KGLEYLH 142
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
               +HRD+K  NILL+ +GH +
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAK 165

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 70/133 (52%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLDADGHVR 290
            +NILL  DG V+
Sbjct: 144 SDNILLGMDGSVK 156

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 70/133 (52%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLDADGHVR 290
            +NILL  DG V+
Sbjct: 144 SDNILLGMDGSVK 156

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 70/133 (52%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 144
Query: 278 PENILLDADGHVR 290
            +NILL  DG V+
Sbjct: 145 SDNILLGMDGSVK 157

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 70/133 (52%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLDADGHVR 290
            +NILL  DG V+
Sbjct: 144 SDNILLGMDGSVK 156

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 73/143 (51%), Gaps = 4/143 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
            NGI+HRD+KP NIL+ A   V+
Sbjct: 134 QNGIIHRDVKPANILISATNAVK 156

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 74/133 (55%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V   R   +    A+K+M    + ++   E + +E  I+    H  +V++  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L+++++F+ GG L   + +  L  E +A +  A ++ A+++LHA G++HRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEA-VLQALAYLHAQGVIHRDIK 168
Query: 278 PENILLDADGHVR 290
            ++ILL  DG V+
Sbjct: 169 SDSILLTLDGRVK 181

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 73/143 (51%), Gaps = 4/143 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
            NGI+HRD+KP NI++ A   V+
Sbjct: 134 QNGIIHRDVKPANIMISATNAVK 156

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 81/153 (52%), Gaps = 5/153 (3%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           ++N  V  +D E +  +G+GA+  V ++R + + +I A+K +R     ++     M  + 
Sbjct: 43  NQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 102
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQG-LFREDLARIYTAE 258
           ++ T VD PF V    +   +  +++ ++ ++      + Q+  +G    ED+       
Sbjct: 103 SMRT-VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVS 161
Query: 259 IVSAVSHLHAN-GIMHRDLKPENILLDADGHVR 290
           IV A+ HLH+   ++HRD+KP N+L++A G V+
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVK 194

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 73/143 (51%), Gaps = 4/143 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
            NGI+HRD+KP NI++ A   V+
Sbjct: 134 QNGIIHRDVKPANIMISATNAVK 156

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 4/133 (3%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K +G+G FA V Q     T + YA K ++K +  +   AE +     +      P ++ L
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 216 RYSFQTKYRLYLVLDFVNGGHLF---FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
              ++    + L+L++  GG +F        + +   D+ R+   +I+  V +LH N I+
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-IKQILEGVYYLHQNNIV 153
Query: 273 HRDLKPENILLDA 285
           H DLKP+NILL +
Sbjct: 154 HLDLKPQNILLSS 166

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 73/143 (51%), Gaps = 4/143 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
            NGI+HRD+KP NI++ A   V+
Sbjct: 134 QNGIIHRDVKPANIMISATNAVK 156

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 73/143 (51%), Gaps = 4/143 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
            NGI+HRD+KP NI++ A   V+
Sbjct: 134 QNGIIHRDVKPANIMISATNAVK 156

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 80/163 (49%), Gaps = 8/163 (4%)
Query: 134 TGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
           +G +   P ++     ED + L  +G+GA+  V ++    + +I A+K +R   + EK  
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQ 64
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF-----R 248
            + +     ++   D P+IVQ   +   +   ++ ++ ++     F  Y   +       
Sbjct: 65  KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE 124
Query: 249 EDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR 290
           E L +I T   V A++HL  N  I+HRD+KP NILLD  G+++
Sbjct: 125 EILGKI-TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK 166

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 78/142 (54%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRDLKP+N+L++ +G ++
Sbjct: 119 RRVLHRDLKPQNLLINREGELK 140

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 78/142 (54%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRDLKP+N+L++ +G ++
Sbjct: 119 RRVLHRDLKPQNLLINREGELK 140

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 38/195 (19%)
Query: 109 VEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQ 168
           + G+     + PN +  V A+ GK TG    +   N C         KV+G G+F  V+Q
Sbjct: 10  LNGVKLNPLDDPNKVIKVLASDGK-TGEQREIAYTN-C---------KVIGNGSFGVVFQ 58
Query: 169 VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF------QTK 222
            + + + E+   KV++  +        +   E  I+  V HP +V L+  F      + +
Sbjct: 59  AKLVESDEVAIKKVLQDKR--------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110
Query: 223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLA--------RIYTAEIVSAVSHLHANGIMHR 274
             L LVL++V        +YR       L         ++Y  +++ +++++H+ GI HR
Sbjct: 111 VFLNLVLEYVPE-----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165
Query: 275 DLKPENILLDADGHV 289
           D+KP+N+LLD    V
Sbjct: 166 DIKPQNLLLDPPSGV 180

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 78/142 (54%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRDLKP+N+L++ +G ++
Sbjct: 119 RRVLHRDLKPQNLLINREGELK 140

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 70/133 (52%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HR++K
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRNIK 144
Query: 278 PENILLDADGHVR 290
            +NILL  DG V+
Sbjct: 145 SDNILLGMDGSVK 157

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 11/141 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ + +G G F  V +     T E  A+K  R++ +  KN   +   E  I+ K++HP 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC-LEIQIMKKLNHPN 74
Query: 212 IVQLRYSFQTKYRL------YLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSA 262
           +V  R       +L       L +++  GG L     Q       +E   R   ++I SA
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 263 VSHLHANGIMHRDLKPENILL 283
           + +LH N I+HRDLKPENI+L
Sbjct: 135 LRYLHENRIIHRDLKPENIVL 155

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 11/141 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ + +G G F  V +     T E  A+K  R++ +  KN   +   E  I+ K++HP 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC-LEIQIMKKLNHPN 73
Query: 212 IVQLRYSFQTKYRL------YLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSA 262
           +V  R       +L       L +++  GG L     Q       +E   R   ++I SA
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 263 VSHLHANGIMHRDLKPENILL 283
           + +LH N I+HRDLKPENI+L
Sbjct: 134 LRYLHENRIIHRDLKPENIVL 154

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L  +E++K +G+GA+  V++     T E+ A+K +  D       A+    E  ILT++ 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREIMILTELS 66
Query: 209 -HPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
            H  IV L    +      +YLV D++        + R  +      +    +++  + +
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH+ G++HRD+KP NILL+A+ HV+
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVK 149

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR- 184
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 185 --KDKI-MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
             K+KI  E    E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKNKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 73/143 (51%), Gaps = 4/143 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 150
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
            NGI+HRD+KP NI++ A   V+
Sbjct: 151 QNGIIHRDVKPANIMISATNAVK 173

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 78/148 (52%), Gaps = 5/148 (3%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  +D E +  +G+GA+  V ++R + + +I A+K +R     ++     M  + ++ T 
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT- 62
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQG-LFREDLARIYTAEIVSAV 263
           VD PF V    +   +  +++ ++ ++      + Q+  +G    ED+       IV A+
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 264 SHLHAN-GIMHRDLKPENILLDADGHVR 290
            HLH+   ++HRD+KP N+L++A G V+
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVK 150

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 72/133 (54%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 154
Query: 278 PENILLDADGHVR 290
            ++ILL  DG V+
Sbjct: 155 SDSILLTHDGRVK 167

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 72/133 (54%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 274
Query: 278 PENILLDADGHVR 290
            ++ILL  DG V+
Sbjct: 275 SDSILLTHDGRVK 287

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 72/133 (54%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 147
Query: 278 PENILLDADGHVR 290
            ++ILL  DG V+
Sbjct: 148 SDSILLTHDGRVK 160

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 72/133 (54%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 152
Query: 278 PENILLDADGHVR 290
            ++ILL  DG V+
Sbjct: 153 SDSILLTHDGRVK 165

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 72/133 (54%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 143
Query: 278 PENILLDADGHVR 290
            ++ILL  DG V+
Sbjct: 144 SDSILLTHDGRVK 156

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 72/133 (54%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 197
Query: 278 PENILLDADGHVR 290
            ++ILL  DG V+
Sbjct: 198 SDSILLTHDGRVK 210

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 72/140 (51%), Gaps = 5/140 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EVLKV+G+G+F +V +       +  A+K++R +K   +  AE ++   + L K D   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH-LRKQDKDN 157
Query: 212 IVQLRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSAVSHLH 267
            + + +  +   +R ++ + F       ++L ++  F+     L R +   I+  +  LH
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 268 ANGIMHRDLKPENILLDADG 287
            N I+H DLKPENILL   G
Sbjct: 218 KNRIIHCDLKPENILLKQQG 237

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 72/140 (51%), Gaps = 5/140 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EVLKV+G+G+F +V +       +  A+K++R +K   +  AE ++   + L K D   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH-LRKQDKDN 157
Query: 212 IVQLRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSAVSHLH 267
            + + +  +   +R ++ + F       ++L ++  F+     L R +   I+  +  LH
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 268 ANGIMHRDLKPENILLDADG 287
            N I+H DLKPENILL   G
Sbjct: 218 KNRIIHCDLKPENILLKQQG 237

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 74/147 (50%), Gaps = 6/147 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS-----ERNIL 204
           + +  +  +G GAF  V+       ++   +K ++K+K++E    E  K      E  IL
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAV 263
           ++V+H  I+++   F+ +    LV++    G  LF  + R     E LA     ++VSAV
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            +L    I+HRD+K ENI++  D  ++
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIK 170

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 71/140 (50%), Gaps = 5/140 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EVLKV+G+G F +V +       +  A+K++R +K   +  AE ++   + L K D   
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH-LRKQDKDN 157
Query: 212 IVQLRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSAVSHLH 267
            + + +  +   +R ++ + F       ++L ++  F+     L R +   I+  +  LH
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 268 ANGIMHRDLKPENILLDADG 287
            N I+H DLKPENILL   G
Sbjct: 218 KNRIIHCDLKPENILLKQQG 237

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 12/140 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F V++ +G G F +V   + I   + YA+KV+R  K     +    K E +IL K+ +  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDD 92
Query: 212 IVQ---LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVS 264
           I     ++Y  +  Y  ++ L F   G   +++  +    G   ED+ ++Y  EI+ A++
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDI-KLYCIEILKALN 151
Query: 265 HLHANGIMHRDLKPENILLD 284
           +L    + H DLKPENILLD
Sbjct: 152 YLRKMSLTHTDLKPENILLD 171

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 77/153 (50%), Gaps = 7/153 (4%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           EN  V  +D E +  +G+GA+  V + R + + +I A+K +R    +     + +  + +
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRA--TVNSQEQKRLLXDLD 84
Query: 203 ILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQG-LFREDLARIYTAE 258
           I  + VD PF V    +   +  +++  +  +      + Q+  +G    ED+       
Sbjct: 85  ISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVS 144
Query: 259 IVSAVSHLHAN-GIMHRDLKPENILLDADGHVR 290
           IV A+ HLH+   ++HRD+KP N+L++A G V+
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVK 177

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 75/145 (51%), Gaps = 9/145 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F+ L+ +G G +A VY+     T    A+K ++ D   E+        E +++ ++ H  
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHEN 64
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR------QGLFREDLARIYTAEIVSAVSH 265
           IV+L     T+ +L LV +F++     +   R      +GL   +L + +  +++  ++ 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-ELNLVKYFQWQLLQGLAF 123
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
            H N I+HRDLKP+N+L++  G ++
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLK 148

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL- 215
           ++GQGA A V++ R   T +++A+KV      +     +    E  +L K++H  IV+L 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLF 73
Query: 216 --RYSFQTKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHAN 269
                  T++++ L+++F   G L+  L       GL   +   I   ++V  ++HL  N
Sbjct: 74  AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN 131
Query: 270 GIMHRDLKPENIL 282
           GI+HR++KP NI+
Sbjct: 132 GIVHRNIKPGNIM 144

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL- 215
           ++GQGA A V++ R   T +++A+KV      +     +    E  +L K++H  IV+L 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLF 73
Query: 216 --RYSFQTKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHAN 269
                  T++++ L+++F   G L+  L       GL   +   I   ++V  ++HL  N
Sbjct: 74  AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN 131
Query: 270 GIMHRDLKPENIL 282
           GI+HR++KP NI+
Sbjct: 132 GIVHRNIKPGNIM 144

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 65/132 (49%), Gaps = 7/132 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA-EYMKSERNILTKVDHPFIVQ 214
           +++G G F KVY+   IG     A+K  R D   + +   E ++ E  +   + HP I+ 
Sbjct: 13  EIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG---I 271
           LR     +  L LV++F  GG L   L  + +   D+   +  +I   +++LH      I
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 272 MHRDLKPENILL 283
           +HRDLK  NIL+
Sbjct: 130 IHRDLKSSNILI 141

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 71/133 (53%), Gaps = 4/133 (3%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       T +  A+K M    + ++   E + +E  I+    H  +V +  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  + ++ A+S+LH  G++HRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSYLHNQGVIHRDIK 168
Query: 278 PENILLDADGHVR 290
            ++ILL +DG ++
Sbjct: 169 SDSILLTSDGRIK 181

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 17/149 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 118
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 119 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 178
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 179 LTYLREKHKIMHRDVKPSNILVNSRGEIK 207

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 67/130 (51%), Gaps = 8/130 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F +V+++    T    A+K +R    +E   AE + +   + +    P IV L  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR----LEVFRAEELMACAGLTS----PRIVPLYG 152
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   +  QG   ED A  Y  + +  + +LH+  I+H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 278 PENILLDADG 287
            +N+LL +DG
Sbjct: 213 ADNVLLSSDG 222

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 17/149 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 56
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIK 145

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 17/149 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 56
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIK 145

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 17/149 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 56
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIK 145

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 69/142 (48%), Gaps = 9/142 (6%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K ++ D      H    K E +IL  + H 
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHE 93
Query: 211 FIVQLRYSFQTK--YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I++ +   +      L LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHA 152
Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HRDL   N+LLD D  V+
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVK 174

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 2/151 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS  +    + F+ L  +G G++ +V++VR      +YA+K         K+ A  +   
Sbjct: 48  PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEI 259
            +      HP  V+L  +++    LYL  +   G  L       G    E     Y  + 
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           + A++HLH+ G++H D+KP NI L   G  +
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGRCK 197

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 67/130 (51%), Gaps = 8/130 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F +V+++    T    A+K +R    +E   AE + +   + +    P IV L  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR----LEVFRAEELMACAGLTS----PRIVPLYG 133
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   +  QG   ED A  Y  + +  + +LH+  I+H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 278 PENILLDADG 287
            +N+LL +DG
Sbjct: 194 ADNVLLSSDG 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 17/149 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 56
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIK 145

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 17/149 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 56
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIK 145

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 17/149 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 83
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 84  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 143
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 144 LTYLREKHKIMHRDVKPSNILVNSRGEIK 172

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 9/142 (6%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K ++ D      H    K E +IL  + H 
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHE 76
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I++ +     Q +  L LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHA 135
Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HR+L   N+LLD D  V+
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVK 157

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 I--YTAEIVSAVSHLHANGIMHRDLKPENILLDADG 287
           I      +++ + ++H N I+HRD+K  N+L+  DG
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 162

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 17/149 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 59
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 60  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 119
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 120 LTYLREKHKIMHRDVKPSNILVNSRGEIK 148

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 21/159 (13%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 I--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           I      +++ + ++H N I+HRD+K  N+L+  DG ++
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 165

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 21/159 (13%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 I--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           I      +++ + ++H N I+HRD+K  N+L+  DG ++
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 165

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 43/170 (25%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR-------KDKIMEKNHAEYMKSER 201
           L DFE ++ +G+G F  V++ +       YA+K +R       ++K+M +  A       
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA------- 56
Query: 202 NILTKVDHPFIVQLRYSFQTKY----------RLYLVL-----------DFVNGGHLFFQ 240
             L K++HP IV+   ++  K           ++YL +           D++NG     +
Sbjct: 57  --LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             R       L      +I  AV  LH+ G+MHRDLKP NI    D  V+
Sbjct: 115 RERSVCLHIFL------QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK 158

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 15/149 (10%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  ++ EV +VVG+GAF  V + +       +  K +   +I  ++  +    E   L++
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSR 58
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAV 263
           V+HP IV+L  +      + LV+++  GG L+  L+       +    A  +  +    V
Sbjct: 59  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 116
Query: 264 SHLHA---NGIMHRDLKPENILLDADGHV 289
           ++LH+     ++HRDLKP N+LL A G V
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGTV 145

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 67
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 125
Query: 254 I--YTAEIVSAVSHLHANGIMHRDLKPENILLDADG 287
           I      +++ + ++H N I+HRD+K  N+L+  DG
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 161

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 17/149 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 75
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 76  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 135
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 136 LTYLREKHKIMHRDVKPSNILVNSRGEIK 164

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 15/149 (10%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  ++ EV +VVG+GAF  V + +       +  K +   +I  ++  +    E   L++
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSR 57
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAV 263
           V+HP IV+L  +      + LV+++  GG L+  L+       +    A  +  +    V
Sbjct: 58  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 264 SHLHA---NGIMHRDLKPENILLDADGHV 289
           ++LH+     ++HRDLKP N+LL A G V
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTV 144

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 70/142 (49%), Gaps = 9/142 (6%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K ++ D      H    K E +IL  + H 
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHE 76
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I++ +     Q +  L LV+++V  G L   L R  +    L  ++  +I   +++LH+
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHS 135
Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HR+L   N+LLD D  V+
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVK 157

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 63/120 (52%), Gaps = 6/120 (5%)
Query: 171 RIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRL 225
           R+  +   A+K + KD+I    E  +   +  E  +L KV   F  +++L   F+     
Sbjct: 72  RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 131
Query: 226 YLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
            L+L+       LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 132 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 191

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 68/141 (48%), Gaps = 11/141 (7%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           ++ +G+G F+ V  V  +     YA+K   +    E+   E  + E ++    +HP I++
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALK---RILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 215 L-RYSFQ---TKYRLYLVLDFVNGGHLFFQLYR---QGLF-REDLARIYTAEIVSAVSHL 266
           L  Y  +    K+  +L+L F   G L+ ++ R   +G F  ED        I   +  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 267 HANGIMHRDLKPENILLDADG 287
           HA G  HRDLKP NILL  +G
Sbjct: 151 HAKGYAHRDLKPTNILLGDEG 171

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 84
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 85  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 143 AIQYLHSINIAHRDVKPENLL 163

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 127 AIQYLHSINIAHRDVKPENLL 147

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 120
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 121 --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 179 AIQYLHSINIAHRDVKPENLL 199

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           VG+G+F +V++++   T    A+K +R +         +   E      +  P IV L  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYG 117
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 278 PENILLDADG 287
            +N+LL +DG
Sbjct: 178 ADNVLLSSDG 187

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 127 AIQYLHSINIAHRDVKPENLL 147

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 69
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 70  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 128 AIQYLHSINIAHRDVKPENLL 148

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 76
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 77  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 135 AIQYLHSINIAHRDVKPENLL 155

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI---L 204
           ++D++V  +V+G G   KV Q+    T E +A+K+++          +  K+ R +    
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----------DCPKARREVELHW 109
Query: 205 TKVDHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAE 258
                P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 169
Query: 259 IVSAVSHLHANGIMHRDLKPENIL 282
           I  A+ +LH+  I HRD+KPEN+L
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLL 193

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 74
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 75  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 133 AIQYLHSINIAHRDVKPENLL 153

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 129 AIQYLHSINIAHRDVKPENLL 149

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           VG+G+F +V++++   T    A+K +R +         +   E      +  P IV L  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYG 133
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 278 PENILLDADG 287
            +N+LL +DG
Sbjct: 194 ADNVLLSSDG 203

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 129 AIQYLHSINIAHRDVKPENLL 149

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 75
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 76  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 134 AIQYLHSINIAHRDVKPENLL 154

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 129 AIQYLHSINIAHRDVKPENLL 149

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 111 GINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
           G  E   +GP ++SV  A            PS      ++ +  +  +G+G + +VY+  
Sbjct: 10  GTLEAQTQGPGSMSVSAA------------PS---ATSIDRYRRITKLGEGTYGEVYKAI 54
Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD 230
              T+E  A+K +R +   E      ++ E ++L ++ H  I++L+      +RL+L+ +
Sbjct: 55  DTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113
Query: 231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL 283
           +     L   + +       + + +  ++++ V+  H+   +HRDLKP+N+LL
Sbjct: 114 YAEND-LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLL 165

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 83/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E  A+K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+L+D
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVLID 165

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 68/145 (46%), Gaps = 3/145 (2%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           +P +   +  ED  + + +G+G F +V+  R    + + A+K  R + +     A++++ 
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQE 162
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAE 258
            R IL +  HP IV+L      K  +Y+V++ V GG     L  +G   R         +
Sbjct: 163 AR-ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 259 IVSAVSHLHANGIMHRDLKPENILL 283
             + + +L +   +HRDL   N L+
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLV 246

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 68/145 (46%), Gaps = 3/145 (2%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           +P +   +  ED  + + +G+G F +V+  R    + + A+K  R + +     A++++ 
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQE 162
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAE 258
            R IL +  HP IV+L      K  +Y+V++ V GG     L  +G   R         +
Sbjct: 163 AR-ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 259 IVSAVSHLHANGIMHRDLKPENILL 283
             + + +L +   +HRDL   N L+
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLV 246

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HP 210
             V +V+ +G FA VY+ + +G+   YA+K +  ++  EKN A  +  E   + K+  HP
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRA--IIQEVCFMKKLSGHP 86
Query: 211 FIVQL-------RYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIV 260
            IVQ        +    T    +L+L  +  G L     ++  +G    D       +  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 261 SAVSHLHANG--IMHRDLKPENILLDADGHVR 290
            AV H+H     I+HRDLK EN+LL   G ++
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 176
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 204

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK-IMEKNHAEYMKS-ERNI--LT 205
           E ++++  +G G  + VY    +    I  +KV  K   I  +   E +K  ER +   +
Sbjct: 11  ERYKIVDKLGGGGMSTVY----LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           ++ H  IV +    +     YLV++++ G  L   +   G    D A  +T +I+  + H
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
            H   I+HRD+KP+NIL+D++  ++
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLK 151

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 14/141 (9%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K ++      +    + ++ +      
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQC----- 114
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V + ++GG LF ++  +G   F E  A      I  
Sbjct: 115 --PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGE 172
Query: 262 AVSHLHANGIMHRDLKPENIL 282
           A+ +LH+  I HRD+KPEN+L
Sbjct: 173 AIQYLHSINIAHRDVKPENLL 193

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F +V++++   T    A+K +R +         +   E      +  P IV L  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYG 131
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 278 PENILLDADG 287
            +N+LL +DG
Sbjct: 192 ADNVLLSSDG 201

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 61/138 (44%), Gaps = 14/138 (10%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 86
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-----DLARIYTAEIVSAVSHLHANGIM 272
            + TK +L +V  +  G  L+  L+      E     D+AR    +    + +LHA  I+
Sbjct: 87  GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLHAKSII 142
Query: 273 HRDLKPENILLDADGHVR 290
           HRDLK  NI L  D  V+
Sbjct: 143 HRDLKSNNIFLHEDNTVK 160

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 61/138 (44%), Gaps = 14/138 (10%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-----DLARIYTAEIVSAVSHLHANGIM 272
            + TK +L +V  +  G  L+  L+      E     D+AR    +    + +LHA  I+
Sbjct: 75  GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLHAKSII 130
Query: 273 HRDLKPENILLDADGHVR 290
           HRDLK  NI L  D  V+
Sbjct: 131 HRDLKSNNIFLHEDNTVK 148

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN     F+ 
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD--FKQ 123
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
            RQ L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 124 LRQTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 176
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 204

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 142 SENQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           S N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDS 100
Query: 200 ERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
            RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKS 159
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           Y   ++ AV  +H +GI+H DLKP N L+  DG ++
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLK 194

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 18  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 77
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 78  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 129
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 130 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 170

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 142 SENQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           S N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDS 100
Query: 200 ERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
            RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKS 159
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           Y   ++ AV  +H +GI+H DLKP N L+  DG ++
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLK 194

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 7/132 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F  VY+     T+   A   + +D+ + K+  +  K E   L  + HP IV+   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 218 SFQT----KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--I 271
           S+++    K  + LV +    G L   L R  + +  + R +  +I+  +  LH     I
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 272 MHRDLKPENILL 283
           +HRDLK +NI +
Sbjct: 153 IHRDLKCDNIFI 164

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 142 SENQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           S N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDS 100
Query: 200 ERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
            RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKS 159
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           Y   ++ AV  +H +GI+H DLKP N L+  DG ++
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLK 194

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 68/137 (49%), Gaps = 11/137 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR---KDKIMEKNHAEYMKSERNILTK 206
           E + + + +G+G F  V++     + + Y  K ++    D+++       +K E +IL  
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-------VKKEISILNI 57
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSH 265
             H  I+ L  SF++   L ++ +F++G  +F ++        E     Y  ++  A+  
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 266 LHANGIMHRDLKPENIL 282
           LH++ I H D++PENI+
Sbjct: 118 LHSHNIGHFDIRPENII 134

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 139
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 167

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/160 (23%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 130 LGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
           +G      D        + +++ ++L+ +G+G F  V      G     A+K ++ D   
Sbjct: 1   MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT- 57
Query: 190 EKNHAEYMKSERNILTKVDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--L 246
               A+   +E +++T++ H  +VQL     + K  LY+V +++  G L   L  +G  +
Sbjct: 58  ----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 113
Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
              D    ++ ++  A+ +L  N  +HRDL   N+L+  D
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 153

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 76/153 (49%), Gaps = 25/153 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEI-------------YAMKVMRKDKIMEKNHAEYM 197
           DF++  ++G+GA+  V       T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
           K E NI+T     F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHE-NIITI----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           + + AV  LH + ++HRDLKP N+L++++  ++
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK 152

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 80
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 137
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 138 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 165

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 12  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 71
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 72  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 123
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 124 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 139
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 167

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 13  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 72
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 73  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 124
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 125 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 160

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 11  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 70
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 71  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 122
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 123 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
            D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++ 
Sbjct: 12  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 71
Query: 186 DKIMEKNHA----EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL 241
            K  +        E ++   NI+T  D   IV+   S        LV + VN    F QL
Sbjct: 72  VKKKKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQL 123
Query: 242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Y Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D
Sbjct: 124 Y-QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 159

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 76/153 (49%), Gaps = 25/153 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEI-------------YAMKVMRKDKIMEKNHAEYM 197
           DF++  ++G+GA+  V       T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
           K E NI+T     F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHE-NIITI----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           + + AV  LH + ++HRDLKP N+L++++  ++
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK 152

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 160

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 75/138 (54%), Gaps = 4/138 (2%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY-MKSERNILTKVDHPFIVQL 215
           ++G+G++ KV +V    T    A+K+++K K+    + E  +K E  +L ++ H  ++QL
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 216 RYSF--QTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
                 + K ++Y+V+++ V G         +  F    A  Y  +++  + +LH+ GI+
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 273 HRDLKPENILLDADGHVR 290
           H+D+KP N+LL   G ++
Sbjct: 132 HKDIKPGNLLLTTGGTLK 149

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 76/153 (49%), Gaps = 25/153 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEI-------------YAMKVMRKDKIMEKNHAEYM 197
           DF++  ++G+GA+  V       T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
           K E NI+T     F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHE-NIITI----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           + + AV  LH + ++HRDLKP N+L++++  ++
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK 152

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 63/140 (45%), Gaps = 7/140 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  E  E+ +++G+G F +VY  R  G   I  + + R ++    +  +  K E     +
Sbjct: 30  IPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNE----DQLKAFKREVMAYRQ 85
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL--ARIYTAEIVSAVS 264
             H  +V    +  +   L ++     G  L+  + R      D+   R    EIV  + 
Sbjct: 86  TRHENVVLFMGACMSPPHLAIITSLCKGRTLY-SVVRDAKIVLDVNKTRQIAQEIVKGMG 144
Query: 265 HLHANGIMHRDLKPENILLD 284
           +LHA GI+H+DLK +N+  D
Sbjct: 145 YLHAKGILHKDLKSKNVFYD 164

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + +++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T+
Sbjct: 9   LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQ 61
Query: 207 VDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+
Sbjct: 62  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 121
Query: 264 SHLHANGIMHRDLKPENILLDAD 286
            +L  N  +HRDL   N+L+  D
Sbjct: 122 EYLEGNNFVHRDLAARNVLVSED 144

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/142 (22%), Positives = 71/142 (50%), Gaps = 2/142 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L  +G+G +A VY+ +   T  + A+K +R +   E+        E ++L  + 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T+  L LV ++++     +      +      +++  +++  +++ H 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRDLKP+N+L++  G ++
Sbjct: 119 QKVLHRDLKPQNLLINERGELK 140

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R            + + R +     L  
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFRE---DLARIYT 256
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E   DL R   
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR--- 127
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            + +  +  LHAN I+HRDLKPENIL+ + G V+
Sbjct: 128 -QFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 160

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLK 166

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLK 166

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLXG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLK 166

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 75/146 (51%), Gaps = 10/146 (6%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  + + +G G+F  V++    G+    A+K++ +     +   E+++ E  I+ ++ HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTA-EIVSAVSHL 266
            IV    +      L +V ++++ G L+  L++ G  RE L    R+  A ++   +++L
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYL 153
Query: 267 HANG--IMHRDLKPENILLDADGHVR 290
           H     I+HRDLK  N+L+D    V+
Sbjct: 154 HNRNPPIVHRDLKSPNLLVDKKYTVK 179

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +  ED  + +++G+G F +VY+       G     A+K  +KD  ++ N  ++M SE  I
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 78
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSA 262
           +  +DHP IV+L    + +   +++++    G L   L R     + L  + Y+ +I  A
Sbjct: 79  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 137
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           +++L +   +HRD+   NIL+ +   V+
Sbjct: 138 MAYLESINCVHRDIAVRNILVASPECVK 165

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 71/138 (51%), Gaps = 10/138 (7%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMK-VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           +V+G+G F +  +V    T E+  MK ++R D   E+    ++K E  ++  ++HP +++
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLK-EVKVMRCLEHPNVLK 71
Query: 215 LRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
                    RL  + +++ GG L      +  Q  + + ++  +  +I S +++LH+  I
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVS--FAKDIASGMAYLHSMNI 129
Query: 272 MHRDLKPENILLDADGHV 289
           +HRDL   N L+  + +V
Sbjct: 130 IHRDLNSHNCLVRENKNV 147

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           D        + +++ ++L+ +G+G F  V      G     A+K ++ D       A+  
Sbjct: 181 DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAF 233
Query: 198 KSERNILTKVDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARI 254
            +E +++T++ H  +VQL     + K  LY+V +++  G L   L  +G  +   D    
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
           ++ ++  A+ +L  N  +HRDL   N+L+  D
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 325

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 6/137 (4%)
Query: 152 FEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E++  +G+GAF KV +    + G   +    V   D+  E   +E    E    T  + 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 210 PF-IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHL 266
            F  VQ+   F+    + +V + + G   +  +   G   FR D  R    +I  +V+ L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 267 HANGIMHRDLKPENILL 283
           H+N + H DLKPENIL 
Sbjct: 135 HSNKLTHTDLKPENILF 151

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 72/149 (48%), Gaps = 17/149 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V +V+   +  I A K++         H E   + RN       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLI---------HLEIKPAIRNQIIRELQ 66
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L       E++    +  ++  
Sbjct: 67  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 126
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVR 290
           +++L   + IMHRD+KP NIL+++ G ++
Sbjct: 127 LAYLREKHQIMHRDVKPSNILVNSRGEIK 155

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 14/131 (10%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  +KV+  D   E+  A   ++E  +L K  H  I+ L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVV--DPTPEQFQA--FRNEVAVLRKTRHVNIL-LFM 98
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ----GLFRE-DLARIYTAEIVSAVSHLHANGIM 272
            + TK  L +V  +  G  L+  L+ Q     +F+  D+AR    +    + +LHA  I+
Sbjct: 99  GYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIAR----QTAQGMDYLHAKNII 154
Query: 273 HRDLKPENILL 283
           HRD+K  NI L
Sbjct: 155 HRDMKSNNIFL 165

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 6/137 (4%)
Query: 152 FEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E++  +G+GAF KV +    + G   +    V   D+  E   +E    E    T  + 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 210 PF-IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHL 266
            F  VQ+   F+    + +V + + G   +  +   G   FR D  R    +I  +V+ L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 267 HANGIMHRDLKPENILL 283
           H+N + H DLKPENIL 
Sbjct: 135 HSNKLTHTDLKPENILF 151

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLXG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLK 166

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + +++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T+
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQ 55
Query: 207 VDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 264 SHLHANGIMHRDLKPENILLDAD 286
            +L  N  +HRDL   N+L+  D
Sbjct: 116 EYLEGNNFVHRDLAARNVLVSED 138

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +  ED  + +++G+G F +VY+       G     A+K  +KD  ++ N  ++M SE  I
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 66
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSA 262
           +  +DHP IV+L    + +   +++++    G L   L R     + L  + Y+ +I  A
Sbjct: 67  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           +++L +   +HRD+   NIL+ +   V+
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVK 153

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +  ED  + +++G+G F +VY+       G     A+K  +KD  ++ N  ++M SE  I
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 62
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSA 262
           +  +DHP IV+L    + +   +++++    G L   L R     + L  + Y+ +I  A
Sbjct: 63  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 121
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           +++L +   +HRD+   NIL+ +   V+
Sbjct: 122 MAYLESINCVHRDIAVRNILVASPECVK 149

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLXG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDXTLK 159

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  +L  V+
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 79
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYL-LYQMLCG 136
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 137 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 164

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 158 VGQGAFAKVYQ-VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +G G F  V Q V R+   +I  A+KV+++    EK   E M  E  I+ ++D+P+IV+L
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS----HLHANGI 271
               Q +  L LV++   GG L   L  +   RE++     AE++  VS    +L     
Sbjct: 76  IGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 272 MHRDLKPENILL 283
           +HRDL   N+LL
Sbjct: 132 VHRDLAARNVLL 143

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRL-----YLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
           R  L +V HP IVQ+    +   R      Y+V+++V G  L     ++    E +A  Y
Sbjct: 130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--Y 187
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILL 283
             EI+ A+S+LH+ G+++ DLKPENI+L
Sbjct: 188 LLEILPALSYLHSIGLVYNDLKPENIML 215

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ F+V ++ GQG F  V   +   T    A+K + +D        + M+     L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD----LAVLH 77
Query: 209 HPFIVQLRYSFQT-----KYRLYL--VLDFV-NGGHLFFQLY--RQGLFREDLARIYTAE 258
           HP IVQL+  F T     +  +YL  V+++V +  H   + Y  RQ      L +++  +
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 259 IVSAVSHLH--ANGIMHRDLKPENILL-DADGHVR 290
           ++ ++  LH  +  + HRD+KP N+L+ +ADG ++
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  +L  V+
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 78/154 (50%), Gaps = 14/154 (9%)
Query: 144 NQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S R
Sbjct: 4   NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDSYR 58
Query: 202 NILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYT 256
           N +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + Y 
Sbjct: 59  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYW 117
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             ++ AV  +H +GI+H DLKP N L+  DG ++
Sbjct: 118 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLK 150

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 78/154 (50%), Gaps = 14/154 (9%)
Query: 144 NQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S R
Sbjct: 1   NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDSYR 55
Query: 202 NILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYT 256
           N +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + Y 
Sbjct: 56  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYW 114
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             ++ AV  +H +GI+H DLKP N L+  DG ++
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLK 147

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 83
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLY-QMLCG 140
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 141 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 168

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 6/134 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 75
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 76  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 277 KPENILLDADGHVR 290
           K  NI L  D  V+
Sbjct: 136 KSNNIFLHEDLTVK 149

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 67/132 (50%), Gaps = 6/132 (4%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           V+G+G +  VY  R +      A+K + +    +  +++ +  E  +   + H  IVQ  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARI--YTAEIVSAVSHLHANGIMH 273
            SF     + + ++ V GG L   L  + G  +++   I  YT +I+  + +LH N I+H
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 274 RDLKPENILLDA 285
           RD+K +N+L++ 
Sbjct: 146 RDIKGDNVLINT 157

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/165 (21%), Positives = 74/165 (44%), Gaps = 25/165 (15%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--------------DKIMEKNHA 194
           + D+ +++ + QG F K+    +   ++ YA+K   K              DKI  K+  
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL------FFQLYRQ--GL 246
           +  K+E  I+T + + + +           +Y++ +++    +      FF L +     
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 247 FREDLARIYTAEIVSAVSHLH-ANGIMHRDLKPENILLDADGHVR 290
               + +     ++++ S++H    I HRD+KP NIL+D +G V+
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVK 192

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%), Gaps = 3/58 (5%)
Query: 227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           LV +++N    F QLY Q L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 112 LVFEYINNTD-FKQLY-QILTDFDI-RFYMYELLKALDYCHSKGIMHRDVKPHNVMID 166

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 60/138 (43%), Gaps = 14/138 (10%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 86
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-----DLARIYTAEIVSAVSHLHANGIM 272
            + T  +L +V  +  G  L+  L+      E     D+AR    +    + +LHA  I+
Sbjct: 87  GYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLHAKSII 142
Query: 273 HRDLKPENILLDADGHVR 290
           HRDLK  NI L  D  V+
Sbjct: 143 HRDLKSNNIFLHEDNTVK 160

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 139
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 167

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 76  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 160

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 86
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 143
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 144 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 171

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 6/134 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 71  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 277 KPENILLDADGHVR 290
           K  NI L  D  V+
Sbjct: 131 KSNNIFLHEDLTVK 144

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 6/134 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 75
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 76  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 277 KPENILLDADGHVR 290
           K  NI L  D  V+
Sbjct: 136 KSNNIFLHEDLTVK 149

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 72/143 (50%), Gaps = 8/143 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+  +LK +G G F  V   +  G  ++ A+K++++  + E    +    E   + K+ H
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFFQ----EAQTMMKLSH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P +V+       +Y +Y+V ++++ G L  + + + +GL    L  +   ++   ++ L 
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGMAFLE 121
Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++  +HRDL   N L+D D  V+
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVK 144

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 38/58 (65%), Gaps = 3/58 (5%)
Query: 227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           LV +++N    F QLY Q L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 117 LVFEYINNTD-FKQLY-QILTDFDI-RFYMYELLKALDYCHSKGIMHRDVKPHNVMID 171

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 6/134 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 71  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 277 KPENILLDADGHVR 290
           K  NI L  D  V+
Sbjct: 131 KSNNIFLHEDLTVK 144

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 6/134 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 72
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 73  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 132
Query: 277 KPENILLDADGHVR 290
           K  NI L  D  V+
Sbjct: 133 KSNNIFLHEDLTVK 146

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 65/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 76
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V +++N G L  F +       R       +A+I S ++++     +HRD
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 137 LRAANILV 144

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 65/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 76
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V +++N G L  F +       R       +A+I S ++++     +HRD
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 137 LRAANILV 144

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 67/132 (50%), Gaps = 6/132 (4%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           V+G+G +  VY  R +      A+K + +    +  +++ +  E  +   + H  IVQ  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARI--YTAEIVSAVSHLHANGIMH 273
            SF     + + ++ V GG L   L  + G  +++   I  YT +I+  + +LH N I+H
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 131
Query: 274 RDLKPENILLDA 285
           RD+K +N+L++ 
Sbjct: 132 RDIKGDNVLINT 143

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLK 166

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 71/151 (47%), Gaps = 25/151 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF+ ++++G G F +V++ +     + Y +K +       K + E  + E   L K+DH 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHV 64
Query: 211 FIVQL---------------RYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            IV                 + S ++K + L++ ++F + G L  + +  R     + LA
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILL 283
                +I   V ++H+  +++RDLKP NI L
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFL 155

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 158 VGQGAFAKVYQ-VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +G G F  V Q V R+   +I  A+KV+++    EK   E M  E  I+ ++D+P+IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS----HLHANGI 271
               Q +  L LV++   GG L   L  +   RE++     AE++  VS    +L     
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 272 MHRDLKPENILL 283
           +HR+L   N+LL
Sbjct: 458 VHRNLAARNVLL 469

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 75/146 (51%), Gaps = 10/146 (6%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  + + +G G+F  V++    G+    A+K++ +     +   E+++ E  I+ ++ HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTA-EIVSAVSHL 266
            IV    +      L +V ++++ G L+  L++ G  RE L    R+  A ++   +++L
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYL 153
Query: 267 HANG--IMHRDLKPENILLDADGHVR 290
           H     I+HR+LK  N+L+D    V+
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVK 179

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLK 166

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 6/134 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 97
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 98  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 157
Query: 277 KPENILLDADGHVR 290
           K  NI L  D  V+
Sbjct: 158 KSNNIFLHEDLTVK 171

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 6/134 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 98
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 277 KPENILLDADGHVR 290
           K  NI L  D  V+
Sbjct: 159 KSNNIFLHEDLTVK 172

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 6/134 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 98
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 277 KPENILLDADGHVR 290
           K  NI L  D  V+
Sbjct: 159 KSNNIFLHEDLTVK 172

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 11/143 (7%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E+  ++G+G+F +V +       E  A+K+++  K    N A+       ++ K D
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHD 92
Query: 209 HP---FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSA 262
                +IV L+  F  +  L LV + ++  +  + L R   FR    +L R +  ++ +A
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 150
Query: 263 VSHLHAN--GIMHRDLKPENILL 283
           +  L      I+H DLKPENILL
Sbjct: 151 LLFLATPELSIIHCDLKPENILL 173

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 6/134 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 90
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 91  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 150
Query: 277 KPENILLDADGHVR 290
           K  NI L  D  V+
Sbjct: 151 KSNNIFLHEDLTVK 164

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/159 (22%), Positives = 78/159 (49%), Gaps = 19/159 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C   + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +  
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAV 64
Query: 204 ---LTKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDL 251
              L   +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +   +++  +  LH++ ++HRDLKP+NIL+ + G ++
Sbjct: 123 KDMM-FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 73/141 (51%), Gaps = 18/141 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+     G +++ A+K ++   +  ++  E    E  I+ K+ H
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKV-AIKTLKPGTMSPESFLE----EAQIMKKLKH 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSA 262
             +VQL Y+  ++  +Y+V +++N G L     + G  R        D+A    A++ + 
Sbjct: 64  DKLVQL-YAVVSEEPIYIVTEYMNKGSLL-DFLKDGEGRALKLPNLVDMA----AQVAAG 117
Query: 263 VSHLHANGIMHRDLKPENILL 283
           ++++     +HRDL+  NIL+
Sbjct: 118 MAYIERMNYIHRDLRSANILV 138

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 11/143 (7%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E+  ++G+G+F +V +       E  A+K+++  K    N A+       ++ K D
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHD 111
Query: 209 HP---FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSA 262
                +IV L+  F  +  L LV + ++  +  + L R   FR    +L R +  ++ +A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 263 VSHLHAN--GIMHRDLKPENILL 283
           +  L      I+H DLKPENILL
Sbjct: 170 LLFLATPELSIIHCDLKPENILL 192

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 29  DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 88
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 89  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 139
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 140 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 180

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 11/143 (7%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E+  ++G+G+F +V +       E  A+K+++  K    N A+       ++ K D
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHD 111
Query: 209 HP---FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSA 262
                +IV L+  F  +  L LV + ++  +  + L R   FR    +L R +  ++ +A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 263 VSHLHAN--GIMHRDLKPENILL 283
           +  L      I+H DLKPENILL
Sbjct: 170 LLFLATPELSIIHCDLKPENILL 192

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 9   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 68
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 69  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 119
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 120 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 160

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 22/154 (14%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFRE---DLARIYT 256
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E   DL R   
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR--- 119
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            + +  +  LHAN I+HRDLKPENIL+ + G V+
Sbjct: 120 -QFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 152

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 22/154 (14%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFRE---DLARIYT 256
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E   DL R   
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR--- 119
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            + +  +  LHAN I+HRDLKPENIL+ + G V+
Sbjct: 120 -QFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 152

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +    +V  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLV-G 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLK 166

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 67
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 68  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 123
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+++L +   +HRD+   N+L+ ++  V+
Sbjct: 124 STALAYLESKRFVHRDIAARNVLVSSNDCVK 154

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLMGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +    +V  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLV-G 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLK 166

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 22/154 (14%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFRE---DLARIYT 256
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E   DL R   
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR--- 119
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            + +  +  LHAN I+HRDLKPENIL+ + G V+
Sbjct: 120 -QFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 152

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +    +V  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLV-G 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLK 166

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 69
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 70  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 125
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+++L +   +HRD+   N+L+ ++  V+
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVK 156

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 66
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 67  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+++L +   +HRD+   N+L+ ++  V+
Sbjct: 123 STALAYLESKRFVHRDIAARNVLVSSNDCVK 153

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 71/151 (47%), Gaps = 19/151 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+++L +   +HRD+   N+L+ A   V+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSATDCVK 151

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/159 (22%), Positives = 78/159 (49%), Gaps = 19/159 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C   + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +  
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAV 64
Query: 204 ---LTKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDL 251
              L   +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +   +++  +  LH++ ++HRDLKP+NIL+ + G ++
Sbjct: 123 KDM-MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+++L +   +HRD+   N+L+ ++  V+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVK 151

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/138 (23%), Positives = 70/138 (50%), Gaps = 8/138 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 243 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 268 ANGIMHRDLKPENILLDA 285
               +HRDL+  NIL+ A
Sbjct: 302 QRNYIHRDLRAANILVSA 319

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 92
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 93  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 148
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+++L +   +HRD+   N+L+ ++  V+
Sbjct: 149 STALAYLESKRFVHRDIAARNVLVSSNDCVK 179

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 61
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 62  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 117
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+++L +   +HRD+   N+L+ ++  V+
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVK 148

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/138 (23%), Positives = 70/138 (50%), Gaps = 8/138 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 236
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 237 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 268 ANGIMHRDLKPENILLDA 285
               +HRDL+  NIL+ A
Sbjct: 296 QRNYIHRDLRAANILVSA 313

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/159 (22%), Positives = 78/159 (49%), Gaps = 19/159 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C   + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +  
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAV 64
Query: 204 ---LTKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDL 251
              L   +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +   +++  +  LH++ ++HRDLKP+NIL+ + G ++
Sbjct: 123 KDM-MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 9   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 68
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 69  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 119
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 120 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 160

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 71/151 (47%), Gaps = 19/151 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 444
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+++L +   +HRD+   N+L+ A   V+
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSATDCVK 531

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+++L +   +HRD+   N+L+ ++  V+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVK 151

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+++L +   +HRD+   N+L+ ++  V+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVK 151

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 10  DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 69
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 70  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 120
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D
Sbjct: 121 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 161

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 65/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 140 LRAANILV 147

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 328
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 329 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 389 LRAANILV 396

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 83/169 (49%), Gaps = 17/169 (10%)
Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMK-VMR--KDK 187
            KPT  +    S+ Q    + +E+  ++G G++  V +        + A+K ++R  +D 
Sbjct: 36  SKPTASMPRPHSDWQIP--DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL 93
Query: 188 IMEKNHAEYMKSERNILTKVDHPFIVQ-----LRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           I      + +  E  IL +++H  +V+     +    +    LY+VL+  +    F +L+
Sbjct: 94  I----DCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLF 147
Query: 243 RQGLFREDL-ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           R  ++  +L  +     ++  V ++H+ GI+HRDLKP N L++ D  V+
Sbjct: 148 RTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVK 196

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 69
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 277 KPENILL 283
              N L+
Sbjct: 130 AARNCLV 136

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/138 (23%), Positives = 70/138 (50%), Gaps = 8/138 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 70  DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 268 ANGIMHRDLKPENILLDA 285
               +HRDL+  NIL+ A
Sbjct: 129 QRNYIHRDLRAANILVSA 146

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/63 (36%), Positives = 38/63 (60%), Gaps = 2/63 (3%)
Query: 222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE 279
           K  L ++++ + GG LF ++  +G   F E  A     +I +A+  LH++ I HRD+KPE
Sbjct: 98  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 157
Query: 280 NIL 282
           N+L
Sbjct: 158 NLL 160

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 65/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 140 LRAANILV 147

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 70/137 (51%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 133 RDLAARNCLVGENHLVK 149

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 65/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 140 LRAANILV 147

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 9/144 (6%)
Query: 152 FEVLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E+L V+G+G      V   R   T E   ++ +  +         +++ E ++    +H
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAE-IVSAVSH 265
           P IV  R +F     L++V  F+  G    L    +  G+   +LA  Y  + ++ A+ +
Sbjct: 70  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM--NELAIAYILQGVLKALDY 127
Query: 266 LHANGIMHRDLKPENILLDADGHV 289
           +H  G +HR +K  +IL+  DG V
Sbjct: 128 IHHMGYVHRSVKASHILISVDGKV 151

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 69
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 277 KPENILL 283
              N L+
Sbjct: 130 AARNCLV 136

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 444
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +A+++L +   +HRD+   N+L+ ++  V+
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVK 531

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/63 (36%), Positives = 38/63 (60%), Gaps = 2/63 (3%)
Query: 222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE 279
           K  L ++++ + GG LF ++  +G   F E  A     +I +A+  LH++ I HRD+KPE
Sbjct: 79  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 138
Query: 280 NIL 282
           N+L
Sbjct: 139 NLL 141

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 77/153 (50%), Gaps = 14/153 (9%)
Query: 145 QCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           +C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S RN
Sbjct: 1   ECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDSYRN 55
Query: 203 ILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
            +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + Y  
Sbjct: 56  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYWK 114
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            ++ AV  +H +GI+H DLKP N L+  DG ++
Sbjct: 115 NMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLK 146

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 72
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 277 KPENILL 283
              N L+
Sbjct: 133 AARNCLV 139

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 59/134 (44%), Gaps = 6/134 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + T  +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 71  GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 277 KPENILLDADGHVR 290
           K  NI L  D  V+
Sbjct: 131 KSNNIFLHEDLTVK 144

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKIRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 140 LRAANILV 147

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 9/144 (6%)
Query: 152 FEVLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E+L V+G+G      V   R   T E   ++ +  +         +++ E ++    +H
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNH 85
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAE-IVSAVSH 265
           P IV  R +F     L++V  F+  G    L    +  G+   +LA  Y  + ++ A+ +
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM--NELAIAYILQGVLKALDY 143
Query: 266 LHANGIMHRDLKPENILLDADGHV 289
           +H  G +HR +K  +IL+  DG V
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKV 167

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/147 (22%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++E+++ +G GA+  V   RR  T +  A+K +     +  N    ++ E  IL    H
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 113
Query: 210 PFIVQLRYSFQTKY------RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             I+ ++   +          +Y+VLD +           Q L  E + R +  +++  +
Sbjct: 114 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV-RYFLYQLLRGL 172
Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            ++H+  ++HRDLKP N+L++ +  ++
Sbjct: 173 KYMHSAQVIHRDLKPSNLLVNENCELK 199

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 71/137 (51%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIIIEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 133 RDLAARNCLVGENHLVK 149

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 67
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 277 KPENILL 283
              N L+
Sbjct: 128 AARNCLV 134

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 71/137 (51%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIIIEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 135 RDLAARNCLVGENHLVK 151

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           +NL  ++  V    + +LK +G G  +KV+QV      +IYA+K +     +E+   + +
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTL 70
Query: 198 KSERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
            S RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWER 129
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           + Y   ++ AV  +H +GI+H DLKP N L+  DG ++
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLK 166

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 8/171 (4%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEV--LKVVGQGAFAKVYQVRRIGTSEIYAMKVM 183
           ++  L +P       P++ Q   L++ E+  +KV+G GAF  VY+   +   E   + V 
Sbjct: 12  LETELVEPLTPSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVA 71
Query: 184 RK---DKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ 240
            K   +    K + E+M  E  I+  +DHP +V+L         + LV   +  G L   
Sbjct: 72  IKILNETTGPKANVEFM-DEALIMASMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEY 129
Query: 241 LYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           ++  +      L   +  +I   + +L    ++HRDL   N+L+ +  HV+
Sbjct: 130 VHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVK 180

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 140 LRAANILV 147

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/156 (21%), Positives = 74/156 (47%), Gaps = 27/156 (17%)
Query: 150 EDFEVLKVVGQGAFAKVY--------------QVRRIGTSEIYAMKVMRKDKIMEKNHAE 195
           +++E+  ++G+G++  VY              +V R+    I   +++R+  I+ +  ++
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF-REDLARI 254
           Y+    +++   D      L++       LY+VL+  +      +L++  +F  E   + 
Sbjct: 88  YIIRLHDLIIPED-----LLKFD-----ELYIVLEIADSD--LKKLFKTPIFLTEQHVKT 135
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
               ++     +H +GI+HRDLKP N LL+ D  V+
Sbjct: 136 ILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVK 171

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           +NL  ++  V    + +LK +G G  +KV+QV      +IYA+K +     +E+   + +
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTL 70
Query: 198 KSERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
            S RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWER 129
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           + Y   ++ AV  +H +GI+H DLKP N L+  DG ++
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLK 166

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 71/137 (51%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIIIEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 135 RDLAARNCLVGENHLVK 151

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 193 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGNM----SPEAFLQEAQVMKKLRHEKLVQL-Y 246
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 247 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 307 LRAANILV 314

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 306 LRAANILV 313

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 19  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 72
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 73  AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 133 LRAANILV 140

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 306 LRAANILV 313

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 277 KPENILL 283
              N L+
Sbjct: 131 AARNCLV 137

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 140 LRAANILV 147

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 17  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 70
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 71  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 131 LRAANILV 138

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 15  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 68
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 69  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 129 LRAANILV 136

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/147 (22%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++E+++ +G GA+  V   RR  T +  A+K +     +  N    ++ E  IL    H
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 112
Query: 210 PFIVQLRYSFQTKY------RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             I+ ++   +          +Y+VLD +           Q L  E + R +  +++  +
Sbjct: 113 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV-RYFLYQLLRGL 171
Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            ++H+  ++HRDLKP N+L++ +  ++
Sbjct: 172 KYMHSAQVIHRDLKPSNLLVNENCELK 198

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 140 LRAANILV 147

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 70/137 (51%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 77
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 78  VCTREPPFYIIIEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 136 RDLAARNCLVGENHLVK 152

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 70/137 (51%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 140 RDLAARNCLVGENHLVK 156

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 38/164 (23%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF+ ++++G G F +V++ +     + Y ++ +       K + E  + E   L K+DH 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV-------KYNNEKAEREVKALAKLDHV 65
Query: 211 FIVQL----------------------------RYSFQTKYR-LYLVLDFVNGGHL--FF 239
            IV                              + S ++K + L++ ++F + G L  + 
Sbjct: 66  NIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI 125
Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL 283
           +  R     + LA     +I   V ++H+  ++HRDLKP NI L
Sbjct: 126 EKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFL 169

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 8/156 (5%)
Query: 141 PSENQCVGLEDFEV--LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK---DKIMEKNHAE 195
           P++ Q   L++ E+  +KV+G GAF  VY+   +   E   + V  K   +    K + E
Sbjct: 4   PNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 63
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARI 254
           +M  E  I+  +DHP +V+L         + LV   +  G L   ++  +      L   
Sbjct: 64  FM-DEALIMASMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN 121
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           +  +I   + +L    ++HRDL   N+L+ +  HV+
Sbjct: 122 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVK 157

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 70/137 (51%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 135 RDLAARNCLVGENHLVK 151

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 70/137 (51%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 133 RDLAARNCLVGENHLVK 149

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 70/137 (51%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 135 RDLAARNCLVGENHLVK 151

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 70/137 (51%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIIIEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 140 RDLAARNCLVGENHLVK 156

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILL 283
           L+  NIL+
Sbjct: 306 LRAANILV 313

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +++  + E +  E    E  ++ K+ HP +VQL  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKV-AIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYG 89
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 277 KPENILL 283
              N L+
Sbjct: 150 AARNCLV 156

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 9/100 (9%)
Query: 197 MKSERNILTKVDHPFIVQLR-YSFQT-KYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            + E  IL  +   FIV+ R  S+   +  L LV++++  G L  F Q +R    R D +
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDAS 127
Query: 253 RI--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           R+  Y+++I   + +L +   +HRDL   NIL++++ HV+
Sbjct: 128 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVK 167

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 63/128 (49%), Gaps = 8/128 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILL 283
           L   NIL+
Sbjct: 140 LAAANILV 147

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 9/100 (9%)
Query: 197 MKSERNILTKVDHPFIVQLR-YSFQT-KYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            + E  IL  +   FIV+ R  S+   +  L LV++++  G L  F Q +R    R D +
Sbjct: 58  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDAS 114
Query: 253 RI--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           R+  Y+++I   + +L +   +HRDL   NIL++++ HV+
Sbjct: 115 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVK 154

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 9/100 (9%)
Query: 197 MKSERNILTKVDHPFIVQLR-YSFQT-KYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            + E  IL  +   FIV+ R  S+   +  L LV++++  G L  F Q +R    R D +
Sbjct: 55  FQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA---RLDAS 111
Query: 253 RI--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           R+  Y+++I   + +L +   +HRDL   NIL++++ HV+
Sbjct: 112 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVK 151

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 9/100 (9%)
Query: 197 MKSERNILTKVDHPFIVQLR-YSFQT-KYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            + E  IL  +   FIV+ R  S+   +  L LV++++  G L  F Q +R    R D +
Sbjct: 59  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDAS 115
Query: 253 RI--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           R+  Y+++I   + +L +   +HRDL   NIL++++ HV+
Sbjct: 116 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVK 155

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/150 (22%), Positives = 67/150 (44%), Gaps = 21/150 (14%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           CV +E     +V+G G F +V    ++  G  EI+      K    EK   +++ SE +I
Sbjct: 34  CVKIE-----QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASI 87
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV--- 260
           + + DHP ++ L         + ++ +F+  G L          R++  +    ++V   
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL------DSFLRQNDGQFTVIQLVGML 141
Query: 261 ----SAVSHLHANGIMHRDLKPENILLDAD 286
               + + +L     +HRDL   NIL++++
Sbjct: 142 RGIAAGMKYLADMNYVHRDLAARNILVNSN 171

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY    +G  + Y++ V  K    +    E    E  ++ ++ HP +VQL  
Sbjct: 40  LGGGQYGEVY----VGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y+V +++  G+L    Y +   RE++  +   Y A +I SA+ +L     +H
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLL--DYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIH 153
Query: 274 RDLKPENILLDADGHV 289
           RDL   N L+  + HV
Sbjct: 154 RDLAARNCLV-GENHV 168

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 140 RDLAARNCLVGENHLVK 156

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 73/144 (50%), Gaps = 10/144 (6%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  +   +G G + +VY+      S   A+K +++D  ME    E++K E  ++ ++ HP
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVE--EFLK-EAAVMKEIKHP 276
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHL 266
            +VQL      +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 267 HANGIMHRDLKPENILLDADGHVR 290
                +HR+L   N L+  +  V+
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVK 358

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 77
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 78  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 136 RDLAARNCLVGENHLVK 152

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 140 RDLAARNCLVGENHLVK 156

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 79  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 137 RDLAARNCLVGENHLVK 153

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 68/142 (47%), Gaps = 9/142 (6%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K +++    +       + E  IL  + H 
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG--WQREIEILRTLYHE 71
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+ +     Q +  + LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-LFAQQICEGMAYLHA 130
Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HR L   N+LLD D  V+
Sbjct: 131 QHYIHRALAARNVLLDNDRLVK 152

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 68/142 (47%), Gaps = 9/142 (6%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K +++    +       + E  IL  + H 
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG--WQREIEILRTLYHE 70
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+ +     Q +  + LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-LFAQQICEGMAYLHA 129
Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HR L   N+LLD D  V+
Sbjct: 130 QHYIHRALAARNVLLDNDRLVK 151

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 79  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 137 RDLAARNCLVGENHLVK 153

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 140 RDLAARNCLVGENHLVK 156

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 80
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 81  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 138
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 139 RDLAARNCLVGENHLVK 155

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 79  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 137 RDLAARNCLVGENHLVK 153

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 89
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 90  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 147
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 148 RDLAARNCLVGENHLVK 164

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 67/145 (46%), Gaps = 18/145 (12%)
Query: 150 EDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           E +E++  +G+G F +V Q    R G + + A+K++   K +EK + E  + E N+L K+
Sbjct: 33  ERYEIVSTLGEGTFGRVVQCVDHRRGGARV-ALKII---KNVEK-YKEAARLEINVLEKI 87
Query: 208 DHP------FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAE 258
           +          VQ+   F   Y  ++ + F   G   F   +   +        R    +
Sbjct: 88  NEKDPDNKNLCVQMFDWFD--YHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQ 145
Query: 259 IVSAVSHLHANGIMHRDLKPENILL 283
           +  AV  LH N + H DLKPENIL 
Sbjct: 146 LCQAVKFLHDNKLTHTDLKPENILF 170

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 58/136 (42%), Gaps = 12/136 (8%)
Query: 157 VVGQGAFAKVYQ-VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-LTKVDHPFIVQ 214
           ++G G F KVY+ V R G       KV  K +  E +            L+   HP +V 
Sbjct: 46  LIGHGVFGKVYKGVLRDGA------KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV----SAVSHLHANG 270
           L      +  + L+  ++  G+L   LY   L    ++     EI       + +LH   
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159
Query: 271 IMHRDLKPENILLDAD 286
           I+HRD+K  NILLD +
Sbjct: 160 IIHRDVKSINILLDEN 175

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 58/136 (42%), Gaps = 12/136 (8%)
Query: 157 VVGQGAFAKVYQ-VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-LTKVDHPFIVQ 214
           ++G G F KVY+ V R G       KV  K +  E +            L+   HP +V 
Sbjct: 46  LIGHGVFGKVYKGVLRDGA------KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV----SAVSHLHANG 270
           L      +  + L+  ++  G+L   LY   L    ++     EI       + +LH   
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159
Query: 271 IMHRDLKPENILLDAD 286
           I+HRD+K  NILLD +
Sbjct: 160 IIHRDVKSINILLDEN 175

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 135 RDLAARNCLVGENHLVK 151

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 14/148 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL------ 204
           +F+ +KV+G GAF  VY+   I   E    KV     IME   A   K+ + IL      
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 106 ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 163
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           +++L    ++HRDL   N+L+    HV+
Sbjct: 164 MNYLEDRRLVHRDLAARNVLVKTPQHVK 191

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLL--DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVR 290
           RDL   N L+  +  V+
Sbjct: 135 RDLAARNCLVGENHLVK 151

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 15  LKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 71
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++F+  G L  + Q +++ +    L + YT++I   
Sbjct: 72  QHDNIVKYKGVCYS-AGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQ-YTSQICKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + +L     +HRDL   NIL++ +  V+
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVK 157

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 53/121 (43%)
Query: 166 VYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL 225
           VY+        I A+K+  +    +       + E     ++  P +V +    +   +L
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL 109
Query: 226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA 285
           Y+    +NG  L   L RQG      A     +I SA+   HA G  HRD+KPENIL+ A
Sbjct: 110 YVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169
Query: 286 D 286
           D
Sbjct: 170 D 170

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/130 (23%), Positives = 66/130 (50%), Gaps = 11/130 (8%)
Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           GA   + ++ R   SE++A +  R+ ++++     +M+ E N++  +D   +     +  
Sbjct: 50  GAKVAIKKLYRPFQSELFAKRAYRELRLLK-----HMRHE-NVIGLLD---VFTPDETLD 100
Query: 221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN 280
                YLV+ F+  G    +L +     ED  +    +++  + ++HA GI+HRDLKP N
Sbjct: 101 DFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN 158
Query: 281 ILLDADGHVR 290
           + ++ D  ++
Sbjct: 159 LAVNEDCELK 168

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 25/168 (14%)
Query: 139 NLPSENQCV-GLEDFEVLKVVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAE 195
            L SE + V  L ++E  KV G+G +  VY+ +R    +   YA+K +    I       
Sbjct: 10  KLSSERERVEDLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS------ 62
Query: 196 YMKSERNI--LTKVDHPFIVQLRYSF--QTKYRLYLVLDFV--NGGHLFFQLYRQGLFRE 249
            M + R I  L ++ HP ++ L+  F      +++L+ D+   +  H+  + +R     +
Sbjct: 63  -MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII-KFHRASKANK 120
Query: 250 D-------LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
                   + +    +I+  + +LHAN ++HRDLKP NIL+  +G  R
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 5/141 (3%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR---IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +G +D  +L+ +G G+F  V +       G +   A+K ++ D + +    +    E N 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSA 262
           +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++   
Sbjct: 75  MHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 263 VSHLHANGIMHRDLKPENILL 283
           + +L +   +HRDL   N+LL
Sbjct: 134 MGYLESKRFIHRDLAARNLLL 154

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/156 (21%), Positives = 75/156 (48%), Gaps = 27/156 (17%)
Query: 150 EDFEVLKVVGQGAFAKVY--------------QVRRIGTSEIYAMKVMRKDKIMEKNHAE 195
           +++ +  ++G+G++  VY              +V R+    I   +++R+  I+ +  ++
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF-REDLARI 254
           Y+    +++   D      L++       LY+VL+  +      +L++  +F  E+  + 
Sbjct: 86  YIIRLYDLIIPDD-----LLKFD-----ELYIVLEIADSD--LKKLFKTPIFLTEEHIKT 133
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
               ++   + +H +GI+HRDLKP N LL+ D  V+
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVK 169

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 5/141 (3%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR---IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +G +D  +L+ +G G+F  V +       G +   A+K ++ D + +    +    E N 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSA 262
           +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++   
Sbjct: 75  MHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 263 VSHLHANGIMHRDLKPENILL 283
           + +L +   +HRDL   N+LL
Sbjct: 134 MGYLESKRFIHRDLAARNLLL 154

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 5/141 (3%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR---IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +G +D  +L+ +G G+F  V +       G +   A+K ++ D + +    +    E N 
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSA 262
           +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++   
Sbjct: 69  MHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 263 VSHLHANGIMHRDLKPENILL 283
           + +L +   +HRDL   N+LL
Sbjct: 128 MGYLESKRFIHRDLAARNLLL 148

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	291
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-89
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-87
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-87
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-86
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-86
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-85
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-85
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-84
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-84
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-84
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-83
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-83
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-82
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-81
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-81
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-81
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-79
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-79
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-79
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-78
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-78
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-78
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-62
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-61
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-54
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-49
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-49
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-49
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-48
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-47
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-46
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-46
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-45
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-45
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-43
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-43
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-42
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-42
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-42
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-42
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-42
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-42
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-42
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-41
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-41
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-41
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-41
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-41
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-41
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-41
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-41
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-41
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-41
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-41
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-41
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-40
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-40
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-40
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-40
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-40
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-40
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-39
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-39
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-39
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-39
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-39
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-39
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-39
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-39
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-39
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-38
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-38
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-38
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-38
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-38
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-38
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-38
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-38
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-37
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-37
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-37
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-37
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-37
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-36
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-33
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-32
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-32
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-27
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-27
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-25
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-21
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-20
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-20
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-20
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-20
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-20
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-19
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-19
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-18
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-18
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-17
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-17
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-17
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-17
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-17
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-17
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-17
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-17
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-17
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-16
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-16
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-16
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-16
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-15
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-13
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-13
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-12
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-12
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-12
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-12
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-12
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-12
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-12
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-11
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-11
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-11
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-11
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-11
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-11
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-11
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-11
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-11
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-11
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-11
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-11
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-10
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-10
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-10
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-10
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-10
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-10
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-10
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-10
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-09
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-09
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-09
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-09
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-09
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-09
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-08
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-08
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-08
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-07
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-07
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-07
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-07
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-07
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-07
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-06
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-06
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-06
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-05
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  269 bits (689), Expect = 4e-89
 Identities = 81/181 (44%), Positives = 114/181 (62%), Gaps = 3/181 (1%)

Query: 111 GINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
           GI++  +  P  ++   A    P+  I+  PS N      DF  LKV+G+G+F KV   R
Sbjct: 1   GISQPQE--PELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLAR 58

Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVL 229
                  YA+KV++K  I++K   +++ SERN+L K V HPF+V L +SFQT  +LY VL
Sbjct: 59  HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118

Query: 230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           D++NGG LF+ L R+  F E  AR Y AEI SA+ +LH+  I++RDLKPENILLD+ GH+
Sbjct: 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI 178

Query: 290 R 290
            
Sbjct: 179 V 179

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  261 bits (670), Expect = 6e-87
 Identities = 77/164 (46%), Positives = 112/164 (68%), Gaps = 7/164 (4%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDK 187
           G     ++  P +   +  E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  
Sbjct: 1   GSSETSVNRGPEK---IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM 57

Query: 188 IMEK-NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
           I+       + K+ERNIL +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+
Sbjct: 58  IVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI 117

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           F ED A  Y AEI  A+ HLH  GI++RDLKPENI+L+  GHV+
Sbjct: 118 FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  261 bits (668), Expect = 7e-87
 Identities = 64/160 (40%), Positives = 100/160 (62%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           G  +      P + +    EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I++
Sbjct: 11  GAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK 70

Query: 191 KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
           +N   Y+  ER++++++DHPF V+L ++FQ   +LY  L +   G L   + + G F E 
Sbjct: 71  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             R YTAEIVSA+ +LH  GI+HRDLKPENILL+ D H++
Sbjct: 131 CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQ 170

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  260 bits (666), Expect = 3e-86
 Identities = 70/156 (44%), Positives = 110/156 (70%), Gaps = 4/156 (2%)

Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHA 194
            ++   ++      FE+LKV+GQG+F KV+ V++I      ++YAMKV++K  +  ++  
Sbjct: 12  HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71

Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
              K ER+IL +V+HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + 
Sbjct: 72  R-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF 130

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           Y AE+  A+ HLH+ GI++RDLKPENILLD +GH++
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIK 166

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  259 bits (665), Expect = 6e-86
 Identities = 65/144 (45%), Positives = 98/144 (68%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  +++RD+K EN++LD DGH++
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIK 145

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  258 bits (661), Expect = 1e-85
 Identities = 54/144 (37%), Positives = 95/144 (65%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
             L+DF++L+ +G G+F +V+ +R       YAMKV++K+ ++     E+   ER +L+ 
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           V HPFI+++  +FQ   ++++++D++ GG LF  L +   F   +A+ Y AE+  A+ +L
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  I++RDLKPENILLD +GH++
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIK 146

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  257 bits (659), Expect = 7e-85
 Identities = 76/199 (38%), Positives = 113/199 (56%), Gaps = 5/199 (2%)

Query: 97  LTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLK 156
           +  H                               K      NL    + VG+E+FE+LK
Sbjct: 1   MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK 60

Query: 157 VVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILTKVDH-PF 211
           V+G GA+ KV+ VR+I    T ++YAMKV++K  I++K    E+ ++ER +L  +   PF
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V L Y+FQT+ +L+L+LD++NGG LF  L ++  F E   +IY  EIV A+ HLH  GI
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180

Query: 272 MHRDLKPENILLDADGHVR 290
           ++RD+K ENILLD++GHV 
Sbjct: 181 IYRDIKLENILLDSNGHVV 199

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  258 bits (660), Expect = 1e-84
 Identities = 59/149 (39%), Positives = 96/149 (64%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
            EN+ V  + FE+L+ +G+G+F KV  V++  T ++YAMK M K K +E+N    +  E 
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I+  ++HPF+V L YSFQ +  +++V+D + GG L + L +   F+E+  +++  E+V 
Sbjct: 67  QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVR 290
           A+ +L    I+HRD+KP+NILLD  GHV 
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVH 155

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  254 bits (652), Expect = 7e-84
 Identities = 64/160 (40%), Positives = 101/160 (63%), Gaps = 1/160 (0%)

Query: 132 KPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK 191
                     + +  +G+++FE ++V+G+G+F KV   R   T ++YA+KV++KD I++ 
Sbjct: 5   SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD 64

Query: 192 NHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
           +  E   +E+ IL+   +HPF+ QL   FQT  RL+ V++FVNGG L F + +   F E 
Sbjct: 65  DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA 124

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            AR Y AEI+SA+  LH  GI++RDLK +N+LLD +GH +
Sbjct: 125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  254 bits (652), Expect = 8e-84
 Identities = 58/153 (37%), Positives = 93/153 (60%), Gaps = 1/153 (0%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           +       + L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E   
Sbjct: 9   DNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM 68

Query: 199 SERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
            E+ +L      PF+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y A
Sbjct: 69  VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA 128

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           EI   +  L + GI++RDLK +N++LD++GH++
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 161

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  253 bits (649), Expect = 2e-83
 Identities = 63/145 (43%), Positives = 107/145 (73%), Gaps = 1/145 (0%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125

Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           LH  GI++RDLK +N+LLD++GH++
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIK 150

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  254 bits (652), Expect = 3e-83
 Identities = 63/160 (39%), Positives = 110/160 (68%), Gaps = 1/160 (0%)

Query: 132 KPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK 191
           K   +       +  +GL+DF++L+V+G+G++AKV  VR   T  IYAM+V++K+ + + 
Sbjct: 34  KEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD 93

Query: 192 NHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
              +++++E+++  +  +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+
Sbjct: 94  EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE 153

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            AR Y+AEI  A+++LH  GI++RDLK +N+LLD++GH++
Sbjct: 154 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 193

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  252 bits (645), Expect = 5e-82
 Identities = 60/145 (41%), Positives = 94/145 (64%), Gaps = 1/145 (0%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  +DFE+LKV+G+GAF++V  V+   T ++YAMK+M K  ++++      + ER++L  
Sbjct: 58  LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSH 265
            D  +I QL ++FQ +  LYLV+++  GG L   L + G     ++AR Y AEIV A+  
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           +H  G +HRD+KP+NILLD  GH+R
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIR 202

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  248 bits (635), Expect = 3e-81
 Identities = 59/180 (32%), Positives = 98/180 (54%), Gaps = 2/180 (1%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNL--PSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
           N    +  +    V   L K                  L+ F+ +K +G G+F +V  V+
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61

Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD 230
              +   YAMK++ K K+++    E+  +E+ IL  V+ PF+V+L +SF+    LY+V++
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           +V GG +F  L R G F E  AR Y A+IV    +LH+  +++RDLKPEN+L+D  G+++
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  250 bits (640), Expect = 7e-81
 Identities = 69/182 (37%), Positives = 108/182 (59%), Gaps = 1/182 (0%)

Query: 110 EGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQV 169
           +G+ ++     +  S   +          +L      V + +FE LK++G+G F KV  V
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILV 167

Query: 170 RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL 229
           +   T   YAMK+++K+ I+ K+   +  +E  +L    HPF+  L+YSFQT  RL  V+
Sbjct: 168 KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227

Query: 230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGH 288
           ++ NGG LFF L R+ +F ED AR Y AEIVSA+ +LH+   +++RDLK EN++LD DGH
Sbjct: 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH 287

Query: 289 VR 290
           ++
Sbjct: 288 IK 289

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  253 bits (649), Expect = 8e-81
 Identities = 73/227 (32%), Positives = 107/227 (47%), Gaps = 9/227 (3%)

Query: 70  QPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAA 129
           +    +  SH+       V + L  +     E      L + +   T E    LSV   A
Sbjct: 103 RNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHE---YLSVAPFA 159

Query: 130 LGKPTGHIDNL----PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
               + + +        E Q V    F   +V+G+G F +V   +   T ++YA K + K
Sbjct: 160 DYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEK 219

Query: 186 DKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG 245
            +I ++       +E+ IL KV+  F+V L Y+++TK  L LVL  +NGG L F +Y  G
Sbjct: 220 KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 279

Query: 246 --LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
              F E  A  Y AEI   +  LH   I++RDLKPENILLD  GH+R
Sbjct: 280 QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIR 326

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  249 bits (637), Expect = 2e-79
 Identities = 61/154 (39%), Positives = 92/154 (59%), Gaps = 4/154 (2%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYT 256
           + IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YT
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           A+IVS + HLH   I++RDLKPEN+LLD DG+VR
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  246 bits (629), Expect = 2e-79
 Identities = 56/145 (38%), Positives = 92/145 (63%), Gaps = 1/145 (0%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  EDFE+LKV+G+GAF +V  V+     +++AMK++ K +++++      + ER++L  
Sbjct: 71  LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSH 265
            D  +I  L Y+FQ    LYLV+D+  GG L   L + +    E++AR Y AE+V A+  
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           +H    +HRD+KP+NIL+D +GH+R
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIR 215

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  244 bits (625), Expect = 5e-79
 Identities = 57/144 (39%), Positives = 97/144 (67%), Gaps = 1/144 (0%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+  
Sbjct: 66  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            + P++VQL Y+FQ    LY+V++++ GG L   +       E  AR YTAE+V A+  +
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAI 184

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+ G +HRD+KP+N+LLD  GH++
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLK 208

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  240 bits (616), Expect = 1e-78
 Identities = 54/151 (35%), Positives = 93/151 (61%), Gaps = 1/151 (0%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS    + +EDF + K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67

Query: 201 RNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           + +L+   +HPF+  +  +FQTK  L+ V++++NGG L + +     F    A  Y AEI
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           +  +  LH+ GI++RDLK +NILLD DGH++
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIK 158

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  249 bits (636), Expect = 4e-78
 Identities = 69/253 (27%), Positives = 115/253 (45%), Gaps = 1/253 (0%)

Query: 39  FDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLT 98
           F   +      +   I      S  + +      +   +   + G    +SQ        
Sbjct: 230 FQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNV 289

Query: 99  LHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVV 158
               E S G  E   +  +      +         T    +       + L DF  L V+
Sbjct: 290 PVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVL 349

Query: 159 GQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY 217
           G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L      PF+ QL  
Sbjct: 350 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  L + GI++RDLK
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 469

Query: 278 PENILLDADGHVR 290
            +N++LD++GH++
Sbjct: 470 LDNVMLDSEGHIK 482

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  249 bits (636), Expect = 8e-78
 Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 11/224 (4%)

Query: 75  HSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPT 134
           +     L     +   +++  +  L + +    L +      +E   NL          +
Sbjct: 112 YIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQ---PYIEEICQNLRGDVFQKFIES 168

Query: 135 GHIDNL-----PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
                         N  + + DF V +++G+G F +VY  R+  T ++YAMK + K +I 
Sbjct: 169 DKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK 228

Query: 190 EKNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
            K       +ER +L+ V   D PFIV + Y+F T  +L  +LD +NGG L + L + G+
Sbjct: 229 MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV 288

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           F E   R Y AEI+  + H+H   +++RDLKP NILLD  GHVR
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 332

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  197 bits (504), Expect = 2e-62
 Identities = 42/141 (29%), Positives = 80/141 (56%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DF++ + +G+G F  VY  R      I A+KV+ K ++ ++     ++ E  I + + 
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+++   F  + R+YL+L+F   G L+ +L + G F E  +  +  E+  A+ + H 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 269 NGIMHRDLKPENILLDADGHV 289
             ++HRD+KPEN+L+   G +
Sbjct: 133 RKVIHRDIKPENLLMGYKGEL 153

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  195 bits (497), Expect = 2e-61
 Identities = 47/148 (31%), Positives = 84/148 (56%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
           A+S+ H+  ++HRD+KPEN+LL + G +
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGEL 148

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  177 bits (452), Expect = 2e-54
 Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 5/181 (2%)

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
                Q  P  +S       +        PS  +    + F+ L  +G G++ +V++VR 
Sbjct: 20  FQSMHQLQPRRVSF-RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRS 78

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLD 230
                +YA+K         K+ A  +  E     KV  HP  V+L  +++    LYL  +
Sbjct: 79  KEDGRLYAVKRSMSPFRGPKDRARKLA-EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137

Query: 231 FVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
              G  L       G    E     Y  + + A++HLH+ G++H D+KP NI L   G  
Sbjct: 138 LC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRC 196

Query: 290 R 290
           +
Sbjct: 197 K 197

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  163 bits (416), Expect = 3e-49
 Identities = 39/141 (27%), Positives = 69/141 (48%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
              +   + +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + 
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V     F+    +++VL+      L     R+    E  AR Y  +IV    +LH 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 269 NGIMHRDLKPENILLDADGHV 289
           N ++HRDLK  N+ L+ D  V
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEV 154

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  164 bits (416), Expect = 8e-49
 Identities = 39/141 (27%), Positives = 69/141 (48%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
              +   + +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + 
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V     F+    +++VL+      L     R+    E  AR Y  +IV    +LH 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159

Query: 269 NGIMHRDLKPENILLDADGHV 289
           N ++HRDLK  N+ L+ D  V
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEV 180

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  162 bits (412), Expect = 9e-49
 Identities = 45/142 (31%), Positives = 84/142 (59%), Gaps = 1/142 (0%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +EDF+V  ++G+G+FA VY+   I T    A+K++ K  + +    + +++E  I  ++ 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL-YRQGLFREDLARIYTAEIVSAVSHLH 267
           HP I++L   F+    +YLVL+  + G +   L  R   F E+ AR +  +I++ + +LH
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 268 ANGIMHRDLKPENILLDADGHV 289
           ++GI+HRDL   N+LL  + ++
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNI 151

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  162 bits (413), Expect = 1e-48
 Identities = 43/156 (27%), Positives = 79/156 (50%), Gaps = 18/156 (11%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
             DFE + V+GQGAF +V + R    S  YA+K +R  +         + SE  +L  ++
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST----ILSEVMLLASLN 60

Query: 209 HPFIVQLRYSFQ-------------TKYRLYLVLDFVNGGHLFFQLYRQGLF-REDLARI 254
           H ++V+   ++               K  L++ +++   G L+  ++ + L  + D    
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
              +I+ A+S++H+ GI+HRDLKP NI +D   +V+
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  161 bits (408), Expect = 2e-47
 Identities = 32/164 (19%), Positives = 69/164 (42%), Gaps = 25/164 (15%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--------------DKIMEKNHA 194
           + D+ +++ + QG F K+    +   ++ YA+K   K              DKI  K+  
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--------L 246
           +  K+E  I+T + + + +           +Y++ +++    +                 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 247 FREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHV 289
               + +     ++++ S++H    I HRD+KP NIL+D +G V
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV 191

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  160 bits (405), Expect = 2e-46
 Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 7/148 (4%)

Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +Q      + +  ++GQGA A V++ R   T +++A+KV      +     +    E  +
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEV 60

Query: 204 LTKVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAE 258
           L K++H  IV+L       T     L+++F   G L+  L          E    I   +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDAD 286
           +V  ++HL  NGI+HR++KP NI+    
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIG 148

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  156 bits (397), Expect = 8e-46
 Identities = 49/144 (34%), Positives = 77/144 (53%), Gaps = 3/144 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G+F K   V+       Y +K +   + M     E  + E  +L  + 
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMK 81

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHL 266
           HP IVQ R SF+    LY+V+D+  GG LF ++  Q   LF+ED    +  +I  A+ H+
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H   I+HRD+K +NI L  DG V+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQ 165

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  155 bits (394), Expect = 1e-45
 Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 7/148 (4%)

Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +Q      + +  ++GQGA A V++ R   T +++A+KV      +     +    E  +
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEV 60

Query: 204 LTKVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAE 258
           L K++H  IV+L       T     L+++F   G L+  L          E    I   +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDAD 286
           +V  ++HL  NGI+HR++KP NI+    
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIG 148

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  154 bits (391), Expect = 3e-45
 Identities = 39/146 (26%), Positives = 74/146 (50%), Gaps = 4/146 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F + K +G+G F++VY+   +      A+K ++   +M+         E ++L +++
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVS 264
           HP +++   SF     L +VL+  + G L   +        L  E     Y  ++ SA+ 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 265 HLHANGIMHRDLKPENILLDADGHVR 290
           H+H+  +MHRD+KP N+ + A G V+
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVK 176

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  148 bits (376), Expect = 2e-43
 Identities = 45/135 (33%), Positives = 79/135 (58%), Gaps = 1/135 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 64

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 270 GIMHRDLKPENILLD 284
           GI+HR+LKPEN+LL 
Sbjct: 125 GIVHRNLKPENLLLA 139

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  149 bits (378), Expect = 7e-43
 Identities = 27/153 (17%), Positives = 59/153 (38%), Gaps = 13/153 (8%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAE 195
           P     +G +   V  ++G+GAFA+VY+  +         + + +KV +     E     
Sbjct: 56  PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---Y 112

Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-----FQLYRQGLFRED 250
                   L        ++   +   +    LV +  + G L      ++   + +  + 
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILL 283
           L   +   ++  +  +H   I+H D+KP+N +L
Sbjct: 173 LVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL 205

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  149 bits (377), Expect = 1e-42
 Identities = 45/135 (33%), Positives = 77/135 (57%), Gaps = 1/135 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K +     + ++ E  I  K+ H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQH 87

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147

Query: 270 GIMHRDLKPENILLD 284
           GI+HR+LKPEN+LL 
Sbjct: 148 GIVHRNLKPENLLLA 162

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  146 bits (372), Expect = 1e-42
 Identities = 42/135 (31%), Positives = 77/135 (57%), Gaps = 1/135 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K    +      +  E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDH 80

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L    +     Y+V +   GG LF ++ ++  F E  A     ++ S ++++H +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 270 GIMHRDLKPENILLD 284
            I+HRDLKPENILL+
Sbjct: 141 NIVHRDLKPENILLE 155

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  146 bits (370), Expect = 3e-42
 Identities = 47/134 (35%), Positives = 84/134 (62%), Gaps = 3/134 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F  ++V+G GAF++V+ V++  T +++A+K ++K           +++E  +L K+ H
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKH 65

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV L   +++    YLV+  V+GG LF ++  +G++ E  A +   +++SAV +LH N
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 270 GIMHRDLKPENILL 283
           GI+HRDLKPEN+L 
Sbjct: 126 GIVHRDLKPENLLY 139

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  146 bits (370), Expect = 4e-42
 Identities = 42/137 (30%), Positives = 74/137 (54%), Gaps = 3/137 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + +++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V++L
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 267 HANGIMHRDLKPENILL 283
           H   I H DLKPENI+L
Sbjct: 132 HTKKIAHFDLKPENIML 148

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  148 bits (377), Expect = 6e-42
 Identities = 43/134 (32%), Positives = 76/134 (56%), Gaps = 1/134 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E++++ + +G+GAF+ V +  ++   + YA  ++   K+  ++H + ++ E  I   + H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKH 69

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YL+ D V GG LF  +  +  + E  A     +I+ AV H H  
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 270 GIMHRDLKPENILL 283
           G++HR+LKPEN+LL
Sbjct: 130 GVVHRNLKPENLLL 143

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  147 bits (372), Expect = 6e-42
 Identities = 44/137 (32%), Positives = 75/137 (54%), Gaps = 3/137 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + +++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           V HP I+ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V++L
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 267 HANGIMHRDLKPENILL 283
           H   I H DLKPENI+L
Sbjct: 132 HTKKIAHFDLKPENIML 148

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (369), Expect = 8e-42
 Identities = 43/137 (31%), Positives = 73/137 (53%), Gaps = 3/137 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + ++  + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           + HP ++ L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +L
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 267 HANGIMHRDLKPENILL 283
           H+  I H DLKPENI+L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  144 bits (366), Expect = 9e-42
 Identities = 49/137 (35%), Positives = 78/137 (56%), Gaps = 3/137 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + +E+ + +G G FA V + R+ GT + YA K ++K ++         E ++ E NIL +
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           + HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A  +  +I+  V +L
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 267 HANGIMHRDLKPENILL 283
           H+  I H DLKPENI+L
Sbjct: 125 HSKRIAHFDLKPENIML 141

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  145 bits (367), Expect = 1e-41
 Identities = 39/151 (25%), Positives = 66/151 (43%), Gaps = 11/151 (7%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  + +  ++ +G+G F+ V  V  +     YA+K +      E+   E  + E ++   
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRL 82

Query: 207 VDHPFIVQLRYSF----QTKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAE 258
            +HP I++L          K+  +L+L F   G L+ ++ R         ED        
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           I   +  +HA G  HRDLKP NILL  +G  
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQP 173

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  145 bits (369), Expect = 1e-41
 Identities = 45/152 (29%), Positives = 83/152 (54%), Gaps = 7/152 (4%)

Query: 140 LPSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA--EY 196
           L   +  V  ED +E+ +V+G+G F+ V +     T + +A+K++   K         E 
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72

Query: 197 MKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLA 252
           +K E +I   + HP IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
             Y  +I+ A+ + H N I+HRD+KP  +LL 
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLA 164

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  143 bits (364), Expect = 1e-41
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 14/154 (9%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           G   G I+           + + +   +G+G++ +V    + GT    A K + K  + +
Sbjct: 1   GSTKGDIN-----------QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED 49

Query: 191 KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
               +  K E  I+  +DHP I++L  +F+    +YLV++   GG LF ++  + +FRE 
Sbjct: 50  V---DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES 106

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
            A     +++SAV++ H   + HRDLKPEN L  
Sbjct: 107 DAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFL 140

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  144 bits (366), Expect = 2e-41
 Identities = 46/140 (32%), Positives = 81/140 (57%), Gaps = 6/140 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 265 HLHANGIMHRDLKPENILLD 284
           +LH NGI+HRDLKPEN+LL 
Sbjct: 129 YLHENGIIHRDLKPENVLLS 148

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  143 bits (363), Expect = 2e-41
 Identities = 40/141 (28%), Positives = 78/141 (55%), Gaps = 2/141 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 269 NGIMHRDLKPENILLDADGHV 289
            GI HRD+KPEN+LLD   ++
Sbjct: 124 IGITHRDIKPENLLLDERDNL 144

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  143 bits (364), Expect = 2e-41
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 6/154 (3%)

Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           +NL  ++  V    + +LK +G G  +KV+QV      +IYA+K +  ++  +    +  
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSY 73

Query: 198 KSERNILTKVDHP--FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
           ++E   L K+      I++L     T   +Y+V++      L   L ++        + Y
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY 132

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
              ++ AV  +H +GI+H DLKP N L+  DG +
Sbjct: 133 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGML 165

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  142 bits (361), Expect = 3e-41
 Identities = 46/149 (30%), Positives = 75/149 (50%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
              +  V +  + +   +G G F KV       T    A+K++ + KI   +    +K E
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
              L    HP I++L     T    ++V+++V+GG LF  + + G   E  AR    +I+
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHV 289
           SAV + H + ++HRDLKPEN+LLDA  + 
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNA 150

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  143 bits (362), Expect = 4e-41
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 8/161 (4%)

Query: 138 DNLPSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA-- 194
             LP  +   G  + +E  +++G+G  + V +     T + YA+K++        +    
Sbjct: 4   AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63

Query: 195 ----EYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE 249
               E    E +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
              R     ++  +  LH   I+HRDLKPENILLD D +++
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 164

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  144 bits (366), Expect = 4e-41
 Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 7/185 (3%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLED-FEVLKVVGQGAFAKVYQVRR 171
            E  +         +    +  G  D LP           ++   V+G+G  + V +   
Sbjct: 56  AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVH 115

Query: 172 IGTSEIYAMKVMRKDKIMEKNHA-----EYMKSERNILTKV-DHPFIVQLRYSFQTKYRL 225
             T   +A+K+M                E  + E +IL +V  HP I+ L  S+++   +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175

Query: 226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA 285
           +LV D +  G LF  L  +    E   R     ++ AVS LHAN I+HRDLKPENILLD 
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235

Query: 286 DGHVR 290
           +  +R
Sbjct: 236 NMQIR 240

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  147 bits (372), Expect = 4e-41
 Identities = 45/135 (33%), Positives = 81/135 (60%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + ++  +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DH
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L   F+ K   YLV +   GG LF ++  +  F E  A     +++S ++++H N
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 270 GIMHRDLKPENILLD 284
            I+HRDLKPEN+LL+
Sbjct: 146 KIVHRDLKPENLLLE 160

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  142 bits (360), Expect = 5e-41
 Identities = 35/160 (21%), Positives = 67/160 (41%), Gaps = 25/160 (15%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
             DF+ ++++G G F +V++ +     + Y +K ++ +        E  + E   L K+D
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62

Query: 209 HPFIVQLRYSFQ----------------TKYRLYLVLDFVNGGHLFFQL--YRQGLFRED 250
           H  IV     +                     L++ ++F + G L   +   R     + 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           LA     +I   V ++H+  +++RDLKP NI L     V+
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  142 bits (359), Expect = 8e-41
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 12/153 (7%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            ED+EVL  +G G++ +  ++RR    +I   K +     M +   + + SE N+L ++ 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELK 63

Query: 209 HPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSA 262
           HP IV+        T   LY+V+++  GG L   + +         E+       ++  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVR 290
           +   H      + ++HRDLKP N+ LD   +V+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  145 bits (367), Expect = 8e-41
 Identities = 45/140 (32%), Positives = 81/140 (57%), Gaps = 6/140 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A++++ K K       E + A  +++E  IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 265 HLHANGIMHRDLKPENILLD 284
           +LH NGI+HRDLKPEN+LL 
Sbjct: 254 YLHENGIIHRDLKPENVLLS 273

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  146 bits (370), Expect = 1e-40
 Identities = 43/135 (31%), Positives = 78/135 (57%), Gaps = 1/135 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+    +  E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDH 80

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L    +     Y+V +   GG LF ++ ++  F E  A     ++ S ++++H +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 270 GIMHRDLKPENILLD 284
            I+HRDLKPENILL+
Sbjct: 141 NIVHRDLKPENILLE 155

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  142 bits (360), Expect = 2e-40
 Identities = 39/150 (26%), Positives = 71/150 (47%), Gaps = 6/150 (4%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           +E   V    + +LK +G G  +KV+QV      +IYA+K +  ++  +    +  ++E 
Sbjct: 1   NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEI 58

Query: 202 NILTKVDHP--FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
             L K+      I++L     T   +Y+V++      L   L ++        + Y   +
Sbjct: 59  AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM 117

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHV 289
           + AV  +H +GI+H DLKP N L+  DG +
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIV-DGML 146

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  140 bits (356), Expect = 3e-40
 Identities = 36/139 (25%), Positives = 69/139 (49%), Gaps = 6/139 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F   + +G GAF  V+ V    +     +K + KD+       E +++E  +L  +DH
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDH 79

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF----FQLYRQGLFREDLARIYTAEIVSAVSH 265
           P I+++   F+  + +Y+V++   GG L         R     E        ++++A+++
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 266 LHANGIMHRDLKPENILLD 284
            H+  ++H+DLKPENIL  
Sbjct: 140 FHSQHVVHKDLKPENILFQ 158

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  141 bits (358), Expect = 3e-40
 Identities = 40/141 (28%), Positives = 78/141 (55%), Gaps = 2/141 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 269 NGIMHRDLKPENILLDADGHV 289
            GI HRD+KPEN+LLD   ++
Sbjct: 124 IGITHRDIKPENLLLDERDNL 144

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  144 bits (366), Expect = 4e-40
 Identities = 46/135 (34%), Positives = 79/135 (58%), Gaps = 1/135 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ +K +G GA+ +V   R   T    A+K++RK  +   ++   +  E  +L  +DH
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVLKLLDH 95

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S V++LH +
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 270 GIMHRDLKPENILLD 284
            I+HRDLKPEN+LL+
Sbjct: 156 NIVHRDLKPENLLLE 170

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  141 bits (357), Expect = 7e-40
 Identities = 42/142 (29%), Positives = 74/142 (52%), Gaps = 4/142 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            + ++ +K +G G F     +R   T E+ A+K + +   ++    E ++ E      + 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLR 74

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP IV+ +    T   L +++++ +GG L+ ++   G F ED AR +  +++S VS+ H+
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             I HRDLK EN LLD     R
Sbjct: 135 MQICHRDLKLENTLLDGSPAPR 156

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  140 bits (354), Expect = 1e-39
 Identities = 54/149 (36%), Positives = 87/149 (58%), Gaps = 3/149 (2%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             E   +G  ++ +LK +G+G FAKV   R I T    A+K++ K ++   +  + +  E
Sbjct: 8   ADEQPHIG--NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS-LQKLFRE 64

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             I+  ++HP IV+L    +T+  LYL++++ +GG +F  L   G  +E  AR    +IV
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHV 289
           SAV + H   I+HRDLK EN+LLDAD ++
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNI 153

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  139 bits (353), Expect = 2e-39
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 8/155 (5%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             E +      +  +  +G GAF  V+       ++   +K ++K+K++E    E  K  
Sbjct: 17  ACEGEYSQ--KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74

Query: 201 R-----NILTKVDHPFIVQLRYSFQTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARI 254
           +      IL++V+H  I+++   F+ +    LV++   +G  LF  + R     E LA  
Sbjct: 75  KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
              ++VSAV +L    I+HRD+K ENI++  D  +
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTI 169

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  140 bits (354), Expect = 2e-39
 Identities = 59/185 (31%), Positives = 98/185 (52%), Gaps = 10/185 (5%)

Query: 100 HEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDF-EVLKVV 158
           H +       E +  ++       +    A   P   ID    +     L DF EV   +
Sbjct: 6   HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDA----LSDFFEVESEL 61

Query: 159 GQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS 218
           G+GA + VY+ ++ GT + YA+KV++K    +      +++E  +L ++ HP I++L+  
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-----VRTEIGVLLRLSHPNIIKLKEI 116

Query: 219 FQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKP 278
           F+T   + LVL+ V GG LF ++  +G + E  A     +I+ AV++LH NGI+HRDLKP
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKP 176

Query: 279 ENILL 283
           EN+L 
Sbjct: 177 ENLLY 181

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  137 bits (348), Expect = 4e-39
 Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 26/173 (15%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S   CV L  + +   +G+G++  V        +  YAMKV+ K K++ +         R
Sbjct: 5   SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64

Query: 202 N-----------------------ILTKVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGH 236
                                   IL K+DHP +V+L        +  LY+V + VN G 
Sbjct: 65  GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           +  ++       ED AR Y  +++  + +LH   I+HRD+KP N+L+  DGH+
Sbjct: 125 VM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHI 176

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  138 bits (349), Expect = 5e-39
 Identities = 42/129 (32%), Positives = 70/129 (54%), Gaps = 4/129 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
            V+G+GA A+V     + TS+ YA+K++ K     +     +  E  +L +   H  +++
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLE 75

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++++  F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135

Query: 275 DLKPENILL 283
           DLKPENIL 
Sbjct: 136 DLKPENILC 144

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (353), Expect = 6e-39
 Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 10/196 (5%)

Query: 100 HEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPS----ENQCVGLEDFEVL 155
           H    S GLV   +   +                    D+  S    E   V    + +L
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIV 213
           K +G G  +KV+QV      +IYA+K +  ++  +    +  ++E   L K+      I+
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           +L     T   +Y+V++      L   L ++        + Y   ++ AV  +H +GI+H
Sbjct: 120 RLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVH 178

Query: 274 RDLKPENILLDADGHV 289
            DLKP N L+  DG +
Sbjct: 179 SDLKPANFLIV-DGML 193

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  139 bits (351), Expect = 9e-39
 Identities = 37/135 (27%), Positives = 75/135 (55%), Gaps = 4/135 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +++L+ +G GAF  V++     T  ++  K +     ++K     +K+E +I+ ++ H
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 107

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHA 268
           P ++ L  +F+ KY + L+L+F++GG LF ++  +     E     Y  +    + H+H 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 269 NGIMHRDLKPENILL 283
           + I+H D+KPENI+ 
Sbjct: 168 HSIVHLDIKPENIMC 182

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  141 bits (357), Expect = 9e-39
 Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 21/165 (12%)

Query: 130 LGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI- 188
           + K  G I            E +  ++ +G GA+ +V   +        A+KV++K +  
Sbjct: 27  VRKKEGKIG-----------ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFD 75

Query: 189 ---------MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF 239
                      +   E + +E ++L  +DHP I++L   F+ K   YLV +F  GG LF 
Sbjct: 76  KGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE 135

Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           Q+  +  F E  A     +I+S + +LH + I+HRD+KPENILL+
Sbjct: 136 QIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE 180

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  137 bits (347), Expect = 1e-38
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 7/129 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQ 214
           K +G+G+F+   +     +++ +A+K++ K            + E   L   + HP IV+
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHPNIVK 70

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F  +   +LV++ +NGG LF ++ ++  F E  A     ++VSAVSH+H  G++HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130

Query: 275 DLKPENILL 283
           DLKPEN+L 
Sbjct: 131 DLKPENLLF 139

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  136 bits (344), Expect = 2e-38
 Identities = 41/157 (26%), Positives = 67/157 (42%), Gaps = 17/157 (10%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L DFE ++ +G+G F  V++ +       YA+K +R     E    + +  E   L K++
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREK-VMREVKALAKLE 61

Query: 209 HPFIVQLRYSF------------QTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLAR 253
           HP IV+   ++              K  LY+ +      +L   +  +         +  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +I  AV  LH+ G+MHRDLKP NI    D  V+
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK 158

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  136 bits (344), Expect = 2e-38
 Identities = 36/142 (25%), Positives = 75/142 (52%), Gaps = 4/142 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY-MKSERNILTKVDHP 210
           + +  ++G+G++ KV +V    T    A+K+++K K+    + E  +K E  +L ++ H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 211 FIVQLR--YSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            ++QL      + K ++Y+V+++   G         +  F    A  Y  +++  + +LH
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126

Query: 268 ANGIMHRDLKPENILLDADGHV 289
           + GI+H+D+KP N+LL   G +
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTL 148

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  137 bits (347), Expect = 3e-38
 Identities = 38/134 (28%), Positives = 75/134 (55%), Gaps = 4/134 (2%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
                +++G G F +V++     T    A K+++   + +K   E +K+E +++ ++DH 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHAN 269
            ++QL  +F++K  + LV+++V+GG LF ++  +     E    ++  +I   + H+H  
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 270 GIMHRDLKPENILL 283
            I+H DLKPENIL 
Sbjct: 207 YILHLDLKPENILC 220

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  139 bits (352), Expect = 3e-38
 Identities = 43/149 (28%), Positives = 76/149 (51%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
              +  V +  + +   +G G F KV   +   T    A+K++ + KI   +    ++ E
Sbjct: 7   QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
              L    HP I++L     T   +++V+++V+GG LF  + + G   E  +R    +I+
Sbjct: 67  IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHV 289
           S V + H + ++HRDLKPEN+LLDA  + 
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNA 155

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  135 bits (343), Expect = 7e-38
 Identities = 40/150 (26%), Positives = 79/150 (52%), Gaps = 3/150 (2%)

Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           +    + +G   + + + +G+G+F KV       T +  A+K + +  + + +    ++ 
Sbjct: 1   MAISKRHIG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER 58

Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E + L  + HP I++L     T   + +V+++  GG LF  +  +    ED  R +  +I
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHV 289
           + A+ + H + I+HRDLKPEN+LLD + +V
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNV 147

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  140 bits (354), Expect = 7e-38
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 11/157 (7%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
                      +E+ + +G G F  V +     T E  A+K  R++   +  + E    E
Sbjct: 5   SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLE 62

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLY---RQGLFREDL 251
             I+ K++HP +V  R       +L       L +++  GG L   L         +E  
Sbjct: 63  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
            R   ++I SA+ +LH N I+HRDLKPENI+L     
Sbjct: 123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  135 bits (343), Expect = 7e-38
 Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 8/135 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VD 208
           + +EV + +G G+++   +     T+  +A+K++ K K            E  IL +   
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQ 74

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+ L+  +     +Y+V + + GG L  ++ RQ  F E  A      I   V +LHA
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134

Query: 269 NGIMHRDLKPENILL 283
            G++HRDLKP NIL 
Sbjct: 135 QGVVHRDLKPSNILY 149

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  134 bits (339), Expect = 7e-38
 Identities = 25/147 (17%), Positives = 58/147 (39%), Gaps = 4/147 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
             +F  L+ +G G F  V++  +     IYA+K  +K      +    ++          
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG----HLFFQLYRQGLFREDLARIYTAEIVSAVS 264
           H  +V+   ++     + +  ++ NGG     +         F+E   +    ++   + 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 265 HLHANGIMHRDLKPENILLDADGHVRS 291
           ++H+  ++H D+KP NI +       +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNA 156

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  134 bits (340), Expect = 1e-37
 Identities = 32/135 (23%), Positives = 63/135 (46%), Gaps = 5/135 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + + + +G+G F  V++     + + Y  K ++     +      +K E +IL    H
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
             I+ L  SF++   L ++ +F++G  +F           E     Y  ++  A+  LH+
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 269 NGIMHRDLKPENILL 283
           + I H D++PENI+ 
Sbjct: 121 HNIGHFDIRPENIIY 135

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  138 bits (349), Expect = 2e-37
 Identities = 37/135 (27%), Positives = 68/135 (50%), Gaps = 4/135 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRH 213

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P +V L  +F+    + ++ +F++GG LF           ED A  Y  ++   + H+H 
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273

Query: 269 NGIMHRDLKPENILL 283
           N  +H DLKPENI+ 
Sbjct: 274 NNYVHLDLKPENIMF 288

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  133 bits (336), Expect = 4e-37
 Identities = 39/144 (27%), Positives = 76/144 (52%), Gaps = 8/144 (5%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM---KSERNILTKV 207
           ++ +  ++G+G F  V+   R+      A+KV+ +++++  +          E  +L KV
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 208 D----HPFIVQLRYSFQTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
                HP +++L   F+T+    LVL+  +    LF  +  +G   E  +R +  ++V+A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 263 VSHLHANGIMHRDLKPENILLDAD 286
           + H H+ G++HRD+K ENIL+D  
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLR 175

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  133 bits (336), Expect = 4e-37
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 6/162 (3%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
                     P + +      ++V  ++G G F  VY   R+  +   A+K + KD+I +
Sbjct: 24  CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 83

Query: 191 KNHAEYM---KSERNILTKVDH--PFIVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQ 244
                       E  +L KV      +++L   F+      L+L+       LF  +  +
Sbjct: 84  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 143

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
           G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D +
Sbjct: 144 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN 185

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  133 bits (335), Expect = 8e-37
 Identities = 45/179 (25%), Positives = 76/179 (42%), Gaps = 42/179 (23%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKV 207
           + + +   +GQG++  V       T  I A+K+M K+KI + N  +   +K+E  ++ K+
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF----------------------------- 238
            HP I +L   ++ +  + LV++  +GGHL                              
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 239 -----------FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
                      F+     + RE L      +I SA+ +LH  GI HRD+KPEN L   +
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  131 bits (331), Expect = 3e-36
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 4/132 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQ 214
           K +G+G FA V Q     T + YA K ++K +  +   AE +  E  +L      P ++ 
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVIN 93

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLY--RQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           L   ++    + L+L++  GG +F         +  E+       +I+  V +LH N I+
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153

Query: 273 HRDLKPENILLD 284
           H DLKP+NILL 
Sbjct: 154 HLDLKPQNILLS 165

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  123 bits (310), Expect = 2e-33
 Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 16/156 (10%)

Query: 136 HIDNLPSENQCVGLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA 194
           H+ +     +   ++D++V  +V+G G   KV Q+    T E +A+K+++      +   
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--- 59

Query: 195 EYMKSERNILTKV-DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LF 247
                E  +  +    P IV++   ++  Y     L +V++ ++GG LF ++  +G   F
Sbjct: 60  -----EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL 283
            E  A      I  A+ +LH+  I HRD+KPEN+L 
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 150

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  124 bits (313), Expect = 2e-33
 Identities = 27/173 (15%), Positives = 55/173 (31%), Gaps = 33/173 (19%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER--------- 201
                 V+GQ       +     T E + + V    +    N  + MK E          
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 202 ----------------NILTKVDHPFIVQLRYSFQTKYRLYLVL-------DFVNGGHLF 238
                           +++       ++++R   +  + L           +    G + 
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 239 FQLYRQGLFREDLARIY-TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
                        AR+  T +++  ++ LH  G++H  L+P +I+LD  G V 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVF 246

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (305), Expect = 2e-32
 Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 16/156 (10%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +G     V +V+ +G FA VY+ + +G+   YA+K +      E+     +  E   + K
Sbjct: 25  LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS---NEEEKNRAIIQEVCFMKK 81

Query: 207 V-DHPFIVQLRYSF-------QTKYRLYLVLDFVNGGHLFFQLYR---QGLFREDLARIY 255
           +  HP IVQ   +         T    +L+L  +  G L   L +   +G    D     
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141

Query: 256 TAEIVSAVSHLHANG--IMHRDLKPENILLDADGHV 289
             +   AV H+H     I+HRDLK EN+LL   G +
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  120 bits (303), Expect = 4e-32
 Identities = 36/142 (25%), Positives = 68/142 (47%), Gaps = 16/142 (11%)

Query: 150 EDFEVLK-VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           +D+++ K V+G G   KV +     T +  A+K++       +        E +   +  
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQAS 79

Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV +   ++  +     L ++++ + GG LF ++  +G   F E  A     +I +
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 262 AVSHLHANGIMHRDLKPENILL 283
           A+  LH++ I HRD+KPEN+L 
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLY 161

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  121 bits (305), Expect = 5e-32
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 16/161 (9%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
             P  H+ +     +   ++D++V  +V+G G   KV Q+    T E +A+K+++     
Sbjct: 42  QFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA 101

Query: 190 EKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY----RLYLVLDFVNGGHLFFQLYRQ 244
            +        E  +  +    P IV++   ++  Y     L +V++ ++GG LF ++  +
Sbjct: 102 RR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 153

Query: 245 G--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL 283
           G   F E  A      I  A+ +LH+  I HRD+KPEN+L 
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  116 bits (293), Expect = 9e-31
 Identities = 33/139 (23%), Positives = 64/139 (46%), Gaps = 8/139 (5%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +        VG+G+F +V++++   T    A+K +R +    +        E      + 
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLS 108

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            P IV L  + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH 
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 269 NGIMHRDLKPENILLDADG 287
             I+H D+K +N+LL +DG
Sbjct: 169 RRILHGDVKADNVLLSSDG 187

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  116 bits (291), Expect = 2e-30
 Identities = 30/209 (14%), Positives = 66/209 (31%), Gaps = 34/209 (16%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI 172
            E  +E    +  V A +             +Q  G    ++++ +  G  + V+ VR +
Sbjct: 27  EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQ--GERKLKLVEPLRVGDRSVVFLVRDV 84

Query: 173 GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR---------------- 216
              E +A+KV        ++  E +        ++      + R                
Sbjct: 85  ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144

Query: 217 ----------YSFQTKYRLYLVLDFVNG------GHLFFQLYRQGLFREDLARIYTAEIV 260
                               L++   +         L F    +G        I TA+++
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLI 204

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHV 289
              ++L + G++H    P+N+ +  DG +
Sbjct: 205 RLAANLQSKGLVHGHFTPDNLFIMPDGRL 233

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  114 bits (288), Expect = 3e-30
 Identities = 35/141 (24%), Positives = 76/141 (53%), Gaps = 3/141 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  ++  ++   E ++ E  +L++ D 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDS 79

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 270 GIMHRDLKPENILLDADGHVR 290
             +HRD+K  N+LL   G V+
Sbjct: 139 KKIHRDIKAANVLLSEHGEVK 159

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  113 bits (285), Expect = 9e-30
 Identities = 46/163 (28%), Positives = 80/163 (49%), Gaps = 9/163 (5%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           GK TG++  +  +     + D E L  +G G   +V+++R   T  + A+K MR      
Sbjct: 7   GKQTGYLT-IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RS 61

Query: 191 KNHAEY--MKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF 247
            N  E   +  + +++ K  D P+IVQ   +F T   +++ ++ +       +   QG  
Sbjct: 62  GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI 121

Query: 248 REDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHV 289
            E +    T  IV A+ +L   +G++HRD+KP NILLD  G +
Sbjct: 122 PERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQI 164

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  114 bits (287), Expect = 3e-29
 Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 17/159 (10%)

Query: 137 IDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY 196
           I N+P+  Q +        K++G G+   V   +        A+K M  D        + 
Sbjct: 3   IANIPNFEQSLK-NLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFC------DI 54

Query: 197 MKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
              E  +LT+ D HP +++   S  T   LY+ L+  N   L   +  + +  E+L    
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQK 113

Query: 256 TAE-------IVSAVSHLHANGIMHRDLKPENILLDADG 287
                     I S V+HLH+  I+HRDLKP+NIL+    
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSS 152

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  113 bits (285), Expect = 5e-29
 Identities = 33/161 (20%), Positives = 62/161 (38%), Gaps = 14/161 (8%)

Query: 132 KPTGHIDNLPSENQC--VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
            P+   D+   E     VG   F    V+G GA   +   R +  +   A+K +  +   
Sbjct: 4   SPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF- 61

Query: 190 EKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY--RQGL 246
                 +   E  +L + D HP +++   + + +   Y+ ++         +    +   
Sbjct: 62  -----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA--TLQEYVEQKDFA 114

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG 287
                      +  S ++HLH+  I+HRDLKP NIL+    
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (276), Expect = 1e-28
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 10/149 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D+E+ +V+G GA A V         E  A+K +  +K       + +  E   +++  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 72

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG--------HLFFQLYRQGLFREDLARIYTAEIVS 261
           P IV    SF  K  L+LV+  ++GG         +    ++ G+  E        E++ 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVR 290
            + +LH NG +HRD+K  NILL  DG V+
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (277), Expect = 4e-28
 Identities = 29/172 (16%), Positives = 57/172 (33%), Gaps = 33/172 (19%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---------- 201
                V+GQ       +     T E + + V    +    N  + MK E           
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 202 ---------------NILTKVDHPFIVQLRYSFQTKYRLYLVLDF----VNGGHLFFQLY 242
                          +++       ++++R   +  + L     +     N       L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 243 RQGLFREDL---ARIY-TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
                 + L   AR+  T +++  ++ LH  G++H  L+P +I+LD  G V 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVF 251

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (274), Expect = 5e-28
 Identities = 37/141 (26%), Positives = 67/141 (47%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P  +Q R  +  ++  +LV+++  G         +   +E      T   +  +++LH++
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 270 GIMHRDLKPENILLDADGHVR 290
            ++HRD+K  NILL   G V+
Sbjct: 174 NMIHRDVKAGNILLSEPGLVK 194

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  108 bits (273), Expect = 7e-28
 Identities = 41/165 (24%), Positives = 80/165 (48%), Gaps = 14/165 (8%)

Query: 134 TGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
           +G +   P ++     ED + L  +G+GA+  V ++    + +I A+K +R       + 
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDE 61

Query: 194 AEY--MKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF----QLYRQGL 246
            E   +  + +++ +  D P+IVQ   +   +   ++ ++ ++     F          +
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV 121

Query: 247 FRED-LARIYTAEIVSAVSHLHANG-IMHRDLKPENILLDADGHV 289
             E+ L +I T   V A++HL  N  I+HRD+KP NILLD  G++
Sbjct: 122 IPEEILGKI-TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNI 165

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  108 bits (271), Expect = 9e-28
 Identities = 35/140 (25%), Positives = 70/140 (50%), Gaps = 4/140 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +    +G+G+   V   R   +    A+K+M    + ++   E + +E  I+    H
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQH 101

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             +V++  S+     L+++++F+ GG L   +  Q    E+        ++ A+++LHA 
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNEEQIATVCEAVLQALAYLHAQ 160

Query: 270 GIMHRDLKPENILLDADGHV 289
           G++HRD+K ++ILL  DG V
Sbjct: 161 GVIHRDIKSDSILLTLDGRV 180

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (270), Expect = 9e-28
 Identities = 43/142 (30%), Positives = 75/142 (52%), Gaps = 4/142 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+      E    E    E  IL   DH
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDH 75

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P+IV+L  ++    +L+++++F  GG +    L       E   ++   +++ A++ LH+
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             I+HRDLK  N+L+  +G +R
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIR 157

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  107 bits (268), Expect = 2e-27
 Identities = 37/140 (26%), Positives = 70/140 (50%), Gaps = 4/140 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +   + +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKN 76

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV    S+     L++V++++ GG L   +  +    E        E + A+  LH+N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 270 GIMHRDLKPENILLDADGHV 289
            ++HRD+K +NILL  DG V
Sbjct: 136 QVIHRDIKSDNILLGMDGSV 155

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  106 bits (266), Expect = 4e-27
 Identities = 34/138 (24%), Positives = 63/138 (45%), Gaps = 7/138 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
            V+G+G +  VY  R +      A+K + +       +++ +  E  +   + H  IVQ 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 216 RYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
             SF     + + ++ V GG    L    +      E     YT +I+  + +LH N I+
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144

Query: 273 HRDLKPENILLDA-DGHV 289
           HRD+K +N+L++   G +
Sbjct: 145 HRDIKGDNVLINTYSGVL 162

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  107 bits (268), Expect = 4e-27
 Identities = 36/145 (24%), Positives = 73/145 (50%), Gaps = 9/145 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTK 206
            +DFE +  +G G    V++V    +  + A K++     +E   A    +  E  +L +
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----LEIKPAIRNQIIRELQVLHE 87

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED-LARIYTAEIVSAVSH 265
            + P+IV    +F +   + + ++ ++GG L   L + G   E  L ++ +  ++  +++
Sbjct: 88  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV-SIAVIKGLTY 146

Query: 266 LHANG-IMHRDLKPENILLDADGHV 289
           L     IMHRD+KP NIL+++ G +
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEI 171

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  106 bits (266), Expect = 5e-27
 Identities = 42/145 (28%), Positives = 73/145 (50%), Gaps = 9/145 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +E +  +G+G++  V++ R   T +I A+K     K +E      +K     E  +L
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRML 56

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            ++ HP +V L   F+ K RL+LV ++ +   L      Q    E L +  T + + AV+
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116

Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
             H +  +HRD+KPENIL+     +
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVI 141

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  106 bits (267), Expect = 5e-27
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 9/148 (6%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ER 201
              +E +E L +VG+G++  V + R   T  I A+K     K +E +  + +K     E 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREI 75

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            +L ++ H  +V L    + K R YLV +FV+   L             + + Y  +I++
Sbjct: 76  KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            +   H++ I+HRD+KPENIL+   G V
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVV 163

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (265), Expect = 2e-26
 Identities = 32/144 (22%), Positives = 60/144 (41%), Gaps = 5/144 (3%)

Query: 150 EDFEVLKVVGQGA--FAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
             +E+L V+G+G      V   R   T E   ++ +  +         +++ E ++    
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF 83

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGLFREDLARIYTAEIVSAVSH 265
           +HP IV  R +F     L++V  F+  G        +      E         ++ A+ +
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 266 LHANGIMHRDLKPENILLDADGHV 289
           +H  G +HR +K  +IL+  DG V
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKV 167

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  104 bits (261), Expect = 3e-26
 Identities = 40/200 (20%), Positives = 64/200 (32%), Gaps = 58/200 (29%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM-------------KVMRKDKIMEK-NHA 194
           L DFE ++ +G+G F  V++ +       YA+             KVMR+ K + K  H 
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 195 EYMKS-----------------------------------------ERNILTKVDHPFIV 213
             ++                                          +   +        V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF---REDLARIYTAEIVSAVSHLHANG 270
                   K  LY+ +      +L   + R+         +      +I  AV  LH+ G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 271 IMHRDLKPENILLDADGHVR 290
           +MHRDLKP NI    D  V+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVK 204

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  103 bits (259), Expect = 3e-26
 Identities = 41/151 (27%), Positives = 77/151 (50%), Gaps = 13/151 (8%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNIL 204
           V  +D E +  +G+GA+  V ++R + + +I A+K +R       N  E   +  + +I 
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLLMDLDIS 59

Query: 205 TK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF---QLYRQGLFRED-LARIYTAEI 259
            + VD PF V    +   +  +++ ++ ++     F    + +     ED L +I    I
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI-AVSI 118

Query: 260 VSAVSHLHANG-IMHRDLKPENILLDADGHV 289
           V A+ HLH+   ++HRD+KP N+L++A G V
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQV 149

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  101 bits (254), Expect = 2e-25
 Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 14/148 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E    E + S    E ++L
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ET---EGVPSTAIREISLL 56

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAEIVS 261
            +++HP IV+L     T+ +LYLV +F++       F            L + Y  +++ 
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQ 114

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            ++  H++ ++HRDLKP+N+L++ +G +
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAI 142

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  102 bits (255), Expect = 2e-25
 Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 13/150 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
             FE++++VG G + +VY+ R + T ++ A+KVM     +  +  E +K E N+L K   
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79

Query: 209 HPFIVQLRYSF------QTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
           H  I     +F          +L+LV++F   G +    +  +    +E+       EI+
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +SHLH + ++HRD+K +N+LL  +  V+
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  101 bits (254), Expect = 2e-25
 Identities = 39/142 (27%), Positives = 72/142 (50%), Gaps = 6/142 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F+VL+ +G+G++  VY+     T +I A+K +     +E +  E +K E +I+ + D 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIK-EISIMQQCDS 83

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P +V+   S+     L++V+++   G +      R     ED         +  + +LH 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HRD+K  NILL+ +GH +
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAK 165

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 99.7 bits (249), Expect = 8e-25
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 8/141 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
             +G+G+F  VY+     T+   A   ++  K+  K+  +  K E  +L  + HP IV+ 
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 216 RYSF----QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG- 270
             S+    + K  + LV + +  G L   L R  + +  + R +  +I+  +  LH    
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150

Query: 271 -IMHRDLKPENILLDA-DGHV 289
            I+HRDLK +NI +    G V
Sbjct: 151 PIIHRDLKCDNIFITGPTGSV 171

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =   99 bits (250), Expect = 2e-24
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 12/148 (8%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
            + +E L  +G+G FA VY+ R   T++I A+K ++          + +      E  +L
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG--HRSEAKDGINRTALREIKLL 66

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNG---GHLFFQLYRQGLFREDLARIYTAEIVS 261
            ++ HP I+ L  +F  K  + LV DF+       +        +      + Y    + 
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQ 123

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            + +LH + I+HRDLKP N+LLD +G +
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVL 151

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 98.4 bits (246), Expect = 3e-24
 Identities = 36/157 (22%), Positives = 65/157 (41%), Gaps = 15/157 (9%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
            +    +E +  +G GA+  VY+ R   +    A+K +R            + + R +  
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 204 ---LTKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLA 252
              L   +HP +V+L           + ++ LV + V+       +           +  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--QDLRTYLDKAPPPGLPAETI 122

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           +    + +  +  LHAN I+HRDLKPENIL+ + G V
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV 159

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 98.4 bits (246), Expect = 4e-24
 Identities = 35/149 (23%), Positives = 72/149 (48%), Gaps = 15/149 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILT 205
             F+ L+ +G G +A VY+     T    A+K ++    ++    E   S    E +++ 
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSE--EGTPSTAIREISLMK 58

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHL--FFQLYRQGLFREDLARIYTAEIV 260
           ++ H  IV+L     T+ +L LV +F++     ++              +L + +  +++
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHV 289
             ++  H N I+HRDLKP+N+L++  G +
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQL 147

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 98.0 bits (245), Expect = 4e-24
 Identities = 36/147 (24%), Positives = 75/147 (51%), Gaps = 13/147 (8%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   +    E + S    E  +L
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DD---EGVPSSALREICLL 55

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNG--GHLFFQLYRQGLFREDLARIYTAEIVSA 262
            ++ H  IV+L     +  +L LV +F +      F      G    ++ + +  +++  
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKG 113

Query: 263 VSHLHANGIMHRDLKPENILLDADGHV 289
           +   H+  ++HRDLKP+N+L++ +G +
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGEL 140

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 98.1 bits (245), Expect = 6e-24
 Identities = 31/158 (19%), Positives = 77/158 (48%), Gaps = 12/158 (7%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           ++ +      ++ +  +  +G+G + +VY+     T+E  A+K +R +   E+   E + 
Sbjct: 23  SVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EE---EGVP 77

Query: 199 S----ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLAR 253
                E ++L ++ H  I++L+      +RL+L+ ++    + L   + +       + +
Sbjct: 78  GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--NDLKKYMDKNPDVSMRVIK 135

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVRS 291
            +  ++++ V+  H+   +HRDLKP+N+LL       +
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASET 173

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 97.3 bits (243), Expect = 1e-23
 Identities = 35/148 (23%), Positives = 72/148 (48%), Gaps = 16/148 (10%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +  L  +G+G +A VY+ +   T  + A+K +R    +E  H E        E ++L
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR----LE--HEEGAPCTAIREVSLL 54

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVS 261
             + H  IV L     T+  L LV ++++     +L        +      +++  +++ 
Sbjct: 55  KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKLFLFQLLR 111

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            +++ H   ++HRDLKP+N+L++  G +
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGEL 139

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 96.3 bits (240), Expect = 8e-23
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 30/195 (15%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLED----FEVLKVVGQGAFAKVYQ 168
           + +  + P+    +  +  K    +  + +             +   KV+G G+F  VYQ
Sbjct: 13  SCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQ 72

Query: 169 VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR---- 224
            +   + E+ A+K     K+       +   E  I+ K+DH  IV+LRY F +       
Sbjct: 73  AKLCDSGELVAIK-----KV--LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125

Query: 225 --LYLVLDFVNGGHLFFQLYR--------QGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
             L LVLD+V        +YR        +        ++Y  ++  +++++H+ GI HR
Sbjct: 126 VYLNLVLDYVPE-----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 180

Query: 275 DLKPENILLDADGHV 289
           D+KP+N+LLD D  V
Sbjct: 181 DIKPQNLLLDPDTAV 195

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 93.8 bits (234), Expect = 2e-22
 Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 16/148 (10%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E ++ L+ VG+G +  VY+ +      I A+K +R D   E    E + S    E ++L
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA--ED---EGIPSTAIREISLL 73

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVS 261
            ++ HP IV L     ++  L LV +F+       L      +   ++   +IY  +++ 
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVL---DENKTGLQDSQIKIYLYQLLR 130

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            V+H H + I+HRDLKP+N+L+++DG +
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGAL 158

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 93.3 bits (233), Expect = 2e-22
 Identities = 40/148 (27%), Positives = 78/148 (52%), Gaps = 16/148 (10%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E    E + S    E +IL
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK--ED---EGIPSTTIREISIL 54

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVS 261
            ++ H  IV+L     TK RL LV + ++      L      +G      A+ +  ++++
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLN 111

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            +++ H   ++HRDLKP+N+L++ +G +
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGEL 139

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 93.1 bits (232), Expect = 6e-22
 Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 23/159 (14%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K +  +   EK   E        E 
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EK---EGFPITALREI 67

Query: 202 NILTKVDHPFIVQLR--------YSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFRED 250
            IL  + H  +V L            + K  +YLV DF      G L         F   
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL---SNVLVKFTLS 124

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
             +     +++ + ++H N I+HRD+K  N+L+  DG +
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVL 163

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 93.2 bits (232), Expect = 7e-22
 Identities = 42/152 (27%), Positives = 77/152 (50%), Gaps = 27/152 (17%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +   KV+G G+F  V+Q + + + E+ A+K + +DK        +   E  I+  V HP 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDK-------RFKNRELQIMRIVKHPN 93

Query: 212 IVQLRYSFQT------KYRLYLVLDFVNGGHLFFQLYR--------QGLFREDLARIYTA 257
           +V L+  F +      +  L LVL++V        +YR        +      L ++Y  
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-----TVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           +++ +++++H+ GI HRD+KP+N+LLD    V
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV 180

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 91.1 bits (227), Expect = 2e-21
 Identities = 33/171 (19%), Positives = 72/171 (42%), Gaps = 37/171 (21%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRI-GTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
            +  C   + +E +  +G+GA+ KV++ R +       A+K +R            +++ 
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------------VQTG 50

Query: 201 ---------RNI-----LTKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGH---LF 238
                    R +     L   +HP +V+L           + +L LV + V+       +
Sbjct: 51  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--QDLTTY 108

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
                +     +  +    +++  +  LH++ ++HRDLKP+NIL+ + G +
Sbjct: 109 LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 159

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 15/147 (10%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            ++ EV +VVG+GAF  V + +        A+K +  +   +     ++  E   L++V+
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKWRAK--DVAIKQIESESERK----AFIV-ELRQLSRVN 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSH 265
           HP IV+L Y       + LV+++  GG L+  L+       +    A  +  +    V++
Sbjct: 60  HPNIVKL-YGACLN-PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 266 LHA---NGIMHRDLKPENILLDADGHV 289
           LH+     ++HRDLKP N+LL A G V
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTV 144

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 32/141 (22%), Positives = 63/141 (44%), Gaps = 4/141 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D    +V+G+G F +  +V    T E+  MK + +     +        E  ++  ++H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEH 66

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE-IVSAVSHLHA 268
           P +++         RL  + +++ GG L   +           R+  A+ I S +++LH+
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 269 NGIMHRDLKPENILLDADGHV 289
             I+HRDL   N L+  + +V
Sbjct: 127 MNIIHRDLNSHNCLVRENKNV 147

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 87.4 bits (217), Expect = 3e-20
 Identities = 32/146 (21%), Positives = 63/146 (43%), Gaps = 9/146 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM----KSERNIL 204
             + E  K +G+G F  V++ R +    + A+K +       +          + E  I+
Sbjct: 18  DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAV 263
           + ++HP IV+L Y         +V++FV  G L+ +L  +    +  +      +I   +
Sbjct: 78  SNLNHPNIVKL-YGLMHN-PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135

Query: 264 SHLHANG--IMHRDLKPENILLDADG 287
            ++      I+HRDL+  NI L +  
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLD 161

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 87.4 bits (217), Expect = 4e-20
 Identities = 33/148 (22%), Positives = 70/148 (47%), Gaps = 12/148 (8%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
             D  + + +G G+F  V++            A+K++ +     +   E+++ E  I+ +
Sbjct: 36  WCDLNIKEKIGAGSFGTVHR----AEWHGSDVAVKILMEQDFHAERVNEFLR-EVAIMKR 90

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYT--AEIVSAV 263
           + HP IV    +      L +V ++++ G L+  L++ G   + D  R  +   ++   +
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150

Query: 264 SHLHANG--IMHRDLKPENILLDADGHV 289
           ++LH     I+HR+LK  N+L+D    V
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTV 178

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 85.8 bits (213), Expect = 8e-20
 Identities = 36/141 (25%), Positives = 59/141 (41%), Gaps = 6/141 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
               V + +G G+F  VY+ +  G     A+K++       +    + K+E  +L K  H
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAF-KNEVGVLRKTRH 79

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHA 268
             I+     + T  +L +V  +  G  L+  L+     F          +    + +LHA
Sbjct: 80  VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138

Query: 269 NGIMHRDLKPENILLDADGHV 289
             I+HRDLK  NI L  D  V
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTV 159

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 85.9 bits (213), Expect = 3e-19
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 15/141 (10%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           +EVLKV+G+G+F +V +       +  A+K++R +K            E  IL  +    
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF----HRQAAEEIRILEHLRKQD 154

Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR---EDLARIYTAEIVSA 262
             +   ++ +  +F   +R ++ + F       ++L ++  F+     L R +   I+  
Sbjct: 155 KDNTMNVIHMLENFT--FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212

Query: 263 VSHLHANGIMHRDLKPENILL 283
           +  LH N I+H DLKPENILL
Sbjct: 213 LDALHKNRIIHCDLKPENILL 233

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 84.7 bits (210), Expect = 4e-19
 Identities = 34/148 (22%), Positives = 65/148 (43%), Gaps = 18/148 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVY------QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
            E  E+ +++G+G F +VY      +V         A++++  ++  E     + K E  
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHGEV---------AIRLIDIERDNEDQLKAF-KREVM 81

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVS 261
              +  H  +V    +  +   L ++     G  L+  +    +    +  R    EIV 
Sbjct: 82  AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVK 141

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            + +LHA GI+H+DLK +N+  D +G V
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYD-NGKV 168

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 82.3 bits (204), Expect = 1e-18
 Identities = 23/148 (15%), Positives = 56/148 (37%), Gaps = 9/148 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            +    L  + +    ++++ R  G  +I  +KV++      +   ++ + E   L    
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQGN-DI-VVKVLKVRDWSTRKSRDFNE-ECPRLRIFS 65

Query: 209 HPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYT--AEIVSAVS 264
           HP ++ +             L+  ++  G L+  L+    F  D ++      ++   ++
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 265 HLHA--NGIMHRDLKPENILLDADGHVR 290
            LH     I    L   ++++D D   R
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTAR 153

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 82.3 bits (204), Expect = 2e-18
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 2/139 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           + + ++VG+G    VY+        I A+K+M +    +      M+ E     ++  P 
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 212 IVQLRYSF-QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           +V + + F +   +LY+ +  +NG  L   L RQG      A     +I SA+   HA G
Sbjct: 96  VVPI-HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 271 IMHRDLKPENILLDADGHV 289
             HRD+KPENIL+ AD   
Sbjct: 155 ATHRDVKPENILVSADDFA 173

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.9 bits (205), Expect = 3e-18
 Identities = 36/157 (22%), Positives = 68/157 (43%), Gaps = 18/157 (11%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
              L ++E  KV G+G +  VY+ +R      + YA+K +    I      E       +
Sbjct: 18  VEDLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA-----L 71

Query: 204 LTKVDHPFIVQLR--YSFQTKYRLYLVLDFV--------NGGHLFFQLYRQGLFREDLAR 253
           L ++ HP ++ L+  +      +++L+ D+                   +       + +
Sbjct: 72  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
               +I+  + +LHAN ++HRDLKP NIL+  +G  R
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 82.4 bits (204), Expect = 4e-18
 Identities = 41/150 (27%), Positives = 64/150 (42%), Gaps = 34/150 (22%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           F V++ +G G F +V   + I   + YA+KV+R  K          K E +IL K+    
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY----TRSAKIEADILKKIQNDD 92

Query: 208 -DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGL-----------FREDLAR 253
            ++  IV+    F   Y            H+   F+     L           F  +  +
Sbjct: 93  INNNNIVKYHGKFM--YY----------DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK 140

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILL 283
           +Y  EI+ A+++L    + H DLKPENILL
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILL 170

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.2 bits (198), Expect = 1e-17
 Identities = 21/139 (15%), Positives = 49/139 (35%), Gaps = 2/139 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           + +L   G     + +Q          A+  +    ++  +  +   S    L+++D P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           + ++     T+    +V +++ GG L  ++           R     + +A    H  G+
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSPSPVGAIRA-MQSLAAAADAAHRAGV 150

Query: 272 MHRDLKPENILLDADGHVR 290
                 P  + +  DG V 
Sbjct: 151 ALSIDHPSRVRVSIDGDVV 169

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 80.4 bits (199), Expect = 1e-17
 Identities = 32/138 (23%), Positives = 67/138 (48%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           ++++  +G G  + VY       +   A+K +      ++   +  + E +  +++ H  
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV +    +     YLV++++ G  L   +   G    D A  +T +I+  + H H   I
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 272 MHRDLKPENILLDADGHV 289
           +HRD+KP+NIL+D++  +
Sbjct: 133 VHRDIKPQNILIDSNKTL 150

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 20/147 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVR--RIGTSEIYAMKVMRKDKIMEKNHAEYMK---SERNILTK 206
           +EV   +  G    +Y      +    +  +K +          AE      +ER  L +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPV-VLKGLVHS-----GDAEAQAMAMAERQFLAE 135

Query: 207 VDHPFIVQLRYSF------QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           V HP IVQ+ ++F            Y+V+++V G  L  +  +        A  Y  EI+
Sbjct: 136 VVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQKLPVAEAIAYLLEIL 192

Query: 261 SAVSHLHANGIMHRDLKPENILLDADG 287
            A+S+LH+ G+++ DLKPENI+L  + 
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQ 219

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 80.7 bits (199), Expect = 1e-17
 Identities = 33/159 (20%), Positives = 65/159 (40%), Gaps = 29/159 (18%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNI--L 204
           L++ ++L+++G+G +  VY+    G+      A+KV          + +   +E+NI  +
Sbjct: 12  LDNLKLLELIGRGRYGAVYK----GSLDERPVAVKVFSF------ANRQNFINEKNIYRV 61

Query: 205 TKVDHPFIVQL-----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
             ++H  I +      R +   +    LV+++   G L   L           R+    +
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSV 120

Query: 260 VSAVSHLHA---------NGIMHRDLKPENILLDADGHV 289
              +++LH            I HRDL   N+L+  DG  
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 79.7 bits (197), Expect = 2e-17
 Identities = 37/154 (24%), Positives = 61/154 (39%), Gaps = 23/154 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKV 207
            D  +L+ VG+G + +V++    G  E  A+K+            +    E  +     +
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQG--ENVAVKIFSSR------DEKSWFRETELYNTVML 59

Query: 208 DHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            H  I+        S  +  +L+L+  +   G L+  L    L      RI    I S +
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSIASGL 118

Query: 264 SHLHA--------NGIMHRDLKPENILLDADGHV 289
           +HLH           I HRDLK +NIL+  +G  
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC 152

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 79.8 bits (197), Expect = 3e-17
 Identities = 39/164 (23%), Positives = 65/164 (39%), Gaps = 23/164 (14%)

Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           LP   Q    +  +++K +G+G + +V+  +  G  E  A+KV                 
Sbjct: 27  LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG--EKVAVKVFFTT------EEASWFR 78

Query: 200 ERNI--LTKVDHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E  I     + H  I+           +  +LYL+ D+   G L+  L    L  + + +
Sbjct: 79  ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLK 138

Query: 254 IYTAEIVSAVSHLHA--------NGIMHRDLKPENILLDADGHV 289
           +     VS + HLH           I HRDLK +NIL+  +G  
Sbjct: 139 L-AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 79.4 bits (196), Expect = 3e-17
 Identities = 32/156 (20%), Positives = 61/156 (39%), Gaps = 25/156 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKV 207
              ++L+V  +G F  V++ + +   E  A+K      I      +  ++E  +  L  +
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLLN--EYVAVK------IFPIQDKQSWQNEYEVYSLPGM 75

Query: 208 DHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            H  I+Q     +        L+L+  F   G L   L    +   +L  I    +   +
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAE-TMARGL 134

Query: 264 SHLHAN----------GIMHRDLKPENILLDADGHV 289
           ++LH +           I HRD+K +N+LL  +   
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 36/159 (22%), Positives = 67/159 (42%), Gaps = 28/159 (17%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ F+V ++ GQG F  V   +   T    A+K + +D        + M+     L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVLH 77

Query: 209 HPFIVQLRYSFQTKYR-------LYLVLDFVNGGHLFFQLYR---------QGLFREDLA 252
           HP IVQL+  F T          L +V+++V        L+R                L 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-----TLHRCCRNYYRRQVAP-PPILI 131

Query: 253 RIYTAEIVSAVSHLHAN--GIMHRDLKPENILLDADGHV 289
           +++  +++ ++  LH     + HRD+KP N+L++     
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 78.5 bits (194), Expect = 4e-17
 Identities = 40/144 (27%), Positives = 65/144 (45%), Gaps = 7/144 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV 207
             +  + +++G G F KVY+   IG     A+K  R D   +     E ++ E  +   +
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I+ LR     +  L LV++F  GG L   L  + +  + L      +I   +++LH
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW-AVQIARGMNYLH 122

Query: 268 ANG---IMHRDLKPENILLDADGH 288
                 I+HRDLK  NIL+     
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVE 146

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 78.7 bits (194), Expect = 6e-17
 Identities = 40/164 (24%), Positives = 64/164 (39%), Gaps = 23/164 (14%)

Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           LP   Q        + + +G+G F +V++ +  G  E  A+K+                 
Sbjct: 32  LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSR------EERSWFR 83

Query: 200 ERNI--LTKVDHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E  I     + H  I+           T  +L+LV D+   G LF  L R  +  E + +
Sbjct: 84  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK 143

Query: 254 IYTAEIVSAVSHLHAN--------GIMHRDLKPENILLDADGHV 289
           +      S ++HLH           I HRDLK +NIL+  +G  
Sbjct: 144 L-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.0 bits (195), Expect = 6e-17
 Identities = 35/181 (19%), Positives = 67/181 (37%), Gaps = 48/181 (26%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + + + K +G G+F  V +V  I + + +A+K     K++      Y   E +I+  +DH
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVL--QDPRYKNRELDIMKVLDH 59

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR--------------------- 248
             I++L   F T              H        G+                       
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 249 --EDLARI------------------YTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
             + L ++                  Y  ++  AV  +H+ GI HRD+KP+N+L+++  +
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 289 V 289
            
Sbjct: 180 T 180

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.5 bits (194), Expect = 7e-17
 Identities = 39/140 (27%), Positives = 74/140 (52%), Gaps = 12/140 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
           +D+++++ +G+G +++V++   I  +E   +K+++  K       + +K E  IL  +  
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRG 89

Query: 209 HPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            P I+ L    +        LV + VN    F QLY+     +   R Y  EI+ A+ + 
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNT-DFKQLYQT--LTDYDIRFYMYEILKALDYC 146

Query: 267 HANGIMHRDLKPENILLDAD 286
           H+ GIMHRD+KP N+++D +
Sbjct: 147 HSMGIMHRDVKPHNVMIDHE 166

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 34/152 (22%), Positives = 57/152 (37%), Gaps = 36/152 (23%)

Query: 152 FEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV--- 207
           +E++  +G+G F KV +           A+K++R          E  + E N+L K+   
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY----REAARLEINVLKKIKEK 76

Query: 208 ---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGL-----------FREDL 251
              +    V +   F   +           GH+   F+L  +             +    
Sbjct: 77  DKENKFLCVLMSDWFN--FH----------GHMCIAFELLGKNTFEFLKENNFQPYPLPH 124

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILL 283
            R    ++  A+  LH N + H DLKPENIL 
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILF 156

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 76.5 bits (189), Expect = 3e-16
 Identities = 38/160 (23%), Positives = 63/160 (39%), Gaps = 36/160 (22%)

Query: 152 FEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV--- 207
           +E++  +G+GAF KV +           A+K+++          E  +SE  +L  +   
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY----CEAARSEIQVLEHLNTT 71

Query: 208 ---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGL-----------FREDL 251
                   VQ+   F+  +           GH+   F+L                FR D 
Sbjct: 72  DPNSTFRCVQMLEWFE--HH----------GHICIVFELLGLSTYDFIKENGFLPFRLDH 119

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVRS 291
            R    +I  +V+ LH+N + H DLKPENIL     +  +
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 76.1 bits (188), Expect = 4e-16
 Identities = 37/142 (26%), Positives = 69/142 (48%), Gaps = 4/142 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 212 IVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +              Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 268 ANGIMHRDLKPENILLDADGHV 289
            NGI+HRD+KP NI++ A   V
Sbjct: 134 QNGIIHRDVKPANIMISATNAV 155

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 17/143 (11%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           +E+  ++G+G+F +V +       E  A+K+++  K          + E  +L  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNKHD 111

Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR---EDLARIYTAEIVSA 262
                +IV L+  F   +R +L L F    +  + L R   FR    +L R +  ++ +A
Sbjct: 112 TEMKYYIVHLKRHFM--FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 263 VSHLHAN--GIMHRDLKPENILL 283
           +  L      I+H DLKPENILL
Sbjct: 170 LLFLATPELSIIHCDLKPENILL 192

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 73.6 bits (181), Expect = 5e-15
 Identities = 33/150 (22%), Positives = 71/150 (47%), Gaps = 21/150 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           + +++ +G G F+ V+  + +  +   AMK++R DK+  +      + E  +L +V    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDAD 76

Query: 208 -------DHPFIVQLRYSFQTK--YRLYLVLDF-VNGGHLFFQL--YRQGLFREDLARIY 255
                      I++L   F  K    +++V+ F V G +L   +  Y          +  
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136

Query: 256 TAEIVSAVSHLHAN-GIMHRDLKPENILLD 284
           + +++  + ++H   GI+H D+KPEN+L++
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLME 166

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 33/146 (22%), Positives = 69/146 (47%), Gaps = 10/146 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILT 205
            +F+ +KV+G GAF  VY+   +      +I  A+K + ++    K + E +  E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMA 72

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            VD+P + +L         + L+   +  G L  + + ++  +  + L   +  +I   +
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGM 130

Query: 264 SHLHANGIMHRDLKPENILLDADGHV 289
           ++L    ++HRDL   N+L+    HV
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHV 156

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 67.7 bits (166), Expect = 4e-13
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED  + + +G+G F +V+  R    + + A+K  R+        A++++ E  IL +  H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQ-EARILKQYSH 171

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P IV+L     T+ + +Y+V++ V GG    F +     L  + L ++   +  + + +L
Sbjct: 172 PNIVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGMEYL 229

Query: 267 HANGIMHRDLKPENILLDADGHV 289
            +   +HRDL   N L+     +
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVL 252

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 67.2 bits (164), Expect = 8e-13
 Identities = 35/157 (22%), Positives = 63/157 (40%), Gaps = 34/157 (21%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           + V++ +G G F+ V+    I   +  AMKV++  +    ++ E    E  +L  V    
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSD 94

Query: 208 -DHP---FIVQLRYSFQTKYRLYLVLDFVNGGHL-------------FFQLYRQGLFRED 250
            + P    +VQL   F+        +  VNG H+             +            
Sbjct: 95  PNDPNREMVVQLLDDFK--------ISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLP 146

Query: 251 LARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDAD 286
             +    +++  + +LH    I+H D+KPENILL  +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 65.7 bits (161), Expect = 1e-12
 Identities = 31/145 (21%), Positives = 63/145 (43%), Gaps = 7/145 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +D  +L+ +G G+F  V +       G +   A+K ++ D + +    +    E N +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
           +DH  +++L Y       + +V +    G L    + ++       L+R Y  ++   + 
Sbjct: 78  LDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR-YAVQVAEGMG 135

Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           +L +   +HRDL   N+LL     V
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLV 160

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 33/146 (22%), Positives = 69/146 (47%), Gaps = 10/146 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILT 205
            +F+ +KV+G GAF  VY+   +      +I  A+K + ++    K + E +  E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMA 72

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            VD+P + +L         + L+   +  G L  + + ++  +  + L   +  +I   +
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGM 130

Query: 264 SHLHANGIMHRDLKPENILLDADGHV 289
           ++L    ++HRDL   N+L+    HV
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHV 156

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 64.9 bits (159), Expect = 2e-12
 Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 9/145 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ED  + +++G+G F +VY+         +I  A+K  +KD     N  ++M  E  I+  
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMS-EAVIMKN 69

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
           +DHP IV+L      +   +++++    G L  + +  +  L    L   Y+ +I  A++
Sbjct: 70  LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL-YSLQICKAMA 127

Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           +L +   +HRD+   NIL+ +   V
Sbjct: 128 YLESINCVHRDIAVRNILVASPECV 152

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 64.6 bits (158), Expect = 3e-12
 Identities = 32/145 (22%), Positives = 69/145 (47%), Gaps = 9/145 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           E  E+ + +G+G F  V+Q          +  A+K  +     +    +++  E   + +
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFL-QEALTMRQ 72

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
            DHP IV+L     T+  ++++++    G L  F Q+ +  L    L   Y  ++ +A++
Sbjct: 73  FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALA 130

Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           +L +   +HRD+   N+L+ ++  V
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCV 155

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 64.3 bits (157), Expect = 5e-12
 Identities = 32/143 (22%), Positives = 63/143 (44%), Gaps = 10/143 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-P 210
           F V K +G G F ++   + + T+E  A+K+        K+ A  +  E     ++    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65

Query: 211 FIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I Q+ Y         +VL+ +  +   LF    R   F      +   +++S + ++H+
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVHS 123

Query: 269 NGIMHRDLKPENILLDADGHVRS 291
             +++RD+KPEN L+   G+   
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQ 146

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 63.9 bits (156), Expect = 6e-12
 Identities = 35/148 (23%), Positives = 71/148 (47%), Gaps = 12/148 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + L+ +G+G F  V   R       T E+ A+K ++     E++  ++ + E  IL 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER-EIEILK 97

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            + H  IV+ +       +  L L+++++  G L  + Q +++ +    L + YT++I  
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICK 156

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            + +L     +HRDL   NIL++ +  V
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRV 184

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 63.8 bits (156), Expect = 6e-12
 Identities = 35/148 (23%), Positives = 72/148 (48%), Gaps = 12/148 (8%)

Query: 150 EDFEVLKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + L+ +G+G F  V    Y   +  T E+ A+K ++     E++  ++ + E  IL 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER-EIEILK 66

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            + H  IV+ +       +  L L+++++  G L  + Q +++ +    L + YT++I  
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICK 125

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            + +L     +HRDL   NIL++ +  V
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRV 153

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 63.5 bits (155), Expect = 9e-12
 Identities = 35/156 (22%), Positives = 68/156 (43%), Gaps = 18/156 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + F + +++G+G F  V +  +++   S +  A+K+++ D I   +  E++  E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL-REAACMKE 81

Query: 207 VDHPFIVQL------RYSFQTKYRLYLVLDFVNGGHL--FFQLYR-----QGLFREDLAR 253
            DHP + +L        +        ++L F+  G L  F    R       L  + L R
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
               +I   + +L +   +HRDL   N +L  D  V
Sbjct: 142 F-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 63.1 bits (154), Expect = 9e-12
 Identities = 32/148 (21%), Positives = 66/148 (44%), Gaps = 11/148 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + ++ +G+G F KV           T E  A+K + K +    + A+  K E  IL 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKK-EIEILR 78

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            + H  IV+ +   +      + L+++F+  G L  +    +  +  +   + Y  +I  
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICK 137

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            + +L +   +HRDL   N+L++++  V
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQV 165

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 37/152 (24%), Positives = 68/152 (44%), Gaps = 18/152 (11%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNIL 204
           L+ ++ LK +G GA   V            A+K     K+      + HA+    E  ++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLM 115

Query: 205 TKVDHPFIVQLRYSFQTKYR------LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
             V+H  I+ L   F  +        +YLV++ +       Q+ +  L   +       +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL-DHERMSYLLYQ 172

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           ++  + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 63.0 bits (154), Expect = 1e-11
 Identities = 25/137 (18%), Positives = 62/137 (45%), Gaps = 6/137 (4%)

Query: 156 KVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           K +G G F  V +   +     +  A+K+++ +   +    + + +E N++ ++D+P+IV
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNPYIV 81

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           ++           LV++    G L  +    + +  +++      ++   + +L  +  +
Sbjct: 82  RM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNFV 139

Query: 273 HRDLKPENILLDADGHV 289
           HRDL   N+LL    + 
Sbjct: 140 HRDLAARNVLLVTQHYA 156

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.4 bits (153), Expect = 1e-11
 Identities = 36/192 (18%), Positives = 65/192 (33%), Gaps = 48/192 (25%)

Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-----HAEYMK 198
           + C+  E  +  + +G+G F +V+Q     T    A+K++  +     N       E + 
Sbjct: 14  SHCLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 199 SERNILTKV---------DHP--------FIVQLRY----------------------SF 219
            E  I  ++                      VQ  Y                       F
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 220 QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKP 278
               +L++VL+F  GG    Q  R  L     A+    ++ ++++   A+    HRDL  
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQ-MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190

Query: 279 ENILLDADGHVR 290
            N+LL      +
Sbjct: 191 GNVLLKKTSLKK 202

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.4 bits (152), Expect = 2e-11
 Identities = 25/137 (18%), Positives = 60/137 (43%), Gaps = 14/137 (10%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDH 209
           ++V + +G+G+F  +++   +  ++  A+K        E   ++   ++ E      +  
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-------FEPRRSDAPQLRDEYRTYKLLAG 64

Query: 210 -PFIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
              I  + Y  Q      LV+D +  +   L     R+  F      +   ++++ V  +
Sbjct: 65  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSI 122

Query: 267 HANGIMHRDLKPENILL 283
           H   +++RD+KP+N L+
Sbjct: 123 HEKSLVYRDIKPDNFLI 139

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 33/145 (22%), Positives = 70/145 (48%), Gaps = 9/145 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           E  E+ + +G+G F  V+Q          +  A+K   K+   +    +++  E   + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFL-QEALTMRQ 447

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
            DHP IV+L     T+  ++++++    G L  F Q+ +  L    L   Y  ++ +A++
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALA 505

Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           +L +   +HRD+   N+L+ ++  V
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCV 530

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 37/148 (25%), Positives = 70/148 (47%), Gaps = 12/148 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + +  +G+G F  V           T  + A+K ++     ++   ++ + E  IL 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQR-EIQILK 79

Query: 206 KVDHPFIVQLR-YSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            +   FIV+ R  S+    + L LV++++  G L  F Q +R  L    L   Y+++I  
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL-YSSQICK 138

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            + +L +   +HRDL   NIL++++ HV
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHV 166

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 62.3 bits (152), Expect = 2e-11
 Identities = 32/146 (21%), Positives = 62/146 (42%), Gaps = 9/146 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNILTK 206
                 KV+G G F +VY+     +S    + V     K    EK   +++  E  I+ +
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQ 102

Query: 207 VDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
             H  I++L     +KY+ + ++ +++  G L  F +          L  +    I + +
Sbjct: 103 FSHHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM-LRGIAAGM 160

Query: 264 SHLHANGIMHRDLKPENILLDADGHV 289
            +L     +HRDL   NIL++++   
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVC 186

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.0 bits (151), Expect = 3e-11
 Identities = 27/142 (19%), Positives = 59/142 (41%), Gaps = 14/142 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDH 209
           + + + +G G+F  +Y    I   E  A+K       +E    ++  +  E  I   +  
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-------LECVKTKHPQLHIESKIYKMMQG 63

Query: 210 -PFIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
              I  +R+         +V++ +  +   LF    R+  F      +   +++S + ++
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYI 121

Query: 267 HANGIMHRDLKPENILLDADGH 288
           H+   +HRD+KP+N L+     
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKK 143

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 35/179 (19%), Positives = 73/179 (40%), Gaps = 31/179 (17%)

Query: 132 KPTGHIDNLPSENQCVGLEDFEV------LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
           +   H  + P+ +      D+++        ++G G++  V +        + A+K    
Sbjct: 29  QRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---- 84

Query: 186 DKIME----KNHAEYMKSERNILTKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGH 236
            KI+         + +  E  IL +++H  +V++         +    LY+VL+  +   
Sbjct: 85  -KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-- 141

Query: 237 LFFQLYR-----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
                 +       L  E   +     ++  V ++H+ GI+HRDLKP N L++ D  V+
Sbjct: 142 ---DFKKLFRTPVYL-TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVK 196

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 61.4 bits (150), Expect = 3e-11
 Identities = 31/143 (21%), Positives = 68/143 (47%), Gaps = 10/143 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            +   ++ +G G F  V+    +   ++ A+K +R+   M +   ++++ E  ++ K+ H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGA-MSE--EDFIE-EAEVMMKLSH 62

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +VQL Y    +   + LV +F+  G L  + +  R     E L  +   ++   +++L
Sbjct: 63  PKLVQL-YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCEGMAYL 120

Query: 267 HANGIMHRDLKPENILLDADGHV 289
               ++HRDL   N L+  +  +
Sbjct: 121 EEACVIHRDLAARNCLVGENQVI 143

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 61.5 bits (150), Expect = 3e-11
 Identities = 30/143 (20%), Positives = 61/143 (42%), Gaps = 9/143 (6%)

Query: 153 EVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +V+G+G F  VY   +      +I+ A+K +          ++++ +E  I+    H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 85

Query: 210 PFIVQLR-YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P ++ L     +++    +VL ++  G L  F +        +DL      ++   + +L
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMKYL 144

Query: 267 HANGIMHRDLKPENILLDADGHV 289
            +   +HRDL   N +LD    V
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTV 167

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 61.6 bits (150), Expect = 4e-11
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 9/146 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + ++ +G+G F KV          GT E+ A+K ++ D    ++ + + + E +IL 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQ-EIDILR 88

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            + H  I++ +          L LV+++V  G L   L R  +    L  ++  +I   +
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-LLFAQQICEGM 147

Query: 264 SHLHANGIMHRDLKPENILLDADGHV 289
           ++LHA   +HRDL   N+LLD D  V
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLV 173

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 61.5 bits (150), Expect = 4e-11
 Identities = 30/152 (19%), Positives = 62/152 (40%), Gaps = 20/152 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILT 205
           + +     VG GA+  V       + E  A+K     K+      +  A+    E  +L 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----KLSRPFQSEIFAKRAYRELLLLK 78

Query: 206 KVDHPFIVQLRYSFQTKYR------LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAE 258
            + H  ++ L   F            YLV+ F+        ++       E+  +    +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQ---KIMGLKF-SEEKIQYLVYQ 134

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           ++  + ++H+ G++HRDLKP N+ ++ D  ++
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELK 166

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 61.1 bits (149), Expect = 5e-11
 Identities = 32/152 (21%), Positives = 66/152 (43%), Gaps = 17/152 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
               + K++G+G F  V +  +++   + +  A+K M+ D   ++   E++ SE   +  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL-SEAACMKD 92

Query: 207 VDHPFIVQL-----RYSFQTKYRLYLVLDFVNGGHL--FFQLYR-----QGLFREDLARI 254
             HP +++L       S Q   +  ++L F+  G L  +    R     + +  + L + 
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
              +I   + +L     +HRDL   N +L  D
Sbjct: 153 -MVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 61.6 bits (150), Expect = 6e-11
 Identities = 32/143 (22%), Positives = 65/143 (45%), Gaps = 10/143 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +  +       +E N++  + H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEA----FLAEANVMKTLQH 242

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVSAVSHL 266
             +V+L ++  TK  +Y++ +F+  G L   L            L    +A+I   ++ +
Sbjct: 243 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-SAQIAEGMAFI 300

Query: 267 HANGIMHRDLKPENILLDADGHV 289
                +HRDL+  NIL+ A    
Sbjct: 301 EQRNYIHRDLRAANILVSASLVC 323

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 60.8 bits (148), Expect = 8e-11
 Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 10/146 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
            +  + KVVG G F +V    ++     EI  A+K ++     EK   +++  E +I+ +
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLG-EASIMGQ 102

Query: 207 VDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            DHP I++L     TK + + +V +++  G L  F + +        L  +    I S +
Sbjct: 103 FDHPNIIRL-EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM-LRGIASGM 160

Query: 264 SHLHANGIMHRDLKPENILLDADGHV 289
            +L   G +HRDL   NIL++++   
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVC 186

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 60.3 bits (147), Expect = 9e-11
 Identities = 36/143 (25%), Positives = 75/143 (52%), Gaps = 10/143 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+  +LK +G G F  V   +  G  ++ A+K++++   M ++  E+ + E   + K+ H
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGS-MSED--EFFQ-EAQTMMKLSH 62

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +V+  Y   +K   +Y+V ++++ G L  + + + +GL    L  +   ++   ++ L
Sbjct: 63  PKLVKF-YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGMAFL 120

Query: 267 HANGIMHRDLKPENILLDADGHV 289
            ++  +HRDL   N L+D D  V
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCV 143

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 60.4 bits (147), Expect = 9e-11
 Identities = 35/146 (23%), Positives = 65/146 (44%), Gaps = 10/146 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILT 205
            +   LKV+G G F  V++   +    + +I   +KV+ +DK   ++           + 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT-DHMLAIG 70

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            +DH  IV+L         L LV  ++  G L    + +R  L  + L   +  +I   +
Sbjct: 71  SLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN-WGVQIAKGM 128

Query: 264 SHLHANGIMHRDLKPENILLDADGHV 289
            +L  +G++HR+L   N+LL +   V
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQV 154

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 59.9 bits (146), Expect = 1e-10
 Identities = 35/143 (24%), Positives = 73/143 (51%), Gaps = 10/143 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++   M ++  E+++ E  ++  + H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGS-MSED--EFIE-EAKVMMNLSH 78

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 79  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 136

Query: 267 HANGIMHRDLKPENILLDADGHV 289
            +   +HRDL   N L++  G V
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVV 159

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 32/146 (21%), Positives = 68/146 (46%), Gaps = 10/146 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
               + K++G G   +V    +R  G  ++  A+K ++     E+   +++  E +I+ +
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLS-EASIMGQ 106

Query: 207 VDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            DHP I++L     T+ R   +V +++  G L  F + +        L  +    + + +
Sbjct: 107 FDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM-LRGVGAGM 164

Query: 264 SHLHANGIMHRDLKPENILLDADGHV 289
            +L   G +HRDL   N+L+D++   
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVC 190

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 35/143 (24%), Positives = 70/143 (48%), Gaps = 10/143 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E   +   +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 238

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR-QGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y+  ++  +Y+V ++++ G L  F +    + L    L  +  A+I S ++++
Sbjct: 239 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYV 296

Query: 267 HANGIMHRDLKPENILLDADGHV 289
                +HRDL+  NIL+  +   
Sbjct: 297 ERMNYVHRDLRAANILVGENLVC 319

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 60.2 bits (146), Expect = 1e-10
 Identities = 30/143 (20%), Positives = 60/143 (41%), Gaps = 9/143 (6%)

Query: 153 EVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +V+G+G F  VY   +      +I+ A+K +          ++++ +E  I+    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 149

Query: 210 PFIVQLR-YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P ++ L     +++    +VL ++  G L  F +        +DL      ++   +  L
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMKFL 208

Query: 267 HANGIMHRDLKPENILLDADGHV 289
            +   +HRDL   N +LD    V
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTV 231

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 36/138 (26%), Positives = 66/138 (47%), Gaps = 8/138 (5%)

Query: 156 KVVGQGAFAKVYQ-VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
             +G G F  V Q V R+   +I  A+KV+++    + +  E M+ E  I+ ++D+P+IV
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMR-EAQIMHQLDNPYIV 399

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +L         L LV++   GG L  F    R+ +   ++A     ++   + +L     
Sbjct: 400 RL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMKYLEEKNF 457

Query: 272 MHRDLKPENILLDADGHV 289
           +HR+L   N+LL    + 
Sbjct: 458 VHRNLAARNVLLVNRHYA 475

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 48/229 (20%), Positives = 93/229 (40%), Gaps = 22/229 (9%)

Query: 67  VYDQPAVIHSRSHSLVGPSSYVSQSLK---LSKLTLHEAEDSLGLVEGINEETQEGPNNL 123
           +  +  V H R ++      YVS   +   L++L  H +  + GL+             L
Sbjct: 145 LRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLI-----------TTL 193

Query: 124 SVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM 183
                   KPT +  +   +   +   D  +   +G G + +VY+      S   A+K +
Sbjct: 194 HYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 253

Query: 184 RKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL-- 241
           ++D +  +        E  ++ ++ HP +VQL      +   Y++ +F+  G+L   L  
Sbjct: 254 KEDTMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 309

Query: 242 -YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
             RQ +    L  +   +I SA+ +L     +HR+L   N L+  +  V
Sbjct: 310 CNRQEVSAVVLLYM-ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV 357

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 18/152 (11%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNIL 204
           L+ ++ LK +G GA   V            A+K     K+      + HA+    E  ++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVLM 78

Query: 205 TKVDHPFIVQLRYSFQTKYR------LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
             V+H  I+ L   F  +        +Y+V++ +       Q+ +  L   +       +
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLCQVIQMEL-DHERMSYLLYQ 135

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           ++  + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 30/142 (21%), Positives = 60/142 (42%), Gaps = 14/142 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKV-D 208
           F + + +G G+F ++Y    I T+E  A+K       +E    ++  +  E  I   +  
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLLYESKIYRILQG 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
              I  +R+         LV+D +  +   LF    R+         +   ++++ V  +
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFV 119

Query: 267 HANGIMHRDLKPENILLDADGH 288
           H+   +HRD+KP+N L+     
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRR 141

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 31/148 (20%), Positives = 63/148 (42%), Gaps = 15/148 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIY-------AMKVMRKDKIMEKNHAEYMKSERN 202
           ED    + +GQG F K+++  R    +          +KV+ K      N++E      +
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAAS 64

Query: 203 ILTKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEI 259
           +++K+ H  +V   Y          LV +FV  G L  + +  +  +       +   ++
Sbjct: 65  MMSKLSHKHLVLN-YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-AKQL 122

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADG 287
            +A+  L  N ++H ++  +NILL  + 
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREE 150

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 36/163 (22%), Positives = 68/163 (41%), Gaps = 41/163 (25%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILT 205
             DF++  ++G+GA+  V       T EI A+K     KI   +   +      E  IL 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKILK 64

Query: 206 KVDHPFIVQLRYSFQTKYR-----LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
              H  I+ +    +         +Y++ +               L + DL R+ + +++
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQE---------------LMQTDLHRVISTQML 109

Query: 261 S-------------AVSHLHANGIMHRDLKPENILLDADGHVR 290
           S             AV  LH + ++HRDLKP N+L++++  ++
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK 152

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 58.8 bits (143), Expect = 3e-10
 Identities = 37/145 (25%), Positives = 69/145 (47%), Gaps = 9/145 (6%)

Query: 150 EDFEVLKVV-GQGAFAKVYQ-VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ++  +  +  G G F  V Q V R+   +I  A+KV+++    + +  E M+ E  I+ +
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMR-EAQIMHQ 66

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
           +D+P+IV+L         L LV++   GG L  F    R+ +   ++A     ++   + 
Sbjct: 67  LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMK 124

Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           +L     +HRDL   N+LL    + 
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYA 149

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 35/143 (24%), Positives = 70/143 (48%), Gaps = 10/143 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E   +   +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 321

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQ-LYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y+  ++  +Y+V ++++ G L  F +    + L    L  +  A+I S ++++
Sbjct: 322 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYV 379

Query: 267 HANGIMHRDLKPENILLDADGHV 289
                +HRDL+  NIL+  +   
Sbjct: 380 ERMNYVHRDLRAANILVGENLVC 402

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 58.8 bits (143), Expect = 4e-10
 Identities = 32/150 (21%), Positives = 61/150 (40%), Gaps = 17/150 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTK 206
             +  L  +G+GA+  V            A+K     KI    H  Y +    E  IL +
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 81

Query: 207 VDHPFIVQLRYSFQTKYR-----LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIV 260
             H  I+ +    +         +Y+V D +    +   +L +      D    +  +I+
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY---KLLKTQHLSNDHICYFLYQIL 138

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
             + ++H+  ++HRDLKP N+LL+    ++
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLK 168

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 58.1 bits (141), Expect = 6e-10
 Identities = 35/152 (23%), Positives = 63/152 (41%), Gaps = 19/152 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILT 205
             +  L+ VG GA+  V       T    A+K     K+      +  A+    E  +L 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLK 79

Query: 206 KVDHPFIVQLRYSFQTKYR------LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAE 258
            + H  ++ L   F            YLV+ F+        +L +     ED  +    +
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG---KLMKHEKLGEDRIQFLVYQ 136

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
           ++  + ++HA GI+HRDLKP N+ ++ D  ++
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELK 168

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 56.8 bits (138), Expect = 1e-09
 Identities = 30/143 (20%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++++ +G G F +V+     G +++ A+K +++   M     +   +E N++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGS-MSP---DAFLAEANLMKQLQH 67

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFR-EDLARIYTAEIVSAVSHL 266
             +V+L Y+  T+  +Y++ +++  G L  F +           L  +  A+I   ++ +
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM-AAQIAEGMAFI 125

Query: 267 HANGIMHRDLKPENILLDADGHV 289
                +HRDL+  NIL+      
Sbjct: 126 EERNYIHRDLRAANILVSDTLSC 148

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 33/165 (20%), Positives = 67/165 (40%), Gaps = 43/165 (26%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----EKNHAEYMKSERNIL 204
            +++ +  ++G+G++  VY      T +  A+K     K+     +    + +  E  IL
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILREITIL 79

Query: 205 TKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE- 258
            ++   +I++L              LY+VL+  +                DL +++    
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD---------------SDLKKLFKTPI 124

Query: 259 -------------IVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
                        ++   + +H +GI+HRDLKP N LL+ D  V+
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVK 169

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 26/152 (17%), Positives = 53/152 (34%), Gaps = 21/152 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS--------EIYAMKVMRKD-------KIMEKNHAEY 196
           +++     +     +Y+     T         + +++K+  KD          ++     
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 197 MKSERNILTKVDHPFIVQLRYS--FQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
             ++   L       I         Q KYR +LVL  + G  L     +  + +  E   
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL-GRSLQSALDVSPKHVLSERSV 161

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
                 ++ A+  LH N  +H ++  ENI +D
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVD 193

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 34/143 (23%), Positives = 66/143 (46%), Gaps = 8/143 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D  +   +G G + +VY+      S   A+K +++D  ME    E++  E  ++ ++ H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVE--EFL-KEAAVMKEIKH 68

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +VQL     T+    Y++ +F+  G+L  + +   +      +      +I SA+ +L
Sbjct: 69  PNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127

Query: 267 HANGIMHRDLKPENILLDADGHV 289
                +HRDL   N L+  +  V
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLV 150

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 56.1 bits (136), Expect = 2e-09
 Identities = 35/145 (24%), Positives = 68/145 (46%), Gaps = 14/145 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ ++L+ +G+G F  V      G     A+K ++ D   +        +E +++T++ H
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQLRH 73

Query: 210 PFIVQLRYS--FQTKYRLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVS 264
             +VQL      + K  LY+V +++  G L   L    R  L  + L +  + ++  A+ 
Sbjct: 74  SNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAME 131

Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           +L  N  +HRDL   N+L+  D   
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVA 156

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 56.1 bits (136), Expect = 2e-09
 Identities = 31/155 (20%), Positives = 67/155 (43%), Gaps = 25/155 (16%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTK 206
              +  LK +G G    V+        +  A+K     KI+  +    ++   E  I+ +
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRR 64

Query: 207 VDHPFIVQLR--------------YSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDL 251
           +DH  IV++                S      +Y+V +++         +  QG   E+ 
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA---NVLEQGPLLEEH 121

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
           AR++  +++  + ++H+  ++HRDLKP N+ ++ +
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE 156

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 33/152 (21%), Positives = 68/152 (44%), Gaps = 18/152 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           ++  +++ +G GAF +VY+     +    +    A+K +  +   E++  +++  E  I+
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALII 87

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR------QGLFREDLARIY 255
           +K +H  IV+       +    +++++ + GG L  F +  R        L   DL  + 
Sbjct: 88  SKFNHQNIVRC-IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV- 145

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADG 287
             +I     +L  N  +HRD+   N LL   G
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 36/149 (24%), Positives = 63/149 (42%), Gaps = 17/149 (11%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTKV 207
           ++ L  VG GA+  V       T    A+K     K+        HA+    E  +L  +
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-----KLSRPFQSIIHAKRTYRELRLLKHM 85

Query: 208 DHPFIVQLRYSFQTKYR------LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            H  ++ L   F           +YLV   + G  L   +  Q L  +D  +    +I+ 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKL-TDDHVQFLIYQILR 143

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVR 290
            + ++H+  I+HRDLKP N+ ++ D  ++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELK 172

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 36/145 (24%), Positives = 69/145 (47%), Gaps = 14/145 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T++ H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKND-----ATAQAFLAEASVMTQLRH 245

Query: 210 PFIVQLRY--SFQTKYRLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVS 264
             +VQL      + K  LY+V +++  G L   L    R  L  + L +  + ++  A+ 
Sbjct: 246 SNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAME 303

Query: 265 HLHANGIMHRDLKPENILLDADGHV 289
           +L  N  +HRDL   N+L+  D   
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVA 328

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 55.7 bits (135), Expect = 3e-09
 Identities = 28/147 (19%), Positives = 59/147 (40%), Gaps = 11/147 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
                 +V+G+G F  VY         + I  A+K +       +    ++  E  ++  
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFL-REGLLMRG 78

Query: 207 VDHPFIVQLRY--SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
           ++HP ++ L        +   +++L ++  G L  F +  ++    +DL      ++   
Sbjct: 79  LNHPNVLAL-IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF-GLQVARG 136

Query: 263 VSHLHANGIMHRDLKPENILLDADGHV 289
           + +L     +HRDL   N +LD    V
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESFTV 163

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 55.8 bits (135), Expect = 4e-09
 Identities = 29/156 (18%), Positives = 68/156 (43%), Gaps = 19/156 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           E   + + +GQG+F  VY+     V +       A+K    +    +   E++ +E +++
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIEFL-NEASVM 82

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYT----- 256
            + +   +V+L     ++ +   ++++ +  G L  + +  R  +    +    +     
Sbjct: 83  KEFNCHHVVRL-LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 257 ---AEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
               EI   +++L+AN  +HRDL   N ++  D  V
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 54.9 bits (133), Expect = 7e-09
 Identities = 37/142 (26%), Positives = 68/142 (47%), Gaps = 12/142 (8%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +F+   ++G G F KVY+      +++ A+K    +    +   E+ ++E   L+   HP
Sbjct: 40  NFDHKFLIGHGVFGKVYKGVLRDGAKV-ALKRRTPES--SQGIEEF-ETEIETLSFCRHP 95

Query: 211 FIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTAEIVSA--VS 264
            +V L  +  +    + L+  ++  G+L   LY   L    +    R+    I +A  + 
Sbjct: 96  HLVSLIGFCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC-IGAARGLH 153

Query: 265 HLHANGIMHRDLKPENILLDAD 286
           +LH   I+HRD+K  NILLD +
Sbjct: 154 YLHTRAIIHRDVKSINILLDEN 175

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 54.7 bits (132), Expect = 9e-09
 Identities = 35/153 (22%), Positives = 68/153 (44%), Gaps = 18/153 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNIL 204
           ++  +++ +G GAF +VY+  V  +         A+K +  +   E++  +++  E  I+
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALII 128

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR------QGLFREDLARIY 255
           +K +H  IV+       +    +++L+ + GG L  F +  R        L   DL  + 
Sbjct: 129 SKFNHQNIVRC-IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV- 186

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
             +I     +L  N  +HRD+   N LL   G 
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 219

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 54.7 bits (132), Expect = 9e-09
 Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 46/165 (27%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNIL 204
           L  +E++K +G+GA+  V++     T E+ A+K     KI +       A+    E  IL
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRTFREIMIL 62

Query: 205 TK-VDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           T+   H  IV L       + +    +YLV D++                 DL  +  A 
Sbjct: 63  TELSGHENIVNLLNVLRADNDRD---VYLVFDYME---------------TDLHAVIRAN 104

Query: 259 IVS-------------AVSHLHANGIMHRDLKPENILLDADGHVR 290
           I+               + +LH+ G++HRD+KP NILL+A+ HV+
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVK 149

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 31/164 (18%), Positives = 55/164 (33%), Gaps = 34/164 (20%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---------- 199
             + V + +  G++  V            A+K     ++          +          
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVD-SEGIPVAIK-----RVFNTVSDGRTVNILSDSFLCKR 75

Query: 200 ---ERNILTKVDHPFIVQLRYSFQTKYR-----LYLVLDFVNGGHLFFQLYR-----QGL 246
              E  +L    HP I+ LR  F          LYLV + +        L +     + +
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQRIV 130

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
                 + +   I+  +  LH  G++HRDL P NILL  +  + 
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 53.4 bits (129), Expect = 2e-08
 Identities = 43/185 (23%), Positives = 70/185 (37%), Gaps = 40/185 (21%)

Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V +     + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63

Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRY--SFQTKYRLYLVLDFVNGGHL- 237
            M K+      H   M SE  IL  +  H  +V L      +    L ++++F   G+L 
Sbjct: 64  -MLKEGATHSEHRALM-SELKILIHIGHHLNVVNL-LGACTKPGGPLMVIVEFCKFGNLS 120

Query: 238 ----------------FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI 281
                              LY+  L  E L    + ++   +  L +   +HRDL   NI
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHRDLAARNI 179

Query: 282 LLDAD 286
           LL   
Sbjct: 180 LLSEK 184

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 26/151 (17%), Positives = 56/151 (37%), Gaps = 22/151 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKD--------KIMEKNHAEYMKSE 200
           + + K +G G F  +Y        E    + +KV  ++        K  ++   +    +
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 201 RNILTKVDHPFIVQLRYS-----FQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLAR 253
                ++D+  I     S         YR ++V++ + G  L           F++    
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYR-FMVMERL-GIDLQKISGQNGT--FKKSTVL 154

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
                ++  + ++H N  +H D+K  N+LL 
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLG 185

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 27/165 (16%), Positives = 56/165 (33%), Gaps = 47/165 (28%)

Query: 152 FEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKD--------KIMEKNHAEYMK 198
           ++V   +GQG F  +Y         +G+     +KV   D        K  ++       
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 199 SERNILTKVDHPFIVQLRYS-----FQTKYRLYLVLD---------FVNGGHLF-----F 239
            +     K+ +  + +   S         YR ++++D         +      F      
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR-FMIMDRFGSDLQKIYEANAKRFSRKTVL 155

Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
           QL  +              I+  + ++H +  +H D+K  N+LL+
Sbjct: 156 QLSLR--------------ILDILEYIHEHEYVHGDIKASNLLLN 186

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 52.3 bits (126), Expect = 5e-08
 Identities = 36/157 (22%), Positives = 66/157 (42%), Gaps = 23/157 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            D +   V+G+G F +V +  +++ G     A+K   K+   + +H ++   E  +L K+
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFA-GELEVLCKL 82

Query: 208 -DHPFIVQLR-YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYT------- 256
             HP I+ L        Y LYL +++   G+L  F +  R        A   +       
Sbjct: 83  GHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 257 -------AEIVSAVSHLHANGIMHRDLKPENILLDAD 286
                  A++   + +L     +HRDL   NIL+  +
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 35/165 (21%), Positives = 72/165 (43%), Gaps = 28/165 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNI 203
           +   + K +G+GAF +V     V         A+ V   M KD   EK+ ++ + SE  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 93

Query: 204 LTKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR---------------Q 244
           +  +  H  I+ L     T+   LY+++++ + G+L  + +  R               +
Sbjct: 94  MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
            +  +DL    T ++   + +L +   +HRDL   N+L+  +  +
Sbjct: 153 QMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVM 196

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 36/167 (21%), Positives = 65/167 (38%), Gaps = 33/167 (19%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
           ++  + K +G+G F KV +              V   M K+        + + SE N+L 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEFNVLK 81

Query: 206 KVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR------------------- 243
           +V+HP +++L Y   ++   L L++++   G L  F +  R                   
Sbjct: 82  QVNHPHVIKL-YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 244 ----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
               + L   DL      +I   + +L    ++HRDL   NIL+   
Sbjct: 141 HPDERALTMGDLISF-AWQISQGMQYLAEMKLVHRDLAARNILVAEG 186

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 33/159 (20%), Positives = 59/159 (37%), Gaps = 26/159 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNIL 204
            + +  K +G GAF KV +     +G  +   +KV   M K           M SE  I+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKED-AVLKVAVKMLKSTAHADEKEALM-SELKIM 103

Query: 205 TKVD-HPFIVQLRYSFQTKYR-LYLVLDFVNGGHL---------------FFQLYRQGLF 247
           + +  H  IV L     T    + ++ ++   G L                F +      
Sbjct: 104 SHLGQHENIVNL-LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
             DL    ++++   ++ L +   +HRD+   N+LL   
Sbjct: 163 TRDLLHF-SSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 50.2 bits (121), Expect = 2e-07
 Identities = 33/144 (22%), Positives = 54/144 (37%), Gaps = 26/144 (18%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDHPFIVQ 214
            +G+G F  VY+     T    A+K +     +       ++   E  ++ K  H  +V+
Sbjct: 38  KMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQF-DQEIKVMAKCQHENLVE 94

Query: 215 LR-YSFQTKYRLYLVLDFV-NG---GHLFFQLYRQGL-----FR--EDLARIYTAEIVSA 262
           L  +S        LV  ++ NG     L        L      +  +  A          
Sbjct: 95  LLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------G 145

Query: 263 VSHLHANGIMHRDLKPENILLDAD 286
           ++ LH N  +HRD+K  NILLD  
Sbjct: 146 INFLHENHHIHRDIKSANILLDEA 169

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 34/165 (20%), Positives = 71/165 (43%), Gaps = 28/165 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNI 203
           +   + K +G+G F +V     V         A+ V   M KD   EK+ ++ + SE  +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 139

Query: 204 LTKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR---------------Q 244
           +  +  H  I+ L     T+   LY+++++ + G+L  + +  R               +
Sbjct: 140 MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
            +  +DL    T ++   + +L +   +HRDL   N+L+  +  +
Sbjct: 199 QMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVM 242

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 49.6 bits (119), Expect = 3e-07
 Identities = 36/161 (22%), Positives = 52/161 (32%), Gaps = 26/161 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
                 K +G GAF KV +    G      AM V   M K           M SE  +L+
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81

Query: 206 KV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL----------FFQLYRQGLFREDLAR 253
            + +H  IV L     T      ++ ++   G L          F          ED   
Sbjct: 82  YLGNHMNIVNL-LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 254 IYT--------AEIVSAVSHLHANGIMHRDLKPENILLDAD 286
                       ++   ++ L +   +HRDL   NILL   
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 33/162 (20%), Positives = 65/162 (40%), Gaps = 28/162 (17%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNI 203
           +   + K +G+GAF +V     +           KV   M K    EK+ ++ + SE  +
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEM 127

Query: 204 LTKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL-----------------FFQLYRQ 244
           +  +  H  I+ L     T+   LY+++++ + G+L                       +
Sbjct: 128 MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
            L  +DL      ++   + +L +   +HRDL   N+L+  D
Sbjct: 187 QLSSKDLVSC-AYQVARGMEYLASKKCIHRDLAARNVLVTED 227

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 32/162 (19%), Positives = 63/162 (38%), Gaps = 25/162 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
                ++ +G+  F KVY+    G +       V     KDK       E+   E  +  
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRA 67

Query: 206 KVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL-----------------FFQLYRQGLF 247
           ++ HP +V L     TK + L ++  + + G L                   +  +  L 
Sbjct: 68  RLQHPNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
             D   +  A+I + + +L ++ ++H+DL   N+L+    +V
Sbjct: 127 PPDFVHL-VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 167

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 46.9 bits (112), Expect = 3e-06
 Identities = 31/171 (18%), Positives = 66/171 (38%), Gaps = 35/171 (20%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
            + E ++ +G+GAF +V+Q     +       + A+K M K++      A++   E  ++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQ-REAALM 104

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL-------------------------F 238
            + D+P IV+L        + + L+ +++  G L                          
Sbjct: 105 AEFDNPNIVKL-LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
                  L   +   I   ++ + +++L     +HRDL   N L+  +  V
Sbjct: 164 SSPGPPPLSCAEQLCI-ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 213

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 46.1 bits (110), Expect = 6e-06
 Identities = 42/168 (25%), Positives = 64/168 (38%), Gaps = 35/168 (20%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           E+ E  KV+G GAF KV       + + G S   A+K M K+K         M SE  ++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-MLKEKADSSEREALM-SELKMM 102

Query: 205 TKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR----------------- 243
           T++  H  IV L     T    +YL+ ++   G L  + +  R                 
Sbjct: 103 TQLGSHENIVNL-LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 244 -----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
                  L  EDL      ++   +  L     +HRDL   N+L+   
Sbjct: 162 EEEDLNVLTFEDLLCF-AYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 208

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 45.8 bits (109), Expect = 7e-06
 Identities = 31/162 (19%), Positives = 63/162 (38%), Gaps = 27/162 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNIL 204
            D  +   +G+GAF KV+      +   +     A+K +++     +   ++   E  +L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ--DFQ-REAELL 97

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL----------------FFQLYRQGLF 247
           T + H  IV+  +   T+ R L +V +++  G L                   +    L 
Sbjct: 98  TMLQHQHIVRF-FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
              L  +  +++ + + +L     +HRDL   N L+     V
Sbjct: 157 LGQLLAV-ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 26/162 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGT-SEIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
            D  + + +G+GAF KV+             M V     KD  +     ++ + E  +LT
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQR-EAELLT 72

Query: 206 KVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR---------------QGLF 247
            + H  IV+  Y        L +V +++  G L  F + +                  L 
Sbjct: 73  NLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
              +  I  ++I S + +L +   +HRDL   N L+ A+  V
Sbjct: 132 LSQMLHI-ASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 172

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 44.9 bits (107), Expect = 1e-05
 Identities = 38/146 (26%), Positives = 75/146 (51%), Gaps = 14/146 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++F    ++G+G F KVY+ R    + + A+K + K++  +    ++ ++E  +++   H
Sbjct: 30  DNFSNKNILGRGGFGKVYKGRLADGTLV-AVKRL-KEERTQGGELQF-QTEVEMISMAVH 86

Query: 210 PFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTAEIVSA--V 263
             +++LR +      RL LV  ++  G +   L  +   +  L    R   A + SA  +
Sbjct: 87  RNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LGSARGL 144

Query: 264 SHLH--AN-GIMHRDLKPENILLDAD 286
           ++LH   +  I+HRD+K  NILLD +
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEE 170

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.1 bits (96), Expect = 2e-04
 Identities = 30/149 (20%), Positives = 55/149 (36%), Gaps = 13/149 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +  ++ K +G+GAF +V +     + +  T    A+K M K+      H   M  E  IL
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMS-ELKIL 79

Query: 205 TKVD-HPFIVQ-LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
             +  H  +V  L    +    L ++++F   G+L   L      + +    Y  +    
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVPYKTKGARF 135

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVRS 291
                  G +  DLK     + +     S
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSAS 164

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	291
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.97
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.97
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.97
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.97
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.96
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.96
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.96
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.96
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.96
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.95
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.95
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.95
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.95
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.95
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.95
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.95
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.95
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.95
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.95
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.95
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.94
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.94
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.94
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.94
3niz_A	311	Rhodanese family protein; structural genomics, str	99.94
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.94
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.94
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.94
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.94
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.94
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.94
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.94
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.94
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.94
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.94
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.94
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.94
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.94
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.94
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.94
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.94
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.94
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.94
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.94
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.94
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.94
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.94
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.94
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.94
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.94
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.94
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.94
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.94
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.94
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.94
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.94
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.94
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.94
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.94
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.94
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.94
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.94
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.94
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.94
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.94
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.94
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.94
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.94
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.94
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.94
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.94
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.94
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.93
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.93
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.93
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.93
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.93
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.93
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.93
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.93
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.93
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.93
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.93
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.93
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.93
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.93
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.93
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.93
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.93
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.93
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.93
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.93
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.93
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.93
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.93
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.93
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.93
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.93
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.93
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.93
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.93
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.93
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.93
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.93
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.93
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.93
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.93
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.93
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.93
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.93
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.93
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.93
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.93
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.93
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.93
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.93
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.93
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.93
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.93
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.93
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.92
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.92
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.92
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.92
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.92
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.92
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.92
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.92
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.92
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.92
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.92
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.92
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.92
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.92
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.92
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.92
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.92
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.92
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.92
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.92
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.92
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.92
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.92
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.92
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.92
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.91
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.91
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.91
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.91
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.91
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.91
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.91
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.91
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.91
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.91
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.91
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.91
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.91
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.91
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.9
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.9
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.9
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.9
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.89
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.88
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.85
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.06
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.97
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.5
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.39
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.32
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.98
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.95
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.66
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.54
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.34
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.21
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.03
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.83
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.25
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.25
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.53
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.47
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.43
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	94.96
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.73
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	94.66
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.01
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	84.57
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.33

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.5e-38  Score=284.12  Aligned_cols=144  Identities=43%  Similarity=0.783  Sum_probs=135.5

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+.+|+.+|++++|||||+++++|++++.+|
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34568999999999999999999999999999999998776555555778999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|+||
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vK  172 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQ  172 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEE
Confidence            9999999999999999999999999999999999999999999999999999999999999886

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.7e-36  Score=275.52  Aligned_cols=142  Identities=34%  Similarity=0.596  Sum_probs=125.3

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      .+++|++++.||+|+||+||+|+++.+++.||||++.+..... ...+.+.+|+.+|++++|||||+++++|++++.+||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            4679999999999999999999999999999999998776543 346778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||||+||+|.+++..+  ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|+||
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vK  165 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQ  165 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEE
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEE
Confidence            99999999999999764  3578999999999999999999999999999999999999999987

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.4e-36  Score=267.47  Aligned_cols=141  Identities=30%  Similarity=0.526  Sum_probs=124.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++.+.||+|+||.||+|++..+++.||+|++++.........+.+.+|+.+|++++||||++++++|.+++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            46899999999999999999999999999999999887665555567789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||| +|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vk  152 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK  152 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEE
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEE
Confidence            9999 679999999999999999999999999999999999999999999999999999886

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.7e-35  Score=269.01  Aligned_cols=137  Identities=26%  Similarity=0.414  Sum_probs=126.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+.....   .+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46999999999999999999999999999999997654332   345788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|+||
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vK  210 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK  210 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEE
Confidence            99999999988865 5689999999999999999999999999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.3e-35  Score=266.85  Aligned_cols=141  Identities=50%  Similarity=0.896  Sum_probs=123.7

Q ss_pred             cCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .++|++++.||+|+||+||+|++.   .+++.||+|++++......+ ...+.+|+.+|++++|||||+++++|++++.+
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            357999999999999999999984   46789999999876543322 23567899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++|
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vK  166 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIK  166 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEE
Confidence            99999999999999999999999999999999999999999999999999999999999999886

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-34  Score=265.06  Aligned_cols=135  Identities=24%  Similarity=0.347  Sum_probs=126.0

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..+.|++.++||+|+||.||+|+++.+++.||||++++....        .+|+.+++.++|||||+++++|.+++.+||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456799999999999999999999999999999999875432        369999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC-CcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g-~vK  290 (291)
                      |||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++|
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vK  191 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAA  191 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEE
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEE
Confidence            999999999999999989999999999999999999999999999999999999999987 465

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.5e-34  Score=270.43  Aligned_cols=138  Identities=26%  Similarity=0.405  Sum_probs=127.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .+.|++++.||+|+||.||+|+++.+|+.||||++.......   .+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            357999999999999999999999999999999997654332   34578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|+||
T Consensus       227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vK  287 (423)
T 4fie_A          227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK  287 (423)
T ss_dssp             EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEE
T ss_pred             EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEE
Confidence            999999999988765 5689999999999999999999999999999999999999999987

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-33  Score=254.00  Aligned_cols=138  Identities=28%  Similarity=0.442  Sum_probs=125.3

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe----CCEEEE
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRLYL  227 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~l  227 (291)
                      |++.+.||+|+||+||+|.+..+++.||+|++.+.... ....+.+.+|+.+|++++|||||+++++|.+    +..+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            47888999999999999999999999999999876543 3346778999999999999999999999875    356899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecccCCCcEEecC-CCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDA-DGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKp~NILl~~-~g~vK  290 (291)
                      |||||+||+|..++.+.+.+++..++.|+.||+.||+|||++|  ||||||||+||||+. +|++|
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vK  172 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK  172 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEE
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEE
Confidence            9999999999999999999999999999999999999999998  999999999999985 78876

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8e-34  Score=256.47  Aligned_cols=139  Identities=29%  Similarity=0.445  Sum_probs=121.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC------
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY------  223 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------  223 (291)
                      ++|++++.||+|+||.||+|+++.+++.||||+++...  .....+.+.+|+.+|++++|||||+++++|.+.+      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            57999999999999999999999999999999997653  2334567889999999999999999999987544      


Q ss_pred             ------EEEEEEeccCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 ------RLYLVLDFVNGGHLFFQLYRQGLF---REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ------~~~lV~E~~~gg~L~~~l~~~~~~---~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                            .+|+|||||+||+|.+++...+.+   .+..++.|+.||+.||+|||++|||||||||+|||++.+|++|
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEE
Confidence                  479999999999999999876554   3466888999999999999999999999999999999999886

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-33  Score=255.43  Aligned_cols=142  Identities=20%  Similarity=0.307  Sum_probs=125.3

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  220 (291)
                      .+..++|.+.+.||+|+||+||+|++..     ++..||||+++...   ....+.+.+|+.+|++++|||||++++++.
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            4556789999999999999999998753     57889999997543   344667899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQ-------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~-------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      +++.+|||||||++|+|.+++.+.             ..+++..+..++.||+.||+|||+++||||||||+||||+.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999999999999764             3589999999999999999999999999999999999999999


Q ss_pred             CcC
Q 022853          288 HVR  290 (291)
Q Consensus       288 ~vK  290 (291)
                      ++|
T Consensus       166 ~~K  168 (299)
T 4asz_A          166 LVK  168 (299)
T ss_dssp             CEE
T ss_pred             cEE
Confidence            886

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-33  Score=277.15  Aligned_cols=145  Identities=40%  Similarity=0.739  Sum_probs=130.7

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHH---HHHHHhCCCCCeeEEeEEEEeC
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE---RNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E---~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      .+.+++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|   +.+++.++|||||+++++|++.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            5677899999999999999999999999999999999987655433333344444   5566678999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|||||||+||+|..++.+.+.+++..++.|++||+.||+|||++|||||||||+||||+.+|+||
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vK  332 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR  332 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEE
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999987

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.6e-33  Score=253.21  Aligned_cols=143  Identities=20%  Similarity=0.289  Sum_probs=127.2

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF  219 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  219 (291)
                      +.+..++|.+.+.||+|+||+||+|++..     +++.||||+++...   ....+.|.+|+.+|++++|||||++++++
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~  112 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVC  112 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34556789999999999999999998753     57899999997542   34466789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec
Q 022853          220 QTKYRLYLVLDFVNGGHLFFQLYRQ---------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (291)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~---------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~  284 (291)
                      .+...+|||||||++|+|..++.+.               +.+++..+..|+.||+.||+|||+++||||||||+||||+
T Consensus       113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence            9999999999999999999998753               3588999999999999999999999999999999999999


Q ss_pred             CCCCcC
Q 022853          285 ADGHVR  290 (291)
Q Consensus       285 ~~g~vK  290 (291)
                      .++++|
T Consensus       193 ~~~~~K  198 (329)
T 4aoj_A          193 QGLVVK  198 (329)
T ss_dssp             TTTEEE
T ss_pred             CCCcEE
Confidence            999876

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-32  Score=249.80  Aligned_cols=143  Identities=23%  Similarity=0.302  Sum_probs=126.3

Q ss_pred             CCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ..|.+..++|++.+.||+|+||+||+|++..   .||||+++.... .....+.|.+|+.+|++++|||||++++++. +
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~  103 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-K  103 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-C
Confidence            4577888899999999999999999998643   599999975443 3345678999999999999999999999765 4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+|||||||+||+|.+++... +.+++..+..|+.||+.||+|||+++||||||||+||||+.++++|
T Consensus       104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~K  172 (307)
T 3omv_A          104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVK  172 (307)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEE
T ss_pred             CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEE
Confidence            6789999999999999999764 5799999999999999999999999999999999999999998876

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-32  Score=257.53  Aligned_cols=139  Identities=22%  Similarity=0.417  Sum_probs=125.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe------CC
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------KY  223 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~  223 (291)
                      ++|++++.||+|+||.||+|+++.+|+.||||++++.... ....+.+.+|+.+|+.++|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            5799999999999999999999999999999999765433 3345667899999999999999999998764      36


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|||||||+ |+|..++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~K  198 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELK  198 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEE
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEE
Confidence            7999999997 57999998888999999999999999999999999999999999999999999876

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-32  Score=250.09  Aligned_cols=142  Identities=20%  Similarity=0.321  Sum_probs=124.1

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      +...++++.+.||+|+||+||+|.+.     .+++.||||+++...  .....+.|.+|+.++++++|||||++++++.+
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            55678999999999999999999864     356889999997543  22335678999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      +..+|||||||++|+|.+++...                ..+++..+..++.||+.||+|||+++||||||||+||||+.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            99999999999999999999753                35788999999999999999999999999999999999999


Q ss_pred             CCCcC
Q 022853          286 DGHVR  290 (291)
Q Consensus       286 ~g~vK  290 (291)
                      ++++|
T Consensus       181 ~~~~K  185 (308)
T 4gt4_A          181 KLNVK  185 (308)
T ss_dssp             GGCEE
T ss_pred             CCCEE
Confidence            98876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=4.2e-31  Score=243.82  Aligned_cols=145  Identities=22%  Similarity=0.337  Sum_probs=126.0

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCC-CCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~  217 (291)
                      .|.+..++|++.+.||+|+||+||+|.+..++     +.||+|.+.....  ....+.+.+|+.+|.++.| ||||++++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            46778889999999999999999999987643     6799999976542  2335678899999999965 99999999


Q ss_pred             EEEe-CCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCc
Q 022853          218 SFQT-KYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (291)
Q Consensus       218 ~~~~-~~~~~lV~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~N  280 (291)
                      +|.. +..+|||||||++|+|..++...                ..+++..+..|+.||+.||+|||+++||||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            9865 45799999999999999999753                347889999999999999999999999999999999


Q ss_pred             EEecCCCCcC
Q 022853          281 ILLDADGHVR  290 (291)
Q Consensus       281 ILl~~~g~vK  290 (291)
                      ||++.++.+|
T Consensus       216 ILl~~~~~vK  225 (353)
T 4ase_A          216 ILLSEKNVVK  225 (353)
T ss_dssp             EEECGGGCEE
T ss_pred             eeeCCCCCEE
Confidence            9999999886

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=8.4e-31  Score=256.14  Aligned_cols=139  Identities=27%  Similarity=0.524  Sum_probs=126.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++++.||+|+||.||+|+++.+|+.||+|++.+...   ...+.+.+|+.+|+.++||||++++++|.++..+|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            5789999999999999999999999999999999976542   2356688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC--CCcC
Q 022853          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~--g~vK  290 (291)
                      ||||+||+|.+++.+ .+.+++..++.|+.||+.||+|||++||+||||||+|||++.+  |.+|
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vK  297 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELK  297 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEE
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEE
Confidence            999999999998864 4679999999999999999999999999999999999999865  6665

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=1.2e-30  Score=241.60  Aligned_cols=133  Identities=22%  Similarity=0.388  Sum_probs=118.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  225 (291)
                      ++|++.+.||+|+||+||+|+++   .+++.||+|.+.+...     ...+.+|+.+|+.+ +||||++++++|.+.+.+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            57999999999999999999875   4678999999865432     34567899999998 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC-CCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~-g~vK  290 (291)
                      |+|||||+||+|.+++   +.+++..++.|+.||+.||+|||++|||||||||+|||++.+ |.+|
T Consensus        96 ~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~k  158 (361)
T 4f9c_A           96 VIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYA  158 (361)
T ss_dssp             EEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred             EEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEE
Confidence            9999999999998887   358999999999999999999999999999999999999876 6654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.97  E-value=1.9e-30  Score=234.65  Aligned_cols=134  Identities=25%  Similarity=0.353  Sum_probs=115.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC----EE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~  225 (291)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++....    .......|+..+.+++|||||++++++.+++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4699999999999999999988  578999999965431    1222345666677899999999999997654    68


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--------GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~--------gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||||||++|+|.+++.+. .+++..+..++.|++.||+|||++        +||||||||+||||+.+|++|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence            9999999999999998764 578888899999999999999987        999999999999999999886

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.97  E-value=3.9e-30  Score=237.19  Aligned_cols=145  Identities=44%  Similarity=0.810  Sum_probs=132.1

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~  224 (291)
                      .+.+++|++++.||+|+||+||+|++..+++.||+|++++.........+.+..|+.++..+ +||||+++++++.+...
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            35678999999999999999999999999999999999876555555567788999999988 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+||||+.||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ik  164 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK  164 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEE
Confidence            999999999999999999888999999999999999999999999999999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.97  E-value=3.5e-30  Score=236.06  Aligned_cols=144  Identities=45%  Similarity=0.819  Sum_probs=132.9

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +.+++|++++.||+|+||+||+|++..+++.||+|++++.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            34678999999999999999999999999999999998765444444667889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vk  145 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK  145 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEE
Confidence            9999999999999999888999999999999999999999999999999999999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.97  E-value=1.1e-29  Score=233.35  Aligned_cols=144  Identities=44%  Similarity=0.847  Sum_probs=134.9

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  225 (291)
                      +.+++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+...+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            4567899999999999999999999999999999999987666666677888999999988 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~k  150 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK  150 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEE
Confidence            99999999999999999888899999999999999999999999999999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.97  E-value=5.5e-30  Score=239.89  Aligned_cols=146  Identities=42%  Similarity=0.835  Sum_probs=131.9

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCC
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~  223 (291)
                      ..+.+++|++++.||+|+||+||+|+++.+++.||+|++++.........+.+..|..++.++ +||||++++++|.+..
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            345678999999999999999999999999999999999887665555566788899999877 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ik  193 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK  193 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEE
Confidence            9999999999999999999888999999999999999999999999999999999999999999876

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.97  E-value=7.8e-30  Score=234.57  Aligned_cols=146  Identities=36%  Similarity=0.681  Sum_probs=130.8

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCC
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~  223 (291)
                      .....++|++.+.||+|+||.||+|+++.+++.||+|++++.........+.+..|..++..+ +||||+++++++.+..
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            345678999999999999999999999999999999999876543334456677899999876 9999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vk  158 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIK  158 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEE
Confidence            9999999999999999999888899999999999999999999999999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=8.3e-30  Score=231.67  Aligned_cols=143  Identities=38%  Similarity=0.741  Sum_probs=132.4

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      .+++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            45789999999999999999999999999999999987654433446678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~k  146 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIK  146 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEE
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEE
Confidence            999999999999999988999999999999999999999999999999999999999999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=7.4e-30  Score=238.06  Aligned_cols=147  Identities=39%  Similarity=0.745  Sum_probs=136.0

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      ...+..++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+..
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            44567789999999999999999999999999999999998765545455677889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++|
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vk  155 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVH  155 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEE
Confidence            9999999999999999999888999999999999999999999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=3.4e-29  Score=228.53  Aligned_cols=142  Identities=37%  Similarity=0.566  Sum_probs=131.5

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.+.... ....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            456899999999999999999999999999999999876543 3445668899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+++|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~k  154 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIK  154 (328)
T ss_dssp             EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEE
Confidence            999999999999999888999999999999999999999999999999999999999998875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=1.2e-29  Score=235.67  Aligned_cols=146  Identities=49%  Similarity=0.809  Sum_probs=124.3

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHH-HHhCCCCCeeEEeEEEEeCC
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-LTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~~~  223 (291)
                      .....++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+..|..+ ++.++||||++++++|.+..
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            34567899999999999999999999999999999999988766555555566677776 56789999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+.||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ik  179 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV  179 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEE
Confidence            9999999999999999999888899999999999999999999999999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=1.9e-29  Score=232.25  Aligned_cols=144  Identities=38%  Similarity=0.721  Sum_probs=133.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ..+++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            44678999999999999999999999999999999998765444444667889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~k  181 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ  181 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEE
Confidence            9999999999999999888899999999999999999999999999999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=2.1e-29  Score=232.43  Aligned_cols=144  Identities=40%  Similarity=0.756  Sum_probs=131.5

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  225 (291)
                      ..+++|++++.||+|+||+||+|++..+++.||+|++++.........+.+..|..++..+ +||||+++++++.+...+
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            5567999999999999999999999999999999999876544444466778899999887 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vk  161 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK  161 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEE
Confidence            99999999999999999888899999999999999999999999999999999999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.7e-29  Score=237.68  Aligned_cols=144  Identities=41%  Similarity=0.729  Sum_probs=131.2

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +..++|++.+.||+|+||+||+|+++.+++.||+|++++.........+.+.+|+.++..++||||++++++|.+...+|
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            45578999999999999999999999999999999998754444444556788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||++||+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vk  202 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIR  202 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEE
Confidence            999999999999999875 4799999999999999999999999999999999999999999876

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=7.2e-29  Score=222.27  Aligned_cols=143  Identities=23%  Similarity=0.356  Sum_probs=133.4

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            34689999999999999999999999999999999977655556667788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||++|++|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus        89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~k  151 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLK  151 (294)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence            999999999999999888999999999999999999999999999999999999999988775

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.96  E-value=1.9e-29  Score=239.02  Aligned_cols=144  Identities=39%  Similarity=0.734  Sum_probs=130.7

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +..++|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.++..++||||++++++|.+...+|
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            44578999999999999999999999999999999998654333333445788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|||||+||+|..++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vk  215 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR  215 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEE
Confidence            99999999999999987 57899999999999999999999999999999999999999999876

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.96  E-value=2.5e-29  Score=238.85  Aligned_cols=230  Identities=18%  Similarity=0.202  Sum_probs=164.5

Q ss_pred             cCCCCCCCCccccCCccccccccccC--CCeeeecCCccCccCCCcccccccccccccccccccccccccccccccCCCC
Q 022853           44 VFGPAPVQASIEVGGEISYANELVYD--QPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPN  121 (291)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~v~~~~~sl~~p~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~  121 (291)
                      .-|.|.||+|+..+|.++++......  ...+.           ++..+.....++.+.+...+..+.+.+.........
T Consensus        87 ~~G~FLvR~s~~~~g~y~lsv~~~~~~~~~~v~-----------h~~I~~~~~g~~~~~~~~~F~Sl~~Li~~y~~~~~~  155 (452)
T 1fmk_A           87 PRGTFLVRESETTKGAYCLSVSDFDNAKGLNVK-----------HYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADG  155 (452)
T ss_dssp             CTTEEEEEECSSSTTCEEEEEEEEETTTEEEEE-----------EEEEEECTTSCEESSTTSEESSHHHHHHHHTTCCTT
T ss_pred             CCceEEEEeCCCCCCceEEEEEeeccCCCCcEE-----------EEEEEEcCCCCEEEecCcccCCHHHHHHHhhhcccc
Confidence            45999999999999999888764321  12222           333333233334444433344443333333222222


Q ss_pred             CCcccccccCCCCCCCCCCCCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHH
Q 022853          122 NLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER  201 (291)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~  201 (291)
                      ........+..............+.+..++|++.+.||+|+||.||+|.+.. +..||||+++.....    .+.+.+|+
T Consensus       156 l~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~  230 (452)
T 1fmk_A          156 LCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEA  230 (452)
T ss_dssp             SSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHH
T ss_pred             chhhccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHH
Confidence            1111111121111122233455677888899999999999999999999875 456999999765432    35678999


Q ss_pred             HHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCC
Q 022853          202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (291)
Q Consensus       202 ~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~  279 (291)
                      .++++++||||+++++++.+ ..+|+||||+.+|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+
T Consensus       231 ~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~  309 (452)
T 1fmk_A          231 QVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA  309 (452)
T ss_dssp             HHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             HHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChh
Confidence            99999999999999998865 678999999999999999864  356899999999999999999999999999999999


Q ss_pred             cEEecCCCCcC
Q 022853          280 NILLDADGHVR  290 (291)
Q Consensus       280 NILl~~~g~vK  290 (291)
                      |||++.++.+|
T Consensus       310 Nill~~~~~~k  320 (452)
T 1fmk_A          310 NILVGENLVCK  320 (452)
T ss_dssp             GEEECGGGCEE
T ss_pred             hEEECCCCCEE
Confidence            99999888765

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=7.2e-29  Score=222.03  Aligned_cols=141  Identities=15%  Similarity=0.151  Sum_probs=127.2

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++..++||||+++++++.+.+.+|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            33679999999999999999999999999999999987765555666788899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||++|++|..++.+ +. ....+..++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus       109 v~e~~~g~~L~~~l~~-~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~k  169 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT-SP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVV  169 (286)
T ss_dssp             EEECCCEEEHHHHHTT-CC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEE
T ss_pred             EEEecCCCCHHHHHhc-CC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEE
Confidence            9999999999998854 33 5556788999999999999999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.96  E-value=2.9e-29  Score=241.15  Aligned_cols=144  Identities=22%  Similarity=0.315  Sum_probs=130.3

Q ss_pred             CCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ..+.+...+|++.+.||+|+||.||+|.+..++..||||+++.....    .+.+.+|+.+|++++||||+++++++...
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            45667778999999999999999999999988999999999765422    45688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|+||||+.+|+|..++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~k  358 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVK  358 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEE
Confidence            9999999999999999999864  4588899999999999999999999999999999999999888765

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.96  E-value=5.9e-29  Score=236.33  Aligned_cols=230  Identities=18%  Similarity=0.231  Sum_probs=161.8

Q ss_pred             ccCCCCCCCCccccCCccccccccccCC--CeeeecCCccCccCCCcccccccccccccccccccccccccccccccCCC
Q 022853           43 DVFGPAPVQASIEVGGEISYANELVYDQ--PAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP  120 (291)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~v~~~~~sl~~p~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~  120 (291)
                      +.-|.|.||+|+..+|.++.+.......  ..+.|           +........++...+......+.+.+........
T Consensus        91 ~~~G~FLvR~s~~~~g~y~lsv~~~~~~~~~~v~H-----------~~I~~~~~g~~~i~~~~~F~sl~eLv~~y~~~~~  159 (454)
T 1qcf_A           91 NMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKH-----------YKIRTLDNGGFYISPRSTFSTLQELVDHYKKGND  159 (454)
T ss_dssp             CCTTCEEEEECSSSTTSEEEEEEEEETTTEEEEEE-----------EEEEECTTSCEESSSSSCBSSHHHHHHHHTSSCT
T ss_pred             CCCceEEEEECcCCCCeEEEEEEecccCCCCceEE-----------EEEEEcCCCcEEEeCccccCCHHHHHHHHHhccC
Confidence            5679999999999999998877553221  12222           2222222233333333333333222222222211


Q ss_pred             CCCcccccccCCCCCCCCCCCCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHH
Q 022853          121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE  200 (291)
Q Consensus       121 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E  200 (291)
                      ............... ........+.+..++|++.+.||+|+||.||+|.+. .+..||||+++.....    .+.+.+|
T Consensus       160 ~l~~~~~~~~~~~~~-~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E  233 (454)
T 1qcf_A          160 GLCQKLSVPCMSSKP-QKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS----VEAFLAE  233 (454)
T ss_dssp             TSSSCCCSBCCCCCC-CCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHH
T ss_pred             CccccccccccccCc-cccccccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc----HHHHHHH
Confidence            111111111111110 112234567788899999999999999999999986 4678999999765422    4568899


Q ss_pred             HHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCC
Q 022853          201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKP  278 (291)
Q Consensus       201 ~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp  278 (291)
                      +.+++.++||||+++++++. ...+|+||||+.+|+|.+++...  ..++...+..++.||+.||+|||++||+||||||
T Consensus       234 ~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp  312 (454)
T 1qcf_A          234 ANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA  312 (454)
T ss_dssp             HHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSG
T ss_pred             HHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCH
Confidence            99999999999999998876 66799999999999999998753  3678888999999999999999999999999999


Q ss_pred             CcEEecCCCCcC
Q 022853          279 ENILLDADGHVR  290 (291)
Q Consensus       279 ~NILl~~~g~vK  290 (291)
                      +|||++.++.+|
T Consensus       313 ~Nill~~~~~~k  324 (454)
T 1qcf_A          313 ANILVSASLVCK  324 (454)
T ss_dssp             GGEEECTTCCEE
T ss_pred             HHEEECCCCcEE
Confidence            999999998875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.96  E-value=2e-29  Score=237.05  Aligned_cols=143  Identities=40%  Similarity=0.737  Sum_probs=129.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+...+|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            45578999999999999999999999999999999997654333333445778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||++||+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ik  208 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK  208 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEE
Confidence            99999999999988865 4689999999999999999999999999999999999999999876

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.96  E-value=3.7e-29  Score=242.62  Aligned_cols=230  Identities=18%  Similarity=0.202  Sum_probs=164.6

Q ss_pred             cCCCCCCCCccccCCccccccccccC--CCeeeecCCccCccCCCcccccccccccccccccccccccccccccccCCCC
Q 022853           44 VFGPAPVQASIEVGGEISYANELVYD--QPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPN  121 (291)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~v~~~~~sl~~p~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~  121 (291)
                      .-|.|.||+|+..+|.++++......  ...+.           +|..+.....++.......+..+.+.+.........
T Consensus       170 ~~G~FLvR~S~~~~g~y~lsv~~~~~~~~~~v~-----------h~~I~~~~~g~~~i~~~~~F~SL~eLv~~y~~~~~~  238 (535)
T 2h8h_A          170 PRGTFLVRESETTKGAYCLSVSDFDNAKGLNVK-----------HYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADG  238 (535)
T ss_dssp             CTTEEEEEECSSSTTCEEEEEEEEETTTEEEEE-----------EEEEBC-CCSCEEEETTEEESSHHHHHHHHHHCCTT
T ss_pred             CCCeEEEEecCCCCCcEEEEEEeeccCCCCceE-----------EEEEEEcCCCcEEeeccccccChHHhheeeccccCc
Confidence            45999999999999999888764321  12222           333333333344444433344443333333222222


Q ss_pred             CCcccccccCCCCCCCCCCCCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHH
Q 022853          122 NLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER  201 (291)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~  201 (291)
                      ........+.........+....|.+..++|++.+.||+|+||.||+|.+.. +..||||+++.....    .+.+.+|+
T Consensus       239 ~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~  313 (535)
T 2h8h_A          239 LCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEA  313 (535)
T ss_dssp             SSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHH
T ss_pred             cccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHH
Confidence            1111111111111122233455677888999999999999999999999875 466999999865432    34678999


Q ss_pred             HHHHhCCCCCeeEEeEEEEeCCEEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCC
Q 022853          202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (291)
Q Consensus       202 ~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~  279 (291)
                      .+|++++||||+++++++.+ ..+|+||||+.+|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+
T Consensus       314 ~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~  392 (535)
T 2h8h_A          314 QVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA  392 (535)
T ss_dssp             HHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             HHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence            99999999999999998865 679999999999999999864  356889999999999999999999999999999999


Q ss_pred             cEEecCCCCcC
Q 022853          280 NILLDADGHVR  290 (291)
Q Consensus       280 NILl~~~g~vK  290 (291)
                      |||++.++.+|
T Consensus       393 NIll~~~~~~k  403 (535)
T 2h8h_A          393 NILVGENLVCK  403 (535)
T ss_dssp             GEEECGGGCEE
T ss_pred             hEEEcCCCcEE
Confidence            99999888765

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.96  E-value=4.4e-28  Score=225.19  Aligned_cols=143  Identities=22%  Similarity=0.340  Sum_probs=131.1

Q ss_pred             cccCCeEEEEEeccc--CceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          147 VGLEDFEVLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G--~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      ...++|++.+.||+|  +||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            345689999999999  9999999999999999999999876433 3456778899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+||||+++|+|..++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~k  168 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY  168 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence            99999999999999998875  6789999999999999999999999999999999999999988765

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=3.1e-29  Score=232.62  Aligned_cols=149  Identities=23%  Similarity=0.375  Sum_probs=133.2

Q ss_pred             CCCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEE
Q 022853          140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF  219 (291)
Q Consensus       140 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  219 (291)
                      .+...+.+..++|++.+.||+|+||.||+|.+..+++.||+|+++...  .....+.+.+|+.+++.++||||+++++++
T Consensus       104 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            445567788889999999999999999999999899999999987542  233455678899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          220 QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .....+|+||||+++|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus       182 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~k  253 (377)
T 3cbl_A          182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLK  253 (377)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             ecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEE
Confidence            9999999999999999999998765 4589999999999999999999999999999999999999998875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=1.1e-28  Score=226.09  Aligned_cols=142  Identities=27%  Similarity=0.475  Sum_probs=129.4

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      .+++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            45689999999999999999999999999999999976544333334568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~k  148 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVK  148 (336)
T ss_dssp             EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEE
T ss_pred             EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEE
Confidence            99999 678999998888999999999999999999999999999999999999999998775

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=3.4e-28  Score=216.99  Aligned_cols=141  Identities=23%  Similarity=0.473  Sum_probs=125.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.++..+|+|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            3689999999999999999999999999999999986653 233456678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~k  141 (292)
T 3o0g_A           80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELK  141 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence            99999754444444467899999999999999999999999999999999999999998775

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.96  E-value=2.8e-28  Score=216.00  Aligned_cols=145  Identities=32%  Similarity=0.561  Sum_probs=132.9

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      ...+++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            34567899999999999999999999999999999999776544444456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+++++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~  149 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELK  149 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEE
Confidence            99999999999999998888899999999999999999999999999999999999999988765

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.96  E-value=9.1e-28  Score=215.98  Aligned_cols=141  Identities=21%  Similarity=0.358  Sum_probs=129.2

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.++++++||||+++++++.++...|
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            4557899999999999999999999999999999988543   3345677889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+++++|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~k  148 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVV  148 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEE
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEE
Confidence            99999999999999987 56789999999999999999999999999999999999999998765

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=3.7e-28  Score=221.05  Aligned_cols=144  Identities=52%  Similarity=0.910  Sum_probs=123.5

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccccch-HHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      +..++|++.+.||+|+||.||+|++.   .+++.||+|++++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            45578999999999999999999985   688999999998754322 22345677899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+|+||||++|++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~k  161 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK  161 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEE
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEE
Confidence            99999999999999999999888899999999999999999999999999999999999999998875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=1.1e-28  Score=234.17  Aligned_cols=141  Identities=23%  Similarity=0.416  Sum_probs=125.6

Q ss_pred             CCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ..+.+..++|++.+.||+|+||.||+|.+.  ++.||||+++...     ..+.+.+|+.++++++||||+++++++...
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            356678889999999999999999999884  6789999997653     245678999999999999999999998766


Q ss_pred             C-EEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 Y-RLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~-~~~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      . .+|+||||+++|+|.+++...+.  +++..+..++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus       259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k  329 (450)
T 1k9a_A          259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK  329 (450)
T ss_dssp             TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEE
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEE
Confidence            5 79999999999999999987543  78899999999999999999999999999999999999998875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.95  E-value=4.9e-28  Score=223.86  Aligned_cols=139  Identities=32%  Similarity=0.469  Sum_probs=127.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|++.+......   ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            3579999999999999999999999999999999987643221   1245688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      |+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~  152 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN  152 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCC
Confidence            99999999999999998888899999999999999999999999999999999999998776

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.95  E-value=3e-28  Score=237.57  Aligned_cols=144  Identities=41%  Similarity=0.686  Sum_probs=131.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            55678999999999999999999999999999999998765444444566789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||++||+|..++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vK  326 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIR  326 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeE
Confidence            9999999999999888754  389999999999999999999999999999999999999999876

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.95  E-value=1.4e-28  Score=233.08  Aligned_cols=146  Identities=45%  Similarity=0.802  Sum_probs=124.1

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      ..+..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            34566789999999999999999999999999999999987654444555667789999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+||||+++|+|..++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+|
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~k  289 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK  289 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEE
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEE
Confidence            99999999999999999988899999999999999999999998 9999999999999999998875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.95  E-value=1.6e-28  Score=235.11  Aligned_cols=145  Identities=30%  Similarity=0.468  Sum_probs=133.3

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      ....++|.+.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            34567899999999999999999999999999999999876544434466788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vk  156 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAK  156 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeE
Confidence            99999999999999998888899999999999999999999999999999999999999998875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=1.5e-28  Score=221.53  Aligned_cols=143  Identities=26%  Similarity=0.382  Sum_probs=130.3

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC----
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----  223 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----  223 (291)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            3468999999999999999999999999999999998776556666778889999999999999999999987643    


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..|+||||++|++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k  156 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK  156 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEE
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEE
Confidence            3599999999999999999888899999999999999999999999999999999999999988775

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.95  E-value=2.8e-28  Score=221.58  Aligned_cols=140  Identities=29%  Similarity=0.460  Sum_probs=125.7

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            46899999999999999999999999999999999755422  2245678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++|+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~k  145 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLK  145 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEE
Confidence            99999999999888777899999999999999999999999999999999999999988765

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.95  E-value=9.3e-28  Score=215.45  Aligned_cols=138  Identities=27%  Similarity=0.438  Sum_probs=125.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.......   .+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            357999999999999999999999999999999997654322   45678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+|+|..++... .+++..++.++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~k  156 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK  156 (297)
T ss_dssp             EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred             EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEE
Confidence            9999999999988765 689999999999999999999999999999999999999988775

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.95  E-value=1.7e-27  Score=212.38  Aligned_cols=142  Identities=27%  Similarity=0.433  Sum_probs=132.4

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            45799999999999999999999999999999999877655556677888999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+|
T Consensus        94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  155 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVK  155 (294)
T ss_dssp             EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEE
Confidence            99999999999998888899999999999999999999999999999999999999988765

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=1.1e-27  Score=221.05  Aligned_cols=138  Identities=30%  Similarity=0.469  Sum_probs=126.8

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++......    .+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            3456899999999999999999999999999999999765432    244678999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      +||||+.+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~  154 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA  154 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSS
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC
Confidence            99999999999999988888999999999999999999999999999999999999987764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=6.7e-28  Score=234.01  Aligned_cols=145  Identities=41%  Similarity=0.677  Sum_probs=132.0

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+..|+.+++.++||||++++++|.+...+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            45667999999999999999999999999999999999876544444456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||++||+|..++...    ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vk  329 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR  329 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEE
Confidence            9999999999999988764    3689999999999999999999999999999999999999999876

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2e-27  Score=215.85  Aligned_cols=138  Identities=23%  Similarity=0.421  Sum_probs=125.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++....    ...+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            368999999999999999999999999999999987542    2345678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC--CCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--DGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~--~g~vK  290 (291)
                      |||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+|
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~k  144 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIK  144 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEE
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEE
Confidence            9999999999988765 46899999999999999999999999999999999999987  56554

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=1.2e-27  Score=221.06  Aligned_cols=138  Identities=33%  Similarity=0.541  Sum_probs=127.2

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35799999999999999999999999999999999876543 33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      |||+.||+|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~  165 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA  165 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC
Confidence            99999999999998888899999999999999999999999999999999999998654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=1.8e-27  Score=216.93  Aligned_cols=142  Identities=27%  Similarity=0.433  Sum_probs=132.6

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            46799999999999999999999999999999999877655556677888999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k  181 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVK  181 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEE
Confidence            99999999999998888899999999999999999999999999999999999999988765

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=1.8e-27  Score=214.51  Aligned_cols=145  Identities=28%  Similarity=0.396  Sum_probs=132.1

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      ...+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++..++.+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            34467899999999999999999999999999999999876555555667889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+++++|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~k  174 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAY  174 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEE
Confidence            99999999999999999888899999999999999999999999999999999999999988765

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.95  E-value=1.5e-27  Score=226.35  Aligned_cols=136  Identities=31%  Similarity=0.546  Sum_probs=124.6

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++.+..... ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            357999999999999999999999999999999998765433 3456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      |||+.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~  145 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLAS  145 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESB
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence            999999999999999999999999999999999999999999999999999999984

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=1.2e-27  Score=219.93  Aligned_cols=140  Identities=29%  Similarity=0.538  Sum_probs=123.2

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH--HHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK--NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++........  ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3579999999999999999999999999999999975432211  12456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          227 LVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      +||||++|++|...+.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~  168 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKEN  168 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSST
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCC
Confidence            999999999998777643    35899999999999999999999999999999999999987654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=1.1e-27  Score=212.57  Aligned_cols=144  Identities=29%  Similarity=0.591  Sum_probs=131.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            45678999999999999999999999999999999997654333333567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+++++|..++...+.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+|
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  154 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELK  154 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEE
T ss_pred             EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEE
Confidence            9999999999999998888899999999999999999999999999999999999999988765

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.95  E-value=1.7e-27  Score=210.10  Aligned_cols=144  Identities=32%  Similarity=0.471  Sum_probs=131.8

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.....+|
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            45678999999999999999999999999999999997654433344567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~  151 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAK  151 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEE
T ss_pred             EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEE
Confidence            9999999999999998888899999999999999999999999999999999999999988765

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.95  E-value=1.5e-27  Score=215.34  Aligned_cols=140  Identities=29%  Similarity=0.441  Sum_probs=121.6

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC-----
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----  223 (291)
                      .++|++.+.||+|+||.||+|++..+++.||||++....  .....+.+.+|+.++++++||||++++++|.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            457999999999999999999999999999999997653  2334567889999999999999999999986543     


Q ss_pred             ----------------------------------------------------EEEEEEeccCCCCHHHHHHHcCC---CC
Q 022853          224 ----------------------------------------------------RLYLVLDFVNGGHLFFQLYRQGL---FR  248 (291)
Q Consensus       224 ----------------------------------------------------~~~lV~E~~~gg~L~~~l~~~~~---~~  248 (291)
                                                                          .+|+||||+++++|..++.+...   ..
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999999999999987644   34


Q ss_pred             HHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          249 EDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       249 ~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k  204 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK  204 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEE
Confidence            556888999999999999999999999999999999988765

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=6e-28  Score=240.14  Aligned_cols=146  Identities=40%  Similarity=0.743  Sum_probs=131.7

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCC
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~  223 (291)
                      ..+.+++|++++.||+|+||.||+|++..+++.||||++++.........+.+..|..++..+ +||||++++++|++..
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            345678999999999999999999999999999999999876544444566778899999987 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||++||+|..++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++|
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ik  482 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK  482 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEE
T ss_pred             EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEE
Confidence            9999999999999999999888999999999999999999999999999999999999999999876

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=3.3e-27  Score=212.06  Aligned_cols=141  Identities=28%  Similarity=0.420  Sum_probs=128.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.+....|+|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            4689999999999999999999999999999999876542 334456678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k  142 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIK  142 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEE
Confidence            99999999988888888899999999999999999999999999999999999999988765

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=1.5e-27  Score=210.98  Aligned_cols=142  Identities=31%  Similarity=0.538  Sum_probs=128.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46899999999999999999999999999999999765443333456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|..++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~k  152 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIK  152 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEE
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEE
Confidence            9999999999988865 6789999999999999999999999999999999999999988765

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=2.6e-27  Score=215.43  Aligned_cols=138  Identities=31%  Similarity=0.474  Sum_probs=126.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++.+......   ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            569999999999999999999999999999999976543211   12466889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~  151 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN  151 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC
Confidence            9999999999999998888899999999999999999999999999999999999998877

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.95  E-value=2.3e-27  Score=219.67  Aligned_cols=144  Identities=19%  Similarity=0.302  Sum_probs=127.0

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEe
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLR  216 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~  216 (291)
                      +.+..++|++.+.||+|+||.||+|++..       ++..||+|+++...  .....+.+.+|+.+++.+ +||||++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~  153 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL  153 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            44566799999999999999999999753       45679999997653  334466788999999999 899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCc
Q 022853          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (291)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~N  280 (291)
                      +++.+.+.+|+||||+.+|+|.+++....                .++...+..++.||+.||+|||++||+||||||+|
T Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            99999999999999999999999998653                36888899999999999999999999999999999


Q ss_pred             EEecCCCCcC
Q 022853          281 ILLDADGHVR  290 (291)
Q Consensus       281 ILl~~~g~vK  290 (291)
                      ||++.+|.+|
T Consensus       234 Ill~~~~~~k  243 (370)
T 2psq_A          234 VLVTENNVMK  243 (370)
T ss_dssp             EEECTTCCEE
T ss_pred             EEECCCCCEE
Confidence            9999998875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.95  E-value=2.8e-27  Score=215.09  Aligned_cols=143  Identities=21%  Similarity=0.267  Sum_probs=127.2

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      .+..++|++.+.||+|+||.||+|.+..+++   .||+|++....  .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4556789999999999999999999986554   59999997543  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|+||||+++++|..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k  191 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCK  191 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEE
Confidence            9999999999999999998754 5789999999999999999999999999999999999999988765

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.4e-27  Score=213.65  Aligned_cols=144  Identities=33%  Similarity=0.594  Sum_probs=121.0

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch-----------------------HHHHHHHHHHHH
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----------------------KNHAEYMKSERN  202 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~~~~E~~  202 (291)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++.+.....                       ....+.+.+|+.
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            345679999999999999999999999999999999997654321                       112356789999


Q ss_pred             HHHhCCCCCeeEEeEEEEe--CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCc
Q 022853          203 ILTKVDHPFIVQLRYSFQT--KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (291)
Q Consensus       203 il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~N  280 (291)
                      +++.++||||+++++++.+  ...+|+||||+++++|..++ ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            9999999999999999986  67899999999999886643 34578999999999999999999999999999999999


Q ss_pred             EEecCCCCcC
Q 022853          281 ILLDADGHVR  290 (291)
Q Consensus       281 ILl~~~g~vK  290 (291)
                      ||++.+|.+|
T Consensus       168 il~~~~~~~k  177 (298)
T 2zv2_A          168 LLVGEDGHIK  177 (298)
T ss_dssp             EEECTTSCEE
T ss_pred             EEECCCCCEE
Confidence            9999998775

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=1e-26  Score=205.97  Aligned_cols=139  Identities=32%  Similarity=0.539  Sum_probs=127.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+....|+|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            46899999999999999999999999999999999876543 33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      |||+.+++|...+.....+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~  143 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK  143 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSST
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCC
Confidence            999999999999988888999999999999999999999999999999999999987654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.95  E-value=4.5e-27  Score=208.38  Aligned_cols=144  Identities=19%  Similarity=0.320  Sum_probs=126.1

Q ss_pred             CCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       142 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      ...+.+..++|++.+.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.+++.++||||+++++++.+
T Consensus        16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~   90 (283)
T 3gen_A           16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTK   90 (283)
T ss_dssp             CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence            3456677889999999999999999999886 5678999999866433    2457789999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...+|+||||+.+++|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~k  160 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK  160 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEE
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEE
Confidence            9999999999999999999876 46789999999999999999999999999999999999999988765

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.95  E-value=2.6e-27  Score=226.26  Aligned_cols=144  Identities=33%  Similarity=0.523  Sum_probs=130.3

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+...+|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            33467999999999999999999999999999999998765444444667889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec---CCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD---ADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~---~~g~vK  290 (291)
                      +||||+.+|+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+|
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k  169 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIR  169 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEE
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEE
Confidence            9999999999999999888999999999999999999999999999999999999994   455554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.95  E-value=4.8e-27  Score=212.20  Aligned_cols=145  Identities=21%  Similarity=0.367  Sum_probs=128.2

Q ss_pred             CCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ..+.+..++|++.+.||+|+||.||+|++  +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            34456678999999999999999999987  5788999999765433 34456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGL---FREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~---~~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|+||||+++|+|..++.+.+.   +++..+..++.||+.||+|||++|  |+||||||+|||++.++.+|
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~k  179 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK  179 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEE
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEE
Confidence            999999999999999999887553   889999999999999999999999  99999999999999998775

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.95  E-value=6.6e-27  Score=224.87  Aligned_cols=139  Identities=33%  Similarity=0.516  Sum_probs=123.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH----------HHHHHHHHHHHHHHhCCCCCeeEEeEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK----------NHAEYMKSERNILTKVDHPFIVQLRYS  218 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l~~~  218 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+......          ...+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4689999999999999999999999999999999986543221          234668899999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          219 FQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      +.+...+|+|||||+||+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN  183 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC
Confidence            999999999999999999999998888999999999999999999999999999999999999998876

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=1.1e-26  Score=205.15  Aligned_cols=138  Identities=20%  Similarity=0.335  Sum_probs=122.2

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l  227 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++........ ....+.+|+..+..+ +||||+++++++.+.+.+|+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3579999999999999999999999999999999986543333 345567889999998 99999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          228 VLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ||||+++++|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~  152 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTS  152 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCC
Confidence            99999999999988764    6789999999999999999999999999999999999998655

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=9.6e-27  Score=205.64  Aligned_cols=138  Identities=30%  Similarity=0.520  Sum_probs=126.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|.+..++..+|+|++.+.....   .+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            57999999999999999999999999999999997654322   456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEe---cCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl---~~~g~vK  290 (291)
                      ||+++++|..++...+.+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+|
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~  149 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLK  149 (277)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEE
Confidence            999999999999888889999999999999999999999999999999999999   6666554

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.95  E-value=1.7e-26  Score=207.49  Aligned_cols=144  Identities=27%  Similarity=0.481  Sum_probs=129.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..|
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            44568999999999999999999999999999999998755555566777889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+.+++|..++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~k  176 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVK  176 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEE
Confidence            99999999999888864    45689999999999999999999999999999999999999988765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=5.2e-27  Score=208.42  Aligned_cols=139  Identities=22%  Similarity=0.257  Sum_probs=124.9

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCC-------cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS-------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF  219 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  219 (291)
                      +..++|++.+.||+|+||.||+|.+..++       ..||+|++....   ....+.+.+|+.++++++||||+++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            45678999999999999999999998776       479999986543   23356688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          220 QTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~~-~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      .+++..|+||||+.+++|..++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~  151 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREED  151 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCB
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCc
Confidence            999999999999999999999987654 899999999999999999999999999999999999998876

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.95  E-value=7.2e-27  Score=230.92  Aligned_cols=142  Identities=18%  Similarity=0.282  Sum_probs=121.9

Q ss_pred             cccCCeEEE-EEecccCceEEEEEEE--cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          147 VGLEDFEVL-KVVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       147 ~~~~~y~i~-~~LG~G~fg~Vy~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      +....+.+. +.||+|+||.||+|.+  ..+++.||||+++.... .....+.+.+|+.++++++||||+++++++.. .
T Consensus       365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~  442 (635)
T 4fl3_A          365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-E  442 (635)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            334445554 4899999999999965  45678999999976533 23335678899999999999999999998865 5


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+.+|+|..++...+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+|
T Consensus       443 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~k  509 (635)
T 4fl3_A          443 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAK  509 (635)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred             CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEE
Confidence            5899999999999999999888899999999999999999999999999999999999999988765

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.95  E-value=4.6e-27  Score=210.96  Aligned_cols=146  Identities=21%  Similarity=0.297  Sum_probs=128.4

Q ss_pred             CCcccccCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeE
Q 022853          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY  217 (291)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~  217 (291)
                      ..+.+..++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~   93 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG   93 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence            345566789999999999999999999984     345889999997543  3344567889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCCEe
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGL------------------------FREDLARIYTAEIVSAVSHLHANGIMH  273 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~------------------------~~~~~~~~i~~qil~aL~yLH~~gIiH  273 (291)
                      ++.+.+.+|+||||+++++|.+++.....                        +++..+..++.||+.||.|||++||+|
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  173 (314)
T 2ivs_A           94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH  173 (314)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            99999999999999999999999987543                        788899999999999999999999999


Q ss_pred             cccCCCcEEecCCCCcC
Q 022853          274 RDLKPENILLDADGHVR  290 (291)
Q Consensus       274 rDLKp~NILl~~~g~vK  290 (291)
                      |||||+|||++.++.+|
T Consensus       174 ~dikp~NIli~~~~~~k  190 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMK  190 (314)
T ss_dssp             CCCSGGGEEEETTTEEE
T ss_pred             cccchheEEEcCCCCEE
Confidence            99999999999988764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=7.6e-27  Score=205.63  Aligned_cols=142  Identities=23%  Similarity=0.357  Sum_probs=126.1

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .+.+..++|++.+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.++++++||||+++++++.+..
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            35566789999999999999999999987 4677999999865433    245788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..|+||||+++++|..++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k  146 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK  146 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEE
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEE
Confidence            999999999999999998754 5689999999999999999999999999999999999999888764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.95  E-value=4.5e-27  Score=213.76  Aligned_cols=143  Identities=20%  Similarity=0.321  Sum_probs=127.4

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  220 (291)
                      .+..++|++.+.||+|+||.||+|++..     +++.||+|+++...  .....+.+.+|+.++++++||||+++++++.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            3456789999999999999999999974     45899999997653  2344567889999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeccc
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQ------------------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDL  276 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDL  276 (291)
                      +...+|+||||+++|+|..++...                        ..+++..++.++.||+.||.|||++||+||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  200 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  200 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            999999999999999999998764                        56888999999999999999999999999999


Q ss_pred             CCCcEEecCCCCcC
Q 022853          277 KPENILLDADGHVR  290 (291)
Q Consensus       277 Kp~NILl~~~g~vK  290 (291)
                      ||+|||++.++.+|
T Consensus       201 kp~NIl~~~~~~~k  214 (343)
T 1luf_A          201 ATRNCLVGENMVVK  214 (343)
T ss_dssp             SGGGEEECGGGCEE
T ss_pred             CcceEEECCCCeEE
Confidence            99999999888765

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.94  E-value=1.7e-26  Score=206.03  Aligned_cols=143  Identities=32%  Similarity=0.469  Sum_probs=129.0

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeecccc------chHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI------MEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQ  220 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~  220 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.....      ......+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            35689999999999999999999999999999999976531      11233566788999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .....|+||||+++++|..++.....+++..+..++.||+.||.|||++||+||||||+||+++.+|.+|
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEE
Confidence            9999999999999999999999888899999999999999999999999999999999999999988765

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.94  E-value=1.2e-26  Score=213.23  Aligned_cols=140  Identities=27%  Similarity=0.402  Sum_probs=126.2

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      +.|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++++++||||+++++++.+....|+||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45999999999999999999999999999999998765555555677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||+.| +|..++. ....+++..+..++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus       134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k  194 (348)
T 1u5q_A          134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK  194 (348)
T ss_dssp             ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEE
T ss_pred             ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEE
Confidence            99985 6766664 456789999999999999999999999999999999999999988765

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.94  E-value=6.4e-27  Score=211.41  Aligned_cols=140  Identities=27%  Similarity=0.415  Sum_probs=122.7

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC--EE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RL  225 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~  225 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.......  ..+.+.+|+.++++++||||+++++++....  .+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            3467999999999999999999999999999999997654322  2456778999999999999999999998765  78


Q ss_pred             EEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEe----cCCCCc
Q 022853          226 YLVLDFVNGGHLFFQLYRQGL---FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHV  289 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~---~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl----~~~g~v  289 (291)
                      |+||||+++++|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceE
Confidence            999999999999999886433   8999999999999999999999999999999999998    555544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.94  E-value=6.7e-27  Score=220.81  Aligned_cols=140  Identities=23%  Similarity=0.388  Sum_probs=126.6

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----C
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----Y  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~  223 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            368999999999999999999999999999999997643 3334466788999999999999999999998766     5


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+.+ +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~k  169 (432)
T 3n9x_A          104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVK  169 (432)
T ss_dssp             CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEE
Confidence            79999999875 8999998888899999999999999999999999999999999999999998875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.94  E-value=5.2e-27  Score=209.05  Aligned_cols=139  Identities=27%  Similarity=0.471  Sum_probs=122.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++++.||+|+||.||+|++ .+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            35899999999999999999998 67899999999765422 22235577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+ +|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  140 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELK  140 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEE
Confidence            999987 888877753 6789999999999999999999999999999999999999998875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.94  E-value=6.7e-27  Score=211.62  Aligned_cols=139  Identities=30%  Similarity=0.448  Sum_probs=126.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .++|++.+.||+|+||.||+|++..+++.||+|++........   ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4579999999999999999999999999999999976543221   1245688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      |+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~  152 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN  152 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCC
Confidence            99999999999999998888899999999999999999999999999999999999999887

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.94  E-value=4.7e-27  Score=212.20  Aligned_cols=141  Identities=29%  Similarity=0.499  Sum_probs=120.9

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++++.||+|+||.||+|++. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence            34578999999999999999999985 588999999976532 2333566788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+++ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~k  159 (311)
T 3niz_A           96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALK  159 (311)
T ss_dssp             EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEE
Confidence            99999996 676766654 4589999999999999999999999999999999999999998775

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.94  E-value=2.3e-27  Score=225.15  Aligned_cols=139  Identities=22%  Similarity=0.351  Sum_probs=115.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-----CCE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-----KYR  224 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~  224 (291)
                      ++|++.+.||+|+||.||+|++..+++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++..     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            68999999999999999999999999999999997643 233446678899999999999999999999843     357


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+||||+. ++|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.+|.+|
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~k  196 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVK  196 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEE
T ss_pred             EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEe
Confidence            999999985 58988888888899999999999999999999999999999999999999998876

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.94  E-value=4.2e-27  Score=210.02  Aligned_cols=141  Identities=24%  Similarity=0.373  Sum_probs=124.2

Q ss_pred             cccCCeEEEEEecccCceEEEEEE----EcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-  221 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-  221 (291)
                      +..++|++.+.||+|+||.||+|+    +..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            455789999999999999999998    45688999999997542   3445678899999999999999999998854 


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 -KYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ...+|+||||+++|+|..++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~k  154 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK  154 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEE
Confidence             356899999999999999998754 489999999999999999999999999999999999999888765

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=3.2e-27  Score=217.36  Aligned_cols=147  Identities=48%  Similarity=0.849  Sum_probs=128.8

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHhC-CCCCeeEEeEE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIM-EKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~  218 (291)
                      ...+..++|++.+.||+|+||.||+|++.   .+++.||||++++.... .....+.+.+|+.++..+ +||||++++++
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  127 (355)
T 1vzo_A           48 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA  127 (355)
T ss_dssp             CCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             cccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence            34456789999999999999999999985   47899999999754321 111234466799999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          219 FQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       219 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.....+|+||||+++++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k  199 (355)
T 1vzo_A          128 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV  199 (355)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred             EeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEE
Confidence            999999999999999999999999888899999999999999999999999999999999999999998775

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.94  E-value=6.4e-27  Score=212.83  Aligned_cols=132  Identities=32%  Similarity=0.587  Sum_probs=120.2

Q ss_pred             CCeEEE---EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEE
Q 022853          150 EDFEVL---KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       150 ~~y~i~---~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  225 (291)
                      ++|++.   +.||+|+||.||+|.+..+++.||+|++.+..      ...+.+|+.+++.+. ||||+++++++.+....
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            457775   78999999999999999999999999997542      345678999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      |+||||+++|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~  143 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN  143 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC--
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC
Confidence            99999999999999999988999999999999999999999999999999999999998765

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.94  E-value=1.5e-26  Score=203.44  Aligned_cols=140  Identities=22%  Similarity=0.361  Sum_probs=125.1

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .+..++|++.+.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.++..++||||+++++++.+....
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            345678999999999999999999876 5677999999765433    24577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+++++|..++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~  144 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVK  144 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEE
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEE
Confidence            99999999999999887754 589999999999999999999999999999999999999998765

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=1.2e-26  Score=205.35  Aligned_cols=138  Identities=36%  Similarity=0.552  Sum_probs=126.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ++|++.+.||+|+||.||+|++..+++.||+|++........   ...+.+.+|+.++++++||||+++++++.+....|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            469999999999999999999999999999999976543221   12566889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      +||||+++++|..++.....+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~  145 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN  145 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC
Confidence            9999999999999998888899999999999999999999999999999999999998876

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.94  E-value=1.2e-26  Score=213.23  Aligned_cols=137  Identities=38%  Similarity=0.642  Sum_probs=119.7

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....     ..+.+.+|+.++++++||||+++++++.+...+|+|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            457999999999999999999999999999999997643     235577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC---CCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~---~g~vK  290 (291)
                      |||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+|
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~k  191 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLK  191 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEE
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEE
Confidence            999999999999988888999999999999999999999999999999999999975   56554

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.94  E-value=1.3e-26  Score=212.81  Aligned_cols=142  Identities=23%  Similarity=0.427  Sum_probs=130.5

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            44568999999999999999999999999999999997653  3344567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+++++|..++...+.+++..+..++.|++.||.|||++ ||+||||||+|||++.+|.+|
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~k  172 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK  172 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEE
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEE
Confidence            9999999999999999888899999999999999999999996 999999999999999998775

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.94  E-value=6.3e-27  Score=223.97  Aligned_cols=140  Identities=31%  Similarity=0.519  Sum_probs=126.5

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++.+...... ..+.+.+|+.++++++||||+++++++.+...+
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            3445789999999999999999999999999999999976433222 245678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      |+||||+.+|+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~  157 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK  157 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC
Confidence            9999999999999999888899999999999999999999999999999999999999643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.94  E-value=1.4e-26  Score=208.40  Aligned_cols=136  Identities=31%  Similarity=0.499  Sum_probs=123.5

Q ss_pred             CCeEEE-EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEE
Q 022853          150 EDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       150 ~~y~i~-~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l  227 (291)
                      +.|++. +.||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+.++.++ +||||+++++++.+.+.+|+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            579985 789999999999999999999999999976532   2245677899999885 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      ||||+++++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~  149 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ  149 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSS
T ss_pred             EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCC
Confidence            9999999999999998888999999999999999999999999999999999999988765

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.94  E-value=3.8e-27  Score=215.73  Aligned_cols=145  Identities=22%  Similarity=0.315  Sum_probs=125.4

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEE-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~  217 (291)
                      .+.+..++|++.+.||+|+||.||+|++     ..+++.||+|+++...  .....+.+.+|+.++.++ +||||+++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            4556678999999999999999999994     4566899999997653  233356788999999999 8999999999


Q ss_pred             EEEeCC-EEEEEEeccCCCCHHHHHHHcCC--------------------------------------------------
Q 022853          218 SFQTKY-RLYLVLDFVNGGHLFFQLYRQGL--------------------------------------------------  246 (291)
Q Consensus       218 ~~~~~~-~~~lV~E~~~gg~L~~~l~~~~~--------------------------------------------------  246 (291)
                      ++...+ .+|+||||+.+|+|..++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            988755 49999999999999999876532                                                  


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          247 ----------------FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       247 ----------------~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                                      +++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k  233 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK  233 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEE
Confidence                            78889999999999999999999999999999999999888765

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=1.2e-26  Score=210.79  Aligned_cols=143  Identities=29%  Similarity=0.432  Sum_probs=129.9

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ..+++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            456789999999999999999999999999999999876542 3344566788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+.+++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~k  164 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVK  164 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEE
Confidence            9999999999988877778899999999999999999999999999999999999999988765

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.94  E-value=3.7e-27  Score=213.27  Aligned_cols=139  Identities=25%  Similarity=0.438  Sum_probs=109.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            4589999999999999999999999999999999976542  12234577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+ +|..++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~k  148 (317)
T 2pmi_A           82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLK  148 (317)
T ss_dssp             EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEE
Confidence            999995 888887654      3588999999999999999999999999999999999999998875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.94  E-value=1.6e-26  Score=208.57  Aligned_cols=143  Identities=25%  Similarity=0.374  Sum_probs=120.1

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++.+.||+|+||+||+|++..+++.||||++...........+.+..+..+.+..+||||+++++++.+.+.+|
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            34468999999999999999999999999999999987654433443444443344444559999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+ +++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k  197 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCK  197 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEE
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEE
Confidence            999999 55787777654 5689999999999999999999999999999999999999888765

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.94  E-value=8.4e-27  Score=214.76  Aligned_cols=136  Identities=18%  Similarity=0.329  Sum_probs=118.0

Q ss_pred             CcccccCCeEEEEEecccCceEEEEE-----EEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC---CCCeeEE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQV-----RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQL  215 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~-----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l  215 (291)
                      ...+..++|++.+.||+|+||.||+|     .+..+++.||+|++....      ...+..|+.++..+.   |+||+++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            34455678999999999999999999     466788999999997653      334667888888886   9999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYR-----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      ++++...+..|+||||+++|+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~  207 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN  207 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence            9999999999999999999999999874     456899999999999999999999999999999999999988

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.94  E-value=1.4e-26  Score=206.20  Aligned_cols=136  Identities=26%  Similarity=0.435  Sum_probs=122.5

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..++|.+.+.||+|+||.||+|.+..++..+|+|++......  ...+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            346899999999999999999999999999999999765422  225668899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          228 VLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      ||||+++|+|...+..    ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~  159 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD  159 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESS
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEec
Confidence            9999999999888754    367899999999999999999999999999999999999943

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.94  E-value=1.7e-26  Score=214.36  Aligned_cols=145  Identities=20%  Similarity=0.307  Sum_probs=128.4

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCC-------CcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGT-------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQL  215 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l  215 (291)
                      .+.+..++|++.+.||+|+||.||+|++..+       +..||+|++....  .....+.+.+|+.+++++ +||||+++
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            4556678999999999999999999997643       3579999997653  334456788999999999 99999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCC
Q 022853          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (291)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~  279 (291)
                      ++++.+.+.+|+||||+.+|+|..++....                .+++..++.++.||+.||.|||++||+||||||+
T Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  220 (382)
T 3tt0_A          141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  220 (382)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence            999999999999999999999999998754                4899999999999999999999999999999999


Q ss_pred             cEEecCCCCcC
Q 022853          280 NILLDADGHVR  290 (291)
Q Consensus       280 NILl~~~g~vK  290 (291)
                      |||++.+|.+|
T Consensus       221 NIll~~~~~~k  231 (382)
T 3tt0_A          221 NVLVTEDNVMK  231 (382)
T ss_dssp             GEEECTTCCEE
T ss_pred             eEEEcCCCcEE
Confidence            99999988775

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.94  E-value=1.9e-26  Score=205.96  Aligned_cols=142  Identities=24%  Similarity=0.350  Sum_probs=122.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEE----EcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      .....|++.+.||+|+||.||+|+    +..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++...
T Consensus        18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            445679999999999999999999    46688999999997553  222346688999999999999999999999876


Q ss_pred             --CEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 --YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 --~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                        ..+|+||||+++++|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.+|.+|
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k  166 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK  166 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEE
Confidence              679999999999999999854 46789999999999999999999999999999999999999888764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=8.5e-27  Score=211.96  Aligned_cols=140  Identities=21%  Similarity=0.410  Sum_probs=120.7

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+...+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            3456789999999999999999999999999999999976542 223345567899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      |+||||+.+ +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~  169 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSD  169 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC--
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCC
Confidence            999999986 8999999888899999999999999999999999999999999999996443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.94  E-value=2.2e-27  Score=216.93  Aligned_cols=142  Identities=27%  Similarity=0.423  Sum_probs=127.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH-----HHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK-----NHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.+......     ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            3579999999999999999999999999999999987643221     12334667999999999999999999999999


Q ss_pred             EEEEEEeccCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg-~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+.+| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k  170 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIK  170 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEE
Confidence            999999999777 9999998888899999999999999999999999999999999999999998775

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.94  E-value=7.6e-27  Score=207.25  Aligned_cols=143  Identities=22%  Similarity=0.312  Sum_probs=129.4

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .+.+..++|++.+.||+|+||.||+|.+..++..||+|++....    ...+.+.+|+.+++.++||||+++++++.+..
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            45567789999999999999999999999999999999997643    23566789999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+.+++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~  151 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK  151 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEE
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEE
Confidence            999999999999999999874  4488999999999999999999999999999999999999888764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.94  E-value=9.1e-27  Score=229.32  Aligned_cols=143  Identities=24%  Similarity=0.301  Sum_probs=122.6

Q ss_pred             cccccCCeEEEE-EecccCceEEEEEEEcC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          145 QCVGLEDFEVLK-VVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       145 ~~~~~~~y~i~~-~LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      +.+..+++.+.+ .||+|+||.||+|.+..  ++..||||+++...  .....+.+.+|+.+|++++||||+++++++..
T Consensus       330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            344556777777 89999999999998763  45679999997653  22335678899999999999999999999876


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ..+|+||||+.+|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vk  476 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAK  476 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEE
Confidence             5699999999999999988654 4589999999999999999999999999999999999999988765

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.94  E-value=1.8e-26  Score=215.25  Aligned_cols=139  Identities=27%  Similarity=0.519  Sum_probs=124.4

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++.....   .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            4689999999999999999999999999999999976532   2245678999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC--CCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~--g~vK  290 (291)
                      |||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+  +.+|
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vk  191 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVK  191 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEE
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceE
Confidence            9999999999888755 368999999999999999999999999999999999999753  4443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.94  E-value=6.8e-27  Score=214.49  Aligned_cols=130  Identities=32%  Similarity=0.504  Sum_probs=119.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l  227 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+....       ..+|+.++.++ +||||+++++++.+...+|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            45799999999999999999999999999999999776422       24577778777 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      ||||+.||+|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||+..
T Consensus        94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~  151 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVD  151 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESS
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEec
Confidence            9999999999999998889999999999999999999999999999999999999854

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.94  E-value=6.9e-27  Score=206.06  Aligned_cols=140  Identities=29%  Similarity=0.452  Sum_probs=127.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            3579999999999999999999999999999999976542  23356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.+|.+|
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  145 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLK  145 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEE
Confidence            99999999998887777899999999999999999999999999999999999999988765

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.94  E-value=1.6e-26  Score=221.67  Aligned_cols=137  Identities=34%  Similarity=0.529  Sum_probs=120.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++++.||+|+||.||+|++..++..||+|++.+...... ..+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            479999999999999999999999999999999986543222 2456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      |||.+|+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~  173 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE  173 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC
Confidence            9999999999998888899999999999999999999999999999999999997643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.94  E-value=1.1e-26  Score=214.74  Aligned_cols=141  Identities=21%  Similarity=0.247  Sum_probs=121.9

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEE-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  220 (291)
                      .+..++|++.+.||+|+||.||+|++     ..+++.||+|+++...  .......+.+|+.++++++||||+++++++.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            34557899999999999999999994     4567899999996542  2233456778999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQG-------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      +....|+||||+.+|+|..++....       .+++..+..++.||+.||+|||++||+||||||+|||++.+|.
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~  219 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP  219 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCC
Confidence            9999999999999999999988653       4788899999999999999999999999999999999996654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.94  E-value=2.6e-26  Score=206.68  Aligned_cols=142  Identities=27%  Similarity=0.435  Sum_probs=124.0

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE----e
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ----T  221 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----~  221 (291)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.    .
T Consensus        25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            345568999999999999999999999999999999986542   344667889999999999999999999886    2


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ....|+||||+.+|+|..++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~k  174 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV  174 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEE
Confidence            3478999999999999988876    46789999999999999999999999999999999999999988765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.94  E-value=1.4e-26  Score=209.17  Aligned_cols=144  Identities=21%  Similarity=0.306  Sum_probs=115.1

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      .+..++|++.+.||+|+||.||+|++..++.   .||+|++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            4556789999999999999999999877765   79999997654332 3356788999999999999999999999877


Q ss_pred             CEE------EEEEeccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRL------YLVLDFVNGGHLFFQLYRQG------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~------~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...      |+||||+.+|+|..++....      .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence            655      99999999999998886542      588999999999999999999999999999999999999998775

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.4e-26  Score=211.03  Aligned_cols=145  Identities=24%  Similarity=0.357  Sum_probs=124.4

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~  217 (291)
                      .+.+..++|++.+.||+|+||.||+|.+.     .++..||+|++....  .....+.+.+|+.++.++ +||||+++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            34566789999999999999999999973     356789999997543  223356788999999999 9999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEec
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG-----------------------LFREDLARIYTAEIVSAVSHLHANGIMHR  274 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------~~~~~~~~~i~~qil~aL~yLH~~gIiHr  274 (291)
                      ++...+.+|+||||+++|+|..++....                       .+++..+..++.||+.||.|||++||+||
T Consensus       117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  196 (344)
T 1rjb_A          117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  196 (344)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            9999999999999999999999987643                       26888899999999999999999999999


Q ss_pred             ccCCCcEEecCCCCcC
Q 022853          275 DLKPENILLDADGHVR  290 (291)
Q Consensus       275 DLKp~NILl~~~g~vK  290 (291)
                      ||||+|||++.++.+|
T Consensus       197 Dikp~NIll~~~~~~k  212 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVK  212 (344)
T ss_dssp             TCSGGGEEEETTTEEE
T ss_pred             CCChhhEEEcCCCcEE
Confidence            9999999999988765

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.94  E-value=3e-26  Score=208.48  Aligned_cols=145  Identities=19%  Similarity=0.288  Sum_probs=126.2

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEc-------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRI-------GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQL  215 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l  215 (291)
                      .+.+..++|++.+.||+|+||.||+|++.       .++..||+|++....  .....+.+.+|+.+++++ +||||+++
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            34566789999999999999999999986       356789999997653  234456788999999999 99999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCC
Q 022853          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (291)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~  279 (291)
                      ++++...+.+|+||||+.+|+|..++....                .+++..+..++.||+.||.|||++||+||||||+
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence            999999999999999999999999988654                3788899999999999999999999999999999


Q ss_pred             cEEecCCCCcC
Q 022853          280 NILLDADGHVR  290 (291)
Q Consensus       280 NILl~~~g~vK  290 (291)
                      |||++.+|.+|
T Consensus       187 NIll~~~~~~k  197 (334)
T 2pvf_A          187 NVLVTENNVMK  197 (334)
T ss_dssp             GEEECTTCCEE
T ss_pred             eEEEcCCCCEE
Confidence            99999988765

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.94  E-value=1.5e-26  Score=207.52  Aligned_cols=145  Identities=21%  Similarity=0.265  Sum_probs=128.1

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEE-----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~  217 (291)
                      .+.+..++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.++.++ +||||+++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   94 (313)
T 1t46_A           17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (313)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence            4556677999999999999999999985     3467899999997653  223456788999999999 9999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCC
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~  279 (291)
                      ++...+..|+||||+++|+|..++....                  .+++..+..++.||+.||.|||++||+||||||+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~  174 (313)
T 1t46_A           95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (313)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence            9999999999999999999999988654                  3889999999999999999999999999999999


Q ss_pred             cEEecCCCCcC
Q 022853          280 NILLDADGHVR  290 (291)
Q Consensus       280 NILl~~~g~vK  290 (291)
                      |||++.++.+|
T Consensus       175 Nil~~~~~~~k  185 (313)
T 1t46_A          175 NILLTHGRITK  185 (313)
T ss_dssp             GEEEETTTEEE
T ss_pred             eEEEcCCCCEE
Confidence            99999988764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.94  E-value=9.6e-27  Score=204.14  Aligned_cols=142  Identities=15%  Similarity=0.238  Sum_probs=126.2

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC--C
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--Y  223 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~  223 (291)
                      .+..++|++.+.||+|+||.||+|++.  ++.+|+|++...... ....+.+.+|+.++++++||||+++++++.+.  .
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            456778999999999999999999984  788999999865433 33456688999999999999999999999877  7


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+++|+|..++....  .+++..+..++.||+.||.|||++|  |+||||||+|||++.+|.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~  153 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTAR  153 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEE
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCccee
Confidence            8999999999999999998765  4899999999999999999999999  99999999999999988754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.94  E-value=2.5e-26  Score=204.75  Aligned_cols=146  Identities=17%  Similarity=0.262  Sum_probs=124.9

Q ss_pred             CCcccccCCeEEEE-EecccCceEEEEEEE--cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEE
Q 022853          143 ENQCVGLEDFEVLK-VVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF  219 (291)
Q Consensus       143 ~~~~~~~~~y~i~~-~LG~G~fg~Vy~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  219 (291)
                      ....+..++|++.+ .||+|+||.||+|.+  ..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34455667899998 999999999999954  55678999999976532 233456788999999999999999999998


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          220 QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ....+|+||||+.+++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~k  157 (291)
T 1xbb_A           88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAK  157 (291)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEE
Confidence             5677899999999999999999888899999999999999999999999999999999999999888664

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.94  E-value=3.4e-26  Score=205.15  Aligned_cols=138  Identities=34%  Similarity=0.642  Sum_probs=123.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            579999999999999999999999999999999976532   22345788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEe---cCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl---~~~g~vK  290 (291)
                      ||+++++|..++...+.+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+|
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~k  149 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIM  149 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEE
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEE
Confidence            999999999999888889999999999999999999999999999999999999   5566554

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.94  E-value=4.2e-26  Score=210.71  Aligned_cols=141  Identities=34%  Similarity=0.519  Sum_probs=128.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeecccc-----chHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCC
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-----MEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~  223 (291)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++.....     ......+.+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999998999999999976531     1123356678999999998 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..|+||||++|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence            9999999999999999998888899999999999999999999999999999999999999998875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.94  E-value=3.4e-26  Score=200.67  Aligned_cols=141  Identities=23%  Similarity=0.350  Sum_probs=126.3

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      +.+..++|++.+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4456678999999999999999999986 5678999999865432    3457889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .|+||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~k  144 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK  144 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEE
T ss_pred             eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEE
Confidence            99999999999999998765 5689999999999999999999999999999999999999888764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.94  E-value=7.8e-27  Score=216.41  Aligned_cols=142  Identities=23%  Similarity=0.313  Sum_probs=125.8

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      +...+|++.+.||+|+||.||+|++.   .++..||+|+++...  .....+.+.+|+.++++++||||+++++++.+..
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            45568999999999999999999887   457789999997643  2344567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+++|+|..++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k  187 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK  187 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEE
Confidence            9999999999999999998654 689999999999999999999999999999999999999998775

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.94  E-value=3.3e-26  Score=206.42  Aligned_cols=149  Identities=19%  Similarity=0.229  Sum_probs=129.3

Q ss_pred             CCCCCcccccCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeE
Q 022853          140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ  214 (291)
Q Consensus       140 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~  214 (291)
                      ...+.+.+..++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.++||||++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~   92 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVR   92 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEee
Confidence            334456677789999999999999999999876     357889999997543  2233556889999999999999999


Q ss_pred             EeEEEEeCCEEEEEEeccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec
Q 022853          215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ----------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (291)
Q Consensus       215 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~  284 (291)
                      +++++.+....|+||||+.+|+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA  172 (322)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred             eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence            999999999999999999999999888753          3568889999999999999999999999999999999999


Q ss_pred             CCCCcC
Q 022853          285 ADGHVR  290 (291)
Q Consensus       285 ~~g~vK  290 (291)
                      .+|.+|
T Consensus       173 ~~~~~k  178 (322)
T 1p4o_A          173 EDFTVK  178 (322)
T ss_dssp             TTCCEE
T ss_pred             CCCeEE
Confidence            988765

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.94  E-value=8.8e-26  Score=207.10  Aligned_cols=136  Identities=31%  Similarity=0.466  Sum_probs=121.3

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-----CCCeeEEeEEE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----HPFIVQLRYSF  219 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~~~~  219 (291)
                      .....++|++.+.||+|+||.||+|++..+++.||+|++....    ...+.+..|+.+++.+.     ||||+++++++
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            3345578999999999999999999999999999999997532    23455677999999986     99999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          220 QTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      .....+|+||||+ +++|..++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  172 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD  172 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcc
Confidence            9999999999999 889999988754  5899999999999999999999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.94  E-value=1.7e-26  Score=208.97  Aligned_cols=138  Identities=33%  Similarity=0.586  Sum_probs=119.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----hHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.+....     .......+.+|+.+++.++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            5799999999999999999999999999999999765321     1222345778999999999999999999987665 


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      +|+||||+++++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~  152 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE  152 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSS
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCC
Confidence            8999999999999999888888999999999999999999999999999999999999987654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.94  E-value=2e-26  Score=208.89  Aligned_cols=144  Identities=22%  Similarity=0.271  Sum_probs=124.5

Q ss_pred             CCCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEE
Q 022853          140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF  219 (291)
Q Consensus       140 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  219 (291)
                      .+...+.+..++|++.+.||+|+||.||+|++.  ++.||+|++....    ........|+.++++++||||+++++++
T Consensus        14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~   87 (322)
T 3soc_A           14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAE   87 (322)
T ss_dssp             CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhccee
Confidence            445566778889999999999999999999885  7899999996543    2233455688889999999999999999


Q ss_pred             EeCC----EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC----------CCEecccCCCcEEecC
Q 022853          220 QTKY----RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN----------GIMHRDLKPENILLDA  285 (291)
Q Consensus       220 ~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~----------gIiHrDLKp~NILl~~  285 (291)
                      ....    .+|+||||+++|+|..++... .+++..+..++.|++.||.|||++          ||+||||||+|||++.
T Consensus        88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~  166 (322)
T 3soc_A           88 KRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN  166 (322)
T ss_dssp             EEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred             ccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence            8743    479999999999999988764 589999999999999999999999          9999999999999999


Q ss_pred             CCCcC
Q 022853          286 DGHVR  290 (291)
Q Consensus       286 ~g~vK  290 (291)
                      ++.+|
T Consensus       167 ~~~~k  171 (322)
T 3soc_A          167 NLTAC  171 (322)
T ss_dssp             TCCEE
T ss_pred             CCeEE
Confidence            98775

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.94  E-value=1.6e-26  Score=209.87  Aligned_cols=134  Identities=22%  Similarity=0.270  Sum_probs=121.5

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l  227 (291)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....     .+.+..|+.+++.+ +||||+++++++......|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            3689999999999999999999999999999999875532     23467899999999 99999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~  143 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN  143 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC
Confidence            99999 8999999886 467999999999999999999999999999999999999998775

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.94  E-value=2.5e-27  Score=219.50  Aligned_cols=141  Identities=17%  Similarity=0.150  Sum_probs=118.6

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHH---HHHHhCCCCCeeEEe-------EE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---NILTKVDHPFIVQLR-------YS  218 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~---~il~~l~HpnIv~l~-------~~  218 (291)
                      .++|++.+.||+|+||.||+|++..+++.||||++.+.........+.+.+|+   .+++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45799999999999999999999989999999999866554555667888999   455566899999988       66


Q ss_pred             EEeCCE-----------------EEEEEeccCCCCHHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHHCCCEec
Q 022853          219 FQTKYR-----------------LYLVLDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSAVSHLHANGIMHR  274 (291)
Q Consensus       219 ~~~~~~-----------------~~lV~E~~~gg~L~~~l~~~~~~~~-------~~~~~i~~qil~aL~yLH~~gIiHr  274 (291)
                      +.+.+.                 .|+||||+ +|+|.+++...+.+++       ..+..++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            665542                 89999999 5799999987655555       6677799999999999999999999


Q ss_pred             ccCCCcEEecCCCCcC
Q 022853          275 DLKPENILLDADGHVR  290 (291)
Q Consensus       275 DLKp~NILl~~~g~vK  290 (291)
                      ||||+|||++.+|.+|
T Consensus       231 Dikp~NIll~~~~~~k  246 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVF  246 (377)
T ss_dssp             CCCGGGEEECTTCCEE
T ss_pred             CCCHHHEEEcCCCCEE
Confidence            9999999999998875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.94  E-value=5.5e-26  Score=206.16  Aligned_cols=136  Identities=26%  Similarity=0.405  Sum_probs=123.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|+..+.||+|+||.||+|++..+++.||||++......   ..+.+.+|+.+++.++||||+++++++......|+|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            488889999999999999999999999999999765422   24567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|..++.+ ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k  181 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVK  181 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEE
Confidence            9999999887754 5689999999999999999999999999999999999999988765

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.94  E-value=1.3e-26  Score=217.99  Aligned_cols=138  Identities=32%  Similarity=0.557  Sum_probs=121.2

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch-----HHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.+.....     ......+.+|+.++++++||||+++++++. ..
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            468999999999999999999999999999999998654321     122334778999999999999999999875 45


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      .+|+||||+++|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~  276 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE  276 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC
Confidence            6899999999999998888888899999999999999999999999999999999999997654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=3.5e-26  Score=212.48  Aligned_cols=140  Identities=29%  Similarity=0.471  Sum_probs=114.9

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCC--E
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKY--R  224 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~--~  224 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.++..+. ||||+++++++...+  .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            35689999999999999999999999999999999865432 3344566778999999996 999999999997654  7


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+|||||.+ +|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        86 ~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~k  149 (388)
T 3oz6_A           86 VYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVK  149 (388)
T ss_dssp             EEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             EEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEE
Confidence            9999999985 78777765 5788999999999999999999999999999999999999998875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.94  E-value=3.1e-26  Score=203.15  Aligned_cols=143  Identities=21%  Similarity=0.320  Sum_probs=123.9

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      +.+..++|++.+.||+|+||.||+|.+..+   +..+|+|++....  .....+.+.+|+.+++.++||||+++++++ .
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~   86 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI-T   86 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEE-c
Confidence            345667899999999999999999998654   4579999886542  334466788999999999999999999987 4


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++..|+||||+.+++|..++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  156 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK  156 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred             cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEE
Confidence            567899999999999999988654 689999999999999999999999999999999999999888765

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.94  E-value=3e-26  Score=218.55  Aligned_cols=139  Identities=25%  Similarity=0.401  Sum_probs=121.3

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----  222 (291)
                      ..++|++++.||+|+||.||+|.+..+++.||||++.+.. ......+.+.+|+.+++.++||||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            3578999999999999999999999999999999998653 2334466788999999999999999999999654     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 -YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 -~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ..+|+||||+.++ |...+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus       139 ~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          139 FQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             CCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred             CCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEE
Confidence             4689999999875 545443  3588999999999999999999999999999999999999998875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.94  E-value=2.8e-26  Score=207.88  Aligned_cols=142  Identities=23%  Similarity=0.388  Sum_probs=124.2

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEE--EEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY--AMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~v--AiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~  223 (291)
                      +..++|++.+.||+|+||.||+|++..++..+  |+|.+....  .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            45578999999999999999999998888765  999886532  233355688999999999 9999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      .+|+||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            9999999999999999987654                689999999999999999999999999999999999999887


Q ss_pred             CcC
Q 022853          288 HVR  290 (291)
Q Consensus       288 ~vK  290 (291)
                      .+|
T Consensus       180 ~~k  182 (327)
T 1fvr_A          180 VAK  182 (327)
T ss_dssp             CEE
T ss_pred             eEE
Confidence            764

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.94  E-value=5.1e-26  Score=203.22  Aligned_cols=140  Identities=29%  Similarity=0.514  Sum_probs=123.9

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++.....   ...+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            34689999999999999999999999999999999865432   225567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  157 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIR  157 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEE
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEE
Confidence            9999999999888775 46789999999999999999999999999999999999999988765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=9.4e-27  Score=212.00  Aligned_cols=138  Identities=33%  Similarity=0.525  Sum_probs=120.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+....  .....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            5799999999999999999999999999999999765322  23346678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 022853          228 VLDFVNGGHLFFQLYR----------------------------------------QGLFREDLARIYTAEIVSAVSHLH  267 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qil~aL~yLH  267 (291)
                      ||||++||+|..++..                                        ...+++..++.++.||+.||+|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999888741                                        111356778889999999999999


Q ss_pred             HCCCEecccCCCcEEecCCC
Q 022853          268 ANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       268 ~~gIiHrDLKp~NILl~~~g  287 (291)
                      ++||+||||||+|||++.++
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~  205 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNK  205 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSS
T ss_pred             HCCccccCCChhhEEEecCC
Confidence            99999999999999998776

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.94  E-value=1e-25  Score=200.55  Aligned_cols=140  Identities=27%  Similarity=0.425  Sum_probs=125.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe----CCEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRL  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~  225 (291)
                      ..|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++..    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            4589999999999999999999999999999999865543 3446778899999999999999999999875    4669


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecccCCCcEEec-CCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLD-ADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKp~NILl~-~~g~vK  290 (291)
                      |+||||+++++|..++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+|
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~k  172 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK  172 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEE
Confidence            999999999999999998888999999999999999999999999  99999999999997 666654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=9.2e-27  Score=207.74  Aligned_cols=145  Identities=30%  Similarity=0.462  Sum_probs=110.7

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .+.+..++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++...+
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            345667899999999999999999999988999999999865432  223456778999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYR--------QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~--------~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..|+||||+++++|.+++..        .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence            99999999999999988874        35689999999999999999999999999999999999999988765

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.94  E-value=1.1e-25  Score=203.46  Aligned_cols=140  Identities=30%  Similarity=0.485  Sum_probs=124.9

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEe----
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT----  221 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~----  221 (291)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++......    .+.+.+|+.+++++ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            4457899999999999999999999999999999999754322    34577899999998 89999999999987    


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 --KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 --~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                        ...+|+||||+++++|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEE
Confidence              56899999999999999998864  5689999999999999999999999999999999999999988765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.94  E-value=2.2e-26  Score=214.66  Aligned_cols=140  Identities=27%  Similarity=0.412  Sum_probs=122.2

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC--EE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RL  225 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~  225 (291)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.......  ..+.+.+|+.++++++||||+++++++....  ..
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            3467999999999999999999999999999999997644322  2456678999999999999999999998765  78


Q ss_pred             EEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEe----cCCCCc
Q 022853          226 YLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHV  289 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl----~~~g~v  289 (291)
                      |+||||+++|+|..++....   .+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeE
Confidence            99999999999999887543   38999999999999999999999999999999999998    555444

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.94  E-value=7.1e-26  Score=205.24  Aligned_cols=141  Identities=24%  Similarity=0.385  Sum_probs=125.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEE----EcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE--
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--  220 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--  220 (291)
                      +..++|++.+.||+|+||.||+|+    +..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.  
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            445689999999999999999999    45688999999997653   344567889999999999999999999886  


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +...+|+||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~k  167 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVK  167 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEE
Confidence            56679999999999999999876 45689999999999999999999999999999999999999988765

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.94  E-value=4.1e-26  Score=206.94  Aligned_cols=145  Identities=20%  Similarity=0.310  Sum_probs=127.5

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCc-----EEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE-----IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~  217 (291)
                      .+.+..++|++.+.||+|+||.||+|.+..+++     .||+|++....  .....+.+.+|+.+++.+ +||||+++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            455667899999999999999999999977654     79999997653  233456788999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEe
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ--------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL  283 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl  283 (291)
                      ++...+.+|+||||+++|+|..++...              ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL  197 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence            999999999999999999999988753              357889999999999999999999999999999999999


Q ss_pred             cCCCCcC
Q 022853          284 DADGHVR  290 (291)
Q Consensus       284 ~~~g~vK  290 (291)
                      +.++.+|
T Consensus       198 ~~~~~~k  204 (333)
T 2i1m_A          198 TNGHVAK  204 (333)
T ss_dssp             EGGGEEE
T ss_pred             CCCCeEE
Confidence            9887664

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=7.1e-26  Score=201.51  Aligned_cols=137  Identities=31%  Similarity=0.535  Sum_probs=122.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--------
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--------  221 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--------  221 (291)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+        
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            5799999999999999999999999999999999653    2345678899999999999999999998865        


Q ss_pred             -----CCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 -----KYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 -----~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                           ...+|+||||+++++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.+|.+|
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence                 457899999999999999998654 567888899999999999999999999999999999999988765

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.94  E-value=7.5e-26  Score=200.81  Aligned_cols=143  Identities=25%  Similarity=0.428  Sum_probs=121.1

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.++...++.++||||+++++++.+.+..
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            3556789999999999999999999999999999999976532 233344455566668888999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+++ +|..++..    ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+|
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~k  150 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVK  150 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEE
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEE
Confidence            999999986 77665543    46789999999999999999999998 999999999999999988765

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.93  E-value=6.9e-26  Score=200.14  Aligned_cols=141  Identities=27%  Similarity=0.518  Sum_probs=125.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--CCEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLY  226 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~  226 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++..  ...+|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            46899999999999999999999999999999999866543 3446678899999999999999999998754  67899


Q ss_pred             EEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANG-----IMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~i~~qil~aL~yLH~~g-----IiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+++++|..++...    ..+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+|
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEE
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEE
Confidence            999999999999988753    34899999999999999999999999     99999999999999988765

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.93  E-value=8.6e-26  Score=209.48  Aligned_cols=137  Identities=28%  Similarity=0.495  Sum_probs=115.7

Q ss_pred             CeEE--EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          151 DFEV--LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       151 ~y~i--~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .|.+  .+.||+|+||.||+|.+..+++.||+|+++....   ...+.+.+|+.++++++||||+++++++.+...+|+|
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            3554  6789999999999999999999999999986542   3356688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec--CCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD--ADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~--~~g~vK  290 (291)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+.  .++.+|
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  229 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIK  229 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEE
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEE
Confidence            9999999998888654 4689999999999999999999999999999999999994  445543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.93  E-value=1.1e-26  Score=210.73  Aligned_cols=139  Identities=24%  Similarity=0.419  Sum_probs=120.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++.+.||+|+||.||+|++..+++.||+|++......  .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            36899999999999999999999999999999999654311  1112344699999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~k  140 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELK  140 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEE
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEE
Confidence            999985 787777764 4589999999999999999999999999999999999999998775

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=3.8e-26  Score=211.27  Aligned_cols=139  Identities=25%  Similarity=0.369  Sum_probs=117.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC------
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------  222 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.++||||+++++++...      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            357999999999999999999999999999999996543 2334466788999999999999999999999765      


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k  168 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELK  168 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEE
Confidence            3469999999 7799888766 5789999999999999999999999999999999999999998875

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.93  E-value=7.8e-26  Score=201.73  Aligned_cols=140  Identities=28%  Similarity=0.519  Sum_probs=121.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.++++++||||+++++++...+.+|+|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   80 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccc-hhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEE
Confidence            46899999999999999999999999999999998754322 12235577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.+ +|..++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+|
T Consensus        81 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~k  143 (299)
T 2r3i_A           81 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK  143 (299)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred             EEcccC-CHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEE
Confidence            999984 898888765  4688999999999999999999999999999999999999988765

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.93  E-value=1.3e-25  Score=201.01  Aligned_cols=139  Identities=25%  Similarity=0.489  Sum_probs=125.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            35799999999999999999999999999999999765432  2356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++++|..++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus        99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  159 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVK  159 (303)
T ss_dssp             EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEE
Confidence            999999999887754 5789999999999999999999999999999999999999988765

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1e-25  Score=205.24  Aligned_cols=143  Identities=20%  Similarity=0.244  Sum_probs=125.4

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCC----cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      .+...+|++.+.||+|+||.||+|.+..++    ..||+|++....  .......+.+|+.+++.++||||+++++++.+
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            455678999999999999999999987653    459999997543  23345568899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...+|+||||+++++|..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~k  187 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCK  187 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEE
Confidence            99999999999999999998764 6789999999999999999999999999999999999999988765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.93  E-value=1.3e-25  Score=201.93  Aligned_cols=138  Identities=26%  Similarity=0.434  Sum_probs=120.5

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.....     .+.+.+|+.+++.++||||+++++++.....+|+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34689999999999999999999999999999999976532     3457789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~-~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+.+++|..++. ....+++..+..++.||+.||.|||++||+||||||+||+++.+|.+|
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  165 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAK  165 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEE
Confidence            999999999999887 456789999999999999999999999999999999999999988765

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.93  E-value=6.8e-26  Score=212.03  Aligned_cols=135  Identities=29%  Similarity=0.485  Sum_probs=117.0

Q ss_pred             ccCCeEEE-EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHH-HhCCCCCeeEEeEEEEe----
Q 022853          148 GLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIVQLRYSFQT----  221 (291)
Q Consensus       148 ~~~~y~i~-~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~~~~~~----  221 (291)
                      ..++|.+. +.||+|+||+||+|.+..+++.||||++...        ..+.+|+.++ +..+||||++++++|..    
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            34678887 7899999999999999999999999999643        2355777776 45599999999999876    


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC---CCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~---~g~vK  290 (291)
                      ...+|+||||+.||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+|
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~k  204 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK  204 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEE
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEE
Confidence            667999999999999999998653  5899999999999999999999999999999999999997   56554

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.93  E-value=6.2e-26  Score=206.07  Aligned_cols=141  Identities=23%  Similarity=0.363  Sum_probs=116.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEE----EEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY----AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      +..++|++.+.||+|+||.||+|++..+++.+    |+|.+....  .....+.+.+|+.++++++||||+++++++.+.
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            44568999999999999999999998877655    666664332  222346688999999999999999999999876


Q ss_pred             CEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      . .++|+||+.+|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|++|
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~k  157 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVK  157 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEE
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEE
Confidence            5 7899999999999999887 45789999999999999999999999999999999999999988765

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.93  E-value=8.7e-26  Score=204.39  Aligned_cols=134  Identities=27%  Similarity=0.472  Sum_probs=120.0

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEe--CCE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQT--KYR  224 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~  224 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....      .+.+.+|+.+++.+. ||||+++++++.+  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            3468999999999999999999999999999999997543      355788999999996 9999999999987  678


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC-CcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g-~vK  290 (291)
                      .++||||+.+++|..++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~k  171 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR  171 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEE
Confidence            999999999999987764   378899999999999999999999999999999999999776 443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.93  E-value=3.7e-26  Score=209.07  Aligned_cols=141  Identities=28%  Similarity=0.382  Sum_probs=121.4

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe------
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------  221 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------  221 (291)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....... .....+.+|+.+++.++||||+++++++..      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            4578999999999999999999999999999999986654322 223446689999999999999999999877      


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 --KYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 --~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                        .+.+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~k  164 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK  164 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEE
Confidence              4578999999987 56666554 46789999999999999999999999999999999999999988765

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.93  E-value=1.2e-25  Score=205.43  Aligned_cols=140  Identities=27%  Similarity=0.406  Sum_probs=123.5

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCC--CCeeEEeEEEEeCCE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFIVQLRYSFQTKYR  224 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~  224 (291)
                      +..++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.++..++|  |||+++++++.+...
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            44567999999999999999999884 588999999976543 33445678899999999976  999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+||| +.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++ +|.+|
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~k  147 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLK  147 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEE
T ss_pred             EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEE
Confidence            999999 56779999999988999999999999999999999999999999999999996 45443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.93  E-value=9e-26  Score=199.60  Aligned_cols=143  Identities=18%  Similarity=0.318  Sum_probs=124.5

Q ss_pred             CCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       142 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      .+.|.+..++|++.+.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.+++.++||||+++++++. 
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-   78 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-   78 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence            3456777789999999999999999999975 5678999999765422    456788999999999999999998876 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k  149 (279)
T 1qpc_A           79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCK  149 (279)
T ss_dssp             SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred             CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEE
Confidence            456899999999999998886532  688999999999999999999999999999999999999988765

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.93  E-value=1.4e-25  Score=199.44  Aligned_cols=140  Identities=30%  Similarity=0.516  Sum_probs=126.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.++++++||||+++++++.....+|
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            33468999999999999999999999999999999997654322 23456788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      +||||+.+++|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~  158 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE  158 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC
Confidence            9999999999999988888899999999999999999999999999999999999997654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.93  E-value=8.3e-26  Score=202.96  Aligned_cols=142  Identities=27%  Similarity=0.407  Sum_probs=117.2

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch--HHHHHHHHHHHHHHHhC---CCCCeeEEeEEEEeC
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKV---DHPFIVQLRYSFQTK  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~  222 (291)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.......  ......+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3468999999999999999999999999999999997543211  11122345666666655   599999999999876


Q ss_pred             C-----EEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 Y-----RLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~-----~~~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .     .+|+||||+.+ +|..++.....  +++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEE
Confidence            5     58999999985 89888887644  89999999999999999999999999999999999999988765

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.93  E-value=4e-28  Score=221.08  Aligned_cols=138  Identities=20%  Similarity=0.250  Sum_probs=114.8

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----hHHHHHHHHHHHHHHHhCC---------CCCe
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVD---------HPFI  212 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~---------HpnI  212 (291)
                      +..++|++.+.||+|+||.||+|++  +++.||||++......     .....+.+.+|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            3456899999999999999999998  6799999999876421     1222456788999988875         8888


Q ss_pred             eEEeEEEE------------------------------eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHH
Q 022853          213 VQLRYSFQ------------------------------TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA  262 (291)
Q Consensus       213 v~l~~~~~------------------------------~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~a  262 (291)
                      +++.+.+.                              ....+|+||||+.+|++...+.+ +.+++..++.++.||+.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            87776643                              26889999999999976666543 568999999999999999


Q ss_pred             HHHHH-HCCCEecccCCCcEEecCCC
Q 022853          263 VSHLH-ANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       263 L~yLH-~~gIiHrDLKp~NILl~~~g  287 (291)
                      |+||| ++||+||||||+|||++.+|
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~  199 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTS  199 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECS
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccC
Confidence            99999 99999999999999999886

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.93  E-value=3e-25  Score=198.83  Aligned_cols=135  Identities=29%  Similarity=0.485  Sum_probs=118.9

Q ss_pred             ccCCeEEE-EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHH-HhCCCCCeeEEeEEEEe----
Q 022853          148 GLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIVQLRYSFQT----  221 (291)
Q Consensus       148 ~~~~y~i~-~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~~~~~~----  221 (291)
                      ..++|.+. +.||+|+||.||+|.+..+++.||+|++...        ..+.+|+.++ +.++||||+++++++..    
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence            45679888 7899999999999999999999999999643        2355788777 56699999999999987    


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC---CCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~---~g~vK  290 (291)
                      ...+|+||||+++|+|..++....  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+|
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred             CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEE
Confidence            778999999999999999998764  6899999999999999999999999999999999999998   55554

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.93  E-value=6.3e-26  Score=200.47  Aligned_cols=135  Identities=25%  Similarity=0.433  Sum_probs=120.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-------
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-------  221 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-------  221 (291)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++....       +.+.+|+.+++.++||||+++++++..       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            357999999999999999999999999999999997653       235689999999999999999998864       


Q ss_pred             ---------CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 ---------KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ---------~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                               ...+|+||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                     45689999999999999998754  5789999999999999999999999999999999999999888764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.93  E-value=4.5e-26  Score=203.83  Aligned_cols=141  Identities=26%  Similarity=0.461  Sum_probs=120.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch-HHHHHHHHHHHHHHHhCCCCCeeEEeEEEE--eCCEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKYRL  225 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~  225 (291)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++....... ....+.+.+|+.+++.++||||+++++++.  +...+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999999999999999999999997654321 234567889999999999999999999984  45679


Q ss_pred             EEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+.++ |..++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~k  149 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLK  149 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEE
Confidence            9999999987 6666655  45689999999999999999999999999999999999999988765

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.93  E-value=1.5e-25  Score=198.88  Aligned_cols=140  Identities=22%  Similarity=0.350  Sum_probs=121.8

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHH----HHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH----AEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++..........    .+.+.+|+.+++.++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            44578999999999999999999999999999999997544322221    16688999999999999999999998766


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecccCCCcEEecCCCC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGH  288 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~g~  288 (291)
                      .  ++||||+++|+|...+... ..+++..+..++.|++.||.|||++|  |+||||||+|||++.++.
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~  162 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE  162 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC
Confidence            5  6999999999998887654 46899999999999999999999999  999999999999987765

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.93  E-value=1.4e-25  Score=197.28  Aligned_cols=136  Identities=29%  Similarity=0.467  Sum_probs=114.6

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch-HHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  225 (291)
                      +..++|++.+.||+|+||.||+|.+.  ++.+|+|++....... ....+.+.+|+.+++.++||||+++++++.+....
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            45678999999999999999999984  7889999987653322 22346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecccCCCcEEecC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG---IMHRDLKPENILLDA  285 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKp~NILl~~  285 (291)
                      |+||||+++++|..++. .+.+++..+..++.|++.||.|||++|   |+||||||+|||++.
T Consensus        82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~  143 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQ  143 (271)
T ss_dssp             EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESS
T ss_pred             EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEec
Confidence            99999999999987774 567899999999999999999999999   999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.93  E-value=5.3e-26  Score=204.17  Aligned_cols=144  Identities=22%  Similarity=0.319  Sum_probs=124.4

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~  218 (291)
                      +.+..++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.++.++ +||||++++++
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            3455678999999999999999999863     467899999997653  233455688999999999 79999999999


Q ss_pred             EEeCC-EEEEEEeccCCCCHHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcE
Q 022853          219 FQTKY-RLYLVLDFVNGGHLFFQLYRQGL----------------FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (291)
Q Consensus       219 ~~~~~-~~~lV~E~~~gg~L~~~l~~~~~----------------~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NI  281 (291)
                      +...+ .+|+||||+++++|..++.....                +++..+..++.||+.||.|||++||+||||||+||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni  179 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  179 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence            87654 59999999999999999987543                78899999999999999999999999999999999


Q ss_pred             EecCCCCcC
Q 022853          282 LLDADGHVR  290 (291)
Q Consensus       282 Ll~~~g~vK  290 (291)
                      |++.+|.+|
T Consensus       180 l~~~~~~~k  188 (316)
T 2xir_A          180 LLSEKNVVK  188 (316)
T ss_dssp             EECGGGCEE
T ss_pred             EECCCCCEE
Confidence            999888765

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.93  E-value=1.7e-25  Score=202.21  Aligned_cols=140  Identities=29%  Similarity=0.389  Sum_probs=121.3

Q ss_pred             ccCCeEEEEEecccCceEEEEEEE----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--  221 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--  221 (291)
                      ....|++++.||+|+||.||++.+    ..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+  
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            334459999999999999988764    3478899999997653  33446678899999999999999999999987  


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...+|+||||+++++|..++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~k  174 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVK  174 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEE
Confidence            46899999999999999888664 489999999999999999999999999999999999999988765

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.93  E-value=1.5e-25  Score=201.50  Aligned_cols=144  Identities=22%  Similarity=0.262  Sum_probs=120.1

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      .+..++|.+.+.||+|+||.||+|.+..   +++.||+|++...... ....+.+.+|+.++++++||||+++++++...
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3455789999999999999999998865   4568999999765432 33456788999999999999999999998765


Q ss_pred             C-----EEEEEEeccCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 Y-----RLYLVLDFVNGGHLFFQLYR------QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~-----~~~lV~E~~~gg~L~~~l~~------~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .     ..|+||||+.+++|..++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence            5     35999999999999998853      35689999999999999999999999999999999999999988765

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.93  E-value=3.3e-25  Score=204.93  Aligned_cols=138  Identities=25%  Similarity=0.402  Sum_probs=121.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC-----
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----  223 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            4689999999999999999999999999999999976532 3344566789999999999999999999997665     


Q ss_pred             -EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       .+|+||||+.+ +|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~k  167 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  167 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEE
Confidence             79999999986 6766664  4588999999999999999999999999999999999999998775

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.93  E-value=2e-25  Score=199.08  Aligned_cols=135  Identities=25%  Similarity=0.355  Sum_probs=115.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHh--CCCCCeeEEeEEEEe---
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQT---  221 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~---  221 (291)
                      ...++|++.+.||+|+||.||+|++  +++.||+|++....      ...+..|.+++..  ++||||+++++++..   
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~   76 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRH   76 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence            3456899999999999999999988  68899999986542      2334556666666  799999999988654   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCEecccCCCcEEecCCCCcC
Q 022853          222 -KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH--------ANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH--------~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ...+|+||||+++|+|..++. ...+++..+..++.||+.||.|||        ++||+||||||+|||++.++.+|
T Consensus        77 ~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           77 SSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             TEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             CCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence             356899999999999999884 457899999999999999999999        99999999999999999988775

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=6e-26  Score=210.66  Aligned_cols=135  Identities=29%  Similarity=0.482  Sum_probs=114.3

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe------
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------  221 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------  221 (291)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++..+..       ...+|+.+++.++||||++++++|..      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34689999999999999999999999999999999876532       13469999999999999999999844      


Q ss_pred             --------------------------------CCEEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHH
Q 022853          222 --------------------------------KYRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSH  265 (291)
Q Consensus       222 --------------------------------~~~~~lV~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qil~aL~y  265 (291)
                                                      ...+|+||||+++ +|...+.    ....+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3458999999996 6655554    35679999999999999999999


Q ss_pred             HHHCCCEecccCCCcEEec-CCCCcC
Q 022853          266 LHANGIMHRDLKPENILLD-ADGHVR  290 (291)
Q Consensus       266 LH~~gIiHrDLKp~NILl~-~~g~vK  290 (291)
                      ||++||+||||||+|||++ .++.+|
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~k  182 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLK  182 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEE
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEE
Confidence            9999999999999999998 466554

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=2.2e-25  Score=198.51  Aligned_cols=138  Identities=21%  Similarity=0.273  Sum_probs=120.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE-E
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL-Y  226 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~-~  226 (291)
                      .|.+.+.||+|+||.||+|.+..++.   .+|+|++....  .....+.+.+|+.+++.++||||+++++++.+.... |
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            57788999999999999999876554   79999986532  334567788999999999999999999999766655 9


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+.+|+|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.+|.+|
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~k  164 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVK  164 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence            99999999999999876 45688999999999999999999999999999999999999998765

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.93  E-value=4.2e-25  Score=201.66  Aligned_cols=138  Identities=23%  Similarity=0.402  Sum_probs=121.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----C
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----Y  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~  223 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            468999999999999999999999999999999996532  333455677899999999999999999987654     6


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..|+||||+.+ +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        88 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~k  152 (353)
T 2b9h_A           88 EVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK  152 (353)
T ss_dssp             CEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred             eEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEE
Confidence            79999999985 78877765 5689999999999999999999999999999999999999988765

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.93  E-value=3.2e-25  Score=197.48  Aligned_cols=136  Identities=21%  Similarity=0.289  Sum_probs=122.1

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  225 (291)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++.....     .+.+.+|+.++..+ +|+||+++++++......
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            344689999999999999999999999999999999875432     23467899999999 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          226 YLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      |+||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~  144 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS  144 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC
Confidence            9999999 899999998754 5899999999999999999999999999999999999988765

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.93  E-value=2.5e-25  Score=207.44  Aligned_cols=140  Identities=27%  Similarity=0.400  Sum_probs=123.2

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC--CCCeeEEeEEEEeCCE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD--HPFIVQLRYSFQTKYR  224 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~  224 (291)
                      +...+|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.++..+.  ||||+++++++.....
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            334569999999999999999999865 88999999987643 3344677889999999996  5999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+||| +.+++|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++ +|.+|
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~k  194 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLK  194 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEE
T ss_pred             EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEE
Confidence            999999 66789999999888899999999999999999999999999999999999995 45554

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.93  E-value=5e-26  Score=206.37  Aligned_cols=141  Identities=23%  Similarity=0.341  Sum_probs=119.3

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcE----EEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      +..++|++.+.||+|+||.||+|.+..+++.    +|+|.+.....  ....+.+.+|+.+++.++||||+++++++. .
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            4456899999999999999999999888776    66666643321  111234567999999999999999999886 4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...|+||||+.+|+|..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|++|
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~k  155 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQ  155 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEE
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEE
Confidence            5689999999999999988764 5788899999999999999999999999999999999999988775

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.93  E-value=8.6e-26  Score=199.80  Aligned_cols=142  Identities=23%  Similarity=0.414  Sum_probs=121.9

Q ss_pred             CCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       142 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      ...+.+..++|++.+.||+|+||.||+|.+  +++.||+|++....     ..+.+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (278)
T 1byg_A           13 RSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE   85 (278)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred             hccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            334567778999999999999999999987  47899999987543     24568889999999999999999998754


Q ss_pred             C-CEEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 K-YRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~-~~~~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      . +.+|+||||+++++|.+++...+.  +++..+..++.|++.||.|||++||+||||||+||+++.+|.+|
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  157 (278)
T 1byg_A           86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK  157 (278)
T ss_dssp             C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEE
Confidence            4 479999999999999998876543  78889999999999999999999999999999999999988765

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=3.7e-25  Score=196.80  Aligned_cols=142  Identities=24%  Similarity=0.310  Sum_probs=123.1

Q ss_pred             ccccCCeEEEE-EecccCceEEEEEEEc--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          146 CVGLEDFEVLK-VVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       146 ~~~~~~y~i~~-~LG~G~fg~Vy~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      .+..++|.+.+ .||+|+||.||+|.+.  .++..||+|+++...  .....+.+.+|+.+++.++||||+++++++ ..
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~   81 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA   81 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence            45567888887 9999999999999864  467889999997653  334567788999999999999999999998 55


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|+||||+.+++|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~k  150 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK  150 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEE
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEE
Confidence            6799999999999999988654 5689999999999999999999999999999999999999888764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.93  E-value=2.9e-25  Score=196.69  Aligned_cols=143  Identities=25%  Similarity=0.357  Sum_probs=123.3

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      +.+..++|++.+.||+|+||.||+|.+...   +..||+|++....  .....+.+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            345667899999999999999999987643   4569999997653  23345678899999999999999999998765


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ...|+||||+.+++|..++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  153 (281)
T 3cc6_A           85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVK  153 (281)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEE
T ss_pred             -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEE
Confidence             4578999999999999998765 4589999999999999999999999999999999999999888764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.93  E-value=4.2e-26  Score=206.22  Aligned_cols=142  Identities=23%  Similarity=0.309  Sum_probs=124.9

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      .....++|++.+.||+|+||.||+|.+. +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++...+.
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            3345578999999999999999999964 688999998876532   335668899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+||||+++|+|..++....    .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEE
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEE
Confidence            999999999999988876543    478899999999999999999999999999999999999988765

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.93  E-value=1.2e-25  Score=207.55  Aligned_cols=140  Identities=16%  Similarity=0.275  Sum_probs=106.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC--CCCCeeEEe-------EEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV--DHPFIVQLR-------YSFQ  220 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~-------~~~~  220 (291)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++..+  +||||++++       +.+.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            4599999999999999999999999999999999987655556677788886555444  699988755       4554


Q ss_pred             eC-----------------CEEEEEEeccCCCCHHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHHHCCCEeccc
Q 022853          221 TK-----------------YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLA------RIYTAEIVSAVSHLHANGIMHRDL  276 (291)
Q Consensus       221 ~~-----------------~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~------~~i~~qil~aL~yLH~~gIiHrDL  276 (291)
                      ..                 ..+|+||||++ |+|.+++... ..+.....      ..++.||+.||+|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            33                 34899999999 7999998864 23333333      456699999999999999999999


Q ss_pred             CCCcEEecCCCCcC
Q 022853          277 KPENILLDADGHVR  290 (291)
Q Consensus       277 Kp~NILl~~~g~vK  290 (291)
                      ||+|||++.+|.+|
T Consensus       221 kp~NIll~~~~~~k  234 (371)
T 3q60_A          221 TPDNLFIMPDGRLM  234 (371)
T ss_dssp             SGGGEEECTTSCEE
T ss_pred             CHHHEEECCCCCEE
Confidence            99999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=4.1e-26  Score=208.86  Aligned_cols=141  Identities=30%  Similarity=0.481  Sum_probs=116.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH--HHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK--NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++........  ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            4689999999999999999999999999999999975432221  11245778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+.+ +|...+... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~k  152 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLK  152 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEE
Confidence            99999997 777777654 4588889999999999999999999999999999999999998775

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.93  E-value=2.5e-25  Score=198.51  Aligned_cols=139  Identities=19%  Similarity=0.229  Sum_probs=119.3

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEE-EeCCEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF-QTKYRL  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~  225 (291)
                      .+|++.+.||+|+||.||+|.+..+   ...+|+|.+....  .....+.+.+|+.++++++||||+++++++ ..++..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            4699999999999999999997543   3468999886532  334466788999999999999999999985 556688


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||+.+|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k  168 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVK  168 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEE
Confidence            9999999999999998763 4578899999999999999999999999999999999999988765

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.93  E-value=6.4e-25  Score=202.22  Aligned_cols=137  Identities=21%  Similarity=0.348  Sum_probs=121.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----CE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YR  224 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~  224 (291)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.++++++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            57999999999999999999999999999999997533  333456788999999999999999999998655     46


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+||||+.+ +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~k  168 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK  168 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEE
Confidence            9999999985 88887765 4689999999999999999999999999999999999999998765

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.93  E-value=2.5e-25  Score=201.65  Aligned_cols=139  Identities=21%  Similarity=0.263  Sum_probs=118.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEE-----EcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVR-----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      +..++|++.+.||+|+||.||+|+     +..+++.||+|++....  .......+.+|+.++++++||||+++++++..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            455789999999999999999998     45678899999996442  23335567889999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQG-------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ....|+||||+++++|..++....       .+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~  177 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG  177 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC
Confidence            999999999999999999998753       478889999999999999999999999999999999998554

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.93  E-value=1.2e-25  Score=199.58  Aligned_cols=144  Identities=22%  Similarity=0.352  Sum_probs=116.2

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcC-CC--cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-TS--EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~--~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      .+..++|++.+.||+|+||.||+|.+.. ++  ..||+|+++..........+.+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            4556789999999999999999998753 33  36899999776544455677888999999999999999999998776


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      . .++||||+.+++|..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~k  161 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK  161 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEE
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEE
Confidence            5 89999999999999988764 5689999999999999999999999999999999999999888664

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.93  E-value=3.6e-26  Score=208.40  Aligned_cols=142  Identities=21%  Similarity=0.455  Sum_probs=125.3

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHH--------------HHHHHHHHHHHHHhCCCCCe
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--------------HAEYMKSERNILTKVDHPFI  212 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~--------------~~~~~~~E~~il~~l~HpnI  212 (291)
                      ...++|++.+.||+|+||.||+|.+  +++.||+|++.........              ..+.+.+|+.+++.++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            4457899999999999999999999  8999999999765332111              12678899999999999999


Q ss_pred             eEEeEEEEeCCEEEEEEeccCCCCHHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEe
Q 022853          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQ------LYR--QGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILL  283 (291)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~------l~~--~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl  283 (291)
                      +++++++.+.+.+|+||||+++++|..+      +..  ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            9999999999999999999999999877      555  5678999999999999999999999 999999999999999


Q ss_pred             cCCCCcC
Q 022853          284 DADGHVR  290 (291)
Q Consensus       284 ~~~g~vK  290 (291)
                      +.+|.+|
T Consensus       186 ~~~~~~k  192 (348)
T 2pml_X          186 DKNGRVK  192 (348)
T ss_dssp             CTTSCEE
T ss_pred             cCCCcEE
Confidence            9988765

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.93  E-value=1.9e-25  Score=205.81  Aligned_cols=142  Identities=17%  Similarity=0.149  Sum_probs=116.1

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccccchHHHHH--------HHHHHHHHHHhCCCCCeeE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAE--------YMKSERNILTKVDHPFIVQ  214 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~-----~~~vAiK~i~~~~~~~~~~~~--------~~~~E~~il~~l~HpnIv~  214 (291)
                      ..++|++.+.||+|+||.||+|.+..+     ++.||+|++...........+        .+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            345899999999999999999998765     578999998765421111111        1234556677889999999


Q ss_pred             EeEEEEeC----CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec--CCC
Q 022853          215 LRYSFQTK----YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD--ADG  287 (291)
Q Consensus       215 l~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~--~~g  287 (291)
                      +++++...    ...|+||||+ |++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            99998764    5689999999 99999998875 6799999999999999999999999999999999999999  667


Q ss_pred             CcC
Q 022853          288 HVR  290 (291)
Q Consensus       288 ~vK  290 (291)
                      .+|
T Consensus       192 ~~k  194 (364)
T 3op5_A          192 QVY  194 (364)
T ss_dssp             CEE
T ss_pred             eEE
Confidence            664

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.93  E-value=3.2e-25  Score=200.96  Aligned_cols=141  Identities=24%  Similarity=0.353  Sum_probs=123.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEEE----cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      ...++|++.+.||+|+||.||+|++    ..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++...
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            3456799999999999999999984    5678999999997642   34456788999999999999999999988654


Q ss_pred             C--EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 Y--RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~--~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .  .+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k  185 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK  185 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEE
Confidence            3  789999999999999999875 4589999999999999999999999999999999999999888764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.93  E-value=2.6e-25  Score=202.24  Aligned_cols=141  Identities=23%  Similarity=0.363  Sum_probs=120.9

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEE----EEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY----AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      +..++|++.+.||+|+||.||+|.+..+++.+    |+|.+....  .....+.+.+|+.+++.++||||+++++++...
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            44578999999999999999999998888766    555554322  122356688899999999999999999999876


Q ss_pred             CEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      . .++|++|+.+|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~k  157 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVK  157 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEE
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEE
Confidence            5 8899999999999998886 45689999999999999999999999999999999999999988765

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.92  E-value=4.6e-25  Score=199.39  Aligned_cols=143  Identities=28%  Similarity=0.453  Sum_probs=122.8

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEE--
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQ--  220 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--  220 (291)
                      ...+...+|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++.++. ||||+++++++.  
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            33445568999999999999999999999999999999986543   334566788999999995 999999999984  


Q ss_pred             ------eCCEEEEEEeccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecccCCCcEEecCCCCc
Q 022853          221 ------TKYRLYLVLDFVNGGHLFFQLYR---QGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHV  289 (291)
Q Consensus       221 ------~~~~~~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKp~NILl~~~g~v  289 (291)
                            ....+|+||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                  3456899999997 578777764   467899999999999999999999999  9999999999999998876


Q ss_pred             C
Q 022853          290 R  290 (291)
Q Consensus       290 K  290 (291)
                      |
T Consensus       178 k  178 (337)
T 3ll6_A          178 K  178 (337)
T ss_dssp             E
T ss_pred             E
Confidence            5

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.92  E-value=6.2e-25  Score=197.12  Aligned_cols=137  Identities=23%  Similarity=0.360  Sum_probs=114.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE--------
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--------  220 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--------  220 (291)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            368999999999999999999999999999999987542   344567889999999999999999998873        


Q ss_pred             ------eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC-CCCcC
Q 022853          221 ------TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVR  290 (291)
Q Consensus       221 ------~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~-~g~vK  290 (291)
                            ....+|+||||+. |+|..++. .+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                  4578999999998 48887775 467899999999999999999999999999999999999974 44543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.92  E-value=1.6e-25  Score=207.23  Aligned_cols=138  Identities=25%  Similarity=0.371  Sum_probs=114.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC------C
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------Y  223 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~  223 (291)
                      ++|++++.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.++||||+++++++...      .
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            68999999999999999999999999999999997543 2334456778999999999999999999998654      5


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~k  172 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK  172 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEE
Confidence            689999999 6788777765 5789999999999999999999999999999999999999998775

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.92  E-value=2.7e-25  Score=198.07  Aligned_cols=142  Identities=25%  Similarity=0.349  Sum_probs=120.5

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      ...+..++|++.+.||+|+||.||+|++..   .+|+|+++.... .....+.+.+|+.+++.++||||++++++ ....
T Consensus        18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~   92 (289)
T 3og7_A           18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAP   92 (289)
T ss_dssp             CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSS
T ss_pred             CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCC
Confidence            345666789999999999999999998643   599999976543 33446778899999999999999999985 4566


Q ss_pred             EEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..++||||+.+++|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+|
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~k  160 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVK  160 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEE
Confidence            78999999999999988864 35688999999999999999999999999999999999999988764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.92  E-value=5.5e-25  Score=195.64  Aligned_cols=139  Identities=25%  Similarity=0.370  Sum_probs=120.5

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|.....||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            344555568999999999999999999999999997653   23356688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC-CCCcC
Q 022853          229 LDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~-~g~vK  290 (291)
                      |||+++++|..++....   .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~k  163 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLK  163 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEE
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEE
Confidence            99999999999888652   4568888899999999999999999999999999999987 67654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.92  E-value=5.9e-25  Score=199.03  Aligned_cols=147  Identities=26%  Similarity=0.425  Sum_probs=122.9

Q ss_pred             CCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHH-HHHhCCCCCeeEEeEEE
Q 022853          141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSF  219 (291)
Q Consensus       141 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~  219 (291)
                      +...+.+..++|++.+.||+|+||.||+|.+..+++.||+|++..... ... ...+..|+. +++.++||||+++++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~   90 (327)
T 3aln_A           13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKE-QKQLLMDLDVVMRSSDCPYIVQFYGAL   90 (327)
T ss_dssp             CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHH-HHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred             hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chH-HHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence            334556677899999999999999999999999999999999976532 222 333444554 67778999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          220 QTKYRLYLVLDFVNGGHLFFQLYR-----QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...+..|+||||+.+ +|..++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.+|.+|
T Consensus        91 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           91 FREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             ECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred             EeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence            999999999999997 67666653     56789999999999999999999999 999999999999999988765

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.92  E-value=8.4e-25  Score=202.18  Aligned_cols=136  Identities=24%  Similarity=0.398  Sum_probs=117.0

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC--------CCCeeEEeEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD--------HPFIVQLRYS  218 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--------HpnIv~l~~~  218 (291)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....    ...+.+.+|+.+++.+.        ||||+++++.
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            34578999999999999999999999999999999997542    33556788999999885        7889999999


Q ss_pred             EE----eCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCC
Q 022853          219 FQ----TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADG  287 (291)
Q Consensus       219 ~~----~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g  287 (291)
                      +.    ....+|+||||+. ++|...+.+.  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|
T Consensus       110 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             eeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            87    5568999999995 4565665544  5689999999999999999999998 999999999999998775

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.92  E-value=1.7e-24  Score=197.58  Aligned_cols=135  Identities=27%  Similarity=0.429  Sum_probs=114.1

Q ss_pred             ccccCCeEEEE-EecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe---
Q 022853          146 CVGLEDFEVLK-VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT---  221 (291)
Q Consensus       146 ~~~~~~y~i~~-~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~---  221 (291)
                      ....++|++.+ .||+|+||.||+|.+..+++.||+|++....       .........++.+.||||+++++++..   
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            34457899965 6999999999999999999999999996542       112233344677899999999999876   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          222 -KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       222 -~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                       ...+|+||||+++|+|..++.+.+  .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~  165 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE  165 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC
Confidence             556899999999999999998754  689999999999999999999999999999999999998644

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.92  E-value=5.1e-25  Score=202.12  Aligned_cols=140  Identities=23%  Similarity=0.335  Sum_probs=119.5

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeecccc--------chHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--------MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  220 (291)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|++.....        ......+.+.+|+.++++++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            4689999999999999999999865 88999999865322        22334577889999999999999999999985


Q ss_pred             e-----CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 T-----KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~-----~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .     ...+|+||||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       100 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence            4     3478999999995 677766654 4689999999999999999999999999999999999999888765

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.92  E-value=3.4e-25  Score=202.68  Aligned_cols=141  Identities=18%  Similarity=0.158  Sum_probs=115.7

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcC---CCcEEEEEEeeccccchHHH--------HHHHHHHHHHHHhCCCCCeeEEeE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNH--------AEYMKSERNILTKVDHPFIVQLRY  217 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~--------~~~~~~E~~il~~l~HpnIv~l~~  217 (291)
                      .++|++.+.||+|+||.||+|.+..   ++..+|+|++..........        ...+.+|+.++..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4689999999999999999999987   78899999997653211111        123556888899999999999999


Q ss_pred             EEEe----CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC--CcC
Q 022853          218 SFQT----KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG--HVR  290 (291)
Q Consensus       218 ~~~~----~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g--~vK  290 (291)
                      ++..    ...+|+||||+ +++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+|
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            9988    78899999999 999999988777899999999999999999999999999999999999999877  554

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.92  E-value=2.1e-25  Score=201.99  Aligned_cols=145  Identities=29%  Similarity=0.438  Sum_probs=125.6

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHHhCC--CCCeeEEeEEEE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVD--HPFIVQLRYSFQ  220 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~--HpnIv~l~~~~~  220 (291)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++........   ...+.+..|+.+++++.  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            3445689999999999999999999999999999999976543221   11234567899999985  599999999999


Q ss_pred             eCCEEEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec-CCCCcC
Q 022853          221 TKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~-~~g~vK  290 (291)
                      .....++|||++.+ ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEE
Confidence            99999999999986 89999998888899999999999999999999999999999999999998 566654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.1e-24  Score=197.30  Aligned_cols=134  Identities=25%  Similarity=0.360  Sum_probs=115.1

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHh--CCCCCeeEEeEEEEeC---
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQTK---  222 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~---  222 (291)
                      ..++|++.+.||+|+||.||+|++.  ++.||+|++....      ......|.+++..  ++||||+++++++...   
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            3468999999999999999999884  8899999986542      2223345555554  4999999999999887   


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEecccCCCcEEecCCCCcC
Q 022853          223 -YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--------GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 -~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~--------gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ..+|+||||+++|+|..++... .+++..+..++.|++.||.|||++        ||+||||||+|||++.+|.+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence             7899999999999999988654 688999999999999999999999        999999999999999988775

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.92  E-value=6e-25  Score=199.55  Aligned_cols=142  Identities=27%  Similarity=0.410  Sum_probs=123.6

Q ss_pred             ccCCeEEE-EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEE
Q 022853          148 GLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       148 ~~~~y~i~-~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  225 (291)
                      ..+.|.+. +.||+|+||.||+|.+..+++.||+|++.+..... .....+.+|+.++..+ .||||+++++++.+...+
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            34568887 89999999999999999999999999997654322 2245677899999998 569999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC---CCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~---~g~vK  290 (291)
                      |+||||+.+|+|..++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.   +|.+|
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEE
Confidence            9999999999998887543  67899999999999999999999999999999999999987   56554

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.92  E-value=1.5e-25  Score=201.51  Aligned_cols=144  Identities=28%  Similarity=0.473  Sum_probs=117.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHHhC----CCCCeeEEeEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKV----DHPFIVQLRYSF  219 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l----~HpnIv~l~~~~  219 (291)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            344689999999999999999999999999999999976543221   1223355788888888    899999999999


Q ss_pred             EeCCEEEEEEec-cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec-CCCCcC
Q 022853          220 QTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVR  290 (291)
Q Consensus       220 ~~~~~~~lV~E~-~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~-~~g~vK  290 (291)
                      ...+..|+|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+|
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEE
Confidence            999999999999 78999999999888899999999999999999999999999999999999998 677654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.92  E-value=2e-24  Score=195.15  Aligned_cols=135  Identities=28%  Similarity=0.420  Sum_probs=118.3

Q ss_pred             cccCCeEEEEEecccCceEEEEEEE-cCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCC------CeeEEeEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRR-IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP------FIVQLRYSF  219 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp------nIv~l~~~~  219 (291)
                      ...++|++.+.||+|+||.||+|.+ ..+++.||+|+++...    ...+.+.+|+.+++.++|+      +|+++++++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            3446899999999999999999998 5678999999996542    3356678899999888665      499999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          220 QTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      ...+.+|+||||+ +++|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~  154 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS  154 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCC
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecc
Confidence            9999999999999 789998888765  68899999999999999999999999999999999999873

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.92  E-value=8.7e-25  Score=202.08  Aligned_cols=137  Identities=23%  Similarity=0.365  Sum_probs=120.9

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEE----
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL----  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~----  225 (291)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++......    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            689999999999999999999999999999999976542 334456788999999999999999999999877654    


Q ss_pred             --EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 --YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 --~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                        |+||||+.+ +|...+  ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       121 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k  184 (371)
T 4exu_A          121 DFYLVMPFMQT-DLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELK  184 (371)
T ss_dssp             CCEEEEECCCE-EHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred             eEEEEEccccc-cHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEE
Confidence              999999985 776655  34589999999999999999999999999999999999999998765

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.92  E-value=2.2e-24  Score=203.58  Aligned_cols=136  Identities=27%  Similarity=0.463  Sum_probs=119.6

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC------CCCCeeEEeEEEEe
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV------DHPFIVQLRYSFQT  221 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~~~  221 (291)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++....    ...+.+.+|+.++..+      +|+||+++++.+..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            3457999999999999999999999999999999997643    2344566788887766      67899999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      ...+|+||||+. ++|..++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~  238 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR  238 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC
Confidence            999999999997 48888887653  4899999999999999999999999999999999999999876

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.92  E-value=2.2e-24  Score=195.59  Aligned_cols=136  Identities=22%  Similarity=0.372  Sum_probs=112.9

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHH--HHhCCCCCeeEEeEEEEe--
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDHPFIVQLRYSFQT--  221 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~i--l~~l~HpnIv~l~~~~~~--  221 (291)
                      .+.+++|++.+.||+|+||.||+|++  +++.||+|++....      .+.+..|..+  +..++||||+++++.+..  
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVT   80 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence            45678999999999999999999977  67899999997543      2223334444  445899999999876542  


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCEecccCCCcEEecCCCCc
Q 022853          222 ---KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN---------GIMHRDLKPENILLDADGHV  289 (291)
Q Consensus       222 ---~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~---------gIiHrDLKp~NILl~~~g~v  289 (291)
                         ...+|+||||+++|+|..++.... .++..+..++.||+.||.|||++         ||+||||||+|||++.+|.+
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence               336899999999999999887654 47888889999999999999999         99999999999999998877


Q ss_pred             C
Q 022853          290 R  290 (291)
Q Consensus       290 K  290 (291)
                      |
T Consensus       160 k  160 (336)
T 3g2f_A          160 V  160 (336)
T ss_dssp             E
T ss_pred             E
Confidence            5

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.92  E-value=7.1e-26  Score=204.82  Aligned_cols=144  Identities=22%  Similarity=0.314  Sum_probs=123.3

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      ......++|++.+.||+|+||.||+|++. +++.||+|++........  ...+.+|+.+++.++||||+++++++.+..
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            34455678999999999999999999854 688999999976532211  224788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHLHAN---GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..|+||||+.+|+|..++....    .+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+|
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999988643    388999999999999999999999   999999999999999988765

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.92  E-value=1.9e-24  Score=194.21  Aligned_cols=144  Identities=29%  Similarity=0.455  Sum_probs=116.3

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      ....+++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+..+..+++.++||||+++++++.+...
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence            34556789999999999999999999999999999999986543 22334455566667888899999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~k  165 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIK  165 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEE
Confidence            99999999 4455554443 56789999999999999999999996 999999999999999988765

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.92  E-value=7e-25  Score=196.45  Aligned_cols=137  Identities=22%  Similarity=0.237  Sum_probs=119.7

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      |...+.||+|+||.||+|.+  +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+....|+|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            33458899999999999986  578899999875432 233456778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYR---QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~---~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+++++|..++..   ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~k  173 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAK  173 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEE
Confidence            9999999998874   34588999999999999999999999999999999999999988765

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.92  E-value=4.2e-25  Score=202.46  Aligned_cols=130  Identities=19%  Similarity=0.263  Sum_probs=115.0

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCC--------CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeE------
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGT--------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ------  214 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~------  214 (291)
                      .++|++.+.||+|+||.||+|++..+        ++.||+|++...        +.+.+|+.++++++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            36899999999999999999999874        789999999754        24678999999999999887      


Q ss_pred             ---------EeEEEEe-CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEE
Q 022853          215 ---------LRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (291)
Q Consensus       215 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NIL  282 (291)
                               +++++.. ...+|+||||+ +++|..++...  ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5667665 78999999999 99999999876  78999999999999999999999999999999999999


Q ss_pred             ecCCC
Q 022853          283 LDADG  287 (291)
Q Consensus       283 l~~~g  287 (291)
                      ++.++
T Consensus       192 ~~~~~  196 (352)
T 2jii_A          192 VDPED  196 (352)
T ss_dssp             EETTE
T ss_pred             EcCCC
Confidence            99887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.92  E-value=6e-25  Score=214.56  Aligned_cols=134  Identities=19%  Similarity=0.147  Sum_probs=109.4

Q ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEE
Q 022853          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-------EKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       154 i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  225 (291)
                      .....+.|++|.+..++..-.|+.||+|++.+....       .....+.+.+|+++|+++ .|+||++++++++++..+
T Consensus       238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~  317 (569)
T 4azs_A          238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG  317 (569)
T ss_dssp             EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred             hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence            344577888888888887778999999999765321       223456789999999999 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||||++|++|.+++.+.+.+++.   .|+.||+.||+|+|++|||||||||+||||+.+|+||
T Consensus       318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vK  379 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHAR  379 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEE
Confidence            9999999999999999998888764   4789999999999999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=6.3e-25  Score=203.72  Aligned_cols=138  Identities=19%  Similarity=0.235  Sum_probs=119.1

Q ss_pred             CeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE-eCCEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ-TKYRLY  226 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~  226 (291)
                      .|++.+.||+|+||.||+|.+..+   +..+|+|.++...  .....+.+.+|+.++++++||||+++++++. .++..|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            588999999999999999987643   2468999886532  3344677889999999999999999999864 456889


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +||||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k  232 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVK  232 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEE
Confidence            999999999999998764 4578889999999999999999999999999999999999998775

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.92  E-value=2.2e-24  Score=194.64  Aligned_cols=141  Identities=25%  Similarity=0.420  Sum_probs=117.0

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEc-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC---CCCCeeEEeEEEE---
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRI-GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQ---  220 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~---  220 (291)
                      ..++|++.+.||+|+||.||+|++. .+++.||+|++........ ....+.+|+.+++.+   +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3468999999999999999999995 6789999999975432211 112344566666655   8999999999987   


Q ss_pred             --eCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 --TKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 --~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                        ....+|+||||+. |+|..++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEE
Confidence              5667999999998 48988887753  489999999999999999999999999999999999999988765

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.91  E-value=2.4e-24  Score=195.61  Aligned_cols=133  Identities=26%  Similarity=0.364  Sum_probs=118.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHh--CCCCCeeEEeEEEEeCC---
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQTKY---  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~~---  223 (291)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++....      .+.+..|++++..  ++||||+++++++....   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            46899999999999999999998  58899999986542      3446678888887  79999999999998876   


Q ss_pred             -EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCEecccCCCcEEecCCCCcC
Q 022853          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH--------ANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH--------~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       .+|+||||+++|+|..++.+. .+++..+..++.|++.||.|||        ++||+||||||+|||++.++.+|
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence             899999999999999998764 6889999999999999999999        89999999999999999988765

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.91  E-value=9.8e-25  Score=199.90  Aligned_cols=137  Identities=23%  Similarity=0.355  Sum_probs=120.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE-----
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR-----  224 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-----  224 (291)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.....     
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            57999999999999999999999999999999997643 233445678899999999999999999999987654     


Q ss_pred             -EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 -LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 -~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       +|+||||+.+ +|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       103 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~k  166 (353)
T 3coi_A          103 DFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELK  166 (353)
T ss_dssp             CCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEE
T ss_pred             eEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEE
Confidence             5999999985 7765553  3589999999999999999999999999999999999999998775

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.91  E-value=8.1e-25  Score=205.90  Aligned_cols=130  Identities=34%  Similarity=0.560  Sum_probs=110.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC------C
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------Y  223 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~  223 (291)
                      .+|++.+.||+|+||.||+|++..+++.||||++.....       ...+|+.+++.++||||++++++|...      .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            369999999999999999999999999999999976431       234699999999999999999888542      2


Q ss_pred             EEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          224 RLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      .+++||||+.+ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~  193 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT  193 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC
Confidence            47799999997 4544443    246789999999999999999999999999999999999999664

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.91  E-value=1.6e-24  Score=195.02  Aligned_cols=133  Identities=30%  Similarity=0.492  Sum_probs=116.7

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +..++|++.+.||+|+||.||+|++.  ++.||+|++...     ...+.+.+|+.++++++||||+++++++.+  ..|
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~   75 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC   75 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence            45678999999999999999999884  688999998643     235668899999999999999999988763  479


Q ss_pred             EEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCEecccCCCcEEecCCCC
Q 022853          227 LVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHA---NGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKp~NILl~~~g~  288 (291)
                      +||||+++|+|..++....   .++...+..++.|++.||.|||+   +||+||||||+|||++.+|.
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~  143 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT  143 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC
Confidence            9999999999999998654   36788889999999999999999   89999999999999998875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.91  E-value=5.5e-24  Score=189.27  Aligned_cols=136  Identities=18%  Similarity=0.264  Sum_probs=116.9

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEe-EEEEeCCEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR-YSFQTKYRLYL  227 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~-~~~~~~~~~~l  227 (291)
                      .++|++.+.||+|+||.||+|++..+++.||+|++......     +.+.+|+.+++.+.|++++..+ .++......|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            35899999999999999999999999999999998765432     2467899999999887765544 44577888999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec---CCCCcC
Q 022853          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD---ADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~---~~g~vK  290 (291)
                      ||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+|
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~k  148 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVY  148 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEE
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEE
Confidence            99999 8899998874 45789999999999999999999999999999999999994   666654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.91  E-value=3.9e-24  Score=192.41  Aligned_cols=143  Identities=26%  Similarity=0.383  Sum_probs=124.5

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC--CCCeeEEeEEEEe
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD--HPFIVQLRYSFQT  221 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~  221 (291)
                      ...+..++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.++.++.  ||||+++++++..
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            34455568999999999999999999885 488899999976543 3344677889999999996  5999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...+|+||| +.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++. |.+|
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~k  166 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLK  166 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEE
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEE
Confidence            999999999 667899999998888999999999999999999999999999999999999964 5543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.91  E-value=3.8e-24  Score=190.09  Aligned_cols=135  Identities=18%  Similarity=0.264  Sum_probs=114.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeE-EEEeCCEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY-SFQTKYRLYLV  228 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~-~~~~~~~~~lV  228 (291)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.....     .+.+..|+.+++.+.|++++..+. ++......|+|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            579999999999999999999999999999998765432     223678999999998877665544 45788899999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEe---cCCCCcC
Q 022853          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl---~~~g~vK  290 (291)
                      |||+ +++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+|
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~k  148 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVY  148 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEE
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEE
Confidence            9999 8899998875 4678999999999999999999999999999999999999   6777654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.91  E-value=1.3e-24  Score=202.86  Aligned_cols=134  Identities=30%  Similarity=0.481  Sum_probs=111.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC-----
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----  223 (291)
                      ..+|++.+.||+|+||.||+|++..+++ +|+|.+.....       ...+|+.+++.++||||++++++|....     
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            3479999999999999999999987766 88887765432       1236999999999999999999986543     


Q ss_pred             -EEEEEEeccCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec-CCCCcC
Q 022853          224 -RLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVR  290 (291)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~---~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~-~~g~vK  290 (291)
                       .+|+||||+.++.+.....   ....+++..++.++.||+.||+|||++||+||||||+|||++ .+|.+|
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~k  182 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLK  182 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEE
Confidence             3899999999864433322   256789999999999999999999999999999999999999 677664

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.91  E-value=1.5e-24  Score=215.74  Aligned_cols=137  Identities=27%  Similarity=0.391  Sum_probs=117.4

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE---
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR---  224 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~---  224 (291)
                      .++|++.+.||+|+||.||+|.+.. +++.||||++....  .....+.+.+|+.++..++||||+++++++...+.   
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            4689999999999999999999976 78999999986542  23445678899999999999999999999987655   


Q ss_pred             --EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 --LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 --~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                        .|+||||++|++|...+..  .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+|
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~k  221 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLK  221 (681)
T ss_dssp             EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEE
T ss_pred             ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEE
Confidence              7999999999999876654  68999999999999999999999999999999999999874 443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.91  E-value=1.2e-23  Score=191.45  Aligned_cols=133  Identities=26%  Similarity=0.355  Sum_probs=114.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCC-cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCC------eeEEeEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF------IVQLRYSF  219 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~~~~  219 (291)
                      ...++|++.+.||+|+||.||+|.+..++ +.||+|+++...    ...+.+.+|+.+++.+.|++      ++.+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            34568999999999999999999998776 789999997542    33556778999999887665      89999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec
Q 022853          220 QTKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (291)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~  284 (291)
                      ...+.+|+||||+ +++|...+...  ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~  157 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFV  157 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEES
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence            9999999999999 55666666654  3689999999999999999999999999999999999993

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.91  E-value=4.8e-24  Score=211.47  Aligned_cols=143  Identities=20%  Similarity=0.316  Sum_probs=123.7

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      ..+..++|++.+.||+|+||.||+|.+..+   +..+|+|.+....  .....+.+.+|+.+++.++||||+++++++. 
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-  461 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            345567899999999999999999998654   4679999886542  3344567889999999999999999999884 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++.+|+||||+++|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vk  531 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK  531 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred             cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEE
Confidence            567899999999999999988654 688999999999999999999999999999999999999988765

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.91  E-value=1.7e-24  Score=198.08  Aligned_cols=140  Identities=27%  Similarity=0.389  Sum_probs=106.2

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE-
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR-  224 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-  224 (291)
                      ...+++|++.+.||+|+||.||+|++..+++.||+|++......    ......++..+..++||||+++++++..... 
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            35567899999999999999999999999999999998665322    2234567778888999999999999866433 


Q ss_pred             ------EEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH--HCCCEecccCCCcEEecC-CCCcC
Q 022853          225 ------LYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLH--ANGIMHRDLKPENILLDA-DGHVR  290 (291)
Q Consensus       225 ------~~lV~E~~~gg~L~~~l~----~~~~~~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKp~NILl~~-~g~vK  290 (291)
                            +|+||||+.++ |...+.    ....+++..++.++.|++.||.|||  ++||+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  89999999985 433332    4567889999999999999999999  999999999999999996 77664

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.91  E-value=2.4e-25  Score=200.41  Aligned_cols=144  Identities=24%  Similarity=0.408  Sum_probs=122.3

Q ss_pred             CCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       142 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      ...+.+..++|++.+.||+|+||.||+|.+..   .+|+|++....... ...+.+.+|+.+++.++||||+++++++.+
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            34566778899999999999999999999854   49999987543221 223446679999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...+|+||||+.+++|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ +|.+|
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~  169 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVV  169 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCE
T ss_pred             CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEE
Confidence            999999999999999999887654 688999999999999999999999999999999999998 55554

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.90  E-value=3.8e-24  Score=199.92  Aligned_cols=134  Identities=28%  Similarity=0.482  Sum_probs=106.6

Q ss_pred             CeEE-EEEecccCceEEEEEEEc--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--CCEE
Q 022853          151 DFEV-LKVVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRL  225 (291)
Q Consensus       151 ~y~i-~~~LG~G~fg~Vy~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~  225 (291)
                      .|++ .++||+|+||.||+|++.  .+++.||+|++......     +.+.+|+.+|+.++||||+++++++..  ...+
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            4666 457999999999999976  46889999999765432     346789999999999999999999955  6789


Q ss_pred             EEEEeccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEe----cCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl----~~~g~vK  290 (291)
                      |+||||+.+ +|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+|
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            999999986 676666522         248899999999999999999999999999999999999    5556654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.90  E-value=1.3e-23  Score=193.10  Aligned_cols=135  Identities=23%  Similarity=0.395  Sum_probs=117.5

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-----------CCCeeEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----------HPFIVQL  215 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l  215 (291)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....    ...+.+.+|+.+++++.           ||||+++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            34568999999999999999999999999999999997543    23455778888888875           8999999


Q ss_pred             eEEEEeCC----EEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCEecccCCCcEEecCC
Q 022853          216 RYSFQTKY----RLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDAD  286 (291)
Q Consensus       216 ~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKp~NILl~~~  286 (291)
                      ++++....    .+++||||+ +++|..++...  ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence            99987654    799999999 88999988763  4589999999999999999999998 99999999999999643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.90  E-value=2.3e-23  Score=199.58  Aligned_cols=136  Identities=21%  Similarity=0.293  Sum_probs=118.3

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCC-CCeeEEeEEEEeCCEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~l  227 (291)
                      .++|++.+.||+|+||.||+|++..+++.||||++......     +.+..|+.+++.+.| ++|..+..++......|+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            46899999999999999999999999999999998755432     236789999999976 566667777788899999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEe---cCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl---~~~g~vK  290 (291)
                      ||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||   +.++.+|
T Consensus        81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk  146 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY  146 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEE
T ss_pred             EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEE
Confidence            99999 8899998875 5679999999999999999999999999999999999999   5666654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.90  E-value=5.7e-23  Score=190.47  Aligned_cols=139  Identities=26%  Similarity=0.431  Sum_probs=118.5

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CC-----CeeEEeEEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HP-----FIVQLRYSFQ  220 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv~l~~~~~  220 (291)
                      ...++|++.+.||+|+||.||+|.+..+++.||||+++...    ...+.+..|+.++..+. |+     +|+++++.+.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            34578999999999999999999999999999999997542    33455677888888774 54     4999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCEecccCCCcEEecC--CCCcC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLH--ANGIMHRDLKPENILLDA--DGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKp~NILl~~--~g~vK  290 (291)
                      ....+|+||||+.+ +|.+++...  ..+++..++.++.|++.||.|||  .+||+||||||+|||++.  ++.+|
T Consensus       127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence            99999999999975 898888765  45899999999999999999999  579999999999999954  55554

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.89  E-value=3.7e-23  Score=195.49  Aligned_cols=132  Identities=23%  Similarity=0.317  Sum_probs=110.3

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCE
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~  224 (291)
                      .++..+|.+.+.||+|+||.||. ....+++.||||++.+....      .+.+|+.+++.+ +||||+++++++.+...
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~   92 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQF   92 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred             EEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence            34455799999999999999764 34457899999999765432      245799999999 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      +|+|||||.+ +|..++.... .+.+..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        93 ~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~  153 (432)
T 3p23_A           93 QYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM  153 (432)
T ss_dssp             EEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECC
T ss_pred             EEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEec
Confidence            9999999975 8988887653 3445566789999999999999999999999999999953

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.88  E-value=1.1e-22  Score=192.18  Aligned_cols=130  Identities=29%  Similarity=0.312  Sum_probs=106.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +.|.+.+.||+|+||+||.+. ..+++.||||++..+.      .+.+.+|+.++..+ +||||+++++++.+...+|+|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            346677999999999998753 4578999999987543      34567899999876 899999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          229 LDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~-------~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ||||. |+|.+++........       ..+..++.||+.||+|||++||+||||||+|||++.+|
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~  152 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSS  152 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCH
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCc
Confidence            99996 599998886543322       23467899999999999999999999999999998653

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.88  E-value=3.9e-24  Score=211.33  Aligned_cols=139  Identities=30%  Similarity=0.396  Sum_probs=119.9

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe------
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------  221 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------  221 (291)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.++++++||||+++++++..      
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            3468999999999999999999999999999999987642  33446678899999999999999999988755      


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      ....|+||||++||+|..++....   .+++..++.++.|++.||.|||++||+||||||+|||++.+|.
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~  159 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ  159 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSS
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCC
Confidence            677899999999999999988654   5888899999999999999999999999999999999997764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=2.1e-22  Score=180.09  Aligned_cols=126  Identities=15%  Similarity=0.194  Sum_probs=99.0

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH---------------HHHHHHHHHHHHHHhCCCCCeeEEe
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---------------NHAEYMKSERNILTKVDHPFIVQLR  216 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~---------------~~~~~~~~E~~il~~l~HpnIv~l~  216 (291)
                      |.+.+.||+|+||.||+|.+ .+++.||+|+++.......               .....+.+|+.++++++|   +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence            55669999999999999999 7899999999965432110               235568899999999984   5555


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.+.. +..|+||||++|++|.. +.      ...+..++.|++.||.|||++||+||||||+|||++ +|.+|
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence            54443 45699999999999976 31      123456899999999999999999999999999999 88765

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.85  E-value=1.4e-21  Score=183.41  Aligned_cols=140  Identities=17%  Similarity=0.114  Sum_probs=103.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCC-CCe----------------
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFI----------------  212 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnI----------------  212 (291)
                      ..|.+.+.||+|+||.||+|++..+++.||||++...........+.+++|+.+++.+.| +|.                
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            468999999999999999999999999999999975443333345678899999999977 211                


Q ss_pred             -----eEEeEEEEe-----CCEEEEEEeccCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecc
Q 022853          213 -----VQLRYSFQT-----KYRLYLVLDFVNGGHLFFQLYR-------QGLFREDLARIYTAEIVSAVSHLHANGIMHRD  275 (291)
Q Consensus       213 -----v~l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~-------~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrD  275 (291)
                           ..+...+..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||+|||++||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence                 111111111     23467777765 4688877741       23356667788889999999999999999999


Q ss_pred             cCCCcEEecCCCCcC
Q 022853          276 LKPENILLDADGHVR  290 (291)
Q Consensus       276 LKp~NILl~~~g~vK  290 (291)
                      |||+|||++.+|.+|
T Consensus       237 iKp~NILl~~~~~~k  251 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVF  251 (413)
T ss_dssp             CCGGGEEECTTCCEE
T ss_pred             cccceEEEecCCeEE
Confidence            999999999998875

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.85  E-value=1.5e-21  Score=189.36  Aligned_cols=123  Identities=18%  Similarity=0.106  Sum_probs=95.0

Q ss_pred             EEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch-----HHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       153 ~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ...+.||+|+||.||+|..  .++.+++|.........     ....+.+.+|+.++++++||||+++..++......|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            3457899999999999944  56789999875543321     2234568899999999999999965555567777899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      ||||++|++|.+++..        +..++.|++.||+|||++||+||||||+|||++.
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~  466 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK  466 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC
Confidence            9999999999888765        5578999999999999999999999999999986

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=6.9e-20  Score=161.37  Aligned_cols=127  Identities=17%  Similarity=0.141  Sum_probs=95.6

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcE--EEEEEeeccccch---------------------HHHHHHHHHHHHHHHhCC
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIME---------------------KNHAEYMKSERNILTKVD  208 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~--vAiK~i~~~~~~~---------------------~~~~~~~~~E~~il~~l~  208 (291)
                      |++.+.||+|+||.||+|.+..+|+.  ||||+++......                     ......+.+|+.++..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999999778888  9999976542110                     111235778999999998


Q ss_pred             CCCe--eEEeEEEEeCCEEEEEEeccCC-C----CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCCEecccCCCc
Q 022853          209 HPFI--VQLRYSFQTKYRLYLVLDFVNG-G----HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-ANGIMHRDLKPEN  280 (291)
Q Consensus       209 HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH-~~gIiHrDLKp~N  280 (291)
                      |+++  +.++..    ...|+||||+.+ |    +|......   .++..+..++.|++.||.||| ++||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            7754  333332    346899999942 3    56554322   234456788999999999999 9999999999999


Q ss_pred             EEecC
Q 022853          281 ILLDA  285 (291)
Q Consensus       281 ILl~~  285 (291)
                      ||++.
T Consensus       202 ILl~~  206 (258)
T 1zth_A          202 IMYID  206 (258)
T ss_dssp             EEESS
T ss_pred             EEEcC
Confidence            99976

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=4.6e-18  Score=157.88  Aligned_cols=128  Identities=15%  Similarity=0.148  Sum_probs=90.6

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc---------------hHHHH----HHHHHHHHHHHhCCCCCe
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---------------EKNHA----EYMKSERNILTKVDHPFI  212 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~---------------~~~~~----~~~~~E~~il~~l~HpnI  212 (291)
                      |++.+.||.|+||.||+|.+. +|+.||||+++.....               .....    -....|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999885 6889999998643210               00001    112346667777755544


Q ss_pred             eEEeEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      ....-+....  .+|||||++|+.|..+.      ....+..++.||+.+|.|||++|||||||||.|||++.+|.
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence            3222121222  37999999998874321      12234567899999999999999999999999999998763

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.32  E-value=5.6e-12  Score=110.05  Aligned_cols=110  Identities=12%  Similarity=0.055  Sum_probs=84.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeCCEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l  227 (291)
                      +.+|++...++.|+.+.||++..  .++.+++|+........   ...+.+|+.+++.+ .+..++++++++.+.+..|+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            45799999999999999999875  36789999986532111   23477899999988 46778889999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA  268 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~  268 (291)
                      ||||++|.+|...+.     +......++.+++.+|..||+
T Consensus        88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhC
Confidence            999999998865421     112234567899999999998

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.06  E-value=1.8e-10  Score=99.54  Aligned_cols=105  Identities=13%  Similarity=0.068  Sum_probs=71.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCC--eeEEeEEEEeCCEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYL  227 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~~~~~~~~~l  227 (291)
                      .+|.+....+.|..+.||++.. .++..+++|+.....      ...+..|+.+++.+.+.+  +.+++......+..|+
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            4577655555677799999864 456779999976541      134667888888884434  5668888888888999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN  269 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~  269 (291)
                      ||||++|.+|.  .   .....   ..++.+++..|..||+.
T Consensus        93 v~e~i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~  126 (264)
T 1nd4_A           93 LLGEVPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTL  126 (264)
T ss_dssp             EEECCSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTS
T ss_pred             EEEecCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCC
Confidence            99999998873  1   11111   23456677777777764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.97  E-value=9.1e-10  Score=100.59  Aligned_cols=109  Identities=14%  Similarity=0.234  Sum_probs=75.8

Q ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEee--ccccchHHHHHHHHHHHHHHHhCC--CCCeeEEeEEEEeC---CEEE
Q 022853          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR--KDKIMEKNHAEYMKSERNILTKVD--HPFIVQLRYSFQTK---YRLY  226 (291)
Q Consensus       154 i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~--~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~---~~~~  226 (291)
                      ..+.|+.|.++.||++...  +..+++|+..  .....  .....+.+|..+++.+.  +..+++++..+.+.   +..|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            4678999999999998764  4578888775  33211  11345778999999886  45577888877665   4589


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA  268 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~  268 (291)
                      +||||++|..+....  ...++......++.+++.+|..||+
T Consensus       118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhC
Confidence            999999998763211  1235667777888999999999997

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.39  E-value=4.7e-06  Score=72.37  Aligned_cols=84  Identities=14%  Similarity=0.116  Sum_probs=59.8

Q ss_pred             CeEEEEEecccCc-eEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEEE
Q 022853          151 DFEVLKVVGQGAF-AKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       151 ~y~i~~~LG~G~f-g~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .|+... +..|.- +.||+......+..+++|+-....      ...+.+|...|+.+. +--+.+++.++.+.+..|+|
T Consensus        26 g~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           26 GYRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             TCEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            455433 334444 479988777677789999875432      445778999888773 33366788888899999999


Q ss_pred             EeccCCCCHHHHH
Q 022853          229 LDFVNGGHLFFQL  241 (291)
Q Consensus       229 ~E~~~gg~L~~~l  241 (291)
                      ||+++|.++....
T Consensus        99 me~l~G~~~~~~~  111 (272)
T 4gkh_A           99 TTAIPGKTAFQVL  111 (272)
T ss_dssp             EECCCSEEHHHHH
T ss_pred             EEeeCCccccccc
Confidence            9999998775543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.32  E-value=6.2e-07  Score=79.78  Aligned_cols=101  Identities=15%  Similarity=0.212  Sum_probs=66.8

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCC--eeEEeEEEEeCC---EEEEEE
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPF--IVQLRYSFQTKY---RLYLVL  229 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~Hpn--Iv~l~~~~~~~~---~~~lV~  229 (291)
                      +.++.|....||++.     ..+++|+....     .....+.+|..+++.+ .+..  +.+.+.......   ..|+||
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            458999999999863     45889986432     2355688899999887 3333  334444333322   358999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA  268 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~  268 (291)
                      ++++|..+.....  ..++......++.|++..+..||+
T Consensus        96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~  132 (304)
T 3sg8_A           96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHS  132 (304)
T ss_dssp             ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHc
Confidence            9999988754332  234556666677777777777775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.29  E-value=6.6e-06  Score=73.43  Aligned_cols=75  Identities=16%  Similarity=0.117  Sum_probs=53.2

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCC---CeeEEeEEEE-eCCEEEEEEe
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP---FIVQLRYSFQ-TKYRLYLVLD  230 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~E  230 (291)
                      .+.++.|....||+.     +..+++|+-..     ......+..|..+|..+.+.   .+.+.+.+.. ..+..|+|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            355788998999987     45688898432     12355688999999998642   2455555553 3456789999


Q ss_pred             ccCCCCHHH
Q 022853          231 FVNGGHLFF  239 (291)
Q Consensus       231 ~~~gg~L~~  239 (291)
                      +++|..+..
T Consensus        94 ~i~G~~l~~  102 (306)
T 3tdw_A           94 KVQGQILGE  102 (306)
T ss_dssp             CCCSEECHH
T ss_pred             ccCCeECch
Confidence            999987754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.95  E-value=1.1e-05  Score=74.25  Aligned_cols=79  Identities=13%  Similarity=0.167  Sum_probs=48.9

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeecccc-chH---HHHHHHHHHHHHHHhCCC--C-CeeEEeEEEEeCCEEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-MEK---NHAEYMKSERNILTKVDH--P-FIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~E~~il~~l~H--p-nIv~l~~~~~~~~~~~l  227 (291)
                      .+.||.|.++.||++.....++.+++|....... ...   ...+.+..|..++..+..  | .+++++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            5689999999999997655677899998753211 000   012345678888877632  3 34455543  4455689


Q ss_pred             EEeccCCC
Q 022853          228 VLDFVNGG  235 (291)
Q Consensus       228 V~E~~~gg  235 (291)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.66  E-value=0.00064  Score=60.44  Aligned_cols=74  Identities=16%  Similarity=0.191  Sum_probs=41.2

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-----CCCCeeEEe-E--EEEeCCEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-----DHPFIVQLR-Y--SFQTKYRLY  226 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~-~--~~~~~~~~~  226 (291)
                      ++.|+.|..+.||++...  +..+++|+.....       +.+..|..++..+     ..|.++... +  +....+..|
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            356677788999998763  3458999987531       1222344444433     234444310 0  123567889


Q ss_pred             EEEeccCCCCH
Q 022853          227 LVLDFVNGGHL  237 (291)
Q Consensus       227 lV~E~~~gg~L  237 (291)
                      ++|+|++|..+
T Consensus       108 ~l~~~i~G~~~  118 (346)
T 2q83_A          108 VVYDWIEGRPF  118 (346)
T ss_dssp             EEEECCCCBCC
T ss_pred             EEEEeecCccC
Confidence            99999998643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.54  E-value=3.6e-05  Score=69.62  Aligned_cols=83  Identities=12%  Similarity=0.147  Sum_probs=53.4

Q ss_pred             eEEEEEe-cccCceEEEEEEEc---C---CCcEEEEEEeeccc---cchHHHHHHHHHHHHHHHhCC-C--CCeeEEeEE
Q 022853          152 FEVLKVV-GQGAFAKVYQVRRI---G---TSEIYAMKVMRKDK---IMEKNHAEYMKSERNILTKVD-H--PFIVQLRYS  218 (291)
Q Consensus       152 y~i~~~L-G~G~fg~Vy~~~~~---~---~~~~vAiK~i~~~~---~~~~~~~~~~~~E~~il~~l~-H--pnIv~l~~~  218 (291)
                      ....+.| +.|....+|++...   .   .+..+++|+.....   ...   ...+.+|..+++.+. +  -.+.+++..
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~   98 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI   98 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence            3445778 88999999988653   1   15678899865432   100   123567777777763 2  346677766


Q ss_pred             EEeC---CEEEEEEeccCCCCH
Q 022853          219 FQTK---YRLYLVLDFVNGGHL  237 (291)
Q Consensus       219 ~~~~---~~~~lV~E~~~gg~L  237 (291)
                      ..+.   +..|+||||++|..+
T Consensus        99 ~~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A           99 ETTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             ECSSTTTSSCEEEEECCCCBCC
T ss_pred             ccCCCccCCceEEEEecCCCCh
Confidence            6554   356899999998653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.21  E-value=0.0036  Score=54.75  Aligned_cols=78  Identities=13%  Similarity=0.101  Sum_probs=53.2

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-C--CCeeEEeEEEEeCCEEEE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-H--PFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-H--pnIv~l~~~~~~~~~~~l  227 (291)
                      ...-.+.+|.|..+.||+.+.. +|+.|.+|+........   ...+..|+..|+.|. .  --+++.+..  +.  -++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence            4566788999999999999864 67889999865443211   234678998888773 2  123444433  22  378


Q ss_pred             EEeccCCCC
Q 022853          228 VLDFVNGGH  236 (291)
Q Consensus       228 V~E~~~gg~  236 (291)
                      ||||+.++.
T Consensus        88 v~e~l~~~~   96 (288)
T 3f7w_A           88 AMEWVDERP   96 (288)
T ss_dssp             EEECCCCCC
T ss_pred             EEEeecccC
Confidence            999998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.03  E-value=0.0021  Score=59.49  Aligned_cols=76  Identities=13%  Similarity=0.110  Sum_probs=44.0

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeecccc--chH----HHHHHHHHHHHHHH-hCCCCCeeEEeEEEEeCCEEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--MEK----NHAEYMKSERNILT-KVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~----~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      .+.||.|..+.||++..  .++.+++|.......  ...    .....+..|+..+. ......+++++.+.  ....++
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            46789999999999854  467799995322110  000    01222333333222 22334566666554  566789


Q ss_pred             EEecc-CC
Q 022853          228 VLDFV-NG  234 (291)
Q Consensus       228 V~E~~-~g  234 (291)
                      ||||+ +|
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.83  E-value=0.0065  Score=54.29  Aligned_cols=95  Identities=9%  Similarity=0.103  Sum_probs=71.8

Q ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC---CCCeeEEeEEEEeCCEEEEEEe
Q 022853          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       154 i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      -.+.|+.|....+|+...  .+..+++|+.....      ...+..|...|+.+.   ...+++.+......+..|+|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            357789999999999874  46678999876432      456778888888773   3567788888877889999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG  270 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~g  270 (291)
                      |++|..+.          .    ....++..+|+-||..+
T Consensus       112 ~l~G~~~~----------~----~~~~~lG~~LA~LH~~~  137 (312)
T 3jr1_A          112 ALNKSKNK----------Q----SSFTIFAEKIAQLHQIQ  137 (312)
T ss_dssp             CCCCCCCC----------T----THHHHHHHHHHHHHHCC
T ss_pred             eccCCCCC----------c----hhHHHHHHHHHHHHcCC
Confidence            99998641          1    13457888889999864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.25  E-value=0.0049  Score=54.21  Aligned_cols=71  Identities=7%  Similarity=-0.042  Sum_probs=41.4

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCe-eEEeEEEEeCCEEEEEEecc-
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVLDFV-  232 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-  232 (291)
                      ++.|+.|....+|++      ..+++|+........    -....|..+++.+...++ .+++..  +...-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence            578889999999998      458899876432110    012346666655521111 455443  333357899999 


Q ss_pred             CCCCH
Q 022853          233 NGGHL  237 (291)
Q Consensus       233 ~gg~L  237 (291)
                      +|.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.25  E-value=0.012  Score=51.88  Aligned_cols=78  Identities=10%  Similarity=0.111  Sum_probs=44.2

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-----CCCeeEEe-E--EEEeCC
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----HPFIVQLR-Y--SFQTKY  223 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~-~--~~~~~~  223 (291)
                      ..-.+.|+.|....+|++...+ + .+++|+.....  .   .+.+..|..++..+.     -|.++... +  +....+
T Consensus        24 ~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g   96 (322)
T 2ppq_A           24 LTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG   96 (322)
T ss_dssp             EEEEEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred             ceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence            4456778889889999987632 3 68899886531  1   123445666665542     23333210 0  123356


Q ss_pred             EEEEEEeccCCCC
Q 022853          224 RLYLVLDFVNGGH  236 (291)
Q Consensus       224 ~~~lV~E~~~gg~  236 (291)
                      ..+++|+|++|..
T Consensus        97 ~~~~l~~~l~G~~  109 (322)
T 2ppq_A           97 RPAALISFLEGMW  109 (322)
T ss_dssp             EEEEEEECCCCBC
T ss_pred             EEEEEEEeCCCcC
Confidence            7899999999864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.53  E-value=0.039  Score=48.70  Aligned_cols=75  Identities=13%  Similarity=0.161  Sum_probs=44.9

Q ss_pred             EEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCC--CeeEEeEE-----EEeCCEEEEE
Q 022853          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIVQLRYS-----FQTKYRLYLV  228 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~-----~~~~~~~~lV  228 (291)
                      ..++ |....||++... .|+.+++|+.......    .+.+..|..++..+...  .+++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3455 777899987543 3557999998643221    23345577666655211  13333322     2345677899


Q ss_pred             EeccCCCC
Q 022853          229 LDFVNGGH  236 (291)
Q Consensus       229 ~E~~~gg~  236 (291)
                      |++++|..
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998853

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.47  E-value=0.034  Score=51.74  Aligned_cols=73  Identities=11%  Similarity=0.087  Sum_probs=47.3

Q ss_pred             EEEEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEE
Q 022853          154 VLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRL  225 (291)
Q Consensus       154 i~~~LG~G~fg~Vy~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  225 (291)
                      -++.|+.|....+|++....       .+..+++|+.....  .   .+.+..|..+++.+. +.-.+++++.+.  +  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence            35678889899999998653       25779999884321  1   123446888887763 322356665543  2  


Q ss_pred             EEEEeccCCC
Q 022853          226 YLVLDFVNGG  235 (291)
Q Consensus       226 ~lV~E~~~gg  235 (291)
                      .+|+||++|.
T Consensus       148 g~v~e~l~G~  157 (429)
T 1nw1_A          148 GRLEEYIPSR  157 (429)
T ss_dssp             EEEECCCCEE
T ss_pred             CEEEEEeCCc
Confidence            3899999864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.43  E-value=0.013  Score=53.70  Aligned_cols=74  Identities=9%  Similarity=0.046  Sum_probs=42.2

Q ss_pred             EEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEE
Q 022853          156 KVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l  227 (291)
                      +.|..|-...+|++....       .++.+++|+.-...    .....+.+|..+++.+. +.-..++++.+.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            467778888899887642       34679999853211    11334557888887762 3333566655533    28


Q ss_pred             EEeccCCCCH
Q 022853          228 VLDFVNGGHL  237 (291)
Q Consensus       228 V~E~~~gg~L  237 (291)
                      ||||++|.+|
T Consensus       128 v~e~i~G~~l  137 (379)
T 3feg_A          128 LEQYIPSRPL  137 (379)
T ss_dssp             EEECCSEEEC
T ss_pred             EEEEecCccC
Confidence            9999998644

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=94.96  E-value=0.033  Score=49.43  Aligned_cols=75  Identities=5%  Similarity=-0.054  Sum_probs=34.5

Q ss_pred             EEecccCceE-EEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-C-CCeeEEeEEEEeCCEEEEEEecc
Q 022853          156 KVVGQGAFAK-VYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-H-PFIVQLRYSFQTKYRLYLVLDFV  232 (291)
Q Consensus       156 ~~LG~G~fg~-Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-H-pnIv~l~~~~~~~~~~~lV~E~~  232 (291)
                      +.|+.|.... +|+... .++..+++|.......      +.+..|+.++..+. + -.+.+++......+  +++||++
T Consensus        24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l   94 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL   94 (333)
T ss_dssp             CC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred             eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence            3454444443 556543 2255677776544320      12334555555542 1 22445554422233  7899999


Q ss_pred             CCCCHHH
Q 022853          233 NGGHLFF  239 (291)
Q Consensus       233 ~gg~L~~  239 (291)
                      .+..+..
T Consensus        95 ~~~~l~~  101 (333)
T 3csv_A           95 GDALFTE  101 (333)
T ss_dssp             CSCBHHH
T ss_pred             CCcchHH
Confidence            7766543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.73  E-value=0.12  Score=46.19  Aligned_cols=68  Identities=16%  Similarity=0.070  Sum_probs=40.6

Q ss_pred             cccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC---CCCCeeEEeEE------EEeCCEEEEEE
Q 022853          159 GQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYS------FQTKYRLYLVL  229 (291)
Q Consensus       159 G~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~------~~~~~~~~lV~  229 (291)
                      |.|....||++... .+ .+++|+......         ..|..++..|   .-|++++.+..      ....+..+++|
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~  100 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY  100 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence            33446899998753 34 799998876542         2344444433   22324443321      23457889999


Q ss_pred             eccCCCCH
Q 022853          230 DFVNGGHL  237 (291)
Q Consensus       230 E~~~gg~L  237 (291)
                      +|++|..+
T Consensus       101 ~~i~G~~~  108 (339)
T 3i1a_A          101 PFIHAPNG  108 (339)
T ss_dssp             ECCCCCBT
T ss_pred             eccCCCcC
Confidence            99998754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=94.66  E-value=0.032  Score=50.39  Aligned_cols=74  Identities=14%  Similarity=0.077  Sum_probs=41.8

Q ss_pred             EEEecccCceEEEEEEEcC--------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCC-eeEEeEEEEeCCEE
Q 022853          155 LKVVGQGAFAKVYQVRRIG--------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYRL  225 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~  225 (291)
                      .+.|+.|....+|++....        .+..+++|+.......    ......|..+++.+...+ ..++++.+  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            4577888889999987643        1257889987543211    101245777777663222 44565443  22  


Q ss_pred             EEEEeccCCCC
Q 022853          226 YLVLDFVNGGH  236 (291)
Q Consensus       226 ~lV~E~~~gg~  236 (291)
                      ++||||++|..
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999998753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=84.57  E-value=4.7  Score=37.53  Aligned_cols=100  Identities=13%  Similarity=0.171  Sum_probs=59.7

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCe-eEEeEEEEeCCEEEEEEeccC
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVLDFVN  233 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~  233 (291)
                      ++.|+.|-...+|++.....+..+++|+.......-   .+ ...|..++..|...++ +++++.+  .+  .+||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---id-R~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---IN-REREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SC-HHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cC-HHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeC
Confidence            467888999999999875545788999874322100   01 1468888888754444 5676665  23  25999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 022853          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG  270 (291)
Q Consensus       234 gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~g  270 (291)
                      |.+|..    ......    .++.+++..|.-||...
T Consensus       185 G~~l~~----~~l~~~----~~~~~ia~~La~LH~~~  213 (458)
T 2qg7_A          185 GYALSR----EDIKNP----KFQKLIAKNLKLLHDIK  213 (458)
T ss_dssp             SEECCT----TTTTSH----HHHHHHHHHHHHHHTCC
T ss_pred             CccCCh----hhcCCH----HHHHHHHHHHHHHhcCC
Confidence            865521    111111    24556777777787643

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.33  E-value=0.15  Score=47.88  Aligned_cols=57  Identities=4%  Similarity=-0.016  Sum_probs=13.6

Q ss_pred             ceEEEEEEEcCCCcEEEE------EEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE
Q 022853          163 FAKVYQVRRIGTSEIYAM------KVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (291)
Q Consensus       163 fg~Vy~~~~~~~~~~vAi------K~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  220 (291)
                      ||.||++.+......||+      |..+.... ..+....+.+|..++..++|||+++.+.+..
T Consensus       152 fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          152 YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence            999999988765567888      65543322 2233445677888999999999999877654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	291
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-50
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-45
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-44
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-42
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-41
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-41
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-40
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-37
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-37
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-37
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-37
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-36
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-35
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-35
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-34
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-34
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-34
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-34
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-34
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-33
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-33
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-32
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-32
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-32
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-31
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-30
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-29
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-29
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-28
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-28
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-27
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-15

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 9e-50
 Identities = 62/141 (43%), Positives = 95/141 (67%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 270 GIMHRDLKPENILLDADGHVR 290
           GI+HRDLKPENILL+ D H++
Sbjct: 128 GIIHRDLKPENILLNEDMHIQ 148

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (402), Expect = 5e-48
 Identities = 46/142 (32%), Positives = 82/142 (57%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + + 
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H+
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRD+KPEN+LL + G ++
Sbjct: 125 KRVIHRDIKPENLLLGSAGELK 146

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  157 bits (398), Expect = 3e-46
 Identities = 61/145 (42%), Positives = 89/145 (61%), Gaps = 3/145 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V 
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  + H
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           +H   +++RDLKP NILLD  GHVR
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVR 147

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (391), Expect = 8e-46
 Identities = 37/141 (26%), Positives = 67/141 (47%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P  +Q R  +  ++  +LV+++  G         +   +E      T   +  +++LH++
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 270 GIMHRDLKPENILLDADGHVR 290
            ++HRD+K  NILL   G V+
Sbjct: 135 NMIHRDVKAGNILLSEPGLVK 155

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 9e-45
 Identities = 40/142 (28%), Positives = 79/142 (55%), Gaps = 2/142 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLN 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 269 NGIMHRDLKPENILLDADGHVR 290
            GI HRD+KPEN+LLD   +++
Sbjct: 122 IGITHRDIKPENLLLDERDNLK 143

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-44
 Identities = 33/142 (23%), Positives = 73/142 (51%), Gaps = 3/142 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +  +G G    V++V    +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-A 268
           P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 269 NGIMHRDLKPENILLDADGHVR 290
           + IMHRD+KP NIL+++ G ++
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIK 145

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-44
 Identities = 65/144 (45%), Positives = 98/144 (68%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  +++RD+K EN++LD DGH++
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIK 145

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (380), Expect = 3e-44
 Identities = 54/142 (38%), Positives = 95/142 (66%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+DF++L+ +G G+F +V+ +R       YAMKV++K+ ++     E+   ER +L+ V 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFI+++  +FQ   ++++++D++ GG LF  L +   F   +A+ Y AE+  A+ +LH+
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             I++RDLKPENILLD +GH++
Sbjct: 123 KDIIYRDLKPENILLDKNGHIK 144

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (382), Expect = 4e-44
 Identities = 58/149 (38%), Positives = 95/149 (63%), Gaps = 1/149 (0%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQNT-AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHV 289
               +LH+  +++RDLKPEN+L+D  G++
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYI 180

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (376), Expect = 8e-44
 Identities = 44/142 (30%), Positives = 76/142 (53%), Gaps = 4/142 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E++  +G GAF KVY+ +   TS + A KV+       +   E    E +IL   DH
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDH 68

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
           P IV+L  +F  +  L+++++F  GG +   +   +    E   ++   + + A+++LH 
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 269 NGIMHRDLKPENILLDADGHVR 290
           N I+HRDLK  NIL   DG ++
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIK 150

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  147 bits (372), Expect = 1e-42
 Identities = 38/140 (27%), Positives = 72/140 (51%), Gaps = 4/140 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 81

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++  +     ED A  Y  ++   + H+H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 268 ANGIMHRDLKPENILLDADG 287
            N  +H DLKPENI+     
Sbjct: 142 ENNYVHLDLKPENIMFTTKR 161

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  145 bits (366), Expect = 2e-42
 Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 7/148 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK------SERNI 203
           E++E  +++G+G  + V +     T + YA+K++        +  E  +       E +I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 204 LTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           L KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E   R     ++  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           +  LH   I+HRDLKPENILLD D +++
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIK 150

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-41
 Identities = 38/141 (26%), Positives = 70/141 (49%), Gaps = 4/141 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +   + +GQGA   VY    + T +  A++ M   +  +K   E + +E  ++ +  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV    S+     L++V++++ GG L   +       E        E + A+  LH+N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN 135

Query: 270 GIMHRDLKPENILLDADGHVR 290
            ++HRD+K +NILL  DG V+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVK 156

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  143 bits (361), Expect = 4e-41
 Identities = 37/141 (26%), Positives = 76/141 (53%), Gaps = 4/141 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            + +++L+ +G GAF  V++     T  ++  K +     ++K     +K+E +I+ ++ 
Sbjct: 28  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLH 84

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLH 267
           HP ++ L  +F+ KY + L+L+F++GG LF ++  +     E     Y  +    + H+H
Sbjct: 85  HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144

Query: 268 ANGIMHRDLKPENILLDADGH 288
            + I+H D+KPENI+ +    
Sbjct: 145 EHSIVHLDIKPENIMCETKKA 165

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 7e-41
 Identities = 52/143 (36%), Positives = 90/143 (62%), Gaps = 1/143 (0%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           +EDF + K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E+ +L+   
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           +HPF+  +  +FQTK  L+ V++++NGG L + +     F    A  Y AEI+  +  LH
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           + GI++RDLK +NILLD DGH++
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIK 143

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-40
 Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 12/152 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKH 62

Query: 210 PFIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAV 263
           P IV+       +T   LY+V+++  GG L   + +    +    E+       ++  A+
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 264 SHLH-----ANGIMHRDLKPENILLDADGHVR 290
              H      + ++HRDLKP N+ LD   +V+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 7e-40
 Identities = 74/156 (47%), Positives = 110/156 (70%), Gaps = 5/156 (3%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHA- 194
           NL    + VG+E+FE+LKV+G GA+ KV+ VR+I    T ++YAMKV++K  I++K    
Sbjct: 13  NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72

Query: 195 EYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E+ ++ER +L  +   PF+V L Y+FQT+ +L+L+LD++NGG LF  L ++  F E   +
Sbjct: 73  EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ 132

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           IY  EIV A+ HLH  GI++RD+K ENILLD++GHV
Sbjct: 133 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV 168

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  136 bits (344), Expect = 3e-39
 Identities = 37/144 (25%), Positives = 73/144 (50%), Gaps = 4/144 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 210 PFIVQLRYSFQTK----YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           P IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++ 
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 266 LHANGIMHRDLKPENILLDADGHV 289
            H NGI+HRD+KP NI++ A   V
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAV 150

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (337), Expect = 5e-38
 Identities = 48/144 (33%), Positives = 80/144 (55%), Gaps = 5/144 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + ++   V+G GAF++V       T ++ A+K + K  +  K     M++E  +L K+ H
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKH 66

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV L   +++   LYL++  V+GG LF ++  +G + E  A     +++ AV +LH  
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 270 GIMHRDLKPENILL---DADGHVR 290
           GI+HRDLKPEN+L    D D  + 
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIM 150

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 7e-38
 Identities = 41/140 (29%), Positives = 67/140 (47%), Gaps = 2/140 (1%)

Query: 153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA--EYMKSERNILTKVDHP 210
           E L  +G+G FA VY+ R   T++I A+K ++     E           E  +L ++ HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I+ L  +F  K  + LV DF+             +      + Y    +  + +LH + 
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 271 IMHRDLKPENILLDADGHVR 290
           I+HRDLKP N+LLD +G ++
Sbjct: 121 ILHRDLKPNNLLLDENGVLK 140

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-37
 Identities = 32/142 (22%), Positives = 65/142 (45%), Gaps = 5/142 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + + + +G+G F  V++     + + Y  K ++     +      +K E +IL    H
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHA 268
             I+ L  SF++   L ++ +F++G  +F ++        E     Y  ++  A+  LH+
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 269 NGIMHRDLKPENILLDADGHVR 290
           + I H D++PENI+        
Sbjct: 121 HNIGHFDIRPENIIYQTRRSST 142

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-37
 Identities = 34/147 (23%), Positives = 71/147 (48%), Gaps = 10/147 (6%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + +++ ++L+ +G+G F  V      G     A+K ++ D   +        +E +++T+
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQA-----FLAEASVMTQ 56

Query: 207 VDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            +L  N  +HRDL   N+L+  D   +
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAK 143

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-37
 Identities = 35/142 (24%), Positives = 59/142 (41%), Gaps = 6/142 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
               V + +G G+F  VY+ +  G     A+K++       +    +   E  +L K  H
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRH 63

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHA 268
             I+     + T  +L +V  +  G  L+  L+  +  F          +    + +LHA
Sbjct: 64  VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             I+HRDLK  NI L  D  V+
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVK 144

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-37
 Identities = 43/141 (30%), Positives = 73/141 (51%), Gaps = 3/141 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + ++  + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           + HP ++ L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +L
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 267 HANGIMHRDLKPENILLDADG 287
           H+  I H DLKPENI+L    
Sbjct: 130 HSLQIAHFDLKPENIMLLDRN 150

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (330), Expect = 4e-37
 Identities = 31/146 (21%), Positives = 62/146 (42%), Gaps = 6/146 (4%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +   D  +   +G G + +VY+      S   A+K +++D +  +        E  ++ +
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKE 69

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVS 264
           + HP +VQL      +   Y++ +F+  G+L   L           +      +I SA+ 
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 265 HLHANGIMHRDLKPENILLDADGHVR 290
           +L     +HRDL   N L+  +  V+
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVK 155

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 8e-37
 Identities = 33/140 (23%), Positives = 72/140 (51%), Gaps = 1/140 (0%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   ++        E  +L ++ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     +  +L LV +F +     +     G    ++ + +  +++  +   H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 269 NGIMHRDLKPENILLDADGH 288
             ++HRDLKP+N+L++ +G 
Sbjct: 120 RNVLHRDLKPQNLLINRNGE 139

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-36
 Identities = 34/148 (22%), Positives = 65/148 (43%), Gaps = 5/148 (3%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +G +D  +L+ +G G+F  V +       G +   A+K ++ D + +    +    E N 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSA 262
           +  +DH  +++L Y       + +V +    G L  +L   QG F       Y  ++   
Sbjct: 65  MHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + +L +   +HRDL   N+LL     V+
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVK 151

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 5e-36
 Identities = 40/143 (27%), Positives = 83/143 (58%), Gaps = 2/143 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVN-GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           ++ ++HRDLKP+N+L++ +G ++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIK 142

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 1e-35
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 9/153 (5%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
           C  +  +E L  +GQG F +V++ R   T +  A+K +  +   E      ++ E  IL 
Sbjct: 6   CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQ 64

Query: 206 KVDHPFIVQLRYSFQT--------KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
            + H  +V L    +T        K  +YLV DF               F     +    
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +++ + ++H N I+HRD+K  N+L+  DG ++
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 157

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-35
 Identities = 44/147 (29%), Positives = 75/147 (51%), Gaps = 16/147 (10%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            +   KV+G G+F  VYQ +   + E+ A+K + +DK  +         E  I+ K+DH 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73

Query: 211 FIVQLRYSFQT------KYRLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVS 261
            IV+LRY F +      +  L LVLD+V         +    +        ++Y  ++  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 262 AVSHLHANGIMHRDLKPENILLDADGH 288
           +++++H+ GI HRD+KP+N+LLD D  
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTA 160

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  126 bits (316), Expect = 4e-35
 Identities = 37/142 (26%), Positives = 78/142 (54%), Gaps = 2/142 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRDLKP+N+L++ +G ++
Sbjct: 119 RRVLHRDLKPQNLLINREGELK 140

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 5e-35
 Identities = 38/146 (26%), Positives = 69/146 (47%), Gaps = 8/146 (5%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
            +    +G+G+F  VY+     T+   A   ++  K + K+  +  K E  +L  + HP 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPN 69

Query: 212 IVQLRYSFQT----KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV+   S+++    K  + LV + +  G L   L R  + +  + R +  +I+  +  LH
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 268 ANG--IMHRDLKPENILLDA-DGHVR 290
                I+HRDLK +NI +    G V+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVK 155

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 8e-35
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 16/148 (10%)

Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +        E  +  + 
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 61

Query: 208 -DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIV 260
              P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I 
Sbjct: 62  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGH 288
            A+ +LH+  I HRD+KPEN+L  +   
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRP 149

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-34
 Identities = 31/143 (21%), Positives = 58/143 (40%), Gaps = 2/143 (1%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--DKIMEKNHAEYMKSERNILTKV 207
            +F+ +KV+G GAF  VY+   I   E   + V  K   +       + +  E  ++  V
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           D+P + +L     T     +      G  L +    +          +  +I   +++L 
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 268 ANGIMHRDLKPENILLDADGHVR 290
              ++HRDL   N+L+    HV+
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVK 151

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-34
 Identities = 40/143 (27%), Positives = 71/143 (49%), Gaps = 6/143 (4%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN---HAEYMKSERNILTKV 207
            ++V  ++G G F  VY   R+  +   A+K + KD+I +     +   +  E  +L KV
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 208 D--HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVS 264
                 +++L   F+      L+L+        F    + G  +E+LAR +  +++ AV 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 265 HLHANGIMHRDLKPENILLDADG 287
           H H  G++HRD+K ENIL+D + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNR 147

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 3e-34
 Identities = 30/142 (21%), Positives = 66/142 (46%), Gaps = 6/142 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            +   ++ +G G F  V+    +   +  A+K +R+  + E++       E  ++ K+ H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED----FIEEAEVMMKLSH 59

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P +VQL      +  + LV +F+  G L  +   ++GLF  +       ++   +++L  
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 269 NGIMHRDLKPENILLDADGHVR 290
             ++HRDL   N L+  +  ++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIK 141

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (311), Expect = 3e-34
 Identities = 29/148 (19%), Positives = 60/148 (40%), Gaps = 6/148 (4%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           + +   ++ +V+G G F +V         +     A+K ++      +       SE +I
Sbjct: 23  IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASI 80

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSA 262
           + + DHP ++ L         + ++ +F+  G L  F     G F           I + 
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + +L     +HRDL   NIL++++   +
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCK 168

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 3e-34
 Identities = 30/142 (21%), Positives = 63/142 (44%), Gaps = 6/142 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  +  A+K++++  + E         E  ++  + H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDE----FIEEAKVMMNLSH 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHA 268
             +VQL      +  ++++ +++  G L   L   +  F+         ++  A+ +L +
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 269 NGIMHRDLKPENILLDADGHVR 290
              +HRDL   N L++  G V+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVK 140

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 8e-34
 Identities = 32/167 (19%), Positives = 62/167 (37%), Gaps = 17/167 (10%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P+    +   D +   V+G+G F +V + R           + R  +   K+       E
Sbjct: 1   PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE 60

Query: 201 RNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--------------- 244
             +L K+  HP I+ L  + + +  LYL +++   G+L   L +                
Sbjct: 61  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 245 -GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
                      + A++   + +L     +HRDL   NIL+  +   +
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 2e-33
 Identities = 30/143 (20%), Positives = 65/143 (45%), Gaps = 3/143 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE-IYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           E  E+ + +G+G F  V+Q   +       A+ +         +  E    E   + + D
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+  ++++++    G L  F   R+         +Y  ++ +A+++L 
Sbjct: 67  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 268 ANGIMHRDLKPENILLDADGHVR 290
           +   +HRD+   N+L+ ++  V+
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVK 148

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 3e-33
 Identities = 28/143 (19%), Positives = 69/143 (48%), Gaps = 8/143 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++++ +G G F +V+     G ++  A+K +++  +          +E N++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA----FLAEANLMKQLQH 67

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++ + 
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 268 ANGIMHRDLKPENILLDADGHVR 290
               +HRDL+  NIL+      +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCK 149

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 3e-33
 Identities = 28/144 (19%), Positives = 60/144 (41%), Gaps = 9/144 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +  L  +G+GA+  V            A+K +   +   + + +    E  IL +  H  
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHEN 67

Query: 212 IVQLRYSFQTKY-----RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           I+ +    +         +YLV   +      ++L +      D    +  +I+  + ++
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADL--YKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 267 HANGIMHRDLKPENILLDADGHVR 290
           H+  ++HRDLKP N+LL+    ++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLK 149

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 5e-33
 Identities = 35/147 (23%), Positives = 63/147 (42%), Gaps = 9/147 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
             +  L+ VG GA+  V       T    A+K + +    E       + E  +L  + H
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRH 76

Query: 210 PFIVQLRYSFQTK------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F            YLV+ F+  G    +L +     ED  +    +++  +
Sbjct: 77  ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134

Query: 264 SHLHANGIMHRDLKPENILLDADGHVR 290
            ++HA GI+HRDLKP N+ ++ D  ++
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELK 161

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-32
 Identities = 33/154 (21%), Positives = 71/154 (46%), Gaps = 9/154 (5%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMK--SERN 202
           C   + +E +  +G+GA+ KV++ R +       A+K +R     E      ++  +   
Sbjct: 3   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62

Query: 203 ILTKVDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYT 256
            L   +HP +V+L           + +L LV + V+     +     +     +  +   
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
            +++  +  LH++ ++HRDLKP+NIL+ + G ++
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 156

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-32
 Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 8/143 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E   +   +GQG F +V+     GT+   A+K ++   +  +        E  ++ K+ H
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA----FLQEAQVMKKLRH 71

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLH 267
             +VQL Y+  ++  +Y+V ++++ G L   L  +     R        A+I S ++++ 
Sbjct: 72  EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 268 ANGIMHRDLKPENILLDADGHVR 290
               +HRDL+  NIL+  +   +
Sbjct: 131 RMNYVHRDLRAANILVGENLVCK 153

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 4e-32
 Identities = 34/167 (20%), Positives = 60/167 (35%), Gaps = 27/167 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMK---VMRKDKIMEKNHAEYMKSERNILTK 206
           E+ E  KV+G GAF KV      G S+        V    +  + +  E + SE  ++T+
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--------------------- 244
           +  H  IV L  +      +YL+ ++   G L   L  +                     
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 245 --GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
              +   +    +  ++   +  L     +HRDL   N+L+     V
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 203

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 5e-32
 Identities = 29/150 (19%), Positives = 67/150 (44%), Gaps = 8/150 (5%)

Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           + + + LED    K +G G F  V +   +     +  A+K+++ +   +    + + +E
Sbjct: 4   DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAE 58

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
            N++ ++D+P+IV++           LV++    G L   L +    ++        ++ 
Sbjct: 59  ANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVR 290
             + +L  +  +HRDL   N+LL    + +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAK 147

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 5e-32
 Identities = 36/144 (25%), Positives = 60/144 (41%), Gaps = 7/144 (4%)

Query: 150 EDFEVLKVV-GQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ++  +  +  G G F  V Q   R        A+KV+++    EK   E M  E  I+ +
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQ 65

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSH 265
           +D+P+IV+L    Q    L LV++   GG L   L  +              ++   + +
Sbjct: 66  LDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124

Query: 266 LHANGIMHRDLKPENILLDADGHV 289
           L     +HRDL   N+LL    + 
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYA 148

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (297), Expect = 5e-32
 Identities = 38/143 (26%), Positives = 73/143 (51%), Gaps = 12/143 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
           +D+++++ +G+G +++V++   I  +E   +K+++  K       + +K E  IL  +  
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRG 88

Query: 209 HPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            P I+ L    +        LV + VN      QLY+     +   R Y  EI+ A+ + 
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQT--LTDYDIRFYMYEILKALDYC 145

Query: 267 HANGIMHRDLKPENILLDADGHV 289
           H+ GIMHRD+KP N+++D +   
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRK 168

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-31
 Identities = 32/145 (22%), Positives = 60/145 (41%), Gaps = 5/145 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKH 76

Query: 210 PFIVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             ++ L   F     L     + L     G     + +     +D  +    +I+  + +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 266 LHANGIMHRDLKPENILLDADGHVR 290
           +H+  I+HRDLKP N+ ++ D  ++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELK 161

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 2e-31
 Identities = 31/163 (19%), Positives = 59/163 (36%), Gaps = 26/163 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
                 K +G GAF KV +    G      +   A+K+++    +     E + SE  +L
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80

Query: 205 TKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL----------------- 246
           + + +H  IV L  +        ++ ++   G L   L R+                   
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 247 -FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
               +    ++ ++   ++ L +   +HRDL   NILL     
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (287), Expect = 8e-31
 Identities = 23/138 (16%), Positives = 53/138 (38%), Gaps = 6/138 (4%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP- 210
           + + + +G G+F  +Y    I   E  A+K+        +     +  E  I   +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 63

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I  +R+         +V++ +         +    F      +   +++S + ++H+  
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 271 IMHRDLKPENILLDADGH 288
            +HRD+KP+N L+     
Sbjct: 124 FIHRDVKPDNFLMGLGKK 141

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (287), Expect = 2e-30
 Identities = 35/148 (23%), Positives = 66/148 (44%), Gaps = 10/148 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 74

Query: 209 HPFIVQLRYSFQTK------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +        +YLV++ ++          Q     +       +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCG 131

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVR 290
           + HLH+ GI+HRDLKP NI++ +D  ++
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLK 159

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (276), Expect = 3e-29
 Identities = 29/170 (17%), Positives = 65/170 (38%), Gaps = 31/170 (18%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
            + E ++ +G+GAF +V+Q R  G        + A+K+++++     +     + E  ++
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 70

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL------------------ 246
            + D+P IV+L         + L+ +++  G L   L                       
Sbjct: 71  AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 247 ------FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
                            ++ + +++L     +HRDL   N L+  +  V+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 180

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 4e-29
 Identities = 28/146 (19%), Positives = 56/146 (38%), Gaps = 7/146 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILT 205
                 KV+G G F +VY+     +S       A+K ++      +        E  I+ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMG 64

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVS 264
           +  H  I++L         + ++ +++  G    F   + G F           I + + 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 265 HLHANGIMHRDLKPENILLDADGHVR 290
           +L     +HRDL   NIL++++   +
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCK 150

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  109 bits (274), Expect = 5e-29
 Identities = 23/138 (16%), Positives = 57/138 (41%), Gaps = 6/138 (4%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-P 210
           ++V + +G+G+F  +++   +  ++  A+K   +     ++ A  ++ E      +    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I  + Y  Q      LV+D +              F      +   ++++ V  +H   
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 271 IMHRDLKPENILLDADGH 288
           +++RD+KP+N L+     
Sbjct: 122 LVYRDIKPDNFLIGRPNS 139

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-28
 Identities = 29/164 (17%), Positives = 64/164 (39%), Gaps = 24/164 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE-------IYAMKVMRKDKIMEKNHAEYMKSERN 202
           +   + K +G+GAF +V     IG  +         A+K+++ D   EK+ ++ +     
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEM 71

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------L 246
           +     H  I+ L  +      LY+++++ + G+L   L  +                  
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
                      ++   + +L +   +HRDL   N+L+  D  ++
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 175

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-28
 Identities = 31/163 (19%), Positives = 62/163 (38%), Gaps = 23/163 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +  ++ K +G+GAF +V +    G     T    A+K++++       H   M   + ++
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILI 71

Query: 205 TKVDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LF 247
               H  +V L     +    L ++++F   G+L   L  +                   
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
             +    Y+ ++   +  L +   +HRDL   NILL     V+
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 174

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 9e-28
 Identities = 35/153 (22%), Positives = 64/153 (41%), Gaps = 19/153 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
               + + +G+G F +V++ +     E  A+K+    +        + ++E      + H
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRH 56

Query: 210 PFIVQLRYSFQ----TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             I+    +      T  +L+LV D+   G LF  L R  +  E + ++      S ++H
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA-LSTASGLAH 115

Query: 266 LHA--------NGIMHRDLKPENILLDADGHVR 290
           LH           I HRDLK +NIL+  +G   
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 2e-27
 Identities = 29/159 (18%), Positives = 61/159 (38%), Gaps = 17/159 (10%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVR-----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           V  E   + + +GQG+F  VY+       +       A+K + +   M +       +E 
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEA 74

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---------- 251
           +++ + +   +V+L           ++++ +  G L   L        +           
Sbjct: 75  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR 290
                 EI   +++L+AN  +HRDL   N ++  D  V+
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 6e-25
 Identities = 29/140 (20%), Positives = 56/140 (40%), Gaps = 7/140 (5%)

Query: 156 KVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           +V+G+G F  VY    +   G     A+K +  ++I +        +E  I+    HP +
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 213 VQL-RYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           + L     +++    +VL ++  G L  F               +  ++   +  L +  
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150

Query: 271 IMHRDLKPENILLDADGHVR 290
            +HRDL   N +LD    V+
Sbjct: 151 FVHRDLAARNCMLDEKFTVK 170

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.8 bits (242), Expect = 6e-24
 Identities = 27/150 (18%), Positives = 64/150 (42%), Gaps = 13/150 (8%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-------L 204
           + +++ +G G F+ V+  + +  +   AMK++R DK+  +   + +K  + +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH-----LFFQLYRQGLFREDLARIYTAEI 259
             +    I++L   F  K    + +  V            + Y          +  + ++
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 260 VSAVSHLHAN-GIMHRDLKPENILLDADGH 288
           +  + ++H   GI+H D+KPEN+L++    
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDS 164

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 70.6 bits (172), Expect = 3e-15
 Identities = 20/148 (13%), Positives = 49/148 (33%), Gaps = 19/148 (12%)

Query: 153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-------HAEYMKSERNILT 205
            + K++G+G  + V+            +K  +      K           +         
Sbjct: 3   AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 206 KVDHPFIVQLRYSFQTK----YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           + +   + +L+     K        ++++ ++   L+         R +        I+ 
Sbjct: 62  RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR-------VRVENPDEVLDMILE 114

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHV 289
            V+  +  GI+H DL   N+L+  +G  
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEGIW 142

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	291
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.98
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.97
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.97
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.96
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.96
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.96
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.96
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.95
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.95
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.95
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.94
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.89
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.11
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.49
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.18
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.15
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	91.46

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-35  Score=260.84  Aligned_cols=142  Identities=32%  Similarity=0.584  Sum_probs=133.4

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++.+.||+|+||+||+|+++.+++.||+|++.+....+....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            57899999999999999999999999999999999876555555567788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||++|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~k  146 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELK  146 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEe
Confidence            99999999999999888999999999999999999999999999999999999999999876

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-35  Score=268.04  Aligned_cols=144  Identities=45%  Similarity=0.819  Sum_probs=135.5

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      +.+++|++++.||+|+||.||+|+++.+++.||||++++.........+.+.+|+.+|++++||||++++++|+++..+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            45779999999999999999999999999999999998776555555677889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|||||+||+|..++.+.+.+++..++.+++||+.||+|||++|||||||||+|||++.+|++|
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vk  145 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK  145 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEE
Confidence            9999999999999999999999999999999999999999999999999999999999999886

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-35  Score=260.86  Aligned_cols=140  Identities=29%  Similarity=0.460  Sum_probs=127.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+....  +..+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            46899999999999999999999999999999999765432  2345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~K  143 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLK  143 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEE
Confidence            99999999999988888899999999999999999999999999999999999999999876

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-35  Score=260.46  Aligned_cols=142  Identities=44%  Similarity=0.801  Sum_probs=133.2

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+.+|+.++++++||||++++++|.+++.+|+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            36799999999999999999999999999999999876655555567789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+||+|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.+|++|
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vk  148 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQ  148 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEE
Confidence            99999999999999989999999999999999999999999999999999999999999876

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-34  Score=257.85  Aligned_cols=140  Identities=26%  Similarity=0.395  Sum_probs=131.7

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEe
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  230 (291)
                      .|++++.||+|+||.||+|++..+++.||||++.+.........+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999988776666667788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       231 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||.+|+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++|
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~K  155 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK  155 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEE
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEE
Confidence            999999987778888899999999999999999999999999999999999999998876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-34  Score=259.76  Aligned_cols=143  Identities=38%  Similarity=0.741  Sum_probs=133.6

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+++.++||||+++++++.+++.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            35789999999999999999999999999999999987655444556778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||||.||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vk  144 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIK  144 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEE
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEE
Confidence            999999999999999999999999999999999999999999999999999999999999886

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-34  Score=259.61  Aligned_cols=141  Identities=23%  Similarity=0.427  Sum_probs=130.3

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++++..  .....+.+.+|+.+|+.++|||||+++++|.++..+|+
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3568999999999999999999999999999999997653  23345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||||+||+|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++|
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vk  145 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK  145 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEE
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEE
Confidence            99999999999999988899999999999999999999997 4999999999999999999876

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-34  Score=253.53  Aligned_cols=137  Identities=27%  Similarity=0.444  Sum_probs=126.0

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      ++|++++.||+|+||+||+|++..+++.||||++.......   .+.+.+|+.++++++||||++++++|.+++.+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            46999999999999999999999999999999997654322   456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+||+|..++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vk  156 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK  156 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEe
Confidence            99999999887665 5689999999999999999999999999999999999999999876

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-33  Score=252.40  Aligned_cols=138  Identities=32%  Similarity=0.520  Sum_probs=126.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      +.|++++.||+|+||.||+|+++.+++.||+|++++...   ...+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            469999999999999999999999999999999976532   22456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+||+|..++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~K  150 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIK  150 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEE
Confidence            99999999988765 46799999999999999999999999999999999999999999876

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-33  Score=248.47  Aligned_cols=142  Identities=32%  Similarity=0.486  Sum_probs=130.5

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccch------HHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEe
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME------KNHAEYMKSERNILTKVD-HPFIVQLRYSFQT  221 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~  221 (291)
                      .++|++.+.||+|+||+||+|++..+++.||||++++.....      ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999999999999999998754322      233456788999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++.+|+|||||+||+|.+++..++.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~k  150 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK  150 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeE
Confidence            999999999999999999999999999999999999999999999999999999999999999998875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2e-33  Score=248.52  Aligned_cols=141  Identities=26%  Similarity=0.399  Sum_probs=130.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC----EE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~  225 (291)
                      ++|++.+.||+|+||.||+|++..+++.||||++++....+....+.+.+|+.+++.++||||+++++++....    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            57999999999999999999999999999999998877666667778999999999999999999999987654    48


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+||||++|++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~  151 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK  151 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEE
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccce
Confidence            99999999999999999889999999999999999999999999999999999999999887654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8e-34  Score=252.83  Aligned_cols=143  Identities=22%  Similarity=0.317  Sum_probs=130.9

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .|.+..++|++.+.||+|+||.||+|.+..+++.||||+++.+...    .+.+.+|+.+|++++||||+++++++.+++
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence            4667788999999999999999999999999999999999765432    456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+|||||++|+|..++.+.  ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+|
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~K  155 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK  155 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEE
Confidence            999999999999999998764  5678999999999999999999999999999999999999998876

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-33  Score=249.14  Aligned_cols=139  Identities=31%  Similarity=0.466  Sum_probs=128.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  226 (291)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+......   ...+.+.+|+.+|++++||||++++++|.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            469999999999999999999999999999999986543321   23567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC
Q 022853          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~  288 (291)
                      +|||||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~  151 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV  151 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSS
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCC
Confidence            99999999999999998889999999999999999999999999999999999999998774

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-33  Score=256.96  Aligned_cols=142  Identities=39%  Similarity=0.733  Sum_probs=133.4

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            57899999999999999999999999999999999876555545567788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++|
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ik  181 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ  181 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEE
Confidence            99999999999999989999999999999999999999999999999999999999999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-33  Score=252.63  Aligned_cols=142  Identities=37%  Similarity=0.707  Sum_probs=128.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHH-hCCCCCeeEEeEEEEeCCEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      +++|++++.||+|+||+||+|+++.+++.||||++++.........+.+..|..++. .++||||+++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            468999999999999999999999999999999998765444444555666766655 6899999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||||+||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~k  143 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIK  143 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCcee
Confidence            999999999999999989999999999999999999999999999999999999999999876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-33  Score=249.50  Aligned_cols=135  Identities=24%  Similarity=0.423  Sum_probs=124.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++++.||+|+||+||+|.++.+++.||+|++++...    ....+.+|+.+|+.++||||++++++|.+++.+|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            4689999999999999999999999999999999976542    234578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~-~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ||||+||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.++
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~  139 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR  139 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC
Confidence            99999999999987654 799999999999999999999999999999999999998654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.6e-33  Score=256.55  Aligned_cols=143  Identities=40%  Similarity=0.735  Sum_probs=127.7

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHH---HHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~---E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      .+++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+   ++.+++.++||||++++++|.+.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            4679999999999999999999999999999999998665433332333333   4666777899999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+|||||+||+|..++.+...+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+|
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iK  147 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR  147 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEE
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEE
Confidence            999999999999999999999999999999999999999999999999999999999999999886

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-33  Score=246.13  Aligned_cols=141  Identities=28%  Similarity=0.529  Sum_probs=120.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe--CCEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLY  226 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~  226 (291)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+....+ ...+.+.+|+.++++++||||+++++++.+  .+.+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            468999999999999999999999999999999998765543 346778899999999999999999999864  45689


Q ss_pred             EEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CEecccCCCcEEecCCCCcC
Q 022853          227 LVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANG-----IMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       227 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~i~~qil~aL~yLH~~g-----IiHrDLKp~NILl~~~g~vK  290 (291)
                      +|||||+||+|.+++.+    ...+++..++.++.||+.||+|||++|     ||||||||+|||++.+|.+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence            99999999999988864    467999999999999999999999976     99999999999999999886

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-33  Score=250.56  Aligned_cols=139  Identities=33%  Similarity=0.561  Sum_probs=122.7

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  229 (291)
                      +.|++.+.||+|+||+||+|+++.+++.||||++.+.....  ..+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46999999999999999999999999999999998765432  2356778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec---CCCCcC
Q 022853          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD---ADGHVR  290 (291)
Q Consensus       230 E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~---~~g~vK  290 (291)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+.   .+|.+|
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vk  150 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM  150 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEE
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEE
Confidence            9999999999999988999999999999999999999999999999999999995   356665

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.9e-33  Score=252.32  Aligned_cols=139  Identities=27%  Similarity=0.524  Sum_probs=126.2

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++++.||+|+||.||+|+++.+|+.||||++.+...   ...+.+.+|+.+|++++||||++++++|.+++.+|+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            5689999999999999999999999999999999976542   3356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC--CCCcC
Q 022853          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--DGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~--~g~vK  290 (291)
                      ||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++|||||||||+|||++.  +|.+|
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vk  166 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELK  166 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEE
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEE
Confidence            999999999998854 567999999999999999999999999999999999999964  45554

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.1e-33  Score=252.75  Aligned_cols=139  Identities=27%  Similarity=0.528  Sum_probs=125.5

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++++.||+|+||.||+|++..+++.||||++++....   ..+.+.+|+.+|++++||||++++++|.+++.+|+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46799999999999999999999999999999999875432   245678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEec--CCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD--ADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~--~~g~vK  290 (291)
                      ||||+||+|.+.+.+. ..+++..++.++.||+.||+|||++|||||||||+||||+  .+|.||
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vk  169 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVK  169 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEE
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEE
Confidence            9999999998877654 4699999999999999999999999999999999999998  456664

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.4e-32  Score=240.23  Aligned_cols=138  Identities=28%  Similarity=0.442  Sum_probs=124.4

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe----CCEEEE
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRLYL  227 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~l  227 (291)
                      |++.+.||+|+||+||+|++..+++.||+|++...... ....+.+.+|+++|++++||||++++++|.+    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            47888999999999999999999999999999876543 3446678899999999999999999999875    456899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecccCCCcEEecC-CCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDA-DGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKp~NILl~~-~g~vK  290 (291)
                      ||||+++|+|..++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++. +|.+|
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~K  155 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK  155 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEE
Confidence            9999999999999998889999999999999999999999998  999999999999974 67775

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.8e-32  Score=243.68  Aligned_cols=141  Identities=28%  Similarity=0.506  Sum_probs=121.2

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++++.||+|+||+||+|++..+++.||||+++..... ....+.+.+|+.+|++++||||++++++|.++..+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            46899999999999999999999999999999999765422 22345678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.++.+...... ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+|
T Consensus        80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~k  142 (298)
T d1gz8a_          80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK  142 (298)
T ss_dssp             EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcce
Confidence            999987655444333 45689999999999999999999999999999999999999998775

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=5.6e-32  Score=242.14  Aligned_cols=142  Identities=20%  Similarity=0.311  Sum_probs=124.1

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      +..++|++.+.||+|+||+||+|+++.+++   .||||.+....  .....+.+.+|+.+|++++|||||++++++.+++
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            345689999999999999999999987654   58888876543  2344567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+|||||++|+|..++... +.+++..+..++.||+.||+|||++||+||||||+||||+.+|.+|
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~K  168 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCK  168 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEE
Confidence            999999999999999888764 5689999999999999999999999999999999999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.2e-32  Score=237.84  Aligned_cols=144  Identities=18%  Similarity=0.293  Sum_probs=125.5

Q ss_pred             CCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEE
Q 022853          141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (291)
Q Consensus       141 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  220 (291)
                      ..+.|.+..++|++.+.||+|+||.||+|++. +++.||||+++.....    .+.+.+|+.++++++|||||++++++.
T Consensus         4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_           4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            44567778889999999999999999999986 5678999999765432    345889999999999999999999775


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          221 TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       221 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       ++.+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+|
T Consensus        79 -~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~K  149 (272)
T d1qpca_          79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCK  149 (272)
T ss_dssp             -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred             -cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccccee
Confidence             45689999999999998866533  3589999999999999999999999999999999999999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-31  Score=235.60  Aligned_cols=138  Identities=23%  Similarity=0.365  Sum_probs=123.9

Q ss_pred             ccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEE
Q 022853          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       148 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  227 (291)
                      ..++|++.+.||+|+||.||+|.+. +++.||||+++.....    .+.+.+|+.++++++||||+++++++..++.+|+
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence            3468999999999999999999986 4678999999765433    3457889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       228 V~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~K  141 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK  141 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEE
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeE
Confidence            99999999999988754 5678899999999999999999999999999999999999998876

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.2e-32  Score=239.74  Aligned_cols=142  Identities=25%  Similarity=0.291  Sum_probs=124.6

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      .|.+..++|++.+.||+|+||.||+|++.   ..||||+++..... ....+.+.+|+.++++++||||+++++++ ..+
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~   76 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP   76 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEE-ecc
Confidence            45677789999999999999999999753   35999999765433 34467789999999999999999999875 456


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+|||||++|+|..++... ..+++..+..++.||+.||+|||++|||||||||+||||+.++++|
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~K  144 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK  144 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEE
T ss_pred             EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEE
Confidence            789999999999999998764 5689999999999999999999999999999999999999999876

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=1.1e-31  Score=238.14  Aligned_cols=140  Identities=26%  Similarity=0.448  Sum_probs=126.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++++.||+|+||+||+|++. +++.||||+++..... ....+.+.+|+.+|++++||||++++++|..++..|++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            468999999999999999999986 7799999999776432 23356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+|
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~k  140 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELK  140 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEE
Confidence            99999988777777778899999999999999999999999999999999999999999876

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.4e-31  Score=234.89  Aligned_cols=141  Identities=23%  Similarity=0.473  Sum_probs=130.5

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +++|++++.||+|+||+||+|++..+++.||||+++.... .....+.+.+|+.+|+.++||||+++++++.+...+++|
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            4689999999999999999999999999999999977653 344567788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~k  141 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELK  141 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCcee
Confidence            99999999988888888999999999999999999999999999999999999999888765

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-31  Score=240.75  Aligned_cols=145  Identities=24%  Similarity=0.368  Sum_probs=123.9

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCCc-----EEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE-----IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~  217 (291)
                      .|.+..++|++.+.||+|+||+||+|++..+++     .||+|.+....  .......+.+|+.++.++ +|||||++++
T Consensus        31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            455677899999999999999999999876553     68999886543  223345678899999988 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEec
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-----------------------GLFREDLARIYTAEIVSAVSHLHANGIMHR  274 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHr  274 (291)
                      ++.+.+.+|+|||||++|+|..++...                       ..+++..++.|+.||+.||+|||++|||||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            999999999999999999999998754                       247888999999999999999999999999


Q ss_pred             ccCCCcEEecCCCCcC
Q 022853          275 DLKPENILLDADGHVR  290 (291)
Q Consensus       275 DLKp~NILl~~~g~vK  290 (291)
                      ||||+|||++.+|++|
T Consensus       189 DlKp~Nill~~~~~~K  204 (325)
T d1rjba_         189 DLAARNVLVTHGKVVK  204 (325)
T ss_dssp             TCSGGGEEEETTTEEE
T ss_pred             cCchhccccccCCeEE
Confidence            9999999999999876

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.1e-32  Score=242.53  Aligned_cols=137  Identities=29%  Similarity=0.451  Sum_probs=118.4

Q ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchH--HHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEec
Q 022853          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK--NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (291)
Q Consensus       154 i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~  231 (291)
                      .++.||+|+||+||+|++..+++.||||+++.......  ...+.+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            46899999999999999999999999999976543221  1234678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       232 ~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~K  140 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLK  140 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccc
Confidence            99988776666667899999999999999999999999999999999999999999876

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.9e-31  Score=232.83  Aligned_cols=141  Identities=25%  Similarity=0.329  Sum_probs=122.2

Q ss_pred             cccCCeEEEEE-ecccCceEEEEEEEcC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          147 VGLEDFEVLKV-VGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       147 ~~~~~y~i~~~-LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      +..++|.+.+. ||+|+||.||+|.++.  ++..||||++++..  .....+.+.+|+.+|++++|||||++++++.+ +
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~   81 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E   81 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence            44567999885 9999999999998764  45579999997653  34456778899999999999999999998865 4


Q ss_pred             EEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+|||||++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~K  149 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK  149 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEE
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCcee
Confidence            68999999999999988765 45789999999999999999999999999999999999999998876

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.7e-31  Score=233.62  Aligned_cols=145  Identities=23%  Similarity=0.328  Sum_probs=127.2

Q ss_pred             CCCCCcccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEE
Q 022853          140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF  219 (291)
Q Consensus       140 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  219 (291)
                      +....|.+..++|++.+.||+|+||.||+|++..+ +.||||+++.....    .+.+.+|+.++++++|||||++++++
T Consensus         7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~   81 (285)
T d1fmka3           7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVV   81 (285)
T ss_dssp             SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEE
Confidence            45566778889999999999999999999998765 56999999765432    35688999999999999999999988


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          220 QTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       220 ~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      . ++.+|+||||+++|+|..++..  .+.+++..+..++.||+.||+|||++||+||||||+||||+.+|.+|
T Consensus        82 ~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~k  153 (285)
T d1fmka3          82 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK  153 (285)
T ss_dssp             C-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             e-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEE
Confidence            5 4568999999999999877754  35789999999999999999999999999999999999999998876

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8e-31  Score=232.15  Aligned_cols=133  Identities=20%  Similarity=0.311  Sum_probs=116.0

Q ss_pred             EEecccCceEEEEEEEcC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEEEeccC
Q 022853          156 KVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (291)
Q Consensus       156 ~~LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  233 (291)
                      +.||+|+||.||+|.+..  +++.||||+++.... +....+.+.+|+.+|++++||||+++++++.++ ..|+|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            479999999999998654  457899999976543 334466788999999999999999999998654 5789999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       234 gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +|+|..++.+...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~k  147 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAK  147 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCccc
Confidence            999999999988999999999999999999999999999999999999999998765

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-30  Score=230.01  Aligned_cols=142  Identities=20%  Similarity=0.251  Sum_probs=124.3

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCC----cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  222 (291)
                      +..+.|++.++||+|+||.||+|.+..++    ..||||+++....  ......+.+|+.++++++|||||++++++.+.
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            34467999999999999999999987654    4799999975432  23345688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|+|||||.++++...+... +.+++..+..++.||+.||+|||+++|+||||||+||||+.++.+|
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~K  150 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCK  150 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEE
Confidence            9999999999999998877654 5789999999999999999999999999999999999999999876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.7e-31  Score=230.36  Aligned_cols=137  Identities=20%  Similarity=0.347  Sum_probs=123.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCEEEEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  228 (291)
                      .++|++.+.||+|+||+||+|+++ +++.||||++++....    .+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            358999999999999999999985 6788999999876543    34578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~k  140 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK  140 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEE
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEE
Confidence            999999999888665 46688999999999999999999999999999999999999998875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.7e-31  Score=232.99  Aligned_cols=141  Identities=30%  Similarity=0.486  Sum_probs=123.4

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHH---HHHHHHHHHHHHHhCC--CCCeeEEeEEEEeCCE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN---HAEYMKSERNILTKVD--HPFIVQLRYSFQTKYR  224 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~  224 (291)
                      ++|++.+.||+|+||.||+|++..+++.||||++.+.......   ....+.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            4799999999999999999999999999999999865433211   1223567999999986  8999999999999999


Q ss_pred             EEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC-CCcC
Q 022853          225 LYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVR  290 (291)
Q Consensus       225 ~~lV~E~~~g-g~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~-g~vK  290 (291)
                      +|+||||+.+ +++..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vk  151 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK  151 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEE
Confidence            9999999986 5788888888899999999999999999999999999999999999999865 5654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-30  Score=237.50  Aligned_cols=130  Identities=29%  Similarity=0.480  Sum_probs=115.4

Q ss_pred             cCCeEEEE-EecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHh-CCCCCeeEEeEEEEe----C
Q 022853          149 LEDFEVLK-VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQT----K  222 (291)
Q Consensus       149 ~~~y~i~~-~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~----~  222 (291)
                      +++|+++. .||+|+||+||+|++..+++.||||++++.        ..+.+|+.++.+ .+||||++++++|++    .
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            56899885 599999999999999999999999999653        235678888655 589999999999976    4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      ..+|+|||||+||+|.+++.+.  ..+++..++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~  147 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK  147 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccc
Confidence            6799999999999999999874  368999999999999999999999999999999999999863

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-30  Score=232.72  Aligned_cols=143  Identities=23%  Similarity=0.384  Sum_probs=123.1

Q ss_pred             ccccCCeEEEEEecccCceEEEEEEEcCCCcE--EEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeC
Q 022853          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (291)
Q Consensus       146 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~  222 (291)
                      .+..++|++.++||+|+||.||+|+++.++..  ||||.++...  ..+..+.+.+|+.+|.++ +||||+++++++.++
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            35678999999999999999999999888875  5666664332  233456788999999998 799999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~  286 (291)
                      +.+|+||||+++|+|.+++.+.                ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999999999998754                568899999999999999999999999999999999999988


Q ss_pred             CCcC
Q 022853          287 GHVR  290 (291)
Q Consensus       287 g~vK  290 (291)
                      +.+|
T Consensus       164 ~~~k  167 (309)
T d1fvra_         164 YVAK  167 (309)
T ss_dssp             GCEE
T ss_pred             CceE
Confidence            8765

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-30  Score=228.41  Aligned_cols=143  Identities=20%  Similarity=0.305  Sum_probs=123.9

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      |.+..++|++.+.||+|+||.||+|++..++   ..||||.++...  .....+.+.+|+.++++++||||+++++++. 
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-   78 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   78 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4566779999999999999999999987543   468888875433  3444677889999999999999999999885 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ++.+|+||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~K  148 (273)
T d1mp8a_          79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK  148 (273)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred             cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEE
Confidence            5678999999999999887665 45689999999999999999999999999999999999999998876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-30  Score=228.60  Aligned_cols=139  Identities=24%  Similarity=0.421  Sum_probs=122.2

Q ss_pred             cccccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-CC
Q 022853          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KY  223 (291)
Q Consensus       145 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~  223 (291)
                      |.+..++|++++.||+|+||.||+|++  .+..||||+++++.     ..+.+.+|+.++++++||||+++++++.+ .+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            667888999999999999999999998  46789999997653     24568899999999999999999998854 46


Q ss_pred             EEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||+++|+||||||+|||++.+|++|
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~k  143 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK  143 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEe
Confidence            689999999999999998754  3488999999999999999999999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.8e-30  Score=229.43  Aligned_cols=143  Identities=23%  Similarity=0.360  Sum_probs=115.8

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  223 (291)
                      +..++|++++.||+|+||.||+|++...   ...||||++++.........+.+.+|+.+|++++||||+++++++.+ .
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            4557899999999999999999987543   24689999987766666667788999999999999999999999965 4


Q ss_pred             EEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .+++||||+++|++...+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vk  151 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK  151 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEE
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccccee
Confidence            67899999999999877665 45799999999999999999999999999999999999999998775

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.6e-30  Score=234.98  Aligned_cols=144  Identities=49%  Similarity=0.870  Sum_probs=128.6

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHhCCC-CCeeEEeEEEEe
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIM-EKNHAEYMKSERNILTKVDH-PFIVQLRYSFQT  221 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~  221 (291)
                      +++++|++++.||+|+||+||+|++.   .+|+.||||++++.... +....+.+.+|+.++++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            56789999999999999999999874   46899999999765432 22224557789999999966 899999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ...+|++|||+.+|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vk  169 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV  169 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEE
Confidence            999999999999999999999988999999999999999999999999999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=4.7e-30  Score=231.81  Aligned_cols=133  Identities=27%  Similarity=0.473  Sum_probs=117.8

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEe--CCEE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT--KYRL  225 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~  225 (291)
                      .++|++++.||+|+||+||+|++..+++.||||++++..      .+.+.+|+.+|+.+ +||||++++++|..  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            358999999999999999999999999999999997643      35578899999999 59999999999975  4569


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCC-cC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH-VR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~-vK  290 (291)
                      |+|||||.+++|...   .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +|
T Consensus       108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vk  170 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR  170 (328)
T ss_dssp             EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred             eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeee
Confidence            999999999998654   356899999999999999999999999999999999999997653 44

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.9e-30  Score=229.25  Aligned_cols=145  Identities=20%  Similarity=0.310  Sum_probs=121.4

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCCC-------cEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQL  215 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l  215 (291)
                      .|.+..++|++.+.||+|+||.||+|++..++       ..||||+++++..  ......+.+|...+.++ +||||+++
T Consensus         7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~   84 (299)
T d1fgka_           7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINL   84 (299)
T ss_dssp             TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEec
Confidence            36678899999999999999999999987654       4799999976542  23345577788888877 89999999


Q ss_pred             eEEEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCC
Q 022853          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (291)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~  279 (291)
                      ++++.+++.+|+|||||++|+|..++....                .+++..+..++.||+.||+|||++|||||||||+
T Consensus        85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~  164 (299)
T d1fgka_          85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  164 (299)
T ss_dssp             EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence            999999999999999999999999987543                4789999999999999999999999999999999


Q ss_pred             cEEecCCCCcC
Q 022853          280 NILLDADGHVR  290 (291)
Q Consensus       280 NILl~~~g~vK  290 (291)
                      |||++.+|.+|
T Consensus       165 NiLl~~~~~~k  175 (299)
T d1fgka_         165 NVLVTEDNVMK  175 (299)
T ss_dssp             GEEECTTCCEE
T ss_pred             ceeecCCCCeE
Confidence            99999998875

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.4e-30  Score=233.75  Aligned_cols=139  Identities=25%  Similarity=0.378  Sum_probs=116.5

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC-----
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----  223 (291)
                      .++|++++.||+|+||+||+|.+..+++.||||++++... .....+.+.+|+.+|+.++|||||+++++|...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            4689999999999999999999999999999999976543 3445677889999999999999999999997654     


Q ss_pred             -EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 -~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                       .+|+||||+ +.+|.... +.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~k  161 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELK  161 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccc
Confidence             579999999 44665544 556799999999999999999999999999999999999999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=9.1e-30  Score=227.63  Aligned_cols=142  Identities=20%  Similarity=0.335  Sum_probs=125.6

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  221 (291)
                      +..++|++++.||+|+||.||+|++++     +++.||||+++...  ..+..+.+.+|+.++++++||||+++++++.+
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            345689999999999999999999864     45789999997653  23446678999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccC
Q 022853          222 KYRLYLVLDFVNGGHLFFQLYRQG------------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLK  277 (291)
Q Consensus       222 ~~~~~lV~E~~~gg~L~~~l~~~~------------------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLK  277 (291)
                      ....+++|||+.+|+|.+++....                        .+++..+..++.|++.||+|||+++|||||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            999999999999999999887532                        37788899999999999999999999999999


Q ss_pred             CCcEEecCCCCcC
Q 022853          278 PENILLDADGHVR  290 (291)
Q Consensus       278 p~NILl~~~g~vK  290 (291)
                      |+||||+.++++|
T Consensus       168 p~NILld~~~~~K  180 (301)
T d1lufa_         168 TRNCLVGENMVVK  180 (301)
T ss_dssp             GGGEEECGGGCEE
T ss_pred             ccceEECCCCcEE
Confidence            9999999998876

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.1e-30  Score=228.72  Aligned_cols=145  Identities=21%  Similarity=0.262  Sum_probs=128.1

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~  217 (291)
                      .|.+..++|++.+.||+|+||.||+|++.     .+++.||||++++...  ......+.+|+.+++++ +||||+++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            46677789999999999999999999874     3567899999976542  33455688999999998 7999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCC
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE  279 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~  279 (291)
                      ++.+...+|+|||||++|+|..++.+..                  .+++..+..++.||+.||+|||++|||||||||+
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~  174 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence            9999999999999999999999987643                  5788999999999999999999999999999999


Q ss_pred             cEEecCCCCcC
Q 022853          280 NILLDADGHVR  290 (291)
Q Consensus       280 NILl~~~g~vK  290 (291)
                      |||++.++.+|
T Consensus       175 NIl~~~~~~~k  185 (311)
T d1t46a_         175 NILLTHGRITK  185 (311)
T ss_dssp             GEEEETTTEEE
T ss_pred             cccccccCccc
Confidence            99999988765

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.5e-30  Score=235.02  Aligned_cols=133  Identities=33%  Similarity=0.538  Sum_probs=114.3

Q ss_pred             CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe------CCE
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------KYR  224 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~~  224 (291)
                      +|+.+++||+|+||+||+|++..+++.||||++.++..       ...+|+.+|++++||||++++++|..      ..+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            69999999999999999999999999999999976542       23469999999999999999999854      345


Q ss_pred             EEEEEeccCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC-CcC
Q 022853          225 LYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l---~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g-~vK  290 (291)
                      +|+|||||+++.+..+.   .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~k  163 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK  163 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEE
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCcee
Confidence            89999999987443332   2355799999999999999999999999999999999999999876 543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.6e-30  Score=232.86  Aligned_cols=140  Identities=22%  Similarity=0.323  Sum_probs=122.1

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeC-----C
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----Y  223 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~  223 (291)
                      .++|++++.||+|+||+||+|++..+++.||||++.+... .....+.+.+|+.+|+.++||||+++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            3689999999999999999999999999999999986543 334456678999999999999999999998643     3


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       224 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+++|+|+.||+|..++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus        96 ~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~k  161 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK  161 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             ceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccc
Confidence            4466677788999988775 45799999999999999999999999999999999999999998875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.1e-30  Score=229.95  Aligned_cols=143  Identities=26%  Similarity=0.345  Sum_probs=121.4

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-----
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-----  221 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----  221 (291)
                      ...++|++++.||+|+||+||+|++..+++.||||++.+....+ ...+.+.+|+.+|++++||||+++++++..     
T Consensus         7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            34679999999999999999999999999999999987654332 234557789999999999999999998854     


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 ---KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ---~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                         .+.+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~k  157 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK  157 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEE
Confidence               456899999999887766655667889999999999999999999999999999999999999998876

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-29  Score=230.81  Aligned_cols=138  Identities=20%  Similarity=0.324  Sum_probs=116.5

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC----EE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~  225 (291)
                      .+|++++.||+|+||+||+|++..+++.||||++++..  .....+.+.+|+.+|++++||||+++++++....    ..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            46999999999999999999999999999999997643  3344567889999999999999999999986543    23


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      +++++|+.+|+|..++..+ .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+|
T Consensus        86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~k  149 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK  149 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEE
Confidence            3444566788999888654 689999999999999999999999999999999999999999876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.9e-29  Score=230.53  Aligned_cols=138  Identities=25%  Similarity=0.393  Sum_probs=119.6

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe------C
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------K  222 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~  222 (291)
                      +++|++++.||+|+||+||+|++..+++.||||++.+... .....+.+.+|+.++++++||||++++++|..      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            3689999999999999999999999999999999987654 34456678899999999999999999999953      4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ..+|+|||||.++.+ ..+  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        95 ~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~k  159 (355)
T d2b1pa1          95 QDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_dssp             CEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred             ceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccccee
Confidence            789999999987644 333  45689999999999999999999999999999999999999988765

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.5e-29  Score=224.62  Aligned_cols=146  Identities=20%  Similarity=0.253  Sum_probs=127.9

Q ss_pred             CCcccccCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeE
Q 022853          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY  217 (291)
Q Consensus       143 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~  217 (291)
                      +.|.+..++|++.+.||+|+||.||+|.+..     ++..||||++++..  .......+.+|+.++++++||||+++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~   90 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG   90 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence            4577888999999999999999999998853     35789999997653  2334566889999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ----------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       218 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      ++..+...++||||+.+|+|..++...          ..++...+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus        91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence            999999999999999999998887643          2357788889999999999999999999999999999999999


Q ss_pred             CcC
Q 022853          288 HVR  290 (291)
Q Consensus       288 ~vK  290 (291)
                      ++|
T Consensus       171 ~~K  173 (308)
T d1p4oa_         171 TVK  173 (308)
T ss_dssp             CEE
T ss_pred             eEE
Confidence            876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.7e-29  Score=224.10  Aligned_cols=145  Identities=22%  Similarity=0.337  Sum_probs=118.3

Q ss_pred             CcccccCCeEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeE
Q 022853          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (291)
Q Consensus       144 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~  217 (291)
                      .|.+..++|++.+.||+|+||.||+|++...     ++.||||+++....  ....+.+..|..++.++ +|+||+.+++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3456678899999999999999999998653     46899999875432  22344566677777666 7899999998


Q ss_pred             EEEe-CCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCc
Q 022853          218 SFQT-KYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (291)
Q Consensus       218 ~~~~-~~~~~lV~E~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~N  280 (291)
                      ++.. +..+|+|||||++|+|..++...                ..+++..+..++.||+.||.|||++|||||||||+|
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N  164 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  164 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence            8765 45689999999999999998753                247889999999999999999999999999999999


Q ss_pred             EEecCCCCcC
Q 022853          281 ILLDADGHVR  290 (291)
Q Consensus       281 ILl~~~g~vK  290 (291)
                      |||+.+|++|
T Consensus       165 ILl~~~~~~K  174 (299)
T d1ywna1         165 ILLSEKNVVK  174 (299)
T ss_dssp             EEECGGGCEE
T ss_pred             eeECCCCcEE
Confidence            9999998876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.3e-29  Score=223.33  Aligned_cols=139  Identities=24%  Similarity=0.369  Sum_probs=116.7

Q ss_pred             cCCeEEEEEecccCceEEEEEEEcCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCCE
Q 022853          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (291)
Q Consensus       149 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  224 (291)
                      -.+|++++.||+|+||+||+|.+..+++    .||+|.++...  .....+.+.+|+.++++++||||+++++++.++ .
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            3579999999999999999999988776    47777775432  223356688999999999999999999998765 5


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       225 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      .++++||+.+|+|...+... ..+++..++.++.||+.||+|||++|||||||||+|||++.++++|
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~k  151 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVK  151 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEE
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeE
Confidence            67888999999998877764 6789999999999999999999999999999999999999998876

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.2e-29  Score=222.45  Aligned_cols=143  Identities=23%  Similarity=0.388  Sum_probs=115.7

Q ss_pred             cccCCeEEEEEecccCceEEEEEEEcCC-CcEEEEEEeeccccchHHHHHHHHHHHHHHHhC---CCCCeeEEeEEEEe-
Q 022853          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT-SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQT-  221 (291)
Q Consensus       147 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~-  221 (291)
                      ...++|++++.||+|+||+||+|++..+ ++.||||+++........ ...+.+|+.+++.+   +||||++++++|.. 
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            3446899999999999999999999765 677999999765432211 22344677666654   89999999999853 


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          222 ----KYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       222 ----~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                          ...+|++|||+.++.+...... ...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+|
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~k  156 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK  156 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCee
Confidence                3578999999999877544443 45689999999999999999999999999999999999999988775

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-27  Score=214.90  Aligned_cols=136  Identities=19%  Similarity=0.243  Sum_probs=116.4

Q ss_pred             EEEEEecccCceEEEEEEEcCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEe-CCEEEEE
Q 022853          153 EVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KYRLYLV  228 (291)
Q Consensus       153 ~i~~~LG~G~fg~Vy~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lV  228 (291)
                      .+.++||+|+||+||+|++..++   ..||||.+++.  ......+.+.+|+.+|++++||||+++++++.. ++.+|+|
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            34688999999999999986643   36899998653  244556779999999999999999999998765 5689999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCCCcC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      ||||++|+|..++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+|
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~k  170 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVK  170 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEE
Confidence            9999999999887754 4567888889999999999999999999999999999999988775

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-27  Score=213.98  Aligned_cols=134  Identities=25%  Similarity=0.357  Sum_probs=113.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCeeEEeEEEEeCC----EE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~  225 (291)
                      .+|.+.+.||+|+||.||+|++  +++.||||+++...    ........|+..+..++||||+++++++.+.+    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            4799999999999999999987  67899999986543    11222334555666789999999999987654    68


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--------CCCEecccCCCcEEecCCCCcC
Q 022853          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA--------NGIMHRDLKPENILLDADGHVR  290 (291)
Q Consensus       226 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~--------~gIiHrDLKp~NILl~~~g~vK  290 (291)
                      |+|||||++|+|..++.+. .+++.....++.|++.||.|||+        +|||||||||+||||+.+|.+|
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence            9999999999999999765 57888888999999999999996        5999999999999999999876

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.95  E-value=3.4e-27  Score=210.02  Aligned_cols=130  Identities=20%  Similarity=0.294  Sum_probs=115.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCC-CCeeEEeEEEEeCCEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lV  228 (291)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....     .+.+.+|+++++.+.| +||+.+++++..+...|+|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            579999999999999999999999999999999865432     2236678899999965 8999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~-~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      |||+ +++|..++... ..++...+..++.|++.||+|||++||+||||||+|||++.
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~  136 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR  136 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecC
Confidence            9999 57888887764 46899999999999999999999999999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=7.5e-27  Score=207.94  Aligned_cols=131  Identities=18%  Similarity=0.303  Sum_probs=110.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCC-eeEEeEEEEeCCEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lV  228 (291)
                      ++|++.+.||+|+||.||+|++..+++.||||++......     +.+..|+++++.++|+| |+.+..++.+....++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            3699999999999999999999999999999998765322     23678999999997665 55566777888999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecC
Q 022853          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (291)
Q Consensus       229 ~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~  285 (291)
                      |||+.++.+.......+.+++..+..++.|++.||+|||++|||||||||+|||++.
T Consensus        82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~  138 (299)
T d1ckia_          82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL  138 (299)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred             EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccc
Confidence            999966544444445678999999999999999999999999999999999999864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.89  E-value=2.7e-23  Score=188.83  Aligned_cols=135  Identities=23%  Similarity=0.389  Sum_probs=109.1

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-----------CCCeeEEeEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----------HPFIVQLRYS  218 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~~~  218 (291)
                      ++|++++.||+|+||+||+|++..+++.||||+++++..    ..+.+.+|+.+++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            469999999999999999999999999999999986542    2345667888877664           5789999888


Q ss_pred             EE--eCCEEEEEEeccCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecccCCCcEEecCCCC
Q 022853          219 FQ--TKYRLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGH  288 (291)
Q Consensus       219 ~~--~~~~~~lV~E~~~gg~L~~~l~---~~~~~~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKp~NILl~~~g~  288 (291)
                      +.  .....+++|+++..+.......   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.+|.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCc
Confidence            75  4567778888776654333222   23578899999999999999999998 89999999999999987653

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=5.5e-22  Score=165.08  Aligned_cols=124  Identities=16%  Similarity=0.198  Sum_probs=95.8

Q ss_pred             eEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccc---------------hHHHHHHHHHHHHHHHhCCCCCeeEEe
Q 022853          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---------------EKNHAEYMKSERNILTKVDHPFIVQLR  216 (291)
Q Consensus       152 y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~---------------~~~~~~~~~~E~~il~~l~HpnIv~l~  216 (291)
                      +.+.+.||+|+||.||+|++. +|+.||||+++.....               ..........|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            467899999999999999885 6889999987643211               011123345688889999999999877


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCEecccCCCcEEecCCC
Q 022853          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (291)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~i~~qil~aL~yLH~~gIiHrDLKp~NILl~~~g  287 (291)
                      +..  .  .+++|||+++..+..       ++...+..++.|++.||.|||++||+||||||+|||++.++
T Consensus        81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~  140 (191)
T d1zara2          81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG  140 (191)
T ss_dssp             EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE
T ss_pred             Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC
Confidence            542  2  279999999875422       34455677899999999999999999999999999998654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.11  E-value=5.9e-06  Score=69.25  Aligned_cols=84  Identities=14%  Similarity=0.093  Sum_probs=58.8

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-CCCeeEEeEEEEeCCEEEEE
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +.|++.+..+.++.+.||+..  ..++.+.+|+........   ...+.+|...+..+. +--+.+++.....++..|+|
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv   88 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence            467877776666668999875  356678888876543221   223566777777663 33356777788888999999


Q ss_pred             EeccCCCCHH
Q 022853          229 LDFVNGGHLF  238 (291)
Q Consensus       229 ~E~~~gg~L~  238 (291)
                      |++++|.++.
T Consensus        89 ~~~l~G~~~~   98 (263)
T d1j7la_          89 MSEADGVLCS   98 (263)
T ss_dssp             EECCSSEEHH
T ss_pred             EEeccccccc
Confidence            9999998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.65  E-value=3.7e-05  Score=68.88  Aligned_cols=80  Identities=11%  Similarity=0.129  Sum_probs=48.4

Q ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEeeccccc-h---HHHHHHHHHHHHHHHhC-C--CCCeeEEeEEEEeCCEEEE
Q 022853          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-E---KNHAEYMKSERNILTKV-D--HPFIVQLRYSFQTKYRLYL  227 (291)
Q Consensus       155 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~---~~~~~~~~~E~~il~~l-~--HpnIv~l~~~~~~~~~~~l  227 (291)
                      .+.||.|....||++....+++.+++|.-...... .   ....++...|...|+.+ .  ...+++++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            45789999999999988777888999976431100 0   00123345677777655 2  2345666543  4555678


Q ss_pred             EEeccCCCC
Q 022853          228 VLDFVNGGH  236 (291)
Q Consensus       228 V~E~~~gg~  236 (291)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.49  E-value=9.4e-05  Score=61.28  Aligned_cols=78  Identities=15%  Similarity=0.114  Sum_probs=51.2

Q ss_pred             eEEEEEecccC-ceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC--CCCeeEEeEEEEeCCEEEEE
Q 022853          152 FEVLKVVGQGA-FAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD--HPFIVQLRYSFQTKYRLYLV  228 (291)
Q Consensus       152 y~i~~~LG~G~-fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lV  228 (291)
                      +.+. .+..|. -+.||+.... .+..+++|.......      ..+..|...++.+.  .-.+.+++....+++..|+|
T Consensus        13 ~~~~-~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          13 YDWA-QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             CEEE-ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CceE-EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence            4443 444444 3678988753 456688898765432      23556777776652  23356777777888899999


Q ss_pred             EeccCCCCH
Q 022853          229 LDFVNGGHL  237 (291)
Q Consensus       229 ~E~~~gg~L  237 (291)
                      |++++|.++
T Consensus        85 ~~~i~G~~~   93 (255)
T d1nd4a_          85 LGEVPGQDL   93 (255)
T ss_dssp             EECCSSEET
T ss_pred             EEeeecccc
Confidence            999988654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.18  E-value=0.0043  Score=53.32  Aligned_cols=67  Identities=16%  Similarity=0.259  Sum_probs=42.5

Q ss_pred             eEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCCCCCe-----eEE--eEEEEeCCEEEEEEeccCCC
Q 022853          164 AKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-----VQL--RYSFQTKYRLYLVLDFVNGG  235 (291)
Q Consensus       164 g~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l--~~~~~~~~~~~lV~E~~~gg  235 (291)
                      -.||+++.. +|..|++|+.++....    .+.+..|...+..|....|     +..  -..+...+..+.+++++.|.
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            589998763 5778999998765322    3345667777766532211     111  12335677889999999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.15  E-value=0.029  Score=49.15  Aligned_cols=77  Identities=12%  Similarity=0.137  Sum_probs=49.6

Q ss_pred             CeEEEEEecccCceEEEEEEEcC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHhC-CCCCeeEEeEEEEeC
Q 022853          151 DFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (291)
Q Consensus       151 ~y~i~~~LG~G~fg~Vy~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~  222 (291)
                      ++++ +.|+.|---.+|++....       ..+.|.+++.-... .    .....+|..+++.+ .+.-.+++++++.+ 
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~----~idr~~E~~i~~~ls~~gl~Pkll~~~~~-  116 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T----ESHLVAESVIFTLLSERHLGPKLYGIFSG-  116 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C----HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h----hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence            4554 578888899999998653       24567777764221 1    12244688888877 34444577776642 


Q ss_pred             CEEEEEEeccCCCCH
Q 022853          223 YRLYLVLDFVNGGHL  237 (291)
Q Consensus       223 ~~~~lV~E~~~gg~L  237 (291)
                         ++|+||++|..+
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               588999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=91.46  E-value=0.7  Score=38.14  Aligned_cols=79  Identities=10%  Similarity=0.143  Sum_probs=40.6

Q ss_pred             CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHhCC-----CCCeeEEe---EEEEe
Q 022853          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----HPFIVQLR---YSFQT  221 (291)
Q Consensus       150 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~---~~~~~  221 (291)
                      +...-.+.|..|---+.|+....  +..|++|+.....  .   .+.+..|..++..|.     -|..+...   ....-
T Consensus        18 g~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~   90 (316)
T d2ppqa1          18 GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   90 (316)
T ss_dssp             CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             CCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC--C---HHHHHHHHHHHHhhhhccccccccceecCCCcceee
Confidence            34555667778887889988764  3359999986532  1   122334555555442     22222210   11233


Q ss_pred             CCEEEEEEeccCCC
Q 022853          222 KYRLYLVLDFVNGG  235 (291)
Q Consensus       222 ~~~~~lV~E~~~gg  235 (291)
                      ....+.++.++.|.
T Consensus        91 ~~~~~~~~~~~~g~  104 (316)
T d2ppqa1          91 SGRPAALISFLEGM  104 (316)
T ss_dssp             TTEEEEEEECCCCB
T ss_pred             ecccceeeeecccc
Confidence            55667777777664